ࡱ>    | ~ nɨa3PNG  IHDR;] jPLTERSUPRU[]`egjpruNQUiouMQUbfjORUmquy|z}fhj|~ըgcffcjfiheJPUIOTmlikhkvW\`v{y} r q p p on knz*Hr^ej԰{~ s s v q n u w x syxwtz{vw|}x~}~z| ! #&()+/9Pc҈ݡGOTrz  t{ޜw| ߼!!! """!!! tRNSS%bKGDH cmPPJCmp0712HsIDATx^y\I߉MLu2Ȝ6VǠ!-WD23Ս2#ʖ4ӚfjHKvp.Wǒ]J(iIi9S]3дKIKQJ4㘵~?wEx/<" )z/%Ž=&HHHHTv.Ez@z@z@z=?B!оv;Kn]z@z@z@z@+e?^bY;37"= = =@=UBiVHHHH\\Lߒ"= = = =0=`3_`CzWz@z@z@z`v{ &6;1ygŎHwBeb 5  ;@4x ;!Ez@z@z@z`{R!cQ+Nz@z@z@z{f7HHHH|C®kvC)salY)v-JHHH A;S<@|F_.\gvHHHHIg#옓/M>.\vIz@z@z`z F\1_y;DXxlۿ!Ez@z@z@z`Nzob~N:Lަvȗ@z@z@z@zjDcoJv7FަHHHHTh׫KHHHbYG)Žy}JHHh?IŎ"= = = =0/=yX[a>hHHHHKbǿ2/&Sz@z@z@z_Ŏ%})= = = =07=_"= = = =0/=K)1/)= = = =/ ;K = = = =Pb_+RboK+HHHHK;哖)= = =_"= = = =0/=k)"= = = =0/= 옗OZާ@vKiIz@z@z`^z ;(Ez@z@z@z`^z ;`^:Lާ;$= = =0?=?"= = = =0/= 옗OZާ@Ŏ?wKҒ@{@HnOz@z@z= "$= = =Ŏ.Ez@z@z@z`^z@1/Ox= חҒc^>iyz ;?"= = = =0/=S)Žy}JHHhIƎyaǼ|>@,v| Ez@z@z@z`^z ;R+Ez@z@z@z`^z@1/Ox=.ow]܊GG{}(:zso7Exo7ߛ{@A܉Bw{>~_vb]|c|?tmbÞۿvW۷ߠ/+Arg}:(w#nܿk=ޞX#כ}U'So>rlM5CA+;@*{uin;WuI kw[ߥS?~8r:Ӣ_ZyS[8}yтw2yJFi4;*i~ܸy#+&1;%!w䮓rHSb<oL3{^"=]j_{ 6 w>~Bv_[IFS~z'cEri?/?KFPkQ[_7v `WP~GީPaM9#ۍk'~d&M{cWJo1-;^}ۉhBK EobPhAC)ȯ+^~k@`H=]F|N~ACn/D{νm(PDo%b!5u%o/ݹ7t_3}oppH}Oz_%SKf$fj+;߯a+׭#-?oOv+S}*:BOh~g_$?.8wdiFkos8]ٺ{&}G8H/x? f q蟻ǭlQwńDWu\wA?t?㟂ŝ Ă61aq\Qf!zI>e?#_1c{GT/PW$ 0 X*pۚpopMxEf(w;w nߡVwwwӅJ#+c {/שSwFs?5W眴pK?2Ff: /tCxrXD .ӟ$7UUZVɽIZ۱:G~Ʃ[C%/Mݿt穛7KWOl?6gz=͎? ||/ zTQ_"QS˔nɷC+7/x[Oݿˊ+;I4vnJŽ}vե|5.]vCC'_ܗLʷz9tUKNs{?/~wd[^S3hKEن8!#;EkOo_[β| vt%lEڭ!}kbU|ׄ'D ^{'ű.abg^/9Vk.f~;/>a gAr|eogE>m{ a"4=˽ كnv|Ɋl+~঒ك^ො"jfy6w۾ {/Y3vwLvjhGհ;wD\Fg(}p`Zzt.vR`c&L?,({@[!ȞR*5(rʍ<K˙me"fb;*]-qf~]PM'Qc<jUZ^Ɠ?{?Toj_}Aݔe~'iS=h_IFj~}bNkjnã(vɥ^a޲̌k|/ݯR)RR3߃1l'Czmߣ'х'|G8ڑ)=#趕k37fDxC}庰#I'aGo\rGsW%M)rM7RA0zn@?&r$=hĀ^w8@yJ^kg<-Kova7}v졕?{pM%qk}x4ZXSO5:uo6i87;SR~Hu M3Fѥ{e##_{$;,h[1&~~=l}a ?X ׿_0?#|/>ϲ㇙b~|/;T(O#UU%vjuwH˾qyo׼[tLЦ w0o2Mlc0O?H~rSzov!^A%݌zKɈE#< ^*_xn,s$;Wm߃j۾~#rz^E~y;z-P}-S]?6=K ZX^Mxbf ;ݯ s߉ײN0*}ۆAa;l:޾vao;T- 0k)>QcyvwWl1-uP窾鷹{1_C$CsY|#'%a5q}_p6Kf"ItW3(t%Î&w"۫ckeG )_3Wk:w<%%xHd6*Wt /Tt;v& nt~!r_q]z5`ƼqwؑM}N؇]:2h'SLTgu(U~]/[eviu-^ٟ)PQSéjۨ~=F^/Ejv_OV:[hVLү 8ҶߥK?Ե|3/GP)(a]͜MB*׌Y*K'f7{ +K_~nMJ9vM>P'nߊDOng^y4p|n\14-xnǺ%;1>?՗O2;r;;+m@[OQ5>Cy[eef^#GO5W9c?PiS\ +$s˓_~d<ܷM2eC}>g~N^@+ 6q:^E b+*7o7i^@bO7ݼc-s'Ik$Ce++26^w^-v̭w̟>GO^6aِۛto,k(UW.M7K3F祩\L'kCʼSsk;/(/s0v^/_lZ ;2k2IsdJAe%:gmIaHAY*x֟Sf2oSsrHXc#gsMW-%Rb)kt㺡*ֻ;ߎ}w){yKE օ ;*앤Slig4Vv;OHu`/KY G U9CQZ=ZN1zM տu[mV.m=Ԝ7e;bEc/EΠBK5?Ν~\ic*#AjNӇ {;_HWMBys ˎ@$6kſЯ~󵴭 `'ZP>@h2߱(Qr6_y[{z|w8 ˫(k8&kfWd8=S]wڡj v*\tm8wSo"vۄ\c;n8ƒZІEcM |5N1;;|\%P>?V<_"X_6)5վ֦[Nݻ̷]oӗv{QIӟh~d0 ~O"wEKuiUNE&nǮ@ZEys^mLf;۫zP]`O︯T/ oqm?KqL3Kb#WeX[w?"+6NMUwrzC5svVؑrS_:(Ux\2bؑVIr gG0wrQ@0:5[ʩPX7,C1}ySv(PQ ]=*zzc0LD1#,sdu+;`Mu~HqSG*PEݾz3LKC/9sƇ+Hx'׹Dw2]α@v fY ?}0Wp G|G|nK;{h]ܟ촳0{;ULq]I5wq93tx [yz'ђ>PobVF p+Eƴ A!DwRMv^ͭΓU->zFC+ږȡ&9_k3`q3mK2,%rvAp w$Mc;~@/en9WtCO?]vbv+^}`Nm!lx-uu[U8wеXXffˎPFPm p:/!S;{\EXxvwc;OK%w|ژ[vxڰe5s neɍQ7~ysp.;zxEJۚn/tSW ,}6F.ӂ_OGCxgo/SCslZ8 7EMm?Ko~v9dPhPc<t4ƺy j当7$ pLwvoO)aXL^@R:9+ RF8+Č[7ɌThH5?ٚLaHĎ%ʉ_;;r̻!u+qLxLT8\y<*I ?Gt8s>b8-t7neGsJv}9L[9_=VVWSEܯAspi\BzMKhOަҸx^:='ivחLcIEU cwdݝ[88'k1.um_MaeU;' `ҧe}9 `g{G| O0>|s,yP:A<{[OZ75P?r ~c*xܷf.dlЍ%g Ӏ䧏;l2Cmf, }sIS 9%U˾k?u7lߧQw!M+Ίv]{nǺ̟L?cȣ}nGR{؀1F+̋;ޱ;h^N۝V#(%;3Vgst: '0-Reԗ_ES^ q!;|J2ثoD_dl4Kw^UEKIR~u;Y#R[T>\bW_gԏ=N2f ;=$-|*L9?s?xn_Eք: ί?U"9r| 7;Faks;evr9t[c-sS9 `id^؁'?A` ϙpS/2=`T_H^bM`< ݗg͗|_?=Cm2R:gs('G5p{׮ߐ79{~'y /uGjFwF"^w#WTu];" ;?N)F3 #U4 jT kʺYa~r h6#nGnreJ{'_w7=k-m`ι})V ?G-]O>9KԢ6b`Ӿ>~FV{6ź]a}Mco w k[}vJ@ `F;J摘9֍mSIE7ҍ#K; Ɯ9/3X@28yӕ M%|!3([wގuk9MsNp @ɼ ~E]c/v q쑂:`o.(q(aN_j .XxKvwiS5dѸ_;k*2g5.l]7QNWGϢWNA+euiqJMQ$;y]Qk( =%=,oTݟ4V]2 GeBi s/{<Moa0 v3n ˲ ]i ,խ[zn&WUv8'v9-sܜR*7}6T|{MR[jADn7UR?k^|7}cd'Ӷ^Dtb+؍O|V!-+ّk:fpݻJ^Rwp7[z;IS'לQNA]w蓻 6 ߿o[1/o Vx%cȥ>KTvP]M黪 |ɹɼ\JKdN't:"f7_v12L7m>UK_tDq%ͩ_o67f>s6Mͅ? *9|'p7W/ܜv_Sq \f;~~d 筀{֟C-T'Y/&ؑH}YvE l&<آ.]F805j0C&^7G۱{.{kc#wਪQ߸ 5 &_/eP؀];ُXPNLc*xKT#*1_z߯,*w[֧:7Krt卽M^ QW jY9T[MR!3a_Fw| ))U";=cbfG47}w$,;չ oYfѱIXt nz,쏜Λ__3$ (llbH )!~cCDSs*JPkMoGg&6ڿTaG2#gxއ!cueBo[ʣʇERIO\[;Έ4N) z^h6q7ƩKl2ٷ}߅60ߢ>㘅nT}KFZӼ+[37qceّƑzm1/;ؠd;ܿ_Cj(oE{M.H,vl7)>x.޽} |l_V}=m1(Wy.po4П*ܵ*LYpS%,? %߂K_2L˥߻Ooxw2v.\tsO$/;2"t h* [=/^ S[/ޠ{>L3;N6;ϑ<} _/(]f>G~~A_xv]ܿXf_~bUi&Âҿ8!&щb~MiOzw=@nqG{r6;3]7#K{nK@Dcv7ݷD-oW?ȻB 1lDc p[[$zVVz`z"gCƎұðkm{"÷y=iUz=g8޿y񟛫'Zy= !]aGO'=~Oa&꟩՜TPݻ3F ;j}ҩ)ܮ՚T]E'*y=`vGXA̺񟜧kyy=gO5Į= eW;uZ:s`uyŽmAϢfGJ9-g[Ŏj̼݁\6o^޳@prol-hOI;Fzfz@1k{@~+HHHZ;f#= = =~b?HHHHKb?>:!c^~m:;Rb?OJŎz^:Lާ?;$= = =0?= 옟Zީ@ƎyaǼ|>#^_JKKv'-Sz@z@z ^;$= = =0/= 옗OZާ@vKiIz@z@z`^z ;)Žy}JHHaGIŽx})-IHHK;哖)= = =?$Ez@z@z@z`^z ;#a)/&Ez@z@z@z J\ƎrM_?jZS~VS~V> +ʗUUʓɔs٦ͦ8Lz W.F+/hJ:utq:Qt|1[x2QttiFWUafJSG";/:ZDɨlS88㌠CA):zÎˎ0Ӊ9> sX=ĎJhBGo :jɎacךXum+CБj3CdG5=;{Dv>:zŽ!\Wʫi1;屒hvEv*`gVSʫ; ::c5h]vtdxBD;841yEӋݦ@y.M’f9P.Cwk O>XM1iY~nY(o>kRܤ);";"ydFxE<"E;S[vğv4EȎO A E;LvDB(Êc17$;$PJ Cf؍$;P(hʎ=V+e/;$?9@`G/eGM!^{U}t 741mOj u>VޔYȪ옳y(hG-Dmd/;:;CdGeGh袆݄rS!ttGG咟J g)::汒VR>cVڵC "(@y4OV  tBYȪV V-R4F5$쨌 7vBVYȪ:djGN*"]ǎ[M]Z˴P1!vrj(Xfp!VTG}Vs%P.;>Q2# vUb孳CdG2a.+ Hc\?l|::j,Xuc%UL;KSv]X"&Sfw%?wBCdȎjʛCf7ȱ벐U5h-DDeUGgՔ}(@y]'ʎOi*֝M!ײ#4tQnB.+ Zк]eܠ#@y(E&E;fl!(l"hc%;>3PxB!O>6Exz@ʛ>DDe?jX;PvMѺ4|nseǧP!Rl=$Hv4]2* JQ";z-;BC5:ﱪ쬠H Ae/jdG!;>@%5"/YSvԐU:/;c%#2L*V5b*%1tH~XyEkE&E0h?@yh,d\v";<$lwtt1!ceGaל A-GG/Sel`ޣh]Y?7Ҍ/\V%;uؗڐ(4dnjT$0yXydǧ P(r"͝UԂ-;sr K<6Y5e%P "*W!c9v4E(o2)2CVQ~Tt;";$P.;>ŽO4FRsjȎOhG*EP e4rY(,D*gޭXܠ#KNj "dTâC_#2)&>Y3[hc%;>ɎOeCdǬncndG5TȎXI!*U_ut|jN鎦h]vȎOd("hN O ;s܊\7QQ51_cF!r ˎODiYxkkIP"Mf wd`Sc%rXECJ} Qf'tG@y`g'Pxێn O!PޕZgʻ̎JBqID}Q1!3sTJuFewT@h W_.莹A$v`٦7%; a&k!HY5e? Rȕji툆:1u~ ):d!юU-jpO*!%E@h(l>Ԝ vEvDX}u0!@ANCv|ƎO3vjJ!Q6s&;"C^,DhuY :"Ɏ#0!cvdxUֱCSQ.;>rhE]أ|yVM! Y51TCc9Aǫ 6lon/v̘'VUhT|VM!ю/deAkAXt kzSvHG3)6E;n+S&̎Cs'?w1yvevĘ >n;F}Qa-g4MUǛȎ$iW:;dǧގOrU:ء67:dF?Q Js ;&;(/;ַ-v<$iA5?[P ˽Sz )TRF;fLvAPB]$3OLzݦ@yhG@G2쬯G1<*>/ x}}}OČ=}p*d{J!AG=tLM!~;-Yivp,::GȂĒc`}mBJ}tH\A;";"-E܎} y!+;V>ǏnЀ*cUs&#dH}P[qw`>;(hN +;>Mk^Ȏv])hK$P0`bM/H5UXOI-DQ+*;*|1xܠ#S?١lD+k!r?K=VSw|Jt 47.c:ȵH\݁h* 3;\CvMFAK>AhcndG5ǔR<+#WXe18;qb Q(ok~Th-p:h]vȎOdG@ (a;d%raG4DU e$uGStH~nsv\SWyx &S'XiSs&;d jDCDQC>A1:&ȎCv|jkwjŚԚuINI2Qr塏i ]X L|Cv|j Q rt@`NxnQNkxablXԗ@GWvYE-APB(%crCQ->)ݱ|Nm^Jb ޣGZ|>Ghvy/v t̑˪?@yhG3ʣ$N `Ò5IԲ$;jP ";x vOcrsEv̵XU]aIӵJQn+t3+^(!V~Tt4XMCv|jkǴs/ObĬV)aRUUb#<ɎXICpՠ,1;cz;>eMTV_vH\dG4OVT2x+GDŽAGcttCvTHUԵ;fLvTGkᱚ@~j C*70jB_@tM^t~Z )2:zS h*Gc )^'STǪ'숴TBǼZ,7[95dǧ4ٵEvH~nm5ص#lǧ T& ZCcf&ѺJ5L}UUSc%Y-utGύ:9Zώ*2:;5ChMёQ-(?NR;P>†:DO> +ajs;*M A ՜CvxWatR1;f,?^8S$ɪ'hʎ/Ď-~G ;@|F?BYtĕm(875:G;Dv"F;s): gرÎ ;DvtLvGe xH Ӣ˪XySv(;aɎo|csp[m,90v؁r͎JTauHUS볣H95dǧhSv@)LQ ?aH8;!X!k RLMohgit;١ƍHo8$N~aƠyp1tȌڣi~Z XySv#ŎH EQdy8v ϽQ c`v5>Gv(pN9Y+i3뾲?ۯi9V9IX~ q,*ʎvMѪNJ؁P9eqruHo/*mA0ߢtiũe@Tz|)WL]\ZX.o]6:[D9(fŊ_$A lmhv\VtN"ʎ6s+ Žc)r?/11vTEG+#' p{?LhHMLNA4% \'Y&fAA'h]Gaʕ8UӅR*k<K\QJO0;Cv<=%;0Hw%QSSpUV;iWg{b傎I3+;>bI$tN^ÿnaL#hBJ#C)aߟ9 窉t򧙔){fY*מߡZW;/d"ԗ7 v傎 :rK 5a2yN2nzV)%Y1;~";r1#;> ;L=V,;r%;I<%vUX0/u^F1-vt6?TzD!M옦¥숩;";rرH)]GbGj7('hDvLJvGG/(@y=Dޒ<ۜwj0h]vES'$Czm+{@wZgzuZ*n3<mNhǧ;$P>M!r d6VuGodnIZT#:8JaQ3; XAH Tq94ʞ-pqVQvP)gG:^oqY/"̙Y-Rd+EJר+k0۔>ejUrtt3 8s?0!X'}AGfL&cIV(vxEߠ:;W)570J 5#.;$P^~Cs~2x-; :T&8[<KMTM-zDvTMv kJpqf4}fMnUN@v|*wZ"hG\xBTF3ǎ֣V#z+<o !MG6WC0hCvDNkQm::&';!Z Ni$P>=ϝ1.?zUkIC'ŎbCQ)5TȎeGG-t+,ct#P``-݄6^˽=c2Tj|`pƓicd5 @]'W'tX+6L:;f*P츹wsS 9_X߇8ƃ';'Oƻww tg>9gP j:|4QsȜXI~&mC=dd=Vc3c;?^*ç:;V6Xa@ CD S6 ; +]A@a4+p萅jutcǧnvOvCVs5Hq쬃 v(IjeUiĘx7me؁C=S-'O gPE av7 5N66hAxdXj1H'1Xħ;ȕ-ut8\JHÍsC#JvKM4 oDbGu0k:i.HCfFVc5xD<hoB<V+WIcxC~Ͱc-,h˞*kv >,vNsz]1q\T<8\qUo^%h5zl,  7J0IN({\Jw(vxX@v(qyc!SuG3vl, "R~*f}UgCoaC/>COYS,S  +Pqge؁(`oOebݡ2(l1<v(wuG.;@n@C,Uީ;eJCSA]yVvh*;cU,ʡʹ}VSGG(.d}V"Sobe?>[D2 6; XP]iV ;.8R| ɺⱲGuMP*ESϳ:;z ؛@;HAŽ}>&찲oHR.$؁! ;[xM |)CdG-ȣ͔u#O̭xL« 5@",vP{o>Ơ:<9BUucAY`wp8řVӷ6 j:1o #M=V(Y*WL>tH|i`| S1;B+Z* JvHХQ̄z st 2@<9ó:4mE(mU=8CvH|ތr7a髵2P].+;>5Vl"Pc9}(o}!Bt Ie)OyPt4^>c+YȪ;>ud-D;Dv4} 'x?BT%DA*6Mј(JcU5xCDRT+5/vH_%aGCjN;P9&/ ";5WLV;|ՄQ)P{5KDD~!r GS#>EDtL>ttEvH|zV)Rv4p'&m;DvtYv^ȪO@/{=(j?Ǵ :"ɎEd~gx5%;$P.ю vc%;>3PxB:$P.:;|f!PpYM}jGǦAPݢKjpǧ e &Y87uvDvH#R\v| M<2Cx* @k";Hzf师.*e $(;vYh& rnfމ܀E&{ &X*Bd} ;bSQ#aVɦ@v0Ap|]~ Qݢ qrM>t4(@-C0; 5|'&aW>+`.gI,2EpCUh"vc:r;DvtYv.jصcv7 v^tWf!"f c O~!+01 iO8w2;L;s W^*jʎ ˎO=i;Ύ r=Zc&n~4(vUUdp9Tq lL2hXǪgԧ!\tȎO;>W03;\v؁+J6enj?[rI*ʋÇ O8ѕ\ 4@UkP&AV:Gͳn03+;Cd%> Թ.cs}@ѩs!v 깁;pʟ.̎}~zsaR1U]YPq@f'ʇ O>Pn)& w+&h~IUsUڕ鿀 ' X9P<7p#ΆOfJ|fSseGo\qLLq'w`Cz90k4tv$S\Ê2uya+("I =(aB_֓ʧHk bTݢ5l& :")tQCg VVOa-&`1+,Rs>IiY\-(h+}N]SvHa"5Re+N>+}y"9z*dq!ϛqCdG-H<!jt*PQ"()CDGw|@:";"ydQ5ci R|ұr;DvtYv]vT-S'jM2tD(ȄрU!XGkXԂ$YBECGcT-ѕ'ĎcJs#Σ ocq0J!.{i2쨏:6TL)ѺɎ9˱Jd"cv|F";,;BC5&:@c g5utȎOANiD;fc%3cb>Cv|jr"Je4!+ 1]11v:dǧ&P;fLvAPݢ tH<8P>9CG\ W w%?wh6-pgI@y!.%?@(jEQYEvDQ. Yu, ɪ5غ);fc% OgcȎƲC^/q+!+Xy~JD(@y1A Z>)YȪ" L>tH@yY]dGm#^ *gcx&̎9XQ.Zdi=P>#;>MtM:";$P˔аwu;uc5uYEڶ#@l'+CdGeGu$ט;ˎiXI밒5WXMbM#B1!tH~;s:{dǧ~eǧ.{dǧpb>vǪ+Q^o[d4!ZrYȪm쐅Ɏ9˱Ǫ+ dea7hG@y/s#XJEG>+hS];$YE{(-뎩Cv|jr"JeG8G5!#.C! YBVt^Q/. YICvȎO^0hEFn MTf@ SeGюXd~ayU/咟[,h}fˎO:$P>岐.dX3Mvh첒d'%\Nd!hc%CC {$..w! C(pb5S ^0auAG]tL";&̎9[$9v7UvH9dhq  ˎO)|@(BL"(os';DvtYvfLհPU}KtH\dD-/$;dǧPL226dGXJ-8ȌN)OՖrt}h(Xu%P.;>ɎO~LY:sDnSbx~n}(o=V/p`&ѺɎ9˱ǪqUhGsjp )JocFGK9>v ]԰PcdG$t'{xGFG;::dǧvc3!3B.h6&$>쯟+ YBVU#DsaTˎGD;ʼ_]VӘ!+;1Ri>t4@OSxVz);&Ǫ+rvDՠ!T;ReF>vh2!vW<ʫ!j!;"b+AG^`%PnJe;z5+P^oL>+:$PXuTCGWPg+ Ȏnʎs}Մ1gH3!#6;|@$;>DB'P;DvtYvfLհ˪Ƭ@Xuڈ+ :"Ɏ?@ys3A vxQg܏Q'*;|Ǫ3!,dՈ(AyV>vǪ[_uȌ![# *)NLCGWdG$UռyhN  $!˲F(;"]Vaⱊ옆옱@,d5W YE\wΎhV(@ye/]!(j(UG,D3!!Ǫ3%P.;"cR@y+)ԇ5 UWf<ѫ11!v4ELxPr/;BAcWW99cюT"#*:zŽHC$;>"E\hm"(@+K `Bh嗨<#쐅B'FH j˪\TxeArcXz]0:$P.t$! Yf#(wx%*r#*4њmH#JfǪת*Ҷ!3qF9'-熂]PќɎH萩:BF$tD(Hs*Pӈv4Uo֚?IvC5,eSMk ŽG;$?Ws%?Q"lsxP6&AG=V2h";:#* ;"]ѺhʎHϝHzbcvHZ-mv4E,dBVvaVI!xոɎ::d'7"#&՜Ule5c+ϝ`Ԁ5DhƂ"PPdXyJⱪ-JhWw.;f-Ngю~Th ;C@y5tBVBDdG ;Uvr~n]éU((d!+YȪET4.괦eGIvDQ. YR1ώiȎXI|;Dv42\fˌF7AKThP[Ȏu1:E;$?7Th.jX4,d%0;"yfFʻD CL";Dv-jB(ooL:MIvH|67 ԎȎƾ*Հ_DTL;CH}1`GW!;>E >с+ :"Is,f5c5E@ ^L:]a A ZDv?0*MG+;ZbCՁ^>:zl4KtWvts+S;Bi2юHCfeQZ%\94 ŌʎOTI䰸Q!;>5صC^=eG-8ȶ Ov,d% Y5"Ȏd;ZYjvvH~Wz4bDQeaG\vdцhʎ@;^*R<4tQݮQBюΪ({˴@/:dYozq9P,:Z`GSt(.[+[>vt+ MLCsgZAPݢ !ʪ7>_2vTB+j N aWwDAr_w#;([Ž\R=Q5h uˎUJ񃠺H(og~Gk4;Z>Q ";*Dd`h˪躣);fxruG_,"*VPLEvBV~:#WvfGSt.iv3Q(@y4xLQ "sFsyю躣);JnUtc1o;>Jͩ-P-"E4F5 j q#h~ mvKwTbGeGTxF~eG8%P^L h .6 vR$3e'h6iCfeHuQ! # ;d'e4!3H\imttyXIy~ Qݢu1;>_ySvȎO쬁ќ(wxAKThPZHuDͳj@yhG=V-#<]2A<l>tz~E氪ȎpRdGI( j񪕡?zcJ͛9VoEkTGkǪ_Qy%jY#@(!T,dwjO?lTvtFw1C%NP:/;$?*ܚ( v:E;*y$P^ M]VuYb#.;CS;mZ6 Q+eA \tL=a{DvⱒUWGr$G(@y卓jir$P. lgcϭ嶪d'IO#:"Ɏe~Yqxe-lPiC^>SⲊ >+:((lJ:{$?9dܸoX5X??#;6F(&:dǧ~܇@c%K6C׮ώyӫd's}@v]Ȳ>:z);cMuocOG;:ೊHCi cC(oP}\#ӏGbGͥ?e;(e ";Dvjdh.:.O =Q>*;DvxeG-6*I~n >T BǴu:;>}f>\tL]gG{nnA1 ѭ[7ֶ*~֭ܺ[GuбghmͲR-U}tt0PgGǪ2;c9!I,vd МAd9dG@y<ꂥGޥ|M%: TDۀ,;r 8\gG~v,dUq&!YȪ{іI٭Q/eGVJҖBCuf`-~.;Zr[ y+Q(P^be|Vqar?E9ƺCdtdtuǴБȿqs ˂ yAWuQGxю;Q1=t1>Lp[!{i8P#ˎ1c|c;#!bG&ŋJ(Z?";~%Z`G^BFASY^<Q~ puG6gW6nY<1H 2fBH1ϲ$ #ʡ(~v-$\ Y; s'+Pv쨎蘪-Hɷ?u\)[?b*afãGP(=orرWE-vP#zEv\wͽYhvlG|vGG'G̎m;v DϪ8cRrSAG\tʧ;|&;E 혲AInZCCF[ yѝxO lC0圀+<7n*g=uɐb*c1C'c]vrNĘ/:Ijh\+ A|-^&|grpʎ/^ՋSH/\''\MQDc.l;ޱΜjRyNЉ0;Oë&a;{ O,ψ1T7\ScGk$AbȟWNp& ˕J8p֟հhU"c=b`/݄fGam{2C5kddfɷ"#ȩQʎ-)r= gӁÎ #f .B†fe;73z؁&@7kCxV:8VƿeWŎ!;>i+#PvTf3cɳr-eCvCg^; ;6`tsؑǏB$9X_F+a$N TٱU}#@F1v J` J|wWpT1`W+q}Kz¸U6"aUxz"!,Z:U 7ꍃ@E:rpL(bR:VՉ͎[ʰcB`@SSg=_.=Ed Q*;ړivcZnHУZ ѬIR&AsT|/eGEax(\JB\0@ `0`\T|V|meb LMΝ9Ǝsgn`nclqE ;6tUI +V~yYWTθpE;^[X0(dJX>Hk $rkQ$.VT |x8"#*zemxY+t#~Jbz4veG51Xy$v ;=B,HTw'Ζ)>pI.;.ˎEza;pXd[l%ٹ$C #g~Hv@0>&;ƕ<&Vc>*-k _VX5c]Q$,uT+,CSD[7hCett4@Zwn` ;.VγsXK ݬ>v#}#sW 1ApfGBPv+HȷΥ޶3=Atv;:~";{0ذOõψZm$&Q!.:Ɏ6;Fj1+aV-drKW2KVagXiU9;Qa.op=;.;V;%LI!{.Rz} *]곂,wD't;6DlݡUBC+f,rM鴫ba^:(d&-qQc5Լrrty:,lEx8_Hw8S<,zu*t5'd`0ݚZwpԃz '۞<+ ~vU;&Y#iF;tqfڋ' }СOاuSbW;LΕ x?5f?U$#.;zɎeGj=+X%Jұrktfu5Qx~G ;Oxj㑮I4ɍPv܍w(5<+=7PC#t$ ?7X895MKkRJ&,qtAZ1S>[dEk |r\-V 7.;ɎŎpR;Ԣ4}plO |hU;utTAKDs q]f{dGju$V;Ν^d(:`+XJWei_H@0/W&GF~.^y);5^(f 5;.0v(gyfś ;rFAˎ)Çn^Y*7agN!0ÆG53PYK#2"6 AAp&E޿8x iRUuNS;p9šJwJU3.al9;ҺC A9/ݹZ?<p$spf_Hf`w`'х;>0BPSfqC [e(ybAPrb;/Z~,K'xq>'>v ]@gǧ2_ǎeGvN=#^9ƴEG;iy}eG }!V!x]wr3=V)Q@RH{l-nRoّ;70bAr{3o0wm;vkx]=wp0!r ;,wVbwy@$+YVP,~v2$!>+۳eyI8\?&#.:jx#Pv0K&w v2Zq+VmeDɂ RT ;nj+]ԓ+a2g|\"=7P[JI~gMlCB:,~Ce# P O֏/ =u_H v駳Cxڨv(ЋU^+۴q!xŬ.LJXu_|a#WwxA`1cap6wK_-nNô6 LtX/xYVbW HʉG2PY-qna;utyeC;_JJc_st$my{nbOf*cϓэB(^=щTbȎJd>1tءA0eGz%+;RםR0 vPC )#Ú*BTcU;TVUj(GͰVYvd5kXzyY2Uʲx@Uí`P+ժ^FmB0;Lڕ}I[I}X՝QngfY=n¹vrU8ށxp-(;*wAV ^[k`FܺwěZ:e+Ma*mUe6 &7BV2oCGֳ&";^q9P^C;*>:"1utLZvx!z&&m֩I:&,a.+ 7&Q xX ;œ]>ET i>:ĎhG=V-ʎyXRvDBGxQd%Cv̾@X/T$PuYUw1ŮQVAĉȎ:J$E@ydv4Ddt(@y=|H~nsT'Fv7*AP;fc% `VJoc5zHC(O^ʎ::ͩ!:Q br{1cϭ%:djG-V4yQPT2x&,ܪ>;**2o*;$PwaeU Q  1*GAGǎٗ(o%1 tH\"1Ffm BVFtkZ-PU3RdjAG˺Ç BVV";˫_ vDmd%*4՛)c=V-ʎE qa+ϭEAGu<;" BVXjԌ"c K\3GsEvjd QfO=V2-bȣjd?tQݢ|eU%Ux(@yGEjD8!G낎c}ȎV^Cv|j hz+:$P@y$l" C~3XIɎO͈A%v>tH~n`XQ{4VQݦ.HrvDW)D5xNlr&ю8|VJ.EGN.jEDyow|tԒA1#Ǫv(;"F!+Xuc%U,B/;*/Ev**Yz=g>?]ݢHj{jUV׳tQQ m5qY"Da?Gׇ@Ohca1rDv4W'Au6!>:&ώXhej,d%舆)TrNkmȎ$;$P.;>ɎOfԐxuFuZA1CX5HuxZ>1U囃``Yk%k!pՠpR;般;|LϠuvwnFvD(O]0om2ZO1!mw6J$;^nthLd0ڴOmҳ(X^! zʕ&smxvʱ/"^_]]MW<\0['>AGLp@[3ȎϾE# E.bNhV[9쨄 \;6.{{gGvX~vv]V %a8 $I`H;R_iŽ0gNΟ_#_p!1[ps׹ y\X^L B蘷[BG\Iv('pp|4Cǃ;@簣`~zêcm`2냁Ŏnɓ|:]9~4S<@,;uu v:y-%L >t(_%,hM.Hp㭢`?pZ#@v@U-7F+ ~inDǓf!;v LI+HdGM`:/ˎ7ʋR̎Uxv^,?;ʅq:Hh{Fy@XD>En]ٱe=Jb N[K!v| Z`Mà ;R*Ŏ=z.;ȷ#z䢑2Pto/f3dR*͎stN#;rab@9B\ʎtΡ 8+k'ҥ y{e#וϊ9Y9x ,|@x82;qVq-Ğ'<ɱ!x{m_xW#:u $ ;  EO0;v*@@V8JUkOvDd :\ h HpaԉfIe[~ (: $1s}VG* ;U3pfL 1ÉcЎ;r)28v PW(s}b IBJL ӨvP(P %7cl05Pzp cNj< ;›}&mC I>[ObԜ` h>Ptu|icVJhԀ(r =?OQ%1~jITм9dbG)d9۪*;DvTC} ;m{HpIV̋`&^lGpc~.yaY-R0GS z;`͎[j9WmZSaHOO찢G"! F#;U1 ġ,;( I28EU!R) 9<+}p#sĊ;  3nF v[9=biB*xǤ( UW8ۺQ+G`aWD 5ȨAG\t豊0vD {v|,+ʶb6dA^,p)-V;n&R31AvN( |p؁Ը8B:>V>+J1o6^ ׼@o0MG(`(*Ŏ}p(vl!رYm))ݱIk frs*`ǐnϊ\O `y/V; %;JlT=pLXqUiv<[}pX RssAYUd ;"àZsmʎ0tLpuLU"b[4-WP?f]`L4;@9xCxVBfv A tiz QJIç;D^`8[)W(ξMᕘ"v :0*|v Tb;'E#ys5;[x4;;,v,Í,;Hw@4edf|XĨE;VΧv@;2IT썲JϪ;8PN o>p+'[<B+KjĎ5;>6;@q%t9qG;g >>T h/,O=ʫk2:&;$;~us 7{{^:z"\X(U]aTTʲca/u e m@/ Ǩg ~sˉr(xaq(Xl-3x@Z}V6^Ort/fDLʟ?G@\QI6\ߤ`͎ӽ xeA =vК$0oCtd s3fjv57gOft< OV@NR2tn2#=7;|@Ounh-YIfc;L4rvuӁxnwR@^ĝ+=gpTz]3Ԡ4CPs)ơ"UqiJyH/wV& ⇰|mc2c +G쓂#<(ij_?Ip:23Jmu;vөSD<+."c1 ]SZW)0UvSZ0dO)^wg@0pL6dEF'ON)ꔮ(QNwwdP@IUZuHkٳ`K\8R7Ɇbql ?)Xé1_㍗ΞO(1N'' 8BX*'++WA>@] #l55ib&J%&:^87oaL>E9"pIRaL!ቔ$GPfY2nFqPl[l`G:&8seGDn !b>.-J/с%9ʶűL1 `$Fh,L#dGO0rP3%; S/7AٷPLn0AqPLA@tG ;&~HTvTXOJ/e~ːȎ`T +1!XQ ^`#3|TZ?bzcю|(HJf+Nx &uG1`Gj5"3j쨈 2:;"ɎHMʫ[gD19Vx{ctL?2}}tRvDBDUiPLYLDvt$?& *WώiȎA>kCM #.;&1C%@:$P5 qFY>:$P^E^v #.;&$;Z=fGVv=լP;ixz";qKA ?,ͮd,':eGwѡ!,cY^N bj9īUabGz'O\W9,1Q.z!DcFPM#2-&jaBVn;*G;xK'*tܜǎ[ ^ELP ˀ+cs26s=p"v$z,n# G@vNzvdl*4;`4:jgo- ;*;lv&PRl#l ̭8^^>k";"d&]t|ěvKHE;t'aG L3ف=xPKvHtGJW¸t ;:ކN @Ny-L;2#͎iR]v_w%*SPo n(UhXvD579t,;ppv2zJHaEA[eX @u n]Az܂Ar<3z`8B#Sعu&Tƒ8@i =gm$vq #Ž5 ;/{(}zLG/@6=E:!~ĜN;rUÎgX :6^9ϊ4;>TX¡gx>[}:` bkÎg1|\MЖ.#;ivEiq Ws  `v:ccN<먂m5O>"!|Z;̖aǗ0|gche ^ ;64:a0ޑk]n+g&GPz)卲١ )X uw*煬u lv'L2@TaK(n[oW+vPHCm@ {fбr;h?s :6 qe0@%M92./lv@̛.@!svE%.'Dc@}&L(#20&);cGwe;0`@#t@%Yeف&7H>jv@z x@#]xaqF;P8#C]J7ӺCWQU>;m|=yL" 1fx2 v cVh0> ; vz #g WWUx%-A'rH)pX=Et^a"v$.,{iJUd22fqB>ו!sf4;x̎׎Wv`2 aGdZL)?ut1 ;L*BGA(P™[En+V+'9(bݡKA,v`"q[A^`D} ZT vB) c8Xvj3(t[6W:VN!%ٿ*apc&Swء}S`Q;ȹeɔJ"o0;OdVźBHV ǐUQc#5ðUyV8Lk@(V&X*)VivϱrrVPNJ-JtȎ hgat]K+fGRPL?U;yVI#vE屃hⳢCA98+!A+uq\+㳲uG ?[[Pr #;t -X =yV;G?;g=؆;s@SEv +>t#Ffn`~Cfu-IVpq]#jpe kY?4}VTΰ2{n 8tm@r%СY%Z|VwH;Xw +gdin JؑCE/RCE:8ʝa^ժ_C.Iqj[Ycr7IY@J\QZ*gQrgv8yV=Yaܚ 3;Fkk7ob6$XQUgetLjUv@lEm"ɳ3{jJ $oagU;Ж|K~L[+gu ;^Bq];8yγa1\牁aY-,<+8Źy>+0I2u5k,6;VxV G|V vp ~gtʹ¹D";ZI8: 2v$;8W9W4̎$ϪY(J 'ZÞArΰʰìlH,vЄBG}h%WН@V;pgvx+O؁k[ءFwrX} V[ߑ;2;$gfWP(JY;%Hbyr=YuIT*;W; Wjgn FE GWC'লsl+J됰 cշa`^.pstKAԠ!)w%SBvhh(_G1I%Bp͢뜝$A젉dŅJ3xI 9zkr@z[a5I<ɻX8;׎}ܪd`;0MK)4E`.f_rL'W u 8LBx>L.rDY%)M3ѲƘϪ* ,4+U}уʵ 'gFFbHa2\-2V1cDKZA^D߆>A^Ҫ`+Gza5ZjqA$ o#4YcXMyZ ך5a1+.xT/"; XVOy +h5"^Ê'd?U^ZS_- c#TkTzVL32Vt^mErH31NYae3׏Rq'CZP-7VWxF?U-+oNE b4?XJgV;ʴEd"PJoc󋎨CO豚쨔6 22tK!b_#fj#&;Ivu\ǓʱYC~R/nnCC1}1RU%,R`:f~ ̸ڠI?G=]ڲcc#]uCkLdPKumT[ml;w:n4wcʩ,iq0rskrfyy9'EsھA> Ҳ^,w'G1WJ!舋is6PvLGyH+]j:`'xy/CmY^;7X6@vז; C].3<ۼU q{vbr5Nw5v ϝ,5dG/.9HC"ٿ#{%E3lj)E0)6|٩<ơ\Vnray Q{**W,ESuGoڻG{)ŋeʲA?)vW R)AS ;xێ%QU$@2юPv]>aW;>QO)c+,wu9 *C UAc옾P{O#P ?Tv,iǧmPYv`\dQ fpTȎ%pUA9^1F)v_ @y;\ud mt2yʣ0x`#CxGm;rt{OJu#.:I#RQ~nZw2p&ŎPs*!gB/CG" yv)2|:x70;h#9mdY#T6M|V܆Glx\+@v0`wqerYm+vpPR>+ޯ}(]RAG\tLWvLXwt#+P{GG @slデP8:61NS[ (М9O߻Wn9A/FrȭX964Gvݱ/1/Ӈf$++(b{XՑC|t,"* ;!(ƦcA($V`ewwn 0;(戄c0be04s|C` l tp3-QaR/QWc EE lxG(; \v| 2bv@A; g@Ѐ<`%lB&VX9֗2>!ˎʎyd[ˆ9f>xh8!(CPSpE-@sbRx' bCr}VȎwj]6A0Ơ Y~-84ɓGebȐ+J hEŦ0b79vX`v. %ȉ%o ܹEXBjlUHQZ_82#=`|RRxxG@z5} 9P."/5Gr:gXUfF!YxuFwx$K1;Xpxp)_wk4ʅwPrA$,A^.$g50_* Rc1YvtBv|Q[svA辂av#x@of梉rEa̶rn%0$r"o z<@`( D}V|J86!Bv h γbjGμ"+pAaAA>)2Av0&ȳPn+vX12n+<ĉfx!"v CyP䳃!uءbfNJ0!k2 ;V9:S7蘲j.QhPa!=|d ⲃ`xwܑ^th<}3 96J$yCi\v ;*E\kX-v"Hb"YPH0E̋u)Rxh4rAB#c Ofh7BAJ١fF9nXɶbκ ;@Q*(k=[KHTbU%Ek;cɲ#t߁s`BU=TQ,'Q[V\gI]4ٜ؁?v̜ ѵtG;`S{75Y0Ncd2r/b[gs7a^얰\U.<,Xx9^ ;^wZwUŊsx" `y uGp25 ;03UxgQ&(q1u1IUGYOc Wm;xV!;|V^vajNg8*yYa& ~X^.:a͋rvقmC6TUxH!;^*ȭr}V0#Qк:;uD9;8 E1;(_J㵚>+aGd>47u1x@v4˘db cpUZw,.i@O; {1"fdud N+g^l݁$}VZe(w@;Һ|OmČ `XgM21'rEE0PyeB`v@ZγB ;q q!*+HfXQܼIU(|V\u;e+%NUX~aVAVƅBM1;ZGW;mD5 M K@Q%ٹ&MY)ߡgfAi~8 $:3<+ ,e>Omv8Y=Sl\q%^Ä́8GΣ)*IQìIV@oL dv!gXyVIV8AVPγ"U%uaVJY50ê֬8s ; L saR* M07on`W ƪktcGgdG_-KX,@D9`8(=uH]^ANm;pJJZS8~lJZXG|JzK)Q" <>"r>VQDK`%P` )\uQMZpd'ARputwif~ĄdF <qt3xVJymP`(0.,$Yz44q}xAk‵E@t'0}%N^ɬIbWFpz:NcV43N@ߑ^8S- 8^^^9\ʙƎewj5'vDQv|m)v(A9ҌrKw!L 2_m9؜l QFϊJ[0. ;jī ˆ:;z).(Y=wʆ!tpJdk=c ҈.ޛޟwU&ӄ>%H#%d >@DgYlz ScU=u^sɊ9Ay&(2vP{yL1j,n?~`6@j^f}qItݿC*5@9y%j| krBCY&GhX?4{PR/:t.n}ȻΌhPRx⬟;sS')VGaZ"\q1 t<غykI(5 رߴ9jT505j4j ZU McBAdjPsuPZO]XMLwtyZJW_nn j6bG tдF);m;Lļ*; ; X$ǎ6ڬ̓jLvdw|b|T-~*Y:@ֺ!;&ÎHF;>Ya{kTXEjo]ӐMUǛYF_AUQhe% taGeG%Q-8pɔ~q#+;*BCd;ڈv:⢣ Y*CdG(MfDvbGF}A,8蘈";B+c27W~ڈ~+Yu(ozؠZ5(*~~n-A"3IC幮ͩB}v@GdvtݑYXvT vtc%\Ҕ(E jc@y+ME-6* ;ⲣC}EvH<+Uf 4!r?K|s]v;?}>:$PXu񃠺E4:fm K<^ʎZal_ǁ:ׅq%UCdG;S(@yu#舋NyfG$e'U :!;X,dUKD@Žhgc!%PPH|tEGdG1:$?tHhCvQ:+ޙ|Q "zsXI~nEViͩ!rGQmXF*;DvHyY*Q "FsĎHr)4-k_ю"#k^+,Z~n+ɏ}*CGDzCD;c%3E.\,2q9PybG!YDdu#o4k!y%j⧩Ev(aVXC<'7/x2(cV.?yi4+W眽z1|"sqrbDAGK!\XՈgVW_EO/\ڧWɟ|zaxI[uFu_'.@|DǗ5ؑfA)`U;gG g7M%6#DUBΛ/pXgWΟb 4'mk͎ d( _v\ h1-bNcD?nvF;As׀(02h@wAckT{``zXwa\UC uxw\;R;͕ݗ ;6;,eNjP!l, xI v >1u $Ow0;\4^> Pvx#!)vDŎ`Ug[r!!_vHGXdǘ/25qvHP(;_^GÇGIqjc!sj<|j Z9!5A'ѹ5WJ)M;vO#tJرKA8)]q%(sz8͝;wvwe ݱfO_uYhXZ"1R#^ԏ//Oybx'Pyc8:?<|V䙃O,v\^LEb3cP' ;Μ!vRyFlx)///]̎>cëpj֭z 62e;*_OWe)<<">E\h%vt[vpð}V3<*]EuyY-ŕ yzxz}p ~ر Cv 2f(dזQZ5LPbk` U >)/~-([1o`JIv8;nbo]x50zxt&·n";q. ^'Ԭ@؀zA=b5׷/ ̕XçGp; iaCD6ꎽ5{`xwqytsf#~zDGƓmrO9 Y0~bբ'ޑˎp MXL+cehj୺ ;Ŏ]Pdrd^څfpAϟ#)XAuUȎ!l&*/󬎇(7 х_prrQJp}bXFwDȀDu/!Õ <*Z@P$su6|Is̎enP<{ _p)Ŏc<$V^x Z)v OWH CLсvt\v`fa+ţL DΗȑ[ *P(gR" -@uEh a4oeGr Ѕ#6 O {B*Yq>='J8x, @ opuPc0| {BcSV0$)0VNOG*rQ@(9V@.O!;6=e^PƨHv%bǐqaVB@Ř,g OQX ٷj8Q9>x i"G9)SWO,`q [!g0 Td]H8SRdvgj,~ R}f(b$Q&Fw^yM`zx_ :~(-;1n  0 Ti۶";qK8:(5"J}h;;lTHCEĵHBb, ;IH;mg($T+<-b6aC05`AQv (afzTaDyЄ 2;L2Aph1;6?JHTpL.,‹I˲]U:i Ş!=%ϖu͚BvB RS)v05\v[ 8>+ dR#rrvBÊEL(uvcVdEthAwDX:ŴU`RĎu`H;ўz5H̀@ɰJtUD( Cp @"Є .;6؁B<B&&ڿ yp` b؁>4"gC:8DevIe& Rv iGw6mQp^ze_:Ky8~9;;ӯbi6.:Z`GeG2PQF_2>r|V'1yVptx)$;XWllG \N6; eY(bBJcco3ÍJTWv<,a{ ~U  8PB3 |腙*y ;tٳ+VQ,gsk\gAv/^, iS8 *+v+Nd]d؁,D:KAeR/v@4^*ˎq.-Uh &.mH@= 0Î/m;8̝9y+YAy\LFR| .FwOQlUܩ2vs}VfZ9)=UZ0AW q@:>+h2~(dd `ʼYA$#@HK*aM̲#;c\gXO; C$dY([ЉUĎPIXŽ^-jgBXK؀37X9~ bҺ8S ~CLꨀ8V3>(Yc>Im tBeb/O(Za VNiv,.C|b帐 yRX1!Nxb+7uC*a:r,P9p sLT,4<:ᅨT4?S&;ju|ywӫW)Vs2GoK~YжEe[`GGjVpǧ[ gR./>Qrt?l  Hk!1@{X2j XSgQVQ8\鎇iWC̰$a\W9|r@E 1vHxEvHc#|>"CUq^D-HcMhN\]Y=B.;Q`w1"]& +2P(t])+ߠI!j2x9YY2 R,kx0v5 O!.,=LT.eS\ΰ^FWN.SsxU6 0 !/kȏx?9*]~ >$݂aH0 M,X̎C+`¨ T-gs, LxcXjF˸aMrR ٹx@K#Є $mв#zpV:I\T-Z {=*۪Nе ԳS<1Pc˳b T OD0U#eO:Yi|DX X pz2(8`RTTQbҫ0\$&(GWY*w%+rXqm5;HhTٿ@Ne5ԡN)٫ XR-88.pstAnz*aS+(f&>who͎۠.xǧLJ$1ˎPAK81p\fˋaeg\w]kӂ#T`^.pR bŪYH`8|HLILIu/B:XU橳;L$W 1殠K*PضP y]tUQsY-# ? CGA~߃bvn݂E Ê[-ɱZM>Y[۾xgsYY`̮z Q Kz1ܴ`ر +CGg21tlZ;sرM,.nK^)XC -0{ξ˗W`ݓ+'WX?*rJV8=I T(sa Bs`mdmVu6.'j%W uo]eGJC)zLܳ^>E0v -γ%$lbdJ5v5y{ҦtG;  stǧJq}P;b QIˎI}U;ygUz <N`jTcnVe/^1 ;gÆӞ+؋÷Yz} vT p]j'Ȏ5aG ?SXlSph%/|1eEc~R鎉DG; }V;x#تK8+x]< q-`YѶYٱpְBdO[;T }];/Vz+; ѣÎE6ا}g\J;P\Ut.'M ;&oĎMo6GpB^.E/98xZ@%]Za'44ĭ;s'J0,vkhDwx vxzOYkh7_%cFv\W`fa(6`(W2Qpgvgv̲CW0Vj\@~H tBA7~mei'\Ѿ&J}ciYmXwفs:CVQ>P+9 (Op^wfN0aTGgeoǯ~_`o>,::Ŏ(^ʍw$@0츨P!L0,H]d١WD|oxb^dPI`k@P-n@N5x#@|WUC!;6AQeP;;МP$X8थ;L" fGn@ܰɛa DE8k($"_X8q =2;2'# _9`Q#"( 6j7H]ahr{ l89Vivl`[<+_U7%c{FdYQ9<+;vj"8P@b8f\+k7 رvq Sp|QUMl,vXyV쭑;-f'=m!1+Jb%QM+\Q+%_x?K(2;Pq4EbJaeC4TXVNIvPUxPU5;E[ΎgW0\5ޡ%˔XYHiv-rtb,BUÎu7;*,'v=+VVyXU{B+J}TfY o_կ~'C#%f#bcGš- Ww NvUTX}Fɟg+ S#,=~|TwP>)dQڡ\QE>+rO)UFw6tvgqXຬ;0Ov3\w8I媪fy|rv.Y>*Z 'lغ\ix+UD0Cq"$7\Syj;2;̴U*_;c 1;;&8Cԃ}VP> >`j峂vPkz Pa`[7;qbgJ b xVqZUϊء|Rd C ;А"5ϊW$pb{R>+ex1 Ƈw`زC2js€MfSٖ+Y]Q vp1hmɎ鎨ZÏ * +D8n#$\iv`V;eD)/~*YAav$Bw`•+cc$EرH<G5 33yź|Vpr8C x`U.; Ҳ1Ĵs5Rlɰ8Cpӫ;E懎wV>+Î!2>+]xYLY1#͎E̝:yVPre9tɠ *fKeفN( iY F׀,H;؁٠͎CO Sn1dX}VƖテ9Y3 ?I; N嫿lyV~YвE>fC;숊 HbxA]G*gueY1N s+w ; * AA+X9QgřRT@y|Vah(w G2 PdhvG28W0:M1 *ivp=Pxu9L 3̝BC8aH@V>rC"y~g)_Pv!Z!^t-Zʊwp pK+O ;h%+eM 8Аw9NnsLv6G*63RüySpʳH . UfZrtvMb QX:a('&(`~5 87깁) 8ُd?SE\UxBز!Pvt'1~87 MGul AB[#^JNPg^+.p4s87 K*}rB:[ Ρ 03 ;ypZ}O4+`V ,[iC dcAbOڣ́WF)~VѽUH}f dL#(PR1`1a5jK`gǻRrv_ ts\ ˸2L0\XVՂрa5t2VO9W[%L eN~3񎙐[ɂgG}tՎOhGvTFˌ:cSvYnUIx\"ƎȪÖ#GGdOxTrsK$Ir@Kv:" )DG7j.+ʲh4|hct-CM [+ F֪;Ⳛ1t"- `;gP7ύÎ6!s(ĩԪMkeG't4Qc3+N";j$:ci*o2ķU0P 1 t쨏 7G#[z$MFȎ.莨h#?m  OSuShor::[Ȫ܎Jh }XRvDʱ@yc6W 1-am57i$P U;υ &챱D@[HpǎhJe4Rk$Yml\r`ѪQ%onloBV!x84+ rjHRC}X%S<﫧/c9Z~YU$28d6hdon옾CG\7^B/.o\ j |赪26v6A>nQs+6*ۃ"lJfxw ́2+xG^R -W ^R/he9K䓼Ua*/R9١<;1$?w2Hlm:\=\ 4rTa3^Z~ϹApӢE(6ߠ@yt@oXEtj Z'MaAD4 P`v.>_̃JЯхria֔Uуw*bJ7kR)|9;%qyU\\;)y[[0 `c#w]\ŐSV:UU@D`z alvfȎ#|{UeuGTvʷn Q%s7rqH ;n=@ECtC(ف1P wNAbG9P#@v݅UvOÍ\ۄ+CT!9lܑ;jx2,[̎Z#4U+ŎOKX:rжO4X*WvA{f ZȎi#*:(.e<<::zto uZp.jG?~T vֵ*\aхT }鄲::mCuN+)ѐT3hB.M96CZhCh:ŧxO m^Gz#nΑ;]Xx7D[-tȯ/,hniw+""vGNYO1\"bcrޛoJz>4ɕE 2\"v9.\cgΰ԰1ՁCquv^!;hs'(5:0`~(W%shN8BA[<מipwzO4D\N? S ?U"R?Ǵh -7[Z(*qB9as0vRPr7~"[D9 BhjAڣ~(fOvPY#dM)v?> ϐ 7[EIW&ބ 8oDN( y>;Ի==ւ nk+OcQUB isp`v=!fNqE1od6J;r$r^JG2V/ 2u`likqU*3;4 Pwvz!1w )dx3'(r½uajXDJ^L2 [kmoҰc55Pp#@;n]^8:m=<,m#;Ptж3s uíXdS2@q@fONNV6X5W(OμOK)i݁="'Ƶر΅׏Q60?{}y m0ZwS o<.`y@Nw0 p|)O}~?N  'W@>EkHnV]옮jvlrHIDATv8 u"vl 1{fVp+|тK fQnPIhnx<Spx AP*8qw:_;AHЮI|>W{>?}j q !΁0C;3 zs*5X9  vLAj@.(AE|t&b/0pׁ%[ѱr`7]fƛ)7G\jpamYڏq<[`뎍'y] xZG r%{fz١6βH |0U\X(AÂ8]5 <%vaPw67wEvW0Y?+q.8՞?mڦ79' 3Ď@9,Fbs9WD fJU V,S@_Qdh!v 5p0Sjfyv k+FyPE ̞伀 Oٯ /lv@TBMҫࢢF!QAy@ *gEVcK+ʲH1Lf):AdOZ&ae!u1[s fr$sa tBy 0Qv8;#G8l@nCIt`Vf?s06;}Ln!ʾ@ӑ_b[=aadf6<ѺرOIwaM>@`@8c .'ȁ24X޶;Ci w$]3;m1]jĎ%P4K;1Y;pٍptXR'MرrR;d ՉgĎef!AQt,Wwg رP! hݑfɳ Ay@@y;Ow0&(ϊc'zO^aY;s#&m57iﱚn#q< #:A`XMa;)x `d;[_qy 0qzpkm}}UV1;@^+@!>tޘ =Ϫ g5rtg&pر;[৲فO IU8Ř yC 0;xbp J1;!bd+w%ݱ&tR ڃ,cW>2v,aL+t'Wa@ fyP`~ev-_9$4̎ew|VkfPa>S!Dw!!&C|ku# q(;AN*wC;Դsaj젬*V#\A=YQ:NJY* p=CG/ r[AnT%ϲO*v xr\9mEE;XE8xU*Hl5~V20$Q/r΍J;@w'NȰS: uG:wJIFс= 4T8c#&mٵ67h8DvL11utϔCbюf :BBcac'Q98 5Zqb2&¯}0`HHwc|<;2Q١&< P Ec\P`b0Dn(e1:V7!!++O#Gw !VN72eJ=3 a FwP=̾Mb[N(̶-rciyF{ ި\vJvTx6.]ǯˍwPJ u A\ ^yVp>&Nx9T251!#|{UCdǜXϊBFw`&5Xt'1t $i;(J9&V*"krGv~z@ QrV*ϊ8KcKP0e+ʭ +@8R#jjXPi+V-t5vUA?ð7*+?:,w:VU HBD=&X9W1m+poѬ=o9 P>Xe ~f/l.8BQ+έbϕNҮ5q.:$YYiQ1+jU+v[9%h-2H8BP1(*b椎Y$ZSjܲ2ra?:ʶx71^ k. E2,EEfmPU;PH0|#yn#^':met>wVJ[uL;B"FsjɎ鎨}n-Z tGn+ ʈg9X_[sA,ښ5=Mb"J1 Zi}YUwS#v7750Ft᤾A0l23؁-榻:K kV(<.OjQBOaْTyq N ԕ+fuu:q| 8Cxn /C3ЖF!^@c. rmWWi*2pR3LPC_7y5 7΄;Q \jzyv"%vmRjТk:p0tLQUEm !Vs:(H2#Q:XQr<^{T2x ۴9j+(P>EU; HdVdX,VK8*Җyl #E֊&|$6:J^7+U̅Ptv9%Cy@N7Q ڤBP۱ʎi0t1½%@}~{_8;RnK7V%ϰQ)cAgtx14jȕXX|jchcO fZj'S;# !&(P6Б)1rjzb!H}fBeǔtGTvD ۺ#CБj|3vDD^cQm,dto&`1vDEH}l4ru^Stn4+pԋ#2I"Q Og f) Ǭ);f b҆JQX{U:$P N zjGmǪYq+{ŽiCe;j3CW&qh5 ]I1hmUӈwDeʛ+~Cd߿2hZs*c 숊:r^WATǸ4V# 5Hrrx%+:07d%+\Z=SE nsh$S;T@/QUw\گXy;Z _ܺj*-G~nŽy6;FT`ˎUSxD7YF(U!;`bYrb4:wxlPq+UKWbUn $ ;^jf M守H0F /U:xV8%v= ׶/k g Tq9N>aj*lP׿#*);7PF;xmrvwvvh`Oyra lk̟CXq2훴xP)0$d7s *?eL&RZ}]Fq'ܭ#VQ钆s޲f%`Gi ɉGְQ_E$);u Z&;&>:V=9bhNv*$ 5@w<7ӎ0"bykOXMy)`Ƒ{utZeGjuDq\xĮ7 7;[Qpp@ܓjYU[Z]d8;XK6°oVTYv0(vY`%  la ò>hzbZvoRDw$W^FM1;pu¯z59{ώx~ĖɎ?{ő{1&tZiԒ3 鍐t]]XMx#FP8b:dV֩+*r&쪕Y?g&RjaW8E|V/X ؁Cөaͷ^U`v?x v~02g+ JGۆ#ݲG' 7ţC_9DÎKDKt:1vwJ0o 6Uggђm!CZ>+\Rgv\ujw7:OتɅޡqv+;柣~7|<f/Vc.>+\HvYP'U=nA' gxrNK)~:j8a4#gØ-Ug`B>+Љ,v ('.-a}V"7s3`/va;:y`}ȉJʎa?v4('au,@ *%+LY h*W0^\%0\"}&rN-8[IzVQD ."VGXyP\sF-rEz,x@O&-ԆSPQ$1`eÆ9JbCuF $/"jO8bH&["E\sV vp'KJY`@`r"oa ;!t[9g X,gXvJ[U Y%&j5gc° "଄?֢"䶊%Q%١Z6(>sX "yV#(Lr6WYt ~h2P<] Obgg6 ūpˎ䰒r.;i?;pPecQvUٱ+*jAgzTVReG0 0Pvs%?M#J屃Wiv-~(3*3xI"% _?_r1Ϯ8; *|KpuB\K;JCĂJر$1N3JC/Fdfot_-,/ 58`jjvL>D%Y:r)*;TNdCrrY!EP "CF] k[:"ƽdx⠹ `hfR)nys ''7$y(Mm{(!L+Cyâ$Jvo>e|]t8@bʹz܋ăi&RcM$+n)vb䧲PCr/Y@ ;$M7ut2eϊ4]Q+vpu=gZ#,*p7Ui1\1 v $x/ճ'lϟ~x;ڱĎ'/vgu>D]\XQ#͎C)J.?vYE8C!1v=&RE'TOz |8UBӶHw,qv@Ww䲣A:˃si=[+:q}V.;fve<;1gKpQ}V'Kx?;v4Yߋ;Q.^?w|Ȕi3av\u<{;ӳ겣bxH?LeC@Ǡ(J$f;~g,wuGĎ_ Iq/n=Xx2ޑQy^Xvr@v5h&-;z$T>j$فWRv5c8H0gO`6|!$HH(TOȯȸ8,n!?7NI%Lv\"#=vˍ>R]zPq +B 0@6jӤ+HjIm8av7ь J%8!ajD:ؖ{lA&ޡ!rIX%bTĆÎ v`RP#jy tCx5˷ (?]?LePuGPvTύCЃ#JC}V6 >+'haś7 ~*c*Y%W?Sj_ǿ?yՓ˿3+g".#vɫW?SbIg~9&K/_Eùu YS"vaO\Qt>1;(϶~+$V<+gdc#;'ǰ?>E@);[|;qob%bpt=QLwPF@w9q|~~cO ;HB}ddտ曓 '[ _B/.-=#v,ء^,f Gwpe|Չ JMfP-,A<ACNLkn4h;g,2Ѳ,UăՙN;/#8ckaaH*GcKިnwVstg vtG,S$l Ӆ[T>P>\;ύ&~"@P߿A_AĎ-f+N~K&{6 |:ƀAۢE}l*v=؈K *Å :ڡ;rm1فXD[耕rk]%h ^]xtwW2dȸ3BjrݥC.;GlW89y%Ȏp ~Ȏ!?t(xTtU&T5qS@[8'Q'Jm=Ӫ S"*HFύR MYNp0yVT_|T \MU!P>L1 tLxŧ#+@ rxĠ;#0;$@쨋a(OZ bG>66*#u{13a lAP~`}ȉ*Ɏ鎠(O1098EܶXv1(6au11Pg$Va?Fddy>+~Ɏ#(:BS(OAXͲ^{#i2rt Cv`Ǹ@eD$Ai 0]>DCYc$;n:)nChG -;*pcH?T@.ܡA(A)+~*ʇheo>f6P^-: Jk (7al9Qe1ǎ6P>`m vԧвCQ7ARs\UCa:G;>JGCș$8,cKuə$ɖ%p8'PO#-"dM=$FsFp2Iљ$82$gkftnBǒ&E& ț,_ P+9:k{ -qs`t,Ɂ$i$%H"6C"cFʱ${F@sCg;|8I2߈q>DY:^tAR83C/;1C`:NlaU7G#:4OjO #:'Oqնlp>`2.@t _rᢜnL# k9uƝ$_?^~qpD:=1_vP)Yȵp${)%C8ٶhG%|"]c="l r~ fW*/lʎGeU^ie& ⇛;dż+/V !Em 0n)B8 `,vr bK֟x5K2qbtv.W*N'Z`vvyvwhIvh@rK|DI) ; s!6/DłFeVfl-f(:zpJ:Ď׸v9Z]bJlqAGOpse3>u4С8ﶄdDZS\;V@ #JsAFPjD;;g\e^8f+-cwqm0vP'/>EcFEkn8S1!sUq4;p:Uw:{]ɥf,E'ntJܯӚ%f :gGPt9*Pи<ӗtC5(3˶-:|-2 rrdS!@Τu@QPqiD.Y.MmcD:@'4RP#b:ZC!atGR@LJ v0%dtW/}P#B  JUL,hCI A ;H9<:PС_ $Ⱥê2/"tsGc*HGb";fqIvP?dp# N;-FXɄQ@*ҁ4/xg O(΁ST|K/K5ZE!p ~ʇc0s)ʳ' ?;~yK8p:n^.T׭}RO 2|j_TzLAß;(Ec_]ı( atǾCYdđ(j9lIa)VלjP'['.%T̉Gh`P\u?B 2?(DxuK> AJd`lQ7*@%رKD]!^NWGO%j# qO%b̕QeP:AN'ݡX<;3YXZ#5!jQwi>b,רdy.;22ﰮ80 %O);jXvȠY.\;);fIT!꺻鎩9-E?7h\w#l~nQ'Ulf!KY\tܰ}JrDR`K%\!CXQDE;2R\:Ò QX96Zy*!(VڷBeQ'r%<`m` κU!gJmE5P;R._!$Qrh0_b崵P@ "PݑQsH  !em1r;ऊDח!F$.;T`RsVPDϊƩ0#T(H  vDdhg{$-lXC9(J% Vy1 tde󬸠,{Pv>U~z9/(*;gE<bm-;jM w[岃~Zգ4GWߺ>PvۊO +A;[5)r?1;Hqt.;K*v+'bv-te;tQ ;#Q\ٺTRⲃˎ>| N(YU;"Iv?TRwpYO&1gźK C#Ë%Ŏ|C 7c0@t$wXzʖ@qvHY)>qE fd Ew +F&;l[wq?qòSYvHoZX*;Dv/尃z̎ ݌[-5$;Cs*lIDH$3ˍwaG~-W#r$8g%;5޺CRn ;ᦪj:(Ԁ }VIv?+`Yׯ_w~EsIT~8\vDg7Qc͛ׯ AY.8|5ޞ 갳}Weٽdbla6U:`xᐢĎj鋫lMy岃;C!@ŷ(V~9(Î*Yr:>~|73bv\uMo96\ VG>*7x9A.ϟ#䪊VqUgkkg_--pcg Xi #Kk_O p_Y{>+`k"kgѧh=/f2qN(άڌÎ=nٱfk  5XW[[Tw;<(J.{sc}j[[CZĴp3՗F@Yљ$+b#+F:,;=dV$+ =軱r֑d!se2`qdiM.rrIO^b\)'˃;t g>)X=PŢIĿ9x vHUvGϨ3Ya|V;LU CTKD}f;]ڈl+GUJZ6;l A\r4VJ[<,;p!oq;vCwPvnxXi`Ep ~ˎaG@zFYYeF47e`f"$+۔IWU8ͱQq(~2Q݌o)~ܡt7HtO6c0+ Jt\^:([3<(3k?T;UvD4:^󟛔kԼAU?7NZcQUbqy|8j0Bb;KHΫJ|YHq!;SӊD>A(A c UiJ:`Rl8QU?v 9PPfo be<KpL:ܣ׫a$V,;[< F,o=Lv+7p2xZuGЈm?TюACϳnCTēUJ  :U0B)Î;*>347 Xy Y+;ӣ2(Q*Pիߏ:WϞPdwD?K"O/_ӿ~RxBr<@v5'GL Pfp~pћCB9Ûc6?>z"8>: nJ@Yv[|YٓcÎ|b!(!lt>~ɌY)>cGÎ>CÛ%;|Pe*hPˎhb=gH1(ziOt:k Diꕳ@ X `s:! \*A"\P BRHB,8;cdբݰ2[mA=V ;1@9#quWyA8\VTQ)vmܶ믿8ԉb^D ox>hIr%伊NrSܪ61`;8ءئHzŽ,0Cfv=ݡ"vP^i4;H}>ICdͷ"vǪ  PqʠCG@yhGIvJ6oxaDU"Y b@!a;vX0H\s577?'U:cBwvӿe QN։U-W*B!옊{ˎ @G9Q_z|8>?T-AƲ~w4|V̎-J2ݑ`G ヨ,v*MȔxώe޶|R‚"c6.,*(NXv|({r1x~}Tpt/&cX L^)HBqhx}dc6-*#ap^cIVNcߨ9z γz\8;$*[C=x@iW+<+fN|V6ށ>+!@Nd[iT⭲>+[>6P^,-:*aА{ʃ'Avtg9jY0?^J*CssN&dbs6w<+Y;b@LlV ٶ!{ ;<+q$<+B#gE6yVbqvXhĜ~ vt@JlWM>Tk-;뎠h"?lxDst-;h+dX,^!eXxd/L]lxpW3u/<9Jt(AlvspxvxHw@8b NrvʠCM˂eY! ;FӿJ1odX+GÎEYw-塳+;7Aawx#f4wAUIdG (@y>ˎ)l*/d?=)jdzV&Qn!`uGF2u }tʌ?2MIu$E-I0jE?i 7I`l!n9 Q~ю@N1B2|p ^hJ'A7:ڃj˄#& (c(s@=ϔ ted,Ah3\Bx5G2u!5ݘ*!hx Wh&ŭ?1J~#CGܲE"/h]1Ĉ.b&{=9ufcǒ G3bW`NK `qq-:m (;F[;Jcpَ"p ~WF+u5P_<̤9C{z^IVĆA ؀;@Oŧ.0htHt ,:"`aF(dʎ"JYDlS4!;#(: JБI(CL[?@ jeGv#0O/gl Pgǎ׆JcHL\:6?j& eG|sŎ"Jg 'A@Aw4KL~_5+G"%ˁ*Uðo4P>X%G]v|f6?F2 ~G]]Q4~8#(;@y(oUUvL뱪-)a@;ʅ*CaGPtYYYR[jt) ;Rb^SJ4eheGXv ADEc(m<30E;*Pܢ#,: ĦY:Tm M*`>hm R#heG1<,gGPt6P~mŧMAP~Cy=&Ž6P hG* ]T0/hGyTQkohpa;Z1hGutL뷠DL[[SLдh1,tLX|\N# @yŽY[Mˎ@;ˎ琰yHAVCU|La4 j!?w[1,tLhv?&e s@٪- /)fhXweGXd+^CZTXiJXyPt yk7eGXvTZۛ%5;D~nsڣK<>hG}j P< vh:ECG[i[;&Rv5+EGXtփIAG+;,;@y+;=tM;*NWԤʎ6PH$5 7W1[TZQGTZ4@yhAV &V|hSF~h"PV|(ʎxDheGXv4, M?D`'?t6P^6Q[_hEGXt@y>IAG(/=%E~YUM* o}ޘ*(;@y(owrdAEc>hm BG(fA;@(%Um~n^(1E`T S9(o~}|UvQ7QS%z*aА|t|5h6P޲ (?]K93 V5CuQAu^-*Q^~3:Ö[ʎLQWuW-; uV cXOYB4;msZDiAMR?Ð ʃmy-3qt+T A t3V5;D~n[7qj+>x _Їxn;1Êv3m+>UR%ˎ>A`T._ơYM :&khIW&YU@!f.*<& ; 7:jo leG%:&2G6מr&tGPt JȰZveGu Vv[ԃD# {mh $PV"Kh+>5VsvRKj ~fS[ S9ûf ʎ6Pʎ[ ;F ])(:@y(oV|rŧ|V~h壌vtVڊOm'EP5RãF%;1@G;@yBӫxT#6*Ȟa T~;E{wa$JH m2 v#F cU "E+; FNvheG[<6xDˎgGU( Iꎠhs6?QJſެ# wEG:ڊO*R BP (?]E~ pÏM|Ӯns>5ڊOmŧPuf9cmOh^ '/rf ** '+/B79nZq۶~fYU V mŧt(gǎ6PH6{ j-:ZQI2P>tᇎ6PddU(**7=3.єPM=#,M BP0[4SLwQ*ɪ [խQ0S%%CdC* m|>&dG)tLvg(ojj% Sw vGy%V| ,7t%V8P>\ᇎ!7_1i[.J|cir*dǤX#dh<(MZO3.advXI~ю(v#9E;`GhIJ::&rGy(oqnXTmh<(ʇtevdtGuvcU[vxJmmްcAá@y($7@yM1a T~d|V~B-adG(/ׂD6&5&h׷,tXJdiQ >Mcc(^ vT O,; yk0sj೺7jSeio|6hr8EG+;JɎh+>A4 svWvT𚡺@h^ ** 'kTQxM^nQXʇjeM;JOM Q1b"]V}PI[JHFM;m~n-邒p&7wU}((CG:@y}!"JbD~H ʾQ-Qf!1D+M R |y믿(nl Ḛ,U+(yv^rr/;6Nlǟ':6 %F Z_625^dgM2{i6Y/6u^Eds9寿C2v2 HKKqvRZxTvTnšaxIJ!)q g5l*ŎM"eǿW `0Eg(~1̨%̎5Q;vvȎ.-tΎÏ|j|Ѭ(5{Ï +;@W[g/Xve(zX[XY vȎR?ٱ>XfvX*=&9;agG &P> ᇎ!]vF;|Ptd3р vv> k>;$VS 7;@G~}h[RJ-T d1yxOSS[Qvĭ~>Yheci';Kv?B r=ᶸtq8=42HfR;vЕE簕Al2Y^,7|t}CW߁]RExGbdn&g} I]ϕYnc(og5rt;Rwӧ~e0IU;^p%G̡. r}VvaUY v|fr vXa >9`oR}Х)x*Rw;"C 'z0d4jY!󬬕c9˺DSSxg,( 70곲p P{]#h Ur}V~n\Sssرip̎}G@Yo7Go߰͛7ʎ#÷xYo߶+G&w 5)v_+5  5#вc$KL.3) k f9cرJbjuuofGSA&;CKݽ{La qv,+StZq1CCI\Luiݽڝa$ͩ' A&ٕ)a1?gHc0;0ip1ߓi!Kv4CǐفmPg#rLuYx D ;`L;>3Q IATp@4 (G7ƎU;ҔÁ`tƼEdtŲH(`ݰA3Lm*;dP&; nZVQ-c'zY\חM7;@G@'I-I?p!?u !Da;P9R!6PFi 9!-geL#v; Pj"dXa dB-; ;(-$PXѣ~;"Br?MgCƻ<``vK0A1Db+:@y&Q*P/~}[-;_pCf3zCD;;(J"AΫC[UWGG(ﶪ';4A]Uʎ5i Q5\3>+Ia>;!PRptҰ v{|9IpP$aL斗2}n쳒y\ cyRUر(6BԪÌg} 38 )+iM눲7;f_9 tc t\-dGgZDK E|\dG}jlPv@}wJ=TX%b-`Gdbxa)!+!LvM+O険*MwDEZwpjpr->+~G;FΎ+i3LʳrRϔe9*'xG˶(7yVHCbXIg%ٹx#/ŀxG.;tQdP,!Z 5278JY52Zk7gYKXy,*!SVɹ,PެjX%ׯ_S>+=<+(bdXqa?Uϝm<2o%ID ;`G-#Cgl%6t̤!UʳҧLU:9LϊuxAަ.r8>+ɶbjXe33g&t&D|9&ʉw Wi?rtɓƃ$WN9yVQbdkx.n+}KB$*1aVQ>=%k,=V_4;1ܔMTx;$\n6DJVvLH\iu<[J͊Y"V^r4sxXOºCDys.e*yTffT/KYEԐɍ 2Ll?gqQ:sCvy$4;a2q>1nFu: 9E5r-3AFhC5#UDuǹM 2tGVc@#i+1ܓ +W$#$f8"1*lOG D2odN+G^xcػn?6kfgN^S6=b_7_zP8*N"o V6O v *QIpF[-6exorN6>4 Vk1)vAYs쀷h{ rp[9V1vȆB1^iÜyBs,_R2h̕Im%>&xb5}L&:hc>8VC@AW|W Ox;WGDʎϥC97kѮb㴅9IVŽp- ü Q)%(og5y#F v$ Rfc[mNHQvd>/vB"D+O0``iM0M?v$P!;gXAqM U1[L2:!e*fPm#]P)VSkvL :^rYQxEߩV>(ʃ%}@k͎欄Uϟ<~yYG)xN G؁xQSFZO2#jYFfϿ. Ue}V#gg* D26;Jx= rMĐkÆs=];Jd{x<,; 5D>ؑO>ǖT@99!76.1#aGTG6gݬsލm[n9upvW?3;~>ZvtS*vLJU/#v{}txA^bvHo`)fGՖ8A#ZCFgK`.BJq)Y>&P)7Rsִx'kML}Zߌ(_ AV///hҥ:\v(:nP Q0xˌ 3~mفZɏlvz[MY9A]#4oV;|އE6=Rp7:?U4`v\`Fo8;XZ =Oe,lN. ͓%U'KK;xcy-vVWSpayZĎ{CeGҿs׽{qKt_ x{IKny"<›;;f3Vt$SrnYF 3o_H˪T~_/"BުTy ¼|yGGWGGTL޾'GOCt>t>!GGǀNL3nCTw|<8H*Vr=~GLEA~ǸhLxpN;L |q~Ns1o/qp_rN [UFGW}_ePd{F3mm xB׳>*sԧ0a ɸi"[:==]Xx)r@8N(k8=0y**;n]gpU"#Ou5 $&K6z%uRmEoyaKCiO_ŕxv̸ALxK]Ya_W]ݡ+}I` 9Jm Ο<bw~?n;&Dvf T;BsK:(@2ܤ\}QNAb~(1SwCEř +WwXzQv4!|fȹh"'BMeRj x7?4?95$šgEAm=vs"zg Œ>5&%9jMt?.+VՔ lT5!Bk>BQ+pYm R:}ӟ]\,g eYL\4X>:/~P H1cjn2#XWL,KUcy6b\vT ]3|-;D):QnA*vOxq_qCc%B\,if譤z&Ev>)ɳc_7>!uK!Dq/DKeVpk@A{.#X8?;0y}v80M.>݊cC"X\%98;eq|{Q'A!mVdw paq2c"1R ;#S)nkbϙ|!1w;Fظ(RИ_Q (_Xc- W vJL PXqOLYf8xp$:o@NfWWc 9HHvm`4GNY\i&DaIBb%cj8H5!Twɮaî8]\herty@,;ij%D[fWEhqE]'d\tLvAQ<8[YkocGJC aZ|uX&B xasJV$2LFngx?1qrE#0_* v,i\a HxL VPo1v;쀡@$؋j=\dWzd7ʳ!rP&H:!.i;,Rv):a*xL;eSWZvrY5( g!pτ/_Y;su| Ug)`+vŽ'Duu#E~6 aAe5G:Ȝd?@(Y?v`DƒsQx5|;`(ܫrtG$YC!pф(;8׊q`@rti.dFSvb -v S*b-ʝ"P\;>ҲtTn)yI}Daءl.e*F9Hȸ٤f4dGw@Ғw,-Pl͟$N(t-,rmݑ-|)i6j^v̞Nk`Ī/v05ptZp)q8Iv^>M dlȰ<;9@•6?v>Ps*\CbNàY?Vϊ]R?AV>LCq@ +$6aY{\v9Jb>+KZb0N(ʰ$jH;"!|)v%FBaJcvhUxIduk~2N9>+%d?tGŧ?nxLyVy>+dXq\9 찱X9Z +Y}go`ec`!X9$ w[$ilE?jB!{10s{`b]ٰ7QbʎۍuQ # :lX$|vוoU&;ʯeŎXy2PGf&cr8R>+aqEy 9$G7G|y,!0N(vHʱ~|FI:VoQ\؁hQ+LA9x˅'Gف]h Kɳ9 9U9ܰyH|`I2GWuYYa/96Rl6v<@ZV,G;q #7GWrMɳ/qhmw|^4M5`yTxs׍rt=a֢ |<v I]-˚"tןוER9f#H"쐴,NB,*;-{4(++7syiYyV:[H}+P] Ud$;>ho D!{Xi^H:]&R.|R9K96ukb~˪h9l3*Uw`oeGJg|^<{yOn.D{=čx 4yV< 4Ⰶ#sS{#?U2#L vrY_EaA 49<+2702+0P@Tܜ2qRE{aX`|]'m4?+GWFⰺo i#0-bv@i<$[Ëc_Uu9D~}|=>D8I"?L3Il݄r&ɍeuwЩ!AM$gUcK 2;n8FBp2IΌ?(!gH3Id^1EHXdIrCt0gO;H 9^䛏| L@=AW̿sHԶ$!;4`@o={.L5g99 ItIB-u& %$#a%$f"Jwhr7l&AidnC7 3l )gi$|9:Tt wy83y Bks{pFvc4|s8ak/ 2-T_1m`1;4zn4tʋ1$Ϫl3!2JF+(QX^O20!aGWΦ3gs<5CW!xw rUB0mV1.4plQ1En?A0֠-dC+Uj;?eG&1bVن }|]Rc*45TvBGs !w!M~rm^ [TSo sHzC_Sa";MT0فzĭ&/; G=t:ΤGVuUGmtORУqˎ8'NLA|< 8:҅fI>ke9|tP.!5|0QJv|&&OI^8!g iEQYnBMG;~QR&ӌt|&(#Jz/ n)/:XЪEGuLd,\G`0Vv Kuv@5ˎ"UQ؈MBl(2h# C+'Ev QwBg("юVvQ"yx!ńʇ;JvҤGˎ#;;Zt|6VvӦUh1NdZUs(.csg12*Ȏ-:c@DUsTl[:j‹ +P=%3t.ptEѷ IwBG((ʎVv@DiP Tg)ʇ;J@9*hƤpgK(Q* (Ay*1NcmG*/ʹ:S!.yTtw&[wF -O r ;Q' (fI!*XmE}yffݽ94cG YWy˒HɎѼOeYdUW}̕ APޢ B . U!C FoCؑ3)(*bG<lUXՖucؑSC`AUaqci` b@UɘU_kYcG:8}Q CX1/^RMYb/~v~AmS7oGycny#G?aE9@snQYee;.TT\pB~'\0. 3Vʎ??Zvcjꡲc!JT-C3١쐐`!H\ !\ 0@H< ÚA<2dv @ DD˕`G a1@WS٫aB{=5n-Ch#(}\#0;dky* 91Ak<- \t% [KX&ScE[yw һ˼sFFUʤV(w hÇi;Jc(a;~~!ᛷGo:՛CfqӚlBف|(nJ@,$YR7bށ(I;x܌[Ww˲\pTe'7>s(n-oU.;D JVoL 0/c୚a+ovHf9Qˎ.%W}bùO~hQ Q]v*;XyXr2x>Nh2l1gLvP8x`G"VrȣQrGwDF57*6aLj#u[qs#%k4Fwct;\"2lA#+b8Zvbǰdaw2fX9,vlWGG(Ti*@I;CAEI|VwHev8;ktFX+ r}Vn֔o#)wX3Q'%ʓ1qqV> [ώD;KX;,%ٹg糲yVY>́occH;<+ڽ簃|VmEpcߙo6J؁<ʑ67x$|VNg9W+gvq*60;x7;L=3\vHnς }sIe)%/ $e3hW` *ζ +äLqW:* dbyVjfd~BC؁<eQJvX@4$Y5rw$XyeQmŧ8sJk @yb<;_r&ona X~ްݡq4~۬ĎQQ^L$:_,?Y:҉a=Y4 O&6؉X]B@{vpsNwqAcĐ:֐]^ٱוަnwk~ }h NJͻ+581{=a$*rgn.h%c0g\ɌleMs_r$'VA 4 vTʨ:b7D}ĢӘhGMfG%ML h^PS6}V(aʎA(3%O:XlTnVvT v,;~#UݚElΦarb&$)Rs赟c^w c2ذ籪#;GGO 5ZutT#N.!>;t| PaxYm6Mslċ5;heenL&9Av1:hGŽcU?IXD(Whi >CvO2GVF쐃z3Q ⱢZ=dU-QCڑR v ?=*dP^4NvL(B.VvHyMQ<_Kdi{ך>lͱc"e_jGÎQ3l,oR@^cRe::@ymu1[ަ9{}VAP~:|6j-:j\dG}j 7"r g0ZxİXM";F[Y3)ĎxD}Pghq 1ɲY㳑E WD(U| őa%m4ɲ!vBDVv-X %?,z&8P;@/M*D;C?z=ˉn;.C`? ehTd%'jvhGXɼCL0: ;ͱ6'2??H1Qю:TK3T]0"qфgq^$w}}jr+7Lt!v4d$1a0^dB<TĎG3;r{E@)5 8|Äˎ&tG)t֎ɩQ%Bx/e怢v1:kӮX߰v\ï7;Jv3;TE_v {~܏BD~ ;pesuU׏qos"D;Ч\ 0zשqk-~u^jH0f#gL\k[WNACujRXQUYUEŠ TzuzN;HB ;qv`*tŪ:C,3}ԸNkir<,ZU%Lr@K7q@q@kX9gXɶZX"j/V 'TD H;0+;H'L i)v0y:(b4eGKdr A1CJCPd=WĎDU.;TԅWe$ C&\ߌͣv<|:*|ʎຣ;JyZʎ:)>Ѱ*9ALTfŅ̵&TbG 8; >Y,!8Î,/ϸp$;#vIP >. YR1VnH Wġe囙s>`KF(Afx=;"0O8>V!vBǸĤJv_wX!"aID}^ȟYou볃RCTD;(#b#.|C -w)5rsc0;JɎV綣S(!xrtG;b-nY#`0TeGcm-`Yݧ)g;EVYrG~Yr#{)%yV `Gv܆΋HZʓ+w#y F :#VBþ#+we*5fG(J-|>^|cHɠѕyV;L]F;rف['SWH 29ek19&JSvfYEn6OT4^I-Ք_эE)4!{&;b9&*?GB&S7r{]+ȷ!o_;Jc\m~nD)dCA+;%NmZ[#K3ԙ~򠵟uG)tG yGqU%T[ƎhLO>#(Ŏ,;JR=*(mR <P얡c,eI:ZQ 4<4RleheG%q?(%;F;J9b$b4 ޢc4dQ /; OPMAPޢEG E >@(b AV4Fc@R+;#LvJ1rGE)φ$ ±cuzuzV]U;DLt$D ݱ>7EEwv}hD;cG驳1dv2tLj\dG tVv[ 2;ԥ.CAʚfGϵdQHTǎ챚cKNg'KK킫rqv?(#5ݻ~dӢ:3!C/wŹfb>5b.zZ4vQeWi0NOMrޑR\l7@sk!#0 [aC`+:(2NMMTw8fBtoH7/=Cw>5#a$Xr{c}vW:28D#g٩G)Wp?)z~Q3(؁فySsovPeuf c$/S뻆2պ }:! ?<\/>Qrz8#{&ǎ,;FqX}Ffg̎ZvPHCՇCC809"` GX;h!!hkh^Juex??zd\:ĬL>|z!;E x6ԾA]e\g֚BxTzej|Rv5,;\&P+5@B ɎZb~dCTgU 4;(B!:-eth"S9DƋhe8ˎ,P>K3 XшoFwOuEI^a*FÎYtJϪvZΩ쀷4!ުYzB;Dwd)v;^땖}ԧ2N_C{y8MŞrҟqv4a*$ {W񼳌}ovM= xOod`/9td%e_k a㖡cjIWxlK7HNJ6gTYXʔĩTn35`3HBC "r({nbζCq[U-7*IJm2߈䱣9T|~$\tPէ l;\E&>Dwꓣ0.<ךg$ 7BG޵u^ _ͻ؁){>ve:bN(7<8uJm#h(t0:;Kv4Ύgg&;AP<ʛU ͍Vj7.юԐ*pDpjp[Q?[ÿiќJͷ겣XH!*(-MZ#P>(ʋaҲc$*=O;ZQ m gaA Zّ@CLvj rRgvQ^MTM A >偎qʽIՏsV W-:F6{&2??Hštń F f:ubUX=h,iQIS/Cn1dHsv7߼y }1q;eZn{|TnV5HcON5-T^ߝW]qlWvwA7P"!f?p:c-;:hoHL;ZQ(;PD竗HP4NAW;qڡyst&]?%uFUj} b7yhNvd eG5xdvU\v8J!hzI`8`==^h(22,;|eGѳ R9td(vƒ~c{{ +XoHhG`Gmt8ˬaqˎ(`X^6'%Pc;`{^(vb(Yy(ij$Ͳ:;~&5y8֪ Lm,;* '$ tFSF4h4 q5 R 0X&%o :2M;䱣9tdd7`h߁G,BrDx`Ta(Q[vğZr1F_KX[pAT"WnAT&0Uɻ~-z Ȩ>+ny^@Cxi@w EpE5~PDuUl@I(ׅ ^*FΫThTwxK7xitNg6!#FQۤdMY.1iʹF6P^C꩎Xh>ʓkk kk2?şkt*¸>^939 CRv,cUci}9_ٴ<3잯G rAC<'s EUrfwvww ݹ]x>+XX0vgf 3 #̈5s/8h"SK >9x^BD8Z#>+utW߹` b1\O8~>yAsp4cќv4`a,7""G甜EC}=W@G+; U}vHrT'CʥAAr}6sfLd}2uyM>%e JONԐbW25iCŁ}Y2E>F+[A&,oH ǸoWˆ|G:V9ԮUCϧV6jq[1L\\U⇒RX6Yj`ճg4;`+)vUndYasu[ b#J֬_ ‘DOKQC8Hf*2Ԉ%+$n(uXJ"vjrvh㌎ 8"P ~}mj *쨀ځڲc#ˊOkK ߒ2q a˩JVF+vec}YV̎98b>vO 30!O,Ŏ]K{‐WLVv?ͪ-uEe$K!JO}n肓#gIVs TP$ASUEnH{8#ʳC YAԦ/);uztDvp֔$NQLtEQ1v?;V(SF ;V>Y ;Ȏt3UsM&V.ÜXyND] h(wt+v?dDyV-bÎ(VnuJxr}V&- {X:J#+'x17r$ntG,^VwBVFB8!J)v7:8V#I=*DID9˳+Vvc])YIR(T?ɠrcyVL 2~q˳"ѕ,+w ;$Jca_䳲ZB:1v0D$Vhɾe[l+(9JxG;&ͩ@o 7-;25}R2a^/AFd 'j]vP %} YcM{&VNk̅OsO^AFhHCjG>=Tϕ`"prhHw0IV6*geƞIbQeG(;~?@YQrPegC"[ Ĝ\vh|XLZwDh$CtHS0 A$$Mm>2;p7e`xsm=D51ԡ!Cy:*;kJ?a&#v^g5ϛu5ǥq&\۵_E2B \{';Ʀv+CaLz!!Q/DG3ceGv]/Ld(l(g&lb F\2ı١:lќ쨃2c' (DG݃2R:ēCy#OL M+FtG):eg[U\V# [~erYVM:\ɏ嬪Xϴ*-*`Per яv1AmbFM;n:ZU1J EА c);|-ȿG4I%1Rv@F-heG6n[~_aG.g%^Uv_1 |CϪ:caKGQ=*0Xζ;w)vt}\3[u4F, 7cI AFT3 7<*XfKLQ8܀5eRXfOF͐kcy<:nUGyt|_ vl:}IۢhG;ʣckKFo1ɉE'KτϖXPX,]0=. * K ;PAe}aGCQvW`GIeǜɮNsM!zU@*:&HvZ۷R) iUgGT|aGDGڶ8.zP^lokE92tF;PsŶ7{֖v )0GYs( n)ĆSJ;"s: c$b4KFPcbP*lt񕎆@sa.; < +* cZOŽXATCcv0;Ҍ*ʗS5sk~w~?kf1݁ SsQ|4k }wOKM"У ^JVnϓy}3;հ#S{Ƌ%~I.)3S]#O chݩt?|sx?" }Bcg^ٹ;b氅':d::FƎdO"-'n>t<|<"(YM>zp*Ӡ￧X=q}``{xq;Q9gdul3 1Y\ė cmuv??D}Kloɗ|(Km\.hG;N~{+ˎᬿ4pkK8[XmuvAgbhBzH,.xH,0Nx-Ё+qI:6,مGQ'vmuuO\>ZbegW>"sy.̩t}}۝]ߠBSrN=C*rXX]?YDwv}5U榺˘u*FNw>\PSs '}p&XUagk 9؀bHVN-1vB};KUaaB q$K> ?)"KQ4ZCTdpϸ2H[JyX.) \yӇ@5f c:[/,b?`m,QJv4iv@a⿢H"dBX5z΢PD?'47Hh`Ay8L4ͳ9&^?FmJ]aRv875ȶF$J`~@K?yq+$VN s bÈsNp;tx ;V$'\F) 2RP})@N[ZmܱTw-K;+"v!>м1v[ǀ0E)^>!MK'Ɍ+XoA38\R Ǖ؁Χ/bՊkKsk>P5Pw ;|d[ej~z{~G۝#>& {Uv`G^gC"S>x^6q-<;poM<;H0Ǐ⍑)yf;=} ;wŻw y^ ϟCq\>q7{qI߸~Aa;?;𫋾cmm z`k|?Ɏ5(4;0,/ /c^\A -;peGamˎ5hՙ5S|8cu ?,K s;f)gZ@v`2 d3 22]F+ne.뻻p570f'5W33!qn<|,껻 {pfX | ?,(x3NDc0f5`{ CR@OY맹s|_?~A+WOtmM;F,; ;?۝<+W}0OFBC8 !C<0ȰC)vV ;Qߨ<;\&D ex!xY%!Bi%b? #*"v0t*3ɾup)JA*JtJ!-CqȃHQЯ4;D\$'B}z-;dr"kc(H82U쳺R@v؇z'>RᒴJevJ/M2Uqm08:d[`pTC\NXߓx4!CӇ! dm!r^¿ŠPPsUwG:h^ða '5#2 m [vJǰIaᰃJC*Й9.GrrtOIÊU߁! w@3E}VُءMLAZ]W 7;t3ŏHwe0!.YU;֌{ ;Xf#;\PN3USo`W}V乲-raU"J`x^`:v]\ FS],v {л쀟J Xc`bsM< AV&Dn䲃u;>+`5KQȎw8U_|V|V܈VUvI0NXC\XfBHb~>;CI؁>K>+Np QQ2[JG*z Z_Q"Ykbݱ<3YtG6;Zݝd\_&)ѥgh.;܂?; nA%:$fJtsbǜL9 fuyk'ibO ΫA#L''c1Bht q8'$Nz(PV%YKKB}Vj4;XT s$trC rsr;L@x^/;"?͕ 볢(8;Dkp ;< 1ݡIW֋ifDz W ;DNXyJFYC ;(-R@uOYa>+g6 gGNse]X}V)vH}ң:FŽmroͰ2 qxCQN#vqU;lthMMH@wz$|VaPeaGbfd[YU)v$*?vؽ<+>+#$ QeGnΎ(A H$=W jlZwo ;ekʊ⸅ĩxG_~ gesIp"owa2p2H$Ͱf04!Af䱣9tx2tୢH;~TCf!M7au+&"j;yVded' <+d[I;bv Y,mKgsx;ge2zQgX ;"j|DC(eaG,+&@zĹ&bn\a2(іUmU[%>+7ϊuGE&݊H5*泒g5gqxUJ2L.|VcG^U1;๊gaA>+cf7{DwV;4_Jt)aGFj NwWv.e^yV]ΰ\#gs<+'m1;hsUͱ/P.(8:]#MktȞ2;RA찻f-6c*f 2 Gb}2V68(&xeLKJ-9L'5Ⳬp)S@wGɷBf\Q1}l4S%x'[1..v[FR68Anq Ew񡽧~7'H;MuW$,="dzf?GΞ+A*A 0so]~EMs%GH[ʸ5%@q쑻{3jlC;#ИA2:Iv\Iї{+X7[07PDѮv\}qqs'&T GȚ"}\QmEgΗZ"CfxH2'V%J\Qr6 upG6OP9ạ'2FQgǸ߿L S!0V1VT*kRP?SH!(*\2N&alv {)|wp) 7I:;cG="ΎAeTa]vEGwG5T28SU@/ʮl?Pw9X{2[J6E>掴; :;cG P˴Ubm<0MJL\͇k6@v('>hG4bQڢ(JL˯G oke Qw4Xqmhs(E-`G(.hͱc5BU(7P %JL5k=VdGs.;6\wS#%ǀz|RWd5hGyϞ\z8d׭ l1;KK'%>=NNJȱKK;F^],FVWSFY]wW>Z޺`Yi~ވn4^Xd 𗈟^4Ny ӿJggi@?nOXʎ·R;qsSNAA#VdKGJ m ?`qAf2n q&'5wVW'vHX eـ옚[ǏDY(Z~ ;{86Ψqㄻg\^ϸ'sԖƉ F6>'4;#4ueߟ-1 ;f)hN_Qsu> }YY]PKiuj35h}}cc}\u>C]6 2w`{u5CqMdv~^'4:b%(ruaY]W\߹W|R0Ac2G{$gJbf7:ihKlѓ5!_(py4hU?(wdR䱣9tT 1ȩD8Ƞ^9wڬ lG;ҒTP sMNsrjG;.9uf;R\l.e^  pY'=b˸йcekKqmQ0gC8DiIϵsX!?ld_u@|8R\}su5J1r/d-zT~G @O|0?nryA;\!#PZ\K/,H@\~Ƃ \i־R*Jr44,~-R\kSSƃVڴ ڢLchѡ%9!")S"|;Ċb> 7_d~F=eMт 3֥Nz^9S5uFٝƅ6)?ʥN=r.sTf\-#B !QVwXv<9:<;<:z"츁[ j3H'q>zB2dD^gYRvjYoodC36;0!Rw.8a22"!rt%f؂?) ǔa%Cq//{(9WL‹y+ Pa;R9Q0Y\lqr~v,8X"}UKӰ8f DzC0&Zt^^JΊiݱbSfo@B>"Xܻ^Xyd1MyV s˴wgn;sS]";0:쀻 柝Vۙ.鎽.f}㺻 ;9l SoxdArBn\ucI?opY; |5 ,]me7InlbG";x:M_P0$!xJ_2)CȚ+cuL Xm+AHAP 5eI. ;zƊA+ic@Ԡ=_}<x iR2 5x; =e%S2 ] r%ʽXB@8$0< *,]Гif3h9/0;>`AUB `IRziᑈyGW AXkH#ub@#."AIN 1;tŊ;XY vj9wLޝn,,x[3XąTys뀅d؁ANJyE_ErO&r <%\ Qduge1 g%B#DHr\yU+sK?>e <닿 ;O A,AC_:ءV@ ɍIetXUP1;Ȏlv8%Gbϕe!;\vhΕZaŦ>x!`qA+~alQv ѿ#V1;$t˳CG<+uE9ުLvy%p!p!(㹲Pse,H>w!4 ;T̎{<+e\峃Z>,pۤN(C ;XPò!An'0+ Ͷba!+ 59yVdfy^D@B4gzq\c~&;ݥG5(Q)Bl-!k뫕uX=\XΤa¢c(;td8;>wd<+Zݡ+=b>Eωy1(b4AOBUv,@a8Xw|FuD:ء;.; gtG' Lh'uFG't;XZBvKYY݁`<[ hÿ_Ž+S%1CP9m v38Bp\%쀞!+(;0Ń 7* bTYwf١7g? bSx:K hA.;2!ɫ2 ֎*P3 ;x "^~;lc A D#HoEʃpyꊲ;bp6|Vy`RH#ǒag,xЖv-CA$bDcc}.p7gd Ӆ=P1;K_A@_4S??v+ +O !+fc9vTXC|V4kʍ +bGHR`?UXp҈ϊّ2Uaź#YkR6Aέ(6fokBH0$*aQev J-3 ;2I;|V;Dq՛ߒl,i24ges Nf[;Vl_LwaGzGyj;\e[EN(p}V7J$ H0iPjeR%ԋֲCGs,;}Vc))+'q|DoJ㛬A`T(dǦR'T;iO쀯Kw{#+xSxVp^UxGĎh l`ߓ)2Y 34;;qȗQWI9P |8ҺCb‹kc.;doˎr8"v -1'pnUfNbj j2ax ӛCˎ!QYv}#=n3jpU1cl+rabso([0\dn%Jc;`(;v`udvB}%wbBV0\a)q +;(w ;'ETq~CXw8#ꪒ$Lݱ@3&Y2J\V9YwhpC6to YqyHY:ogptQ3LA;*])bfbj݃%d<+B•a@2s*%bV]LT甩 chn\W$S ^) ;/cH&B].aHcNd^G;>x<7W2V9yVWi8~RrG0 UfAV#%?fX9]]d=tVI.]g~(Gwuo;$eGy<踗g%khF/\o*xdFIb Ĩ8;@oeC] v&]׭*;yV)M,F$GWHgG=JA %0]UȗڧaϪY0Ãq:{XN|2o@ F"?eF:VAxLJΓ^o,at_ؽ},V(V(B"sK†. ]t)LmA/U0¾yIeQx3i$$x|{18X}ƒnҐPqK_bP5ܗ"y9#:$ ;D},j\P@ Sݞ/Y(1mcK+MQ,;hKɜ \cpr2b+iP"H"kםq4y$NM*r>;?c b?hrD}Q'CH%#>JF̱R £cQca b3hW a~„`9\yz;՚N8 ڡAcm0ZCl;th)UM*zp NW\9ڢ3yfPh},iW tAVV}" our~~@m0:gl'vR~*zHC# 9Y]f)Ai@Zp<Mbh{m`J"dkst1u&rXgkkP">7j/yz:X*b&mP OJ߁nW,/q)9q 6}z]iGt;Q>U^2i*l:;fDGț&=?cɏn}V?)â[FvÝt4;cGmYbDp K#2WvxaQDZhpT$@I­eH]Y5釻ڇ}䱣EG9TF<[ʬT'Nŧ"~cpiZ0YxFW| ˆٚ@GúcQ]uގr::tdLdjQcֳ`99p-;²c/ QьhRw4VvdJhe)R6-:¢c,eG(OA;Hc6P^mU![TbC!tORӠxtܶ@y Q2Cy2Hv k}-:¢cGsDʎ@h偅-CXz@yY5ǎ^Z]V3 vKSeE+; AXD";Y5@G1=0g"iP~=b3^MQKKmoSVCvloDtwrM>07l@<N ;qs"0#@^Gj?StQ{6;bm9z[Qnv4+t~V͠G t=mayHce!;ˎot;C1*ŎHSTqE!\2-;4^Rt$}V-|ّQ#.;~#hTv4;cGفp6qYT*8;Hɵ"vlUgx8}D;R9;̠d~x̊#OźC&%vυ9cjI|pJSeY_:0P)q,v7P=siyAe Mw80AW%LӇT}\hP#/gW >3fv1Lϫj1x{DK/eXC7m3;6=?:`u dPwQ|/#艱A}Ëy#s3uO@#t=G#v\>~s?~It.="<0>-a,vd?^zNXBO)S1jAhl +dPq%`J}t͈sx0G!eXvԟP< ;EG#c-QguksW5J g\#7ȖuQgMdyT059W2VY!+gC$+o.`G$Vx(\/U}Hk3VQv+(bv ']AL˳O2ŒSBeSCx}k+X!WCLeGLqp\|V\ŕR#1@ļ K,* ;\ !#$ZvDB뼢0X%H%tQ86wJ} 69VdD$Vļcj8W,PP[QQ*S җ +U4;FGt^aevZ2 q;5KuZbw x\JJE2*OCPP%`_d.}}\$ݵC eApn"׾ {ədԇeNJ:șC|ZJ fJAh@v$^b}ٱfKE.'ZxBh Ya\!>+FMM;ylvh;8;R;#+`4 OJ~C*!$C" O@y:m7;x UF+;@ƿCv~2(f; [vDxD Ci<鳊'V.;d>+C`Dg%T:quf-agy+TO#;Ò*(hwK(A)!6J7Sˤ䱣9t}V3uG;Ǯ@Q/0L#g]s΢6r!*`XP# %Y 4qEf";$IV$]$+)v$aah#hdG;5%ה5YUýJJ 'ށ\.ɳ2rBGg51Hm0v[Xy;( VaY ;.yV1Dz. gE3bn j̹TX/pET.'*;kj (g=^$ȴZ%v3>E'YggEu)q|\wVCʊwcj"w 16aX0hn8;Y;V4 ~K<p|Vt`VBwws ~' g_aGrCҲ*L(gͣ#8;&Y0yVo9fg+Hݡ<Zgem-;(pͰ*wGFkY%8YAY쐴,a`pU"C#%gESHK8GSC7oh ;0yVyVɉcݭJ˰CdMFXF"JF3V@QVwHHdgGsXQ=T|:z8ޡ{C@RēhS^F[n@d[!Sk=fU{ ;LwLA;5!H;;g 4@ɪkع#yV}`Ro9$2`o&$1/o4t8AIV/9D*ΝzǿwVZRw܍mKjꭌ]A1ѕopr03`N kYmꭳTy' 3s*'Awr trt4DZw4ǎ+`II&ͻuxxgΓ^&;6{=s>.O:gF+b&b,-Z|Y~z2'.l01ݶ4"v3.+A;q ` lD$. hWu->~L{NzťY|ow >A^3?֚"M<@\Bm;09Npdiq Jh;dBN/`GiFOurs\:_EfqG ;ErzJa{WWzӳ6gB#ctuwzv}v{]Rkqb\᫘4&ºKi;2Nm: @MPّo+:x\@SuqtB>yh/;F겣ײ23 9*÷oz9v#KEǷ%@y  *hP-. .׷9;7 J~䱣EG9QcʎbasտM}EGIZp'~TV#GG+;X`-h2 }ۑc%up=@&cə.X9 _Jp@y}\f9;ٷtnbejRC9; A<=J %jy 9\}`;stalwTaGqy1st:ΈploQ}`0%lJN'v\E sָZYZS[#tY;8P3"n땣/7GurbTkZq|e`"sCM9͞,CoS\&:U5gg*;Zir 9>9)?q}ANr;\_B.!ꂊKr~V1;j eID֒[5)Ir*KЍXR bIeʩ9c+ ;$WopszA^;x[R8rftq\`+k8ϊ߮ʹL*cZRw}SZwLq|9%NQh~jq!PrVJT;ZQ_ RQʙ73fkysD ~Krr"x:`͹>n*ROw 3L1r,u4*|5,ը;(=>uc-@S>.#Pw|ee*R\Z~T<  Nv܁}.Sd9J5IY.;hqvp\PL 4f5EVan ѣ] S-qbND]m>?+й'>HVZ4&2Ŏ9Vn(@N ɠHʅ 2/:<掵bSb_v).v)s;q2Ԭ Ŗ?Q/vh&<+H<,ax&e``VruuG"8\vp_ ÙYX)-qIW kh^.?оd+uH^cpVĎu y ipFR`0^i]=PU2VFI D#]aSءƋJV/]e>baGylv׈9+ZM6#Rjԙb*VxRFDN1bC!ثaF2g L bSS‘;9o^P =?~ȯ͎wHA苗D/,;.?я ~csDɋq3|IuCLdGԚ=Ok8#aq̎%(~ W1˅`ˎfu31c2Zhs1v2˃1Pv);vNA`p;x1فu1ώ+;+wvww ]~ŰKp!wVs|ŏğ4,ꟸ=_v|BrYŽ?>}у?#1Y50y;䉲I`b0UxМuCR賲*P5)Gw0;Jx.|Q3ϪAtBC)3pܲ# ft}Vf?E@쐩]Ua#$U>;ȅ$B"v8ыOQ9>;DBzkN#HDG %"U v+;H6JveX:Q ](<;ì@YxױY1p"RDB82";L "ipHf 8~/&q|V?ݭg5ѐwIJw;d{{Sb;ʰ#O6]睴([nCoaIQ9ڼÎ>xX;H%ywxb2Drxr}V0cpt 1Cm0YI@Av` J%1a/~Ns+3V^#xFv +̾'xnja\J6(fзXٝ,uUh2}ˎ0{8')>6J{m3V0

st By \}+Yaϊ>F"vcl%_8 o{C3cTZNCViK+/ޱǞ-Yٯ`:8-@N&*%!,8yV%[gYShGyp8~ Ŗ]gd_Z);EG;lX{P~( cUfC*(WiVw(Qgo 7'XX(vr5tvy6bQI3嗊 !{&BXNU5wv R(7P#Ja_ЀvO%E tymN$,*GHnsw;r ;5%l;ko"K+wM)v,qӽv77P*4+70 JLu;QFy(1y!nnR ZZ"U(8f-us7>H#5΅CͳM Q1V|yߐwTzt<ѰƍRms[)T9;Ght@v,ю`Љ|k:I|6e1LJdP4>쨸lֲI멑CbG)h;K#[^3(:$ɪ~ˑ6_kt[Qn\#GyLL{l 8IMveK1$tT+R;J@CM]S9uQFurէϐ >+В k/^ -J莑CQf7SY_ eUd߿UQ8^ɗ*:bIVQ8M Y%?(}y5O#lUAƑCQGɐ%6 L .: (^CZWT]`\>cH汪ѳ#sY>vC\-:cU@AqPjˎ[&;@y-r֎qQ܇9:c5^cZ/ǎVvd:0~gl Q9cc8.d(k/h\G:Rk|kQ]vTv|6Vv"}Hc,eǨuf;vTIHyH25rv(2Ɩ[Z;Ztd&duYюJh ,2/!-ZtdrKQcyT*`PG+cWvJ[ʤroq|~i[1PqyyI%j o)?9;ۨ8۸>av#*6ׯC \_Bي'{(?i:\Ysϕ?G)cA;VCyaƍ;۝"t|4T7;+sX';R#Zީ>C@4̎):n%ND Չ_㓖OSSo >:ʎxު]D6 cӄA@YƋCBmc]ʰ(;Ot|l)Gy0;rP!ѱh#XuzaYw,A(1ovf]OvB)<|T;Zv13V:[Eu ر)M.;Tߕ8*;zzU\VT2ΙZB)Vz]C%asNbDS`2cTY__{Rɫe;݅˪t/洫VyQyqEUOpZ8, {dG-Q0ݑŎéW3ʎ v*c˺BV9 V{oZs2t[sLv`lU)<"Ul4ĎaɎM`ot|FqCV Vwl3Aݠ-A[ty$!#zMeOkLLۛޅ%im!*Î 2q _K^=l 'KhioW`s},?~<莋%% zbC0c,]" o 1'Q\qbMkǢ7H\4ȘrV.ф;u7+r enRMn ѥ*aF K*y8`;<%`Fǰ݁+W=^ٖ:i|ƝGiml{WMI?yĦXޘyHw<|&rSwvܵ:;`N`bG) fc? gy @ICIqD}(pqlz󝃏,bM]ĠB t>~Gm?Z4V.#;}< xmD%qӘ|`xܜۏ"q|N +e9>@|<{ܿ$l\7ߜ\^mɶ77@+<~h8vx;Tu7EAKKe>㫵#$ EʰbvP+o0܉#}?[YZZ;;{2/aq>lg@gkKK37h&k.8yD5>=][]Y8EݿOfVQfڽ{#ctvZPsXp~yj}Kq p;" h )gq %nwzv}Q+W s0;dxmݶzڲ,[?xـ24 `5{8Vٱ)d3yp9yvW,0Xذ gN꯺%;oh VG[IXyC`cV0|Vp^B ȫk4U#^lC+̡:;;;= =9LIM0D#m ;劮@r /aeAç 4qi!%jhHF-LT*wjkk㝔=;Jᴹ,οOjwFA=n3eصQ;.!?~9u;VW v WHg5}\ǏyO1IXs( w= *=*Oʟ'5RvwXCn&Pj/q1^c++BvE`e%YѐWaA#t"8WAjV-QCZV=UPY8ψ8> /V_ T*dgg{g i"\% ١&vsss 5b77_aAuE)dVL vP}h?`(n/%ww'.[&Eq^hK_Cv_zB38 tIě&4(U!;$}/ 8`Gh.ٱ FїNq(AD}GdEW!GZ`,dS8c2̱c Hc<elw80γز*0/BG߂`@yv8yBvx0v8X6;lBvMYPe\Udk oUgEU*7BGW8c;p_]U*%;*`qʵMeGF1S̿1\q5;fuPBvm$YEA J5!U̗2=q++b@;;+td* V>C 2cGh؁TpK]@v(;;Ũ}Z>b匠#jtuu?(1v ݯ;"vlPoCΟ;ƲCl^55;Jp0ݡN16 xٺ;Tw%UYſ2%9]m=vDX9rXH,vӧt/h%Ɯ)O >Hw4O4O[1Sّ,22 wZYk2C3nӺ#p>+!`!"mԓx"; M؜N?uU1sLܔxG!A055e!]Ɂb7+` lMU{CX㺃ɸwxvl Fq츗Bv\>+MmUA4CˋwDaҺCm-'ʙ>`FJ/]A!`uO%+g\+vKF=1x#Y V]cgSThojwS+J+;؃yViv0*2PBQU(Yi<f8va咨ʰ#n١lvyA\v9l;me$Î(؁2؇ˠbOJщȕU$ɎG;•~ ;ԱYYG7dG"fG(O;lq7<,+HR?Uuv4O6OK1[ّ;ͶB F-AM)VA}&YR*(V)AaN;f˭9j=vmcyV!deU#BU`"Vnkdf\Jg MPwt4 K0~AyDⱱ^X돉{$;Dk[؁Z83J4ۼʃTRdAt@!r9x1J-f&Fa!p)rtKhCzT!;Bt 6,p-L`agpHw`Έ[U̶B8v$9kIvl> ɖF3Fǿ$"I Ѩ"3u +ȝbIϹb?%Z63ށ簕T.&R1`r y:̫޹Y(; P7BHb`"eRH̬@Q"GٺCͳ[ Wb#+ Zɀu@9̼jWJMv`:rU;V#OH !cWAB ;8YUkw 5gtB鶱<+ceP1GWSz? BXV/R-]P-IO|Q;lwEYP,TeGcO;@% IbZߡiY?L(rFM; XC5MuCŽ :>ʺ?Z mPW1<+͝i#mBqyYaiYY-QC̈Q Mr[T&oa l JJ]<0<+0Ζd I.4zyAJ5tLIzU̚Jz.ej9] W#ιe ]u?$c١qU-W61\RX$o`7\Cp”ʪ9i-Gl\6P/%dẸ, oURw4&&cFp[y&^*+5'ɰRl,ppBEg?n5WOF&^n5s IVuPM$qg?"~h?;I5g;6, *-dG[t*Qx5ss7t:t?g?%ԊB>$W'g4by^bXf.?{ 6Sx՚@tݓď`9%&#FEWq^rݍhO*"$P .6ғ|*&1OAC Uxvؒ={n3ų =4sMLh gB4}mwdgV+]y_L*4Atϴ# |'৯6s;|=IIc~polĎHvT8x?wnmv]9wrgݭ]b~(&1Zw|8]1Xj}Gf_WoLZr#JtzFy)S 6O:Q1{vdg%yVu%PGAKvJ*gEvᇌ]pɎ?W+1`Gj :>o^caeYR 7%gWhc2-}}[ʎ&U ͍o lx4acxǤ@Y`#m(fGذ9<裍+=2(ĪQiH6> ,볣m6Vqa@ IQ-P>=v؁Qጚ[i옣KLaΙ͕cRt4RQ8*F=vra^kBv)j`쐕^Nm l`G:qjyugub>y}vq8Ƕx꯷p hgAU ~೺}{{-)U1{t+rucqjM ">+x.M#};t}"8屺;o}_;Kuꋡ<Y@0$49$q,-'r1mQ0Bhd {tgşh#5sS|@zO\C[]54vDʦ8 5761?!+CŕHYV Ma泂`BJdl4i? cg0a'-k%΃ci܏-0˓þʓ*br@O&ؗƣ]#;ˢP(t:O:zF@+ޡfnjׄ(rx;8Ggݗ\Crη_rP.Id/S丧*7^o鼭Rsɤ]wy0;O.Odrg8xpÉm85O@wg;QљtODI]؊Dsc@`N0JuX% aGp9WH̉$\ъW( j|{;}2n fAVO{=!ETQvЊWank֢d@xxu M0C;1[CAD <U!;6XE@\$xȸV ;H\ y5.Obԅ6n%V#bB""Vw5:! O%[)4q[ή(NtI5YxFҿY..1l zoYeIh+"^Yxr$&tWž|knonoQ;_Jq[yv<.KY`zqvg-rP[L-^5C#Q_qs~<8HwF諗+KvlDr"v೺=QΊq WD G r+fXyacW} qn jj W/`}?>7ostq'ebrBv :XY⍂P[h̅{nb܇x8vI8 8>gI /2.C"9X;NvՅżH=aǦ\]apm;6yStÁضnWI~r}>;>*UzX1V- 4/vUv$uuI U ڑk+wV&MRz%`P=繲(G2"-,׼U;y);:4!cN}sHWlRcwBy!H(ԋP [%Cx;F2迊F|T$r@Oâ1ݑ"q?G>+ÅDR>+a#  }48[E}>;\`\^i" Vat<9bcL@ݑ>#ry $B)vc/|a0we^OG\+ :ϭfXAwg*,ȭ6xlv \Yݞ09Dչ ;`kYQTX*,V+r?j +n>tL`o_,vJZec=ʔuz)lvxt|VX[+Cwph|vh>+%`U"*Ra˵DS'7zxشyv k*PYafdXE>Kv)sFG >+ukXv[KY* fc1ΖYQY"=8v$}Vqvc Ux֒>*q)"vPk>bݑ+WWU(Vѭ +&#Ui;r|VRb#SwġaIP vgh>+սgGv8AY`GZɩ;fĎL1i#RcddXGW?UH{vhUf dDyVp[CSo#A?'H,*w`Dð&KQ}ԋw5W8ɠ)SxV*vU1ޑ\F/b YY1Q/Av8oU>;yTM;\F92qbG*˳rlhrorcF?)#?%Yi94}Yew $5vH)_ yVʎ<+ 2v*aGgu ϕ/J'yVȰlbyV;Ȱ׌<+m<+jэY9v0Y*ԅ+?ϊɳbꭺ̬$;gk;5"Bf;~FZBbPcǑmoU9*;2r-|)MY13K(jl\J(kvn<+);Pg>+͚‡yVl<+hʔYyV򓓚 ds LDQ(r\[fG#CXgpv'+sMJqދ*; ҕ*;,DWZa=cx}GaeR*deGgEDϳ|V䁧st<+\eCՅTeTy6$ZOqvQs-Nf5 vDJe,;ȋxG5A}qKh]nyEΕ*yx;u\";\|ܪ@WcAPg[QxYǎ @漣<;8YҐX}G#t57:<1wCMAi}vWoeG?(oz3Î^ogL!A`.}~|v+DgE#(Pv|g{{wwۛvF8͗g `cŽcx67c1# d^evc]e͆ Uމڧ.ѣH?Wvl 'Xn&]KS,хbx]`eSJ+_WW~NJ->O#S2Eygˎ;   ɭoOcmcW,'J(p]sýs%`f7VD؁޸vF8g0(dTvHn`S{>vݼHI3Ƹ9-F5d̶$t]|S-ܙmi=x$<0 t^U[<FdžQ>#v\\6וq4%9Î ʎq9Oj'~5 Pa8֝0\ ;uДh9O?ȱNC&q !yȪnÎ`f2;vTX'2m곃'D11iĎg8 V;zԌN(hCzzά&rmʁv6+@xGvw'>3I)撓r`vaCdo(Gz+$ ãfgcE_(88nqCf?rv=UNÇIvGz|y,1TZO=6Woc[0]4Z'!!'&>O?uZfVcmio_X{oؑ0wV !F{p 9 v4UC7P9&.؍؁zjW @: $܌[8؎<2^`qu(g@=g`z'Gņu|bϊΤ5n 1D:x@F<+]֩;, mTi. \ 02ѾM찉xX~MhV%:| @n֎ @.o2 ;3"ז?OU£fqӉyޤ mz*WVH|KN'4xj `:3M `xr?/+u;ml;ʡ_>}{vvqTe8{+Vgjy EW [}ر_^Ci"DF;GV${sNb4ّm}fsx1oqO3OOȎC;:<찿#䤧Ý~th/!n{v.nG`}]+pԬ;@~;lk+Y'CH H ?jT^ǎ=;h3J{c˗\]]R;/_P^1EWۗ/_~Hw)ں^O7 ӱ\Oqt5z x}a{v{7>ف&#=rN9gėxxp;~)4>fL= h嫄?na?|eTPV`Dǿ%_L{p5vVgӧLwK!vPH赧J74sU^}8©A09C!Z08P(y\V)S΍+#f%>8ء`ALj+ʒOvA4Ê_c4Hh^8UOUQ; r A8=;8{xdgބC!wO5 ']W9ux'}缦QB+7 uGRqu vpPwH*|1NO:v,1SvD16|+OzgLB8$;4} @R[u&zvb9rnɼ(DaICD;11v0 fِ`p$(;B6|V!a!N*O ԀCި0GWDo2^vD> v8?'HdLH! x ʦ١V5 "!2u^D߱ClJlʳqFرO+M>;JIU|dGhc v8ORC擨vܛ\ =y@ %HKl|Vi >)BjOʱ>}VFfΨ.ǎ[qIPRC#7)''* ;N^`\JFex";0(P Q;;;$;H>;>Jzc7Գ'c+vgP2v T*PPt莮t1쀷Jt+Gn\|>6ر~|veE4&ޙ \NS vЅN*YE2P+\{vTX'2-@w8Cs}V|]gZsqQXa7Sivg7Z>`TcCatrbbvpQbICՖ/%n ~eEJ%OwqgertXy&;"|V~jzrt:v@<~KC=##e0Qp[vXX<3V%ʰù (S߳FGg/nd*l{"+L>M"#CɍigG+SqНeyV̈؏N5&AvV:>+s5);:-Q;z2?6ܡ˻*;Q|,;\xij#`}VAuC,klJTPj=W|VkC|VMf*OfYHvxҠl)$Y@D=zrVyl+QeϳdVaUg숂\= x5-K ]ƿR(y"QxYF@ R&;";,*,wgE+ɳR2Lpl+g`H9u0pyV|wxñIVtbWձJbvж ;Q# bUY1$"ɀn< R./WtLv'bč\R;B3nȄJxꪇ*1'T-w>d_|ft-vG<+GQC" Y1VXyNU6;|iuO.,LSZ0+Vnюx.99򈵁.;HuG6P 1!st e$c@=f;$-ˡF(i|q v" ʵ6ߛ ȷ W7U&tG; pi#}Dv/(bTΆ>VV(G3xy <;l^{Qa ݇;쬺=_PU6}m 1E0hs|&(OfYRHsIBioݜWC $Kizд#VAcz1Ǖ0A*qP'츱[M[%򆊒s'yQm jPw>  |*-Ч m8萺>@1:ɮ[ȳuo&X"\U:Yا/,ܐ$z_RaBN#+:"&i|M[ *XZʣ{@swaf'd|rVҜn-O;&GfGX?̇B'!,JwQ"?d(wշ"Ry>noY1;ǎq\m`~\:~/Z,ܐKzrDCs-l^~;CG #;0`_uP4 X3R M;Z]1UBoc'>˄^$!<_ʎڴFvO|۶Wcd}ٔk'AQ'Q3 RD+Å6Kt8(UR 7 ӵO_Xr]y"L*9wv4$;J`ɒƎiPik}#MKv,R|!eGC-':t# P> i Kv,=VŴ(v4;چ {Ò$;gRv4 J@Ȏe|frt);kxkE InbTj6ce ^5EvLă  bbC%:%G+?wq[C Y|vGBʗȲDGh%;cg?UPgG:eL$ s\nkwQ_b%5\ƅ^󛊈nX q"p膁GS$H%~0Zlx3ojxpa>!{gJj/7^yy- mMʎ? 4pߴq' ssA^NN%v&qrt!LLJLg898>ipyn݉v?qOUwcs=IJ卺+Uّj?eaٱ+ώIU#((/E h?|{ŝR;⎽q%=Oc-z/NDǛ=H~,< jz[,0ƎꞫ mGzZs8*;&A &E wDcXq-ꎉy=pcv Oe+/pa1 #Y]Dg.GɎeG _[%p,Yt3 H~ܦH/_""uX]w+$n#ŝ='.,qǣٮy| ToDlh Ih3I|Dࡺ~Zw\bQvryyp.XB!'ïv T8(4/w⓰"؈rcxzr aExuc=ɁQg{r|yO2XNSkwE}v 'q]X8k0͡~br Y#]bj`:񜳻{_.p3:^[~z#;&B#Rg*d3b@?D= .?d?703q(؜q=`##Aß+b?sC]fG=Bms !'%ܵ@A8(4/wbxV<7w`t".$Cx M#y8 "vcCdqN;0<10Ir;Cbviv>`yOQ+kSPN$Gʄak_*8iɎ 0fZ=mۯ{7z{{SJ_l*d=eYpNOꡏٙ%VoH.oyx:{n|1zwވ׿alasPKrtv{bȏ-\"<+mu?s5s'kb5\!nF6 [aa+') yXl>9 7v_Lw\r /0^Ņg̜wr`?w^77yGM.fxu]Uεf^!ǧ*'ٱ&VCǎMaL\?fjgUv7W}OL} V'!T1vnu]|u}g[N-ʎXW6gmGd^r|ZD VM$g8f\Knv͵ Ť2C#>a< 7]!OXE~boy=kȎu4Cn8acIXXapwDn8~mE ":b bp&k<ѓڮ^]˕\0V~rvt/H륀$. 'm!["j"cuSUB/䊵>YDR)&G`~eW+>8ݚL464j{o9WT*6#Oɂd D ;@E| MB  t3W٩1Ao m?)V"xu#;pG>@1A!#uiǚ!3D\cx!nȈ (X?k 7#[Nz8;h|B8;_G!??;vԇAu/>+"HA1Ao9ؗ%!au#8ߦ*涢]eޖs_3 ` =u[8(^#I;:[QnnPG'sEu$Hml@=\AvIv0qEĄUy*遲b-8WN#% $ae;^F\xcI sB$2v`E2yTa|]c`.Xԝo^AVR#f^r3Y9]MTʳíH€JGx70(ݏ>+ώT'jm|gUkñ/HPQ<*A.,vM S!;A-!rώ @* DJ] A! oU \>r.X :ۋ-qa9=ͶpݯA@k8;Fcof 3ۊxQp vDD{W'\_źEĎ11vPqw R!UF&/h߻egGFLS`AΨ#WpR˾xx""疱#qH/xq||+*4RxLwhb N`#aCSYA.Su]Y'>!.ر#\&! $;"Q:GtˠR"Q/w$?O]- vX~d;xY^/[H%@<*;HΥU|ej!1vx'pGCSogi(Sa_#Ȼu$|vЀNZU>jӈu!iP]^v-1u>1ݑA"Kv4. Q Sw݀3P߁_;lb- cODko@ J<>QEV]х&CX[5Kwjr츆9Ya"JMc]рxB"Yѕ @  IuRAKDA<;TbQ M4J}v %s%;הWe@M _G_!p&xx<+tȤ.V(;0%!j[ءQj`;,0v06Dw`cwd;PfאHt0VF=DqQ*axJ%qWD:PQn#gw4[CU&JyY);yVdP,gepV!;Oea<+ɶru,ȳ"AQ*ʱ% ̳bOaxPgU2ϳ:;^c|;,;7˳z.Bʀ!!@9?<+-!;$~+~t}D>a}YY!Y߁o@&MߠK5ұr)@Y~}`}CtEycl}kd[!3K;B١~(z.MF9#d{HɗG00vH}}R;\)ظu7C{"rɳ ++V$RaE#Eʎ萍XȎ4wGV}.yT)+g ;j>tѺrm-=g]9zJ;P"nC}8킈rC sO,,+|++sm#mM:>;j\ p0Im&bU~0"RJħNSĎ vNthOzv*A|[ė-(; rFyYvTaE6exP" /m[BCnF% ynU'fcG& |kX쨮3#&P7xtO[VQtAdKKyc;O䧪z̫- Xǎm1J|Z쨋 ";fŽBEݱ#dU%:Ȫ}vSXl쨏SxǤсfiE!PɎIЁ-qumw%Ec)YJ̅2(;ʇQtRv,Ǫ-f0?v-;ʂ юM > ˬmYDv,:&z, 0(UX0Ǫю#\dG]Qub@t[ʎfqӀHh~_5UW7ȎkXXʎb4($F@ٚ_'q(ofY۪-%Ph\got fh\ nzuF5ǎ2G-crjpd((\5hu&?[S(PcKtԊ7ĎbTX3uVfL7?2P^oojԒc2?7`(1bɎ{,;Z,;޾ 4'u$Y~9C4Qs$ R^ ){Fl_׋N; >0;ʰvpzʭrR+iWnI` q㻧BWso Ǝ~nt8.~ᰛ]90hvS:&?Ǘn U{Â;oS3N*wG`=J ,c mklD ;(!8]١8hĎK;p`t'@Nz KM2yƒR#iȎ!n_W?QRC|R,'eX4ASm:UM"*}V8nPߋV*PA7 ުr(`s6;[;Žˎ4; r0`NcGFxv~AHd'rLm@]\V-CsV*?pF-l0\| RE:jk )*bGryT:nA=7$NWq^hdr"? M4\i}%W &QWj +M&վ{آI:n^C|!~dR|F{VĎ;mP_EtPzPE;u ԉvS מPMPt@N@nx[zf֡JEt AvGDI*! 7qW+FS-wn'bȉ؅(I5+yXODD8p9!C퉘;+IZQHD)O VbK"ߥP;o{7W(VCPQ!#TrWxl+5!Ed2E؁WcɦЫuEG(PVQnP|`5O4'V?_*A쪚 JEqS1I9fWBXIu`b.9WŽCD *swJR4:.ϪxQrqX!! >-!HJw̒3ޝ*$;g5vhjfcfX5]qy,vJ󥒭̳";% f$Aߒx}GtIMcfO;/byX[%;jp @Uv#+qr3Tlj4J@#Qj n&$O/Svpv;5Jb;5 ?7_ώw߻1uvxliw#5~TVxG\y8vMcrt ̲1GT@Gޡ?mt?iŋr/j>_OݏCsԦKޖLq.?ǃ51<ݮ$] dϟcT};~x3ZZxG]p5vhfD̙A$,s{!VؓD01z0Jn;˥Au$roW#{D@9st}Htߟ$O{feo`W`^.і?LjA#pqqD;,j _!h몀MNvhDX/g%?U8!ItgRP!vLxЬcG=RG5C,uj=yp Pc(x6ŽV"EƻJ#Y+~E`Te6)QYf$LIjC(Db1gFv9ovl:=J>|k? *~͎߿x/LM&Edzj&YtёY2;Ț[k#:ʝ4E$r_u-~`G}Q  Ic'eǤc=sÆ@.0;&EIJ#]Q> EZZcPi#:.;&VՕgRvrbM`좰c);J+ѱJQ%sSN{CkfJռKG7̎yD;1կKaTd;AP}VʎIym`hcΎcXʋaSKW Zʎx;XzZfɎ11Q @ǷX0 MFt,MMrv,e2P^L쨆"Vc);Z󛚧쨏r1&U rF`!V "-cbYuـIA"N.* G`B!f4k8┪m8&\BLcb[F$W~?`,?#!aipg-u1=x@9wD[kjn<*;G;xS5wGLtvkNT[Ԟl rGv~$nNӸY*ʏ=@w~GrĐv4݊țnuC5w .C4J*m c'ZO4Y-[V(3Q o-L(ŎPw(Nʎa6=S |yM}O15ّJȎqITUv vvaGOOȎ6sdG#S'W8;x;HB+ ư#;P^}灏bvGGaEy/sFr UeBh#ȼ~;b]i1|;|ަIpd9I~ wh;[!/;p iu< )I8Dwvp9:8[5AC\,GcGs:1O#.LoHۊ ctF~HM#ڏ{ yg5 6TMxZdbêDGK4,d΃>tf}7`;lw@wwcȣy =ۜ͝g_or^# Ł_[ʩ;d(: 9?G:}ї)-SCPWV6 8M cp=Ktpw[G NZ7A$; -Vo+F rY.UTn;8H6sΓzN"L4PnG-n@υ(v97X0bSv;\m ڄv>#fޮ%Z)XA:M8Aœʥ@aG١dM7/GrL!=5a6Eaǵ!4!Gm@LST8z<;\ᕈ3:"N=fwGlj;Q;NNw- 48P%;t1R#dƦk[o#Ǝoޒoo{orE_W0óc策ilx gF}eNti3D2ȎQ`;w[=9Y;vqP (fpgpXő`!& e^ڇgJNMt Wcfw=g4Ddwxjb݉C;sc;*dޤc^hW| 첨 +(>=;,eMHgUtXQH@,,vЭBRlt Sޖ..;ORS*'-OEbE]\X=:2tW!8*L c `ʐ;hZjBoե3U/+CFrQ 4;'lcu;ʜPrN(?)Ɯ[qv@);K•mPw8^ ivx AP} Nlj*IDLvXdJ|Pdsu ~ ׉xBC=WHpSeCwpʳCQ/Jb(1v*>a5\l<[q]>v8ϕ{o,vxdtc#)v ڡ{"d̿` 1#점犜aȧx`8vPJró#c>+=W_c+h,'|#AΕ8fhpnTmeTex'N(vv>+ >؁/U\z\B=;dAv: sG→`ۤG b.;<^ R2?U2WU)F$j|:[RaCwʼn;\L< UQwЭeIVgEIgGUeI}VY8ZCCK͎5^wQr* gEW4O"v}V2B\5Ppo%>qyVeUgcbsv`ƳxY;η`ܲs5YwD+>VqJˌwh;%莍wD D=|“ ;,ÊxǾ}Te)Mb"*w2["aZJCm Yg5qX9Oj';ˎRpCtv_32B[_t$Q!!<+cGFZDÊu Zh$6!)pPőSX;vfwPD}> ώX}GT/.M^ꎸ@/Uv4;\<"vXԙ9<,ݑ B\ZV>;9$A9H1X&b;'dd%N+K?Ε<*o\+ N9[G{}VwunJ-AjZ4[k7uX>AU Q+yฬr@F7E㖩K0RHbɷ@V֒[]VXac;`5Lr6>:J#\QWzpU3{bIVD2q ~aUOM&Y  q i#MJ$ +o(jkC w>%~ڵah$#R6'Y"W~$, $ 7STB;26WO}g츌YJ(DHRؒ#L=)}nAS>tԲ??*uS4t~5Pst5_JEV? n>x@0wS:j"uZGM-g7u뼤P(GݵWZUphY'%聲A?k?Nm'\oq+CU0(Iq1oI&;&,ҭ %d7Z9apfʎ6Iyorn\-dG}ٱ(z L@vLŠXGϖGX5̆骠IT9O]TvPv,fkrG-QWnظ:#1ʘRׄ^G8Jn1;nTvi0?cSQu PeKQ)6dH[QI!K}JWT.mdGOV~TQPtRv)]tx|ѱȲU}C (o-$;f yK,ѰijWe il)-y&EEj|ٱ 77>ےb,eGiU'l#:cct'l;c(/M% QǸpoԠJ߼}ٱ 7ѱ O*-APâ*i 5ς3,;ھ7} ;ю0PǸpoԠB߼@y %;|4 W;RCTCJcʑdEi]i-H2P/TbM2ەusOWrκ݆1; ;zYVIFz䂃3TwH(A Jc\رvn8eH%ӓmn eސo8PĎ>:ɴ{bǨUGsfd錢'N"4bBEb,2#JA%@ݗ[Xݡe#(x/ߡ|pLqx?HC_;x21͆bec-X8r8mɎZljon8#f;Oǰչ7 E(I͂<ϩaXۿ/cYd|-7ΫO^,D( &|v?| xvX)ar*JWٱ!ʱS!,#ZyWI'&[oB4?_y_mxչSEj;!;HSTTcGsCs*Ŏ1ޭ8;8"vʳeڟgQE>^KU\7o%:CpNJqh =)lajJ(P[FL(=0K8Ό!z5H+ƒL9@jɎ&q}eP<[G#[4AbMyT3ZG g(u^I:C]' ]qk֡2; Jx%sE?BP/> _ N(+ ܡbqk쇃?sdGt8c qE_xG>nﳽ\W{B6Va6[#;iҿ z'v[O/Z>P)ݱ,a8>I'w'wk^GvwmuJډBW-z@>(N(ePPkљ{v-g?nxᔊ D,,،؁&P(F$ e9 ;jE0[ώMV6íYm1hɎ2%:~T9v|b h8=>+6=˟aD],;ȱdDq8N\`0 b72ϕUv8 3ʣS ~Oa4B Cv+ D.=ͨ`_'Owx4=W_j'{SLPaʿ,qrKO9QPy6#);luQm{c/‚K_f., cOt^5QOA_1꽆~xF^A}eG`žfC9גG5Pklr;v+ý-Ckuy%ػz7謡uɚe ;0bE0{pI}WE3zvpyG>6Y7DlIq+7ʎuњP؁= Apc~pK" K}ڈtEB!<;ln[tǧ ( :Z}V`@!ao;sc#`TILm?^2):~$oP(&<r+#M&g!P^H_ڃ iO/ޫ֡ 8R\D+AvjA=PEŃw` HGYl^w9OpPB@? TY :*0h*`ɓ'CΕF8vFȋ.9(5d^.?_/KLp>%SD5_}tŇc\=ƣfM|mdGz#+TV9v@>/XcݔӶ2Ł_IVoID@5 ADK^ΐ!;J% VzRv%GbdGhЦ>:j92*pBQbXBv`y66 !9![~*D=Ws[a@yl Q%؁ <+AĎs>;c%# ~0v(ABv6ѸH" g5 vTv뎀{o5Hyv+^u<vTK$.ƲnKv4;o{HY9acMf* $ꎐPA;B#;.Ï\auϜ|vI[7v n^oء؈gSڦˎ2# IK56-Іj VPw*r1 vj^ߡO(|b.|eyA C$YpUVB/пϹܠta޷2ԐU-m/;jCxR#^;Hw-w!*Gr _6w^w ;sUJw0e*gf̛rSPo@{{8P'1xBA1wL`I('@ ~Fn*6ف^qoǎ(10jLFviQFcN,;}H ,+L4_W+]%C]a`YVJa`wE#ܵ^qoW#블^p>\YʰVa؇YEުƳÍc_A袄*ʲʊw䰃>+ma,.W$;;hccrv<,ˠJb4;R";ڈ[,v*BӹK7Z{K\ZVJmiveb)oFɥf᭒^:VEHF-^(Y1;+F'+? +\xHH(9Fd&rcc#"IV$;t&2VntG:!mdG IR{¥Tr@"(Dv6>:jʥ*9Pst+gm nj[%>+\5_7>oX_!geɳA"+wv6YyV{K,GyV.G7b0Vμ[dXr͵Jn- `nJw$rtId.Jן@8 st=;FGstX9r(fDaT(+;/Z]>ۦ};Mb rtyVf~Iv ;+c֔s6Pv/V8'e?ݞ$̻Sv$˳=/a*͎Dmg]O1Mvضa)aVm`PN9`kIR}oxķRÿمyfk;f/;~~=InmI"Ij ]?Sԗ}$;#n$~y =ODh@|[F*=/ۋ؞$ڿ7gGh3KKɟ3bY1cI"Vt?BٺeH!'n7m;쉨$:ϱyYAI`sE"@|}$˼6(W!@ۓ؁=IGKdDmt)C KCB$@Ev]tAȎ?7XąfG]١BC+&o$g[*7dKr Ya"&pچ?#ePAA]QW/ޘd&Ee3O8;:T˲eAa 46Oﱎ FXFt4j5hxa^ώctĸ(1(l&G;6PB_r#L,Fv X٧>d?qɎj)l!QnY6UB@1YZגu0nLѱMӝoXʎܐ;t+qQت£\hʪiTXʎM>ovGGj:#a£)S훂By*/h#;)ϷGCldx[ mDc5奾̎cI*OeY*ˈ WF ۷K> *e$rUEAeFP8Y,8cѱS^雟~Xʎe2QPu@jߨAŅyVc(o~qseG}t,'Z5 nQ%Cdͳmdc5~ /(;2QKcMN ΰdQpoԠJ߸}ѱXMamdG}ٱXʫk,#h 5K1~ /Q6V  Zp(T F */Mh#:c Kԧ#;/;yNsMիXv˹c.|VJ4@[2(v(: )_c4 Fv,S_>: ~> 8̩'͎hpG1&gXyt`qˀX MrCNdGUT/F7Ŏ6ceErX?rXŲ㩰#=$*YT߯|gTD=%E[Q Lhx 層( sn옫s*Gl%Сp͎4 z%1 =ZhŎTUz`Vfbg0jLFv,SXg0Nh@vx-d+rM#\"׃ўQOΫCFvq &$pLAW1wm+A$-r؁&1.˂%p-/VCa 8aNd,vp,qqypPGF3tsyK`G>/rώ6ˁ:@yk0 vzERXrBՆO j.,H` !nx.~#"56[UGdGUKܵ$j2/ Dg~7X|@Z ~F,E|_]L|Z!Ra*CLQ=&?i#:c1ü1Wq&4 +كٱȅE  Χs;;;rgGG$,3C11P)qے#q#:<ݭjq- Y}bAwrqC̓!"8ʎu1A_38"mݳ+wg$k<;:hw]\U`Av5إQ%n\_b78څ7 x.pLvk GD/?Dsc^ D^m[*Q ԙXʎd;꣣DGv8p[yܨ[JԇslG>+: <++wPp-V3ۊ!Iv`E':LagRXouqXQ\`?suQvO8S̥hsʱH>+sE`|Vaɿϕx&$;0/4dS`GlmdcdGݖE uG+ MʡD,8ٱýdDpq*je>Ur@tV|*GwrI);ܪ&twRzCqQgotLѱ莹c*Ue;`calq9X< Kk#?}VQw+\v`/;+::Xg5u5f&V(C*ժ$V5+7;X/;vds, (эY*;,j[ RE,j<`UsYy+7U>Ug%U<+E#H<+J0*+wV.q&tG1[ѱX-2:;ˎ1b9yuߡJ2>˳gmEflm}hͥZXdst;4wv#A0mRwxtrtf_{ﱴ<;v;"uHrt9}21p ]R1^߽6kTr܏Qxu}xx#0V$Ϫjnž!mdRv,Qi?6㷿z^ME"ˆכ7⊢-Uhh7rS?} $Կެ |+~^Ee ůݵv\ȝL[㗋Ng,`B9¼CA XI6>(dR_%I⹮G܂j{4;ã{L30[81qfy%WZ:Mw x8R0OFt,eBcHso0,^%- O| q<4+VWG;twnF?mk,V_Fv, v!Q˃CF&ap^DV v">KZLZ()Q%<2C$<_ѱȲc1z\<&eG:$}uu5RX`ZOn[yoẕdGp!v4Ƌ` 6MnzʅC 82C$>_ٱ 7vc9,j̶D2PtTwGB.=VuȑyFyu>Qeܶb6c(ol5DǎyD;1Uss('&Ufhէk#:c !G:`d9V9X:Ǝh#;٪XdG1[rI ZYvKb>yŎBRvu/c);f78:f+iʿ&qOntI,]vŭe%9VөlŭvA0Ƹmijɳl@ACј2Mtk6*nQnlsǁw1}} ǛЗE, 峞f1h?JƔX4m#|cݲc); ߲dG<Ύ/g870v77<)%@f{J[!dGIJ# EL9dZi"^Έ/Ri\ y^FwxWՇ.ZKtLuB/~sItJwOv*G (Y[c4<5ϭdSc ~±${ilpE]'!xS'Sfq8HB6!4D9ءs۰06{tk9M'^!Μl{8P.qaljFr[>;Nf؁{P>$Xqge|1BnjQS o#vX>7vtYm7rDy FD,5zWCIDHdAmE79JC;Cw-فή 9Ug%~;¯Cq9ڳAhy;,nԱCkf mmGdqAQթg {EJ`-W/;8{ݓLw}} 1oΥ7ƎsO[BˎÝCEƨUz;t俄qOlwxNtL-%J`sxʞZgwHn ׊ <&d`cGݾMC*'dL eGg :/<ɘKlGRVUN3A2Fw7t՗/_^v(5^+Aa)w^^qx!+kc;a:t])*&ǧbP$bر/|xqwĈ7UÙYMUx!Ic6:~{+$0v > yr8"*zF AXQt:`B%*PCU"7LN&-F:(@ y8H^B+F$VFfCOA} eGv4)-Ypk|h j b,^"v8MClR#U- I:v5 >ϊn+cyH#rQj6WraZ41jdCa."m8`R!OQ#c|z4ex|OqK~>ViCWSs]VJ zAẄMKYη~#!;f;ZߜmȎ;vcu>g=q=1v}o& Eg6_:?zsx v\@qn+c1v[UA.;ŧ5 >@)R젛c Ϋ,v 47; },7dHx/eyVNQhGzU|wtu0g*tB+pq-d)MߊcDU[R"}tP THN*xƎe|dc쨏% Ȇ;N#~D '\YB5dqs7XIeG.;CB QreGXta@DFf t w,adzDQDxahf.m w8Zl5L ``o!rgXr Tݹc2w|n ӊv(2ưC;fVMl@(`F;H糊z ّ5 a,;Q툳IVtE'ŐF9v0Bd;Uc |Vtw¢<;t#;ΎNצ|ߒCϊ~lvJbZyXQcN!UwJX |Va#xG,֔ʱC}V*5>br2AFH8,* CH$R|VYȚBU;gqY%YzbB;^ryVQ#g5ov,^zcjeXeC2$WqXyPAvZX<̰a>*aUϊ#dOwUUN<ZXÊ}U;g|VXSʝnX9Dq|jȍyVȉϛ3 Ux!FuG}1=t8vdY9vd2n;|М˳%ۆ9Avw0*eY`}R]Q*D9yVQJm]n*;W\J˵EVn0oU+0;}ƿDZJ|`[gUK5WTt[9t%y-V&\stgg /$9~Awʎh":}#U )Wv;b+-^kRPϕP>+dc%X[*h, JY8 tyVRe~X("=2 ѡe~(Ӳ T}VAm <]="B_pb}"0`]ĈP؁tg%}Fͳ5gEv0Օh6Pk+WJ@\kPҫz?`+4vD?%Ϫ (JEVmX t\y7 kb\v#!;' ɝ'UZS9o֓[XU6NY<l*K(l# e["UzO*;EU ; 6/q|Zje}~ fXa\\em$ge1oH}D7ؓĊ3eБ+ʈzؖ1ByS%Ÿ,HFV3cRv4z2%H;s5~TJ[뫎'Ů(t26q3v = +N~#/;; ";z6فMc[<;U.eqX88h5 PTpPi6c(o~M!:MuӲ͞?DVG>%Ŏ7od@ZwxE!8;R3>#Ł( qQqdG%@KQvnݼر#H.;E;8m.HƟ5cu}OrJ"'@Pcv#yScGE 4DRv %?њܘϪbżRuGpǔe#q٭4;褚";꣣Ϫ6c(/Vl1h_=iJ{Ҿc >Qo{'n7ȡcsz-V#ynV/cQ#Are~2`>t rOuPo]p S25qgCPtY0T+&lvhs\|/_< %$Iܱcx$͇GGGw.1á^[;쎎04=W뿓?i6>rCA44$"@yڈǪmL(=%1Q_v g}v c_ ,hKQrnْy zzyA!cr0qW;HfPJv~r00sf3_ʎ2jRoӵm9A4tGeogg8>cʎm)45^ŦCPT!;XĞ6P4J=Fn)#/\\ '`Şzv\]IGȎ^ !d ءB#)pX fs%Bv\^FX]ox)eԸ݈Vi ڀ4y|"bp}؀J14C)֘z;Q|6@,U S`G}t0P~ z);Bǎ7qyV8`w%pЂ h;~;> 9F1v9\vๆG!]X5L1P4Z20[CJ;.:Rw"&pI!7Ɏ5ʊкMeʋ#"A_/A h>K8̬s!b:>>Qwt]Q0AGفAP $Ƚ̥Vwon̹PKUsLgZJ:G^%ǎ `8]VoorPe|1RM>:f(w/HcG5F+@da.tTZ쐬cAGLw:i()#;5"^'H;ȎxYC70γ])bo)$~;$w*d=6.ry}6VkȅrU#Jҧ#gXߛ@ HQ`:ٗ-W/;f@-;(wITBܐ(@?rM-ww?/z=hXz vh_s}*jS2{;\D $!}e-Y`$=ԝoOǹxG_mtٹ~0b JȄRA RWVKVXw*D%YU k(<>fxv|mdR8,ON212|5 /4ѰXayVYb?ZU`b$YE4g#}.) .h&dcZ'NkHܭ$CwyVVVtZت+ʄ~Ċ4JQhzx0D@c1pH;)4JnU|D3qhLhn釜<+1qtw0S;=՛p2P(>-0bKgLeoi}dzaN_779IxtQ>*I$OZGo]ru ¤!)`0W:$vr'eZ~Ґ;ǿ4P~кz[w8DfDmS6'O*x.$|$~SP"ڸ~8Tn$h_Af %(.R$>A.A'9L]_9[toˎfu )XӟAwdH#O#FSULhy1NګTqmfU=|@y#+'up@s.\hY058ݴ-CMv2j`(fLgzݦ΋KQ/V̅U#kh):gmSGLVn\%ٛ,eGP[IQ3u%!;ƃǪ/iȎX`GACu,37xVKcCa]>dG!Q@Ɋ9XZc*AQ_v(/%:LY32r鱚Xf@i5f+\aаtM-Ë8O5tAw,eGyygY`"G;2RcovI(#Ib,~0捧q5%cӴݞ7VFuRv@yp)\5hXCԘU~]|P@ywe`44w{Iut,";(@9ΙD{hRw{C7*rTTQu`Su=+0jz]E\c^Ը{ vG``e&:e>53~Z}8ߪ  tfUzeeEldf\yWi5 e/-zcN<`%-蘷dG{ L(Oi9<فˎ_ҺȐ5Dtj2yJ_LΎ!rϲX=Uu˳eTTƏ"=;)0Uu|v v޴x쨁s+#8<UJ\12vc%cɎH`;i0jT.;ī4%cG4Îń+\xD(Sc7Ϟc'xY؁[ -=v`E;pis[u}Wo-#wxkYPJ>zl~ː2U95}N`lìuV ; "?a ?}\OOA.vXr49G_(= iVAnqu{sG-֦\f!;uƛuf=)0Q^73vLv I|c+eiWd rWt[e>"{UP֥]1S%;* =rJ#򾞛K/WOǎh*Pb!c0v$dAseE;yٺ#;$P d8Aa J{Q,mBBG~ | 2cZ*; BŁU*= ;ҥcu*Y!;Uf쐄^u٢pE !`Vs2>(Nxc\>+ѕbGLf;UEwŨ͎Bq ѳ*$Y)eUw$ٱ##aF=6K*!n-oi+OǰcM ^w|VtalpiṖ۲!'VNge&TDiAϕLC$/:NbIldU #+P $cAAF+ʓyVps8ܨ0Jc- [68vLV6:;j@y[1ʼNYZn^U;byVRaIe46;2G7;0G,* DMnUh uww5Y;+5b匐a<:/tRfP^DyVÍzoCWW/яO~Dcj< nm~"v ȇ(G䧟aGws~z^G}Zrccѧ7`Io{>uT,v|,،|Íல;^t9J[RC 1N|secg烵矐DZ0s'1 Gz.C?=:Ǝ"/ mN蘗:\<ٵaepfVyH ;ʎ@ǎH0.`u_ѱ<+Nk3m J]F+Gaonk>ΎxebP!ͳƹ;@ez+MDloAH G7 cX]"(̳Jwn2`}"kA١Vxq;XÎؖ;uY0?:*$,6wDVf]>ʭ65pH>JT͒c/;?H) 볿onȟ_DY$u 踋o{"W >`w 4ȍ;O& m 'wwlַqruu{~Ȏ>/'jq0>MPk2$򎺮CN\w쉤!_EBPKȚ>qry'A<./7v!$} o蓬Z2> p2dZAu J#;g$Pc '/&S̾BıccpSĄPV8p^uT&+({ +,<&s@G ;#HuOI[OKz oTkozuѱ:t׶O.:Sw}&#FxY#f.z0QDd W1:oC+#G4Oݍh4Wt%<"{ AH ڐzbفBY{-%؟xYA\;sNv`GC^Ud 9p#. P&6M~k9> 2аBuRwi \C?T])5x {Ǖۓ ;dv $mf>C{FtnQwvC]?o+?*dpp//9SÎY$$٭4rSѮVρDs%4ۓFevZ>Y3o[d/)4]\k*\eu6c"tEwp/I{:BG'x"n0Kt4_!:C|Z޿{&B>Р]ST\%!3k+eX H> ĐVhKvc']`ob 0)fwɎyy P^LiɎ;FmUrT vL &qIUGm!}<cA1@y1;}1 tsYU<2a90E{~h߳쨩2()U(P˶? W.0:kvL9옻Xzj Uf|t|s Oȭ~x쨁7*vNeZ|e"=Jq{pccXʋCtE* mrߤKXgn u`rt|)6a߾:a`\(¹ _^gV,;Wv`F@]3fF~V'pm;EVAEF9FLHEJ"*-қ}mЪ\=+1 ~)on_qS؉\{VE I}>S*~T6#1ҺZ{g5Xv#+xq՝lZ&d|v$e]E⭳lq6!q0m֫[7Ŏ~nrDV50vgOcO:ʱ{A/gNe51;ry)`^j%:tG낍{J#.~Ǝ1d"%؉ȧ`]o;6ܹM,Ʋ>׏pgGTYK^Y9v`ـ17޸Utl\Oz :fˎyNǮz|Mqb|q#'pvX#ǔ{XaNŽAdQ $Xvyy8_6^|3[e{8%f;M[a%]] ,5wS5y>jZv4&(r2Quםܣm9ܝ4Xui/QƝU'P~[Xͳg_ySUv PcVUّ# 7X6v:<5gvXgWtNuLpXp\`Rt#lIjXI[ʎF1S*فs=V$ ؑ%7 8q=JuG(P^cGlZ(>d|vU*|eC6;.ąuECaĀCeڰ'JHSw{v 0 j`1NqpP݈'cKz39;ϐo&@ɎfvvQcmrevt4`̎!Xώ0nx>A=<`|v XZieDF.;(ώ h]pGVIv\DvvSVAlCCd>jcG8.;xm:<26ǎ21>PZ^{>cX dUd9б͓ȵgNª H@t-~lOՅ%nj$#gŦTG'!`u'2 Q #m+:~p's!DPMO&w⏾;d hf3#bj%+;Tu Mgepb_IfH0 ?!MF~q@ *xNկRK+W[ƿq@x{;+|&}Wˇw?w88Mq&pK9ΐgҒ~FjP+4f/Є#C㸮ԶƋJ3c?x "bDs,.oمS=!1C*tK?9ޑJmܼy|u Yẃ[;;aǨ;4+t)=pPY20P%>tסp v;^ $~2 ~c]G}a{͞;5Ouc|W j8v/ ?=ZR1+<f!}`F$|N W%d]Ac|e<', ;>p.ڞz\n$;0맧8t]~P850LkD|;e#v<8E;dq.SO(Ύw+Z b/CLq ~êh+Xu:asJ^9b):Ux 1Uέ*;03~DoseGȗj";0+0u\?4cS+D"v`RL9>L=G^ 1{푙/<!&d"Kvqgyg29vT١B#Vʍd^*鶢Umء}8LHDtzɠ E,YNVV;(v `?jaud' zz%YQkJS@T.wpXCJY㝄뉊lUtxG| ̖󩭽CYݩ%BvrO>i T``G]^ڽ9]7E۳C/K;ăT5uF9Cws);0>C}VѕL枫s+Ύ0>Ye$zd g{UsO-K452vSkN]\&+H8vg;:A# s!lvs+q^i u;8Ʋ>+RKJ _zgʱ#X'yT/ ~2}"vlqء$N?*EK.궒.%5J.Ó)|F;zv0u[0^0JC%}vc&7RS^t$yYPзT6p<;*\zHlЭYe(!$p3ǎT4ۤ@+#;%0Ʋ#(aobGِ zIdCtG vLOvD>J{*I4;2!sq1&#utIC;rt3}V4N;:|V1YUqwlxG*JMgE4;f(1gcG$/<;Sȳ o̫\)UxGg-^wT`G ,h$RCAV=_!V(/|n|".eL< +*>+fx\\3y+ 7˝*gBgw~P\G`7^ɳdJn ȊyV_ 򬐅YH󬒱ϊ:/Q%ϪYv$߮"L+g8<{2aTQU2V%E+#U*aa73ޑfGPy%Ƴ.Q5];p steePf6فhJ-x+qa!%Ij9UwӅW)vԭ";W6- Ĉxm2#bzE4*e5LIYᳺVo5b$g+$^&T':譒G;h'ĐͼUa_|4R4||+Vy bp&71#X'5|E~&>cY9 %VD}V86Ey?􎵁;4JJ4kJWERb;Yiu#角ƚwVm +WGZ@ξ8S,k yhaZX'MjFb?PM}pZ$dPAYou#2ށ8/sM$*yC1vH dqwW&6\`S* 8aSXq Y5O`]Ct3_^<0ƈ1v8a5nk~R'IP~1r/^d<NNP1Mmſ k=x'UFT,;jcr.+`ErƀL4 \1wLƎFG|b~xU(^`gfEfcb蘅:c41Ab Y"o^~:J˙ċC%>%;ʸi1VCQٱ(?)=cZv3$4L/am`Hh~B܍5z~/2Dߗ4vǃ}!p}x?Ǝ _wƟ>O4~Uz w -i{ʦn;x>Ǥm11t|sh8?G1cx.f-&ϸA)vnfkx?jĒoƑRu1%tLSw`,77Rnnnvj݉UŽۻ;F wfDJ~php}w'Fx~::Q"(CS*%`Ņt닫n_~:= ]_/v_0qry_/׎ss)o78-q8jirD5ޢFtp,%'<8ޔk6v_inp$;r2S^gcb쀤庛zBcG t4P#υ<vIDATz4 t[%W9Q9w&OA #vOzvh̅gәv=\=E<Ǝʯv9CSI 5𧒃:= i ;w\N* QĜ[0 =eA_!2gݱ/畿@.7{}?u8_'ԢqA鈮 =0])2Α-2=X qX}K1vP(;81-tLOw=7S{mh8|C֞&Vz=#۪ ad\?0u(<`Ggg뮿%9Wo-Ca_D@ld»tuq{ ⡣iEgmO͕0Iϙ#"ݱfǓp5OHȶ_^G8tyu6۝L!kھw.WnMwn5,v蛰cЋՍa! <;"Gü+7b\:6d(iN[.WX 5;f.#ƌg !35t|[((荞vg_zm{- =;TB`GࣷCmͅF ۊ8T*\t^CzqAP1JHm5{CC?n+R.F`Wj0*VH ag⑂FQ\\rur`}[<:Bn|T mk"=DecH΢9"+S*:BpCXB!bA\U`&r8cCUqq (2١o1N ű |Æ'߃{89sűh#4'a+tO k;qv`.bVT81vlJSI1v- iYB`UG,09**+=;L?~ه+/=vgn jcCvV6% AXխ?VjÚp8ر!_9W̎b&|SٱL|zq 3s|C_\\ʹcGe3mSUew vU"xaj.}VpBJ:&!X)Bv*n+.;:meިrVpBNvݥh[%Po\QJd܂/qέu[˶:rHCma0H=^.aB * |N+CyCo|v:UV Y"$d]\iK8ucJ~]JCv>+|q8"fOQ0O) ٚniYH&4 $ofNvY$W"<١t~Eku,d"ý@s{ g6֦a<ŅKlv@}X &v,1q؁NMء2C#vWkء.'ruxQpPa]>פ 04`q!;*4%ט7mP>;t*?7($"vxW;<;(8Te±CI^k2έ-bdžCv0FšbѧF>;r\Mm>rAoU;Ʊ32BuN%!b*FcG tL(/xRw}GvxYeÇȵ\\Wo :T^Պ@#jiY i D+CZz; !Y)sPQ Al+CqIv(<@ Q"9#`%C;d`qvF,vDNV:v`Xyv8qK|ON*S}ux@D;$n#n)N>Zw9łx\`:;؇+~(ŋAxʘK܎.l#+gBgSXk-ARRwG(tq{QC١A^<}~.MpVMS-GG;nqTx4VkOlavOB®E;4}*Q:+ra;)vO sAB_'d#IItJ(t+JHIɕLvŎxBvċ vaVs\F:*Y%g[xAey?SMvD|N<}j%;ʸJʙ;gWT;uGs/(;$--Y1ejԁۊrLA4;#nTȈwiv@w,!.ˍ5ʛOƎMK;528.>Qt&а!SLV>Pτ(Zක:;$9 ;+",~z\> vLm4}Bk+IVw0 xg;dEyx{c3\f;Qch ;(N|ʊ)&QE9!;.aeVūVVJ\^%ϰ̳bהɳbW'+gjnR>e;RyViU}V>6YYaFyXZg!3᳭X9yxtUTS0,m BvRq˚'Mŋg 6TB=Df3r1z5 oqN/u|~[^*oYQ[ #B<~;N3;XNuFQ7\K#bevHUΊ2Q;*ʵ vxVzv}fzwжr^PUf ɈRMCAF֏ˎ*~Fx׼Pѕ*6qŁ;TòCj$kT^?<A׿-sJۇX@u SU5Hq9/8@w`}5W~JjH!2?OwhRDN\-(kNrI`\ajjbͮX},tD\M%!'):?:+Y*R!; 8<-q{&uV +*bATO:O͑+' 5IC*yu{-tŞ= "US@9( 7ZI:!_jpyam N15(d?ݮ욡Fo`tzʧ4nEwLduۉ+xa ܨĴCɟTߛŵ-C[emFװ*3 2ɘՈC1.:K9|/р4&q!wЁ8˘ٜ߁+\LuA꒤3aZ[dEuV-H(ZEE$!jh$% ^1 6Uw.z~]V;a\pTb}9C̥k /^M*Z'u>Z9TL'@GZ7u2Ƞ6kRo3%*s -˱!2T',?"7cQ-$CvA9%3̾@*q<\|nDfQ`CnԱBFX*A5XwDalR 47$$֔Ӈ$I/ 0ʭ;\1=LƖّeG dh_v WZuGzh/>8dEyrňEar=2:TC@^)VkvB dǺ#Dڲ#Etٱx ;;h//,ׅf;Qm$:Wo tD=رD_(9b F$Qm{O_?v@X*j}nN c?z{Qu*БB%X5"ѵn";X)?tS qcZɎʗ $RvΎkz {yM=pv#9y{LecY鰣?f!;ˉIqoS7qv_١(_);ݾ'=d;Qn+_j; .b?ˢYKupv TՂ8f];r [p%S$'c=@Չh/!(~Y0b"J4)§Cz "<$}qY ;m=]ꁹR"P !$0\ԇ||iᔁ'>urx[mv| 9@~kM*!` ÎNr%T. 9ٯK}Irvȥfp):X ;>c.<>Cu8VkipX΁z>Dqj8ZK̹4w8.VI<;$>iA^-@&D uG+<,3aٲCa"W:-Fkx6ȒA"CaGpQ8O05@*v_b؁ 2pECA+o+uV4fP5r$BUEvAh&) 쐴w W̫ז\maEV\j B`fP#Ԡ3IC ; ) Rx!askhScTgz4~xliM-mUn!=$4fGP;:.SC}vP?< b%pdQc;goZphoYŠBtώObqtP #$%a.ypEaED1+e`^WcKʎ#CXYYYQ,S5xzvp$ ";( xEYBPF!+~xѾ-ءCy~P׾ƊbVI9xm0ڲ@bN|a&.1+/L;\޺CԚu"C|vx`ġ ys͢S?f兵 إ eD}԰Cc2U$ĻhKQݡ}6bEa{wb eZk(-JpXjfCAP*+Rbn[;eף%;Ƿb*K$$ t"ʺabVacRt/;Hw(;|QBQ.B٘ǥWDяʋYy A3FR<@)v8-*;Rv$LcR.v6 8mNG1;x3?"VP2vx(=nww+Ov\xY#Qq[:m)gN^`!o /Cv|+Fǻ/.ݻG2Lvձ [;Pb"WU;;رw:]RjJ }^e?'9 jb TcWSGvÏ͡M;=gkcVACr~5VUY]U%;XYL [o놩K֛Grώ}wlWcV vbOXnOzH+?CbO~zkdh~w|xx+%)~9|{ C0;n0!␨B,5$j`5A+~; p-Yy V; ~Q>рk$u1y&k0v˸"遰9a$䂩qzu(=l5\] ;`wu1D#{<;:OؐDXGgskl79`ahY#aŁQ,D,qxQ|XsB/W7Ə\xE>|WYKA?6Pٞgv/uaǷca݈f&ѳ ;hv=mղY2UŬ\0 Qm{Tv]/ 䬬Ar|O>㋽od;x&ZVʎWj a]!)ў$6.rmvO;DtT4uZdP@AZ?ٿ!(ЭFj !K"+1ɨ&.Kk]gvIkOHd:(^dkt:G[Bh Fσqc. xi^A̱A6%N"TмYeYv/2ۨPj^Mh! HLV]ì3+,Dwt\h u͆Y(JEiڌ{^pc|%C(el2F}YV>;9?3Ber;vLհc(:ʎoJ Ϣ4Ρۯ(&Ffpk dǴt=;u2q-^S}v\IM_$3=Rx2gPa;(V>Ꜿ>7W}uNHQrdB!X㪹)ֺ;;;k;( ~KCA)6nMBF4q53~ss[]gwsϾP9[qkvaEac9ZAu鵌#ogĖ2?O^}'?>aA!1w?fiNv\?Ȗulib4%*FBGuI7Ko+cpANZ'yO0( pP$CSm +aA1ZҮ+_";j8"!bb`u1qw4i4t)ߖ(WMGwξUe#4Ruxүf3fA]}]U~Vu>I!hb`JϨr3N}mCǬ.QfkS3;Zqeh*70F{t=I2; IF `Rtthڽ־u tmJkvLUVxi#+-:0 ^g;鋚^1dFqXJ#+Fn4is[|U k5l{`<8ّ(*3{ mֈ SmDݚzdvP1}j)d2 >H;]Ic x1z h4 c FjEc<`GFG#zhG.:Kd3FnMuw8Mjcgή ;ieʣv~Ğ4G6p8aM7 W"e;:$;&Y%;BTC76.ڬǬZ%sĪE=*[9:xZ% {Xh{evPձ+YL}T#5l|h婓3Z :m瑩 BQ8ёXDyX1VucG\ieGdpB,;G#zaIRj݇KQdEn$QQnnՈ /~ֵǪ1X9::f;^EV/ C,oXa{Tr.ƅ޴bG46EtiCl[(['Q kPBȊ{%nXknED9{6!ad%7pqRofgfg\>ci_x/ƶ}67ԍ` 'CVtt+찧 HݔZ;hv')Ǝ^ߝ9[c,րE zYI(#zږ~Z{ S9$@P3EM 0'tۮS6xH>;\:>aˎV.YŽr7G;CuvBعosJ/="'#Üp<&5`gсEt 1!;V?Q5> A1gv8ppJlY:dx$fD#1+fXT;np{|Eɂ ;QbwwIFj\/`|^` _jn> b``wvAg|Q,^>'g+_ ;0qwqp768;D;rF_\#O_~.ȦOsY._^ڃڡqq-/9ropekr4:+'`NC{_xmɑ~Ď}{ njۋ``mǽ=AsaτO m>i< :K\,GoJܷ^<~0o $cdH0QNh?_0mPq{uV̠H<) =ar!'ċ$Rd} Bq[0"Ǘ{ &~",R.\{Y`:mWtG+< A( w! 5AJ ‰eM@ "_ d5ּH0;,5*' )lRAx7 ~'ezk&ruTt]Ŭ M'|<ф<::ÀUtH0+Cx!=l?$ϙ_|k_:y,]cRlܱC;X|ͧX$)k[[fG U (Hq5Ѫ~ qPa!+[cV7,l@TɱC.D,;d^ċ8CH·;`pz@"W5&06GQdGc& e\j);HC (5v9ZuK)cC /w(Ԋ%agHR;|"ȴ%"P6E(1| 5؁P#ǖW;we=khx8PĞ|=Jvifώ}fb]IVqhiJ=up@0v04eamhU!bQ쐿mXʣFUl*;Ė" 착|G0̎. DJbVBw؁h?8eGwPơaz[ˎ ki ?ڪ?  ,ż:MCTnYIý*j); mfH\źbVHGvHZuYIӂĈvٺFiώUˎitPt/CQȊ"P_)Q7?ߜjYWCY!vPՔ:ZGKem  ~B|JT7]B!}z+ف|('|kktQ5;vpan^8k7`eyuV(bCibVTae߾KNf74avi=`!WVPEax{ҤFи&Ί͹\I$8a^Xg)X hɟ-q(JU\9Jb&߁e\*jdvH%,"cta`,sԱ PgUZR%jQВ(UX7O\8U *'Z$i͎c=1׉.YQ%،@P_١‹`F-4fG!.$u}|(^wC^C*-WOs岲CBS>;dMƬP9u;0kmXʮaR0y]* wH\w]akmW^y(V`Jَ;ZYi_eVc,:vX$d  ^\*Ϊ;;B} Ņʎ;5|}I"jNam;$!tMVA偼(Vڌ+gV JRKktM\ᾖUR}[8Wk{YG._y ͈|&~gZmLbBRLdG6Eɻ"+ -eYk9<>`q*cKuOrߖAY@Εz流4kF^[5,'p~zX*nE$v.a*h/res+2;&T\BF\ztL;D٦̎VeSAv- oV[VAI5sMzss+)p[SY 9{-$J Ûmn^lPٯQReVMzߌ.{_7/;R6?SYhؠB݁*.m=n=E{fѦS~2?nFt-zH7̊v~tm20oׯv*3}çNUK-<[)^0oRf,5(\XQB7)JFu%ݫ/*[}@'{Mɵ&c i'`God^\Ƭr\OCPvDXycƠ~( $JXEBя~9Hqܢ}?' ;&C=Q 9:ȗl DH|qQQ}t44> !bةD9|(;t5`eķRCك^6)(n?ʠ!į[}' ;D$'``x"c4IWv6a@ , t;VR}nUF 0t7_( `EfG+ YDE[$nYv411AR0Y׏'L_- t;Za`$;bcHYv!ѿ>e̎6\:6 bшcluQ;~h:Fm0OGqS>ʐa";N7&^ÁRAǸX9:6@ve*Y%FzxShŕ!4Gܜ(7%hk#P.gHɠcT La5\އFc;znz s1[EۖȎk>p[wlqS5{gqku#>Wrtxw=R}|싎6Skąm{3;pehX9䈣5A-'zc d޸m0;ޡNk ]9;t۴Wc!/o(ld~cLMxM0 tj 5x=7c,C;ީ0O7)t,#oGC`h%uw&rN!fgg .w{EnϨ by F' 6~+Yѭ0G O#qwv<=y}'t!Vr/'cq7ϥ̵-W;71J?>y8ə~c>ױehOp?'?еegNV13#t![l|+ܒ\lЖ8uOkN5a*moSvG)_ntuWq:fņ7ZULRW|C1'$<?,70 MC1O`'QZC'#CYV6n!dk#AM|R+Ͳ@NY4g;4XɅvn F0TsEgssh4|vXs\|p9Nֿf֚!O2p˿9qCpB 7V֐#Ѫ+T.VΜra{}e;]R1 3"*J?!;mÜQǐ$>y~rNI I嶟x+t9g~WCUѵeDž|Ĵ11#aaXvx3sJ u3|9\~[G m;tqt&97d[U~JOrN@zhϧ4I#ʎCN_ϞJ%-!L(l *w.W"p Cq6|>|ǎ]fBU]ͳջ&;Wa+hɠkH [ӃA=a+3PwѓX8=PرGb |swtGR qDL /5!;5|!Ξ$^(\ao$c. }.bvܽa= pW<b^ Gij̤97BOt};>`%G|cǞ;O$B{fg>aLgK8T!Sߢme AL{n)cK͓9`>q#HiKy{bᰥ/#ffPKѭϺ(LJ=(C S>tǷkTv|TEX N8f=jp-JVPv]!()1r< e=!fP;L>f[S"~`BJdhbS2K_ L5&@&S3}&lӠD_wL)AU>M3bEdCQ;ޡ\ +I;v Tv8;^#d]!]_(fuG%;$KnAS>8Yrt-ƒqttdGDw,a wQU;&(R*pʯVwD`"qZ)pvX-1'š쀄 "~UcDD},e6&NBaL=;Yug*$-ª^=SV5evҋzvXG])ЏcOVuXevq1~v |`h\j;BgeG;>CvsVRANKJv\ Í;\CtT2W΋$Z% @ &W^0rʏrSay74s혀E69bQs$ xjÈ{g5;XwHlEb-oQ IB-}Y =*-_$~!fEc^ >aўƧN̅cUॄx_E#(v,;%<7]`Eԗ=ͩњ{#WAHp; ro}މ‚;h}+Dw@E?y=-46 &j+X!{78 힖;FO8ldU  4uG({S4Dܦ:8ͬ\j{NuMɈSu"mfG21$W+DcA _GfP<dO0و_:Cְv w7=xd҉ 47 -r8+Ifns/ֺ{YWjvOnt 69jC=`R6P+|[rqɣokڹ$Vٱ >B~ vąL 0mxPOlI 0_;|&Bfќ(o?7BkW7n1":̎F64`H&/{v=2;;VΎ6َ =;ɲYv=IZ6 OWvyrn۽oS,x*\vf3J8:c(qe)C;skncV]2;Ȏ=1(@̎0-:}c?z=!nCyuxӛFlS뉶ϋ;cZIU'&4+-˲c(, 'fGD}ġۺbGj< M"p|F&;F=9>0*;J#z#GB=Be1ˏ|zX9:ֵ>B2:=k'6ڰDy,ϽqgB'Ď'j_=}.Srj3|vٱriiGύ#@9i&}dBxbhm:F*'aIiiYv$ShWak);aQٗ:85:^1;h tRiew3Gw-Q=ǝ=n6UhVPCڸ}syHѻ[b9Z?Lpq Z.+lB\Z?3v@v|Pۃ!PzqpqCٱ1:>vҔ#ŎKl푂]Rrqt;L-ݸ8y{v烨*Z ]0y֒<'zڏ鰣?16g?]cLv1N>6ᶻb[zSw?Q!ڱtTQw;:dGL*ɰc( 5VM1+A^![$8e10Vl^>3*Qvhڲ=taj<+7Q1x፻,QεÓ6,peK|nMJ 18@9㫰LCyiLJ'~Gbŵwn9} }c̭hϿ0o_Z5T McCUAp!rX{Ia[6krU5p,^rB9~ɰZh⊻^1?]1̻s|ߒ H5;v7DosĀ5{#m5)X].o9rxMʿn#:mX*Zv '-ĎYHSa*Oeَ_rb\+Czb^C{Lh' `gȆ(׳Cɕ#xC0$^nhr'xac >՜s\qNY~#W=ѲrɟKdæB+/}~fsyqثMYc֮op*F$ PD4vL-;>`0 t5OF><r_m5؜0 <R"/͟|J!+[5.zy H bɵKEp(ݑؓ6E C d pkD/>wa3܃/^ri#:s"F7T; HZ8(D+uKYA|5<ȀaO蚳96drVa24_aոdA'~?< Eᐨ!ھj /@%( X!cR['8r@JbV L+D,vz!EXsA"ۨߋ#5Ş|vD?!?~~vL_6[&)&G;['-;ߏv7@ɔ)b! G |h:]5zv QNG G;h|đ10;pR%A𠛼l.p&Nx؉NAT?k1GаCF|MV\5l\a[~\ h@oF~";h>>d_; 榘T%*A>~/VƴL'2Kx#SW{1.1+QZÿ>>;ıL * d`2zIɟ ۉ txjΉr]!uVHWH.-CFL =iŬ4eءq* Ey1+Hkd1\=bV^v=~CV0;04AߨtPӚ;XIC=AUuhSd`bVFtcv\}فo~.TkCCQ2䉉YU#jfEa߾`P!i Z!QUjFay˛˵\2VuHVh+A<so2&V0-(*t5W;H3}5 [O O{ ,;Y߮48U:^9_mǬv١k;FWjN-,a 3_cÚ*a_a%Qvm|Vo|x'ϐ7ZkD.R,ʯkY-W/__3}^` s?w^N';ˢjwXs7b\a)ٙWg[;%YEEUYw@x6W$8R+??;3q]+oɎвo;sSA5]Îɸ46K"1{VzYUc_]Z~W38{m RUME>Ra#Qq?{#|Ƕlx5b{.fE0ٱtTYj SgVuV%wʃS벾gAeY;,E*١+; ;%1Ǘ~a];t_Xg%0%rUx#d)j+tʃm;ne[$&%WNCv#)Ŭڮ(Fwj UCׂʱVfٕ:4jB(cib;:hTim`{_tHnU쨬v~mЇȎsULPvtXhX:9+;`E$_`{xN]ְ >BO\YAq;~'j~(zc 5E"0x|G㭫\粯W߸j"; P NԬ2@ mϱC ;`%8vi\|As. ww4zs_0pLWPހ7ڟ2Ş[$8eov$ewgzij#aV)k6$mfoDg=~.9eH@N "5_lq xmL{ΉvZ2%v`2zOz֞}dGv geB ]+D_:}0U;nzRחU~d [i"d,ēҰN7h#+X`F !9n ؓO!]x{PC5bGp1!J ݓčQ. G;ho2%נextEh#"1P:#W{u"~Sess|5t9~bOɒN˜xB3yu}ɂ)%!^y dž91k<{KJ w` ǐ 6CHE?鮫١rS:AQ4sEfyf$5!dk3múlȔq Tw+CħȪ#G7av YLU<Eeϓ9Jٱ/<ȵ{0:\mj$T~ w]@05ѳk 9x+Cё@gGJ]!##O-(yubva2V:cRσTaﱣ:~\U񣰣 Zv a^MfvtŭջпGŖVkUc(:(RJ dwHi eNN9u;9s写 g}DcvlCTzf \j(;D1=rMǎfYPeQ:<0Ďb=0-LH WntfV-b ?ΫaPt >~%!_~?}k=R~p>5ܯ_ >!%49NÚtt"bnՇƬ<ۂZA2nq%ϰ]п}P.>8#cq 9oNGt8~x~L_ .5rC;֟ʸfdXG\ZQ΁e(NF9N OnL*t0@[S(_;sH:/v+ZfǶw>9'pfrj3דN|Jl9éa/|/iE _j/ nʎC>$._,vwӃS9kd8Ҏ8oN1,Y<<듇>ٜv{ܤ+'0'=qmռ44N%v|>Mt0ےd˟:SdˆņqE_i t5O oOa{m+~;'v #V?1+f$C~k?.})2( eXEϰfb)0WXv\ ۵:`%BUvp׏dbFzA>H>z@$ER;1 и2aG9%(|¯ȵt"'7ITeJ3; 4}9}(OX=cؚڱ{7* ; brX9})S=4)⮫gr{j}$L|\h!WNsnl#|@W v (.n"pa"i2VdP*muDVw97*1"VY?0pΣ;ĖQ.F)/8rȧcGUXJD!G<`hġvr)C` E;ihQ^[&UgLء' !zScV."v$; DW ?Oo;64:4:s;,"+(: e!O#/Ddbh>q=Ԉ ݼ|\o/ R%Тi0=ƧJ!0UPBAWgvTʎP}8>9!hBLKeDJ+c5NCv 9 qHXPvH<DĚء1FA v< nI )BLmBIĬ@Ǒf:p˱(ÎO@f:gO,Wc1 Յ:RvM5v@Dف 7VwPaXqZv؀V;dP!Hah$Bc&$RD=*A!Zvp^mŁ?zQFH]qg!;7u~CP.`uG;*2.TZXUcV%vw))MJ|;j١Åe\ ;FE*1vF*pWkv&~ܪL&1S)܉g嘕|P"W! *vHDf~';$bcV!;lC<  V}$0Tge9%Z& \x_vY!Zu]ĬJs.Ǭ7l fʠ;B>"TѕL(ŬVWx>Q\U6fU QJO1J+f-i/oeaj:abU%;+bVTZyb3?l~ĵ+j\%%\8#0s|CjbVNwpUӊ 9#eYJZhC18=فb:vHǬPmn+Εx'm>A+B;r.cn2ΊVvD4ʫ\̪ auVrV4:+K5ʫaQ Ter}-W$f%1Ϊ&f/+g]2lJ Bwr!;lf \F|*;84TˉpTj՘+;Ĭr~;ġ*/vB *Im9s٪LYqVX1+(膑Py$«5L.e2l 22Š|MJ`KVrݭN9]VZ55l[S[W+:ϐ6); W:hM~K9u Pwr'T>;̵t:+?Q="ZUY,,x|~7:Qd@8>'t1`@,(䵁Tgky!r/`NMk]Ƈ~ZuVjE|D`.M̱N|Bl馰2ŋP+@,F0@-g \ E.t=u{6ATd~buT;Uki)aa -YH x_dm vm C؊( -@YJ؊o?EW^H 8TX+,YJ(/nq, lٚc %$vNвd q1Zw`ⵁR[J]4 nBvhƋiTEx ŬxF|\?:+ˣfb]  5Y;fbf or<_ LO2ff[6fwIBvr2)ZtO6$uҜw+{d*M{صZ=uv~VǷz5?S7\ԩQzU~ÎSAkV6ԩdXomM徯T}B{eYEI,LBca+ *o1"dnSbH1̸{Fͣyf*ǟU<쐀U44E !fIU66mPvDI8C"[UCQ5ʣMFLk@a)ү[WMFl𦖨~򛚃wAe3ރ:e0xT"zV~~c(:p(&~}ѩOGp[);8ߑ8Hcv;nfv]l_8|(;Ď d vt@UjtKBNIdN܀A7ޡψ&?b}eǤgEGR㧟:QuCgvO F cA+g DjZ;fRw eGR,;lpfrtd sk0rfG|PtUVF>XеѬV`Sg~)3:&CّeG/vt@ёH-QP5x1;#ˎU p@T4>2'׀UShU;txVsSsja2kˎF? .f^?ʴ鎡H>busx8pG/]Щm#4|{W?~';..ߧ# ]v<aH< xExzc*v EGS=#$_ ձ/'qpwuuG_gn缩magw,zG 󳳻11͞Ϳ?v|ށ7erQy2W=>^U0u4(?tGI2]RBhoաp ١[=yv:xtnzg F65玳niRELGv_k.{}? rJn(Ư {5o;m^,hΕeG$9#^ӡ,#AFdep0x)0Y tOGZD<|讁=NmetGoNd6Q'v4K{hU[ә:o͎_טmp}ΤvIw U#VS᳻070!jN?^CuuV7\v8x}>:}O7|˗̟<15]8q2|)Ncb@%SZ!ESw:+߂q&X\I#\^@i{a~-;J±C#mp$疛gƒ;5\n#Jc 9bےG;GCէҹR8V<rmcV{0bf fv E&/<[!ñ?1c65F 3;lWt 2{{=-Ԝ~"B|ÚNvH24߁B"/;pn_~@sϷr~;oOo?0;>e,9Rzv><|w'q~ׇs?2~Z3_~Oq)N1I|BEfű̧wt9\πɂAgj0!K{s< ( wH2@\;Q{G#83>)N1WG_pg|OsR0W "= ϰ.ް>GTrL@d=dpғ}K8BvĄv`E8GvZGm~#&|!o}.#s8-4뉻qv=Ėxǂ~ ~cy8I{^c^qN6McڧSYQ[gagM3XF; 6=WjmocqLx>-b<%p7Qg(AClHy'*_5eoH!O$3ٚq.AΞKͩ\oK %CLOS١ '†9Ǜפ0YpjAt+kz&@^tir<}ʈ3s*l2S;ps-bAw<#QnдրeG5;>U!!e*.j%쀐)_v>g?)t^v\a5iʎ=^XÎ ֪e*ԳS߆8?5 B˲cȚ5PՆ"`*!uFMse.E Aséߥ^R8}"dlu*~Vu b؁N,4`!M -Z%.E{[X~2Gxh1"(z 10VEv|+CBQ @zEhx={5+<@4whįͰC#ϠN2 F'vsC귘-ZQbi w}f,=gG?E{g4XNv!`BJL]!5BJEQh$űTw@XACs+ Sq0zzvfGbp)BmOuQs&\k-ȍI&60:`"A!,4źl8%v¶6LH4j.Ú8 չ|YwHS>D<l;K;(TQ 1kR] GxYAJbxϪ88d$H` ScVB[ ؒnk ,l̚ < |*/dEڊFȦ /)4Cc\}?!߷&rb)_Vnȕ.px؏J=a S`S?yj5; 1+LFW'aˈ ,84򺘕EF)fe!KJSkj 5ˀ6jᣆl][vUB-gb*)@ LDn2:+|= lJU%d[Uʧ쐮M0an;0hu쐛B);WEHs?f?fvPPv2iBNwx0z;XwyЏ;P8%QC$!;$k6/- إ@FՅ_8oACUA+tKqV"ztv)ʧBv@Eh`ݯt>W9֒[fGv";jꬖbY>;lTCU:+V\U묚ѹVfYReɵ !h(YѪ;ZY!xQHe=YٌD?vÖeƬ4WАQ%;lI|x:+(!!.k&dA.9YN+O2bS1azŬf^VUʎF\̊o@z1rYWΕb? j!!*Ur҆z. Zvs cΠARLFΕvD8퉆(K-rJtkdH0gźye8IY h 0tK*ht^.T[EL"W׎ .{o ;$X"&#$zP!Bf7\Ȟ$? yK<nb2:u VʈD TZlB  ԃ?<[aT@%ˎ,;(Qy?cбg>:>c#ˎȎH2bjЬa sFbCk;zr̎hC,Ɵc6C)I9b &qёE0є1knɎS^lhꉖO[dqf?)MvdD(KZ:iͲʧ%e (ȲQbCq`x 힖S;HS$;F:ixF0hܑdZNT<3*FhUcDk9L911TvU/dGdLLV˲c-=sF`Pt䍬zcSύ 7\+_>Ѫ$C箩׏2wn #ˎ^Ȳ#2EBDyO> }s#ˎG/6:Q1A 2ƕOn1NI3cG$71^kɎdhcr,y~ǦʧK_v*;"#9DAڸmr|jyi3bc(:r(LpQ8XgXh(hH^x-;ŎYEFZHNYv4?zSfG\vSEvS 0scGMYťld5tqf8O/.;ʎ'C#Vmq\wΉʎH,QO|2vT+&ruBL;Ȳ#ˎj* TԻdY)'*%EN)b?}r`RbGMȉXDyI9ّeGņUod58pȉbx#:y `8qʧ}aG$t2:1ˏ='ʧvaӏXZːUTU8 ( Or!ny-,;z%OqZH^ ?hiˎ^lhCl1*QGvS 0ZtNdGNGIc)A\m?t)}}gӏ3&;"#'3:z#mّq\ sk;vDy G>kNtȲ;̓>}>9Q>ۏġ.ymi#'s|l"?TDk:ڸ]);rĪȉȪ#ɭ׳`HKv4%{UR޼TL$<^{-0e갦^?ʴuIJvdы,9љ;LH֏ʉ(|Ar#OfxV:^cEAZ) R]2N#뤆_!;"Ɏ|Sd!cZt{LISOɕO=|ؓY;"#1&9Q>ӏuR㯎O?bO|j(~R] 0I'2vPv|Pn O.׸.|o:h'3VƎʎoK 7};}l;Ln+kߪرBQ\vZY5GbZ: }iB\ 9!iUX`GF&cyAn?J Q9Q{7]ZZY卬Z &S_SeڣLjR{jtGX hE-,bZDQ=#VQz(U'U#-tDyN%J>!O>TsLh>#';"|SdLSz:G ȎC]q^O]b:BoC×c/FujF# ݋rM:j_DemzwttnOr'6 :Z 6<::jIMVlv}ŌLV?M Vt!͌m\sIίO1ّ$Ž=v_;9u^_񾆕䚿5\ˏ/.>^ =/%v\ώlώ;xGp>;vv_쟝WCG`1.w-j|ž<[y|E&l vO91b xz1djw=czv$ ;~x NZxP40C~zp?^GbG{t2^0ؘ~c۝a\^ᢣ뀍^}A;v\:v6#Dd ARK'Kz~}MΎHc؉OʎCڏX yE:uLxMAܱC5:e%]]]);v? ;$W{)leǣ[r >!rtP6u{&ag{IWO~8GvЋ[s\PLŅv ;5n|5x8&x-9P;!CVyfGL|숄'>);>`cO%,A~wAVtcK8E(X*;>rDw`J1q xpC.`# 1DX=pqZswcl-;xwGͳ= U9sW'+B=")da.fo5}'^@{2虠_bJS#O&f! ESBXy&r1-fǂA8"1)C=;.%0Gf,:ΆkɊ~tHR)qNs!& 7WTG;!6N# ١8PoPmX*;^'c*w7&Tu~څy(fh;K?*2J4 vXukcGnE9*$ԙ**\9P\%@Ǝ~ tLѭO2ّ v|ɎVQKmAi Y/|άaI쨼krJv:9r{.c8@CR*@ޤCv4|Gĺ!c X9t{ B|vPHbVEjPrǩ8u ?uff2ǎymᯯꮟ 2-;j6!BQAËYձCJ;[gE}#IWm` pB"Y`C`uVX#VA}6?F ;(~uK>2:Ƭ+![ǻ=SiRve*hTPj%제 Y]No<;u.eQXNTk*Yk5E>ќdG2s( cV 0d9;60>;::>^ .#oM')ّ`vp픟+ Y”Z ;!k+DXCGG)[OgI:&5!;ґ̎0񊋬xԕZ4E9f峃cZ0uV'AeXƣa vDAᢸ؃dǕO=D^:LȎtdz_"; $CS}hЩOl]|>vn?x zajwtj:v$vH龖h2f˫hQlt/>FOD|ēI'ؑPĊ8š( Yq\jA('7l.uVᵱ);nhAe$DFoՠ!ߏ0`XKԩO4ؑɮ $*’?Ɉ+ŲW[lH}pЩOT44]~9XnxǙGؑp *@Imfc\[%?sBug}t qG' XcY5Aw{nlƎESU4K5QO fEZѢ.֐tA~DZт4(ڵ |?Ⱥo`O{>x[ZRkpb*5D˜QqGQ>}yMŎdO902DWZ8]xp JOvCA4lKN'l2S{zߔ~Fw1q;&^){},{փL!Z5MDn(=S1ŝ}tF&UOj΀mf[[[Bh^c{kP=nޟGIv ;vEEvV~bu9Ǯ*ו|22K#w tgvCqGN TEru ;Uٽd*9@ۃ? О6HEQ͎c2t U`V;BHmRte'VfԐ c7ڱR4SukvDB,;^- \/n^,䯾IЬ74d\/-h~h%;Z`*7 ;nN77*- |vqNǷON ׶Fv0hKb.ݹP.;ei'&5s$Xd=mIPaKzlN.)*%GiؑVʥ5"^^a(Vk*|vX&سXlȎOT$A(5ieAت(CYrSOP0ni\鳜MSQ ?^J\6eT z5 ;RaZ:$(WA6rɎIf 97^ofF!C";|C/0';Y਒=/#;ZP:Ioevp?i `BQI( aږ5hbm-1}mSr'spPq|L碓}$xc tl%;39v\Qhl\eqvL3 ޙG&l3l~)դ;ڑ}%{ [E;۽=z?r\A?Mvks N[K"gCrRvPX =lR=%0-3h#L'ev fzWvh(vl4dPd=tYvBK+thwR00StlxSYw,-s쪁 ϕ SËYj+b9zl(ejU!,?K p)2;= ]dk&ښ ;4;X}?NI#cDt*ΪT^ä<tڪbUq!)QFʏlEZ;,/,;vtGGvp)8}\TGek{M\LcV-` [hUFڊ[7Om;Ĭ̎cev[/84tj';Z;5WΊbURM2eY/PJ>Q4xE8EaǧO04ߨ9u%Z4PClZ;eW\a 4ѥ%@(&)2ѡ6 vcV^);$ZĬǖI l =kf]B9$וIyp%\ :fpBf fuVcQ~܆SǓBQ;:+ti~U3 xl+i<~|vdы,ma^(JLM*XwyqaYQ^!)p|Cc$jRds"CHw6.LSQKΊ@V&oI6ʫ|v!%\x5`%L[A=sɮӅ\9Zv0m8nkXwԣf bw٥,U_KiixbdvUnU`onK;6?Ȏd$Ds{4f02;Ғ9Qnx30َ4ESDdzIHYOgi8f1.;Ȳ9vȎq#0l'$¸qsߤ|H0],;&RJr;ʶi(OYOi։81*;"ɎX'>:l>7i0oXetL,۹'}ױ$дQDFk9L>;)ɎHvcۢ :CPrGʡO >jV>CWPhuбD9 ;{x^8˺IMA1kcM:ǝ=BcevLFcT?YI {Xӥ'\ >{`+:Nf ##]*;`(+itdG;0*ˎD=;,GWc9DFdG8 ^hYaԃW.2EA>ڪa^pBˮƎՁO.;d?Nxš(841l0wKqaFr\v2sd(W7DfÛz}Pcǻ%v\^q8yy(A)4ˎχ ##cBsѧ;bOH;?a\'120x=l>?l6(DFcG$t(aU͵ *IRVkIs~|˘uGKlбD9ɕ*͜OREzxgǪm':ĞNf#rv8ur[Y5MUEZ\95^'Z0ٱZtHTt}#_DwȑH7'sdE}̥ǜ6߿Jtd~:HH[vPy7(Vr] ˋ =vD BFe3%m:V``ksyY"HUЈ[|ӱ#A>ݔiLev|Sz} t"!s=) ,FaGeQ'Z̲c)Ɏ~s(%\FaGZZbD]oaX=(*f0c` =urJ]'51ؑeG/gB˞I>)9*PRN;Ɍ,;%m:V(TX%⮓H 9Q嫗fF{Dz}%SL|vUՑsc/Ln&YvL>)w<#-QB=죫kzyi[jv,S;v5?vP;)#t<{ve;A-S^&!YVYۻlw⟀_SٱMF{qFr&6;"ɎQN|r(5oH"6uX@}ypoH"ے'9BU9WKv61ܐ;zίNMKzX4M(8Tw8ZOmYfV*InK !(|݁FOzeFޞ#i{ʃ}24";tˣ#X[{&`fؑNl" TˎwL '-NyGDcA;C/]_4аB164c/O8:o@ HS?Nǂ_d{vkT̎Ow̎s a|??:>Sлwwq X]=}|4؁#.o.d;į'GWK|nk0 {) Z$Ǥ2':i;-zgXs H.voFpkbV?^m"aKWO\~$沓NdvE g?1+YV6feͅL\aNrޓ;܋YzvH@&{Q%ً`XB|Z*TX*B\]CPC>֓^ [1sLbG7+CUhMc~d|ujˎ5Tpe!;v_tG;4 U ǺseNjx.d.r@?h5j2눩ȎgBۿ:ҏsDT8_'i]=A?!Aw,cŌFظ]B4;rH#lHڷ bGj;eǚ rFy e ;-{TQUԇd7CwSITv(ŬYfcV8]pQ,YUTQs2-r!8V1+ tIĬLDl0TĬ  vT&[u B#ƩPg%?7ak| m:*aO|ZaEѪJa'4XAXq՗QVu}pzpw8-;` 8Q0yyHw& ,͙B888EӃCv,h:+Pv.HF,1&`vOКci#$O~yyy vx@TgAE$);N4=@+Ǭ'֊q #%LMk_|Ƣ2-Hȉh*1ّ:mdM Z–W"Wh\tkPC>+s&FG'Ϋ'\g"WK?/k+Q, LDvt5!P̦ScG2cM"͂[o _j daR"ӪczO4Z肎@!۰B\*BU2cSر"ȎXk;`RZg~r%'ֹk2&o"k (‰hّĄƞG(jl2;:u!ujfqXW^cFYGʝIcd2;6JvE(aБLgد8 sdteK;FȪepڬ tEAg cGcё#V=.O|Ĉ]ƾ3 v0tdSYv'~#ڰMWt0vdّ w{zbfG=gttB(b R,p 洺D[df_ כ7L]㵁 [>jB|'DmV9D']UM?=td%zn^ώa v4MxͬVYv xE},𻹱b;Yɧ^\/]>]FhNgXv`_*7k@yq( qIt vϥ=BvȞQ=Pԉxa[<* o%;Up$gDtD*UcGY"VXPU M߻,LaR4 l3jFn:qos0׿w$%vD{J ,Ӏv}fcs ޸CYնh;-Gf+o+!wTl-FCBہCt:䰯8K?ZCTa_ʳ (n$6Vꇫί`((CdaGz oYTn;b= HPñwPۖO̎NQVPT7cw0݉%2RvDBaOH!b;D91쐦lN(nk[=`B :Rϵ쐓;dux\2|ǎ~p$BG ,T;с;* Ӧ(8|[boh$Å>A`Xa4d @fl雋'p̈@^fttՙ%8viuT*6kAkNOǎvpǔ ;G;i:BN!;h3Dtu3=q(a;v؇q^r崩:"3ATh}KW(fݣ]yX5X:|xxymع*%fEVr e`nbZEI{+(TguDiJl9sq0$g zz 9ŏe":i9.3/Yz_E=RQ1+Yj8CuT\:+t,srI8mb?4f vA!b+=BQ&Q2bV\:+Ndv<9vt)r9a+"1ǔ;bNsr=P }A VhP\٪)^#&jС4kC[z`)fEVrhHc)_f)|~F^Ϯ[AonK$;ЋuUR\IBNaDa]流$+79v{a!++؁Deǖ2ʫ̎dIvtAG[ےrT. k;jv,SD h?TCͯSTrkŽ/ha:&3D=;}~i$"6It8lgl֭&Ž5AbR@^vȎ_r4>T6G$ؖщi#:Z&.x2vD!)#G&D{Ns;A`NT : [?]Ȳc7MA= vD`*21)#ˎ~{:ύ6XΒёFVħuKu<htS`G²c-G5h)3˲#.;'гh '#$g;b$#.:Ҏ ht;:1ZGE0LFG\t$ʉ{=;ύ6_=;"ɎV,j݊ eّeG4l4 Kxё>:yEy4o>@]fۯ ˎ1БIJF"7"Ȳ#WfA~숄(7in?edt.#.:r\'Ž6cȎ(=RdGN'Zgs17_1;"Ɏ6(lѨL"p)#(oS3@7SfGS2:GGNU4m0eG²c tDywev,;yi@7WfG9IFr}.?6=cdGFG\t$ʉX|qz: JvDBG( I[' f@_ sU9bxeGRDh?tdG t69Q(oﭓ`3;2;rcؑIdzM:vlxbx݇RSXin2z+cG$tDyN Oَ>7㺳s*EʉpYvL=m_;"Ɏ$nّ>;z;EV@fw(%#}t$,0'אfo"v$,;/}T=VƟT'}z:H=7j 9Q彼(ziGr~=c-eGTQ8Xd cQ|As|-ɑCVvD aّ>;zqO+>mM~iv1#KFGȉgo<zU#a1:FV=R˺ٝO:\t^^3w71v# ttɎLo`0ّkwlN':ڎX\sǑ}F4akL{]ѣKXDyr<˲#'~ o`rvl:r|"Vħ~'p1 cGveG/Y0v('$Ao`jݑ&Aq9g1gy ϙ;O̎Hȉ(9w=pqz7hz0ȉFG(36j뉎\; ;"Ɏdhّ>;9zO"?lM~i#avdtUFGl }##n<42ldw>p:4sS#:r<'ʻ8qm.?֜֐ͩ9b#V屜 y IvtC鳣oSl)0x{=7AdH9Q+I'3q&MXvUܕIc7[#tdž#rEUyF 27vy#v6gb:ݑ&Q8Xw_G/>r(oˎ?JwDBG#7t:1gc2-J:툫1*FkT Q bu蓙դ?òߏ&(N;|?s7RǙJwl;ˎɤDeٱ~YEd4##.Mˁ>uqSDz#o #:r<'ʧ"Cs&lG~ؚz(ӎ98ĎYr<ˎfNTXdœO?H$;ZIfGY L:;'ryIr ##}t$IN.3.?@wdtM-ƟT'}XWly<숄(ω>}"|ў:BG|kÎ9b#V`uJ=gjtvD aّ>;z;M+>-%W>\6#'#oF{nXc#a1:FV}/35~dw>pS6G3;"$rEU>oӔ>O&GfdžɎ 9Q>Ϗ wq >7玬%: [ L9^,7D>ZG Uc*,ˎ yE:}ntԍʎH= @GNo:O뉎̎̎2;ˎqLXOvDy1udžɎHriGN':Ϻ 9QɊ'M؎5QsgG U0LXMeGO> #2;gG/>vR`w<1#xSHIf;r<tIvctGFGyj9}D >91N\s^~7yȲ]}8aDN?qyԑc#odÜH#+)tGzHȉ(=~֚z(qa1Fc w LriGNGXo` ݑ0:r1ّ啢$rv:OqqG #ˎFvDN]G@i.9Q$cБ=)eBguOv<ϙG*Er#.;xdٱP~7&;2:#'#ˎtf=CGgG$t\;h|"y&1@ʎvTp>w-}>hvLtD?S$;9Q9Q>XSeڣz<{x7Dvl#'ʣx}76Pvdtl:rjrz\:ZÛIL_>XZ}_"1txU,;aiّkI\;6:-&;6>wtth 1-"p)R!Gs&W9۱3:"rr죿(!+ˎ#c3ё7與]? pEȉVSYvdvDc{_@ͬ]߁Dّ åȎ('htϙGvx1y#xYEˆY'~dǎc]1zURj݇KQu<˲#1&؎3e] I|ȉd07jS3˾}7emGCt3;6ŸȄJ͝O9g)莿TkѱH>7Gt}o :x4낎(XHyEy^8#XvDy\v$ʲ#pvS1QdGoxdtU2ɉ }GM>7#Zs&^P~VɎdx1j`>ůF˒@%vWxdtl&:Lgٱ?S8Ѝ}FdQɎ{,y#qS=F˲#r`l[?#vq11n$9QރIN'?&7ѡ*Ǭy|dt(5KA},;ʎtf}?K|W32;63ۑyi~tÆ?9&1 7@~jcV o`71ҋ7@~O dvyO|fyyLPN TQJ X\_b)m:yLW Yfc]YU jom_pbkM{HrEmhvrn^V~{yvs{v~   7?BDECRMqjXGqLzܣ澃R㯑ZԅؓޤĂO`ۗeޝ綮jns]wm9979976799976~39987օNX;{9;{;v9_}tՒmȊg}s>^FztWgN~t=lRJ[h +wfߞϙ=sf-[?g7s;~̯  @(!kJ Q |k! @PƉR ` < 8Q  g 2XC'JA 5 @ PFk(D)@@` e(@3@@ @x @(#5q @X @e2N @k @PƉR ` < 8Q  g 2XC'JA 5 @ PFk(D)@@` e(@89oOk& ְ@LkX @k"5np. H!N !֠e5,v1 @RҐab Gm @#@ $0NVs )tJg d%P>-SX ! 4Ziސ! +FvubkXâwC@෹6M;w^ְ駁6HK@ӄ5̍AN@5rCr Bܐ'@q8&콮Z=&^]U'2bh(^Ynٺ^n ڔ60 #IVTx]GvO.3q;|iG{os)t7tn"}t|;o}:1'K}ᝃ<#+Bz o .bb CQ$Y?v|fb.$"GsmhDŽt(ޛ#jt|GIx58'~%ÒsiD5~\3s;!|Bbij=zR5X{[Rsy뇜80e![]vWZLXC[;&,֐0J"uף[#nc׹; b~tc ^6aVkhM%yV{ke5qvN_g`O/L-fUs_])iiS UfӾ`-'O:>Nt~Lw+2[Go2t9z?$q.:=#0W %YCƞ80A`W_ntuǑ0WGA- kb~N#:5ANEF:nM6;TJRRۊ#=YiAv=z3 ߣ`Ǒ!/0‚b 3evAk&|b=@tN2uFM:9Q$PEb &[IwLqcKL( f!/YE[;7V "m3w V9$b xuUɤ` #E ǛӱsS E)$؄)E0XC0ڿZ=qϿ v;@n#A$D(dZz/L;?AkE# AQ &j a l큣Ct&Us5x,'ɀqR25^Fݝ~am!>P}8䷮cYt>%1ˬo:5XŇG5~)L#35V;c! ' h*ʇ!78iZE41Q''J{\yg- >2;<ߠcFZtQyFJ!#Ӿd%G$0?yL"C&g a֐8M/y3Ad!,^[.9yhC\xi&;Z̤Ն|N_D:RgI X~ USWoK{Z87M>ɚ;!gg9z"R\8nl*Id 0Pr&}f`>k4MgV.{vY.gn'{7w]w_t*Gk Kd,5Lg ChjkT˄l!% #{w݊pe˄2Mĉ"t b}jIx.hgw)kRa{\Qa.8dlLpXCg>It( h Rߤ`zXI9 &lߑPXI !EkHmf!) A7HxIVM8Φ:'q 4YC,)KHH&sq/t.cI?eJ9g!~(тb7}Br5Wt >_5 Ga%a3RA,Xs%O C!7sak(b fM5P}C"e Q{ 3Fv7ܟ!qJ ][?YCb5$O_WƧ#oOĕ2U*5DuՇ  G`5uV4+z!PoC7h+Ѕ% Hf:E$?FW a goiiQ#r qA:Y(oV} vܾwg˾[F֥z,sbăaSNƓi)c.jW!9gB #_.;vJf/t, 5J\yMa 8*9.=`gM >fja仁r9l"х'W4hfkpoct:S.:+efAJoFQ45DO}";ɿ)MDaB o=[sZa}^}ڿCt33Dz 9V7XCwNDyE?Ia%--wݥ{8D0IKs=}'Ft\w} ` coAdEǶs?rRkckc7osiL$-@>sWT#u]DXG4Cٻc>7tӞG"h Nx~ŒT;kr/Bj :@,dgPq,k_X=͞;_ e54~v Tll ,Dj X.~8[/;=󼒴sh|Σ?ܖ1Kwvphܽ j -ӂI}_Cf@(Z%Ú[=t RS;A/ ]q,츖;eYGH\Sr'd+؝E䕻']3qVYz{겉fE뾒MWl7>ݪ5dkH~-Kv(Coȑ  ;Xn9 @Ik @#5s   ;Xn9 @Ik @#5s   ;Xn9 @Ik @#5s   ;Xn9 @Ik @#5s   ;Xn9 @Ik @ f) @$ P X6  P@u"o R M56S` | *@@?@~d @( }"5A!@x @(#[CO2 l@BN~  @K5,B @lր@D1k  @`5  * @VLkX @";/u?8@  ψ PrXC %@ a < 8Q  g 2XC'JA 5 @ PFk(D)@@` e(@3@@ @x @(#5q @X @e2N @k @PƉR ` < 8Q  g 2XC'JA 5 @ PFk(D)@@` e(@3@@ @x @(#5q @X @e2N @k @PƉR ` < 8Q  g 2XC'JA 5 @ PFk(D)@@` e(@3@@ @x @(#5q @X @e2N @k @PƉR ` < 8Q  g 2XC'JA 5 @ PF`y,#@N)@B`ְ}聟) 2{"[AC`kְA-XØ=@G`SְKzЙ4:ٟkg+@clv`7 =5Cn-XZ@(%p*ְKz~->-})@ 5>n|-FP'` ۋ\ќ-X/=!&vk n-Xo?BJ`/OnyZ~U.ڙ0ѧ<  &nk/?SawCk<kXw3 p|Xְk8@['5` Xֿ\ ` Xa/oXr k @ր5` eJAր5`  PFk @k@(#5` XCwR 5` X B)@z` XP] ` X@=@eo(/^S a-!ր5` sr?])_<:ir?P/*|BMK% rY3ixj4<ڥ0[cu eD}#ӕ| #y"| }'>|͙gK=õ=!ğӏ\k^<G?O5-(;yi7 dkot4^"<̇H.LA9Uh$L[DjhbC0!3 "`z/Tr𨌺x3ۓ;/ Q^|2N V` ik:C6AXFՆ0?acQFAV>Bh #< }h >] uX5W\~6?:C?dTEB3䵦d ְZ ` ` ik9>mW|Ԭ7gGM#b,GuI}559 # mpՍ2YA JDϏggAsGdCXCn?")ΚJ0zHZ=EFH |f]!$)g#<Š&g nxǞbя< k0+5HM`-֠#j7`f'LgHh Kg\m5Nx .'rN1AvvM?/ ,!e ?/ O6 ;  I3:TR(ҦOIdH_ȧ*kΕ]ɞlIy;3HŸ8)'IsCRtbrhz1P}X8 !e   v'I<ȏ'H^gF i.u^'Q”߭I~ m6 mΐAf)5,GZ(5C(d ݁*f6Cν!OfR {_% @ R t4鞴+ ):X!ڞJ aT?u@gM@[$`cmMr~b!e b3i IC5,f S= |1=!dԄ4:jB]^)8/}AsOm3SۓAFM'HsAHJAS ujx(e b%WUsC+miҴ/jw30PT2 6H4v|Y=Ǔ*'-_;C44.n?SPhKU3Yr|I_Y: \c($W`qvrte-"@.G$We? 3x<@@ !)5$S afv>YJJ pikjNpV# 3F~ZfUmGt#HwV͡jh~澅h/ iJ=+/d6x=#k}[EBCkHx7m&*$u^Y0,P ;S^ȯc&*nRNu52~_ g2؏莼s &pٓ ]t&'զB_`_@!a NgHȟ0 z3dc+4ca?Y"* OiSyA,k4!ڤ/cW?Q$m;c*RiD3inbZ8~_ K  \hWWV+>4 kch`Bg}6[}P? Ѻy5Ha祖«j:tlix7$ؙސfC t*ofHIB&M3d<*Yh[( ڞ 'ˌՄN6?n4ԋ6<} iA3匌\}y*+"f xGo <t&G_OrM=_}f`ʁ=#{S X^@8r IqPaY5_uhecO?f؄D~'}IEm P3"YBWcAsD` :/+'+==Kty4T 2(E @!k2w))d  ?KAv0ѵE~doNh |o!@h520?(`fq&ls AzJto0M L7Pj ҡA_d! - ө7ahBam[X@8.r 5HC 9IJAM۳'YC>yo_/<CٯXCa4HSTKGae |[!@`5-Lgb(ԅb}0ְ/ @k enio)dB(,6 h |O!@`55-j'5kp'\7 Ps Er,O $Bas |C!@`]5-אr kX7 r cr }rB k 0}P}o +pJ PY_L@X+kX5yAc@oHw$ r 5/aյ'@uXI@X?kX5B3Gd@EG嗝.,h|Xr 5/ %U/Xchh W/% 5` GGqvZCc &g_"fBxjPC[ÏM?ig!i3 XΠ>Oqax!ܐxO؏̐L5+t/Ӑr hCEnhjx@`~5|<^~WֿOxe҆|i0$m0}!u[L 2}68znkyA!6'tD|n!+ p4Ot(57qؤ5hӷ k8x=vhGÎ}ٜ5,$9<۳&F[b GCs_zFv, ΥwLЯ0l2;CCQsϐ3iث@L` E MY'~)Ka{v,$s"pa25 XC+JCLp00tNvh?Nt X.Hgl_C 5Ab Q(9~Y3H>`ԘP! l" ФҙIg߷!o"hp :$ 'ח8}kYCi#G{ : {T!-k A`9n ׶JCh dJ4mȽײ0=C:ˢ-E KभTkf?0GW~<:75RڋNβ"! 5hk!?~ׁ /}-5G}2A =Bs M)!u ;n?!:Kr 1I3g v~'W4NΏHm1eib/x|# 'h ~]k mh"C Iz3܄˯̿|v埍MSr69տ:Td #SS>=4|f4<7Y^_~e ig`D]\,C` ن: Kơ(~L^,#9Z Sr30T,#Bu)ʀ5t#]\,Cԭv| mwtߛe~8N̲\L4zsr :Z.SrVAD0HJ 60_Kyh}iB~^kTk6kU]B06c 6x9C -4& -a\wO :(T"5AͰD1NFnfoshf5.b!p۱vo;¢_ۘ]bH}Hn63k 90(Ge5_$fԈ q=Tw߭ٴސ7B{t۲: 7ȿ%0tB ao^@kYFLlr` X0ml fsir 5؊5ȼ Q`_%NĥF28o0kXsܶGk*  k-XCGC-Pl/pE -kqʒFܪBĎa^n 6Xր5h;-k(zI&ְ@ O``M/dt6Z?i` [ \"Xր5l܀o /IiX^:$b=0:5\ r & k6h / >A~^ N/.2!?Y^ 8p2ր5` I%[/_h6hg5!+X{!5` XA!&a`{*\8/'& )+HCsx.a>D Xր5tZó>{7>|,V|.J(/4`{?R>̒ ] u)C-5+ԟXѓ~gHf'RLAN>HkA猲 AXb Xր5b+v|O;mKN(ڠ~rNA?']Bm:RZ%8n>TgHc'AȰ/b:= ր5` Ik&48;'FC}U6O:ɨ@ʹ:!INj(S&TW2<# :Pk5PH?j7z2kdp=6 X]!e 6_Y_\}G]Z8oK3`uF.Jԇi!¹;v9̧%ʊ5Hs}ZVvU aAuX녚…:KiTԋ6~\pLt{P0[$DngT)sv]yzigt3װK/! ` X֐ ҙAf$!dc :bk 1f2& gZ0Vꌑݥ~,bz6[#Ă9zF'ڔHih`JU7KӆP|kbgXր5` 5x,= ?dWI5W> 6< c/kv̥Fl4hgo5iȆg ҒPY5C+vsZ^%d9_ kXfXkbki{M*]5JV&l-Ru5x/.?ZsFV.^s M6XC39ٜ4^ !|De3Z.qkXY@`1Xր5 ?/48z Y:FjC݈Б:R@X`EAxEGBV!=*ΐ5Y%􃞕ۤ!.W4bn Zò5&{ ` X֐kΐ XR:W[k0-6 mɰ}sY1ΐN`4l? ц!]93}YLS\+t! )q1`z=f;C*ݠ)=;SK^ fi}d` G/63K;`&wFy3NT%R!}k].z7 U:t!WPߓٹr WU4_i㖿ѿaДE] ˧&/bh# ~fA^b;eyϾp^Z%jK:g^Z}ɾQ̑ jnO3MuIh53n&v!~VZ 4Pc T!k 0La kϤӣXQ"1 RYhYi}Om;C>F)鵶3LdߥBm*C}vfz*&v4Mngurʒc@k0ʁN$4wirl#J}To99_[?LP/÷geD:idm*)dz@|gBr fOMkń Ӥ8kRo~ǟ7.23d6Ѽ)L \N*f8;Be q7M/M No f_2ShDkRd#>\d/deSp%G5xP hhh2 isHϜ!/Y #e#-훫uvnMEApl;}k0`!\ M IuҺb3C90! @@"*j&3S0xoYQo[o콭ٗ^־}xil5>UȇUNA,@.5Rċ B[_~]k?5&M\Yr8@~ ~\C@la RYvI.]"zS_/L9aT 8r  Ta`l@FcVo,_ƺBW"^tOap%DŽ5k Uir d"v_ՇyUåSٺB I r kc :A*8f~(j0kǫ-92  P sr y{L ٭vr%5T{KʭJ82r y`A/ pb@^o]k pp!@5 S5 P}SaATgmY@Ă*k 0L5  4kp(*'r )%r VC\a@a8 &Aa5т@Mk۫A(P}2kTXkҎ0XP N0L0,A@ $@\0q_qFZ|zY,^˿믿^n9^[eIA ` X@ źZ(P@,A=ATAl0T qS9ր5` XÊ ,xKdiﮖUVNր5` XZQ=b5xʀ5xlJkaӋ&ths ~*ְ֠y8kX|aq5\'-v9ʙӇ* vC1 KCooL΀ ŒpBC'LÍ7ؖ au[,!Y҉^LS-[uT*(y[e}Tg_e_\-Ո0|Q_@`$K#,'X%ekd'Hغ5$qA!p+|f]js`Fp7?dTZ&#ikH(C k]ó!&0n᷻װ\`l[&vΖ]B#$/_dro 7f>fҝ K4L uT#UkH X X2-Xr=C`P2Lf(Â, Y6h*g7OܘolX! Qaщ+\'9tf_r=C`rʠ} q@Kgij^ AՉ{:HAFOxl[v  ׽›)T6k*C3rk8ndkxEnDhחؐ5L9¦N f\"Q0$g4)9rL` %-k A`9[4Cr`7$ְHa{"05\װ\`J 29ZKݹۙ)ml笃: ~d2HEZxQ:=! l X G'0LB1`N!1vm^R%o2R54;% &[ڔ_ݖٜCAD5*CrְxekahE?'l %Πon4|v ~a什 &`H~o/6{3\];3ra+>(S2ea1?6E9BqРvN$X^ NDbr %,ih6@^7e5.Q'h f C ZÔ aѠwNԬa2}!)!wOsC&Αf9 eVjD{&zg kؠ5R 5j * m5]6+!W)5LCk Zу@^[g ν6 V^s x00cHnw:51g S!5` XAB` fuo|98I/Q9/ΐ5P'k8(yB`k6k AgW5E۷A;;L\~՛nQNMgOc0&,Nր5` ig5IMx6Io̿E()׽cPJyB`*kة5\-t__^U˽ҥj>ҭ۰咷}S-.%_}ӥ7]dV|kr[=kWhě*_Psn؄y+n}+ -51CT` X:XK.]/p&/؊zWh~Xs]g㒮dvkn.ޢpcǍn08w.rrY5ZV!W4c q fER^wfh0+i2m} b3 Y#C`Kt{3}Y .xtL8\YDsƋ /&5T/88h /x^۸@S)JÅ˗l~Jmb^gHi0? о Ή\Щ6W fNր54_7KZe/o(}^m7J_5hBX jPQ/k* MZ2xwo3kXFH7` CVb XCCo[`b 6E@Z&e|A5|u|e2DCq1" @l*bp1{'pL` XoI-__ZriJ& PI!P|ʰMր5` Էxy2MW a&k}wf ϰ++w:-Xր5I7KëKXC{2zb}54c H~mD%^GȭDcg"]XD\v5LCu}"hpkB (͠ci+ {0\ i8 'o ?uDC $% %KxeHL$@Y.gw~;{ yi[CUHh։d!~U@ "z3 Qf]`uelCb{?ek0Mz\N 4C-Y }]ژ Z(3khi!N ^OHۨ!tehL^25ZR2t5nJ@`濮qxbޮhtppk0f58ڐ6ASohfsJ+33-nzu=;9k^wVڔ m!.m^O'/ 4L̀5l-z aK:-kp̜5$A*6*@`N0GL2` [-P̓(؋,XHi}A`w\g( V|}sL` ~"shbG(48f".-^<-X Jзә}w ɌL% e; ۽Z&?SY iAfmlgvd&=_Y L{CӤ54Yhm5:J( 7osص7˘P%'u䥽mgUE w4b+{{&qvnk/cZ.-'??mg_~d[|?ǚ?h?G-]L˖TO/`/,_xy-otyإ/8AQO~AzCF!=9P,C‡3|bpd?#nx R` \K;GKÝAmֱVз}lk i!n85$4HT#F:Dl Ʌր5k fT9XȊm࿳3,1ȲeFS(<Z !h@5 _~m*m;tã?:&q3f- n-tl6#rL''Db#edx7Co@gdS\v.A(zDBP ZDUzedzی Z(FPg*kș&r:I?!1kFGs(s QZ(0 $Կ3)VO$>ЎVH?ڳd\"zcp?l&|>h)݇w= ,S1k8!f A=C*g ?S4! ]wpmOK(*UZkh#,vZa?Xr7t c{>b =}5$׀57 &gy\Cx|PZu/9%58DF\,2 `)6_!NmV_S[(r(.95^:%ȿSKYJ S>>ep'j E50B6 PPg*x-6Puث?]Pg^SKi/?5~)TD{F*ps =K*ɒI-H\Hyf` c[ß/2T^Wp Pmn7d^"{? I[Cg[5V\CB~eQadallW幆?їl>/=45 fymd8;0oAT5Z1m F^fU’,=kT!.y*1y5` N\/5dS1oP{;\ְ}` XP^Q81*{㹆#ڳ*\s';I (kTvuu(T1b@R4~r =5Pفy\ְ͜5ti0Dh @K[CDQ|/ų!(MARS<40khK:(V]X$ b Xְ5kZ]gi +r>i|&x)p耓TX{b Xa.kmY6Zowt ŕwUADALdjyj5ߪ *,^qC(ʛ1DS8 ր5` !ww{bi7evL'L4zjtEDA[} ]c sXր5lZiW=gzC{ZCP"k0=2r'+Y{S;ELJ6W: wXmO(Xր5l{{ wk|u5HR3d6`Z8Tpqfu}+ o} Kkxk8saC֠}n|1k|@k0?k0I+iW5`mw\ְK/mKaPg5` Xvok%<{r{wpוzWjW էw4j=MzߝF-(h߂V6Dɇ)'ӎ4J`wS Edwɵo-o15LqP1ya;֠4$3 w2ooAz/wmQYDZ]Іۮ`LAXk"j>/p6sPM|VSmwS=Iz󎺀Yse6k$kX4?b XְkDo{&$CS/w?o.sUv*a ygo wShiNL{e+w9 xO;⢞ k`pk6c SzajfUjS^O}kM=$&y778vV0F`sk &QY{d30ޫAgH7KR5Ro8~` :Ckb ڲJ5P[aWJ\ﵨui$k3 E)V:ovإ9~l!~!m-TAXLr5*&8Xր5l4EB?qEKG45\U˸zC=•;ƋT)hN۽f]&nʕTgVsvkeMGq4Sisa&g簆GC!ր5` [ Ή:4K،Do5l]6H_5X.fzT5[ЎWfkfm_FҐQ)DRǝOZfyBk0􆤅b6ivtxqjXր5lTqM .΍@hφ;5H@VX 6L3nI/|ݲ}mÝvd0ȖwṼGxW{d*(^0ixbc(kXA#Bk-6;q85ƈz * 6[a@ f ^DR4Bf2rwL֠b^eMƱ5܆5LִPvkغ5/w֠_zF[c(tlٻ TTN5N]S'UT[QY34c&ڔחAE6cKoG[(^ 50_ÜvCacxB:cݞ5veЖ iϮ8!33عNKQ/և6`[jWDSĠ+tn敼ǎݨoͶCV ={cɳ]a n r 6x)Xր5l4Iݩ&@I+Y3vW34,Q5]H{odv._A 7տ*Hw k8bСk؊5hvlPMPkmMGA227ݦ3vW4Ai%jh5XY5;4hE4!DY" Yo_A![g=dᚹ!e[j-6'^ ր5` [i1lATsJ[#[d*d~^a`mpEkψ;ΐ$s j r`5X-k؎5ټ }c lheBfhQ gd{*iwR/%ifm龲>uDhCųc1qAl^~{ţ;Hd[(g8:ְU~]Xր5l%A~M{2bx!F>h&uj'vi'瓮 ߮`3컍Ą=MfJF)x!?S|Oufb~ 3k]ր5` [;3M)P/:@9wdC=oS Uivռ^gZlý捘 T '-h2!2UCb$fNed 3Z,'5l_ր5` U+w~Mq!f1]N~Z`OsJ@hw{g=D۠/u'n7w4o-5'g鬾SgTעp.j)0K^Nu[` Xְ1k w]R j,X* J7>MhYwV4|fP4R!BBa ksְU~]Xր5lek tA$5{e+S5AHDT a~ suk]ր5` XCDZ1m_J҆I^G,:kX5N ܑLC>qǨ)0c^ͮu[` Xր5LE0PKm#j0 Vg=a0kb }`?/y{e5״3axtXր5` XCíaMQ~sï kkn suk]ր5` X08a0kIְ@^.u[` Xր5` am}ï kki ˄k]ր5` X0FN kت .ka5Kuk]ր5` X0<+a0kߗ[2aEk]ր5` XPl {TJ:k a6uk]ր5` XPb ;M3ï kk赆3X-kks\Vka@ Ͱk5 G_ր5` X֐A;8Яat܆Xր5` XCPO亭aݣV9;@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@` \- @`<a<; ְBƳcK@>_}ݎc^-K?~X<^ ҵZf2;l>?a{5HWj  ?}=w'/t;N[1lv/}5Wt~ljb?T_Z>ׄkM[&XJױwف !f@]vs vP<]b ߓ!2O`g jo;l /,H |k?<7H2hX @XC @c [xn$ࣖ<Nʂx5 RhpUsWgSZUϦ/n?]_C<2m{]T~4~;Wc sS_H59Sn8ׄt&f'@z'"~p<<_uZoL!H x|=>F+W6 'r]gѳqo uY<<_ ҵZC3Ya}$s  @G0<~xGx07q@4X4~l @a?+ L#5L sR@4X4~l @a?+ L#5L sR@4X4~l @a?+ L#5L sR@4X4~l @a?+ L#5L sR@4X4~l @a?+ L#5L sR@4X4~l @a?+ L#5L sR@4X4~l @a?+ L#5L sR@4X4~l @a?+ L#5L sR@4X4~l @a?+ L#5L㷫?^vuGX0(zP鸏k~b n8/8q:>Ca^'qá~Ph 7o/{8CX4OA{:1߼Cwۂ<}%eN20h)98ߢdP/^UAB|WNlxq^p׃ [sp. D].9TFw7Ȅ4D]ku9=Z䪉fWqLǃoYя6}fA%G(wX TX뀾nyTָ pC:7u z uC D(;_YB5WNd_rRh2wEɊ hfw¹hl*y?x{l^p2{O@/'z5(XRR 碯\-T1;OwւBMw/;_#5.`\ w?DT iι E_9Rotq-x쳆/ i5twx$e#Qk>Q ̡y T*qw?ְ k'\BauzIO-ts!T@ O:y"3;Owv |XC7)ge]cW3}djtKv/#7$ m` P<%YÞְ k(zk/='?^:K7O…?<xw}g=4謱BV5hC|цZCO0$aGMZnkyѝk8#5 N֐(Nǝ*z) v\j]{nۄzu Σ<ՙ9&w{k8B5Z~{k?¹e ͩ+#\ʉ2ƒ"OwG}5;/(yq k8zqiAM@tr=8|5=0U Tx{XAsKn%NcB+[|5tgO0~Z+>ޙAwZo:XC>2Z_=?w:9tkT6}%OCfza_Il :8#5?PBi2uAr*"W50ѪwauYi=GkvOP49qa\` ŷ!7.z7@,<W&ͳoǎk(N p^i_[GhN9R` an91ob +~f;! 8`G)065p<#VҀ5m%CN0+Εl4~wU%װ7crАph&X!y=X 7xa ng 0nZ^w+ R>qk)k'e?$axqw݇:qW{Э$95VkǀxƇtx!8~W ޙO5$n>׹4ɈL;\l 4R0ˎ= ;H"</70ydyPR Qq~C|cWcKTw{#f,0^&]g:(f) )nX!a]b 3yeu/0_.h6^vKCs'fl= (t#*ytz#~@b Co)={\vA5+yW17< 1  A%7vm M8 D(Нj P&T_d.5- [ k9_`/?![}*?mq-}\ &]@Hk)5yXYiTXCtK?w}H].gRMɇ- ) L>NBS-ۑ, ҎK7pN4./S_rGw=rC0Rqق e =6;R54yŮ2rXC<֫4:8|S~ MD ESEX=P!c +Z8~\^r/>U^;lveY`' SXV])Ca< Z yuwQgO, 2XC'JA 5 @ PFk(D)@@` e(@3@@ @x @(#5q @X @e2N @k @PƉR ` < 8Q  g 2XC'JA 5 @ PFk(D)@@` e(@3@@ @x @(#5q @X @e2N @k Me}[j5 @b":RxaXC!(A ,ua %(@('dB`}_!ψ ,ދzQ 0qa@Q@@/X:Db  r KqG_b %!@b J6`  r;X\K:k(( @#p~Ck|@('p~C` w oNH_?A" ɛ5C!S#钢0'ξ{x i+ܳv_M݋wv(ۧt0ߤ`K=v|wLw]Y䓗U_D{J=}H-՞#%ϼj8+{ŰñH8~u\wԩ]Ńz3_;5tV^՞۴\L51N>JF_?͵)|K9zxJw=) Bq1+8uQ3|DoeW2 g"$_MRǮ˝AW̅dWF;I\WA$ats7w-Tf pN-?IrW tnt%cЮ' pX @>**TWvqxmxqE|.sSJĎD qbwd ]Q$w5\0apG%8B'Ia/0qr]@dVk8s^ bv"Q_rB싕;n$t0s""@F^$qN BI[tJCIĖΪ4╝ |_:G=,v #JƗ[Ok8,oS ׋17r6@#aW7IT+t\a mTC KCW{i=krVFô="k)!e o}:{/~J AtYCTuyORΎ`68< ɋ)lnu]={ 4X{֥!՞,{ u kqL-503Pv +S;b<!8ߠ0I_M#yF8׎ ZCj OOn*ƞ&5r!Gasl6jְʔK.tXC|{58C5舕9vo5D)7/ֈGa3=2k =5$; #<5;U2S]߉5R"!i5?dI .?zӯ!KܨNw4CF/ԜM>' w3d)*iWrFGIJ褀=d|)3O9Z(^ %ikP{?-#F/J=#&$vo 8n8+wJ׆E6}zhoȾsw2igb[C6I\V+#ɢF2B5lFZ udztiϧ/V&l5$"kA:g]9D`PA.J@⪋9^'-t>ǻ/: >}&9wײ\D vΐL2 ^w7M ^$65?";v{@/E.͌xTc v28+Z2?z|Sj  lrڙ5?uNZ5WWd u}[e 5֐c!e TN9/ VK3BOB8>͙>柜9L7()arAΝ\i_ѫFNHhG:33u^Uƀo84!3;+Q$ Vā=BڝZC9͆s(kHߵ7tyHx2}pU!ǚ#ATcv.5GXCz}h B=mؙWp:U)xtu @_Ljrb E\nq5v\`]b R[r@.f/k 2 u%pVODoĮ!_sYCнA&_2xe =.it$Gz'(aY ?Sy,jb@t8195|@ agY "kH1'Dj}IPky<4+!nkbk vN /~/^` #89%W15DKyT'e lF ?N9a / }TȌ=\$shGY`X5kH6qw ͌w "5Hdx ; "֐I[ \{eɋowCUy[C~4s  EvkOu~kH=UչBRÙ@dMe޽ Aa>n0ʄ,kt5 홵/Q>m-k1HF'B>BAGϔ5dnDW|YԱSE9W@5t䎓~i:[CsH k=tG\in0{VkLӣ4tbl5t2v繞U!p?[7p bۓKݴh'MecIM6%oEy|~bl쉄)'O9yiκT{[hg#)^Eѳ9ְ8b#m AKiYSD?4m\6}5[:N9~dlɜӕg nA]9>&Css5dnI7Sߙ>Ӭx9*tN@6 gJ?vVZ-DOb$9Q@C]}$MRWH~C,<.]0gb(zdh !>LQY( ҷq`  p`CeNND|MJgiw:~xDtwpwMr8x,8hk!A"OYC]P(&Jǒ}-ќu1H;=ѷ7 p@ 'B Uyuq[W}lꗠW6]a9YgۘOLn dA{\PhnR.'[4GB*s]1? r.KӬ@ ʼn&I`2%% Q `"QHE(P%hwZØY< #G]$ҷ(HG$2O+tJ9/v&ߒuⴳ{̵$n!XB TuE9xg[ :ܱeQ/g&=xޢ^߻X$|l @H-{u9ńo<$0 C\ c@ڰ{9kED@  + = X0/P2 !K6Y!Oe!@E҆[tQU!5 @`?\? @PJr p RXC))ANkCJ ` (@;aO@(%5 @`?\? @PJr p RXC))ANkCJ ` (@;aO@(%5 @`?\? @PJr p R?aXB'4;IENDB`FwUD@'eJFIFPhotoshop 3.08BIM8BIM x8BIM8BIM 8BIM' 8BIMH/fflff/ff2Z5-8BIMp8BIM@@8BIM8BIM 1pLPcJFIFHH&File written by Adobe Photoshop 5.0Adobed            Lp"?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?̣{%ÛvfWjA}+s2\Zߋ oRa2}gk斻i{_Wps0>#/9,%s銩ݰog޵ =m@oAbab]P4?{9Vʫ6)6*11Wdc#=&6=b).1>bI1l "@8NgEga;+ZU5۞o{kGm\V9 b4|8$y9#8b~沼V[s2o}K?+ueͬ_u 6W[첺= 6imv}Oҽjlx*avS ]ՙeMk ?}늨"k1?gY,ώ"R\1 ߚޣawիgEuJzuDu+ }^yҳqi=Χ1kMeOK ͭ-i8%=ص6Ue]:NOGŚtÒZϫQ%CsCcKg^?n.5B0L,o7T0ϭ[zgPQqkn>ǙAu)NlJREjn23Yc2A!5sNs70Shz=E[W2n>=7qi6}MWvYe5=WK4 #h}l5SSrsE4~KzUE :9R-OM'*V2 `mQz&1k{Fcb?{u/`Ue[mU6ض7u]~ٱ;pS\,~o>AeM_?~ʽ8of/K }7 }_x*p:M/a 8)BHo`g͛T աz#e,ʭZKjKbٵns}UF30ʫ/#""!]8m550p<&m#;2,'w~WmiQeZ]a,kzΙf<WmEuٲx(?/\pbD EJ<085Z1j0hqqۮ+j:>z=V8WU }&ulps\֐t~@Gteލjs%fsMv?k_L̳~4ši!} *ݻ+VW )4λ,7ݷ gۋz{6K\!V\ιwJЎetu_kzv7%[6zK;5{0 Cf#osd5W=ݵO'C# { i`Gӳ+?5T:hw':Q'Qfϓ6uKadYsnNӥgL0NwR  ?ݒ+sj{ 6f_Cœq}Y}& 7p8}ǽK<_Wlkk}-F]cTYe;C%q/~yYquw^AeMv)OM5_1#"=5du:ѿ3P+D5jk̛_eztSַ,"˴4Xݶ0u꯯YK*~}l=i,}^(k{w+ZSq_[P?E^5i$es˜*y!$8eìiKNJ71GG?wtGM:ڞc5–MʦgK}ߡ]kquurrߴZuWl;f5Cko?$4T˪$WklZ1_gtl\>hpwLk/`[oEe5L3b50F9N#G_Ö\?:N6~Es)D**Sn6.6ps2ӳm bR/JzmFzӦGzr}_*{C{JSh \tSS@ x w+/TȮsYl{{[Ϊ4nn8r&8"A2ÈD ˊ]e\?ua\uM?.ؖWvHu }%1zl>zWзLݔcTag[j΢zeCD/چۚf\gN*dfZ[GԔex5=2y`%Zf<^?try5F"/zvGNʃKlsD58m~.(?g}' \c^ccK?ܗߍW '+^ze F>a}}++^m%=4 .\9pzaȬigBC6äC{;n2eN*X|*xsJ|D p㏣K?9)m+ʿa}wt pӒݰvm߷7(?p 1V!k_YV/U99wӝߣK=. w7gMv{AtcsD`9-諵[5L53$'߼:`f9O0x{S=?aӃShheU79ODi-!^[cLHk4ޅ__k^N.\~JپKZ[nF#I1/TqYB\AbKo?4OM?>ž.go_|ipqs?~ؼ[;U*ߵ6>vFͿ¥@ȳY{XM_l.{/]cюM9LkGxqicc潨fg87?y.̻dd,c=7m-L^Ӣd}PyY]n]%Xk!t­ۿnzO OzoJ1~%_>Lܱ%/8Ǧd'%oI~8|}\\.7% zlT1ߐPlJ6:ct%.?>ƒ.g8BIM XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1,Reference Viewing Condition in IEC61966-2.1view_. \XYZ L VPWmeassig CRT curv #(-27;@EJOTY^chmrw| %+28>ELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)Km&File written by Adobe Photoshop 5.0Adobed@       Z    !a1"AQ2VqBRbr#3Uu7s$t'CSc4 %5vDT6W8ԥ&GąFfh !1AQq"2RaBbr#3STC$4scd5Dt% ?rzԹ 1#G[sc֧4$"-KRkjQoImMf;o|q7b"Kgb!ڥS}3v?gR;o|pسvzL78lY;Tao~6,^7?Gc q/Xz韣 8j=M{ŜCKgb!ڥS}3v?gR;o|pسvzL78lY;Tao~6,^3)or{SU>lY;\e:Qeb$nGzhFسkQcZ<ѯx6,A/zG4k 8v:Qeb$nGzhFسkQcZ<ѯx6,A/zG4k 8v:Qeb$nGzhFسkQcZ<ѯx6,A/zG4k 8v:Qeb$nGzhFسkQcZ<ѯx6,A/zG4k 8v:Qeb$nGzhFسkQcZ<ѯx6,A/zG4k 8v:Qeb$nGzhFسkQcZ<ѯx6,A/zG4k 8v:Qeb$nGzhFسkQcZ<ѯx6,A/zG4k 8v'H/E 32/şڏIrQ}mFNjj?z-Yye~㼦}>P,PW;;<}Tz-Y,wvx=B[;'CY_(Pz跠vO1g⇼qQ o@bye~㼣Aށ<şyGg/Ey?=U^zd~({+>P,PW;;<}Tz-Y,wvx=B[;'CY_(Pz跠vO1g⇼qQ o@bye~㼣Aށ<şyGg/Ey?=U^zd~({+>P,PW;;<}Tz-Y,wvx=B[;'CY_(Pz跠vO1g⇼qQ o@bye~㼣Aށ<şyGg/Ey?=U^zd~({+>P,PW;;<}Tz-Y,wvx=B[;'CY_(Pz跠vO1g⇼qQ o@bye~㼣Aށ<şyGg/Ey?=U^zd~({+>P,PW;;<}Tz-Y,wvx=B[;'CY_(Pz跠vO1g⇼qQ o@bye~㼣Aށ<şyGg/Ey?=U^zd~({+>P,PW;;<}Tz-Y,wvx=B[;'CY_(PG-0VBnDjTY4ͩW83JU* =ם&SQW|XQиz/˰?FRA`P(9PJI:p^/ =N/1NNϟx_vYxǞ~a/{]GϼS/ ;,^a>w>O̿0ype߄|?2ò~a/{]GϼS/ ;,^a>w>O̿0ype߄|?2ò~a/{]GϼS/ ;,^a>w>O̿0ype߄|?2ò~a/{]GϼS/ ;,^a>w>O̿0ype߄|?2ò~a/{]GϼS/ ;,^a>w>O̿0ype߄|?2ò~a/{]GϼS/ ;,^a>w>O̿0ype߄|?2ò~a/{]GϼS/ ;,^a>w>O̿0ype߄|?2ò~a/{]GϼS/ ;,^a>w>O̿0ype߄|?2ò~gk/M;m%дP̫ґ"v6\Y6b ,6h zkʧڣ!A(P@ (P@ (P@ (P@ (P@ (PYg7떟αEvU)+ѹdzvݜYaS3'TA@Cd;&tZn-WFN=*rQ[hf2F1cG7R'H(CbwbD*]!4reZldԵEEֹ FIM[j\%m1nKLҎ NUL/2d~2>$+駉wWv{)PW)!NCm#[QPFI#Xr\[n]|uvh&0,ntI MnTƌ%SnV&c։QZG'܉j.k#+tjzò 𚸡c@fQO4rkCO9&mJR\e/螒|_+v+ؕDc^z}-Қrer"h|ՠdeCv͒!Y1DIjKP_+ZzPyCҮ{@t%,ߖmCOQ: T?vM)2D]}b;rښF@ @ Yg7떟αEOlJҹ*G`~Ŏ&9뭾3aOGA*(4ER?u~鎝5u 9hrCcVT 3/u$*]hJq7q;t]m> UoSJT<va5e-ʺWWJ0Cɘlk'VaxU3$R$E\Jq2Gr;q'īwLD!.ntii48 FDdJu)hʎV>B6=6Gm#kODuMdH{˓FgZ DҗM{TIۑW_JʑK6!)ʖY3>qZi=[<*30EkwҮ7j5jYOwR8>m5*7xҗxFC!Uۺ~{tbOU!"qπmH5P5(D@CEUk>@ )^3;DiR pNR}lTT'j,p7|lԻJ[8vwe-֍l%JZU^-2|k/]F0m'?JQttuPC k,\2& imVJ$ ɦvDUO: eVnΓ?#&Zכ·&D{PN0wYv$^MC;xRߥQW1^kڷW!qπҲr?9$;SOڝmBJ>E9(P@s^[;mcV*J༗u$e+T{!I2R]G "ۙJTDn #ꌖP&Sʪuy)ϳ[O*0phuKTg.hY"Y-,CJO$+q&UthSY;ˈc~˙U6m[4F6jˊA:뎫UeD:N jl*Dnp 'x6}|oiR2Ŷ ֭)#3"kSZ>XJ`"7}7jOp .2qIA y{>(ԚJ9ک&S[ oV+""e;#VSۄ6R6W+QΫ..3t9FiCٻ:g[_wL{Ey'YuKCzDጷLDjUȣ#j5Y_G,c\RvH[ ҍYJ6úwSBgNz3peR,ҕ)n/adI*5HAK;G'n&ŵC^]ZU]n([Zhk*qBIxfU-PՏIW')/R<Ǥ6p䍨G"ybH܅h跏]AVhM F}sNƳY18o3*fWEYK2ZlZRτ$o!W9}k{Me֟i L|qY6q,Bujf;oK KSQ(TRR{zԓFX!"lkRh1jl/N9u:v%CnL2Ky mj2Iw>a|7B8 r>ץ `~M܅w?M#,i'!GBܙpqJr+h/G HAIT@nWyūܹ"U/\_:dK_+*Z\$ҳ$ KHőQz+Jt*}3,,Qw+km n54Q uR%]l8cG>'OR6}o6|垞uKje5ʮVx y95DJۗ#ʧZ;2g3q}#:.qH; -u)o#9ʈXɹSn=0ߓv۔kQ+CH-&t|A =k],7ꈊ)geЗN9Fp+&ielSK22\G#IU5mPGtq69(P@Wl\?Z:9~E"~Ӻ]hOn,15)Aul'A@C=Bj>1'IyL܂7$;I6sQȋFgBEFjjBF^SftZ Ezq,skL"A Ajت6[jcRc55n%?ydiYc=]Mܦ(9F)mGJdFe:*7BU~b.#X[Nin] ]/2@0ȑBl(ͤ D)54vW_Hz"1Fb"1|jQ/ q%L{;% %߻:SqTII?Z3dU\D4MDzc[+Uk+^ =Ni%q!^po1}/No'Y'UZ?lMc[+-FG]C>G -bbd<Pb̖kJQV%/[͙ȝ&mc~brq1n;z{UvO~%|It*Zf/ţػH_Бҫf3qڙSʒ_b>Ũ̻+JP&kQm/wWĜ]"m.nJ9RlT.b򟒎4>ͤ% Ci?6IΆ9O[[K8< xfsv"QZχ4t2J'SlKSÌM:Ɉ#?Z6 EmU1|l:5ǕkU"[HUL8W|mڮb*gQjRs"wU\>+vI"]Rg~MF9l[=9I2K:YlU(nxJhBn+rUeMkݷ?CNIe%kQ/N9fbr@ѣ!#[F_cDI vXLQfU 2]'/#N&:%խJ\LoKK'OcDe/ݭss[aɵGD)$i:IRVTCDѵUnKbzsikTI m61u^We vK̡;A%JRxVo%< <'j!H6繩G=ϵJ!<&xO%䘥#1'VAd-%8j5%RRӰB)#}n.t;'5sUQ#}{_Xq|E6T:4ҽ{oZ_"ziҏr?$;~SX4]A@A@'͗q>~5>E9 fb (0oDnN[7򘽓)*ڎKi/i&.,JWKHlWGDzdt9zSmdV%ǠyRxZ\ui]+]Hq\ٶ溞h5aHxPU{=tÆ]\"rrRؖ]*NeI-pFDdZR#t#!Z[N-<0j5_D}ж{I''5"E컞釲qIshH[QIZ8(5Pq$PzoOʟwՊOP:uߓjE:sAg Ox"C oo|ǸT[moW*"QAqI=2#!!/꧜?ҟ05PhmƯ}?>Sn~j7@!OƬg'ȇgd7ID!׿;_LLj%p?aVOF%:%.9|YU? k?Gʺm'TR]| Oӳb~V$"a~~ѩI{^fDDj' nd~xGQbdmfb=r26ibhh^Ke_%_dYnDEkNqԸѮd8KgXfc3ZcmIV)}]U  &X^G)}uwg-E.Sڨm}.#Z * ΋2ԟ<ÓinVk]}[n=+_bINknV ғOtFߨĆ% ˺Nl<]%[_d2VzrDV$kKhB57rCD[~D,fn-~:2\Ncx2b J"i-ץ)-_\1\j19a,lڢ>r.;5\ﺆ9}6!aߓd!S<n$+I+r5Saxȫ!n6OT+6BpҢ?6ㄤi:S{SIXhrF.e_6oogWCyTK@ +.-?bm霿"IOԺݜXbjRzkoPN)h(((6Ix{:|ZNC-d7ksY|f m4GYLJiLIQ۲JiQbkUM*ovdE'ʍ]-Gmy{n2lH4Qr:r >4Ќ;Fs.ʑBwN _|q=z1v\M%5\9wFsL,L^~HGdPڋNLJWwPЪ܈\N{+_ěvgF 7޴7UɫuS;ב^1(>O^)ɴQdQ6cGc^W*VB&;]dLrciY^ۮ O7{z3wPqަwZo/c]J-Nf"ťV;Zl/"twMZaL aŕT- *'Er"cmLݹcrl9ʗ6EGj&ň.:_aRόfFKpȋjREE2^?}J>kZE{}Y`^xצT;*֛,runKoŎ$Ka\^񙤉$Įej1nZ% %ϹyMIRny.YnxkSyD&o]-j2#4!dZO(Adq9ZJtK6F\i#VƮtw;O Y CyD6g&a(%WI>ujVqd?1hT$k]XFUPmyɏf̍Q%0i5jnvՑ˾S"hmޏZU  ??Uћ_m?{,Gw8rZiEK|LdU:pYj*ٻ~dr&"˵coFe[gU7q9 |vM,* ӯ hO_> "sה:)}PP P P P P*B!i%!DdT՚!~nm!M+on!Ԡ R:7mDzxu_Z[m_0!1i>ԩJ7OZn߲"R65a7URo twI~o[CFi$FPSkQ-JWK3$l2N2SjІz°~:\^Kҧ!.}Y2BKzt+JIfl榊x& bZ)Z[03myEm哏Y CNKmE WD,eT0+B}яf_7{. GLWٟ4(p$m^swDtj{tDt^; ^JF~LIh27F)jB.*[O3c*`t"U|-waD)^Wgn6kF;xmgu@Ug%(J\T/TՃUUj"e4 -+jzъu0`HlqCqَJw[jMtG$3qDJjZ2cDUZ=,7V;=N*چYJ"Bd{ܪRC[j"qubh'Ԕ%Iڦ6,$Jz(c#VIʟ rݜou 4\2 2ݓ%DE4F!/F) Y.qy(! RxmU%2DU>+3y&4ck3fS=ln{{]jscQۖN +e±"%h?}6}^wYvD܈7cm%<Qpi#32ԝIRuׇe(K5 lWK)CrL-\+UoQJKKoW|{"*T86+~`S|ӑආEMJM%I#̝hέjKV"0v]&S36 UHJ.ߒ=V6yHmj.7]HDsܹd3'nZ :Si^>ZoyafjqI:M){t髥 &mAɔӦli:SSڔ{5kh֪N:uk s֦@6t./Y_F-xͳc@Ørlǜ_"_mmoMf4Z /NN818\Y2WL̈לjQSaR]%))rd}]>bTqD*\맷|ܫpS|Q᙭M[zĶ_-"2=jQU O=wdmW)w +e˩u-M JʩSsOj{Q'{M+,DF7NJ֭WJZh:sK}#Z;!*W0oƍXEEZ䡔U=zuk s֦@6t./Y_y?DZEEU&L1^zFY7%N)'IyO!7H:oVq)ym(B:{xܵS<{vhIng(xnJ8[j_&MdjymSٰ.{6!Oad1;ȇ??"bYJeI۔7Ğ,,22sbuCcɆϯE: 'ʯuo=3N !+CS}.)GT2,d_v -sV;WrEYmbҵQr.f[n3}M8[> bR"Eҽ_ndxi.:-4+X.9N%[]*إB%i+ jI,F^kd1krx:Jx>=X;Kq z$0i)7#8))qIeET"j9WDETTGj܇-X:V#~Q6NH䦆kw/gE-͋kKqɳ'/qnYW یI5Ix0L-o~앓I\*3] zl0 XmNڔDηIZkS5G1MU\|j^NDأUk=V26W8=`vqG3BQQDiRTIRLҤd06Q#"LyH֎CaqˮsZ[f%!=*<'n Ij2MOJk>luU|+RTI#XƪƣnTw't|Rsz2,A;vTJ5F{aȾ wh6%]|kc'}$,Ց-I^f?t~K /@)VyRdn4iBi* |J,u^; r{yO? om1vg̞e`'}WPyzKHN.'Rȸ|gF5˓UF~"^&ݏWU=|y76YSrhȍbL"@:h.:REiK݆g୫Oʗ~FjJF厞K^6M.5Fq}5+꘻cQDMHpsJ[UyTK'+S{cƏ2CzҭƓ-ਬ F(:e5'^#[J2UVk Z.+yd2{*Vc?3!ns\7MۿdˡRHՑjUb gu)Iw'򧘱h+‚(((N]>'IyO3f^uoqiZnLj׻ݠOԥ&SPPPc۫Lum|JNCX3###2X~Kr ,9x =Y]2BL$E%1,gГֆ6N\1>'zA5bR_\GMW"զC~.g'3vm_fUD3_l&Mܛ&AwqR}IkH6Y% lo]SKgHK,up}QEhijNj,-cGM BT8ln^s*3 ٶEq[oӼ&E7(PmiE5 dF0ǎ>]7}吓Ezk$|=ն/R&L\wKjoӦjo乯^;wȤ?$+ϊ!KkҟUe )i"fKҭ&~=&46*uSyf+F o#nhW) QRo턜-ȩ{x<<^*1˥_w*RKAVT[ Qh\ܛMCa}~Tl7Z}tK>Q%>Hdh;igN8'N:t^MrӀgx" s;](r?eSI$a~JߍoK(W]մV*_ .޳ |<5;|StDv3%$f,\jUVrk\$JlE,fdDNu'0e6VTI,ĥ>tt"*~|wY;8vcӓ6Ɲ(~s?ޥɏ-]-8J+Y܉cGSIӴI/Gf,YáCwۋ0c^>eLiXC-ݷ/@$>ݏ*yh(((B}9}a>@ (P@ ($IFm.K42$u*eFʼnru/+b*+myCk (P@ (P@ (P@ r i#dм[/Cmv;R[|fiP(Pcuz1!"DgV̆SnB~2QPxS&=ZhyiL@ Vٱ0\6fu#*y" MP]>%"s:(}PaC1@ @ @ @ @ @ @ @9 s C0QQFi[#16ȷU:n?7&XԮ69kM 9 ١HE-S2H%_E5!?UЪ.<,7g r&oBO/E6b:4M]ˣ.53JTcĪ7s}-}[vww^xW}W).uB@(jTn9wwB]]]'5%LT+[\mk^pЭDKK ѴUBUP(P(P( ߫}n:/'1DյxqP z8TD\)2QhfǬ}yQ6Vr.mpSeV$?tկ"eF%f^&+[I"-*O%(E|IIokJo5PP(P(P(P(P(:\u,g|8jѼ/Cߗmv;R[|faP(P%btZG/)c.:nɡi%TrTV+WyħR*F'I ȱlV%u.iRVҨZ IQW“16)*UT(30g}5Z KM@A3o6cH[bjMnePfi"QQI:`TjБ.4"+棺7"]z +v=y ڱZ[!kV IQ]fS]+9'u{H-U6pG4on[8]YjZf)J:31fCUUZ wN2,磏`!P/qTZ7|&(?C˃j'I4{x&&B+V~Mfm3 4YM̄˚iipÄKoQfI(lǕdE#ΊCYb6MI^#4\ϻC;4|$^Q]/okH>+򏓳 t.Oӻ< .ROxA( {Ѭ2>~բqhֶQqI#[u%iQҩvR +Gxr*c!$\dz :8Jm]VdG+_:nJݲܬצUKH}~"Ke]pT U {'XrϾ;j"Gl7C\GtOn$ZE/ʿB;}rM%'}4.K~hvA/j͙/o NgMe3lPxmtI.S)׶% OgCǥ^B<^u 6 K:[NHRU%$aaEJ:\u,g|8ҽ#oѻ@So m7 @+:>'IyNO2qc-2q378F&}eG >=ϓXQ9ӥJE>*6/Lt(]#l$mdԵ$ףZKz,5EGy%ǒDW1?6DۡvRO(] ²xWtc}avqkrJRZQS ogtߍL"S$H6bU)V~5Q:i8g5:htUx- 2oVIUnvd;cQi5ܸ-O#rFt^mjTЧ, d_%>Nb*VѣZR|CSHb^dxn,evu7it}*ξ1g{US9"3abzK͖"qMU-:F$U,EZRxX,rLj5jCk_ްNaWXXUrJHCj>M$+JO }؍{Z պlGH̵˹R{AE\1l;2,}M%K%dvTdWejiE ݦyG*WQxɭ s ]?n}I"#7'9dF) )rӧRI֯'A)#dI-J"MMnb#j?eͯ7U|r/H.r2Fl*;mpSjYҾ$$hzbwkg:=X\Du]ίgM/b$k&qk[%xM J*+QZɐتEu~PǵKdv4N+~ lnh`[ &jCej3Vm_xXr*էʆmX-lGuUj|ۛe0ptl˟ RrB?<ŗATv &h.}9}A?PP(P(m6x8٭ӡIIT{FbV6/& gg8\*,m =Sf)RNRG0;Gd>1О3CDq#ϓbs}32x32$ǥ03CG^ēMP葘VUki;K7ߛ=#_Q l,*o$kTFvir*I".Wx в\L}Nґ+O+$)DJ^lQSIn?b~JMi[w;_E4Ȟ6~+&-O78$ȥE F}w>?pl}+NF6aSbvqr;<|S]ED>Mr>=ݑt`gkDŎEM07|.y:OrT.lok[iRhPP(jαl%%{{ˊ *42)Q%B>8؛-ѺGw9d7?KyޯA~2CB\IHE~Ẳ{7mMOąvT]Z I'h܂Ζ\W]L¡7{eSovN$4/P(3BKJ]4I ]ҁC@ @ @ @ @*8m GO!1⾯goްm[L7 o}3}s5W6bhj\W7JiB_i\2۷8vXŨ3g l#lf{DBWSޞ3\S>C}PyDL*#U6nE2!JNdc>Zr#ҨL#P(@(@(@Wq/r ݩ>Gӽzѻ@S m7ʱ@+:>'IyK_3|;#:ܿ<΅B_$ݏ$W^y>fbj9^!`ͭWl52n8͵nhг%l!327%k5{& |I:Uu>kM"n)8jCIM5 J;16;4rhv-8WKGhƩO!&[d{GQgb9ǰ;["TNtj̍]! ksy:”,ʖ<夑i\_Ԛ,WINܲmCyll=&{rqر.꺨a&3%,ziw7գo1/P:k[[vpD"J֔Գ-a}ih`T]jbzxo=F5kkrL1ި]3;XkXrq*A:H%OBQȓ#FkDW#[_:կzV:WEڕjEuObCjtwȦ8uJSMJ[hSdz[Uv,TJJM+qGʬmFQ-xDrWz#󢥋U9IFFR(č#mJ/9eovs_&lsHk$b } 4z~1N|R LuAT(Q˺^H<$vUSKl劻LeYdsos_b+] F x !Mcٿvh9+\K4IjUQRQd6UܼI9L6Cbt.G,[/exM˔tuuboȚH4!:ĕ[AmN{D%s3SlTn8 G"Փ#W]J`5²+69{VIm}FZLDղ] mgqf9cM%FSN񚾭8O,syvxN1qo\'TU$&ErQ>2'x7>V>3"uURգ:ȕ订Lx6jS EQ:O+m/gRN64jƪ/K]G3R1|fEȲ r[Cmv\m;B`ң5M #ZSNcc;E8yKL"ZQcR-oƘ2"' z.qbP=M*ЕwFV7DkBWeV,osu/k}}T[v WUF4 bgȻ+b9& 4KZPigc#clW^ikttXqS\ļg-j}[\ YZ[]Fg֦M5 X1nTᯟم4#dXUcsxъku56Vdnli%J#ӏ}ٲ y2 hM\Q}LpYYKY^{=>pH#k9wI|jmh b (P@ (P@ (P@ 쟎Q96"6^Mjp2 %p *Ts5[ysc0|?|"eu)|ʪTFN2QmBʴَhcʎu)ZǺ7}5&=<:ߙ.5:_.4i(H?qIҴ I"BcHJ-f(P@ E\Z?:;>|SԾ!z7h1Jm$ʺ q|R^RlӍ&EzU?Sg$w\}Wz/?Yj' ~.?Yj }dvW?w|W(m'i˽OCoY<=ݕO]5ijxA@%|PO*we~zl,5{>yP{+H03L# [R%GKKOő2uI#)W' =ڙ3̅ʩ^]NrP^'˿ߧgL뤷;D]5GSUDڌb''ȕ]D=kD=~kdgcT6+>kdg6ʃ_eށ['K?^T.?Yj }dvW?w|W(m'i˽OCoY<=ݕO]5ijxA@%|PO*we~zl,5{>yP{+>kdg6ʃ_eރ.8N[8Y,ڎkD։(IуիC|X-Xz eKRf)j3R33HmYyP_eށ['K?^T.?Yj }dvW?w|W(m'i˽OCoY<=ݕO]5ijxA@%|PO*we~zl,5{>yP{+>kdg6ʃ_eށ['K?^T.?Yj }dvW?wrٝ `]I1$%M=5(^ G#E[^T$.6rdZGKmm\aky Bd6DHHEQUEwkHz=)Eo(+(((K'!9yO3†@(PS(sK *[εJ|+\ˢ$}w:fTDu#b7qZ5qWj YfgU-GZTwwAUO>͹7JGJI;8y*OXq -{mĈ s2%(#58MU?N\dU'P7V6g hg\'zl8>DҖأY6WUVL9=jݡ’i%2d4HJGC#rEt?HӤOʑ̙QK47izh^=?֫ 4Ss09aMz)lOzhr'"-WPW".Uq"3&s%X^z*R.[Rc"j᭝ickj=( P (e<էr3MɹZh/!I*-.gէZuRjb=S&U \nK )IzeTIQ)quIWgb"*Sr*ٌ(dWp]q_vI sYE)Lf$^7XD]^W*5hxNMUjfnJTlw% g>T|#=jqNwRfC$ʖ77: -Gp^Sͧ'u;,^] 5ŷ'Y}ܘxs~|u?3{rk9pOѷzci]d\f]|o%UE7>}ʛ I3}뉠玴e<վU[)y,eLMҴ+=&LgՎG&Z9*59/OOOtrlrC m2ɖJmH*b62g2K]jb".l3|h0YRqq!$Q(j3YDÊȪg-|ԭM-=8ڷ(xi-Lk7>)*]R5ӯR0 CbuVN*2R}1_v3#-JR[tWiErpO6|J6~Un'In6 V\Kf]Bж6m0lEU]7tdEDn 'ʲ Sw;:gX! xL0uHRwFMnjEׯO11^QacKr Q]u|f}%K~~Gk22S22Ixő)-e\V*䅶_[y3/5e:#H֤nϤ;nopQp5#2]kbC*C$5IDsI*]n9tkmuIOH$z\l~͉ Z͍EMǥR{w˂_\;5ܘ]iDdeEjB45'yף?U^eK"63+] dD0(N{ {Һx4p\:ldpՒedG1&eF[th%-+8Q|壾Z*kEO1-Oh:ԬvcfTQjB #BVHѕ65us8rx W nC`e6;9|RF53NI褙LR=I=f+MhxRf'!T/gܨ7;wĈl!gi㈎FNj~ϳ4Ҽ۽%l[al&-Q!FEt4&Bk]IW*Sz%4Cauݛ9.E2tk{8ZǶLr2Jtn!H}P`dAz7S :|S.7HuJv{6sz?j#v[֯>Oo/w֡Iw,.fDkZH?R:2Uޔ(}ZINO]|>.ٞrU~cm܍S>2~(P@ *htIa+h?tIz,荩leeE!58֋jfIc"~CJU**CS8iM&;FlrΦN7~1T5 3ΟQN5v.|*t"KuJֳB<ҾcXԄg,sVJIu!t2(lvȐ8ZuJצd[AM-"K myƍ**E[nqm-ht .Gh֕j-r# ±<"f%gic6I[qg[RHZn.=f.ר/ݤfLvdfdZ[BS"+Qu&DELgs+t[s&%m\l5cɒT7v쏸z 7nt~u(t&K6c{hOvUC3%%I=ZFiRO@5c r*U \1e^_%kϸИ-r&*$?4DbrRҎ5%e+]esjoZکZ)|PV sE ]\&4gP26Ke)'ptBZգj wH1'KQT3q|!fU1O[Y%TfTE!i3j- j>FEĪew_}"WO8&y?c30Vwdg 3^7(D7S3:KN8 F;GEtɎiM(#(Pd(r Mi/CؐʼM*I2:QUI=FL.fŒnMPgq)/u*Rhy5;Oثt[|K SYnLgKMԠ$B|,=ƥqD?tsV1jeѳq(J{R-)䋽ᐰ8CKNħd6 k%*m[2%HoJjITRsFj ј2r[^Z;yTV-:Ƶ rpr,gC:b6ڭע%[.JOQj$$)'ijW?[?Xsx:n1T)NTog0qc|J=-sĦf; bR$'I$҃$R[hjxAp=\xw57E,R$y&{ Jv Zz](h.-uƃ5Hlیt= omV]hzϨ\ F_`z)hfKɚ$U3I`׊\ӣ!@6=!Wm$ۦ5}"^햜g3L}kb~ӕdtE4稿5ʱħ-l2ڃ>(PE٬kT{zy%J#)?/+}1.DDbEr3Sm~sf&c*" XE_DQ[LLTuoTvB̋q.BdNJ^Q~fݜ҉:2TQoR|?CE&FEU8a2aWbu=5'\SރX@ (P@ (|SMԇ ׋9K6VXDu.<%'A}1a챖U"O}lԅ }l,#uerf] w/rk/yj[oOw#wmޒ*s[|\YP(P(P(P(K)T%'3 RyrDwKWQwo#,<#e&eGJTUZ2JRiK6_uSA8I /^qrjɯ-2Zt-]f+MjxUJű[i["v.-%^nIʑ0KTF]A8ҖZCZ5^'zAIߗSs̐V&"#?% 6xT9:4jx=:d:M};GJNlF)&EF ޹+qI:P *dl)^k-Ô]i?sm93ZPH";EDti[%2F+/IV{VMKB頯P(P(P(ƊYW4#KYʤTIU tG%+|! 8)U)gSѠڝL&ZIgGlO |I:BݠCpP P] 2\~u''h QiYn Ppk;͍sqéR ,R}[^9d&tfb`0RhԺ-*Eh~Vy@H)NK:lnۆ\lp6vkj,wӔ'sI]5ڥv|#L\ WDr0n>WiGrL C+aR(Zhҥ6K&JzAx:&6qI[ӱ$f6FK-ۆEu[kX6% 1$I$HB]#5nĬoDh>b/]m9ڄfu!Ku(:JRհV⬲QD W=NCq!Z 0\F)>w־PDZS>w {@l2qwOsb((5 7(e4\^4kS4),nbr+|/eIŲV$:)Z_Av z\O*Ԗ:u;%vmmiDI) -iQT"CTrU5)@=!) J=D[LUhc^]T jZNYwTI7;M߻R_ ÜnB5͘"0\dg`7n[jz5!RHq6"}_3 ] O3)'<bou֏meړܔS|6h((((((((((((((J]|S ԇډOC !N!j3D bֺ d\MJS9XfE2;avNK?Cf/͉q>S򺬛;LQvLHA(3heCi$DW\j_(ƥF#tP(@(@(@(@DOͺub6ZfzɃ_lғY*2MOmctFH/=.j]58(XgQQIDbжrdCۆZI+K㍭M9ܟ9Ӕ֮Gh] H#=n .VtJ/v+6>jv$&IC'O5+!vr_ zkJՃ4n'UU C)7_]oA4dZJ%VLLjiEk}N<$dWWgiȴUEJtJs1s<^eQE±g"t2IzF(ZIQs/ZW )̴#F*ST2c^RoAfkb6M]#K4Fi2FT27:ΥC;JUhyDL\ sY2{sDu[~;^ .2~ */9ժx棓IӮe0uRpYcslDOB]Na]vh޲ƺUS ]zm_m#|j-w'yY0 (nl8㕌S‰һ!$Ĉu\ժh0z*%UjbR Ը1j>FJmĢ[\e;SƊ.iμhPDE€ %whqgE ɍݮGcZ]`R||BrZ*RZSf]=gli\r(VƒIKU JW(7SAE5Ui^:İ!a S4OkJT4j-43Uuigh~eN[d4kSLdD[*j2GuU|%اW^1'PqWX:-M+/)1LӓAgzp3ӏo m@ꅅVwd^-#>\u-}tibe'\^5ZbwX׋C.u*ԨDHR>71h䢓ȩT8bVR'p,T mtvS'!-5)>s ZVk>HN͌ȎÉZ_HIQxيӫh)K @ fW?떏αoÀ?AO+AWZn PpДiJ)t9W;R&i9h5ШZҐjUD(h0l];)61ҖIa/)I#/j6I3ҊABYuowx̷-/Gx!DGR F[HF=ZhY+kH6DTK`<6H҇VԏFe3ҊBAxi 9$eQmڌfiQVRZUm>kMFVˉsZy]Sjk5$S62W9҂gu/SR%KI!\R4/=jP\:a]lrk7֣Q%Z-] F4.V\uACӜ;&;o5J8VoϹ^B|#ʒ:ڴBHHϝ`'E5%%_^Jd|,_>Zajm>QUl':+$U]'eܽ""~N4JWF)nT[NQvuDʧo nlDUY]Tܤr"#=[LCJT[9[o7ˈ[(VyW5UI5S$TIVt ykQr븽౭FKS-7/ItiIdJANJEtQy+A),asZ#[No˟kDkfSHM2wΰ\\$9x6cuסաNGI K7ZƔ%D|*jN. ~k8f5)N2TG|6i"Ҕwv(mf2&hTFvFŹ1֧5R 58~+d4^ry=ն:)dDUvvv6M+6G&ܙ#ebw8'fa\o?tK&Ѕ̒DUNZ!fؤuR `T +FE!OnzV( =Rg_r'6"g&DJM-xˠ])Pi4@ Hi4@ HLC)޷R~Gfizq& ^ ΋/blq7V{;>쒚i_b],3j䊟grA{Q}ёõ5Q.3}ozꉪלּ_tb (P@݆˒_d6KL)!V[в2x3kTZ).VN(tlJ0f2OG\I >5KjhJ'%ߕvʅ2 lused[!6qNm@5,ZjdOJSlxڔ-N?[ +|Ş% JJD%B"-DD"J:]]K] 7nwPE;r,XmKܧbr$oEDƷ"܅m3y3Na3de03gvT MԨӏTO|V:'*:-)E5X䦪Ԓa=w]&rqʥIͻۢyjJ M_+^ͣTFJ7xjMVozKì9-YY*Im2mZHEͽ:DTOkz=ȵ5<2ERΠm(PZˑ6Xu&ۭ8R *#deǠV=ӧn S̫\#f2Je'Hk=>w'xSQ8իŭ ;e庥,/:*"yV%IK\~3;5< l[L#j^wg+cKq:H&H5p[TEUG;CUvЇŚ1_T"c _ LKStJ_N34s:ֳ>m/E_b#TQEM];^$5}ee$ZTڨu&#NFt~ }2K_V`O [.%, dVS/"{d}V$i&_]X}DȲ;N-kzxxwPT7_OG xRHƕU'J`ehVQ_?7\RLx霨#o mTRZu3{w3 FFժsj[]=}oU֯M (P@ (P@ ( cpWűBǕwe0eA@J$+TRADRpƃ#UrUM.D7ޯ:3j΢y]mw[Dӫ?m6'߈Z mßgQBk:ʖJn:3I%+-hܤMN~pj6@ E~XNϖCR/1ȑ6#O6^-D&LoFNd A נCZ9k,e+KZRLz;tud2V|jբ5.?3r͟E^+Z9P@W=vX?:pS4S[/;_V&/Z? 3?Q Pn:N_q*}`S"=qkvS%m NZ*T"1>(\Yj!ctdt_9 6OѩNpo #lxJAۜJ!g}6 *EqqM"\^lIIK**A'>eKAʄ1IXmRzS!NzHĒe榎>1(/.?aV}4#Db{N|E[6!O/pCN|e"!fmAeNj[WKaA*<̈/_:yhd1ML^coM779 Jk|K1 袡㙷1j :5(7(((((%/p|%;CsC?OSvYTWSC}ڃg못|?a.\ӕxzh7t+,[=V4f|w2$4A^?P;wE;#39: NwqziƞEŠz\5<}Lw*!iPr'Ѕ (P@ (P@fљF6WƶJ~Rm݊AE Gq1GUU?F9v,WIL&>SRh"DI:HkޚuUSs,l'9e;pC6R %xmg(dȪەh4Mg.EenF0"F$H`qWNдI$_WJQPBE l,>*G-dg/l$7\Gym"J/$R$g/ZV  ` Fd.H̤zD˥ $ Ɇ$!w۩f+\rdMiJ4 +zS13݄>ބG"Y'$Iyg19~jbܺ[gx{lUKmgq]/-('&il%$yJǩ ]k WkMk({ ,kr(Qv5In ,R>긎m)ԭ 1lImZ!Mnⷌ(ϲK+l:$16mdyah:JjJ-i誘wNdi?jěЩNpoefDoL&u8КIdF!SJBR) "RT22l!P3eˢ`ԡFQl K<& }[Sud,-£G[ᒖ&҅l3I.A%2k9ciB)vxRMI݉">O@|m${S|f]jw>O(P\ؿGXn47AO{W[m 0zdpklR#2쒏IqiHMOU12'#^ K2g7ui5-KAثe:E(V\rL&)! ^q덷"CH&o02:\>TѼ23[ N+ O}1p ^a6o"187$ҪHwH\,Mku(BP B(@ tպs[}1i2 M3<csQ"8T.1xsoIxc=M{yW|w-ʿ7k/z2Dw"OiI$4!hVJFGM d2&'/uc.R1XڍÈfm&{S^*/9&,zt)ΠoqJx|5J>J=?+%bog M)볅yqҍ"+8%jkQfT=ԼA=բ>ٻdѭQwI5}2J :[" TygՌ6%NZ[a#ohZt$K.P.U*RŔyNDk!n\E#mἏ㗜쫖|} 41izA8z6R sZR~ RBDcs[oI.hne:J$%MrX yq)캷.Q%ۈq/3RȒ_hϚ9ԥ\CTGseo- ɝn!f,5ZMkQ- ;ҘcdJ_|f9ѥJ"*+d1Oo cjiN2ĤRH:i,dL426h^cjssjtV<ض%WL%%zIyMHdJ_zU zkߛrӧ;fT¸9-a,, }DlhrtC/:O!B(@!O^۷R[z}̛1*ԫ`iQ(FCLlVJT~ZzS]ӳVii%Ĕ ܮrS$lF5(GLτZ:\IWЅݲk5zoÁ ]ݐ"guˠ+UݯpLBft/~#ƜS޳ YO}V7H''Ut=oVDezJξ:ly#|䶛Ʈʟ!ch(v3}M.Z׋Ry^'wUN]*}=p]7;*ߙ>SZ;gT[I҂e*Tпx7Bem8X.yVTȘP1+[L6XmTv8zyH (dJAUѭҭU=UClӀőxnи"c Lz,'IG=,pVksZ({U+x4Zvcnݡ^\.4EQ.'H'dƮꐦR֘]Jx^Z,1s:U?MA KnjM/|TԪ{Qh3 b~tLG%_6\RwF%#%]ݢN:U:Ȩkx[xN]K)^!e9F_mhYo2Jݸ6q6ѩM6뎒֎Cd0G9(Zފ&_J[6ع4K cŖvzmc#3^IzY#j5Vʵj}u&klκpwTq·:vIQB'ؠ:hW5S * f'AӛݗC<.d[D$eQ+aN)e$&P=ErQu4 z,_F}i 8ˉyp"$uM[tAhG)Z\۪3EO֋K}x엹DMtz:m*II(,o3_stK3ӯ1eȇ_9>rGfpz?cW'"jIv)L3#؟FOGB?z6ZJj^~^r't2hqՅݣA3 i W[m02/A(P@ HikQЈzS*5*]%~rfNt8xBҺI4!\hc 06 *Sc2prF}"g} fx9g``މ))YU*BF[nkGVSJ|F|6[%*(t#ڏ_TPqVSYaf \R8nڡ>h%ӓC:ne#K^t|KxYR޴fKIu~#x7$jŢmσ:#rz2;6ʆ!@d-ήoEN ЧGC(i5-B,wcN{zQ$@VGkwU ;3̱:0$- ,FCfQ%(RS] A kJlybfZuׁL>uߧXwLkϖ-캗3BԧY%+6ɳ3% &er&;u6C^f5|ʯ9Pq5Fo2lMQ(Cۥ$Je+ck#jE_|쉑Bջf}_3#~e1r\ވe- Sdt:UDI|s,^n~L3M;$j:" lIäiRtMH#YnPs]2ЪokUo&kDD!5Z bg&5Ϧ~U ;^?nm(BR$$D"/KjU"4ԪiM>vkk 'TIJJЏR!dee3hĬRpj^k#dqm2bo5*nx4f{6o~+wkbzD/2,|CK#W'1>Jdrjj"*iHiC32qwa4pj9cjQ[fƛD3Ѡwdjnܝip䷌M"N{mD"銲JKԔj"REx)fjd,iI]uY%N֭en3.<䈦ty$ID'R*-7&ȚyqtJ]END,kZjqq4+Djo 1~4#x5[c4-1M4>rTւiP@VI?ns#B}vm)4$8\Xv gYȟ $uyrK-)uIRwԻ<)-)m-uiA]g4I.Ipٜ¸o53"ԨϱIPޙު~?&Jr%"c1le+|â̪h2%(Z(>esl񟞷0rFԦM eC{|GNC:<5ӋkZ亯Gw:OiG-uB|or *`P P P P P P P P ڟDLf'.9_m4o!D*-')RVMZ.fciSdF 2RttI$%^|UUPDChm)BIBHDE4=<4r|H)*NR#Kό7<ڔ: P(:_مݣA3 ?9 |~^ZDH9ZИPo! (P@Q{TjW6..ߠ,aԪ9ܝnh3ritǭ'׀Zհ1cGZy91IJ?R|~G(mFE'ӏ(e ifTpJHѫG {e2=ηCugjǭM\lOK5kda%EJI[ƈzEB~n"6_饾 ~2X=w6PYգUHIAdztSY+yFbV㮟13+#Ѳ]EXu<wia{[#Y .ȴK"CđJO-#y7U Uc!:;Sf.O}M[EDuh5)/ܟyCiPy_Ӳ۫BTģ*؊r%ts+]$CcZk@_f& qyJMvG"4fd-\9Q# &A"$>c,*'w+fxWG$` eB44*rkG"[%m%G JRDDDXߡfOk˥>ZXkG}vG1HVDR-p"HR6fӋs/+_u+CeEwe6+dXsmݭg:E5_m-o[w*lc/ 6W. x&:TfjRG7wa}vXܭ0ܹΒ}ZZ=].bb\M6tҪ-(tA#E+zi!yo7vS%`N Vr$3A%FNQIYSTЅWo`u{3}棶:[zJc}cΆD6G'.QPC:Gy䛚%SisK/Ԏn{"9zw*U ;x7&J'.pR!_"QmwgW_qohO1JQ@zsv2:9$GQRP7WWy~Sg{gn8k}%~J3IB :Kn*7‚=}F/ʍ\tϼ+g ƥCN G/)_bg0W.vGᠢߛջ/Kz/-kL&$#j3_dVmWZ#ޙUy|޼8kliDif; I&B/uNm瓎ҵTxYۏ 24dNkډx8>g`lַ"G dk4ϼi"*Yȕ;[lāUZĢWYN(P@ (P@ (P@ (P@ }M VRvlIEPDtb:K؎̫WRhUe} !Q{|dn$@a  +~. T?wѫH 'Z : ̊eLӡY#/rbeD"e˲\;<~S 66R4"am-O9/ů?SP/^CB/gg"RB-iҍn)<Mj[4)hS=JώX̋lz524)i%!T?!HEZܜf=/ce7%9w\2L.9|Z]Fj'DJ{~ ["J떞cdVĻ:˭~6M+\y$A-y){ V5{srqթU[yd8qKŒqHDt bmUrfago&bDƮr=W&{҅ S|춵YВI!%ؽ?a"b]F0Ijڤ#yq\;` 3BLU eCI,Ȑul{:Men2J_?K NsK53nm8ٙUoJҴo;u-_HqnTW湾9[c}cu,OFHN^ߴؕGYrF[I f -Ѹw›EW+nz6e~NZ&:l/!&)KpĚ SZ17 EVioEno9ǰ398~ .EkW7fݣ%u MVi[ *L&a7"kR8nuyjk%rʵ]*Czd13nݵ n;4Ed27U$'kCܳn$ ̨\׾KշS+ޛ*͙Q͐G>jw笯KTWk+POa$mTENՒ2t5U]__X3ؑDߗmHNՒKgqꚓ"?XyUTM=|;XnO x^ۄ~r+t$şv%{{,|{k/ 3mxE.)d+hҮD!{1vsTA@BĭH3/iuH݈q7ΨSwkpgYZ O|dWړY}T=LlKwy-ʿ^Ôzś[8.ZLF4ukG~k7\Ji罻X7槄z+3szoK֑κwxvj޲>رvO̗Y7%Aؠ@ (P؊Iu U\Q! /Јd+S5\DDR;'8pX Y8}zt&wjN"f%k%~7RɾX,Ŷع=xJcu<6&)4U|%+JIja2/$j)xʕޖvҗvIsvٺ:7|kK;q@ h.9dVrz'mƓrTfyĠ̌$tUa5Tβ߬3X5:"V\[*~[n'Cy $?jhƃ@ (P@ ?$r"V瘵UF;m:_ʓGObBe0ioc;uldljfg33S#rSŏ6QG~|2\κEpچJ΋RR Ew_\De3jMuvy$}ʧINQy4weO}wwOoKw(ͷܘ[yesUEЧ*9 Pguy7sA11!{JYyX% d:NdP>mӱH79={nJ:.ˈԬ>v9vj(_^&ی nI6wT+rK"#mvj#"L|3xN/)a?I=Y%96vTCVQskn>2n\]_ihu*^dݐG*19=uwc%4hhҧu-qԒS25R߹9;;!H59[s٥ڸzM,l&+^$qJJNí ݥGqmEZ鳚KVó[dbE5Tg qŒ\DˆWErjN!g5:_Ƚ&ybƇ)uyOcW8i3kj{Gw_y1sh'Q?A޷?Nmzmaͳ 51$Y'N(_Xq*@.ǽDcݮ}_5!ָ[斦L[itԨG uJ(Ed(PLG+SiO3tI]ƨI3UGĎwji,}H2Kb6}T;D>U:.EfWuߐ^zXݗ kPiYf)*^^ԧwvvvNc>.5S؏ܮ)Rt{kVe^umF~/*(QdMbJR&Y"T(fM4FN:i& +ʝmZuzoSo 疘NWhIdqH fe5HzÉّ=ike UI'a5[Y=-tMOA& x61*mZͺ>8ki);Y ZowmrYDR=B-m=F_b31&mz&[^#j~[]NuQIZޅʕwԹʿLx V)ZtMQWBV$ms-xkxK]ݬX;$)mn2@ PRO w,t_ J %FeZh.*yC|ޯf T % ~"y?)s3eJS"^\41]Aߦ_'IK$h (P@ ( i JMY5.H%kRASoV: 4RfYU0̎/S3*y$(uNT>D*ӜSCiJJD%B"-DD9B (P^UOvOi^kѫH#n" (P@GQԻC}&%iQ~E*x mċĥw>ܹq.\2KLJUT=$fDBŬG:9 J\!eEshH4O2gM̪D}~gDTbP,ebnoफ$01z3r H32%(dgg۰$8sUZ5 $FAQ?г clEY*v8N22#m$ִ.xTT•FE~2Cg?pL.,CpISF 4%¦Ӧ,{-ic{Zbb:Jڜ>30ޢ7 #3}4OT_.tlfdf=-)1F#Kmݛy2_֤KemrhH"Pդ蒩6! tR:Run.mbj8viғsP#'"2Ji+j5UΪp8>f$qmM/җ[ů),[#JEV6dENj:dZ)2f#9~U+zi*pBl#22 u0c€hZR6ٙ.1QUtTر9k/W=/tQ:$=8SїnjP5! Uu_ԍ[hk=d޸}9[#iTEۧԞ%u 3 ͓nLw̖Q-H2QSשRؕTzX~;j=r\,Cc-Qr>eC| o&i\8Btԝ#bsW&.<)uv6oYiB+Wm/5Ȱ(ȎKI5QIWgJ|.ZhUO!o7wlm.3ywZ:Zʧ9T9vC). -KAҊ/*(`v);+v̨j7fyfbkɤU#qROfW#/H>M~S孨VJOO JkIjog>٩'vwRdsϭju'cюԼɨrgaIwΦ{ֿ>`cܝ7sX}rx4]IXj,fvPi$AQ)I""HZTUj&lWW]I[I:{Gwn|EdEz깔v VI4HG-'3w~5{Sa]jdE;vݝ$;y$r8UvNw了ytDJ+F; O)3wŘeLOwp~D/b$m\Z+BF9z⎻n: RE; b-&%NW̓"EZ9mkjHʄŏSPqB ojDi2#1=UlUFBꏳ#Kל)-Zo5D)*E%Sc;=9U_Dkw8IsR9zzQDOAt:hWi}ء>8YJ)QNoWl=KATRSPƏSd+\^^6RĠ3sϴ>nr>[{-x5-n8gBϻlW!.Kv{[Ս)fWv e䢡64FD}ieOq%9go'1iZJn|طfY8Q:{oÃI9u-dro7gIO:PK%#DOrswoZIWC߲\ :%TSp&e*e:kxl{gzph7 lKfe˴mrTma-ZJMTSB%UEr+w+v\}RL1<$d4jƐfDb8HYRQ(+fw$-bM =EKެTS]t_Z\.k[[nJwf.:ULԓ[IĒhw]sk[|mrwXҵ2/O95Vޑoj#rFFwيk51;S:6e%ДiQ#5s>INwY-R9uS]&M+\W9DphٹOt ̏J'$6R5OģիZnoX:Gȷ^J΅EJm !-Ch"J"Ivv UUj5(NV=o=MR*E"ͳLmJlR|J䩩M$XI8^f4yْ~KHQO}d#ZREٰiUWOQ(I e*ƥɷdrDnQ[ڎ%2nq[ ݩ^j?g>~y:yoKCuQˤFL]x&@xH%l77BkS2vTҕ#ڌO@)okҐ扗X.RJ&"?2n^#. Rb' aJf]*QZ#?)iM9dXR?R2ag ivD^+ &:v'7VBY1UIRmIBQRGBxTxPb#vڴ+ȕ'({MAY.MKSdu%&TpiWwE4\λ/zq.ѷL]Z'>q 2<&KI_/D\Ǭim%dUK.ԧN,mio){ߛ%$ovu+K-_ql2SN8k2qFt4!MqZ뎇w9%bDMOV\L ?''ƿ1k-%V g_!᧤8^;kuC? f;~ {CnEU],|r\O!>yeOfKxηv|9[Ot4#fym&ɴߣ4Nն[7%vSf 1bWfw'*> 86qȖĹ'/z`szMI&}c?I{v /v)XFqbDy$jQ2%%Fy;˫+-3eblUEs^^D,ޚ[3roۓmq0#qO67u"ZI:ǡ9]6+>E;$4/Ogژí.(Z=-KMLխ)clҵ1SY7zohgб>4]yVJ/#2zbǫNC͋6/%OvFdhYUI!hG"Kfou2+ekz6U^G$dlroH׆KMĔv*rJ:窹xܵR ~`2a(ZZDfI-EQL¼m9~wW{cG%1]wR[^5R&4gh-WI~EcC4iE?-; / )DV^bx+<0z7pF׉P!E])BS-GjPa`U#K[U{fn?~?N1֥UxIWwӷTGwW\zt[_v h<%ּ| GmRJ:x{Fׯ誡lSl4u{;DdmJ%}]κx϶ɦ[KL-Bё5F55jyjSL㜮 |m)vSʥ{6ע_jlG:j>VsQ uCrښOGi7^dNzNw;3ioGJ~U ]IfF*(klϵjiWxM|jC1⼃zO6̣rw=C#2'WIOVb9/r-oܲ8b}+0IZw&ca{ӤW9d^v-ƺZ7(}':/7l;բ,֕ /=zv7;OS-O6u9zNΠNP@,ەB[QyQ?iGBjeU|hZqɊmQisSSBrNBqL;\K+3zʛmxSI%DT.w;FbȊj֮Cϲ7HU+DkttG.w[Wޝ_`r R5pFeS%ou)NBcYcrs=+|)rr tydzпWxFVa7;eY )ϒY9pr&M ̶Rҗ)#k,D$4{>dŽ$gKr^Q`ò\Wܰ6o{#;lfң֔$TMEfNtMD_`l'{'`+t#nBO Ͱly-^Ni"CdJRI#Ym3IEm]FJ"UԊuLxDf98x+äۭvDTAj4y,03:$iLDW랪8@dMF58A(P@ (=-dpf=/\fKfH4r־jB9XjҔ,lD Xev٬\b5 2"V&\fD}աI2Q%IQiRRKӜ3j$4E ~vD{,:vUaMnoEv-#%J'~rpJ|"]T+H}QEaq76ӈR :riT#&dKyw ɛY=J#AϼnF'[K [dD۲C-.D2hH*wC]2*+z/;]=Pcq(TQ3/zja"b5PRAJ۪mebj_.;~63>5;b4U_mثi>nಲI=w`v_J@s8UޯMN4r mڮOAlaf{;+U|;t儷+ښ}dO:{6̍lz .ިe6_m_6!-*ND}6&HAJTJ~W:תcwv,ɒMsn+sѤ\:=){.t4kj:Z%,[4OzBAWnJ' Ÿُ&sbF|=!Va7oMƪܞCMˎ|=,ir܉c`I5On-FDIB TޑHꯘz95.c kIUI{I;]ۄ/|Z[\իLw Z! {Ze&]M5SW5 s4])<b*1'xK ]MdoOu2dr-8^钾{ʲc7uw62$yhkQz2K'7)4IunQI$>sLo;Q< 鋜۠z?'oI 8"+O(ٴ17G SZy n%yrZ|M:-7;(r3.IEQlNYoMZj3Eƌ(KAiObJt&EP}>!^,y1Z."*+TΙb]o2-H"F3vKJJ *+m\V|RZԪ/D\_"Q5>Ywn],l^dɥ(Ҵ=4/!Xak[PnL%MOrWEѮiT kuyğğyTo}atzPv:ed;\l_WuSz&ՏČMH}]}ZCJT$fU=3lnr**XDr+Uz\y9Y9S؝h;p):gbPl 3GtMϧS&c69e6ЌZ֮k=QߜK}ݭZ.|[R "蘑DjezȄ> Bbx?5.lͺ+=m|. K+jWMΤ. ljv-zS\54m:b$VEbdvDgS$6IT:{W.}(6#";\>Orfֻu Kjqj4УK1rǮ ?}Ax]"j>.y N|W2V*=h\8DL6ZI_ !GUFpdߥh$I@l{k~IyPުNbQ(N@[u[uhIOC\?LPޯ~_~ZFȳ a@ (P%}LfI[{\y'wh^."KcKa+*WyrU G%fgfт M0ڒg7x-$id0_lF! 6E"BکRA}(ʿlr5S[SԵ%e4(rzojt.7), C:5̙7u^:k:̤eX'lT7IffIVJ|C4{7kZnpLzHRjS}Sc 3*E;{EbJMw}⹹йjGuyUY\h0HdՆw .if ip ʥ ҭZI=c.|9,c2ֲu<9(7![ v2HZ _w} d⓰eڂơk9|I?9oMٵ-;z< >CK4aٰɯ>ƍ$><ivrN(3G $!-pȨII"MvխtJ*"EHRlGirؙUIw%S7sb[wC7'![O丬!m_rѩ):ըhrDTrqN*jzji00YWx$=M"=%laMW}7:"9D/kRĴuIE,k*!(ҍ::|9cw7{~ΟN-x$z䴧Rӧ4.l1UӢOЕ;v~TQim#!,8b~2Sܪh%E (ƛ>qHKH*oQ rfdIs܍O(n}:1ZR7k\#'J#tWMHQIJw1*v4ӤҾrwYityMcǮ|9% mSK#:O-&:Z,Kk];V$c||޵>|4-^AgnvZ[dD|E4)OO*EdD" Юt ;`WRG%Z߇9DM P2>\ڐ)|EJ$"IQ&%gI}p7n2@s2X/\H6ɰdG&ez\5-nG@+M1GV9đ6EDIQ? X5:/Y?ܾC2>fGKIWo;3gV{dMWIpʅJ^uɍY6nb#\_WB $6 r_ZY.R5[I`|e 72VhS/Ftmf]u-HEn-o;o,0Qo>KvN8نreWʨZJh[TʫU-9淛Eڈܭϒ-Φe@ (P@yԎ?>KfuQhGCL̼)J~T_nйuM|.v+wZ6n{o"u?1˵ql[D,SĢ#5/P17V>6;Kn}RGѝFsYwU!. B> <#2tN(ƔQ?.Ul)stpu?)ɡ}'tΉ4ݝA㖎yrpISM#kO2%ѩJFw4> 0Ɋ尕0[-n8-Ե)CKUS6$ (P@ 1nVu]#3ЦeC^aT4 #JF@M(x~l[,B}a`0U*/j4*YqRUSu#jnq/殲ۥ C^c_hܴ\;eHVT^i֬Fڸv, (P[u쿲ۯGhF7!N\KѫH4iP@ (P&$i2դ_BrJ9*hea6LNFQzSCr_]UC^ROSf1w{y uhT%= 1{_bرVs[Un T^/(դln|mniL W?M,G @"kZaD4L*kin!q?Ψ=So:v.=;~apQߌ=jeKEPǵE({ȿ^E=-y+SLV?W5KM߼^n8w1Wm2Rh~#Im>R#*:䮏Y31Ybkۜ,ێ;zE)LNx;]}] +r!E9U#r1Ըq\k3># 33$h d3i_q< JVf7S \6OH| T6PMOO'Iw*J3LZ]T"?̾*f8zȫyHj5UmMHOwjᑸW :a=}w9$j}JҺTЋav4DS>)CCSn ڊJd~2G%JLkey_" MXż9di㏛zd?)qCnB _FZGSor{ i}1#cHIb9u%Q$zxZ1ݝ_-ƕ:C#|"O"53m"C?N BCRP{5JM=m EEe*fwl [ޜ_ߒ<\X_{ou&'rQSvľSw=u9iu7=EJHysLo)@8[52Mtߘ>ZQDЅCs֮UU'7J^PGzR+&$Jhk5}]kNuw}sRQ8'mkˮ_ SI͎EU ԂJKWy45)".rI5;OݑaduҵUVWNrº¤Z_ŭMYnQFj=iq9=y'PZ2MFbzzW,dl\줚#ESltEqgidb.F֙LZܣ-oH58TsW[g h; @7kmݣA#'EO|Dί_~ZF't (P@ @zGVKǓUإGSx5OsWRR&\).JQL\hD HU\fnc4g"߳>[v 'PhyPvmQ44%TlHZ Ҥdecz-L C̠d&ǒ0®YkBk"QbȋmFV*7FeMEO2lJ /i?![D3\1U"%.>vDD`H""Svx1e]rMlfAbfyu1Iښ⸖ȍifEkRP*{v(}daVłXieHY.!DEVJIU]S -vK}i镚,BAn6晑6fvMFҮO( 4̙6շo KN܆K( ʶѥOID>껿۬]%~pmoH(grSe#Y/R%JJA/IqڗdgЗYu;R,%E־٤Ꝇ[HdbG-$_U>uHR22%c83h ϴތӕ$ٞNT`ҍkW5nx׏*WhJ ə2zBvvC+ٺc,iMV>Dlܺ2eɻosGtő4YaǵJ!}7"2W]?G9񻜪]ev1R&ooFFSSiT|X坷%vϩ$Cө+kBLrUrN>ncd%g6Hڼ0Fչ̙U^l̈WPLEEB'weຯkO]5{m$[s+.g4Ѝ2;RԓϾ)SF)8-$[Yx*hrkbo|A?]1NXQZc rRѽF'_χET:<&cMKrkNN>xf[~+O Рöj a:aa!sܮrT顅1F5"hCaCh (P@ (P@Bc$cL ]i{[*."nm;Pr宍 ws[8۵OV4}n~ E9s"_Z\r ttoY #ooG?cذDOY 9{!sCM5.י#kG1νkW^IjMur9GH j> !UKԟr/_ëJkbzN;4m fR~'Dp[+xPݽӗzDkoAJ\c0ky%)VC'+Ǻ:}IN0QTdЏ$n &ڇ-)L)v 5~A\&s :":vm~ Bt(i (P@ UVC7x64GLsexQkQ$Q҉OVZCZ۫Z3[qTy(L7/ .SGƭv3h,4Z$JUJT~ *jJ! (P_?U_vt5S?ѫH<aP@ (P@+Xe"RNӈ!?Oj7Ch9*1\7Y5(c5(AS-Cyw@uٍ} JMdu*JXj19+CD[mt1n=M!.nPnrL:5ImP[u"RDDVZT[`F;($ž[ŭdjFi=M.Ͼ!*;aa2Dym%& &̵ee\2!W9*DDԄ~mu=w%Kpd*L6#33>"<*`WJU3sG{hDC$8.ͧR/[` Sm#qTNHiQ+0:{ՌVbIqrZmh`\Vb7t]ӯ7;5ʚqVv$[װ'O0D<=48J|;I.3T>Fu{q\61|R n(qd56wH(l@XG @ \v>,Nyhۊo{FMZ)ҨYb V@.lu2٪T&@JQ >"J͋mJ ]ZClB;Y'` ojsW^vTR48̒Jj(A%$$WXD )cޑZ|4\ڈJWgH)Wp|߫FkЕZl&TG%ԙ[iIl_֍oi-?Ba$ ׯ˷GhF?!N0ΰ~_~ZF%'F@i4@ Hi4)~ǴXtA澟׆ ,\hWx `r)5"MWABnԦv4"y)5j%8J3~I|- 2FȲdGpK+xY/GV/6=[isJD{L,':b' :%-ҪXy͉N/]k}%q dNЫi##v y66ȕb׈=,\/:5\f\fDT 5?uB{=vCF"sk we>gvtr;.sIhJ4aJtr"JisnS᨞z_bS93ҫ;Wm %SZlDN$$k{OhjEgIiWVr-9 .:lJ:y6'1vtnd>Udd:reQrVʇR)*'hc-R0WTrH=4]*ieqZ^ؔGڞmJ`bPޓKhZuŞ-gJ?b|ouɛėʈmQJ5%e3vpuϕ.m_6)UIZeiehI(K&m#\ mf[TDL  H-uIhQIQPHzC5]JVxBQ'Uqfg%dgOZ L΍&MiwZSwA}fxŝU]9^:~eokL[!4u3G{m4!fŅۥGȿx5Ϙ-ԋE~KkQI!7h%6׆& Kaj# ^/9u *$7R~KI2r{Z% 埡xNx1EbI~>lZbVʞü|hXМ.,mtBQP_L;)s3ws]_L|-Z[{SD)mh۽DU>ƓSCղ'M>-,[7;$LaH׺uᨾT(9'qh{~%'֞`IBEKjJ*"|S4&.W-ߑЙw۴OYZ\i[R)&[ jKEc ; `Wx'2Uőz| 5U8_*dkWڸh2\lBۤ |K(?j_M[okn+>#w* 3sOUxm$zgJZP );Y$z(F%h>QL1yaeKJ#-D'EEp\U'†KSӎMbL? !n30̹S:[B JḽuUtt쥕 R@7[KiQЀPII$^ #@ @:fԟsx1T]eFM%æa"#Վ进9c9Ф oIu AB:ƜAVQmI“OyrƱZ&Kr!lj7[rN5NagEt7ܦ%5!;%ql~j=.~0i3xڣ"Lg14*ߥlEeE)'T22Tz;2ZSKI)*/ԌdMfk^rU==jSB}_2>-Qz'_r5ƌ^8s>]}zL7Z1wy{+/9 স%H@ 5m۸aܳ#_ml)Ӗefg2IIYG(27~R^!bP2Jش;:d#tYڥCT-n7 X}Z[:s>;}푍28T3 k7Q{2{h]|D;%U]%eBcC)$*WjzrO$ιW)LL(1Yd,F' & P P P P P P P P gLH0-b&i5qMJqc<+Rx/Rׁb~,~%wWyeǬ+YnR~bI&W 8leM?B+H @ @ @ ewov$ΰ_ZFƚd, " (P@ )ږV{SVԕy^%$H]ns|f*V !);" JSh3CYa3sڭݏ0\U=pTUnΐmj5}իekD5K9"*\Cn֪ZgFKy5!:utMү7Gb#e5pho?9kfZ?e=fzul32cGDxMhYq*d% D5>n+Z4|J{E54X}6Kv{fgmBjY%`VzD)/ŌדXq:d_b}#Fk$z-2 AeKeiiI61\whkx@;Oo~;` ?CtͳLX'/SVΥ$,m](DjW^f}J^C7Fص¹1qn[ Z(pmnmݭ\ܡp_)?mJu$_%sa3 aϺŗh]a{_C5 o]A(P@-$(*Jd{ *xR鑯]:_9}FgX2BC4얡iláIGqfl%ܥ]]gP 5+cݐi.v%\d)Gތiv,ʙŒ8y έc[[~$T)ʤfRh[AA4eK!$+I:NWrK1a)Ϣ15@!T5958ѫEɖ,#k2*gIrV~CYV[9n_pS(e+3[T-0/%iOZB&)^6|3khDXtԳNոvŚYV *jJiUݣA?QѫHͦ 35C(` 0P C(` ec,^q:⸮>]&c|ގPAx=J6 ̸(в4'E$l21m#Jmlّtu2ո;Y2aKuO6P,%PK,&?S!ͮ;Ϛm&c}ͪQ4m:~` Q\gӸZˏ]ueeԺʵ%IQvxH,zیZꭖÄRtd&t%rv1"Õuj> SRCCZmŦ!*vZϵF6PS6P C(` Xl嘶|f;=EqХnAC_rMUI|E]T}>\b_,`12f^;(xyI4~GS̋'XS7O>:"9y\D>4UhpHplZ*zjoFgb (P@ (P@ (P@ (P?-z;8HׄO8-V]ViokMItX^#=S=+WTr82KΣ%ET$f;CdmDZ@P@ ( ϯGht)C?Ծ~_ZFm5<25(P@ (P[u/8DD;(IP{(-3.YbeYv1I4Pd4C8FI:(iZ*UMIѩZgSs~ZeS9 F᳴-0_R=4iMDFiMꉴj:%%ϰoD1U-ktj ]gOo&/.cupBנ2ho[ E_xwRmuT S9Z%څ{- Qj}5&钙{G3yW3mZqy¡}v]BwlCq[V/ ؚ *3h (P7œ{:SR◇*{V,9Z SV$s~yM/9p{5k56 J?(ߎ|%W CZ#okEK]_-*K} GxxMRv%dU^.V=UE05S538EX(rU43 3ڋR7oR|g8R!@$E:(P@ (P@ (P@ (P9oCv#2vuQ6[R(mX)D1ܵ]F{%tγgz7*rK0a4_ .{jze!H@4 $i IH@4 $i IH@4 $2+Y{2-L >=f~H9=M`f:'rBР;Q@{dY &mcQs Qv)nO ﻹ-as:RgEBUQzg.hk))DYDwi7 Տ( € (P@ (P@ (P@ ;b̽^e7oeSf>CM0MkZ?"ttoⱅڔխUiQR\IxȎۥK\jw䞑<2]DYI˽n-1*[dIoޥƕ-8 mf(P@ (PY{@Swhl.lԾ _ըd,L (P@ (P@ (P@ (P@ (P@ +n4ݷ'd]a5n' HV]sNsHfBkFIVSkC֔͡JmĒ4F)Ub#O(zs_e1#RܕJ&03a#++"=*_ ,eE*洝xug wy#1ܩ0:j(@(@(@(@(@(@(@(@(@(@(@(@Fft"fa@~f{f{NQnOt<_*Qns:Iv]jRڄ㦕59%~^̧r~ZfVOaΠNqeW|kW jphm @ @ @ @ @ /n sڏ~?AkPŕA造@ (P@ (P@ (P@ (P@ (P@svϕlVRq$5a> lY.O>ܾWzLn0=Ύޞ>>Oy%4"aA{[mG}m>"bV%(?c[GFZQ$2e*:.5x)hO۴v(P@ (P@ (P@ pOQ6Fq2+TlIRI&T\THYy?yH75E'7f9|w饥ԕP>/G|Ԧ{bԩ4xډ1%i$ JRDDT"!zP@ (P@ Gh8HbGꞞ~-V銖]((((((((((((((((((((((((((((((((((((((((((hKSk-HQTG#b$*"z5Hcͷ(hs }앙j;9魸k#ˠn)(̘2"*Gٳ{~u1OAtn8naEg0};7k<>T?Ah>qBP(P(P(P(P(P(P(P(P(P(P(P((kfJze0Foײޕai?-Y}/}k¦q˾̾ͷ䊗4܁Krطr]YyJe]m PEbX8;mc…:[mϴWy]tMP(P(P(P(P(P(UvlM&.꾝zOAkO4i4@ Hi4@ Hi4@ Hi4@ Hi4@ Hi3yYt&akGa5vD~PJ?-oqZYbhH+bdZ㬻>k@nb.; gZ[O}z%q_Qc/!D>cC@ (P@ (P@ (#o+KS3^M5$aDhZ] n|[X0U9c%J]SeU)GEx2[#{ROZPF#&; 7m[[&hvgSRfjZf+hMyC(P@ (P@V>{Gh6k1]GV_cZoS--ɽFTylrI5hN6eR}{*9"6jNLnv+c7OZ=lulwpnz7o;{5?ǏhLnvj=cݼ|;c{t?eW1yvq<~GcvQ x[_o{ƣ-:ö;G7OZ=lulwpnz7o;{5?ǏhLnvj=cݼ|;c{t?eW1yvq<~GcvQ x[_o{ƣ-:ö;G7OZ=lulwpnz7o;{5?ǏhLnvj=cݼ|;c{t?eW1yvq<~GcvQ x[_o{ƣ-:ö;G7OZ=lulwpnz7o;{5?ǏhLnvj=cݼ|;c{t?eW1yvq<~GcvQ x[_o{ƣ-:ö;G7OZ=lulwpnz7o;{5?ǏhLnvj=cݼ|;c{t?eW1yvq<~GcvQ x[_o{ƣ-:ö;G7OZ=lulwpnz7o;{5?ǏiLnvͼ%T;~N#~ls]#^'>R񟭽ú_ޘݼ|;Rpz7o;{Լc;-õ/<~G~zcvK=ú_ޘݼ|;Rpz7o;{Լc;-õ/<~G~zcvK=ú_ޘݼ|;Rpz7o;{Լc;-õ/<~G~zcvK=ú_ޘݼ|;Rpz7o;{Լc;-õ/<~G~zcvK=ú_ޘݼ|;Rpz7o;{Լc;-õ/<~G~zcvK=ú}XHԬI-g1}0+xu&?eS{MuJc2l6츮L̖hYiR2Ql2:!nmڪ0Ɖ̍Of/03Ҧm->ddk2K{6#)h+{݉7 l~7jot9g6?ߦ, 7(f%4*JR\^Lj"$ Q~3i_ޘݼ|;R{u?eֿW1yv_ǏhLnvxǸwWZ=k{j^1xZ^o{ڗ{u?eֿW1yv_ǏhLnvxǸwWZ=k{j^1xZ^o{ڗ{u?eֿW1yv_ǏhLnvxǸwWZ=k{j^1xZ^o{ڗ{u?eֿW1yv_ǏhLnvxǸwWZa]:ԫp헼:"mLqƖE9)*: Či"T;ѹ|;g DԪs~?Viy9du3?~Vq^rv7j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j ft$dhj+xJsƍe퍍=c~C)PpR΃ԗ5Sd:.kvo%뭵tMU>]ːP/Fv3fmڹ1JiJHF{(EQY%;VowǼEKTtvuo6 ƶ-seʕ?v"?iSIJ`dgE>ټX֥UXDڧ+bρZ5*5EU%[o|O9ߴeO_v"?i Cp67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67jb #/"46KS8tI&~!.zѩU#fIjkU(<29lje#2RdgzxH1w\ Yړ|ߛ}?\܇w!qgT$xR~k .vbl\ IY}^{G1e,i$AiJR]DD9JZQYDkZDMHzv7j9 xڎCp^67j9 xڎCp^67j9 xڎCp^67j9 xژw|2v\msv ;~/ޙ+&O}y/VsQo}[&oSp}7h9MQSpTm)*6An 7Frh9MQSpTm)*6An 7Frh9MQSpTm)*6An 7Frh9MQSpTm)*6An 7Frh9MQSpTm)*6An 7Frh9MQCaH׷[U"~4ycʕdtn/KTuxv1;Om4xGݼouiDTBUIER>? GdU*_!6;1JFƤmojZ++[QlBB S39I4;?/o޸9Cs~3 ZL?usD:c ^s/_ú;oU9cEqY^g()k$Ԥ$ձ$D[V{~~>,xq]2wv#n;-NtKr69{P#{g]_$RJՑjzqwUIO\EP$IJhE=SSpTh9MQSpTm)*6An 7Frh9MQSpTm)*6An 7Frhk/Ev\-{~_ py_]/"}ד9'V:r9mg>ܷQ,C[,AQx*/E rXT^9b ,AQx*/E rXT^9b ,AQx*/E rXT^9b ,AQx*/E rXT^9b ,AQx*/E rXT^9b ,AQx*/E$\^'vx.2wZ뽴\lm,RTo!@n=մ'z#H};9s?Wħr3)iT>@Yx-j9&V׷~㟶Hy'vjyOw#ʜW7C~;%<oE rXT^9b ,AQx*/E rXT^9b ,AQy[i qAI%dUJG]u8/DT9tQj}ȿxsN8=X=oZɏI:Ps'>GRIlTBGA,c3NC[e^9Iӝ>i2I&M *YIIowG#:Sx'7F.I_:D!YSrXT^9b ,AQx*/E rXT^9b ,AQx*/E rXM0Hc7suw|Кu'Ur9mg>Q4\r/ ,r/ ,r/ ,r/ ,r/ ,r/ ,r/ ,r/ ,r/ ,r/ ,r/ ,»ّtIjO ݘ =U>xWo,Vc>zu :L6IKpVGڃ#ֆf?Af3Zu}. Q>[/-aKM%-RT"eҽ^*W/*!kbcX j#S,5 ,r/ ,r/ ,r/ ,+YRnCMYƣU\/'caK:SG[8iZ/9oz^tՓvv8m‚גE}(J:mR9Ie|U> XFFkPQ&r/ ,r/ ,r/ ,r/ ,r/ ^Ƌ;jO~p,wo8 -ȟyѰ36W;FÖ}&xCZ6NV9_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^EaM4֒cԝ:v&:wdx-w;O/+)(ZQx_pP^9}Ax_pP^9}Ax_pP^B7MK4s|eEI kW$&b;!M\*U8v/Eom&i[2XdDRZIׄ{ՑՑ"x y dOY>>fe̖2QgC6jmZi/d=IJ3k#gϽ﷾% eVKi'5fJn2ZxC f9S,a7ᤁ]11O#Q9WRcޫSq[vqctPݹSG ݫu_O:d#l?䤨ڿ7S&ۼV}zOn%Y8< _pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^Gsvt ^)1Ŏp߇KNDҲfTf/ѻ07I?lO_p(v_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax産bgIW4t)ל:% Gz ؎{ҪB5 lGeFgQ~/I"[FBpuTIcCZ)W+]J* w [%"7iU*#.=TBߓ3/cQy9)r-Hm3>߭JKrbj'=$4Pr /(/࠼r /(/࠼r /(/࠼u:tvyY)oQOT׮B~lWN[^"n{1cWYN+w~_J{H4)3i:)gWxw0@Yku+˓&E{On.F97e7,ǹRHY4j3JIDEZeT1lz=ɥ X|x8ֈ_ rJȲ_ˤI+O]_ZE*N/j#1j+~-c.5tDU6:)}N{GOpE*޼^ =7+(b3)$4I$!IPDE!FUSUMzr2r /(/࠼r /(/࠼r /(/࠼r /(/࠼r /(/࠼r PӍ)^)ֿ1O pÓ<ӵ-:?vqoliţdOs:.AAx(/ r\ːP^9r .AAx(/ r\ːP^9r .AAx(/ r\ːP^9r .AAx(/ r\ːP^9r .AAx(/ r\ːP^i;'=9P/߼' RtXU^8(OS$>3ܦ6eTHP=WEjA>2X̚U4|9ϔԧYk>ΧDD>ֶ6&DOKW;dwi-I=o }ڌZ&;{~ːCr\ːP^9r .AAx(/ r\ːP^FvNG>Mc#̌eR$;u"3/C 9 )"6lσ:hiTڥ}.2fcd$HG)dyje a:q-M8HQ+B•R^!㒩C&YiJ1KEa)zfT[[ЊNQ!L5}cV:6TorhHr\ːP^9r .AAx(/ r\ːP^9r .AAx(/ r\ːP^9r .AAx(/ u!8N~r'8 ⿓CԸT_`~;K|g]39}‚Sx_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^hF)d'Nd6F,7kv}*l+?M-wk(ל?axLSt|wyDbUu\)ɪ8u&ISj녜qCpi^K}6QY޴pQr%P;ǾuĿw/Wd;-EnTqY$dؚUHKz|7vgw;}&"FF[ =3Ng*U}$,d'.7:l8jB2pR">ѩVTMdET (A]zYn2-S-b˫"Yv7ʕB ə4i#v(lݐՅTTOqfIڲ-C'7Y7wda,v(5Pr W~uNw,6µ#Fm,ljZdF?IJm1v [ʥ&^/Zp%5=:|>fzq4Mlu˽eOFM z cΔNe6Z|6Q &^/!7.:uGQ-L'S7gI-E>3ĆU,S a6vf"ZZj2zA!NRQ֕ke:iR mbQ>f5Px_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ax_pP^9}Ay:pN֯q8 ?‡ջxzMݠPoTnE_M.)(tw\(/P^9prAx‚˅ .\(/P^9prAx‚˅ .\(/P^9prAx‚˅ .\(/P^9prAx‚˅ .\(/P^9prAx‚˅ p0Vf')eqP>L2<1b᚛[Aq=b:TjltrGD7 I\66䈊3I:TFTd6*U imrU;n&wĹZ-ZKh2Tv~ *E|!G2DL\yB=G @UCdIBqt_Hh}ȟ.묣[T*L5(Rv6];+> CKFh91Ү7u|姀tnf ݤbu^KnFۉyf]VWXJm;{w,EVo/- 60Sاe]3' BQd$B;0]l/g[⻒Lg[ Т-救jmQ=bd꭫g8ź #N>Hi&! S5dz1ܨ9q*$"[Ht꘷DP Ij#|QtC;6瑦eg1u&O{_n+Zyي3z7O.4PoP^9prAx‚˅ .\(/P^9prAx‚˅ .\(/P^9prAx‚˅ .\(/P^9prAx‚˅ .\(/!]WgN)^)qD$wÄ־!W~~&J|gEn\8pn EÁ-\8pn EÁ-\8pn EÁ-\8pn EÁ-\8pn EÁ-\8pn EÁ-\8pn EÁ-\8pn EÁ-\8pn EÁ-\8pn E{=b.Nt?YSJ{!ϼ b7L%gNfbT3 e-ʇl^BwFr};[WtSuj-tRH<{uGYg>꿅zU y?'5pW.qrV{{CT^cNsw9#Z|vt":vDWI9^P'|;X[Km&rJDpӰzdUj;l.*h|TxWY6GINv -+A)wC?e.J|WM/_7J2$&% J0g 'g9]иj~[:ziHABp~?B+`?8#+O̹o'y͗/-"alѯɖsF}?`MM0Ft26Fj꟟L~:32!Ιl4Nt LlBgYdv";ju:&Hz![Cd*?fߢwƎaaeHEY GoEe($`?|#f:kw=E+Ӝ䷎_pZ/^9}hrx E/-_pZ/^9}hrx E/-_pZ/^9}hrx E/-_pZ/^9}hrx E/-_pZ/ =ggOOg+2(B&c q}Mj+s L}º E/-_pZ/^9}hrx E/-_pZ/^9}hrx E/-_pZ/^9}hrx E/-_pZ/^9}hrx E/-_pZ/^9}hry##ioHv=Ym&j%)I"ZnQ2'3rR> ;PoƚÑ5)uB+b##Bi /yiCy~Н#Dbü(P :Tץ3w咫${Cok9migݧ^`ɡVvaZ%G_q>焻਒P3 fkWk&Nd'IExMVi=5˰MqG"Z.Yv|'|y?@q7a "$t #%欹fz_p-R|l9͔FDlDN2P{b kV5ܨcN)0Զle%CB*jҚaUFt/ 7Vǧ7vIaz'jFTW3'IEIw홲Hͭ ОKM9}J /-_pZ/^9}hrx E/-_pZ/^9}hrx E/-_pZ/^9}hrx E/-_pZ/^9}hrx E/-[{2(B>K|A}Lj!dU DRw!Mp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/ hp7pZ/+573dGXt-硦gU}Kj#Г R 6^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_pX/^9}`rx  /,_Y˪. ͍$uZ꾝7]dݐZFCJ#Y<Dd78RGajB~(yOxZ'h|bgv^>V~3~Z/+X]|-_.߾/q?o Ek8˷OxZ'h|bgv^>V~3~Z/+X]|-_.߾/q?o Ek8˷OxZ'h|bgv^>V~3~Z/+X]|-_.߾/q?o Ek8˷OxZ'h|bgv^>V~3~Z/+X]|-_.߾/q?o Ek8˷FUDs*ma"3mٌ!T>âF/?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-?>xKi-:HpefV&"#6ݹB}E8F/Z=+(Z/zW?P^=hӌ+ hz_VBxҿN1/…G~cX_ E֏J8ⰿ ǭqa~-Z=+(Z/zW?P^=hӌ+ hz_VBxҿN1/…G~cX_ E֏J8ⰿ ǭqa~-Z=+(Z/zW?P^=hӌ+ hz_VBy]?ߦ+u,\.O̴&<8"nB#=uOԓ[?(|qb?8^od5kns\???>/TU?@uPTU?@uPTU?@uPTU?@uPp?~߰6߰~?`~?`~?`~?`%8߰6߲T~ʀP*?e@T~ʀP*?e@T~ʀP"o[v_{?@=)e ~&g%AS =d x}KY^{nobVAtP]0LV[T_ 4dIrH/ ^z1 |9>"Uc(q9=7"u냃=8H^ ><7|p"g_~T:?=/~1xoG;(?>ǿE:;G?~̳}G ϞS;=4'}O>BkSqO~_8>zy\㋓y>^n7ƓʷWf6Mg&j|&M.K1w|vn$]mX߇c.O+y6_n }8jlz1^'?__lg<]}b&JZ-*Upy Ou8?:9}9&Ԟ;-B5kv\EM@</.ᶟoӤFrry. l4!l*?;(uX=4PuAۏ@ ׺VNJ*Q;5I"?һTֆn.` SiQ;l֛*80P`]`x/*D蔌o^хTpPJEyU鉴2*HFPJ7= {b@?項PERpj&W9{-J|#$n} q|ǸOnP^ lC2[dT-8.E'd zzDdH#H=t|iEώ+)$z8fVBf~PGɨkC8$E3G'04A,P&=1ptJVڊsl {lƾ!b|io*^phz6,v#8!kYzG$k 0&1īشb"mNEt@t#̲{F|^q u}Wb0t)P (1'l "&0U۷_)pj8@ՠ!^+rTzM; ~G=SZD9xx+k#JuVk~AEt{C~] z|-c3U4b#9{gCg/bФ y qsI ;rj!G>B`tb0ѐ9Dro(0̑P-މbAaԴۇm=P`LѵUu0`@u ]6\$&:RPWIE`R$PASօk:ǹmNjEh ȷXKᑼ{qF"qMLO"(\99c9641:)WBg7٨v@IiQkJ`F)Ǎ jXUkY#${O*"znz-6HH@^9IiguYV@JS M@$:hcK#Z紸i"9n8Zedp8T= e> ޿i]$hL{ۃ^%ߤj-@m!ZWoFYmb ?bH zlU}Vt_EP-3R;rBJQZHhQpT C ^UUQlvѪT(0CÇF*^QU/0^Y"۽6L&MAkWyźK##"}"Vz`b$re?ŝ8qBGd{`x >b'[URm41okL՛hw( 4[rJ/;(0B*oL)|Ww눏c6!x4z]Ҧ_EHy^WPDSn"a:FUd @X;At΄%-T )f,!|Xab 4I b肉? bP͞,1YkVMI.}ea%85.Iε°_`՝xe?z@WYRlhI)X-79wY7bW ;-;!!yTA‡ LYٞIcb2貨T)'9sr }?8b!M [ J} R{Q9AF$ׅ<2_M.5J8S ZF{ tȳe@)ʸ65͢Yod緫@`8/L ddy/!Lְb{} |9U!+H9pC`T$~XidtrÛ$ԬrI)v <԰y)"ICG88q:ǠNP01.]S X8ti0oN}.i2r\+w1P&̒Ac[x& *y3w5h\ds=; 9{݈/mr; GfDVbis\ȍ]8AJ]4I/d-rGUyܻϑ x%RqbA7(XCl@|Y`{g-t1*t\P(:r771Xl!4KHFn >9@܅Ri9g r-A%<,!a!_3wA%0O rIjwٴF{Mz0Aaf"sV>#ߡLXzpNJXs-֬VI|NU뽽󶊐8.0m^PH@o@ rNCYሓv25)0+k_#F~̓IxσAE`$ viٸ> _' xQO^.cAXp͹A$k_:]dI<ń1..i.4QB_|I ઐG22UpfmjCO|\)|߻=+ѻg&Y yHHKW3=+(1UK79_4.zK$}CL•͠У]GM{橆t6 uՍPN\1gUw{HRúaL[)ƴ SI?F@&ڸ8zI5/u61G-4߅0QYќ$T!8Jsz_r>R;kt _NN˳ E4T4|2Qt1>y =dy kX1ku#s() 8 3N 8OO). #+)NXQejp Xa4We >w(ңG) nhc"f3馺X,(|`Jv&c!$L:W_ޛݝVNp]j^"OYA,v!蛛#}&N85!nEG33(<{ot$:]㱂Ⱦ#TŹS]cၼ^Pr%&]h9; (0o2tjOP 0eBKх"Em)b1+eQ0Wa8)"Dm{3 JF9AK0txCSeR^R`|Ņa2P%3[fqZÙ㟹d PLPȊ〛&NJk(j4`ָTiP"*1t&Dΐ[iU1 ՁX@_Bƅ0LYP&zጾCII8vYUi;II:K,nNIJby" 3IpJ#d$ҡGL5eus] W$!FAPEhJ N:PmtwX<%6T1ʵYup5Ac1e 7L_DԐ*Ȼ 'Ly0Y-FCg5ָb҆2'D(hY--"_舎u8Pr<A~-)I0@ѡ_X$|{p}ɞڶ FèA&(ӄ<ʳ!M:#J,op}ۨ QbR&D.Ipl]o&Mcbðg vwG&JSǯt_t@D0ɢ7[sMb{=JOm[r}tG k իrIŋѳ >]ţtLi<$ _.篮V|jԾϏQA"/"R A*7>'! G%x谰%n6|bҿ/'Ip>ԿC5yT:Ý2kn kXp I8;'yz:ӑ?|Ysc}"("tL=oOsyw!@Zηxߝ>?#e=8›.6?I-&O||CMt c|%owxrV\/є˫$`)]L/Wdu ZN>n5TJ1ֽ`僠SQZЩ BWJɧ{_%ҮJ$ߝ%rL+A|^Lo܎Q޷#|}WZ>{Ӊbj)9 FnSjvuԒ30U38ohN{U!m 5:{{&M^gxoA^@=,=Uh 1C܋B!M']xWWGIf*pGg8KQD_CU*g"h$fܡH{WT!<\{bBb5H-Q=+ &M2[^QAi\-T &}-}Xx͖N 9]I=|9w)ޜT,6!'>[{/bWg8y2)@cn;PDZc ލٯX, Z3yµ$V)=aڡ]1u7eƈ1~SG:g%$V pimx&־@)xQ{>n}t!O)4UqD:@h08ieny ݎ] 9Q[:? D6 sŻh? ]8ɉ8S ]hUt QH (?*w8 ߾'Pn@(T؝Q ms(17D7b\܍Ϸ/m\1 #GMx ϗk%Gn<6cp^)sv{/+[O4A&a:r\5B1/11˶ރ3NhΕٕY)tSvz>GF?ãx5[ vf=~ٶ ~xٷ8+S0YM@u[&a&דNӷ3vmA=_Χ`lO%=l5`Og :A̐K74%`jU+LN&Eҫs HFBL^TERn\jn>Wy=\,9 Y0<>zx#89Y&Wo2Va5e-U1/Oxuc(>T\ըpyJI١" x76Dhdf7^ph,Gj!i#2 fmQPթ=8j%Z6gA}8KN-N;x@+}ʑiprrjQ@MΒP$*LZm•놱 Q/o0d[hex+'/3,fTd!JXHXBT7,i "\2XMB~iKI`96@#LYhiR)IJKio,×J3Z#(2RZVE(O]NMt&ʒ>#34߲$aڛ8+nZ QF{he5LB޹~c?ǔ[xдPu3X|ٲT xdV?D%\|셀Kګl!X;um^\т- gp˜v| ʐI6JZVk`^W2)tQF\]%]EqgnZn*n茆U#vP)bGi+BcV.bّ ۘBD,], obxnYyxOSh `HڥoȲf^N/ܙ}_x9ψY0+vї/cܐL1Rtq;|ur=0/j:d?_j}kSaoSܾ y5wz;0^*p+UBVF'N0ToJg4^yĵa$$2=RR~9"rKdr>^gN%ǘQֈ+}ЮQ&u>-.D d'k˓b!3%eCtf[=..d7X4h`"7GJbA+˟TH2a h~`ŷ)9G5 j53Vs%o atY bb4ǧݤb.Δ-xr9)qb.|M<׊%z;!Jg|jn]E*e䲂?d)`ϛZyȵCig[cThP|is"puq+i_E&"Kf aB;(YPyCߨ ,W">ًK5DPmC ")`)9[2kPaIZבFRwu.eOsvTE-+LM/\!9&\ @SB^l/4R7PީdŐ6DwD#1]!l' hf_ݍ#` ƍ\Ea^T 5.FvgHU> ˴38ȤZ %¹k c+R|foukqxr+-2 JϱA@LV݀MQV,”=ͱk$+5KyDx#u\%itQICü T,#@ -ȘI5֥4UU6(zu($@տVl7KZ͐ ]6ޛk.(ٷmwq] pe뙂.yYi v_lIGSwWB[8/x"fw"xc&Rv5ԃ0 EB6]l1ZkBFtJ}dط(ܫ."w LJW-LtL_gɇUf'08*2=xr['l'ر9^/6o?2e~[Xtjz P&<= SPvC8Qa_xzxa]#+Mt!0۷ioNy/]Kx,TŌ_J0Q>/*%Γ_8z;k&ְMz>s(HNȂ:Eby!=a'\lfp0[x"t[T Fg` =lr E"(cq3f[ôYF6q*V/7l:z^c =9V>(!p#H:ny70$\j'eǧvz-d[C\5Np5 U:)Iv7ٲogDK'3_-_  {#nqVortռK l=Cs{jG+yHC Y^nG+oZ{h|p5OOge}YxM}l<[%t1Ei ayaLA&A;}~x6uS AV}wiWJm|| >ûQK׫"|׀J㓍R0ZM$ú)\.T)H,>F/(.\0 ݍR*:R@O^[Wjiqet9 U+g19lEa!`Dm 'hIzJ5G5d %&%i$AG^+ 6^>=bN (G3<(?wc+ @܂YP6ApX#h1\ĚH 3]̮.i%D8 ^'2]R>}qJ508|I5ߍN&ML[6G;ᖄ;hSV"<#òN@dWzd/=i+aB.l$0s\LEnG-DN1XWNW xS^\gal^ e 4ljDQD{'j*`1ROLÅӑ"(Go/ŀm d} ωڶK8<,7 kToL - o `m*Ko2z$s6|?GM!J=>nݣ8ՙ='xxY&LBWOnUchֳM+nX=z 7PTY1k#zko>dj5|ϲs6f Opw)c3V. 9F%I*|φ{mv 2/&|v")D1֯խq\%T;)8$UdweD e]1m 'nQv'^,<~;$,+ݪ(trFM_OL$9,[2~7_vIAHFraq]@v9K֑oSmL$YBSܥ; H [a> &Iv(4=,d[ NmͰӕ22od"K XڅEJ&]+|6A~(6۲k& ` jDydž8a{2gUyIFr\sVk,enU@0OΎyȸd7xqqfdϐU{=]{ W5:t1<`2ݜK5lPPڌ0-J"r`ѹ=*}Y\cMy^˲?|똳s0{{ C2ۿ@D.w#&03ʖToaJ. ;4ꦿp<Ϭ oq|y7P 9+ܼY/q[^f)COF5TNuw%rM2?O^Y@&߿k/W}_^E33:m d&Fu֟tx$Q@\K᳻C*ZpGDX BEL&& '}֡oL%TW[eb1qͨź>;;DNuةckrǡ؍ȹIx^ϰ 7L '.>C*iS K0G/' 7z o]ofDĞ1DRDՈѸ<]h'S7yv7n%_3ؒ: };=hsF+0jbTD&9 -#w/aԊ]eHNͤhyѯ_rltD)JqٔJAq m*}ԩ( t ,BTNsМtę1yU ZC^I1NCK|_lۈ>i&\nf3CmH^#l?GHf(^*<E/6WC[nI4#jzߛ3=-'DEbU_pC?qǚa0]C+KkՊJ60ȑ+2Cb/ջ93$gwqqHӏ~/V Ksk=js&)rP;$23ut8c-5 #o8AnE$}?',CudjBc,/9B,ٓ<4C.L8h)|EI0@i^ >gp.5jk?'tP3!_:Fe$ J-=8Ts)i=*bvp&Yr>:jaL(ۼy;WXr^Bݚ9]j$14F};*SRJ-G_oZ4Qj3`=elRw>wKcIQ^OQ_Tk&,V~Ttp EK-Bb kTB]v:? (6dΑzК7#[ дa)%Bհ8>iU}:,%)]?v&sbEHsدB{Kب'<ԍN{N92l&hN@9KW6n(/WA9's >VL1Vuޯ~SWӷ鲔DzctӇXB|jΟ];6Ms@GMViBphέ!{c@$VMfMZJ3r xj@T<2t]&ʆ.ɽĸ(?2Ch t7լKz] vrC\qeNM6RfȊ6lHoP|DZ$Z9d".vE]s$uu8+9 .y=ܠ@ 1(\\Ung<`t#b42g'Ck?YsMO"i☔b  O>Ii!}!PO5Ggo5V}m1?|S7 PȑB[y+(f`AK0 pa;A? V`SAñLNT^ghcTS' @*PpH,Xt}SVbj t`Gn(hJ1}EG#nW.Q3)Ls`MZTF BBH0mˤZ,۫*=+Bzɵܔp]xvf¼ S0 ב) kRBPbZRJP}.>Q0R9VX)gb,ÉfN vX~u.X+E'dmk[U]Yו3?7m=x}+X I}1\>^qQT5v+'Ogb\;JQ n==ō:A]h{Pۙ;]'o%ߖk`魽3sDc o!')v(kDOɫS#%~$uĨe-4E!WP#˃eXaAp):\2Pc)ƂVl_ůkG㻂AoGYAF\9NRϰqGUPnBMWī`tݭ=reh|f_2ZB+$-n V ]ޠ9&dI-[rƐX?uC(fj_7>VI '=qxɩbmm!*P/c+dMruJcI̤]|}I/QhZJ:PxAgfYJv'<}[XB*k(pT(WJdLk0lLh' kk!kW@!*`@WEY\sb(DsUdF4hi֊ªڲ+"Ym2-&]R.O} csKsiҐ F;B8A 㨠xZH9b"Lit *)nP3h ԥkU(_6*td, vjg,5RVVR *BגUCIm`J" Er*)A [ӷcz^: a沢c)T])rcTE;JAj B;ya\LȒ}{Y~u[E e}U•c^}U/Gv+ 蝡S:f)7k/x5Uq:da}``D{$èrHt=-p)}3g\ 6 11Z^!WJoϓݢWU0UM|0kC5\}i;z3yvp戼+PGfQ(*m^Can`n_{+KK!)oT'MxK&=.}tSC`#kVK(Ҟ񳩩2/J f9η_j'rYќJ_z ~et;>Mtk>BNۄeGT:Ý|+} # 侹 Y,C+EnmϟQsXb,W-s*.UAӫǧ\ -w];:=5L :nܘg-蔳ĊQDض:]HŅD EwuS`Sj27b< &=} >=,7_uٽc_),^÷?-,!TMϖfnCzt5۫;jutz~R^@|/~Z2( gP}-&q0jpRM6d=rNqH!r=:ir) y]A[y A{ۭ#r2|^=Z!q{.aUJF ^aVG98ٙF{8rCUAYרf!}㊃c hE~۠ó+!醓N>?3 ,tzv§ZbG6o *7s<a9+,x'pT'rM ¡B Q>=c&|1c`=*,hlI F#_tbOJ?ⱏ'|jNr3xZEA;EQnHEcDA>so,(NQ9T꒛刕#Q(Fcuו(Wq PC;1\6iQt]e1I 6IZL&BȬ}$$LQwYY7Ρ1Z(\3g+b5+&xʀ6)8GdU&,qW{(= XjUtuxDU=*t9-7\`0d;8ZXzY TM̶2>#&o~VbRTعLl=OU.Ǫ čP\-gq$?y=|{puQT2C[Q`шʼngޖ^!-rmK0 Mf6 yxdel7~}nM]ni[|7l~u7qn;i7Ԝ0HxNW-!jY' B )˹R_ +tK@1VYTcLa#FXނK6ZdY~Am Vv=k"?W?d#tX/KQƬQ 7ٙ: iaeo^NF<4U6xk51+chB3%~mYRth BQw]b'na!Nd,K't4-ι@]t?1WO>؇'GD'LwsT%Wn | .ւ@p;c1& jq v(ty?9:jM$YdݑS5j#N)OQfjw.(:ꥁ_!/ u‰C<R~4tϽ.bA[gQ(/Uunt Ws"egԅѕۻu&WMqL֔*uCVݽͨL)~{CgwabT݇)edόSOCrQZ>Q3u%Eu=z``d. A\AӇ\YL饣[$€gT2< 6sX< WzGD"௴4*2rZT΅%J ׎C{[:s n)pItYžP9:X5ݢ\ҎG E u-I* h9ED5(2!ˈ~=F*am18mO0wm@ )OmbRLq=nʕ,96 G:RoG0@be֡T$t(~O=q~ ϫ=7xp v*}EP_B6?Ԋ/&b Uܢ1tcWgIE'츗7՞)NSc< T!g| %$>|Jp)'Fsi9ŭq"Od &r# Q V~5:o3F z,6 _'Qz=I1JwLS[;50S%oYO:12M 0thx!&tiTYD:I,f@r' { H3G9Vp`@'9>-PF8;A-2I*Gt寲xH?}};.{gg^5eL'{O (7.?Y./~ѕ} [b.Rl'CqQ \ zאzw*Ur}OHl?2h6.>,S,Gv*~,9pc>LX^Xd l0o+o`9L{g\_ 6YsTR%E@W$˒ .Qk@,I򮷤M 'aQB*aɟ$JS!"2~d~UJ`CV# ^C<Uه=Bt]t06oTo "3^U&|55USLܦ[yX= !:ZNkaG4/f)܇nAemHu,53[,MnPj\ӨْYw ZZ bfkr̕!K0NJX) |iuAY i0QJPsߘIzdC_-ٔ^L470PbT ~BkipMMQ-f/쒯_=zX?í4 0d/ Qj'p5 3 knThcFbO0[uHdWMRK=TC}l4uǗ3 QQOkaCknfKxy9E &M, ~Ϭ4;~@: M %F@" Sš0?a|wpa{w1KXeQ#*_2i <76`x=Q6I k帯߳\!=UInnwťOL Ĥ<$(.8wE U?˗:~j.\!r`zrFi Ū){`R{r*w¦ Iε>Ŵg)z9Oc!N[vO"lÙ(7Բ QmS(jQZ=;KUt%+ Kr+{FuKaer)8,\EY*'/H I>2JKy2G# "&cf 1<0!.w 6X.M(qkF C%c2!XQ*2SF|P*?[tВ<;d.х-X\ +vūG3xfZAvŶ*aY0nakֺS+6njl7T~F>\499J h=)Tt@ q_'!V!) $mYUe8Y'GBRIu;Uo14#3fQ fx# ՝?Dgl![cͨae~&Q- O9bo$&@OfӖњѳb#dbx8\yߙKn@})kЪI/֤ UwV֯e2A05_:j-ky7/aˉ}7227K$|G}Y'pe\?5k^'uz!tW&i;'vla3–qT33١g9I?`9bƈT.^#7 pO?Du5:- Q2N$sxϺn꠹O βupWv{;yC6,knAA &1#JeZxZͭXB{zz' kg{wL%:Ы 4Z\{fDѭҀ@1ڳ+Uὁ ]a2  Cŏ=( LR2b/鋷HE4~aD.)Sktk0dU["5FO!%O} Ƞ u:UlW1bRm?UMB0pku?Al3}1I8E1N Pw 7T1OBk˶Uh^0ɂXD@BtNv3V6gW<} ERWٮ ֛ ](bw]mȵFjRz.h-FrUbrankv2Y:aYVqkg+/I)L/?.#U.Fɭ00+fX#q B|Օ#ZG6J6*#I\bE+miUdFXZ+9`u/EeíƬ5sqʐfuU ә#1oAŃyD!U5{[}vsx(DF+3ghcrq0_SeTG]ζ|nD *阽' |^zoT++* BjWҴ*.¹Qkv{[y5BhSc`p~h(>uTV67.$ޝϠf;87&ݗ@&kIyGeȌ?=Af ^6Ø} wj,$ "?!zٜLtUmv4,a@b`Mf/`G9X^"BJKUNq4+H8Y-Z p|^6h,&|ǃ0 hQ_#M/)߽H5RV;?ַT]jϖGëf6ex 2z{|qB'`Mb)6Id#R&p<͐Ǘ;B][ǤdCVR-ZX)=,B՟Ng"YKn*7}6Sʮ(+AWX0),lNzlj]9$8032uR n0戱nNƾhA}*g>xlASw4!v˵.^*ܐ+w`(J0W%3 $0 ۥ]>fx>,\`UnWĽ~՚~5ذ<_iUk^??Rc[&UW ),da)ZtbMCfq\ה4qo[[ژ-k182f"FuRc -wZk%[['2+5SH*?7 DMIpl#6⍈r 2sFo5^eSj"$j J6](fk q os#q?"KyKc[w}+B74D2~h͟u<+vڸ3Nl>i3oO[\g0k!13H 2LKr 8*mXY^/l@ ~|lp:y 6Zfl ؼ2j'8|olNqу \>}ocgChsԇ_ȿ7Ka*% Tzƣ[x_~GM_|!8ln?|Ǭŏoef{:HǍݘ#Ť4kFD}] :HDiY/Q;-S} .rzG Eeھɸu`.Zgԅ)ydH42L`-Wc]rEd|οjfE/,@KZff͗}NL=f1mvɂvL.|^QaϹߏoe9?\) \[, re/Zku .0u1 Z9 Dd2P,o9m✝gքg?վ~-L`3d́~*fPOK;NՄdo&Zej[^ _nҩ-szw"Ne=3zr'rPg`J2OH$,!qAI%c>]E]S܀ i ^wR MU0lof ÿT_qHwa\$ocd()).!6y i%GͯOKXnb8 [0R+ŷ0ҹpdT1Z&; (;Vt+Uaﵔ1 /x01--{bo?REht춦I(`V0EV ЅaBT2,pk@.cԜxM*cka ݅@CҘ* +CJ0"bAAeZ+ejFftKƆ%/=.Lޏc"\jwRaM͜peEZsٹ[۶ 78;W}M|}C]LN!7mզO]ny~H:g<,toK6 2{.bՄES@y /g ^;#?,13N!kf /ek|ꌉ t ̅k6#` 6RefR$՞,wxCWG]"h67 <{d;uxLŕ{7AA7Đm$KCbz;CñY&VUrFpTdr@9{@pt*\12ctXNNaS"9Qs7rwR'{)vUjn \hPԇ!<,)٧XH&cvB&"A8B}K U-zӌ+B\!͸8:;9,v)uh0(0mM`gdy&ugu~`g^;(B'RWה颰d! (pԛ} L1/xC/2J1(嵈.Έ_59wdDd+6jؗ^NG! S9=zuX?Uh7ANb~M Jƿp'!Lv-pg7|vs*^s0.5&}F40#|qYsLyg:"pz&Yt; b`6æfdL עzNG^W}6bJ0w`aacĴ!QkQ[(3<&m-PHV,$ڿMa2IRCv=.=Trkhgx\՗R3k_ 4=<٨diќ @aY|}yv˲{mj,t\}s(V>- BJߓv3*fC¬DydݝPkQ.fٟBj ޽fӅbӣhlOأj2FWIaOFێ$LG:=n\N<=u /p0)곟l0龢cϤ#}{]{5(߼)-u!!uh"K1 a ) @ YTB۠M^dTqK0m@SG]w [G:IM ?_h_zC4=Q۾SG2)bb)(fKn \X jQP8B%VpI@&tPZvkMС7/L2۶S);.Ph]~U#7W/穔 X`"a" ! ݗ]8Đz-G] ja%6)J+ɗ#ÿ́{gkb!7BnzD& %%_Ƥd hXH*R崔-\|R+'TYhvM!醎*qMv]ҁ͎Jq=H8 1QPTWtwN,]ִ6j)R0qYzCpj7r1MlCǘ(AMk` ;:U6EyEd쾷yթSNUIl fx o@ :bcżA(.t Mi¡/U9NDއZ2toE$\fYPk{mjt Ty4Aksl`)WҔꠘq3g2Zp˚ѧM֪!Rn[.Q֗,Is ͵:ڜ|=zB2hڅ`+d~AF(&nEED B-`$9H p@umkyRdEpe_ESEx]KM-5w?dpUd%l¬1Z6RfKHl61}ɍ@<#ab & 0C˳o's;ȑeRDVP݋/dI8-9)_ƓMG3x&?1 &Ǣo6nHF MaEU+ b/K'}WCM ){#AM@U$o]RF1`AUQ=^ ? ˁwAESXv52ݯJnuIUBr`_t^Zɢ /E4q2A%=ջDąDp+<#q$⭈Ims0):{!08}ч@NneьyW7QÏ|D$OB1G°ȋ{G'&bي͸@5n<\V% W(~j.*9ZiqlA\1_K?.6y0zK)4DMgi~\ SJdcO8s+Z4wJס53~OYW\;+dD"_RF?cuda!lqv%Ͼ7@N9.b)x( &U atw=Ǻӟ_Nܐ̩Sg8Yb;K[պ54R'`itǡthgdD{G򻆇_c Ϧ'O`.gB'*KXHʀJF3S1b{a~sh6%,ZBvrӤZlWgnikp}޻\ں;1J/tfؔ1In:茁 ZtVYW}豢'XD}K.%(%;d@aV,F,iê%II<3X* ذ8 ﳻG}]-4{==ݺTͪdsPф)%! krV44?!(iӁt˪Iʍs+12u42[ti[UU,N g{ΟMm}*ެ$W. ;7~i0,6 bm*!h5՚=[wo5l8+EűH(*pWRH U~KfV@J榑F\Vpb'0 BseP|Jpg%^KS[#G9L1AP=4i& Z Ҥ#/}ru8\ZqߎD,J3K| (TvpwӰ*I +a $ c<:ykFVu8L'Uuƈu& 0(ar;ָHK ZQlHǠcݗWH_qg5ب9yҜ&RVÎС:C7E˄\;!eR6:^"(E8E=MZpZyC;v 9 ޫ57PH9>Z&.pO<j{;yX-$gyYVT(aUm j/E&ak"7 V)4''IJEr)g@EY>Khx( ̻O+ X-s݇k@ CNJhMsuJ?P坭ڐ~Sh*+C@٩8+won~ٗ~ |Lnr+c}8=Se ̄dHZCȍ{{&EHly\QWC˛~I|yϯ I{Cђ}HbFq6E<~wˆZMKɵHbWKC(?D(>r1֮ F>KU5Ǭֵ??}Jd3hذLbݏfe)޼OFϐopL"s:+M&]2^(`9 M4DF`rj3 [>E/z?_qs0@&拿~~== d@Ba}1P־GV^<~u.}u>~yrúSS#* -0/\>zy g\G$kt*\z#S*~aO⨌Mqŝv$H|[4 ,`bV `D_/^\q8,CUx'ө<%jhJϬ ܃S,LߏyNXP(!P1<^jQbv>nlg ~6񳅟mg?Sg?gCNǨ?F1߀01 a c@ƀ01 a @LP&0 La@&   `7Q\o@M@M@M@-@-@-@-@[[[[ ۀ ۀ taa6o!m       0A]߅7 . . . . . . `Sԟn0) La S@0=@=@=`{Kh{{{{ Q maaf0 a3@ f0 a3`0Ca09 as@09 as@8vppppppGpGPhЎ~/URsʠ\Ecr2꾼҃ SZ U!H,ƾ5m\lcpWzIQNc~[^pBdi%0TĩPu,}:.\;x|{3eZ5rc&@q49mX*Vx8:)#$X b"ҽPhtQyj9@j`tvջdgBD2 F}B='`~9L"Li%{+ nw]몇f ISA2ڰ (V1 ^Eה}@:g>kbh%/U} +jņ[S]ܢ䫷h,RE5< u3j**j=c,jS?qx=#lvOXib8#!j-&c"&B@QcDVyNRO$7yO ] ͣbɿ{=ՒWgS*ߞM寜ò%@@HabftTzOC KyqjS.!܇B Ű)e-);)~ d \3eF[uq ny){%?|i9W> l:mRL9P w+=W.Tf0$iEv%ҍuQ{bl:~U]ea)1akW\R$slX,c FNmCGY:h) sU0F6h)nQGő*^q>%64bGۑ̃t I X١j=(el"/zC%$x42ɪn "ZyFJѻ# ) %-FKt(H f*.0:dR"EFpmseJQڨJ?X ]a𧱫i;Z4ր/-\0 fVM52{ qe_H& BwLhɷ&DGGkM2>󑖊HPDY,7,#>=B-v/RDof)[n53]5>`tHkn6 \(ORʠFLڍX[ΠrCs3N po5\)d೯mL=2U/:ǫY֯ٯSqL?'s^mSbv~>x;ywPSbl!Ij-mmpB%zCr8=a[6 -rQFߋRX8 ZAxOl Όv.(wg 0jc,U=;L4ZK.ĺd=\qdx}Cb~kpƬŽX}TTG.9%A*f<%Q.ʱÃwwv4=EI2}knE5\d+eja 2Psr|X]WDԵ'6՝Y=ZboL2ޕZh= =5HBXs D3(@JNby]-p$ tƛʵ/xқz=paP!c1F5ڀRZrٕe0O uV\TR_>:<Q(#p^jJZ1Z{1|aʗU΃jNۙT3Œlj[9jB F7+Oͮj[ٖ=ۺUWĖBUWQ4J[ERMeFANZHZ[dK)H/xyt!qxL< q*qZ(߈JKYlKT8ͬ͐"mu^JQi IH&SRvj%qR,q"ƭM.UsR,DGkM>}Q}]otvd,ߞդe[3K!},6R]VZ j)t"8!8hgܕvSߊ qt98#+'[T-õ1xӟa9?o۱66!N>*]CuJm7֊v+QM*Q-az;zBJȶ;XÖpa.T"`0 --;(KͬRxCu; _NkA]V\}ޅ?@yUݳ5 ,?@YfjZb4(x+Jy*l K9j$ no+ShqeQ>IIH.LJSE a :Re0hlq4d.>__N#+E7&0*v3+(k )hB4bs8G]$a7&E5e1ć3T,y/歹dC9LSt:,4)4 J: n<]6zbJt o5dqيͤ2 0j2C>dwcG7('E]s[kqU_=\Mz_ ;4) tKWd{ck|f)Nd?y3J;rzej܉5pՋĸkY}Q{GZ{>{'*:$p|(f.WZHҥ܆1-lMj\L1~P1=rYPaM}5r%RIe۹pL{h%4HH_&STa`72"F~gdSm |0;YN_$/Dn9wPJH ͈ZSko*~0Ƞ3y"-5\ Ѽn̵}܁挲&W.nX_!U=㕙=I* 2_ ]RGؿJMo1hWwf)c{ nLkלWWR}À [ νF^wXPPقӮ Vs#@ %M/wrx;{r>CtȤ)hNq2A6Qkhv:ߩ$.&F~Y߹i2݆O$z/9& ȗ>,GWFP+f5yA׮p9 sc5#2X݆ (S9 24*-C#-b:؞IVU1G2QݼOs5˕Y=zKإ"nps Tyg碷2e!q\.WEOI֝\=xސWKqg2L('%l;&dYk&'S~m9$d\8L6,iBFw)EP ֧g[H#حꌙ (?'):ʔ `'+cg#tZ<,qSLvݳJP9g:Mgx:"\6`ym=jOᘱTg*s0ifj,6CB0×"w*3.U.#fs؏U uyW"vS1=(MKV%*xy̮ohes4~0?9}H6 6Xyh8d3}X c?~:tdccG ӫW2x kkt]*L/ќw!H`$#c7j*zɴ6zȉ&Z3yDC>gmUIiY-l`ǥ8?oM6ͭx5G;dkgvw݃xpu(0lsogohhg~=EpgǓ|w6|2l:<>p6&ͽ v66s39۟Oӝ?jozqzSd-b[%J?s͝tg2/ngה[̽s,-IjR]5k7~Znw+BXBbY`: ridp4~ L<2|_jR=̭+Ew%鋷n/jYԿ{}af~`6^ |֘>_ܢ7cKA8H'oDջM78x,#Xf' fsSxGhAhh hmNqֺf 3GӲsk4C CHPM:!@ %#T *mE$*˞]~e&+VBF ,fcVYԍAs~mцl۴G8ψѠL$^R!OFUyl=i Z 7=ʠ #0L wPյ>O4Zh~³fmFJH |\N/Ux/rq=0:\Ϻ1m7Tӧ@DJ+@WvQ,ƺgz4-I } y{V)X=G{fE/'}5G)Y͂j"e5@QcÖj-:Zx0;>BXE'>XU@TC}/F3͒.1v!y }]c^Bxeq>8NZ|c< _?f` |<{yՁo `8}C!&,$gȑ#lB'Xɯ2%/ɸD/ٽ|jO߼#GDP ~jt98ayIƥ\hnћMɒh\HsbM/.no~8ׅ@[ GZ%3"Qޜ2v|K%hS 0!l[#,0HpnТ _r/gdV[> n\]T'#aŞ׮tGb3F_*ZXR~sr`H癫%T9ÕN^j啧_%K_\@WzGPJk ~˴YH)*`<z1W zʱԯA~_V+l!`G&唏Ylwᕜd)2$YyGڽeFy^XdRg\@{{QPEsU`ޕ&ei (]humˠQMg.ͧ_ѝkJ ϰ5çE`q,ozڤͺIS(Wʘ1ߒQ2wشJƟrf#0MBCȊ +NH;c7zl0va`Sv%X{W8Qr Au{d!{SQgJ+#U PW;/MV`* ` kUǏΤ.mpǘxriY}<Q{<_u`$E3(}2*s/gW5G^?<~#'rdVlţ M#WVᏳGars XH&s'`}Q<S#&{IQ`pb;v<{MT'\~Ck *,|d^!0XPU ӬDVz]wd]퇞]; yؓT"Q14 :ateG Xeә0k0 M;,el>'bkk-};#*hk3SJk^ ci}_a.9ݗy\# v+1j!ƒhsRNQ /"=΢LKh@˙VoAL=K|׺;oFZ>ܫ YQ (HC-Uu]G=ӶqLS1y}-iwe|Yw$ 6"U9(1xQqdZCK O"\bk *%|dPnLW"Yё5qsLGP P]c99J -Z̪7CƁF`IҢ|%?] 4D^A6/5AK,Eѱ0켉6K7—Eu;h\cZy͏_W*@6De;.T:hRIH>oNڂe-HxjZPY@j (EU.ݱև;揱F r̅{}<,e=C}Kj-FLl.Z[^ :)3@αu.9`BeڙcO-xUUt32k#QdI6hS}E?;ec~>%+GśS?`bab 89 quk芻 n6F!{$ C4,i|YE%HוAlaLJ<P #=fUL(=)Y,w*|$G4è4K@le Ιt0cǽkISpw^K7-JHWo񥋏QN[iiraaJh$[@]AvWkyy&xdx&XFO$v%"H\ 67` ?5E[)F og)א{0#PLy2[l=p-ӌ E5sFD<eF 6 FZƘ|ʍ.6;ALafDDeE6N:)9ËWoMs5dP—?%*gr%jUXde_O#PلѢ.:}H`Ji\6~HEwaʩڽOd> c% ),RݨMu Py+i!%:q%9!cz̧.="4X-füY l sѡ# QyZߥR4ISf%v[HGT x=3x QzWW*&E~7\F?A~K)5tk<ٝ[c:'OӌF(#[uQهꪎ?ŞeSuSPegQ#ț,<|JgI BlOQB$| |8SWk/Җ"K.ovzPTwWC,↼0]?`rl$Ԃm|IW'qZ"|H|/)D]>7na݂MzV5i~jN4^{!C/}\ٯH]s}%<7e35\qk{^'!K ;lۚ%\c[>&#&oڮtw%Z\l,+"O^gcx_̌=0`QP JsT^A_[`6[YќnĸY?^ s ",)␡(W絋U6B-+P5ƗP[f χvNu3|w0%(D\[,9\*+dJYHB5Rds8*%vY.[_ ]SIw'¹6D/![ݐwh(.jҡ 1!024^җA@FMt|=Mk)TUJ|=wZ#xk9\sDz*sUddE0S☌ϥDuWCiaEVCiGr6cVKU/V/-It*"4b"جَEd=oe pk '^jDp(78Fvug4 CT/O' zޖ% d,)wvz_c8Q{MKq{zղpK+6i(!o^b92v7@5Vm% F]6%,Lрkp#[e[w5 wXt^rO7dIEK,ɒlK6 H9Uu/;OZUbX$5OTdf]&T%CɗI=E_Z1m+h5S]13XpTxa铳Y-ELDÓAnqSD:N[83s}b|Fń'\+ ǓOD>믖"1Jl,7/afx=ԃ=/hF`AO%x<{B=@Oj ߊ {NjK}Z&|fx &@KiQ+-Rd?qܵt1)~aA>p8nҢ:eSmy$|}ڗ?922i A|SܔQa*cX.x`9?ZRpX̤lGڡ ,c1 k!*UX+o| e8#s]up彟]JSmK.WYhUD ZbA?]EqÆN{5$FH`#I/զ4& HQM7JzmCh#h $5*M49t)V \\EF6ӆ(@K =%M$O}"*øPE,Pc,>čfag* p28 [d¹h]>y:]gt`ec4kG8&30_b#up{cQ@-5.@JH"PˣX̄, 3RE*p.+m5iy+(&T V2qud>f4zQKu#a3{IM^M8ڤ~tQҺJ#<|euPv5%Z06g{;tBm#r8TxI)ۣZ' %[I,.,YjU0>e/V;z8mċf`Ǎxh.x)E=+DB4X#<1[Xp 0[y-S$TQz̪%U#4;?jf lqlZ+Nj|ACumE/+ R>łhpDBy1^K/Ρ5< ۤL,#\ 6{3&=Y'ߨeMZfԆ'Ѫ5<`?.p<(p/;gxTCph$Nvҙ4r)T^IWjZm-G&Mn$:QQ$>YdAy<Ν_-L.dsiW6ܜp/m{C eZ' 2S߱D-m" B:o(AH?|0 >jI ?#kiZz; h>s$@N9 >%x s r 3$H2vQ}k # fG'6j> ~kn=z h47N:p  :\~Cvz:D^ #5ҁmM$0ɾ lFQAA$resN !l%>Ꮰdnáe"F4B|k'{'i OgR)OD=ˬaTmCN n)57Sm.[x aDzN}pW|碏/Х6*$&5$WT1W/yd(b+ X %*>5ɖqXy>Ӎ|&9p:']g.~ݸ=\ aNPOvLX9aewNYUUUUY_FFL+Rҗ8|iNf Đ*M%w6pG51ǥqFr 6V]C1w b9$P%Y?+%@I5[^PJ0Ks"-T K{8U@(ӰWE(BSB}9NBU)4Gl>ù[دV3*G}8$\J{% Ӟ Tkh_N':,]n?U[.Mbx}- *` waQG, f ouZ0M&YDu C'NCrYDV֒NRUR_z} Dh"[ݴT}5I\҉ݫ;[zEǻyHˋcODws*poThۭ9{b->Y6hgQk\r9<Q֥)bNxP䌮jfJh6/*#^$M}ֱRv-9E[=*ª=P00.LL[jɐ1-QUeUj /]8pG>', Ih5״uKDFztYOֈN52}yr YH_ڧ6j;mځqwBUwVUU:sCW,hx]xp&Y#iE8[\Yj?1b5 ¡@=y(gAndp A<\AI¦k֕tO,ꓩCA+DuiYɝyrn xW\!i(V`1w!U@uПp"=,$\eaR8ܱzL*!YZHsro9V @j zl6Ҧ2ؚC:(-tV*f1(DՕ_FpF]r%;BRO,2 2sCbɸV(pmǢ4< 2l6zG?Z4h1$e2䳁2ڳ9 + z~*+aԐYEmk,,"(6ob0<]j<Gy<vӖ3bٕh>nƚ|Ƭ-ke*"ߒ;1|FcΊ61v -tidy9ǐNh ǥdN)F*ϿxIFfvټ^.a暚0)|29J4 Ý*hQ7k :M@b&O[ yYiTCLQQU:fNߵk+gClAl`B0aDE'uHD+xVU|TLRMPZs5ur+`v|h1kg*UgbU)v[j[>EI(ϐKkēwUKI Efk,ҧ9& UaĜ'߬f֗Ubnbctv{f-IUFoVɴdD<)j{KЄI`#Bgꐧp, E4fE%[b7!ZSk/'SlazL()End,&mTsZxcv*ׄgĿ)U}YFw9q/6_,/J]lJaPT- "?_Ҍ'&JDӯo M㹇ʢBC4sPYΡsObD #^;:{l b:ӻY"9yfYd\>B$C7pA[Y\V;,WmQMh""V҄~ b#G5x )Zll$q>*h_`ddOCK=# ccCWimk]j;i_KEt7}Wnp:\AJΖ|i 8|$aƛZ8>X2뭥Q?մfR(Zj )*b58+dȳ ǰU*1 0A^%o9sSn{3-ev_Xx̧aŢ_,ĉeNv3yQxF~UMv]ca׉ Z"='a3aP#Q!y-.)!{EUx:k㒨9҆IS0 I Zͦ߬QjjRL*V)?v (K8顥wpx⽮4r :z>< {{7)j?kg3ݸgB$Ca)2#P@F,F'|,(,*S7Ɩd!dM1OA٣EO6Z_G`^X vӬUEhܺBb8d &+WИ, kp-L?+Kv%=s#!(iXD"aձ3Cg8^*4ZC"v X;W8* X•C/ʻqS\䴅4"D%Ol+i'Eu]W KHL+"+'("$lbX1ab݃;.q7 va7A%aD[k>Ld9a粺!NؙQanh-jE$ۚQw#zWGXTB܃7}$Ffq,sHv_CedeYbM_gGla{Kjf6(I ŌDl&Z[:νY-֥KZE EwItSM9"#z@8⡄굽pCJ7פ9qDc!ԤLu2\HV,ȥ9OjHW}@1;;Y52P[Q !T"\^PiPoqUZ6x@Y"'yE3*cO}Do$)q#`BZFRm*C=XܤB7Gp\|?foߘCޞ#"rƞn1^%n Խ2Ė.VlDGGĔx٨Z{ו\?a+DMZ. Z4l*W^52nec)ΈՃ.n5ceY9E&[c"(ew(RI\Z)Ju ZkA$<)[lbMHYeoJT Ha\koo9F),:1L "Iw+ qh_؁ Z4\w;>Vfo[H"GuTj1!)?ՅiUesYaFt"_̐jWךS%4 aV}elz* )oI*m|1ىBЙL+Fr̎3|{s"D؍=bjBlZ0Hcm>cײ@Pj~ojc%q׭:!0x#ރa:dNoyIpu8Iy@X C|VӁVq 2jG fE;}u\ur|SM}D_5Ve0[ᦲ&[;5LV$&ĭж]yGVx ]E4䋗5^ D3(DfNQe!,jEꜯoƌ(C2j!R9 a f,‚Zh*ueNJH`Z$>W\q QA*Zq%hWugp7|kݾ5I5F]]a[UuᇣfKF/!_hbWzF?;hBbYO+[<,[p#h &_w$;I'o]I+ 0f^P ~M-'{DuRqYbpؙӖ-ڜ7p>|ζ甆\A.SE/,- L3o, 7Ћ˼׌HK1+0'ӴYb,4x-{5^uiKK#RTvdm1tfO "a2䈒}W$5tJ>`?.<*ÚRbfQr`(hؾ,ʁ{m½Cs;δ+1㩴C&& q.4JLuo(Jn553-VhiHF-V!vԎ>~@R%jhp.j/J*<F#ƿ1dFä=&>.cSHj24x9ﭺY8/C9-t 8%v_Cgo<Nb_ FLDuO^>vGtj`:SHƩRZάVȻ>$ٓp+˺F鶋-INԵ<뿱e=U$b`. dO/fzkbisC w;7(#py5x:gu9/_!]GGXҕ8pzF5\})HpLc;r PDv <ԃ̤QD SBA7,Vaoao"z1v(Kў:IDL9O5Hyxx5;D\Vdx uX"^}ɸ5 " 1[~0ŏ&nTfBj me\j8\xHmls7(EWM+Pmͅh\*١ ȟ8[k7i"RRˇ۪۪T*mzR=a]eY:Z3ѮO V)ʼ%5sGGH9aV!QFsQʿ%6 Ϛr}si>0|^#Նv׶!;iQWN-@iwN_R{ ~J~{`pjoy~(XV:! dUlRV}`c z %PoV ꯞk}fOې4z%q_h;/yV3N\h! æpܥv? SwI%򥮭MZ{ie#[6^2|T FI1(7kȃKR !0Lyt6x1>;dTL].kt ކjˏf}`ֳ۟1 nOOD\đOl©O OI O)3.}oƣ0U1KfNe+K.6;m_6'-+5k ./`T7 C`7<(Ӵ];_U#MÏ)Hsȣ).qRگOYǵ#aJS6-ܸUŮGa os0iwٺ7VNj䘞~k=_o^Wp;%^}.a#]LOK]$mabS$q~9ۯ8Z/mO`t#X( ,۟!ӻ~bRh;v|47Z?ꩳf)}p;-.ɖH9Fߝij:4"ly'c|<.n6]o>|tiMnllJϖ8/}47۳&#zc|;5dεtȭnsƈJHMlڣj|ܟJ>Q#cӻ:v~WT?D׸pVK['| .FyktI7b_wGxZYd&)`@6 dR%b n:DESnjLN[>{rx?#ҏIDlTIVJ=~s2j窩a[)m{Tsn\|:=7R,Ew(?;ݵ7~>9 Ḍ|)?BG(d9ߗAB~![. |]xE hh?/v)U7K'tqԯl2Noqݻ6lzr]u7I>r}sOown1J$b\~$suvnZi'2Uɭzٽj=7ˇp?Y: g;=ݖ pyrx5ɏOKallzl{wn~fz^-P&NN?.uܯg;.U tn_v7EgMG;ٖM~kg ;rMBʽ/|xu<'.^v/Yk Bxї\~&./[ɌP) 8q͡[7ZIsfs_ZįONcXMURkn vwewq=Կ.Y(uT땍3)QZγwIz(QWYڌ7iw?yCdt~,*{#<ħ[MoT60a%FZ]]"y׈7҇;7n? p=ڤs8|]L潋ӭn}û6MjFf?Rܯ_lc)6r_%k;2g0lJ]=՟KU1ߘNë`z"l9z :֨]gGmsqT e?Y(۵}fRfcwjYfG\s+ɜNfn|sG;VW}ɕ[njvuưA8s7;azhڽ/LkF9w@HM{veM򓝾,rճQOI}^k.GEpxPKRcz:^4ݣƗbtxXBdmyޙ|Y?giaJ)wnm j紗=خT3CT=:*~7}?ëN<߂v2g{w5e7ZeYoOнZfi|y*N*lǏNG'Q]D,Ԩ\얳G;_ٰ<>|-/irkA,%H f1y2+;+^D 9N>f)T9Fkj);>|'ަK)qt熜)i2Ͽpx>뻬>tǛ,Al/4ާ -gWQ"X1<%X/yŻFyQnV@y)e7}~ TB$<#t(ȤAX=w,V3 l)޷.v#{\ XkyPh1J]F|F@'h|y|"6X9WuU۫ǂrA!ȳIΨ5KU%?qBLQfr$*G@9/I/GeuO(xܤ 6/N۞M2⋟؞M,UA{6v'$6d1/SEr?q{74/{БijHõ->tm97V"2X)ݛMUk(2?wW+͟^5\_qnFV0zXp'>1 Q z0i:qG%RWc_ASL,.8 ԅIQ'Vg]p$"wW 9(b" o` P`WDdHpu5BWx{VoOӈB( JϾt9}^6i ,apdm:󬹾ihvUzkWRٛRI^YX &˧e9{;'ll/&\4eA .$vĬ zOΫYb.iA%cIbՂDqV廆{{9$UW$ݤ{~]&wY]ex@>.*M1k *̻GK_{W]ZM jyH4T?:2넺">v|ءIQy\nCa3g,,&߲26.R1փ)+d0X,V.\9d|SA\n/؉k[$[,@Bg䊤ZunwSaj,iBNg6vuinשQ? ]D2J)'94B`[ßwp5s;ԦHJ=,^)+M~o<̮7E?6$Hj݁5$]vy}35;xe%Ζt4fA^uxݚ+n#8bԓo .N Űgw85;jk#fxiwqhb8@J&&aܕݯAx^<0xnW»Ŷ;)Wh/RQtE^Rj)qkOv0AD/Ժ})rFD(mldkmq jI:A9"EXL=E~:uÌ1׻ugj_"J@üQ0#8/~6eA .$<\zϖ̬MF+Vճz_tW%,ۯȄ$&j'nسJDguTU~G+ <cU k0!6&sz7>e8wzgZ U:wηV7ܕHQJ8+0 -qsUD40{!o Z5ġ0}?N7^-\a-<ww:<3F.d wT"YYF+]YTKɲSC~kk ȵLNjSp4rxZVC(dǒ5 nKw+zPE{B<_Rؒkz>_9 r{|z)-6-,iVث%IcҸ¦6F#D'|(1AmD{k*pD2}_q#`6qIT0.4L[CJ,ҧr[`YN! l"{kǐ^A%Yomس8Tk|#{tHd~ʮi1TK]Caڗn9f !l38TT-GW/Z1`ȗ`ES3'>ŧ5ٝhmR^zIAqYS5mnHu#ʜL/<1c_ P 8Sa[ʬ|mVYm'kl|ܤ@_suĂ6S.& ܲ_s:<°k+" ,VX+QwS@E]AhU[sl*VH"'p{w@iT̉<\i-_~J)dmsi)ڥ~I$#-ţJz(+al>PmDTnTHlR ۈ~@1e괺{K"sK]=/_2ojq-G9 5$'Cv9.eI:a5 6E9fD)/|="Ӻ/FL^P_7} ًpOn!0J/rk4TA˴wƢ\1Ր1GU1}M +2hղz ^"~a6C.69===ja)W0f7 ( AI_ svt+7N Ns7<:NwbcǨY7,Џm:I@kPD)dR&U%|_1?d㳫<, "(2[d8ma@Ys٩OѩU2T9 G$4."/;Jqzğ*?U :cwʒ׉O=I<\'90(,M60ME"\(x4,!?ScvDdt:{i> b7vWĤS58$R *s!Zٖ&,Nqpg !D+VF%r]!zG6 (a Ƥ(ȖpG''W HL 3 ݀zy6)ӥpq2PD&bgУOw\[upyGT5=0*VϢwv]A񮡨}8;.e3@EPkcǎЅ}]f#+yB~ 1 ̩dN'a272E'&C{@H8"O*VG 8TL( gmxg@9-@x.lׄNjc9o5 ͭt|^fҾT*ۚ/g3WlWS_hz:pisM{{ݕz$1}2 El?_p`30a/裷pfgHvIDpB:.C&*"`gLo? Dݙ76E^iM> _ alȘ@Yw$-ԣh0mu(3 8Ӱ=\͆(}ta}=X" lp:6u0~nU mWŖлF]]ùUV'cc$rjMnqD:r 1={Kz@KaxJEԸm~|;\r5 ׵P; 0n&X>zG~re 4L@jYḭvc.Dk]/r{@|XCɼKY) !iN#hDg#=H}J[g覄h؝Fne0J|;Bd¿JP F@Uky8/`KW|B|ŋב&E/6W|~,<6ʖr̬jH9eQ|]I`vϡD襪6B}=|kh Hg뉜F77}z81[-"w\m8*w,:O/=˷z.-UM|8 ݒXIekAwUT7}J _>^Cpj@.g'.sB3VF@U> !t >S_0 2M ,=! fJCIK%r0Ϙz_-5(?OM>`fNFF,߅t ص/g1m0+Ŏ5{Bm$d0-o^5Mu$ՋՀ  CCݝqT' E\zX*9=sf?<ZȡeEF'O $dx4M/4)3Ղ+9u89~dTKסߏe-V פcq/w"ddp?o B_ءg=@_2\gLΠ{]xc[s2n 7{>\/~0ؓx-Nl}~ȊېL[2SJޝ@m3Ņk10 2w>wCՏ>ԜPMbuY}(9>xZb/c]j9*͜v?ã\g#Zz2Aک ,R &-8"d}UፕOB̫pmB>ճAm91WY]9߻Xj31s b{TDTn+jW_o#J Ѷ*^exM( B0 8ص$p5xE!|n|"qia{XBP/1@o7KCV>{\ma+@ZPADdҠpc.Sgx %4IY~y GyA_Djςԥ !h͍e/鶴4L u4Љ\9UJf^4Q*T`kƆuQ-Y `re-yӱ'P-c (,45Op?= ;K ZokD]9mQ9hSd?J댕b͵&bF_lRcZD?p FJ+8xWGstba*&+˱)0n0H:6kԧ{D!^otp]]nIuϖsadK=A\@Ap淿 *Ji5U|B2ț;'nʉvl2\ww;v"noWo 4y7hG%( 4τl2ڼ+C9Jo(b8MvX G'cpt&ZKf*z}`JV]֌+[DAgaׯU:va7&z}YzCwTw[hVZTql&1L^s~Q'Ǻ격S3Ps BǑ:POK;c,$T K89Qt]Pbޓuƶ\- x2x6L<]ιVj7촥S3mݬ1[^tlhD]@?8ZӦ=ff;VoQ 3ѢsHVn R:`]+ىbw2åro7QiY¹MlZd[<00ϊ%e%w't;TȖ :עy`g 8G] l*Z euk4Hy*뇩\mUNMQ-7ZHV./JO܄l٤pdp ,\xzHU!EMלjǓ]yw9ޏ[Py"2qhHcwmEGZȾ&LWV~u|ìUrAvNG)RSۊ,؋ktV䪺Ko鳉j V1p/u;uNWAYuޱ n1p%g-bt Q:.mӃdKKϤ-9s okU'8)]# ]B 6u\$ 4DI֡4OLèKe8޹'mh:ž)R Դ(ӮΆ. .W Pv{R&\l)9#Rvq~,p4yWX:R҄.@2.JG*?Dq'ŀY7q ]"SFx07([~-V^ Ӥͮ\ha,7G\ЭBCa;pbmVy:)喽V'4@,7W1tWd<"ZcX$ӯVa/h -V9cp4ON6a1+}JVwm* ɢ˔l \`zugvٹ(qQՃh?fTSvacC+yw\q ; &`{;ףk{sewabV1U$t”ʕm)~߰`B]GC0̇+yw4TUE,+sѝugGFn&ڮl f[SL_kT'=d'SMRvNY+̮hsJm;w,imvLa2SG%lE^d퇲'gNsÕ2-!MHY2 T4&E<)G܍6JSغإ]_usRU"(s0zMz?kyie|?sPmwѬTY VDM1:` cm!wh66%tZXe^m^{EF3:c[q1aZrՊۘmpݺ֫!k{]oˈ mucN :jq:)wf-=R;-TY.ɞ̓eqA@q{^)!`Mwlm#,4+N5<Ʌy.-4+{ѮaoPpCvF⩍Oq Az[v`TJG?C[Ѳ}*լ肜Œ skn 4uNݽި֚NTWm\9mg֒S#6qYlTsv%fi>vN. M'9]j\.yTn4OUc, \J/;keaK8v]2Pnic}QᴬXIRBN~/؊I/u]1QeǞRђOjniZVq(O!< fTޖ 낯N 19q&o'-\kApxR TwXLp#YQѝ-Q?&WKsq䶆DIx.hiU6Xh i#SyWפfw+R=&Vl[ӠMrnt͝dr=eH 8HjLCRiq+x8t5YVitaҺ; lJXwJ`.W\osn&ܣպp=*p[w7mk^AUv^Á=P/˅ML zѼtN#Y.rgr8A[uҮDn6[qIh8UbN]jқ&lG\>xcrF+! |x3whbEZ-P*`˽qxkA)nAi5,IU3`pO\5Gс))wٵn2{zu{M*5Aֆ;McQhShO.BTڗj$n AUfF{îE g]@]B", tSJZEM:p$,{6M:K1<ٍaLp,h%#K=RBNl#ePVQOj Iݶpm9bwtj2b8r:UvD+ F9:P6ڵКYSj=fⱞ48%;ϝzV,#7P"Ϗe&"5-|] 돋 `o&SiXCһyU@*eUx1528XCKӍ"PT WbS2Mu4&9_# Оy+3 X]q34Y1ar[bUW(_RѬa?!Wڇ"NUACy%ͬp*ل'yڢut-UG%Tb^iqVq+D_uneo ,ttz듌pq4$Wa;dhZ-cy%ɺyYNGfAJ< AX()B_$5)N,Vv]+҉.5џԕ*.ei9 {fփFRipM\=8hGp_b^:3tCZ"O,K?M)n8AG\e:.Lю+Ҥ(7V-\-ݹ& kUB7ʯc i*]GjﲔuwʼsfXo_~zjHhv/ )G~nu2$8&. 0ϮVYLF"໵UVW|mYߥ]FsXLͣf@nбKmLW&Ak !{q~-_v?+} .7Z^+@6weHO؋r@:bߎ~0qgp!haL*D6`8X>+I}÷t tzh+j_ItHa}=eW1 I"Cb+PwIJ=}.^i*D߰ZwM4?|V|;&`<{ɏ :U2΅ #5s.'}w`E>m%.}Ipxm˟S?\|t$_b?>-:W ܧswr> (2'+teUƒ1<<Ϭ;_D\XDjF""\dv >0<!Ό&3z#|F{J#d?;4363ͮԹ8v8bFgiZg`J\z$a!/ /׾gFWɉ/yVf4m?;6|Jlѓg )^ޞ0X`OF"_ t&vS€8o`A#3ڵ'J`W#II3c􆏀陹W#?˲,#Ͳ4"aTք}F\j] ^Ա˕H'XπL9C!#DFzf>72RujcsrJ\'i<#~zи'x^Ft%4>ZCF=9hĻ(_g{§IJh4ˍEieZrlGZ=9pěH6ҴHvK8h<օ`x g>&޲wO[QL{zWž>_!ȕ"m>fqHyߗ5G*lq8v1,Y[|" EZ;)Ԩ?#,R?Q#r??iğ?-SӇ_R%dS"-yjDώOU 'xiH}??Vg,#M ,_j5$U+߾@w-|bv7|m* ~%Wr]E2EWr]E2E"׋_qo+X7xL+fj+sՃz/~tS6a`oBD $\zo_^7S(VF?غK*c.03f ^%k/cZӗ6P6. ^.Wl<,UlˈԢי>ױ­oZoP;$ħ2p -e@6Z/_R$_FgϿ3^ 3j,C0"hrpxM7-iJaY6-.y7ns^24M \h7M7C#/yEYd24)܈,!JUQs$u޵BI=$֒޽'#Kn8\n(vnd)6 y: ;J7|ԣ`^\q$Iv Ywp7ƓI亟|0n ly*T~s~K|!3,)ehps UnD6Mm?63_<1)N!z$QCȥpBe0 /oJ$(dK\X>#b&17$,KJLwx.7$@-o X;x Y0EXf &N"F$8MK=n|FAv),ܤW`Ӑ;Q3R4h N%:1dп˃5Eǵh˗x&xѴ$͜( QIDS/H4)X#ǯvn#[W <<P9@e BL;?>XUyZ}(0un1w4CXdȏ%wW;J84E?FK1|tĤ"fXZ$̒Vi3bR(慧P@Wf3шE'NK}>"wf|(p.4x4*aPwÁ!Gԍ~Qs4$, &3&@D,$ȏ&]NJ>XnnAFp"^ߓfKI <"꽐4~O%)1-$$]RD]U%Fj#:EA5_j!E=M0 s^`'IVy0u0Q1`<10>k"1wt$sm$`I`0w""$E<\D~m$VyT4}ц+D_Zo~$ӯgB9\zg \X?tq p$=~GB>P:&r!"~*AYe 6IkX#h>D{.!= |,}x`Cb7_4c{nu?hpv{`!:3u Sa&\MoCeoø6h4|B<ĮϾ&vᆭUKD 2 ;Xt&s)ۂ~. 8_ )&s`)/Ԯl``{$DC}Q/0n *+4mOۇ/A3/WF74@3ΣAg)3BvBx!~,>D.T-߳A 4`>*&7P(.FvT~o,sL<ۣJ&-+C+mӇjRi]ү> 3(a޳pM]Ś#cK_ӭXLZMkKі2lGН{Q£wMTkX.&c(<[Tr=՚$IkB;1;R~1dK9OQvy?݉܁w9l&X_tmוZK~Hc=aofӽhٻد4XoQ[pG??ebc]zE ͵ǀ\ > Ix (~vQ#+$("DVި` bV ʡ&!FӁCa|E p*F35 4H_8 z-``Ix8b"7:q"|!Cc;eN "p"-2p .GN twC58>E RZ `76MaN~}N}Y8/D2Aΐ@<@>CSDZH@(>~.@ iI_g%yP(-1k12/ HS^|+!}HBQ J-A9o2#d414`spK#P R1D FS@$S W 9p9bȅ2bGG&GO B*m(rzIˆ69#uQMHD1A?kh `yNwFQ9Lww7 Rmx0$h}і[N  ~< 4#ߦ M_y |6pQ$A@™><{ (b /!qCH"{?O]#+*nyCഷ\&m!0"{ :G_Ai(G{H> n !'} vHM'SA!VQ(P*}=roEA:eU[i?+`\20#X+ݐ.F_xHJiy,I}1(>u?n~+g)b(djڟtH?D2T$"BiVEJ[LJ2 UD8lnD@|oAN9ASP;J) #n 3!mOj}x 1TN"` Q$c:)aP@;JH j0 =L}}_*g1QE<[F?QjU])'o /댑1_!a-?7iU2 GCuJT1 e~>{XOe{ZE*oU<ݜ~-7VXþ~]e}۟Vo%4Hi d[a|/ }_ : gQpxh/@m_zCǹh^_ F!5 r蕆2-?ߘ{pi:wŴtTcn}OvQ2j:x-W'w XäR>@8n'/m ֩,Cqk}][S[+| tɌs4asWy5@@8^OQ~ǰNh@-O Mnת>{,ʬ 3A'1կceLvgvx+dCɤPa8z`I#j,PeұNYkWI̮|gYBL4rL)Òڜw[OgS:mH0c~o5_Lx)p\ݤHg>_mmZ)wB|6jE(NR0߷k~?lil6sbGn[i^8wW~ Gˆ Uklۻ- 6 Ϥ\-\4j|0e5=qow^ ǧ,XkX%9M#ɻT+pKx̫^l%q#-;cÒrk~:ٖX!0/xŔ!V*6̑|:nc{RZ]JpuU:aA\mIst>()Xw^iV6mۑq+4=nyUGkaӢܡNKh 9bY9F ɰg%ԞnIe<_K2v9ZBC^l§ %;cƒ8# 2;2gZ"M$js_'֥<^k)^A3c 2K6L)pP~ZAH/jjBZ}r4glrg)k~;b9.⃍*ۏ8VSjHV}荈z6], _d +nehǵX cV沾'r6{mtԾC~0LSmK>r͆uۡy LintC\9P3g-An7M5&+~m=|T/TDĹ^fY]b_˿?SǻiG"\?`aQ9ŏĢGe `t?Nw MH$A˻]g|n5hcA)P`@ T`efܥ96p^T::*U#kgq_9Hk4WȖkluFw$y{W/]¨lɸFYq{}^vH0/* *b.a#{*J܅4 EX{{hj=Ndj~&;HD*,^y !T6#Da.E7°RSi2:U:"VC#>\fk2,I M}"Kirn-6OjpOZH+Y#dE>@0GK?R;S;fj;^>P3]HGjUƵt_?Nܵ8.R9_za9߈OӤ j==h> (䘇Gr¼N̼ˎz@*.*}53ՍE z3cTCq~JGƙo.,iƺE Cy2@A%A$kM. =$Z85ZD1? w4!,NSN $Fls5};܍o2-q/tW/=*&3ؔa \[-s"ɯTpYGHN\'|NꌯԮ%[A?b (bˈmO D}ƫEJ6yXZр]2/e+M:n\eRIrr!1`"Ahځ^?"T53O6:IZsƖh3n E\c|:Xg98[ܶ~M(FQz^ښ+yuzPcf |BG-C!@яQ)K6;ٺqhQ=e 85p6PƚTgJ":6cr8Kft|{ oh>{&.KYsu3{XU ?-^ _08:su1>ju 3Tc=Ϝ+CL#(ߠ*h0],D"LNa:YA݈w{Ėkq=.׷|bAb}Wu4*ʼ~wγpŎ<п٨+͕nIiA]LcP &A"%]zmcd݀.N4m)&ClMgHDrFrqT42@ٙ 6f-[8WpJ'Tx)iM~ s8'M܊ތW`CY~ H~+.kcu+؛ E &}lGUe P3DoTSfntqV C&l\ G ܥ,OsY||U1IItjuҢ<`g* S¹wCz%h_ҎWר,VfaU<@2t4Ʋ2V2[mG ) îs0T RcYNw~@QQՋ{dP;m@+7r࣮'{+ug-)Xhb(x/ (3V9(.dIhm!7UJG5MF;גǴ=(*^IVV)/$`}(yX9"X0Ա1s.ZThe KÞsYZ@WX~a)] beZE̗6>Ig iNrkĒSo p+S[wp^LaR.[[X?uy9: 駼:)6z4R fUh;ds7-LOem_jUzCͤoJ((`8c-BeǮ-Gs+ۋފrɼSʢ;bδb,kD,b9Oةٔ6xmӼ\pԋFImVR,WdHbX ?:ll}@MiB eˬޕw.:v."ϰO=tԎ{a^ZC35auzՕՄ v1NZ| mHsE>Y_hQ^o"3Fs6yͭ;R+vtZ^NQb-3 u S* g^z@.hB k`;M$ۻ<:>AuCuLRa΀|T؄۷1)CyY&YAa ]JƁuEo3Hv` P/)t+xv;y >uf 6 M: :agDϛRP bcZv); ; ,?2sڋSeѯf¡ݰj}8@*1+b7~xu;w nvY1ՅGx&~hL]~h3$4̹eτU c2a<<R ӡ+- 6 n!5\rb{R&i xGxqJC/Pewr?vY3:WeӇCp%HH3w CmGoO +魡)jzGE ^ e(x*d !b|p3{"5)@ A)4 &%HW k+&/"~r"B^VJ\[5z؆w='Bo {>j԰!\tk >!ݒ&=mGI -3nx^x|h4G-] )h;C3;3!p{:wщ¡YA@/]]qS`si O @F*'9ohhda c¡\)[ycwC+J_B2;yݞu.ٚi5Ǭn5*K&$`q|5Xk<\jme PaȱJ샔"rSuS\Hk|E-6Zmo6l'&?a9mZʒ/>϶7-YE^[z[%c pM4 :hEAZ/H*\j`'_]:{)L+ cB4+ u>%oXn0=\bR&Dt)h|oS\H0}x#tgOD^[AojuX"hLE U:2 6gF>nn CLag2u"ô5#ݽAåͽ`|,5=^cbΕ'XKN٤y&bMBv\9PԈban`+U' MfgOւ !( O@ӞT8nQz@`0"u:UsfVL 3LJ{b}qŲw׻|-w)πN ص 1 x|,V'ԹJ2Pg }ufX ^v <(df')J>!k +Hh;fbt Z!tvX2ާݭ\"&4Z]ǼA+J*4DUB9 c bİ6Y=P=d"\`5|!a z]mrY) RNS7o&WZXۢ:wh@;p|.^ =,a Bd{; @tpd.%s (s`so2e,!gA؍Pд-2?@ tY"i ?Š:H vqu5@<"dfGgNPW UdxDY:ԯKidh'vąR̤O"?Ӧ=hck 0p}&)v@})ŰEN@#e&r!kAʉ UNH2̀@1 45b$7_bǑa*fZV5VN u\vxq鿍Gh/17F:`D!\:@ܪ㭧w_ߵ:~"# ! +vDS8*+3K]]]EWFO9@MɧP" ᎔|9F./cotXž8bx̅ەZ\5Q2赗LD/ڙ 7weA$!K1!Ļ# )F`&Aru?"!`՞aV<Ѫaǎ&q!ޑ6^RE7mEzl;I]jjwdusWc|}\_FqQBF9 :Fy=k/ #}Y@X3(imӓ.F:E $N!9^Ѵ<]=4'%m;^ܓ/fr˜s+)P=no#a0n&\4(|'-=Ff$_jq 8׊|$vckdIŗG٠C&2}Ur?Vޝ2}yc6]ܵU;g%۰3؟5 Pg= L pamw *VXP9NP z+}ئGqo,a2sDϗ勼P X <%o5So PfۛN}\)ʈ_q|u@WS^G2QY|9p~NǃIFgaWѼ;Y_JQf/<( ڟ;HoFNAxa+BCU{g=| #0Ŷn(lȐC<Ɂ0~[i&zlH`{\U_nofrW}Cز\NW0!#!䓂vi;k Nmh{~^9= Zm סNЦBcR)8#8 7SwODr+"Q$8JZGPzs3;{78ퟺqX#7Pv0x#u͆ v:ˇQgaR':|.hPJH"WX}] ?Gp;-< ǧ@^@+9qJZs Kz AVːv`,cx}|PcṪWGbFt ~JqrWpLd )` NsޡhU7_?g u8Xԛ6s`64XW!e>bMM!3Ma,nߒu^Ý+D%d_$MeocdE'bXkW::A3fN:BȩEwc0' ƣ)+D$.j!hۇ0BSDTP+KsSS0l,ns}7fzZw:k,’O\\k6VpaGhQP^<zqhj06s*? &A`l6lf]am"wT B&y$A9ǮD'ki?#O`^9q2+\v rb x=z,UQM.vjJmۏaJy }yQXCUP) a{Q< +Bツi;grG nbֱ=:́ {Eg$L7)Z9AĵaktxV S6omk\:!MdM5>8w\(ёnݐq#0E*gx"Ͷ}4Gi+>?Pͳ);6 Vy24Q:HUo]KBY ꄉ!-|xT4 Zm a|1ke~~{BKtbQ'XN#B1 H{nI< a4I#oo>HUQGͱ ~wVSo [e'kD!o]@S9%қVMh,D"M /+SH&url*WCNN(ٍ)ܖCkљUl3Jx`S?Y߇߫_>_pi?X;ĔIXo NSgCDt{M?46Qp%LgRFs T $zEr;6dțɑ~*.r?iMoXRezM4\̓g2=Zӟ'|#\(נy &N\i2 M(ټwӕW^ @[o4֛2׵mhL1UּΎ4$ gSf|9*ɴ;XX?3I!8)U Z#x9qAy m}ls+{ps AonA>QhT}5R)a+rԥe~V 6!_]ɏnVA~fŸ߅R(- c] j~byc\9˦ڰ` '*iqTrpX2s2(.wtB9^Ҭ؇"oZ *tvKAzW_"-/Xķ$DH e֮moWve|JA4KPzc C#q3 yk氓Q)Y}AZиs~ 1,D⮃5;o)bsNx;0OuINiJl% B$o;9ꠇa+ְAɂY&%9 x kq$$rqن;v^3X]ٕGqDZaҾ-#ad:#R)2őO.$=-0I==# R(_"K#S]O>mz2=lї-{ zU}SJlZps 53hG,a,Gp傧*i "O`PRb}wN |,8ʙñAo9~/*{jCܳXĽcm(KbK۸7^)n&GyM\}:4O7DEy=S?v _<Ӯ׮ӻ+ C1,'@\’@̀$ϼv#38Hg98 7hu)3lr SyU+U6̔]o9kwW)v8j˒v3懡F,81g>KG~M08=cMH_*P2`'*>y pQ?^b- v oq}`ڛ@hiд(oeVMpGQĸVqÁ6% 0@ S])8LKΘ(=q#M* 8aq+ice+2Fm{a*!1-`5\˴^‡<0jC{XIMxA|' 2]h0^9ެ9=@x+4߈f>*0sDOyy4&zck}CkPU !c 7O$Fh}`_,$G#oz%Oc?o_$r,"JX63G3osV:kc?/o65G,,8ps˅hՖv'佶CFtX7ķc;?yio<Ojζ)}-~kY)yu:|.xa^G#5u%}q}En:!o).Ҷp?!$` J_R[K_ȟO )dLh;jOt%Lv0mKs[]֠tqs[uHSg,LY)LM_}}|C-З÷@vyjauGϟ[kxCnNO:E%HSre;2$ÕT=pwZK '0]N9?!tn/NbjBٙ f4C4}l!zUz,_/Q{e'N!ef  x{L;qe2rCHN$YIJ aLR%ǿK p洫۠E2͌a&]7z)J:j*IN+Yzrc8?3M Z&Eq , ςX0VgCJ&^81f+Jhg{mWlԨ3cѱYfpn=xSfT} ]~)CYvX[6q<+Uz\ث~J딣â 9TDNmϕFNs.@zX.*_',9Ї wm;9 +BЛ6c%Ww5~zD2yF'$XW.~CM)7 N/`b4g!w>>k5OHk>_VirZ$_"SQM0l8^|הWXesX&]|1D<̨ mJnaNn?tzG8 3CW;.(15۠p{ushB\4lK8?2 =%*zj@ғ)To *P4`!{y?>zȰ7W3|KL0Rހ\wZdf{Ϛ] 10}@@?m4H,OOU&EU\pn0!OqP^q  jx\YV!Bo!`F$M5:AoMu-B~2'4 bt埮6 iALgH]x~-[N|3_HtFNWn[5opay|586/b4ApPD;"Z@-^PqTJ6nBWʟaqA\oBX{Sr$27]*n%=mlRS-, Ot5=? ;k^ €5La\ |b1/ɻms];Wx4JxF~i3]ӭ`]!B,WE'G^O.GR"'o]*)_x.QY˺ ׂo+]h],uS='俄vi3"Z4-ԫ55 șikN!=gYKC^rMK{dOF!\[_4#iW& A=o\hJ#55j; 5bmC]z#\-[SY`[Mx>(;9ç+!0^z.[wW5m0K:.Bz!hR[AR'+y[C 79œ2HȊɝw_UpFqgٿ,s즻>IR6!e \88 @ݻTײTPwGn\j`&gKv֕2ֺҪ! ` 6ŗNu/>Zz!zAopX7zm9褼ľ3BLᾊ Y+ɦ#KߕÂ%ug #B'L+u P3ѡYwVTѯ1r#7kW:XFX3A,cF2 AKa'k$lY$v_ąW .XsE6ս [HfUJ* a&9~|2[Aᄸ l1ٰ2[ېN?Vcr=7Ûcy8#h6lw84=%$W(UdBqmz,N^Ђr>娼rW/cc o5y&|mSyp: TI 0+=lon@ "Zc֯z;^:C]h+N;TPܖ wm,Q5||̠ĦOk6+u<>uPDUDCoS^VذH4R1Jg*NJi[ h5p_ٽ7" {bjjĆ' PUhôS f;heSa'5m@}yfyJF%:tj\ VaŃr{!Oc{u/~ylܨJ Έ~2?bti<H=,kDYc(G=!vV&hږOKxS| S9 f֑vҲ2YKƐ!z;studr(x>,\j8 еcSlNVqubJM  _7^zQOԆ8da̧nuKz6P{K*pHSccA H2 νf{ٱz8Dg+wǕ5L:iUJ>c؁chAEUuU9jM0Y@7=g挤6n;iJeAGeg&j/ޭ2baset7oϛHEimJoꈪzM1^(]) YSePɀқOP ϳTqL]E x+nksbt}qr`߼'&o|(1Xs+ts IFw՘ݡc$zUDb!nnÉoݙMT&*XoLGրnd2֝]^:t~!Kõݨڽ"^;hw:[h_SN~hܻ@(pޒ)iGzP~px^l>^>q J<ď k6_`q#IalLcMTK!Gq'. OlǪs ?RVEd`@,&?\K'OntT9Oș>8B=/ݮrաEmuQl0\]w\%>0_ha3#括 Q2#i:F[Yp|%EOQ+d;! ł29uUY# ?E mP3Zh:Sk(b:cAvڹ DfOҮ&Sj}sg.?FSlcwK k6W IXei)*si$}u[cG#N[,1t"Dz7nW6j{!C/?;>T?-`{rp(Œ~"TpE~k O\3#!NŚSU<|"C[~1(c7Q xRSϹBߧ'T| p8vF1 kjidݓ!aQ,eW7c䰐ڬ}a8=U1(>!qz|!XˇLk[fqCj¹:QH:Q|\= >낓yۑ>t :ɧT{fe2z$N<K0qsˑiVn!*vM+/u +Nٓpx{`bE\H@3zX"T#nOhmXoH˔5<&[ LjӬ A~MX!2? C۹3'3 hy"H,7GNkžU@('5 @btGt 4.InPb,XZyjXWw}1#HN"Ͳ/o!0:`STA#M@Њ>{.78x*x2Gi6kCvm\W|8b6jxZ}#dNqox4I2. =eʠ@^fƃZYFn=K=bai S2ߥw~}ݑ O rTlYMwlr`Coa0y3pN]AMYC5<]<8-t) d0u e;zɵDy7tA_OWo!jY{Z>,ID WK2Quyc6%O.#+M,=vܷ@ȵߋ;hb8m0K8,Śk.RNP9qIJN(ꟕgDw'S^ m쳥@O9RogF>>k~'F@P)j`Y=v0PL MJԥ|Q֦)2ywױ 4yIZX_I: X~ڎgYHոN1ejAQ RAf~NicQ{~9VeVO*{C@oxTn=cIf_Ċ q aTy\ TeF%C3M`(w𮪰TĠiAOy,g T#5N']?3~jC^E5 "`BdYWEhQUSlSB'ÁxSp_0A43Ў8/4|ɨRY8kv`'+d \n8ce,l3DS"֑EoMBh`3C5+Xvr.Y?=qu8ԯo>>d!ZF bh6r#m)gx\6C@)AgXw%VzVU/\%s+@rC#E dó~Z /c .q6luESHMU2mF0V<5Ief4@s{wU6{&+<M=2󫉧J U*s-|Sxg-onPG]Dew~yWUxQl$Y2I8^j]~W}(vL}3izHx/XOUƫri %SDm:w>O1U)Muxk6Rknx31 ٳq-:G-BTSҚ'n|s)v%o[_02C ڔr,1vXG3cyH]VÒ]a[YA&gᇻVE2gsʉF?Qݼ:3 =BN(nNILJ6o&F8;!Z=OdzFѱ!M%WeBWf5GW {ɕ| GYZeE6Y9w,W\f(V58zAzQ\P`@vz U>B?D 69ŭ{j%^@^O@os&:qJԨ!1]̚ ߃ ۱z%D~ۇ">kglO7WζI@U Nܗ.nir] ΀?Ԥv-N)Ca2[ F`ojtG7\;y,e{l cds үi˪BkQ$bpI_%hڎ1,\ȯZ!8e`ob{6jrϲ0c7_#wU!FN}B=~) mp?$'Fb -hk  ('U3b'T(AE_[ѡf?Z9G9z_&=xJ͇fES>9_o%c|rJb~à;ǁp>~%sP8oEId[LGA:~+WU ptC0Vtp)Nroz(bHĸx> OxJG/o~I{$"|"Q2-ٸTwPPß2;zgBYL iְb-# TgٗWfrǟi9SOɄZ%Lf',-P2-7!̇'PG@B ξ͐ J@i5D9WO=KM5"'` YZ~2_%}z xqTˢގQ>Uhgv3Y'I>lC ArѫE;>䂐͏"RW1NfFQ 5N^+m0t j_ܙ;M%?& P@(Yj$3Wx|#t"+7rg.rYi8+jXhsq;^:/Kea|B #=fy HlvzоB.=||&30sGcl`?[.aFֳtb—}O5ȏm^D5{hˊIsW+`;+Uq 0;WImKl fXBv#^,U?ԶR]D! T鞥C^Yz%Ȗbu՛QyEour@;!deLCaIѪ+a1ͮPwAzpKT"vՙWdڮhVۏndix5⋕H$rTG^ZK?.&Nu[IE\)pómV[pAq!xɟlM{("T4oz[h,guHRjH!R׋t'\ΦBKu!NatǠ4~{g._M9,Z'Je QSR%#N׸4~=P T^=se^ KuAT@@XDŚgClMK~ۃ1σbSLnD]#~gî+7NN009zHnnеb|pM! ^aϯSR8G5 UJta&\@ؠS!x.Ec$[6(:5NƂw^sHF퀟/yG6<'v=c8c{Rʺ҈,g,-6L\ME\Uqo^ >e;ZşLAf nϣWiʬ sU+ 8@6^[nW=@{nޟLoQnv{}1Lsċ҃pk niiI:|y)"T;xGI~Rfo5 /8LW68fbTf e|9bEQ M=\XQ _aوZ܌Cun_8v vN"ԋ`>^d1w]kۃ z=o8N22ldv%?HOyay_Ѽ?LE Ua!=/ *@h&78TE*v]b\7`^? 86G%c57´2}d'76eF=]z,5d~ *&؈vo]d&ȁ軜ImDP{l4׆}3 Yjѵ'a31 g\{*\p{:o}O~Ph ѹw/{'Ok9>DK㊦| X,ܓ'%ԃ35zf) vT)c{jNK{fn@ d+'^NΗ(Ź6~6Ɠ?r4q#g[v5d,+b!a*/K>`9}RAڪ;0xtD|{:(rF4_LryFh9S?맓M/Wtq^8lc(WK.~5-4#'Җ/hD_X Yu1֋]¿&qUҍgJiޙ;ܚX қT81*F%mf~AX`@tj Y~@ӧS{1/1,ڤgéw@s2O c7 @x*\/.2ඦ5S181> bh6vзa*en\9 ?TF~mQ)o|c/udC",ê$[bC(af]E&9AV #j pQzY[R7 zN5_XRe2wPCoF퇶?8}_rk5W h1c=;rrAn /"rʐ~Xs<2w{ڜa~P -Fz$Oo.l{3v y{T90)F͢Xeɜtu %A[_33Pkg*b6w~3?8ޥr~ȭbIt M媨WWj|/x¢eZ=ށ#=1[ȑUX̝]Wy"uħH>MhtdL Y9#,&5py}1]ʎtGg΅ߤlsnbWOjz\p6*ک!6[*F2S=wc'_=&ۉ;sdui}mImmLWHtN41q盒sJ 4RNx4'3c;jT!o1%En*5AvT.Sϕd=}^]>/z$g?fI}wU' Q3v";ɹG|\g7sg x٤k7pfV=3cd[|QǠD K Yv=q\vyWpC(ζ4~V^''7u~7/,}ߍG{n7p*$;ǖ-Q #@ #`}ԭ^E58l;Z B_uوdPoqc~%=/#s7MgLuiޭYͩUըk\iz`̷=EFHIÿc3N4 =W_' (V;Xlv8 Rkne;y,YEv-w&:6|vyyH:V' m]cޭ<9/iѱzqsbf \nXD);i:9YoUa}я<0QnKs-s`(F־'|Lw\#\w ^.%M+blY }<T(s.iyޯd?,xa\-o]Ǖu-]?3$/Ч0wA嵵Zd[oOq$L#{kEt6;&}7@KÕ< =[c!4"t|Q}]lDzˍ9`Fo[=b<Є@?{ٮc*#n.ڜj||Mȡnr ǰF5oz,9dw 'O k˨-׊//p8m{Aw &j~K7, }Ũn.YsTk#cJүH}z@dF* QJau{^*I)jTowR ,Qnzv#:0# kED`Lף; ڒUfpegx3:n{wȍI<ˁZZPf" F3^цGzr/wf?ǤS暶,3уv/H6ߴm8`C[15hR =r ucbv7uG!^[jY26e,q7+X 뇪uGOkK.1:9#Zs[C B iKAI] P®23Jobfջ@-ȴקA g0(]qJc -}d?rbmȎ G3]=z*KBGswMbg~4dY@'l*eq H"uW{s)WPŐO%WQ3b(ScG|eT(U $C2ʧEڟ0UgF(lF%K!Q ~aa2*ƿJ"*PFpjA1@_{Ia|$`*cIT(7U?_x&A)JRqm?T>Q#D~*??OJn\Pb**џ>IQٷ qoVkmZ_y"RȺſ> TXqbA\_ `*)bTFUfg om꧃> +?e>CBG<W/g? nӏ8j.ICZ[XThhZ!Z$~vl-w ;>E _>9SI ~9S~_ AAtIEhNʉ~ QpgMxH FDC,~+B7u#(l;"+` 􁟌+4<ɨfoa6mBX?t4PEs-3'dvUcEhV7f隰=4k!N[gl;.e2frx,^\z8]G{C~sB|L 7z ?L~gF2Ӓp 7>0'}rJ]:T], La9[H> J߹q硫{QLGwl{P}c xeKQ7휳c{/W AS7ys kiQt(agֳ]pFfuf1sUB]ܢ'߯ܩ=Y;n[x1ܳT.9PP3Q. iZ´gsd60^̂tOAiqGEU"gKh>~€ȳJRWxK  I P;X8v<v? ՜]kVJ Ș.@eV& $2c=ؓK c`ͭ|1{yG6\B`eiTC1:j_XVYb;q~ct Yz1k&YvSVP{#%`nN&$.a F;&~S VepHɇ,S;C9oy?\R)o+C$e5])8W pwp.~Ŭv-RN\xq^|A.\Ctvp="~ꩿuFl j ri8>Щzos<\MxHQl6Ѧ{:='J1 XU@MFkֱL.񁲮ϡו>ەjf8D:Q^kʁ`+Gї2yGʎ Ī &¡Ysp Y$b%rgӕœ^Bi绫t<&26m)Ae?bƍV~c.OlCH]qdt $ҁ0̲ᘅPA(ӀmW\+ Q?|sY}uS@L˅#8>pI9##w 'LM82Nq@]U{- G_±>X``N2uܺԧros?f,.g4.[_Іybwɢуu$V9۶)Dh@ };ٛ=(|iN"G%8=-$)mST5$PHz0ous쇖ӹr{})]]E|d4^/0 D"CY}.=EyUJ Ms1LiN?Wh}BI!uZ8hp; 1ihM1}TbuL}Q2xhkWF*ڡ. ځFA+?7g' )4f+3JWA2BJ`E(U'=& \]/[, 3$WpNŷVҹ^ͥcgbfӂy`0WZ/40Oqq2;Sֻ؊vpcͽG8Br-I,|hxLnH8*Ԡ1w ~UK{ [pf][m%-|{Xp@s5ӝr6inL}]̷bþC/ئ ξ:GO&5WҲ`Dρ!ȿלq 56RfM"BCQ҅3Q-Rvo[*C}%y' 4(9Q%T< CUdm>S9;;$f[DiV0G3טSb g_K̨X%_u6s)8P5bs)B  QಘBvtCծ'\Z gGU WY+ `7378|X'kGa9T 29FvAxSR(µ:?Y԰ 9 mM lm~-}DJs U'X?GH@/`mjl1ؽf̖>={1C?` iggjzV@>xeKnP&Om@pܺZ9eTֶ!Q|e \  T\Ѩ6ŏ-[6b)ԋ'k:w)-1Xqu_ OII6ezU^7zλiXJa(7*_+./p%Ҡ qrK((SB3ړ`t& `8`>Ӯ`.$t@@8w`xٓkU*| G7|N/xZgk[y6׿"tPtiaoLvb ag4~`y~ȧ sRx>{#.x@ƁO'm|=NąP3ЋF^_K-{+%̮7VS}60 ir{juWA8x=#Tz i@ ǎ6pvKFRv[܂7".+x4 [=e‹]E.A eqLL"QXc9ed:'rA豺H@pG5qHf\%~>\ewdܔZzp~V.26vyX-Y[ 4Axlh1F<-?iM&W 8*t ǮԵI:Ooj5>P? d doy 038b Bxb{S 5 ?G!R==o|ЗV5z6Pj UȺik]{F4Ө ?4pRE;~ypMy l[r[J.M/vA}Ju+ gBVeR*$/ƭjd,y(M-ROgNO+3cf7Cg]tdj2gqU^c*y@`! щ̵_,>W.g@ άI V^W,ˎbZHΚ\u sAdmdZW#GpW3Q 1U(9!#Qh_:v(sFO4ķ޽tL}VH[uC'e%>)ԟCmۘN_v~@0}.3_#>mʱW6fHLmHE5E9<3;Uum䪁 l\<|R+J9xN3!$N\Zx3HQ@0Rin z/!$Ot{m>f7ȑţOzG[U^𴌀>ؓaX᪜虿-,86;I[lE4'[d-tiQk]$m<13?cjp7JPO7op,jHbb @ OrnpǰV1%fs՘p+osYLe;LL(k]*p˶ӿp,@hN~ʁm䀛;$mq$H)c9apD؍Cރ zڦUe6/`ӳZ,2;ώ{V_JQn dDM`/2*V]߶bRXT(xy&t;&k̋# FW R `cn~|7z;U4AW)l$Pa(p5o0Yާ;C@"M,2 %Aqڻjk Q~vZHv:>`7@@ \nKƱꢫܱ@1f$p(P #Fr4ivXTMl7+rGEgⵟ5$Cvx%?To|'Pࡡ ]WDHqaȌv(Z}unmZA{ĕ1Nu=>;uy_ӳ#iihC9Ac9W*`G` ߉哃K$HkSJcQJ iXʊ$Pti:t o5ؖ_o`̗';IR(gΡ1ȞT: H{p$@N\[IIMjh5`N͢Wd7?=|iLd9"'egi<xj4t LPy=]}3,F]i {NbZ ?vp4(3[ bAVB4AeA, WQHOU9 gW=KOȕ^D#",W}+Еq~XOJ{"!A鞱a!*k_cykZᛠ.p(Z($(f쎳nӧ]gM Wʡ>h GM4x@b&@VR5x;7)HgLaQͦrt\L&N>B_J=-e A9~(V_蓙7gKiIhe7@kTi4!6z87jVmSbvv I߿xsxB~N͞/(/=,Yx*'A/D;Mm9('q \|C$gF:Y?[xڴ/8*3O|` Q{gH;Lsg>;.ϤB;PIDY LHǪJ(K"[z?n;\=}OڙK٨;JSUcp+;[Y:uech|XRCt!PXinp#oY{≕+,T@ L33]Dϟ4eh3ʌMtUWH (-wQ}9/B!Pe=˦+Ȥk]*ͧ`nT1Y"/Ll\4bLJ&"t틾gG͡휠ؔ'Yt mJ:sP8Nw7+.hQxgKceȩE‚&l P[OSY6r$r!}ٯ~w/sRIM@x.EҼsZqAQQ+"}n@ 5eƈvF8A'd[[)|H"(-}Hcys32 2g+ TGx.ŏ(PRˏ-L}c u#lfhz" ؐlz`V,ǵbZ0x^flmgx1]s^#`)Ksi'rˠ̜3tY^Qq֐ovLE'#wI? cGڇM$=F}+vXh3{&P obx}!2X[:D(d=!5n{cFr-̔U BZs?-r͚L]G?5g'@>sg]@VM4Nzu&+ BW󡇢ho b pIS}I]hWթJ1-D)S"ByL;Vjl䴖J|"̚D}K\qˢ~=Lqf!nJX?x}ɷ^7PDdhppJP2B_e{P+<_J0<5:2ҏ0()uCM HDq6d<'^<dpB<@ZX sK@`ׇ 6q-~h6ڗ詌n ]u{fLXY ݽSMMW =c⎦'ħ{zS/%b VX ̽{O?;쐹Qw/ܖn&07j\&\8:;&  F?{/t kcVc΢ ;CT8ǀL*Km406@tA! [:cub|_C|}|]3 #/C &փ x$ P*Wζ?5v mۊ>x ĉhjzZZJ[PwnB\,As\a:BT2DOo|g:"?~'4:F'2qձ3GPY'Jn]tBs9DGrq w|<&7hw ~G]#KJ =u1chБ,z FgED.c' I-?q'k38zyhwuO IUi6Ce3tmeeᔺwŧ[z[Yu-%ܡQO=GuWt:!43>3T/#/j-eta r4nv 參U#^ADO 2oŬ59+uKcYT À9"-G[-1ox6\,C} 5Z\-hfM[;ʹǖ[Ce̔%pTuHrBP&pO3T݀i@9qd`5(G)Q[)GDPbܻF?Xty){̓MH%W8خNf;?~pHS''?dcBZ2RGx/nJ?4rBhUt\-?%ۊ[6Qƾ `s/:(9s4狞vL  =t_t FVIy TeU lfǨ>?lEfU UtDXq*F@SMIrAul6o4 R3ԣ(ZG$buK>'i9je;~!c`FW\?&1uхS LPb7\B5:prD/RMw={nVXE_9c>.܌]B6=Th6 G,XS{pۻbmW^<~kY[%q' X[I򋫸 Dř졗%/UE6' 5t}ы2 yH!ݏeAζU~:[ 8'*s;٦4 O( 8]cBTq!LbMW Dc|HA$UjnB>S-&c׶!2JdI$9cڵNa1by0ܥHnKa)b0ܤ4-Ξ#WwN2:JN.IDc&üM \V2`9yl)]+9Ir{ .3",(xr L׸,G. D[3A8rYBގ7 f :GK>"d\6E߯I=*yZjh hxr [>Clg' aeW*P:& _Qlh4IEzH ک51յ}Sbl J3#kcK 1m 3SkH`7͘3ϊV S9FBG9<,l.pjÁEOyQI/` 7cv1dF/ɶQ:IgHʥCf s՘IdǛ˸ ƧX_M=vS-w (/=N7 7- ]mcj^+Bw*$J?KV] :6tf3Tpèҁ58]? &0W&*p5X@ލg@H3K8< L%+ΛjqW |% I rVqo<!Iu N_?A"D 1`&3ܐ ^bñWؾ>;rgΙksFIp`u i6MCfŧg陽†őF{3Xt"8ZJ?u*ӣg;od8Q~9pJ/24a_2NpIo:| WEPHw{ m%JT5Cj{f<wnMqrÝ2 H\d]g*v)yHpbO6>k6||nJ5vnrF=3oR@زH[pnTp cl^* guF1L%z%?c- (Ȥzg#pk gSrK XF7yl\Ӱ1B> zj<+X!4'* YٕOA(͆!uNz Wur7)-^ Ɲ:˫d\o"疟vL&n9cHB6i L̋Tl%xES]^а(H *ӷqẓmP_!K#[lezKg^ߞlzQۃ-ƞ #) k!hFA퐴8_E5~.go T P-[Ejƅ vg#Z߯)w0v6 .KDd}yHCXe}tOA6Evp"83mmcۃ9<܅ 4RK*O0!ڷ#nb߻\= łwM bxy`w:H泆xF-~K0#a aƁ!QvYEcmc#qr,F.}HT+KΜsP0 _3R؋R L[=:]`>Kgb 5y_OYD]OVrvya q}؇_ {5S S8|JwyM+a:FV=+uv 7}$JX_y@0CsV^K_Ń*HICJٸD984661׻&t=pqzVBY\lOIwd+~)"EZ/@WɊX5A2b:N4LL*a-"T1ۇ n.77`>LIńT8Eqpo/i“o5ᛎ |̲4t3yUJ(b> Dg55ҸollǏ8JC8 /p>!D\j~!%GGVŹ%NaIqUP!bӃ(A1fЉ1SC3^g~3^G6uU#Ղg# 묆kK 4x7<$J5\<4LAgBN.Eh u! AHYLa.{M+o.<Ld HD29"L|B1upL qf`Z$]{DAiX us;uHtN6r=mZM?߼MzWpT;k% RpeV`Zw24DµJ=R < ZC )7 9Srл⪥ nDaaTT !TR H/iv+. /9+v%y/4tdSÈo ]o Qҷ|I]Vh{܌1C:b֕l&g1qL NIԝ ena,%Pؐ+@dLB<b}ùXH0%/_3M8 R b2/?3))y$-ʽa҅t2 M{RNҧ_p1,ӟ%v3m*Ts6 Q4$&NZ&|Ho ,m m,=UfQ @6 y6mA3_SLy.*ù{w!K,"'㢋\9>Ⱥ}.!l_qyr4Nn?5 (gwcɗ7޺Be;墺^_yA R|FwT+2A^[JTj}Sn!_j&htyO- $gOEʀs)%5ſԀQ,4mgB D#e( aɂ_ [$y  J]`/=1%g;<˄UyJRLI$Cb\ܹΕl:+'WaܯIظ',vcƭtnMWtuW='B1 MEeedOZ&]Ag 4v8|.0G62Ff;\ ys6ShB4/V t_kO5sm+{ >[@+5ZJ|, cɂD6qo\GϢv8;>5Y6 9Q)rݞoK׈3#LKgYddz+#sz]6ΐ9$wPB^mU[UhᵴtB4N\N3kO=66߈R%sGt>ȵ7Iׇ:ɯ-^Y,Z"%!*{$[|g PWc lbW=Lħ(micnR&\ȱ"*bEw?.lguR=Q.6'M`{渆T*1 fѨOD"uGCilEdv~7=n(m.fsҘw ̕fi{lrKp!lqleWq kJ;цuiomka\ ȰG-T_=(,F?l 5/Uv7wIZ-)ݐ5LCFWjZLmJ sA79.+`QiQhtcā6~A˅CXNGyRG/@$~̰Xa=8oCTyx3 1nmwuPPoչR qC? o\zW\Zd '$ uM $uۑGGcn =$#* ^O7 >%@ h{j1n%S6+u5Z 'a0Y)2T(qZi ϺY½NErI?C37bH=e^71|‹vd`5YT6([! EzmS Ƀ2q2zʭ`ݡeF W$rՐ. 'w⪠v'tWl`r!Ta30L@ɧ0:$H[丄7M;d -+N ,7rHA!N]>dv m,~o?#[1nLc;#9[79,2m}Lw3'SJcfgN:.K6Y @[\FVʦnm[ۑ{Q_+,/F0[:1VQzIvjkN{> #I>qף_3IԠA>^ꇨ\JCgp|:@9BDzHCƲ-nЌtdfٟV&&_c̼p&$1)mo9K4 訂1_pg&A%)Gz3n-ϾkLݔdGDSAV~;s;=i"p {hd*DŽ{cʈ)5D-x^ʜ5Bk#)R4qbp QюH+ gܿ+cL#ăe_# e??Ew,&;:Y&92,Ξx %;l@;a)@u[F Dxh{I<)ܕky CPQ"-PnS V瀪U(eE{tnd4+ :(a _<,H\A+^u׬p3}>%"|4N4첵ܥT4#8ҙ/1 NY 5B; Fz3p%Լ`h]AYe=A|-Mu:s8G%|xд=X.l$ &-0͎ 3ވ [ixw.{F D7NZ2O2>ȹ2~Y mA[9C.zߒwx)0) HNS ^l+zZgpbd lڡP!ni$Y@_LΌ=U\CO!ʙⷞB 5?Wy^`?f{H2)IȑWjOP(%c%>q. { ,tE(V$h83 3\'` *E~ M5LljޮFtBc O9 !!C#'~jҟXŶnaY,0J,G+W;`T{Ip w,DLe[1q݄.atmRj|OAzi>\ˈ4"v8?!k(4Hp-],fʈá|gTN=4 1i3 ƧSlWh%ڮWf IJPQ2OJv ]&'0ؙގ1v/2Cd׫BBB9L򶣗AJ.6DK f$k\wQsIm,-~caRIyIlqp[}=%î< VuzG%œ9,L#'IJg@fg#iBޤdc3f\"ɲUΡ5*5` #$s']t0;wz[ ac8=2jؕIgD 7y}XGǵۅ 89 ^B6xE>8X[qoO~ h>LfuEp1OH!`j4c(4!,0~~%ll[tnl<%iw23. q>#me?\7qʳ$y@, r7hCtlx" ^ B*:F3 Z8U`n"%):s,`cp{X^<ABFxn/BGzOs0rAܷ k6~t [&+| ;V[= 't.{ڈ&$5GJ3 kp $HajbeZ#rľnN4,f w,2`G>t`֞kl!^3}/6*s틭+m.0Ork cQhۏmLC1b&8~IP kOLo@Vt~9JHy\sIcҜ{ݖ>lq$ZWyښׯKTTz:]~ֻ0( ]7|nm>? r v;5~>~(ܲ:JIb'A~Z?dD<0>^k0}S%ODsExzj~[֑/}}Jf1\Kkt_w`>l$+NOOYğ~Q3}9w%~Ogm;F_ ?we>DY%}9<[%IZ|ʽhHQn4p}b5c'=LÞ&nEr+!r) /_Wg21.ǩl%K/DCp3Y.ʻGCc+KTffeO,o=+gp i/ڀWT{} ψ~^6  P.w(.; %( n-gVR9JM3' _Hta-!`A!&i,yF6J<-...ĊG9|7W j =w'0vK1QY֫H.}˿ʚ è٥{[t/!\j8J7jNu*z4P#F~[ oCT6t7#N"WLrڸ{?ccJ:%)0ݶdX?+CI @)Yx:R*pIxy ]$!h4'&w#30ȝ^JMNT>\)=-r|Z7-R74#digW +d q6ubyVF-[UtgdnP2luxP"^MuWKr"-Eƈ EOn ~:Ui_#'![UR^W)%3 p[TV!~l>j\yN\hFB&k.Lm9Y|`'jҨ~Q+vk@(( (½}"{-w<߹)PSFƯj u4/nNNNvaXl}8$E5]Ί'4o RD< I6uX*9M#u*!Mr!xF;Hpi[%}h33xi[lFُ7StCb`j~zp]n'WVYHցZꐎnT<`4ԝ "~Ӵ!ĘbJXsj@Ӟ"3Kj9Y6Z/t8Fzpٜ-bWd?n"rgyG0 qǁmwW -)1U,x^ҡnZIѕ.v&a0+"J&begrp;B-R`*\NFr2^ȭbqRƩs qσF]̍z]<״bd{ƛ9ʬ-1-ާ`~z|zpڝ8b42* fvMa5To8r׶hS.6b&ag49CFpnhݰ ;3 _§jJp XP" 4[ /P#6=tf)0NNEdǫ{<)L9UYخAbS1dSc ezq>GJE>lɝ?˜Y&Gͣ1w҃˘q *g'5# hfނ5Dl{YE %/cgCXWtҋ 'lQ).R%Rv?L53wpETDQ4MKiWK|m(H,WE/ pR5at,ͨtNHY˻!FT\)vzc{x-Ǫ[uuac'7HW z4&AGs/3D8=['t[MSP4Je3!3쌷$8v=8P5pYuϗ[&YcyOy1~/SPbҥw&Qڄp!+aH# \F*>* (= L^@Dj0+ԙص+Ȱb|琀ʍcm^5XY9HI=^`OSMNc_WX h5u7v n@jaleJe"+10u ~YA)嶀c+X i@IW7]+΀6 }l(J?܇/K͒>Czt MmFC*vGl즚TY%R ݃yq9eNRn\ Lm$8I{@e J (Pd'<"W+ԐGq6p>0CoSsݷɦ5ZV#ڸA%Qw^. HwfA B ƫ(f>i _L[%]`x)T4/DOIzOk 8-26[-[Hd\46M(*.Va|mrdҞ˼C5-Iv |P);E)'Ph%]j虚]jؚA6g@[D­E/%Hݛ%5V1! ߅j GqZ:4|z-3s^1q$ihusAFvPOR1tS>ʇ.)#'NTw}xw Jt*³c1 <6WBQ1yA DDVΘ[U$Ցfa`FPyƙ7Lfd>Rͨ~ЛWh=XfF-)-yz{m3OSUV'i\?T/I"Pa0K?{ɭG/wbA4{‘- s:Zިpk`-],ڲ'Z߁h%2g2Zk1RvfaF#vLяH|:[(V6Nl%CF nK/*EqM}*X' {qQ `B M$ҶLbD)-l%G8>Mu GuڞLqXne'NM%h0GYiu?LJ$zt_/<3=Q,d6HzQs÷kyYV GJ6'W5"d.Z3жW7E6JۈbO歠0:GҸ+\H穀7:ӧH-PE{NYc  Z2D턋 ,Bj߳yS + F]xOyԁJ{ V|fD߬HV>۟X1_kמxY)PoH=?c;]AayEEwPw[ʀER?&e|=xtğ0v#D5>vf2+Noe9IUKKXQ&KAH )Ǿ#qI Z)+ SVwG"y4TC;MD5|"\Ye,/ydV>0n!ncsyyQV ?G?DAC5>o'Vd6iC[yhM%"jl 5mhaN0Lr[4Г ./#lGG>%!6?cv|X>UwB! :FP yLf-H!B WH!ۅMv2V!?ya 77@+a?-힔-C)beC;߷_Xg+ Q 0U~G[]h0;+(Za>+ft̠ztrͰJWipt6F Ml}3:_wܵf۽>qM`Lr"GTKNtJЬtD9&1%\ܬ@\B$)QOܓ>Mi7`bڀ Aݴd ry mqwp };*#P-v|w7_v撆#0gOܭOWa?7ɾ$CRљ}c b,ۛ&kAm|WӇ 3+MNG]ȳ wo^luLln|"qJLC2ùwѻ 冋 C_hNDs[ryu+&!"6uҵ[9ܟ*P 6yȈW 1h>a71{H|ʾ7.(L :_ʚ=)v!d,$6Ŭ^F\@3ͅ^(& ^2ZϞʼϿ.Nޖr_71weܙ[?{ YIF3 qj>O+eb2E9$cs2t$1+D"yi#SgE ~0 ShE1wɸpDdjBA0!. G pͩub~3sh]=~zR 3Azlr4PKp.F2>~ AI U#{O#ioeCbY$I=W0Jb͟NvsP;? Zи\[N1Cu?0e;hf0S+ч=XRA<01ݖ$3fauF ɂõ6:K1Srt_NE4)^ fOQ-FDGT'N[:BW7sX.R߫{c힅4LwiXVzx:Qtĕ^oO T 3K , MwsaRB7$qnO=*.VE vVsY5[B^WN,PdžaO,LOuzDuQ>mAC-!Y#Hy7'fƍ|:u10#X$IXJĺ!ܵ4iy`ė}'[ ǎd:J?*֋Yj_`la<@8+K{,2Iq:%~pA8!P0h"?i/،N l:LȈs,Z %(͂a=+lc"dPGnވJWqDll'-IgC# HV/Әނ)fN(_1RXCBNw6kVbN&’uj~i, [u&[w⋘#lm>-x7j9@ >Kl4';l66g4%wmwOW! 5~G~<hh_gN@Q&ٯo30ϺmW_*P*.ΏZ]0dN rU2?>u\V2nR#IOtzzAgkhoh&f9)Nr[5L?ّAg 6OAU@5zE';Tx͔ǿ= Vv҇!$&u5tAXԲG/v6G,p\(Gz<^sZW`|1>M>-b% b`iTu:Ƒ3@9Xl(,-aZ爖I8)ŲV _Bn?QA%fP۶W$hT}(;ٱV-q@TMeG,3Pk+ӌSS4\Fl dg2v_t*ݿ u;:mrx߈e-m24)ImqYWժy:cDk_$ˍE u37.]c-ƨ}V8WEhm$e̦]BOɴ5nn0~ɎGZwqȑnT&n¡ي7ئd$00L4+k]Ҳ~7pEٍgoZg0F@WVĚqV?ȽExT*T MI[TIix^%Tţ}N-Ih NC+h z0?=4cf|=˞&`XlرMt_rl~? V!%LGE<q֍qΩS>TuSyWQX/:5RI6e/l,ygaovcyL3&() i+Ĕ$Xډ/ ]KE/. aԴ֫.{/X cVNt[Nۏ6.5/B񃊞$ *kwb@|n~?YWG>$fgmB|!g LCQeBe^]h,Ұ !M!GhA @MC t ՀĦ߿%>0J>/ ԈqѶrpS z ow6q":upn6>둖i/ӷIK[=0LmR01tK4Z~|L6COO^YSf 0o`Fgq9*h?9CϤd mC'и!{T+ي(VmqAJEA̐JDm-C%V6ttTљ{Nej|!x.  R}ETsSŏWH'rQ, Wc1|bqӖP9|Gy"ZqBS; ff̞^%Jf~%@o~Cl`&w a@@,2uFU^:֖?KE:ctf-. 9F\>HWI!r D3wDR+MEWX_Ʉ_˴&ᡏI"3y{DZ ru$'Bb3KgϮa||9v:Uصk_UӕqBĠ؝W6g~vN~cl\\tN~B7_`_Xl|3{ݼzQ#%\q~,WkYR[Gpu-Ϭmw+iV8KF^ω;q9\}I.eg#,(uÖUՀu,wf{4th]PCs[`u:9'Pqk3pv~DngHO9>foCjs[s Tosv9cj:?N}3m.iua&e[ǫq4wil~-=Ы`l@\BޚV*vzasbZ!j| 郃Oh8cQ>"H8x|۸d|٧RZ<ؒm]K&n|^8o[f"#vd3^·y9v}HۂRWf9E7X8 =ef}o{}(nնJwnź|bҏZq>FGngUGA0p7R[ǀW Ïk} BM8ݩ[Ƚ8m<1_Li5'XwQ-0 Y§XXaLXHX_ݯNg}L8=L{3ʁ+%`w0ʂVQM'4lχoߏͯ7^cM7Z{#3<ۙbHC{SsxV̥shwb\:3,FճùΉ&cհ=v=^/֓bI}[֢ `*\ Znen ,LxTc7Shnf&Xb4@V2l/\+D,YQvvl([r$lCby/|c˙ora<*Ib[η5P!s,\uY\&H -܎pϼ? g2IgeXpԍlniԙxCڡ\<4Jz}[Zj-h/ɥU%E{@U7Hyv%@p[r){ma9X GZo1gw!$vļ"nټ֡3l}3Owwa|:]f57T."2oN}a!A "҅|\K[7erq94iy;XvKz|q>_Zx$l;^҃KjFnn5Bbe7{1I`/ \{?|W-;U읳ћ4xabĥ/P־ qjmڰ=߷9_[a}v I|G-=A 1A8ieLFD#1L${ ԺBN$[?0M,NELjsbml4>wcB|eKv2 v˖+ ݋22> Aljw[]쾃.;H7o94\ؑ0CA8y*\mw}N_}f[ _hCe$(d'IHm+r3 KT%qV9>ɩݸ$zEƕx<-?#}_Fjrynr_wC.bs Ybl03:YmSzڞz|i.~}[f\dOU8 53/o»Sa׹o 5ԕRpӣ]^?Ρ#2z&L!Sub=SL6Cu-[ch[8Bc4d 1ju4FUM.Lyvq8] L}c]@ wgt>MljpaF-5|+dE9۽˾f_@i[L;gsrù ANV~:嘌3SY%k7mu.Nei[YӘsYrP9`)t症R7h^mTjSSեmk_^uڔ*ꗭl4n4>{yZY®D']l][5e{F5oeٮ+qR?oֳEwj/Pи|jճN< .[ ۊ`^~ٸ;/o֛-߄kurWjrv:.>Ly? gY@ &_JsUVЊS}2k/W=8w2ƽKīm.9JV+%GTjz迦fS]_SMWukS}so_S~~*: |3r 6~}J ŏjsD(\̚?yL"[ft+RSg]S}-4ݘ*D+2bWD +.v9_@r?6:WL*"p0ӆsPuq0f뗢?׆%̦҆h$/Uhnr{&6rb}o7w͊zB ~QZ.m;OYipG_UƤndwbU_LׯtYG1}g"xkN=n*}7i_^мhڍ_˿Nq·+`ʬ9ZslcNA`&'ƻ?sqGf9$L].oZ^} ALBdT4iD!JB[.p]5O d҈qF"v)E^zr4 n0AqRvb4qBpЅ 8=z4)hF@wK EanЊm'Nȁhk~ 9F1 (܁,= 8ҸQq(Ԍiu艋d -2 twAGF'"&|i4m@O5^nz)D~̽e*"Tbfǐ% ͱbEkioX0 esSey .Y!S MߤtcrXRzQF%Yͩ/]sLr0;F-B lfS̜P#䖟 mgpc-n]m|]n;aGG GǸf;74aL#h/%:Ϗ<U C6q2*FCȳm(Hiv0=lQQb0EN 13/ihu+ !DQ\h2a):59UTKbC31ݔZ*JK sw}D_hj?. \ 1J:MÅ S,LK.,n 6z@}jiik~YgP%HMnp<)9L/*sЁbOЄϱ̐Ў&X0Sdxaeܕp? 1Pa`6X.A!7"$(̢Ya31jN =FM̔! umK2SL5Γy2,7ԘzLÈS>0ĺ( M+Aa"Pt }L/ @!#xgRA220\4԰&V2DbO M4 "oQ1>:b 4BL5, N>JI) % neCb46kymڎxf VmYG;7rI1\øtB AEgF| AA=[o_kfG#65_~(Q˯#0 INmr*GY*#cI{u?*h|ѯ_ȱry #UW=RK-8N\¥Gw#EHA.Lz5 .P!:=,1ʄr_{dCC++.Ah(oƿKCR5 Bw;w_;b6֢^&)u&Fө(QC6 ʢH?u`"Kc2}BaJhI';h`":RU?y$k IGAHyzD3 ?"f~8%@)5fT@Njz$f{fLTmB4'`ev鋥R Diq4cx0^L+42G $ "ueJ`Hfx}dhģ^ROS"Oިpʄ;X/,e@{EVJ29%B4U]ݖ*WrNkV=מ{a7x EI{Tva.Q%B{O8$7cqR~%KOA:6ԯ6I}ܨu8]tљj.2i( ztˏr5[ 4gek8x9 nrR 8^‰n)ωUzJgf )=zEfشǂ`oBzx.r{F]"A1.8 h*\EhP'>K pN_jWQzRN%zR\)xKJS\˒.pȊOt2>ZojÏ@h}H%^|AL̎P%sț9,ԣYUD&+QOĝITj55" ];$ ȦLI+.9Z<  3l#H3Ɋ:@r56+Lac*ٺJLƒ8HjėfW$9Gxw39Z 4P=N*)'+c/Hx0|-ԈPƒL|mNCϺ1 Lձ"loʏr (J(* D ula+= M.?ɕ!H^'2$gEM"o-ojt}%d}@L!/'5qdH"`O6Yg_ m 9 fK@s_w1f !i0JO'o"[n .Yd R/Z !%mF-+= k?Xu#79Ob @nG$LJtwOZI 9n  8&#P"1ZS~%-?!F̏5S+#<S"L0Ea@Rl@XܫMIP]@Of2QG˻&jE?8!0C32*2c@0wԽHmI#-C$^ȋXP9S|^}J5ghSFVRV00=y]KWXEF KY hG,O|IV.yؖKs'rcbOMHYaq^"R+YC.bw87m ~XxhVRy ȿ{Y?C?~^EW7MrYH {^[E?La6-L@L ihaa4b; 1RxPCNV} b%XV?1JT30lt2H,WaP +2$.aU j@uKڸ&n bR;%hl5=鲔WܢϷ< Ӯˍbjs_vٽ vt'[Lbxյ|k$NOi#fqbA/ʔ$B0gy uLo;#S\]jd/A*JRC{@T+GqkshlNC3xR'PM-I k$,d kU1b`rG見 Բ %DfH1L+ j{" :!+ aaK_}rY ژkF WÆ|,Ãg"MddCZB碣! WpiꙔ-7i5ϭd{ڡ#PRȢ& j]19b +#fj|bT3)E+LD].Ru--/ܜ^3%ؐAtj%;oZ#oU2u,˵(tc5'{h Zf}qܘn#Z,7vPI"+]P b jH|ooa{䞍+QwBbu77RQk].i}RR*KFHro#^Fεlߡfq |Dh X0`ŸdmwINM;+7E篡YV꘼$y8%I_{$0VĢȿcQbgc_ %<5sE0Z\p:nwX9?_j]Ձmm-joڟ7og?|\y˛hй |lS #q=<=yzelb`?N=L<^^N ^48Z}616uFNE<3?MMggqer63q9N^携GkeOn޵3'Lq&J-[j{9k]z5\>2=s tުe{{;갾~02u[)k92}4'7o -˱e{r4}T#7:>rMo_NmT/8I7␁ݥ;?co>NvSgbb(_pggG}iWoVFT̡ɦo]@}*xX8<4>gcYўn..{֞ iͅ' ? ̮ώ3sCt aGߝ\.|YԸ^ 7gMzdy04ko:L2 wm״cxr_В8qkk#p՚߾z?>Tx<^,}Ϊw9XWk{+b<lKQƨQƾOQ;EA}\9#Vb+_tS> g'E [FAxZY{l'['1xmWh@8U4<0W;i"lDZJgXWޱyb񙎨4i 1ī^pUxzIHVo&7}wY4׍yGoeQR-ck7Ov·i ^)B }%>E[dӃFq]"x$~[O @5.qfZq@!jADO0&12ex}>깨[#:!ƽIkWTtb jD!:{\75R26Rox=х``҈ r(jDW vG돲%,p^[05}ևapA^{E8~!߈^ r~fb7}e_6&FDΐGN^@Z1<7FM1Q,&{++,ϩ~o1 "\bC] Ks*?ʗN,׏u~ q!%,xl8"&sG]XO-Yko*IO=`Mhmk OTuD|yw|&M"b =a|&n[ā?a2.{Og{Գt9S.z.;GG=3,`_oܬ!H,]MKrHM?3ȸ,5sعr~b-5+O g|3xȖJ:x7JhŠ?d2"%NEԶsqʇk|;q9/S' ^w 67IKїA42q}J/#KsP ƽol5Z7:4rCy#Y=|ʲ*pjZUB;}#yB\5qIZ}n2ipa~3Nwf0?ž68f?- OւpK^ xv.^Z`l]g받ap)݃m(6P_p;UF Ũy$I#BlK_4)΂Z4xF-}uр[jϭ"()4`n4uBapXwG"UnB aKp~*kwu[Unj#>TҰ_n-{Dɶ z [X`D6]3ޭt ʹ>B<̴r4kB-ZrXzr)+_GUFNo1mb1I?`ONM5O%,'[sL>HaI`|~RZtFSs)O#a_>I!둆 OVһ񥏹%v˧ [ҥ3g\nF]P^Hxl5`88!2vYpD8&|Qd? $?G4ZbB?h dI~dRzryTj2N>*JW.X^CyoS8KiuW_h+{]&K|Rߐ: "%*gd vp >/EAP)-+}_H="8k1eUH `x& >Z>JEA93D@#GBK T0yodң'w˧`%Ar~ZCYEVr Ֆe%o ,|Gbe Bw4$rJOi`΂'Q6Me?K\{)\vܡ{.KD;^ƧB;;q6klh*ÍtkAt.L7Bkh ? j8򅻮TKty0?WnzJ7}KWկ⠣%E~.7cGT\Et;5d3)Y殶Ɓ6s/ ~)QoD)X ]Qȏ;/NN{j8}Vpǐx:4pnogcKX#^try=ikeM1! M}hZGr4+۹偝FQod)Q+"_x].3(j:&HEp=i>>*':yx8vElrD-(K%Mƣivq384˳.܈E%f a ذ-MT;7QwV0SuSrDaM̾nF0"+[9̓^x*:۶>rnU%ș6tZEO^5;L/*b.$j ]&d^/>'r{y?H)$몘ݣn1?%fwOsdbl+N%Ȟ}ys|9(%RQ7 y@ZnЃIg׵M u^pu3`vCC~M4R] BkMy* ^9ɥ 1ksEC8YG~jeL䝙>imb0 /`Z_EIĴRƌ q^SEe 0h FMS+֕e[hn'̇O5PDVLFim"2+Pwy2XpYaGoT07)o)  JWÝ'$i/W9N ʥk@PűE3n8ǂ!3חc"q-CJV1vVlGz$P laFRR+adiH Y vdPܖJN&W N!k܆ TԘ?I1\cֿ?"'`"KcKsW8p. H)G+GzNl:5rD08q:ll03X=E~*|q Tq{rޤDS]zZ$np9QᬩV75gQnkzWa!KstD_mҘsYxT8Wl֍"sE1sk]^BD;PcS&a#؇9~!G*Ju)Z_ثO-/I=#At5ז"ŹB|8/yeUE)õTK \ 8V G/P/Z/0\.Bd@8FMy@iڃdf+Z%!ym#^Hlr9y' iL>r[o'?i,m- P&qO7"9lg #6\ ̊Rn3i㖪!+ ^XtI[˽P³mChH5)t/q<̴I :(SL?]fhQz׉:Rb;NRDa7UphpDløEa8{H\\@Fܛ6$j݇zFix)x):)Qƽr C7 nfAa>xNK"K#_nZax9oe,.[b&MK>/SUOۭI>-L*W [ݰ3\P"O\plK`agsS|櫊Pl>@,㳂J_<PB`ٹ|9bѡT@OKҳ)04<{'~5%Gq2źۨekm&"EJXQhےKsfMzAگvz5yқg#XDhO)BM?$6ŘV(J՜_gנL}YJ\ y 8tU}[ss=o*hg&yG1֨Tn}S5N)@7d+%0XE \/VR`ư+۾gXKRD .ơ ͘]0HCyd Arq6o;Œ_+0yckR\kLΙuKee&dOB )MJAFeq٬ vk`21<=)OBg\ ZKnjB3 |%[pm"X@{:c dNV색A/ws*&Ruq!НIm7{&6o͙sIve)ܒO1G1^P¥5Gp`+ORqUKۡG5Fe>py4b#P04.ደ2Buu&lm3%rk k/nT^J(ŴWz)`L\`GUk|4I7:?>agOvlǡA %qs 2.>1 9ғ:*F()fJ"ߨ`NBhWoMW2}xw;A] lzn6TMcQ8vo1KCIKVRM.rby #5 Å};?4ozk٢@U}Ea<U`eA4hG6.2ߋ ڰW#5G AtE*LoO 8ra?okV.P;Ő 7$}31dQוJ-&s;Ή$t(<4bL%߶@]n2^ sXUfkHnXu'DzWx* PG*'uNpd>WgO͜6 "3!bj+]OmY?Ϲ$WE"|ջ[[J9]rJTaz20BzqwV$+8bȃ"Yب3]e3 K]=ֳk3}6,nҟiu'kH<³AWki}Zj?q!tK?䊦YL>>@Vj4( K`}E=Ăf^)b= Q~:!'P2lъ`+QIOsTCe-bx2[3P7IƕsǾU\#,m:gg-w#+ ̴goio[oSj`bAuTU!-\d$1pY 5x Zh'0 c($-#ex8(Lf>#Oȥ?~"kfCﲓ+yڜ=[ kˉz5?{,7H~<,얲 *dي[0ej;kSYtٕgzePM 7?P!}K)u VLIgƆoY:z!n;ti`c#[&2{PMs4eA>FӉsն;tm3t ;hQI'RY$jT9[ ٴyBKU|iTi&%}sT#6}:kw TJ[=q2sRLߖxXwذ?c?qHK;Hm?&d)Ji Ֆ|9{2Җ ڃ(Q8gcؽicqMb͎of9= aV᷌!.S=d-p? }VRC!,, +ҳ:<Yr$vN}Ƒ[*Ol^zT{ u2GηQR]pn|C!W&tS_`G77'^Τ[O`˲(yͱf hb02x[NF/q\D9XM;S@ 7r]uf{ {+ǽher9,@ՠXen;bnu!6 pEmszX˞5|=FsHQ#f0G}-\B(p稄e ADÚBec@2iם>"lR[5Dr$&;UB~O6㙸>Z`k-BӕIUn8ϻ\z#P&9F7ђz֭0+mS f +,@ 8`Z6q2ʺ$3kŀxăRL) t|W$2T\Iᐔu|l$+W8'%?7rܧdA理7 jJps+] prPq&C>Ka0}t&D +PB%w^ ahn8M%57^k7-1 mgI Bda *3{yv "F r+*8G88+ƕ;P6BXa*(ZD-F?78Zw+DR}e[၇920SgֿcPȋz $9[ݓ25 Ѿ2)]sQ9H;9.lu`Lf\qraH~h7sz'Xs=ۯTl ZQ EĐNpe :aIMUﱭ0- q8!d28a$[N@>F݊;{̝ZkM3bx!)UV1g<ŋBWì͒ϮL] Nuv?Җ=an 0 Rcɮ-$ç+qZ b=I616HF G/[u|ѥ[Lb42si Voe^QY`#‘L_ ܉Ýw@_g2C}2m+-"4hi*`J_h}0Ik^#K$0fs+ި3+O%/0p=g2ES>ˬ .]׮iRgngtlvD*b( I?;z[\o{S%"S̩t$R!6o!Adnjbx woˎJhwibVWw (P7 l#Mmo$tL8R1 o;>K2ydHHH1I@c|sYeg4d^qqGu_u}1 3z$3-P8-e߿"#&:~NZכݮ^o*S4,Հ=^2~@2bxlœ81:B]Ԕ^1[${ds#x;}{C܉WjC4! n^E3Ne}᭳ZuG:Ev*!pQk[=/ȍS#ZG^%T!B=5&dG֏ײ$#su p6ܞ2F r$qjEba( )a{"!t>Y 7-L*b'ۂ r8Z=JfvISgY%[f#@hWB.='n^!j%d\{* _)FS 3 aWf W=XKNQY50ߗ ycz|Jɬ[4&5f|w edzw?תx&|/57O8UIdCϭ[Dbݕ l|^_orwS~?`5kf)춅Wm;‘2*G w7EG_)NО1]װqGo{i+? 4iBRLdgo=$lzdlpPܺQz =-Ջo|7v'ub%;`R? G5Pp?0eFi5LJc\B]׭41/{5fԋ3Ok_ɘjgd==l:Dn]k[C9Ft&U9KgD_ff~zE-lv=A U6׵+$rܰvWAkO& @A2}!mf`9TXdSKmn,e'!VLQ)>ZF]@H{?;x Qru-{ZZ`r&O#vbg+-Qm8[.-3$n  (eLuq? owf×v3z鈌06XaCw*ԺEe3N{T"h_NƿDqVrf]!eB C-³A疻1G²GBD6fe*A#;hSs"Ȅh3VxC-]'STxʅL Ԕ+Fsh+lWv2ZP}tB5{Z{=峅ͷQ4:Ęmrk4BѲoἦ˷M?T1AwLbß0ϗښz/ֻQ{R4ZN_6߬i.a^HKeU΄L+,Q+@VflOfFae0Dw$M nhZ˓ ]K-G`0~6SMl[}`LC9d_52D=ANYwEko럽d_sf ŒصyO_tށ9fYӞ~c$3u 0n<>36t1h=TlSnr b^3)zz%czU L1$PAc=cF0ؙv -\7[fB>;. | |FEw2퉩|(nyRPiLkS%C,\n0)@^&=Q (Gmo~ >~AbfrD 6|<u^0 WTΪ7QXVP:V$> SZU ƅiARU{V"Uk :XȄ7_0e|#|4 GW{m)%M"Siԗ`{%oqW[O<]E? 5TдR6.XI,EN `]ĉrR+Ep „P R',~;,?M?aHnAhQ̎ 푎|d2%E4C8n[y(kQU2TO:JF |}mVKB^{MXz;>Bl}6sA;LeS}84ߠygԑc'= lĘV1cL'jjԅ9 .{FBefQ}4!pGZwT/SEHc* %kCiy#s̻&C$,jQ>er=ADHN?B{1!3j3:O`n8:/bPۂ^j+j it}P"/w/?1\`WFTxw1`b.j#OjffT|0&ʗLxg0t?mIWvBCs jWbN]wt4J SAV7[B6p}=Ƶڥ^0 ³FՅG 6v5n`)l5C9\7~iFcr{lfy~h El Q9/?"h]WIT+5iH7yX!hۚVkk4p= fҍDەPL0"&> }q+M%?1XޒfM$$5n2_ Z <ɉ?ۜhnjY#-2-9"¯d-lN& WjEquN0 S $i(j)y0(+/ivskZ n:^s92<+Z@EǗ4*`HsAV{p*11K`4.wjjB$vx;ko W~&G-'8}T2oyvkփ9Y$l?z_ߘ^<h,w"pwfvlׯ9G Xv{A r=κnGJc7e\8|6m||(C \ ӕY]eqZU x?AT=<$vU_͹(\0ct`.|=#P8jPU'Pov Xyl6BL:zg:򻞙ǜ8.]o$G!עZ]h~IbE#wqvÍJk,k>CVh+f7qޜrw2(F|H6Øho~H"D; | =)I$䃾i12hZLt:Y[:B!w,l٢E|TO%Џ|\rd;)F99xQ0qEX|v=bF-ޭv9E*HkG!CGV͎U!Vd&A.euҤ j>Ee2K^e|Ub y0t!KqT|g0B[9~&2, 1fx6%{ ۣWv0ynҳɽ)yEji}Aȯ_`hzK1 .t[4ȅN7|J"&kbxO.3׋tiYR> $rxY YA LIS=&x3jƽsVo.7Hnq`n8"-0i]аk2Ľ_53x>:k8{|̓ufMn} !cDt9E꯳IP%#YnA(r)@xiSl.X6t@fo4 #F29=Qs 8`;WOvwi2ek\nO<-8A}_-cNWq-1Ux)<מKa1=CSF9rDq=cA5$r f)}G2NK 쥋f>vV@ H =3 }+iٹhKkRDI6f(޽9u=Wc 8u&9u-#S(@)ǗY]$lgsDhZiJ _"C[i|@܁*@0(V.joV K пSN 3{7DْQ΢15֬ƨZ:+'ky w dBҟ7ooaw-(95r /gXE}h-,"9Ӫ.ŸY.m1u)Ba,ι` Sm x^Mҋ}GLm%4p }Zmڈ fۥHwG'<}2i87|$JA+.k9+Kn&Bz;!clĻpePք?D)~Sê]=NUK\N1_a{ߓuWcxc U^G`6c;BPPB5h-2|qa$&WTTV_֢{DHCcg#`J4ATu2}x lIOhMs]S?N]h+Bc~zق =kYV KoB4+.ן]zz/v Br/p" ,F 'QꮮSVf%$i ? +7}bwVt'%+×nu!1M-wF D,C3pe Wp0EXULjT 6B18&ϜYW}N9j^NFpDhPȔf6 @mDRXwz8vq7ΚAg):zvJM1xoY&GqQH#zZ.HZYMeh0 !Zr]j:tu\k' OMsߘL_1dR;ugbL_HVr?[I0,í){8*dD? O@Hl&L1ʝy8;҂+yC%.!YjLE"6C)_X-kLZ-*Fd'W||t·W:uO{qO BMP{^.2_ةrab^JIm}Fʅ^{B?씛BPV" 1%ѣP 1ha-A=K5rW&apnB3!B|A7Ϙo.HخqW$J-u+B&tW=(E;$Ҙ3, dOzdf+P,[әMJ/{6q*Y L +(tˆR| :srIB!|U%?eiՊ_+DK@]{,`RѿA/^w>I{֮6zw[*[Owq\\sa=e="kn]ck-K|Dv|>z+&/3z(!N"خ!,ﰸ,nQXAApIvOɋ(Ue[ qO(_z_U…v nq``,&keh0&~ͨ/cAD4#N;R_tHP\h aFcXP:6rgcjq1Liv|fU1T!.hNv H=uJ#vG&u:c/X|\(G {9+RB*}MQ97rM}FL)# nlM)X=Qs3U^ @0~=k'w_Ɏ;}XF3"9#HRl3/xg{${~EZ實f3tsּZJKS6JD*@,$}j?:+یNwq?[N'|"Iau|rؤ6yap=;uB9o(d<7)/*")4nZvY#]ېHwvyX.$NwjIx`Dr9lt1}m$fh`To?uu8ٙ {QvԸzzNDʟ%Jwλt2H'|#8خnO4PT{* dfKvaɋO'y}8B`L^KLC$PC|1~c^%*T8nt!w1.旛ak, ɵ_Д|GjMk\lpπ-FL#mdlj&K?zw1R L26uߟÑ}(vboOR]SZ.@j$6䘾,@‘u]5 #iZ8gdر'6Oy-Z&"o-c#ҙ&_Ec^רH&JoN.ι-:wqxͱ$k#ŻTDQB9 )*pzlSZ`JIO{=xi%.-D:I V#QM8A>28bgIo $GAOT?:O#v?ajEh!'DL}xa/+'SRaH}?+B= @bnYĻ1;‹jIyбbrmꅽmV(~ S6ht~.P dڣЩ.P2^K(%#rsݻ_e7$KKwީGy`0*.s;—Z& qRDΝX g!Jym ȍP=6.eC3nO 2EFݩ[X{$HG2GRBzoV40ܛ}?}kVٶ1JV pƃ!Cuky5S3'X+kN$ r3ŤQ$4q*WnB(ĚdأvV %j½@_-ߣnd%л8dia~+?\s~@\vb"CmoIܼ!s% e/ #ά^D e ;ul7,J&J@VѨc 99" >cnL&("wA Q3uRNAC/zv6T>kAq>Fö|~>ȵ{J,nFv`*n7+Ze|ڤp9}QOd.jD/Ont@YI)t+ X,,,*/9bЪ]26û^A@s'G)y\GVSt%g|*Ka;b4^K$Dڀ5O_##HvzCE.`<GgDfCy,n6BpU-M8Q cT( G.:=27yb)ܙcn%PVXBPtUB~D)9Y=x{o$Ir=j0Ε|SM F{/= 7<|wIZRAtmx{f:b*^g̨yy$=I&v?{+0 '/\͆Q^p39Ji1䮙\<}=\=dS4fu|ހ!/[3=2)щm7p%/* ܤG#[L.Zg[/ED&@fɋ: LXX %Nz|Of"8n1ϣ_<0z@Y3!}KWq@_D)(BU\&Udq1ЃMH*qyqPƓɂ/~J>RR?*os'w h}x]t-+˫0paVMxָtǸLP@?&/sw g {M$kڋxp7x...ўu nV{ݍ#~W\Otp]L*.Cv;l! |5J}W}$e6xP[|$ ]e: 0kxy>nq;kv 8I1"TW:^ -8y WE69^88i`7lF>ʁO3(|ѽoK&p-ͺFpLS_P 8hzMơ,BV\PuO;q𪁻Ђ[U Q)!z;yʣ)#I~WRCe[}꣠Ci4<~Rl.ҁUXP:3Q m3PhF ˃m5y "Rw- md &xdX0LǴJ%hZyUrqU,Fct rP|dk흩W΃yV@cAy ~RT}mޛ u[##P|aȭ`WOp{ Fس8QA3r@y:*mۃ)KMkn7?  ;)CZ;9ySi%!w_=@Wu|i~F?O5 HO G;W| ů&l?d|?cxz$d92dzd)_M.KRQB ߺE K25 hIHYUWχ\cp+NŮ.3Ñ.tai0qw_j0Ъ97zΫtK}F3uUMk~=Om# Ft|wzuFn~|}ᬇ$VEAGcJ{ -ZҎ?ǦqEkDD,`c `@YB|;^;U $k$y[XMhȪXqZ@沷`ޖ*.9k;Fvm?߷tR9p-X-ZV6 {g !nuʚ!}MuNҟZ%@iotjS^^ךގN~y|50=V" *, C o7[ u3h6ѿ>!􃅳>A]%IO/e WqKF$2H]"ȟ|YkXz hSBt_d*$R;Ț +Snv9fhn;{.%{2bvL<{+n&l_r>UҨ jيe_ޯT$"Pך_2;k"4o߆xnA7"n"jrDVBm6'ER&ἐ2#L)ck>aN_P$%}cF[!){(b*s"Nv99NWmq7u1%:KՑ7c+>WT£IkrV%rF͂ɬVC!"t"('=D?D&Jau4Hpq]ָ#SёbYR$ "9@_9x]9;нOl{Geh `hoAяnK> V3Sf px@`fJH֫bbv)B*ED_h ftrěbCy-@)my%[`CħT_ AggntDHRsdƔ1hn$,f" =C%|zW8 A#e4|:i9>N:\f_=N%U7Aݻ}thORDύ)tq8*P uԠWQjp$0.)T1%Dt$CJ&2`-,ZX~)].naTqCyXb4}NAޅ6n/,/ 8"?DѼډӋت۵:DIq|. ! "!bYBʹ]PM.kTNaV7!"uCd+rrtJ쭭zN(ngo+6/hl'hyY)pFfaE.{ f;Qٹf;sSXH7k2AQ$hV؍~⚒&Ltn9a,TPٯ!8.'_q+3i8|'RXgA)-H5+X]ZhVGz6֤T&qgKQYQ%(ŪcElb{r1hDY$(bg}2,0ѽ^<1CouNXA6TR3mZPuHE>-md'R*|"Uf+HoW!]YGBzr;z,FUX>+7^yBU$fP=)ou5T6 ƞuFQ't7-1:ctȜp])CPzƓ\ڙ( !cx(/"Z"*e5rm&D ]|-*kGq&f=8ds*\$'J;G# 5I)18#\=>w$ׅ2a Y- 1? 9 J..y@mr.+ KU h=l}}GDV9RS598R3$q7Ѯ_ .-X~]!_(y}3xWWQ"oǣzDL1h|-4SON Y^#j+XQHqv1ICY8<\&;L#Ve%~4қwn a9Ӑɤ~jDZ׵~c䅈϶]ECZJ=l > 5_&5MͤݾA"+tyz% ko{*>LWO11 er sDsIp(iP~d '.&8{\8/uי`<˫%cV<Xx`EKfqbYH͒n*96Q-K6P Xe)C,]O'֝~jq$>WI"/ɸ/~wrx;0^Hv<9 7e+hhqڙ?m"j$jeUeMنD!i44U>\d(`i)!T VDLz㘽ݟ,F&C&)B7cx+mTkkOx' CgyDzyaS'qI"]7l?f#C?ZvT ֈ(E oO6$ݸtn0 du (ܮTOW}>UM`7 (ՈYFbbʩYҘ~,Kg(ΣEj#p WXJOOcͨ\~w5#xBG›A8԰ok{ǺX325&8*pu/=89@$T ẕ@qH$Ou9lo9aT?(R|)u)Q޵w=yJ&?XS*EmAMV@fW/) fiaQ5"8_АyW7R* Z|_M'K rLI,;Wcuh#(!.$泒wG焊.&c+I7̾GAdCc!C6[5Mq%LqâzhFv EUb?r>(EY01m{=fx4EV৘N3NTG>nAL>aH@|e   hVS%aYN,Z+@zl%'w]O] :}^Lόh;5mHbFKr.+ʡF;9)qO`ץHX0J#FAy t5.NG0~\W#5zz h~{t[r69iz.9˜/@/Ƹ gFL#75 g~٭'m&; j8Q7ԑNkgq+$` >9KBȮ\!ydC)c,l5?Y=m%!xs/ Ȗ7]i5;3Җ?t[e Qx<蔞 DEpy⏞ŜN.?! Lvaf.O訾3^ `haG/i )K,z?u\m3jnr.ljTQ1;٬ P`‚9y+G^sp$ ivaSXg\~}NzD*|G>ڬ#&@P~<;]`hNa U#6zfyhh'9;hn͜7:YbY{Lu+&-^³7X`n)s 9)>} 0hm"TSƉ)Uϻ6(?S $E*zՖR!wsy\{xMw.ڠrSro:Xp=9 Zmx3uo.)]l < 5|fB=q6"nLR"9QRH+5\]KcK'CV{#No?&fnRmr\OojH\X.C]F§(‚6~#EN,j3Dʁ D`g  gPu5yKgNB{s6r4vG-Mr0f3/~;ࢅXlHb]lY80Owq|Br1"`1sO{t ]MqՐ@u>LKZPymv{I+__°n̚%n9m01h V*[RɳmXtn7Fm9ޓK[3QOׅirN ~aj\y2c@Zg|Ln/-R*_[m),r;Sl+˶/)0lkS λxOa$ 52:_ښ O0R ~6ȯ;1ȃH%TaCJ3K>n˘sSX4$/{m]Kh;'vΦ2:pZhaV{%kϤRS,A[Ǥ:Nmys/ͱe/rt,0mbIa=3!bfR 3<܈Ձ=և:,l;t+_>E]1LP֊us=MK}3[u{E@E3&hָuii}lW(Q<*븏L%rj}Qo{KfB6=_YlXG6 釣Xa6f2#yLaKqo-DC'0l/'Jbޫi#_lSZ?+90O\{N1xnw;S,;0% %fw T>p5nr>) tvI|DSBS3qף`XKMPIa;$-SHnq+"\ފ{p wܨ %+1U՞FJZJs a&;aGusxTu5 h+z2qRu(%@iTl܃4N.5$tEOL@Hs1;Z{-նdzgH M Z<chh K׼ie@y:"a0LE_ҷ^YPFґiHd(<L DdΐPm 4:lP}fm ,l;BBE]lJaAɍr"vQr^E2%.L?6շ7&r_Arm <^GLa^4'phol螮tJO^@/9GqZM4,Eb4T-ʬy)nGe/N`+Sfr7yVm^8# j Th]#+iUOp3),^3 y}s׍rmmFAȫV8>)nl u/./kVA#.|kCq/<;$+Oߑ+!32Օ)[Z)M57^b">e m\y:5G8vJȅ?<9OA?9͑\xSInKҋ|QI0B8h(.$D[ѩaH$w+Lb+67[vg}!7eWQұX xELwt"3 mXޫ4.Rv޸]DןwKO+ GIt5<)S[W9R̒nպR*S˨pK)}'MJ.֓~  K0ڎ#ݸz*o ﳶps_DX)0s'b-w\k{ʻK_8ޝ1+#ҕDщ¢)◨̈́#}Â)ş!OrBͅ?~O2X#F kи GFh ϯ _1!ڇof}l amr#zJp4-,\&j9FXů}y@ ~瓷 S"v~?nt C *)DBֹTa}/U?!A =E˯jF/z#"?l^f3y_D)?(AճqQ0&sRsjj.3hâkWsOnh綾Eo1CZ5PZZۢ9NoZ]^U à9xX>mؠY]eJagpKOF FFtJsx0cTG.&lvѓz<Ƌ7ך]bBi!Gjn5k'a,afujʮ-e-f4Ĭ *u.J5ɚ(W#OTxrQ]K;9,ícͥr@e!BńVm0_㣡l <q6) )%s 8/d;+!bV;5 5٠G|XC>_z,U}HAm?G'|3I zt- !C"~=z>ho%vo0mhO~g<~jOyr>b>9vtyK}=ihG݃Na5¯.={72a~_1bD{F CQ@f]H S!OLPw^ɍKڥ*g5?r5nhqV,&p/nhvCHtN%{O'm*kަg@{vorQdF'*Xꁊl_;_ҡjNREX6In(?jRD2؞=]j(?Aք0k:^\1vܵWlR7&m!U<4X׬F#b}5u ̥d0UΒLlM7>l}Rx߭=.nq?l E{FfJsЩ9Yr`Vmv>r<'h\U*k |c&D:2S|ռL 5_֘,Q6冫Ӈi@rd>"BAa?T)fkĚ9K$,H^,|Q_ɻPjt5ܑ!%c`q jz=S0#L.yq?}BХZD4u")A=;I>1" ,*EIS ^n GpZt,,VBR{*ݒgřf/`b'4ɮ0@y~}>e`8yvΤ.pzF0lނӁ]@z;63Qws^]4w{1 듊bkm=`"iGh~ SXu{x3UƔ} ^  N1LhF(LLM,ŔWּ-YoMJ0U3(?8ݙwZor"1{bȭ^7~k/Mk`drcdi%=cd> !;|t)LU6<* lo,Lƫ5]NᖟZg-Ɍp hA#Uˢ b e}Msg{GZ:ļP~BثfM˜9F`@PF`+tm>18w b +t m75>W7n::߈:@Mc>]Y(n684wtZ~^!4>`oL|+`~{l SvV,eX@a3e+_b w\"`K0 k˦"X`,pJ]" @D&q,Wғ{2xa˜T:O&!LNau=Ţ=<#X|8FQV ` ~ bbpH\ R3TsITvK}(DY Bϖjw8Xu(I z?Q{zi>hkRckߛ/xt6aK 3)*'w>N*ɺi|H'߇%KЧvyjk֫1=g8g,b OKLbFZ.g Z8zpe G/4SBa}%ᔎ =:g]+Qzy3:߽Qcy3@OF=BS{}쟈UП.#Ξ:N 1^?YOt @'_ k?PEzt?.fSKt@g|̀s=A[+e#=3lb`rIS&xQ7Vtx⿅5!x/; Gg@ ֿVH.X|i>5I~WL$@Q@`_p_'Rouʸ 'CN&(5T b芓me(^Wɰ_ʶ%Yت'<`p>8Ʋ *~ sgc.*&RzQ8c3tQ˰g޺ڪG$J"0zt3X)`fH\ +?a=>~$H;Ak~1aQ$ӲhG^ ؙOΗ񴡟 EEl'C֥IMg`)Q7eFVqnGhd"vgYE-ܰDbPzj8/m%)mJ0One7o6FGek fgCg$J$JvGQ ȡُߊ/pQ^אá_uJ9j)o'q5Q v?N4`g MN2AORyN#S\~˶P|3L9iZD5 QGqŸ^:I:gۂlHG?~ea̳nLĮjJA\=tM%[IpRg~=@o9c˧PIŸ $wF} qdw+_-&DN-Sd7ѳ_ObӜU:4f)x:+zvW'~dwQF.2e _Rs߮2$30Ϟ_y HՌhф9[# 8=_BK]{Jd#m]9=u dLkqS̈́(> ku-Ɇ8MklJhOI}ўUw򊕮7PìmJDZW"d+$SGyqPjy*a|J Og\ŪE6@}djx3~[ [̿QL0k#y?r}D(W q>t"Hn)gwCzwkv;݋,=Xw4H"}<pP58 >&2⇤죊$߃qq3i/?PPI7 n)a$G0ɿ /*f#`˓¨.C|Gs`^̨ik!$ue ;:ARW*h#I5EQ?84M2[,zO+9EDo$ؑ>$%ֆjM[IGm-2wXCEԩF-R^O]psD>ik2^sɪAȊ޷Nv.c L]ҽw; 4v $!z!S&Ic0LX nr(<̼ФQc,bWV{tgkFt :etYp{)yΨc6lŵnF0AOfdJ B-".D⦈BύcӧOCk)ߊ՜566'ѾPS)zbVtPHd 1  J_@e^4w7dw߆گ z[d .:=.讣[k 3/|] aB*FRu{Lmc6Tt 1*v数-+,On#0o\, | LpVzqFg$vfpGLw˄-ASrBM^@%d7A/ٺC.+b< IW˻)ݻ-|ף)x9uUZ"7xfX:|_mw _`ٻ 4!f.TN^xW/ҙn|;IYN).($rGP9b*jwz;;#}.O(UP&$UAK 3ʵ?EC0R_`jM蔐#s\6 vbCL5B!0 fZ<,Ѩ+;hZ*T5NΟ]ÑJ+.% N@xFf?*J=c'"''VFaXJ8G֒4S[(TZ`j10^ut`Ruxs5z6ԯpX$^'߳P*2nFqْDb^_@aQesY"wJ-.tsQ~H{Ns`9,YQi 5*sgP 9kmﱏ c%P3K~EXwpx)-%s+R3ߑ \56ܟG\ҠKHSLYy27*97!|vw.GQc@2br0`:mn+  䇓*|bv VA4jeYIcI4i6OHJA71*q 5 QvN%]qpәjYzܳw'sܰT*_k6SfbDf_KyR#˰Cԍޖ dZo*˹2)Z` Sņ*QS H픟5/0u*]| J(.FrVR~v20(Ds-֘ú✈guhv_;oGiz沙?y82c=/z8faWW _cz?`dk/G)wf~.5㚡 lp43#D~J~p6Ρ.X|J|ꍈl'".֯ףRu ph i2}­fjT5B<q}w~7&~N**+/(O0W ) Tnϱ٘ K݋4gNLU+h=$.JV&ly{*_2"{Isѯ]$s.[$(CZHw͟ ĉʯib'%p.6/l}jpy6sL~Q"DdrX{%sLOh ҋz6T 2ӲJJqK_-E2WVEOGz@Er eӌB߿pU(_IБ߮~ AQ >E7QϾgBfN5N Ȉ"ID㾧Ax0RksW^ܞa>bLP&36sVZ7{OĵQwC!r M#z"H8tfrz,Wbuh'ie G`}ce@?6' !Q[^}ɔDm>>0뺪6fF:y< N?;"Ԥ|LdUs ؤsV_242ljWp1.F YxGIMe>fFgSn0f\%DiT3*@kz@>Zܐ tLFZ!7$ b|5V5A `R'S2D?YH9hv#ꍸ.鱗J0+N%2˭+UKNn$6[؀+.(.ƭC"2C Ъ+7HVc-Q=Pz9Sη|=T`qgA^:O±MCBzz0L_(%[+ la~+,iF3[+˦U>~DE|N(1sada"r6"4@r!uNj*b؆fG 6KMl`y"/?s>K^@'Y4W"nzXqLBYZ M7uFMJ^{^(E|tͥ#PJ%Gs4ˌ۠FHKعEti$i΢(}Rk#,P?GU Rc35 UnuAGI^r_O@aKCm1+!vVG" fׯM(Gn;]vhՂ_ g H6mzc}6Tt:wQӫT1/]~mKd6ph'vg]@` :cyGe+~؝\}H.:G{k9zuJOk2\.b_BfVBU% )|&;f)pDÈϳ}-O`#.?.TA`́p}ZgX2]9Tʻw 㣅/S2v Txkw#ŌPѸ d 6|b|qk1T¼G#MfDn׷4oL`.d/oޅȄK4ú{ԟӣHC#Z.mm9x7MW/WЁʞԻ,D רT4QoaK!ɩV֒ 2=!ʛ{J-!c6|1 E;8`N0d IO,2NKWBcm m,~=oJ `őQOm 6c=E+Ì"s[&,G &z~m'rq|3ybvF\nT^e"a :w u{Ԕ}H =JZfI 0 }ݯn  w!9MhN!wO ?h!8}bx?KU8{+#uf:{E]?x'«l}:ո =K~0TW,U<׊ߓց ^JUJE- -{f?;׎=U[#dVڝW-yDT{ЌZ"[gzyw<&1Y4!ćlUO'g ^3Av^l/xU `郑7Mb[f 6YᵔDZyIaaAm-_J!PVm!! J4Q$;=R_/;v+!Wws7H)c"xf2] o\9JAg 9ltqd\YͣT9DI%"rch>*thk2])Uo; +UW}qXO Ob-N=%/|DA%G 4vbYVbE<WK_c.b~B_͟<H+kvܒAokWWa&?غ@{^>69n2*#̉;j%dL10KU6uK5".i#Ƭ/d|u^dS"W9:_W4 ȫD%H>9$ PTg} FY_cFH9%YJsQs(_&=ԏ~_ܕG8-A7\«L"mة]MaQY/5S:˱#~dq,Ŧ$Jdz']AZݜAE]2y$D#AR6E%T'^o@]86^IaFF\)cJZ1@q4^{f)wO2мفp4px{lȴ`Ibugi#>H\B|+ɴ n{ml2k @i -o?^d_|j# NHQ=sUy:1p'C^;֦-85$DKG#mJ m^@1 鑻jSL|LHiV۷QPv !p U~,⋊w,B2tyX0GH8\L𚛃w(!&zcK8jrFԲW״Ɲ1@qՅet`TJA`uF N; cpjr_l/i/>Jj~A_y@dؐ\nXȐUPRSw?Oq^=J⍽|tYE!BMfЄүEAb3Fz$(?TbfGj/-9h~R@hc|~DM8X蕣j`gϜ:hgz8N~e$䙪FNl 9׳-@b9Yp]CSVk z.bL~9N:rlf2Pj#H@C߈ dF[NzSTBsw: n N!5MȺ%Z]z>9C mߝSJ2…ÿb<#{6A vg2z Rn\1\wp{V7kYT@5i*8Tpp8Q=g7:v'aSO)/Y΀m1OBjBWGj㰨[J:јg(U01"ee5{+;Bg]VDgJ'n*ٴfYp{D39-![?u$W$h(BOPj h;d)5[4??a꣹z 9T]{V/F;s贁(d{GD2)\8~ m ر X[Iy!&sSu޿:H^Q~|m;hghlݎfOZˤMbHˡH}ʣ|"V6d? +v\96jV'5:BX( zuz̳6Y ^Z=S@%XH Gt uܛEә`"9-9M-AWERidJ*noywY`Qx>/ B炪}&-_Ȉ=ұGqs-,'<1SE2W ~n!-?lHgiԊ^m3\yBsm'GݶտɃJMF& A^A4|*/9+d>诐N9d$O&|d:EP.hcn23L o R5tO.~,Q=tzF: 8-Fwf3c$]\Injyj~~ĊS`urrҟ.ҾifaĬwk79eTĺ19Eȝԕp'K2Kiƺ3Z)ۿ62AR_yq2w="75q.ֵO>}7C/'>S,$\4 ==rJâ"0&HΞ(a6$σ16<[TM1w$ y5X1q)N'R?x@ =:,JI ^0\9<*ڱ'R !o`VWY2Cg1*Q>¥@ᇌm .;ey͢rA?lϾ!׺붔|Dg֔R{ DepSМ~4ݯZ P>u_Q},ڌ~ҭ]:*՜6|*{r*R=8% h9h5^>}O 4JN-W?5v=fg%2s] (E5F1JS}\+lXNPz|懆ZS3-ixIFi9/rߑ cVQƈi,7YUgd-17KEP)c ^ht/.;\yђRI+8ND9f>,J=>UT{EtH0Vꃡ@> ] lSl c2j4⩚"TWŗ-QGpma֥ va^PR3(eVn7l)Éuq3؞C$?iOx1_ZacǶ1 `NPHlWxQ\6; ;"_ji \ke3l9j%>ʎ"#]6.' ╞C}hoDxUa˟]~bۈB'6$s's1%o,9Fݻ|8!g dwV&EǠǘ$qP ŵR)8GOvi_kne2$AEhH6H7t/V@F10z~G&9qcKwZx;F=i쾸g$d=y8f}Pa#G@A{O{ !)(8c“z ="+ژn~X:\*ㆇE}3 x"؂ɡlp zFA+H6*/3;_@23|/lԆIcx0;;3lmELW@Ggnl@='ner+qD|>"r:̬U3"_8`8%@i9a[. kˏAk.ʈe34\ ^ B -3)4M, rY\^Hc-bWm10lO 25Dv4bxZ6G~P697MgFP>0%wG8b+aIZl$vuob Q,[;Ú+%gB'+PfxcmG. 8K  hъ+sCPMV@ӕ=ӍĘ'7*s'Eq^wböݡCsW5D3PsciB#,%<W5P¦{{ P68ì+SR4| ש_%x+`fu}."7X;@ &'(p&r }f'TfnO$-ww㙵z _ȩ`nݽ8/w.G9MOTo2 DPO~ ?t<5q-.ۍL<ō'Ъ&&g҇Vc :/C(&Qp3N@H܁c5f(@1oF҄Bn߰|F3 hkY:&t/"_Wl\hƖ`ĨKwew|`u%Gjd4R`{-&Ґ7NYanxў5l-T#0~/ ߠet0)2yS\zlݴqgdʜSun6/gl;C<*WlbDw/0$ho~Fac&=k$5©'%}j1:cu9#r&C-ޤ 4K@ ӥHz1I1?, tU1GLe5W᪵L]V.M>|P,vT+躺na'VFF MTN͎٭@ggmcЌ<5PqWđOtrƒ$RtƖW.z%)~ 4`xtZ-bE+#,|r?+ux\ou_./(g戽";,Zxc$29*ua`)Q,Li,5q-vN&)&gE־vK9T*ƸJdT3ȃUTѳX"_ qw%V)kUodݘc {.3_KŽ}yŋoJC,0g+'o4wz:A'A7\Ocb] *߶N=HcIBWs [lĭsۍ F19aauW iaRRBe7!% }v{V8or#} )z NLuFC6"LU6܇J<&=+x.u76 ^aۃ꼧9B $b8DQ:i ݔ 5\;ĹA4Hqxu}M#)lyw5 1m֯'gG>Ld\1ŎXʩMVɂCxpObMK 0 _Jj`ܷPm:*ZmWi\uDZYGR<;y3G# PԻEȤd򌼊=@Zo'`x.Pxh& YA=Eܓ Lg:`=ro#9#_O@&)Љ@yml~lKxx<} 4tV n$|iԬ#^i%>Yr)R!--e}d?r'@vc(>l- ͕dP~(\#k wm 4Kɫr ju8!`{9u٬& .5`j2tŚkJjo +/PPCmwlRBy"*-)2=f4Ǐ Lw3 Vm㊆j͖ d&qE6y Y(Z~Y53IqVd},f\Յ3cv:p,yfL^|7 Pnؽ]46T(}=eY*4:g4Xe30Mu{m {z^`͏-<4rqşȌ=y_{NޠIc`.tDQԋB~5;D^|ߛt .[X(^OZlG߶vڶx>mY\]W9X`DT"MTz_1 {¹̀ed.*k(3I (vT1ua˥u-> N=A" њ/~_1Dґt!${&®˩2t3Le~2ĹH]`f|g3g&g}%A1MpTq (K= A,դS:um<[RN=*)0X:NI')6$pVYd;yո󑅾 jfaKWǪ3[};dhP# U]z+_/F>w_K]5Yv'3=+#Lr қp"7\X/SmE)S Ix Sɕ`Dii mq/DiuƬѣO]PkOL,w kXϮ%?Ͷ_z_F]dRn-\~F .9:GR6:c}٠O!ϒԯ}M0|/@n[{[_H $͊#&6ʮ3O NLSXteR2O8[Y!b0뵍'Z\{(U-ͳ,flMl{vm:}}B[|Hml5+*Fm un7?"EpBܮu ۟hѫI(&̉L8mBTVY`̰!e<*YXtTzb]áMG$ [d{Ȅm]2E 7l/$j?J[j d &́[ 3g4n 9&Әv!uin?6,6#5O뵨s+qwWRT`ۦ"=$sX<;czF o1[ .Gf;]q$ Pj?rAӜ">+؏^J:J~+<]!*iʏojMm blou#-1g{|mY*H.5/+e ]0y Hensi#wM蚖y$> (`%WE* s@V(^lۂZ^{B *K dMJ1{PJΧ-͚[[ g槚N )oyr,#V/פuuPUC2Ifǁq.><~,+%w˹ĵku 7gA@ h/rkUlO2+u_Q*8\1nS+&{*'i$5 f[xȢ+V dݻ9H"[\gw`Tv7EcF?QȺquizW@jNcIWꙭ/^}pi<@̐$9Nq}E_W\k*W"%0&zpbv+ň//M\]TNN@0+7%bW6 c՗mG*/C=ɢCm E0)nՂtca[`@yz?SG 6 Rx əu|himBw{Ǝ<>ޛ҆>Mg%$nObfX05^/bWZFݓ R@9/BlnS 6\C BŅ..XjIᧇR*;bcyS;d@>nRrx)jaVW=_0rcF9,?xϦMå.hsS9B 9xQ g(Sd֋Vr a@_J;:7PgF0K%}=6,{P&g4'X#t揯8['j]qՖ3ij˄?|C8F52x9}79p>rT(˘??q j?>q H!a~j{H"jzP`<{2i'P ZI6]G8𳚣PmHAZedZ ߥ4arQI5Ib*,pžžm|(Ib5!vO (j$կEB2N u#-<8%?~ }ORtEPɫ3+2m!`{H}^K}[[/=,-Cn^u$ @@2R=q)/}_LM M0r,#'GTQ dE`4Esc?XE H} PaPሌ4v3"4 R 3Ԧ#(?'14iCnMIrM^ xtVS O>Gw1Rc ;R V}ֱ,/1'řzl( 07di p:-PP~OzCW]9VcRHRJ>Pf?zfTN%Tofr޺'"PxvSHA> D%"=v:]}bΏ~łŦ? j_nB#eʶm|tP/S>[]{ѪY e @#`q#ֻ8 9 >2\-R(F˧kdfTPAB{#w'{(*\&3}kT HF{K﮿Dtza^nSQ8?Pj5BUgq"|ˡ6zOyYI3 D`~ f4!ӺxMjC׌!<&7H^'EVy4 Ne?Iz,v^p. .h](!q>y$s^*D5!$x;2N[iKoe4BL"^s؀\NxYaO0p?9džAG#1/L5e 6- iˁgQ򏩍;3x?j'j # qHR9@CA%WɁ:"nW+ C%: lsW-GG_X$zd2zÔQ?bWp3V5KnX/r\$ _-%\N $I/pkq :Gͱ{EUeY9|qY,}ʰpi#\H=2K1_4Ryt|@\@NI3@?"OfΙ|#R*E}b㺸DڿuÁ\~/ՙ~5/y,n1][cٖ5FCo@! {#$s<'#Gr" Yke <%☜DL=@Na =zD̼L@aul)Ogv*z]3FߝrH6Q~ikG"K߷(='coQuv2T%[A6lm.7hXg]cxVB:E=;wD#[D*Y4d*ņC)"@V}2N{ۗlOuy|;bf?~];o f|r h#!(vi&}KIeSԌeSM"rwB(\t?J?HNKč'3fI4mt_̝zo XD+LnȂ{\$H<ߣQp_,3H]?";#8=JgwYw ,yx$3q,ED& \a-|& ="ȵz-?aDˏ1[ mrI8GnIqx ڷ[ [p{\,c/61-Ѩ}g$$M*ʸZrf.%]]?*?!W";1'E8w_ke^aZj7W ! _ 8d(18Ȱ(UdXlwb5t sdQa?,}t 4$ۅG&5yQ.DDuL6ItrtB\" WHxJ;g gfMV ]_XNn3w˪+k81e@=Kgx'?\#~MOYP^>~"f߽)zPBJ29W!I6Bn/ota^YEg)s+o *ų]`^oۼ9Kp86:x!y$4 Đl9UՁwFÛȆZm[hv@peaǭ3800S.p]-MXKQ& +> M; e A /vW]RmSLX7Ɠ%i%0tuI'3ѭFt\C\_e|5Pt@v/1d1×v 'D~{G7?QW ;2S!ʷ7@lij?aln 49*KAюl$M{$&Zl߹,h,s,"ZP,pL"K;MgaD凡DbU؞w" Gr4>nع ÷p4{X/#vKM}|qW_1 ̜ϛ7gAh_dHf|Þ +Y?cmeq6Jp -ڹRI@gr\)gbmR~ɑepևh [9 k9/GB~{$YiALf1,{)6Ò34H+*Gw#{ei)[ƕ"IGz8(*$Ę#G4reb䡬~7m+nmH/LP#tYjF2`ˬԍ(FdtsزYmNws'o޸aFӹfRx4fF̈́}Z-CKCOxz'Dv5 Ivoxl9/4-IMdc'=ȞZ#ߎٚCazfXGN ‵o~ r|#q4Uya<*AyK.g R}VKܱI-Y2|yq5zNs1l}.|Z*h.x*G;  #ͣeZQaAL Jc2X POQ9:ƎiaKFLQ"hwVqlCcHP /SM_~HU Rb` 0_5ڌ&F{ى,ߒh7_oGhv9 CB35}n 9LZqZ8v"hO :"d[brܳzmce[!oVS. |v?fAB;u'j>"8m-~<İKS}2H 0{_hz+ [Ź_ 藟1I_=dC4H,>\lO1sQY17rB~<^٣kyNP~&+4c R.&ODGTX~=X *'SBaTÞ78hz[SuSM E2m*[5EhO?u:ijw%,#Ҏ;ScAU|g&=ޚiTN)va˨BFhuJOTTŮ؍62J#P9uyän )ŴM)MVt+(>1?f!N3enk/8бh793kYZ+MPs3dz>;+IFVvz6}?}iYَ'"\o3zz|je i*&ֲW%|*ro28e֍I1_Jy_;puDu D磇ȓ`U! ufcD,x |y`b9? ]x"i)\#$!9F!%iΌQe %Yx;97Bu(s/&x+H'q1Nk8&]y_8W/L{k>F녙rBjzp`뀩< lpd)db <9 &񃛭qpͲTxݬgG}:ht}JSzRI`Ҽ1g G1'~@~ lɬHa3@dg,f  7dfL̥[ȝ^"v|Ҳ_{9:H]EHZ.M $T97U.E $Z@cOϙpʩ-PnHXL٬aW$c5 :6#PZmp>#JAyC]S쮵p~)#Y^űTZO5]wpe5]+rŵYBsnOMujQ;OA[r8_hZeǧhY' [ P~ hl̀] ެ%mTEAq8~JtI.&zp t9؀fM7  ýEO$A 7mq]鈬!p;nf ˿`Pvڨ#EqiN,k Y.,Pg$i}pg-GLQy9p`R޸9&M#5U^OB r} ;AimlkKۃGA8p0&8sZR%缳I'+T~ZR1ۀ :ML 7:t񾅹= |j#!A{}4G$-Ӈ" ΀$\zRjrj{I_sf:@'-eXfK}u$?C{sgƝ_Bh~^BW`|cCX[uub3>O5b+4p4bMߘ9/oRf@kfKt/k))fF)@mJ3mރ:$G0ޯW!|KtSyZ9^ 3'a )r|fTQC*KH?L<ӆ:_#; ]+M`7U)ºPUJB'xΟ=O/(Xʷ']Bp-ͥ ctPv&:GeZ`_KHk->@7tbI+3daPqDÇ0+/)ʊ<0M QTdpDlz z>4+ef>4n%J}RSw`-bskݸl:,$ 0:\7wqVP?`݋YTl JW2f裢kR>PDSSM`&+/PRʟEwEUB ,tLm2qH/¬k V{' s>I{`>;˓Z.fIpv15i_Qݫ{ дI\y]o=Ҕ@B6"HC3WpmX|N \7䴷`GH *ť]"[ 2K) $zշFƑsFü.Q> Mm97)Qˀ$ur\6lW) tf̗ ;.H\:!k:l)nlcfIj/Le"M5\Pnn+WU]ej.! h"~^֚́^ z!lMeso%޳ 3@qAQtʜUMŽ̹, S\'{]IHEr# ~m)O9a4euCpae!Q gk Fc'k0/xqUh8Ȯ*ůqkV6 -\I&B`%Y 4ѥ&*:.*# bUv#e?Uz}ʛ#̑Kj-~E]'{orPf y*XPsJD5u ^+r{d>;%=pjz(pDA-Bd瓽1MOzj)z|J@M`~c*BQ׀|}0XF``j~{·5ʶcx!3bԒ6!ґYny]q U+ YG @ '8< ](Н"rk\0kKx.uɤe|Bd>'RBjU(A WݣL-=QG|u@hj<F@wro6'jAYbUӡ4ǻfG>҇.jt2Hgk\us<C4L_R8ŵZm qHC@jkRjY[)J;,2hmz.V8J`\ v _7 _͖w8UR4%cАGEp$Oqi (ǣV?`&#1y_eӊv&n z&/^e{HLXid\"40 NǺM"3z _3zzZcH5~tt)8>]`vB.0"d1u3@ݒpT:m")G !͞0'vuWܜl>ysQNopIvh&'}΁WMx`ký5u6x04S6tr?IXͭMq|2,.žI tPȑ$fmD5V!Eclt|@/\a}'*]e5Mk(}Fk&^Z*Y=` %K|q͍[lyBN0SƮNqT#vyϞ*(=k6@e󴜳sx_ݱO~=P$@StR}879[j^JOحkXֹ%W2),H.SI\4l [[L-8X!Z[ԬQ^?Uf3nN&Q=,t={A35of ]G,Ta.ŀ Vɘy*Rsk%:alax\."~:UBʬ.ycʑi=+FmMJ7+nha3(ή[zzM(5C Mw%ELH,Z8k+E:+Mfd쥟krѤG6.0zVa+I^xضr=cɤbd~DcQ(ikvPmj =.nb)@_GW+:Iq\."y׀eמ8W\R^N#bcBLI7~}6ۋ` VCϤr>|3`?G!Va08MAH|nApyUgBN?}!CwPkNqʩPXЧ@K:)`lɎH r%>׹͝ѳt?A.-ɬo&Fr#U1/nМ>:Y?L @M|9Ds`Wwㅁ *tvSj8e0mR̪SxFr£/蠹$hd̹v>zsjsޙ9ˇ(=NMQH\g@TKE wGK0xb򾅌 BNS Sx³)tds"V_⢣1Fz8'ׄ^l'Ky'{v_X;Q !8@| *Aff3$#jz97. r‡Qcm K V6 R{;#SS cӖ^^Ęu{-'3,cK= V*N-]hx`4aU@9Vbk{N|ރZ#/BXs\+|ݒaccpg"&O:+{X a0cX*rS[d^o8BDqy3#b#H3#Tsh *Uwx!~O6+~^m] DuTŐteftIj:Űy\ EN3Q1u4?/O7D1F]3[ӹz R˱L?ȠeOnD=Z%a~Lw㶮.'YjBJtE3w z)!WOqb*ى=0E _ \C4{MWH"ETy䖣Y /H[m wZ:^.D5g!,Ok;#궺yF(>csWհzx9IrskbBϱǠkvnoسNp|oU 9nS&!t}d ;5>W\fț78r Fwܮ bn0<=egIg'f[n1X{=Z!aS?A{b蝀r^ 9߻[98b2 &mўq`P0,Hs2tP>$W1꫽!zeMTqr|õb3 ONLTD j7ʣ:{z%ӹTZO7ރp)LZl:[>Ij[}20d/'f>S@)/1؉ #p'+EM5KR\~n#'ُa߳ktM]GQ#c,̓-v+ܩwt!ΦP(bO_a'RMgb)FBPv=wt#ד4n(xi̪WȦ6s/lH!a<$ˏ{}wk{r1IBXtݟo |I Jݒگ 2gt8ܽc"M7-vi8AKs} {H{ۏ[@Rh-)~_wΝR \UT= E$+7l|g+1[廦^*Jj't\ > sKtU-i'0`o$E%LnסB`Mp2=h TB/Yd(#,i bp.; 'r'VsX[E3 ~ 9#O($ڹ R*w5(:S}cVzҍyT4Z:en)OûnN̢EowƸ AV+DB;mg>2(tQTfu\x!jnp'1"}/%><*<k*8C ;j'{=ilJÉY*Rt+@w/hB(肼e)BGIo>Tl=8|EUoVgh `[Oqβ#c=N܉(Z>8y~_KLIJ^C)}Y.ܶRתh A8`I[Hw5s|"Bw5q;6Rl@٢ N0CҩfyڍR @ЧTjcp Q>Dfka 8q@.Ν&ODm$bZ]\ HBŭ&=ϛxsRq Z"Ϯ@C77r~5\)hTۻLXg'.('5HJ%K{svY8N•~px4Ekdxs'~vS+ u7/J׹,ڷхM<&)V1gC$kލ82!7 Le&>ZG"]$tf5ciD), (abO4Rc E60Mp(&|`a014Gz <D2)݄O˛R-ZVIN߀O}Im2Hj? '"T6nwmwG= 66Ŕo},c160` A7榬:Rb>< 6☛UHB%8t)c({_Dk% m& 0;7@0iGxBCIg@H_D]v2m _ ]kH֞@]k<سKBcpE|v^"39}P?@VFE~v=OvbWc i#M*a_ S$x^r,m^=>,>l^a tlhoT(oA$bkEDҗa)څ0Șpwt @L8V !;E}X[TȣC^qL7 Z4nDP">HB~?W@n (@hbFp:H1M) p!LEڎW88SoPBKE4  6 5L`@F\%8CYWÞq:@wE_ы0AJ^\"pڡ]QRtKAs<ٟˑt3y2hbYb!d5k0&`؇wHSJV?q{)h<21;<iiԩ 4!q .sI&HڊZ7رNUrMC$3X{eEj[)(2~@h>eEw w'|$eN 7+.݈É@;n~H|(9G*]bqGȾƺ[p&N`5rr!NüEvz{uz`:&݆A5l !oxJ;@%a֦??=V~{;]T#/ȗ$Kŕ8"5#KĢm#0`5[Xn!t/gx!1u#z1~Ր#&>AJ`+_{qv7S$>?VVڥH6-AxKދ4IO֓bBqYzIQY}t+ybQ&6$צ/Dit)ރI.ޮgѺ0V)!@ `ZhAF<{I Zߎ m֭ bA|k*"hH >|у=_v|Zt5'0&b<({#&f¥4|:J7r,Kݰj5}8AA^~Vo')bY2nfTU*b?ؖ8rW6΃9;N2}4~&y D hg-?ޏ}֟0jҡ"qmT,vMu9 @R\?dx22y:D5s օ6܀Yê *P/#hz Wi' pa Zbg 5 ); УUn vR7Bm~u;B9abFcSxؘ"#Vz.-Qxg5Nn]\sQ&{ukX b(X27*p廿$+כYO =kݗFTq;Kj/NHњj?$) %}ӻY?H1vBCAg,Zjڏ$/eJA ߴ`qTs#)2;&$&Xlۑ>!X s91饀kQOi^Ed.apEo]ṉ̌jMB7:2YV4 ʡJArelFYŏ8Ya* cRdo ш:1iottݗZ& ^Es?̫*Vl1@=h^%p}c'ÖS#M0i.w#2MȊQ6JF2Hq Xw軿0-gB2{gs1֓1F춽{;EԈ =6<ě z5 ԫ Y 5'ow?>k@u̩lVKǫЫU m8aj hU|{A4h; YEYj& 8Cp1/[HmͰq6'\n|QM]#ma|hX5?p'}㵖0"ZmYS7飊 fOo!%Y&A7n~K vo\ςSbA}(9(. oX;+ .F3;aF@̵gA"AsHCn\3:=ʍ/ wHog[Hڶ.Hפ,HK9EVNӹk?P`{g 7Kxjұ0w =ӍL&;!{?W` 꿑H_Djd!pO%$c'qh]=N{~V ]Ġ"&l]U6b;l~_I:ɞ m˵J\x=C!&p]Fzʻ{޿d%3V+>j0-F _U}Qmzı$油f,eTF{{Fd*A wty/]nt j6<}p΁LoBD.l -,lY|XN]nzs7|qJն/Afl D1:S;olɶ0Yh{#f|`Â{9-PA4%?Fb_ *6fn]]Mf=M#7qK V"#/e*X4B&C,<m`S+bhLSIU>E^4IF-`)`&'<}B*s\y2кme' N-7'eZܵÀrB#lcҢ7 M#΄Y9*wf%ƮPܻĢH98/g\ᔽ̾n/K3.'XpGqxYF#!u\c.]C}i}X|"=](Y+DtrYږJz"-3RumSK4/(\,T}0![`V-2s3n=uuSg$@QmC౵!ZҘ.>sJW>;b8S?eH:={ka&igQπX4u!vo?>J 6<2+j") 9/\QVj N} Q{= aTP 3CFW7t^Qo=p8#B10Q [ZтwEuZ=#x#eƨ yn,qm)P#;`}85 a)0˜]9-I[ X}uAԳ!T> ?oz#_*C ?:jHd/uOYu&p RJ jB*\p ~+\zI߯id?؛ $)|J_ )m_HIm;?ڹLkq [N~X[ˍ]jERA6bˎglj⼊25_s?5H?5qS "m*B>(TFkB|K0yȴ$x}D;4Y2)|-r}y@8]\Yۗ›l&tAI]aP\`srҒg[.yj5BZ@> ~DJ  w =k@"k껚A@ADbCD =:mcx4M8CIq"[-,.{"!NMH#d6CDr&skJ?s"4]":A |rb~@uAxwQY2eyaqgJ}q+ncLn_ӹ; _JV W9 * QLXB2.;L4?-24yToQ%YRq\Bp.;Nf> {Qxkj ! ޸6V;r[D X#gY!^7i&f ąV!W [I[ŻLe&].*VcKbv6'VD^ SLVٝmTc$;Კ$O؂s5/0 &%hLēMTq@~TE]?ꎤ{'yzsksNPaFW)VJH}+dl4sHɚBj.D&Tת=V)?/-`@KH'&ċ[M|B[!LH57Rw+Eh"tED 9M!9 @ _>?=VQ/g>+xK_<< 0HaVϦM/}D9s $y &FL쭱yYqjΜ^O_ip| ;1'hdF^zU k(7~-$T̿\ics軲ABLiWZ~[)S;peU*i*R K"yn_CrC¿o@/vM+ۜ1=) ?+hq??+ԾOq-43>|\uw?f*6Hֿ!Xqa"]EJhKAP4mv!|` &9ɻ?-D#ccZ9@ks!К4`cdMe8}}b?$r}`?E.t@m,j jgh\e$G;탓,YёGי5d/U/l qf$^ԩ[22hc,<0ڗK!0( uER_8`8 ~\sHXY4Mt㡻=עڐu@Ԙ9s C-uV : 'gylVٶJ%@ {N/gmsTuo&n: $wsmCJaE7FCsے;>vȅPe]ι8pJY4{?c h,Ĺ%zhzA*Ё}K̟ĈFD0hXZr1fG@kdM0ssh+TRX .:dXQp\uF'C>5q_bU͍<fJY^I˫CDI\FHT LOmg--d)4 ϔwJc]㙤:+z~]?,1BJ$bdiR(&"qF^uc#)B݄ c+Rۓw.j˴ڑ_tb{`m E e{{8",`#LZVlu*{9"K|l8B֡:IP{N'}DcK.u>o%H rm5?vpҽ{G}%6>_ls:#rt0?q>w2 361Yܒ:}wD؉.F)L $Dd+8GOWh X O-:Q;iCp2"J*?⪝s\GSmvlyG]`}BJG4mz6ӉXV<[?]#x70?^P@'[=4 }hW^EYy'kɠ)D1gN^cN4e׼ޥMXo}/J="F>Ookdb{=M /BžOhWS<`O@[rk1'5%8=asiE4M d@kn"BxǩkmBH(F2\U(LjޏrFJ:]K &!JJ$+Kލ CĈf}Y5ԶV a>D(H~N\1="tYVZ,@~HZ*Kg"mq2E]DlAsVc CR<mB\ +}x4I ` 5sh|إ5l$ <|:J-tǶliQ|s淎 UV! $1Sͯ ,(us2\L-oZf7TH>Py")ϊ5%IJ| TSŁr{Pe UB;m;(Ցy鐫-[b9_OX!X[4EVHӢ3]6V (2L{.yPoM COAju-()'F;Dv,SLeęj_dH`CRxw #u+#w*-d֗RX2&q{C#E4/:/l.G;[3yB_N_U:b28 OI\^Q3ZM'3ӛۘQVIckefRK@Icl0,oxwhq8L2 ~|}HL!CqHnbjCh+ڥu*QU]Astic]xIP,m6w];%oOs2|jj4ۯ䉾sZU!޴Ԫl:k~fJG=ZHj[<-q@$є[޶J;' |~z-ux* i\}){j +\Bw1p2pDĔ 5S:r6=k'SOaLa-q]v>t8Ctxu7q%?Sk'Nc )Sÿ3古*H:F_HCߧ7~uF;]x.yo3Ǿu0"fRDW=hДiqھ)1gV3Hn )Z^ßr$LzR+~/DרnԒ8l?%{)aD{o5E-{uq61&}(::ށ@톃l)*UF”)Q3( a$PTm÷Oҧ3(!FR q\MmWzeg|k0WkE[lI/-k*~RuSS8" e7O뎷_"Yy~|7+OwƳGEti }5G~p<%F5G8_*IaT)HݵMN㘻@5 y]_ %Юg3]th ÛQbGKR׺wTw`dEI}`DXݨ@;+^>D?}e3TTkwjGZs#W>`h6+ؿg/8sL Ah:? HC&M@|a{쓸+u$tc;hi?uCj\EMKXZ7Ta~0aBb f0~)][_-}{ia~lC7jAܚQMfCu&)q+iC\6n}Y si}qQi4QOG_yNA#?Ϥ.e;Jm"-ۓn;R4߇z;,Dr#:laȍV#6=!O; {6kN^M#)[T?IJ]ABz`jS YZuIE`Hê%~KFE ٢wpHAs~4.λ<ګC'RL-=pL-|N6_B"؏4K`!/*[ux^\d7xy|;#F&ܜ?:A{oڧ_'|~-yRr>m}`I=^3">^ާh=,|8^'"~8<ӿ9AmĹ21=^wߟ2~^1Nyv/wn,˺7lƿm)c\^OWq/xy® onEDˉxހ8 MmNWiXO4oVPΗr7|Z/77^drOX{s~[6}A &oGy7 H$胩!ޣ?OOSoC}RT7^}`7v?>K3~')3 - S,%XퟎqO΄a<> X)8]1j3~ވ=ed}h0.5ͱi˽mP;ܘx|\'=eM^==$q&uTڧ^gVGj4 2012󻄥'yDjcfir0-3@'X(DFڣJrh0{qמ]J0'dA?[F75:ZwG CpO{0);ɗ, m=6SzpՅ܋4#8Vߊ-4/=53h͙̃n.@eCr^=J&\vZqP},<oC$n.Lv]OI'a2VM@BSچB+@;)FSEj+ W[Ǻؤys06?fx_$?þfn⸀k,$"),E{|)T/`7\5|h 2jFJSMe U;ca !;CiO`DU,Wl-S;v9Hb>%ة%e-XghcX=O7׸3hA6Ý8u|7P$\ Iʱu[L\E@ Kf˲4s[۴Bo۪uDƸ-¢N̶}1jXvKtCˬècί[k*ؚ@H.S(h݀$2m+7Ngg5XBJiuk^1l|5^t&g랚#r5l5f'6M LϢ7?sb`L&ELgN7!.,Zp &k>(7ֈ+I{×R.Ƅ^Åua#8wP7y{hٽE2iNJ෎аFV`gS'gNRiSN\6԰ џ z!aĝrʗ'Ļ;yʁeJk)nǍ-א`8Bb;M^,b&`0Wf3[|m݌sF0C hiK ZbF %ϓBCb4Lmyc7<1Mܳhe8*g|b?&f] Z&s3n{ӓldo,:!N%uwK?$HTL /aKJ^:0z6_d,mYbIFʸ ڢ.!+v" ԕ1-3xAu1aҶuGm?٥J9NB/R`>6~ 2&^??JҦ>6B [H?.p\ +K УH`ir%^Ch3?ӿ^~qd/D?parIX!Qퟜ>GK|O/m>G.sI{ |L_V z.⸤|42᠔|8`Nc-Yp u-GSte.fȂ@qєɷz\a҅gwJ:!3銖z]=x&aM _gY3=*Ec)R ؀,8V~gemKb0u 2ԫoBeN393"Ho,+U%CШ;#UIksI̲x]PJ⛁ZPAWftxjmﶜx[͗2u 3}P(j3-07BN8 \~0xoqN.cE +f]\j lh֬&͓{iEf䂈A6P;dJhHflV7f3 H)[xe _c!QZaմG9f~YL*S: `2Wm40Q&c[~:Qgn0Wn%G2"Y}E晪L`gNd@>l69 cmR#=$;hpA 9=N7V<8$8oe'4{p]mn ٳ8ls+ŀ"E϶,`KF"E'S.#έkܩ{f3eKr%@"Bo?aa–؜s9r+t=r q G>({mf,cQ/29'|h\G8qYeQRp~uyp\,xDë"T#UafK#E pM ӺZ`^ t.1xB\brϋ^#Ҹ]k[4;9nދ # ƯCDCaDj%=^Hz5bأXOiRJ.񾊕_77B8=D0b.qPgM9TC8n^pN%4G1sYclO9 TC0=Dpu52!J%{' DUGG>9袐o҃[uye;Tv`]T>}*`m.SŔ61}`jA:95=Hd4YS-X*-:4 m'?@Hv~ Jk zڷPeOg B Ur dЊb"b ۾uDAͫvE%3Ʃ!.V4j3PĤ>~,ZIFs0c^-s>{30nD7h2h|(f!^ ð`q(FunX#Rp5cP 29ڄTDÖ5u;-tROݣ^F`h)JW@>b-;i H~ȣ 0&co`AO$TvW=72fA+@Xgll쬅FcB|nclLuހ4|djb&ǝEص|FG/KU ĸLX|euNؙKv_=]eʂa*#T; aBi[cgF7'.|XG - >Q#Oc{Ţ_ːR4@6TDUe$(p>B؏ZՋO [9A@FΗrx_D8-lo@>rZ[g~KWƬo 2Ҝ𸑯F6=2e=90OmBL|!'KD~[+%_9> NE=C?#ev wީ_ /s/?L]kbڱaj7x[_&@BD\ZKT Kn: \ rwBIkEv[eGם>⽝dtlSika3|o-]6?ޓdf(ɽ{-Zb"ps`Y/G*`=3vx-F>Z y-Z9G2.r\(ioVrWMoxv}(;L~sP|w!ĕCXVcCUp_)^O>s$uƜW&وHX-$N` ѡDs6{.嚕+L4"ӸXGW[ A: G0[fj4ڟkjR&~[R'l혟tkAFQv廘"kny4ﲠhŖU0=Miڥ"w{GX!/,JKG,4Y}$Ur4 ݄/^w&in(5IP{(CN ^bq|x?-:ws }aQ4>bgmQ턖E_Y媌Sfk(M#$ ,OKnlk"".g"1Z5~1:S}ܡBn9&-"-bN tb'|4^88e JxIn?)b~l˝ˠl"Y1wy=ܖz~)ckpGhK.<bPvsc!#UiVޯX1Ң,y& u˘HqRLiIcaH$a4Y8ж/o$09H5bfH ; yW#,!Bn')Y :K>/g~^Mr\Y;r2n;}0R8{q)#HD*?yqh@ٳr QO< M;5OM@#Ցl,WpEcSP; ?tQg*6uO t|oA7 6V *~A/9yi@8!dǭ jL&ZX %]! 3- 1O A Bn C0Zϲ>֏ii34L:y*R 5՗4)h.5I⤯9bG`. tFڟ( f?λ[ן|kےhR=灝l4o 2 [\P>С_f9j?\Ay9T)O1SmӠXDOFd7esayO]*C=Ù4(>|Ӽt9+B;2:(s%=Y.jNɭ VȤSSkva֏#Sܓ[)|;V`F&l^NYbcRc*A@RgCR}T83ST-O݇7nriBLܨ3S>gtʺ,Q/S{@&ona@%ڵ_X94>!Ms6Ԕnw B:{>"VN0UنqOM=vp?7 ׺Hn0{/\):&,iͱ<6u; ˃u#@LY=^LG֑/7 df??\0{YurܴxM4ʦ`"ѤHwD=XqNƟ42#)f&:%JtU85.GE]P=B@nOKbaY4[ڲZ_2(Y<.E&x}s]R g }: 6}vk35kh6q`VzYAx,Rf,1恨j>&}MY`;{g* *֖ yjk(N,3&f<%4\Ʃ8}<,5.BSf=q*%IpWCZ^zK+w݆<,巅!;TqO:vvITtɷ ]ZM$Tg,2c{ ZZm /DʢA5`A+bYAlL 5˙'QB| K97NE<͔\rrFlxVR+z4Ndǯ6]k۞'"s[?Y~#Еb5&72J2L7{+DžI^{ *\(ƉI)pxm&G<,ƞP &P+6m?xq澁$TW3ջA\Z FǼXoVr -MyV35na.2qK 6R+j+ˌzLf<}x]!rȚ/_I%1(fN6;Y*vrT*M>D}{P@TD0a NGf>qC8*ج)$#0]s%G3] Qp4.g1skQ%RPZv 8Gy:P"S.guě^Qh FAz<:j +X97؉/Sϓ,G8A8vGu?Auʇ)J1 bV&{"5x'Ntw]S}L/9 G-l|I̺bj|SoM^ @*&TQ wMD#E/̌^=%VYhthO-E^C@iPBU;AOP;J+ i/x#mȼ${T-p V*Q(pO"9*T1yFɧ\Kh2X t|DIWjz:/rLaw#bcTG 9xy)?"G߈{QO-|u*mnKB.INV&"Rb8Vn_וJ=aV-> 5erU˜D`1ɝ## @H!2`J̓ǸԸ  nxݠ} .ޭ+ֶFf,ڣvjdl5 big>`QfOT ˩>/5KG!Xɍ6p(R'lXoԀe"SP!0 /\8RLnpf2X bW~=wCG#GX~ MiIJ^j7˳hx40jb.D8J9 l +j?a@EkhvܾlTvLlش4[yCb r0dlSձrS䞔QRôD/C~U6'"Q`+rYˊ!o:`{ 65oa/{ JQ>e4:z4zX$0E-;ଏ'qчl_ ws^YGw%=U۰?hxTơR#|ǀk]GʭmFdr' M B}^ y#j@HdU+H%fK4(HiY 0XJ<35UGjQx\֝>ٳOTIlRBV[iaqI@XF͸9sͤ3>PwC򐀮6[+P-.`{ FS7_r!a!?0_Q0bqw Y]&ȣ@De9t| /[iƝSD^IL1ۣ:LggV'HdBb dBjyY.]ZBA FG%HuEv­Wi~7dY]bԯ@$E; zᨄdj؋f+9C8DӨ-XC J'4RGzR8Iݽw>/ϨUi}wF ǩ6s`q?-~7Wn``xi0VƒyQ&n>;5pO]:5 㙿f Q׀[}̖[݄+ I2O,r{h DZ&>^XCJq-ޛ6v>J^RQp..zq~DNs"M:irVhqBm%x 2QPaFB [ҥ؇P2vBvD_[L2a !w2\VGxʌfjir1KMc0Չ [*6{٢6j[8P" Z]J]j?4a-malYa;FRqFkTLQ*969X*H7@gֈg%ͺJ?y) oh%^TŹBc'~+vu<_C]j+Xɋ`Ɵzv}B7e,Iv~Wr]ou28juk*BV{/z V`ܧ+ 1_ܹAkRc bhBUOT;H',t$b|$k4B>5fDR [adp'+h~x?r,FkǵkQ+D箳uGTL1Nη.CGJޯHz){1 Hy^Ѐ/z1V҇:wtT>ZS/Wk4Ctyןu }& 1FeBִ*bڡ}`v(6^v+^ o \XsʵVv4ѡkmf=Vպuov8q|>uȌ(Z=THLB:Ma#Pj}W2kRp<|mp\5běsA$酯{&TŽQσrJ[Y*AiRVZ9!poH22wT#Ⱥ|X.F$X$y(!M磾c+:RXy&2ӫ)jUPuEЄAma@Ⱦ/Mg۞ƌN4·>T#GLəvgG͸Z <# p'rݰΈd#fM'];,w+V1 +^@A՞KWb:B^%Sdžſծ_I(-YArY+ΙUvxPBǙq3aF]>-CLŚAVf$xS=&0WYCJ,M_sCur);X#̉k+֮ WuNPB xC!p0,U L ˪ӿ2: Z4s8.SL;,4$*دQ`6z. h\@mnma!HXőLP0pݰr{+`iQuPӈuo7'c^"oyD,i4=Ce?M!l {n=_Ka:|bB9ϼ UFkLBBɵW_h?˙X;d0t/xM}@B vO^XTÎ uwn+%Fc ^.mwϩej&*T9+Y-5d)kE3H%[/}F|_G[fK%]T熸9?;4P [ԧ-ŇB>punwۣ(<puwl+>(aͰ#}7BȚni<&{t, ^` :1abR.%jߛ|=M|1vȾyͅ{2"0jB?wM'&Ps0NWH18NC q)QuAH[L{~/L8vYc:tƉ¤T$XEbPo사@OU)gx+)t[9>bg5NwURV%K;@L}J;a͘64fe˲mw_ Y++S)ͺs0фS^^dVD.˕7KyT=⭇3`v] 5I ckppaMI[Zn/*C&9Qĥ5Gtu"Sֿ#q_`bIRa2U39;.}8E(ʈJwqQiNTtj_ 2 ZAԪ+.~G ,B?g;W ,5rN53gѠoTnǔDz D{n۾UD=&y@CB)eiV!w푌7u͋I(7x%|ÐFkv:^i#[a47\LzWt pz{Lp@35p1%G]vŊ7ZyX712*RL+׵r9ӝػewuDžj/+J^7J`S(=. a@]{;o>m;'Ũ浰'whV"Y!eZ0g.εsi1q \KUqz,9g”,6|vs~]DqY:hHqs&X߯n >wSmDD kZȃM'0XA12C7;2=:c S{O 'L=LE`Oyoa!ZUwA{j6'/bZIo||dޖK'Tf[fJ|mg$\! ]i]CǧE0t^ vhv{K{Ӗw3x Ua 2c~C|#6ǥ5?Ҋkez {e鷲 JG_'h胒}t7ޔX"jYmJ:!$ ƛ|hG!E:3z\{G g!Ams8f;EgdHi\<;J˫]sC;r> ً}j+4K윛ٸ﹍MDVIi9u}_숎A?`Biw\?㖗gyHC .f(sϚih}f̋J8ZŌ^pxR yS3T 8wWB|\r*{UO twwwqmYJuu]sf`#N!s' /Bm_Mt]$ 1XpW^ފl&TQtS#*^G=P8e-CjgitCTU>;蜰beg;v8mi׮]?ݎǚϒi[YAp7O;@_X`yc'r"Kj`7 x5V 9}+vi$M#ApİQ7ԿS8juvZFtT/<=ܲ1fRs;hB3t-Ndc69SX0[{7K.ք d/}lltW"FgIL HM^#>-Æ#YaTn@EbŤ lƦ8KM}\"6}m)Ԛ}'U@p&y~k lEBl)0HySś2U_U0-v[ ([c:8p̀hTwE3*䇷&,Ht=e\vKyk_8Ώة8.5Z +=̰m߱8mYTD} H~f誨z/zr'Ir9g^'v2$g Z4|eLyXu/V=O^xEhYD9<<"d 6=aiT$wjWcVxuFO^ֻ5;;x)uG1Qnk5m૵,㯷FvZ ξf+,c݈* f$hOIV$n5 =[W yynC=?Or.ˎƺt̓I&#_0z4<}'iG+TdԽq!@_ƙ:XH0LgAޫ>vǺ쑽{L"|Dӥ1Ţ^>;HG>Hy|{*?&19UGBGI.wӣ;Jrol'.CɄw{e^~lb2 d ٕ% @ q2p$GBvE|[d$$olěW-J?6ku}?5鱗KD\FAY%WGgv Yl6QD6 O|xVܼrs U9Z[ ]G$YonKq(h2Ex3T8l?~VFiڳ綠gʧ/d4,k0ŝ/- w?$KqPڿXm`':)hlp[ l#,lx:qOҠH {/S jĻRKV4 0ocO@cۓҘFN>!3L0KM=~UN4oC2\.ҁ|Ue͊mٰ3G6_g\ F((}r@UvRd%t.3#8Pi'2lBg\Nn ,'XE8i/YMI.Cĺ C t]IߧgbwUr!M K3W% 4zb < qG$ZF߈Y\v:CS>&O4 "szܽaFC>Y-l3NQ#K$JPchgjG;Gn3dG&.‡7W'q X5Qvx^6W<W˴ TK30ZaW"1`>54k,M@?2?ltE/GPGF4 l-~<2V:9ꆎwܢYb:C۾.ly$cͫ% sY @!;&wYp#gGrxsxn$~tVDպD^`.H7PJ-˻"lU6Nr MsibUތˢwaQ;8Ou^!;[熮-UunBAPsb[dPV\TfC+Pk!6bG D'VA RQ<[4LTC: RT~%\YzEM.\`qz@#o8ieRPj Y"uHcpK‡99Ѣ73/5E]{X(/TMpH9W9}{e߅boPImckx۔ 8^6(e}ۦ%êHFƩ!ÍζK'k#$VNdZ};,o\!i2.*ܶ#_3+bp1:LnL|Q}L݈ 6pON'oINSV.ٽS^9*A ٹ!1}6! E!a̲$,R'ĻVnAM鳩+5\ҀWX(T<BUW)IEsaO-;_a' cƨEk̀`q=k"vaA34߻1I s6f:°>3wKLTs~(hC06 db(y&bL.vw|s0)N^ )1;?t{o!Nғs8 ..+y]f=H2aL:ޝ|FzpcG?eFMB2Nm@3tA{PeydoP%W '3f\پ2#R&PE Ď.|yzNDnԁѻ|#18{;qf]x/wGX;eȝb *RZ&< p߮l]v2w/nVq I&F27Ȼu+NUPy7݉ƪ.:Geꑿ"FqއW#f]֢LZˏ[5MP8\Ns>gU17E&()mov5h^mP|J:Mj ~XgBda x/z 0Ylv;_Mų?zuYeɺ \o'1Sm3[9Q|`xiB#<{!Ģ@oSq4~L.d@v冐Mr+Rpkۄ$ s5 Z_֝*gq1lH`WwA!CEqhG&h#gR%S_(t$GKJttκîR%\jtHUک23Ouܓ˥޵eis/E i?:񷌕=pT6t tq< @ː:l7HbJ]GcMs_;V?#y4涚-n%$& {s8, L"b3Y3\ ]+@2@]$̛[$ޑ^B4؈꣨dQ٭ bú eEs9/'a36%me;"r2V)LZSΆ'9GP}vCH Ws<`{1G6R, SO_Գ']o;FsW';? `f!^`WJAhC C5Tϝ:zun^ }m>ɏ(@.=$QG9fk'dz Zu3ǼFt-.ׄj4]%j~[5F~,5I.thoB[.=هK#m!_w-D){%e9EF[q lEԔ j{!9NE9#{䢁ʹ޵®CoLy.~lp"UcbBF&Ф>-$g{fhhɲl\wid@j/(d -TXdqӾ1|6.P-\鷨7ՓWJig31BK& ~Q~ˁcs]hq-j%R!Goݵx0XG=R"ȢV0R_G5`i%ywngs+Y8dD*!!lxiP; |郖|>B:3:>>krTYCaۭcZEIzmEq{F"@[U!Cb- .>o&. #WCܽɘ&*:ծf.~*ª g`H 5 iú(l^H"ܽ2t۱SdHGz# 'xY/" 5GB^tP q :ru1{#YLkU:k\?jwQ_GTQmNQûcؿeN]FWDFQ {Lyqܙd-v!+txzV> nTq$k2j#>?t$mj, DVm8Z[0? >嫓4%+Lt\rw!^|\Ot ǣ)[Сq"da:1>`CCkXk^srT =]`P Z@XyGCq6ʪ]DB@UF>W.L7ͪ@ "fW2Ԉ~w!`sf9'5zwg?,='n3,'+|bʃCxA|-/.<鎁q}rl}-j9Aw6}&?E{AqN?$y8~`'G츦ۢ pcȤ4GUR5MD"g$ApITK}'#Xʮ$5tg/H_: ?$} |N`EIfmEOi4ol0 x?NMt\G-pM2t #nr P%}#V{@6VF,o6faQ.f$*8t+(jL%ބ_~׶+>d<ӗ Mf_ @mG@IxHPrlֱȁyBMr kblpUʹ{@qPSwk?#ᾁ*ifA!&aC^GB\yu )s5M1|~cȕ?eoWƮvi^k[b̯/uyejmqDg _l's RNݝ!O\*6kU~j~DSwDɳè²ϑ<"a4-V}eLF.^GX22_2ub  xEae[_y xf>J`p66.jDAB`C Z$Ӎ6dlX.C%<\#I@St/)G$l_)#gppU{Axѩ| ODH- ;مrwBw CSwv$U-s7ƻU>=$UBA%m+Z8n;$N`á 듁L\#5RUJic0l!Ӫ"*;AX%'raIäf6r }1B&w|ݲ7FD=D.pKUbܨ͈9v(/PQwu+S;O^sH e"c՞DH^I{G,eˎ!ЉtoD8 aKG]^ N7cVtz1#9%|(*t>\X]8~ }K&:^_uM7 o$=tU)$=ܳ% c47)jI{j99m]:]mUCg8SX^ D&]{3@u hBǿ t +G:٢M'Rdt@dj-Yf2*uSbjgqk~B}j*,Qp*$[믜)|W92LG(xjہQ7+MieŦ/٧ԝ9*!߳Md}q{~G=g@O {}6:!*kibYMC\i6 v ScVĉ/OߔR#Uf9q"׍10G ~R =wJȏ* *)?W[ExI|dw*v͋\1T$z^?hli$0W| PQHgr/ʪz]ҚV^dN]Va8̇0$%߬\ܫggXבf>䀧•\u_ڨ֏v;"XsY!7i*[HթG~lQC9Po ߗA}3f 'm/a24B1eƢ%ߖ=d=oDjYiW݁?B2D`;-&$ 0_wzǰ67n>!&2F}o9rS9ZXz U$eiGpEp[G. [%"o{^6vË㓢.MwY_{Wq !_hhLCqDލr+Ú sW~y[dz>o12\ 5n{}qs 5rO`R: ${PYW, 6DA7޵H  \+tWwib7VZdofr_f9?5L^+Eb ʥ~k9>M$4H¸7MW<$hS:=]MJ{zԳd~wLr_F+r^s]o2D6,ȆrM_k? "m7c}{J _e~n]Ź9zc@^ ETr`e3 '!H\1"q2d4rxҒ䠷v\ }WLONFpރF77ע n;,~;FX}騉^KԅE( TfFڋfAX)|tDw-9$پYCR+ @ZkZ!@rU==c66Y$<"܏Wjh[W~O'aS7㉵L@6Z͛/Sq=}if ufz-}E&jz^;G FWU{qGE^o*)6ιCtsiƦ(i;p~&SS.,F\pqe P0r{V34~貗>jhTLHh /Gm!Ioٜᕂg۰{C5t<ɶ`A 3k^#kh:8ҳ1Ҁ=^F6t맑5( +rw$3.97B? ^˝D& cg]NtH%߹ p 喸/IG_''[ gzڽM 5Yuں,̌.ݭuBu5!es"N}3WJ933_qel\_[SOQ5q?&MA|Zܦu0lC6(H5rޙwxz3F mC" gь4G*K1. 0qNG5Y-B Ɗ͗*/vaשH^S1 '*eCVAgsV#:Kze$.{W)bA k$^cFqcG-"͜9r1۟`WYm"+^CkC=fH)mHio)^*02]#ugm 0`I6F}yP%iy-mm=uřeÉNۿ 5x^_R81 +orVH*#s7^\6Y .& hҧ ԅ=vIq} u|fǵ@-&!}J]'f u%*m'^3԰Dw7Q&&w1!l6VkewˬR|sNi\UU9OOs$U Ei?Vhyoehc] }6ۗ]"NS I?PAum l ۚo?"M% \c3NY S;9aH5dL$Ź# ᄃs/`F $}/JqvvY.}U%gл_lB娠_*Ɖ|5 sjd4de鵺\ڽ:5mcSIpeVKdqr EY:$; |;3 H⁜8dV72lx·1<Qk@7o`L:"m~,\n9Fb NN?I#{MPG_]'XFԐ L̲6/p`R3 Գ, OWA$NgXq8HJ,n6Y^Q f-S>T25GWC#}Y0-sMRn{0麹HNal1/W{vJwv=x+NlR;@1unݮ udq*{u`a& <1VIQnY2XF+:-R̋!́"YFmNMģ۟yR$sC7&}̍PhEpV8oND],eu!ӂIS}Uvm)'٢1wҼ +^sOFdw?3wp?\dž~[ Zމ(٠F,W32pRY~-$VP>ԙ(/x^S\J3爛sm}P?{=@FM,i,]u.S!cCtƦÜ`N)**::&qd s&'PSkNr=%ru hՊk,kjđo|>u[4ԃ$!6㺇Ym֨zQ] qZ@ld z8EV/Mh!d@U72^+_)RS֟"`,3Hs6u+rC o+d{r gW\1wX&.l>ϭwYQ0oaJXOѾFxuy~[:lr۞/n[QAIOjL9DF/lu„26naڇ?7,!`-QZ[p'OCĹ&Ģ{2Ⱦ^ lfA%tM FBMԅ~  {7xj@迫 ٳ])G͞*Wq84AqO o374N漢x !IްlA:0>WԓhaLm& K&uLl"{/7T 82c8fQ'5%|yY[.WN`#հ_XQ'f_'L rmzʘ`Oи9n^64)akK`l\wBKqFZaAȲF^'c$3 ) |)VcHQ!H6pf_alo3ɤģgz 淰(T2N=\qi*"G([Gn2Ց}]b*KjܛNE1mrLFl\<[ f"gF|GF)CG.+e )3=ê'wؙ]&lAp0V,t3(W򶊯)3t]ӲO{@ǂדD}0wrt U$~~h/H Zĵء\.KEZ"{"S WYb?f=ԅf,0SAYF"/l26_60ZAuHKO=ϰärs$tG"C@MklZu0B*V׭+ַ+3IJ[33X 1 +,p obm:ޖRmaD?yD+Nŏ$W.G"K/+2\xe*[>]%DK}ooEx>ۓҗ(F{v%mGdޏOz W߸ė[_~$j{' У/Vp3"=}e_^iE_זr /!N~9K>˝iX_MX )5]?ߔO eDv[>|ǑWy2_Voj~|w_h.JfF[/(^_;^[ـ;D/xB/OTG!P! w~C?i.]E{m%0 AL׿H XR>!s?0۶Ȣ`㌇g5eӦ#j}*JݵFR-zUNkjpuxR]95z+iVf[E0*E-Utcxd*BSAI5 oR8#Ç!q"_dskL0YMh?>:j;S*0c:9WIp3vf9꫊GPup<w2khv?ЧSud` .d7fo !@]Z4"bMSu.CM(>s^lӌdcFWp `(=8yZpHKo%Z"d1:qV8&;Ϗ!_#itfMWLs'WQOϏ+Bo |k _UUl@oQ+B!D}Ji|>=Nul~˞R: ^AYYZz|S2Ri ,Q+O!QhF靰THqE#M*܇4ާC hʚu@ dSVT6˶" qUKYPTW{qwՃp.ʞc(ctIF6eO/VWMecjzt0pmJ0'Tzx$E+$ Uzh`ю+C` `\$$kpl 6GJOD+24. zmA1r,o>Vŷ0~h m;T h`l4uIjfh帉^t1C:)-1f 6~n/ 4&'7B%PUBg 5N'3 >n @CquuQ 6t)$0g@50ij88~wb>bmxP $A̹On$&7GS¶{MX3g~cϦ6;(ZO`讫 ?ok;>[95ZN!jUUc'VS B*,ɪ\Aݿ 9MP4[ut$zD7~L9QM«NMjӟܣfWnEĿpnyrdq8cXB&Ǧ̢V#/LA>K`9gH"bEl+5V:Ԡ༁$cꏮL5)&l`t妋hB.0l$s#tLԸNs<8v vrQ .ԩenkhdO>Jo֕u!zfu5 z;M9R!6Z&i۵O &Gi cf0s]j2C"'\+U=2$b!P:U5guB dGGaqu`e0!t̡]k:)+l٧n퀺{s?@gRHf6V*MS.TcekݥoAr5j=s-XeucP5X}?C` Gm_BެC觋Ζ:ҝc)M51(öi UuCR/'\/$u_ZR/'BRc<@:c3!bRXt_PRҗckqfr}*l}T4s QQmNR!im48Bz%3vd;kD0+e7m@$@\QtjGf['1U,d@z7:DFH9)HOcG죡Rѧ8"z7R>PABu{gQ))WS05h\T]Kr˝) LǭD7`f->!3Xc1fpAbQ 2^·ԋ.찴*:ݭIe)z&X zU Ԍ.3EB&f-CnQpPZo04ݟ1skzI>+7" t&ܱeKIpUa0Jqv8zgkXw_h*kK;q7~O}<.Ǐ-dV̑r1MR{[.nEH`ꬡ c3gG鰼Qj;>BVH2*<952s>bCs٪ͽ6=z{}{ l?\>&<=ja If5R-K1P;} $*, /&erF,B bQ*Y#Y{w3Iw$˽d ]u(.Y޸v7҃ge!-K8?Rh@[GF=3ٰb I2G34r^l)U+ܵ 0+!rAW\ڐ"?uV&(֔ C cSICGN RC낹zf?x6i(tm!:[;Bj9=<ګK*W-ozǼY!s{Zٝr5i 4:~$/&3 8vGWjeXt‘s!7r)v6EVRm!l|=~ 5Zk}/|2Tա8+TInp;Kas@Wk0|;εᔞp^m&=qK>HS«.㪭"%(-PtԏBps I!"zž'"O["M7NB}h<ӄ3N`,-޽ud;εxaMڢw)Tql j.ue]mB0wOØ䑏b`a6zg-AvIE)m;z=E+4qLnҾZGq*kl1۵ĹI:uu׎&iwZ n='P@8H rO:i#G%?uop|:)3m Vj0+-3W$ҁIR+2K;VdpK |6oJ3yk|<'EgJ] /tZ~3;Rj*z'9#٨I"/\ϥϥD(*/^W3әC/ߑ-?K?2DgN$=\(b\yD׃5f7PelrrP/VW]L7Uk{.ۆk{T TztF9<(/S}sƐ˾ِӢFSnDÓe! &8dz4w#@MŌ?ǹo"tFˏ)\Z$8c)GHVZJA<uk;qhdx;0"^Wc L^M5??+ Ŷ_T@%ՏrwWj#A6 i+<zA%O]ԅDtrB[>d5UP5?TA>SҢA)[%J(3 u ^0CE S8*YEcsV3tjM[STfM-\QD:wu-m۾0DTPAss>ѯg>j1Ø}+1wq>('B%:Ǐ.m\N?sꊑ]̧iV͑i\A֋ކFQ\NH2BUhܘx2 R)bsc2EUy9werdkn๧~`ffs;[9W@x.Pg_='VJo8aS&y;&+ZڍW"ai5ei`B;t?݅tt|T$Z ^b놚|lmLqp%4H/y,k}zHtv& OCpz:<}X_;H qK&#9DC&|39y!b۱HRsj7ܙ|& VMv4 |0ywf5\Q<~ϊBMךŊ^QXQx_kiQ? U37)żMI~\}ng d$F- uS]4W*pG~{<~fNƥ%=f#yd(qր5߳J}tcI Ln8}r <"2DtLu9ƵR2]X^5rC.Dr361`NC/ಮ5rYQ0tD#|iE/ai$]"5m3K?t+W=I Ϛ/^%'Diܨn>ubŗyx'j.k}w[ä1R޲,eV%mGð5r?Kҵ֑TG:z8[ ?NV+4~X- @ BS;1 7mK~ITh y)LBӲ_ΠprGL|#V8OSB p N4ȅkhYU* P.k]o5cGi^1px"0hH7b#J[XԐR?xY;8{- kj|(M|(3?:WćͅNF?}15Is9B?& {rZ\;1N0~ M6p#GJZÿ! W{mWzoԹI!%Tf5^Q =lM hY\!3P9fl\T~߭ Gןr~n22وhAٯ'0j-R'oPzྂB=}S@.@)?tsio﷽Yw7w:4L"x:$%t'@˻&h_z;(|k$#*w/aOW$ŹZ9ITy'gfF^w»x3^FT~\Uoe7\SBvgeD#,71[[2x=HҦdgw ^egk yG C+P? |l["> -irK\ߓ%j,>0Tpb#]S1LNNXVUŜG9k2-=iI Lny˖X1' qY(gؠGk&'}eCϰH]}p U; QQ: ?7nT8@*ZL_pP"~# 0鬃!ƌ5Gv쬣 [z}ߪZ8*~\F5WsA(xļO>)`%HҌ&9#Σn@{Iw:g륏Fzv̀ >@GQ} W}!u~ LjU]~M  +)p)?˸:=$eNu7n)(.wpE(0%C2"mz۾Lx70ր(„fzDf >܏~ȥ R1+GY.slw( 4I%Wʹ=̩D8E/{v7}muOŌGINGĜk%"wA܁幗m[[ _pzl7iVx}8X.+f=TY V})Jr0hpVVݴ#ϛIh 0ϲ',3[a;5Wx)CG2PFMj~g`/+D9ED7N`0 Qgr (s ;^zkx#N#3ڤ*DT_~w6̯#YiW+"4aD9"gX$GJdo hKMӚ(s;`awKn+[vr婇Վ'EHEn3Il!UQ8_OFB痙t8w ae{˿7;?C(͂1"0N ` ev[&a%&xli;<иm=b|NjhSmK |7R/ R/ ͷ]b2/^'@{UuwqZ٨\b2옠]\+Ų pXMBo2 g[,ae)߱&M3F<@ i3I` :ϊd{N{J"щ$~M %N8qBj J7 2nqycBVF^f/+;uBr::^Ml_ "pF3:jP<=5Z;m*)W,9zAXTIRX q7|ɰ/diqz7_ad3e:} D<9ƬKtL5ULk0gu+w-gz/I͘% Qjv u[Ttes4O+H?'NG\𾐽/:΢:{-z=Kh ,W3|x*5R|&2c'8dxg/)Z#@Qc:Hl+A "~z[GxeMr?Z'b>R[/kW~DbїJ+A.P3wilC2"{sHD_U 9Ch|(9|>z [O_- FtRj& .W^_)>4$NBU.35A' C|䨕 5}/X)sa] %}-=9ct(DxGkh8L M{wdq9cPX /aR:t/wt4]gi3J0-XWֻ~M{K|vMyHQP\2۟]5sGMFBvi$j&&LW {PcꭢGФ/\O7p;޵7|C؄Qkй_Hn׾|n0K"(gv:DJWmab6.OA$R ߌ'qJl}R-ģaY՜Sְ)c[[$.\*llK(aw8'?slyQnS[(gWi6TmB`ٱڕ֪R0ܮ}>#bC8۟Exd;|t66|X#RrPaqW 1!ykif/UAi 6_Sߦ2[MNin{WZa0b J0w۱ t  #FbRiT=kdk9+pU޻2w>f)]a׻gGSǴgrsWvۦG(/|a贆F?泥VjRl\{.<ŏCU3䭻52,QӉq'pP,ZM.[EÏ?-qI!QȠ~`3XИ}`IuxޤMֻ0lCKO4 deݝ@a<t8o!((aJyR#ӵ5Cm^k"6?W2[X2e5|DkȣH1|ʞ_V ,6OjRs,MQk}.ǂ C ¨FYp)Z -m0uē٩@!0݆m/HBtɝ{]i( |LJQ%MO'B}VJPxӐ-~]/O~\p=MJ, nO3Oq%xx &A {3IyMDw:{Or^mx Pb2$fg/O6L6I)}7 tҗbd_;t;(:_8'P{ʷ>W\kyjd^IZ(qsg°u"]axx8_4B^G7~iۯd /S P4sO]@}Qa]3/tSc8vYyQ-j{5XWz^RO7#jޕn8.煛o 6ݲovIg i<.v9]j Nͻrŭ(p!* 1p-U~^3%H)BJ_h30xLjda߫*oG˾zXbHX#&A j+cKMa6Zt)RƟ+~H0^Acsw Ec)CG |:oש]CK˅ Ɲ$T7cl~15aP$qU2q$(A:IF CR@} C#~gIˣipɫi>C>=X\! 0\y3 ;kSkоJg6K>{-o!.ROO<0 'K tTjW g9͸'o(^Zl1CWnR4j)zLNd RGiSp{T֔9E{oB_< A40Vʳrq(*dqᆖ]jXZ@4zF _ܞ~IN:cɱ+9zjM-@^ڤ;kK6kI)$uyJGplR|C"<==Ⴕ˹%N;w{#0]n>KWiњÏsrg?jlXY a B-oDp+ؘeSBWhy 3{/7C"$k>5\>$*ҵ(AU jqЈ7<[LԤ3щPt|fӁHlѓI_&{!;^3rZvkSOqas]'vRufW?d\nLu=V75Kvxm2oA]pnaD4pg:{^U!=/;~{$!& f.fLc?bW)}T;˧Y? PҪd<d{czw3޳IrR/+{^\(qBOU̮XGbiz@fDҙ<'`T?.mNGy}hOgdy s왁h"Rz30g8^=P½FRyț?WyNBQԃZj}!Ւ]_8rUOB4/ARӜ6v4NHWwܷO!SDr \)[tm_rO =7Dgz7'zNq{?–8>E#ǖ3n^$ Fm.`}M/1溸/$_m_/LCL\;=rZ)kBqcu&i:Ĉ0; AE{ݞ*(sK'zXWtT4ֻXx v!aT| {Y̿-֜ u z1:R.>63{6hFJlڹ/irr):W3"Qta3AK4lN,%췭ص:8ʲuâF)ʙ`kdXڂ 5// ن'T|xFSEtc> w*lRR76[u3xTiJ3{~񣽍jb˭mN)obum2u4~M\ɹMOzٽssm)^i]L018[K]\kQP}#J!G6#M. 8x,pzHobv(Ȉykɩ;A1Hr}dPnQӗX(E˩/ʾ|+wW?0nN+80ZwrEjL`O_;S[Κ;Y*ꗕ1*v I biVC!i8n!v8kf!qa9vrB^4CrWBFbmiJN 0e ¾gS|D% ̛I,c̸8djE Nڷ$!Qk,JJ7`\xYvvJstCOBiNV: @ k _eT8vh%H6^ {!ll#}Hq`\|c6X?Ye)+~f vx)ęn8Yqii@J/UX >Uq zbjW4-td1@lΠ!ճ۹]qwilbxs k6f5?Kp{6H:<-ba?S w˷!e>Rdo޶P `Ap倃y C'FBMϷL5?hlsO& EBUȡn*-Ck ̢P5mH259r`hXӗ6= hEFD\_!bO_;\FR1|tbP 5yĚt{"V75z-AvXI^pK#_߿ / ?<Y#СM(Wl.v~rjcjWWo;VNst1?Zo: ?z2{Uw`J݈Y6pERwU5連Fig?9WR/- 37loT`: MSfFZ ($}< IW ZMcQ{J'B#[/^rng9Ez_(Sݶ].FmDMyj1|挹23'S x/|:i ":S ֈq8>ZA_Z+%)];C,V ;ԯ}stG[/YGf~w4A ]+t;eC#g L"I]Gw8VB9pZ1cHz"~1-LP:{5dZLæ\ӟ,+H&U;O&\Lqѐw;ұt?[q&WS!]Zɞ $W; DBLJ(\n$jbJ a:U=.)jkq]NK@r_ 񳓝ۻ֏pts3TD$t~Q_X `ԯzTq1[{j!C4~%=d %\H*uxv0T$x+ ٫ GRM7\O斺]F\ăM!枇$5 cgtPhJ^t*f6*k*g\"ARr1wH거2- ~SLu <tK$o}։mg )g N71Iol:CKezn@= 3Fkj:)^Eyix3K5dÄ劸/,n*m)ܙq:qPtv:]@ݎq&lE mti0djׁpvL 4*>i@Ĩ|Vx4XoTsD1H${/yfGw6[~r(Jsr"$z(ɲWn\$tDb7^4pfPG #C~qH`Ĥ)g2`H)<4 䔡X4fr7oWM'k[,MG 2C,)Bg kd|Й&>22qkVqzq+gJ6+}#ȗhN'2jDF !V=@1?TQ2i/|Q1N"qs3;Ee/C\N `7D0QF\k.6FAiL#8-wke3umŸ#ɼlKgw.(5oFBBwOQ"wF] U7JM; D/;slY)DQ 1 8NY,v+jtHrո;Peh1p#`H^u 2cMj\ 7Id:­=؅9G[H~'؉b.7P#,ǼpN7Q(醝'*=Z"Ś{6k1ď *"(5n[BWF Ӏ%l\Cq0ʼi￘bE VŒ.Wo]4yOlKOFU# #8 `)ˍc9nʬ:DާQ7AKPC1g̨l6\R'2~H.KXzG:7x,bXbnz mnzHpЌdicdb)BL[6Ix10MDfQvUXrD)޽ iIoܙOk! HCZ&@kR[է$Xj$T-ⱡFk9-PF;(cThOVmj+4} @sPeL bSkIN_6@64e=_&WhTGuw-/@!w)Svqi^fVzP8JRO^w5`m"mV-3]8ϋ9`N[JJ7וN};ۖD.x.Yy-Fa8h $PoDiKR8Yu*;7瑾/*J KyG0ZkʪLAׅ0Qo=FbmzqP/8@e b'( ߃8Ka H8)U>6S kFe"U s:$q\tmiYo{初Fa%gMas̅pW#ԍY7֣uH _%6S [EyKRd'S;eմfs۪7Jv0oQT,fZWw8$7njZLk:Y3/ C>2TIX%[yNvgXu]Z/`)xe{&l ̒*YehdE ,D!#!jPDtG]s}؛m/$28.DG'؀-e;ɣGK6YfJOͨ9p"5}my @6Cl+Zbi=R &ggBͩHUh`킈FT58 {!gܿ%5WTxUQ G.56Iq lbT=* DYKq_U#WQ.TR~vSM{?Oщ,a"fTdZ`T&"oˬBOc"豝9_30o[ U'D߂bqwV 3md8R5uWM CR⇛wKqt_/^ dE3 D7Q[7 TqS4춼H[fW!Z{\lÕ(N=5ԠJa&}9R1G-E@yPBhmp)Gh4yN\pP`'DPB` %FhJ\qN90l:Ď7lvX~[w*g]G]{Azޟ)|n6{]`yj>4ZHsɣ@Zl5OT(r=b>=e~ "GUdUg0;=0 *^,-!UWFe^uU>a3*(qKqҮ3XHq$kh#HUm$pLM%Y(u(tL4ưMRpt2"'2Ӏ]8128zcp(BHB5ʥ*zC?!i`G ۥ \ET6ڴϛͷ޺ EN-&C#7-J6])ǫHvYB%Vx V8_`s $8&idqEZ:$ٔ4D|E'ș)4*nnŝG2\̈(/{6 >wS*}ĥPHE?C;jiD {v»/B|cR1*=zi .C"x0; 6Ծ`B",*5HXAv):f.}JE6"E*bar?E~ZR.*p5u)X|C\Rd""?p[Ұ!qZf=E<?U#h D*"Sa>P Q8'~Qȿ(!n9_iJ"FrBXB vmyxƞ)ŸS6i:IQ%E;ZGz汏b7N: c'K,w``fKr[n{M,EL^)\S`owc}5=P"~ #̼: ^0:5|%)+~ƌ򙄦6[Mn:Uws`[(;FR/(Q°oV)>X#s{t5\8_ 8d7P_aoALhjf4ǜ3G@ G{f ) FNKPSg(U6[: TFP_"-Ď8v"FIf[WyFY;yGz'q`0N*p@ kI\eR 1H~gJRӼ1PfsRg~U !Ad#+/6aٙF JoșW⤡)eG#p٢:sH l=:(e .\G@/R_TlaF|=aJ ֦3b]HScA〲pƗVꞰؙ "M58}]v `=@O.+TA7@sg6L ?{b { PEF"D?W)~X{B턓:qbT>]{_IRq*15[]* T;7PE^QAcCŸH7 п}UhY!Bohj!PR>D޳hG ~DqI R(8R~Ѯ@>jyRxjYL࿠RK3= W|Q\HW^|c^@Q'UHкZj$`u[yDq:ӈ-`|*gP%s$4 8;^HLjDU>v)4D׈cNoA-[&z (>1%i4rw IQFc~wJs9.EuIpAS9A0n97Y"϶\>4h`kt>>mC/ts5av Ą )fՃf^ zKs^,ޗd]8 . "> ѣ_"OqSVv8gD|Yk|b6(`BO&R$ŒXdMM~.Ez~F >ah1Qu#w= Z)v+ퟂe+tt@`UCr)'"ɼJSDžZdyJ:$(]C)^?~>.7%J#ݾ-Io5}T/I?Rċ.~6{7zva}>?0yGk.OGߧmO63^}xN:נ4/rޜzm.Gy:߲ϿxCp߆s!PJ%ׅnԇ.y|=.cl9eJa^:[o՛3VOr>or9?-oݎq}x\KX sdPxCԏ3/HN/!o~kz7Y냰AoNr7t ?oS'=2&GmD~^XX?)15GfE-:~rҿ9-A_S웉v$˻٧Ε+zpkZC'A_ZӄښUlK[Cٺ[$H9_PBIvF&Ar8 *CR&dlyb{Ov[*ɹ߷=܌j2 98; acE&bwU0o4ڷFl1o΅\ۧ.. E,a}drS׽WPm\pɞiybeΙN$Pb28be$޴$?r))9USdv/%> {R^[/͓7H#5N{ ̳c[բS4LËbJnzk!e"),x]) Օ&g6zvzNxnIo܍,Yf.s?wM,MkR^[Q=˼H̚QLS,huA+Cvs:uKHe*S݇Yu{wtB)ze>S8іvs+C[ɺ3;~>G Cbr 6'~|N^ E."Jq Q7 ݽ8MqfEе nhRIPw1ZwJٹߥ GJgXOdnY$:2$P= rILc5rO,Evip am䪹8M#.zn0IqkC8D zmj95[>N8Y/-i3Q3 ;.-WJq!z u;mh)Sڑτql {;Jgאf/LʢP1䰓V;Nc@1K'Ń I,ϋg]e(#5͉zUOaE/4dӌŎ_+eKF *.xn7NhCff>qY}Fu)Ng YSB$"Øb JL#|i r$u)T),mt, Ye捳sM7^WYMj0ZEybQtLɘON8x; #plAͅc!9s̟|˚cxHL7ZhH|kbs[SJR DSa:7Aqļce msJՐҤ;93F=wrߴ'bnŐs'G,qg\w t N=3?I{*ִ8=g.=\|Ȭ+/qe@prƑ=nu%8c3ӡ+IW>pc+g:[Y<8fDqr7J17wryS,ZwS[Ur/2f ,!rI*珕7]Y:~o!<`BFY`|#Ǣw:DYGμ"rP;Kp1n1 _P6:vVkib,ֽNNt=QSgܼi=-i"5rs&q:(%:SJ|>v+[z#CKAo=*`ٺg usoz5}!+qٶ0oPxn&W~l 'ӶG6u9zv*xh>Jd}vI:־ںwGrswps|-^۰x~NKVt >Z74H=[w.p[|sj LǔcHpqxSHv/+R9V`]?Z7>[gh%ᳵU&^el]I mB\cx$ gkI>_̕gAyo^VKA'(|˔/SZ ; _&TP>&9kkdI+7.>PLޓ #郙Ig| AM/ueT:PM~ǯބ/-7`` 8>O1u stlù >&H (?݀4@Q:`6xo!%36p}}Ӧ b"? " Sx;07]=aB>>}ۗf\`IHǟڠ1sz9\ w_1ɿr_{x9E#!Tz^kZy7E i'oq"r@#|Btr2(@[vtD:_$dG0S-f/&Z4։Xrk@]HA)vrdYrąv6!v$OwcεS. wPL[kf-VʣoV\tf]"J`I-'o4[u0t(p :@7hǛ}b&"䵰SNõI ˧!R#HvpXfzs\ -4ýx5(h1`1dj%aA01,g69Mc0rrʯ㮙LP+^KQH|5!k$6μKZG(0  I^ǹa-s%=C>?̹<}? ˜iE80,TqWgqxNϥ>J}%̍jJn6sTͰff}}j#:aq,Yg\D5~ÓwT-:# =?I5<\0wYD}[ 4GЃq@\JK{H7bVI;(,̿0Α,tHa C{myI\C.hL=;{G=_E94 EK_:<]9鏼{踭a{ldۺG{^ysKMl'Y/H.]0UkI'Y%I n*JzYVgir9|%F5e] Apϊ2o)=8KZ9sYSm 3?FG $1T"枔Nf;TY,~$Z22 PTZZMolΞH6k ~#/y-NWtJ9gJЗ 9w޻ ~4. n4?nUhlҧ: eSbd| 05o%?Tt L4?x&Wk|ȲӦ-% v0THѤQr 4OA=C\J~?=h>+k-ZL{_YJ~vVc)Pr7/s5.b鹓6{u詍"x<EG:jInrf{IBbAi%u_#Kp 1ÌܩQmnO1;s,I\n |6 Vu7#qXe!޺ iX1_(Wy:lRY7jp+ Z$% 3iN>Te,#/Gs9/L?=p{A>QՊ:G9,cJq(/M{6ny x? U[kesnq e?9G0.CzR`(ΘiC}&ԅfmL)QuXc7J/ԑ; CI*#t"i'4WO˽w<1zٌ:RtP>]3)5l}ZΆvIPW| p׾hKj_-x@H[f2? ʤ(,:$U&WD j7aBHUK`8 UskP^k&H}Ey^Gx\ J!{]=]Riw!IUlu{V2aO'hwŪ2<=k<kysg\hؔ:zM/K 6}NFn OCGvG %,o c-x_͚E>zE&Mb *e&r=Fbg=*r㍅ <N(΢{EY.B57p8H)) ^`C4K65f SXI^F P@' @x4Xl:VepH%PYꊒl\/[LRy.U?O=}OlFF4\grkO}Neʞi WE@^J휞Vu1H^x_WN s<@E/s}йȇnCIo-DFεWk8<п!gu]Ceh+w!&vu۴zצDnVMlr_d[hm/FjVaCFݱQs,xHCd}]4fHIu{'ů8!oL  (KKG(f2LxY {.{/H%]^ Te.שK𵍂_ EbCz[6љTd➣2Z|I!.:~^[S=0 Ey2&>=-H2=Buze=#*$% =:&GykbT^t QT)Bg~!oXBKB&83YrTsY#r/A}9Tr[~Q<䣖B6 &gã5d I-"񔔎w/NK)~MGxBTx$ _ԙ\`eY2ڡBڝotOn")H2D(]Q^|TY6Yغi nfe 1GI騪R^fS݆"jN6Jz!׌՟% D8V6_ [{>l7,bN4|TgI_Yh^|—Ii 絫fR2cA|шn Msmpv~K@/xj3mze^{=;Y~ܷ͊|Q͆NoLvîyk O=9"x;7`t6ât|Z"*uk5ϣBcLoWoQ\_2Cy$>e뎧wI78 FN7&J3d?>A hl.+Det]2w|_z1?>2`s`ȮM?3nI،OX?Sm0 z=[A$IJ+_+mdRݣ^ԋP`9'C&:^RZX)< 2S8| rc%!["V%ھi絯62_.si71"Yl6MYXqa5ZЅ|G6̎z%N,cU6+򀾅W./mht]`V%@9-x UL*[r + ŗE3uz %Fu^Ze^]qYQ:?G Vwy;|pXV]n|3^ŏ=N+wACd'(5x[#v^+1keR5Ku9 zu,+ݝY߀FȢFZ'@` &"(,}ϧz _gjp:-V.6K4[byv {ZoO39+/h66,q%|Ašw; odx Wo%ɺ=lD)ZT?PD IiF tRq)\P!( V0ǏOz^6,`U iUqB|?f a(]%: j3 TsUux?ԅCg׸ <ƥsjqQ>D[;6%zp039eQLN"J1:6Դ`cmi5m;rR l-b(&X1uo 8D,b^&!BPae gC"z+gF GaA>!m6*x HEGzăuT'oGsC͂Ab8J}r05p9}`E54u0q ×xF "tq6H`Z*wx Ra Z5?J' @y#s$~`y8,֯~FCZz ,4@~yQY#RdOab5d^^E/ld"2)5#"sZ=UpCå'^*?2C0pJ}|ٍf`y~Y6ayofIT(N,UV+Y98:7Z3m&SݧmILݩGL^}Bw&vCY?pfE}VUx+P=V'eIO9.Xgr/ C"/la+!w3 f.Q RZs*(],/J^j$15L} 8>ϾVaػ||>K=PX!L+6KO#M!a2V_icuSyW2IPjl,@-lY˄d5$RkRaFtR; LQ5`4@xju̵ XjF ?nݩq&xBǻge<'-l{o0Ow5aFRNO""dO$ pg7 u>?c*I Zj9{UiЃ 3?w} `i*> ׎ŷ̓<ơѠt[0pf1R/9\7z)l☌`? ƞƷQ#W'xhlܪ{`H3$g=к 8+m@QW CϊoڸcFus/Yz*(#ig3nRI>6du#̼nR@axp!jS|ڄX%7/pe5:r7qj1RS2 m3XaMKeFۇ1@`5 CugT\cuo=› -o-5S"4!?_ غϤvݒ,*3`'Ֆa <=ܘW牊/|8 nK)fxDA:xW0]7{/ (<d&n<=5娾M]JS `Ua&Cx(C@Ld=#J`WdKFⶢ*Ѓ}=#}ʔ܁mޯE݋7+]oCR^S[t!4`'`6n3tW_byLaŻґ.UY/k]'`&Tӿa0Ʒ*ԎRbD\W|}mRn߾X8ȸchίn!@G90 FVB˻ s)%B+4+ѸNt8{AB/!Tw8XUa7r(uR렙+tRZf@?/LDL;08JbdA2Z_K##F_=ߤ_\1㢨4Os B{"`$@wf',hn;4  N(;w{E[^zk<G~RgXlX?X'n2>zxG0|jê2r۽tEcQ"$kП9/BY@E x%].ɼr9n^_7z;ln t}岹- }Dp8i\59k=`yy |QB+ˣKm7r ]oP-,Ed%r+>;^NG?\.mskWY_67)JbTRc5q]0!vY̡r&~rٺKS9dXwon3,yNKy|\+͓?a2H!ٔ<_09MwK5\&Q@Kwε9u-:[QN$" cygՕJ:q3J#ϟEdbJ\L\ϟtW1h;<:BO;`p'^r NG-$y6w8^s?WWI\1Ep`FKT%XȠ CyQfN^\h3hADj1QDR2]*:ƉM}?wdlm &GBPM(XQ S6Ϸ\="_| :Ҋ}'}ҥirxЃ좸9؋~YPaδ.8 HrHlǿ\i:0Aj%?Cחe Q&8ۺ~Bnm󃏏>f]~[Oo馨f]/AXS8uXi3='UC0Yb֏__~YޔUǯŸo?Eߐ[pwL]OQQpf_NN+Ŀ_C&?긽%ƚj.$*۬E ݰ,M-4D%/m'!,KlV5d/D5C&B, HM9I$n"I)Xi,؈|3xw--1USLC$^ xn9[14K([dSGEI^STICReNDD?JDtTm0OD  5U bj*a/Ik@$d5$Q XLc%]ɠLL^5M $PnHl4x­?KM94 ,p% &O@7m\$mn*db1 Af!gXں,/O f 2|+&JDdEEJEUPc2F@!ZFѡ^e@qIQ50ے "*hIb QAHL^-? yEDD-b:U% AA+J4Y K]AU"ۊiI,kېMNdSpAtT9P!6kYSa%%je+Yjg lkN@m$ٴ5\eM,Xt$F%`@b[a,frDU-cS"X*_(*#:z-}I&TzСA!q膗lS$;BV4Ct 6AraR9́vUYhۖl^_CuV55My޴`SmH-tlt Hg*sf730 > 6H, Dl7713@:N uT!"ah]uH 0eʋ, [ 5"PyÃD[A[U +>|uAkUJ*mCЉUDql]y)Mñ0b D KUL^UH+5p&ETXNbE"t2d~ۢ`BI64/+p'Д&A?!fUYDMe XdEB 7 mD19 Ue-[ D6(u :X,lTpl# +ɜ74γ 9'4!zu[w\~Ă X"o+:":$Ԁ-֦*-"2VҰ(/ ZU X"DQATM @;%`@Q#j}bٶ,瘢!>M1݂Ruj=2o1"P" M.Xc2'YfmɆxdA9KV,fYHMr5(nUdoUa;,< 8"2nw}{9[!2"2|[,LVʰ*@;)2ߋ]&2 0;% R\65d‹#&SBb$tL+EC@+AӥRz (H,(f`)P[l ]*UL 8)6n g ;'M3!`Vi RQD*1*rP 8$ŀ$}caaG|~0bpA3уۧtd3A/ALش\?ؿ,2*$H0x֧DIL`e/}Fd@z)UU9yTJHB)p* <ڪEU} VX_`bX.?mQ@vUA.dwp'a1Pq`:kckalR ghm+0 =E`f^-&X#@Rx *Iu eЖyn?/`[.#J_dۗ,/ =_>^[y}k#w!}Տn?`jm'wh~_J8pk¿{^p c!$F' Oh+h_)/4 Oo7lMy09;>goQd؍o*p%)pܾހc'~~8C{CH0 Թ)|J.A؊(\>Iu3nPB8 K͌L W?\_`O` kO%O?%8<9O|0&5Z l }+?tQ"!`h/˟4?"* l3YxD@q YXp;NeJP6Ď|V`2uW!w2~~߻߿3 K wr`a؂_C.VB0um©;x a? 0>OY%Ùsj᳐ C!]|>Ag_ǣ>O3+Daue8~kfٷ`ݟU BN%7f,4!goX*@ УR_C0/%BKF>Gg/Z ZG v,pk/>@oTCAhǰLooz ;pzP*@d ߽jQAg _<-$2P-GA/>iBLC<v Ar! |pszL28 5©(t:ac{Tї?z^jU Y䏾l z7a?{?Ɖ~ɓ>>~<0s!I!|ͳ$i .2ϖW/y~?@ <W'{??;Nِ*`E_NRay]~nӰ@}B֏0(JiW(-BSPyϿMlԋ?t__㯿@p?_ D߆Y~vkBPNo §dqR ѿA[w7t(HUStYrOyzˆSk]ciAwtWMҟe0|t=[wKumGGa9( V4>I4Cp‰_Е;<|0ulzjerpEy sUO%o3ek |F}lܺL~fAE;jyH=s'HCz!*m ÉokZecƪ0{{^mK9/AY8~BjGŚY:9^뇙Pv77p{՛$Q^zr1\Q3ݶx5 5EbڀV3iں|t FFYqz6Q~NͅNdƀMc3m\KA4+# בl^7Vcx*]*׸X7GIsƶxF(1T_y:;W{/\=G{ޡ \(u־!;DH)zz)rc 0#6RTf#!h̵޷عksS"IF,X*30W֭=[m[AĈL~k#Iw  뢍 4-pی{,#.;=5?fWFO@FǑ27ȩQ=cVQn[L :=[;WvL(TzUt :> S*y.cq ҬqXs.yo[\1T+Vƥd6Q$.|}x[)w,Rk6}=ie s9,@ZyH)R}%ͬ3#bQ ;bsnSZzffFf0ƙَ^r~ ;fҋgVz]^U;O'SЄ㎘<~ gJvBiBqWvd3?Un$Bn&u{Ca5]rbڣW!TZz*?ߝPҵp5ewpGʜbslN[.\UWy{Vמz S~XZ'~&ƅ^h ˎGrmYRDQ+&3tbjx&0) ^LX,n!Dž) 3甛 =0nMRXjE!@(ZmuKT^s{Ɇ}4HvAP ʐaB/'h:*M)m'ɦ^f$}vfi,Z$Uv9U:b2Km:8U"=t*$ -G‡j6l_4ӕ݆8O6K"K5wM+rOW\Cr&-Y"r8Ex`͆7L6SrX+U$7w-&X x(mLX]:n m`Œxݣ-BP,? ^xbxt%lYbSh¦D"Wmt3%w^dVFs׬0f@aα{V"/h} nU4};Mwi뱽.$jc~7{p)}Z _P)YA24qvWHWM2x?Ky޴keiۑ6ym V3A"2O >8&(r#P173'b<= MP57ͅwNOLw'Mom:xe%w<:^rpY{aX5 Rjbv>Q'`3GYu.7 7auTvs*_FFYs٢שhJw7&D(}O)O2䲈ɥK^2uc ULCYY4jv ]O䪐3tz$g滶T7WY^Gs!\>-vxmyNO$Z#$fra|m[)Qb8y! _쓅J%#9jCJ I!/h*#ݚ{-hr%ϲ"!k[6*Z/׽4=yIL ;`K9R3ŴU_$*ާh3lusKvݓ0A+'vT_S&(Q}\3!- y2(Ѥ?&wSfEyڧw( C2;pt "?$&X̥y-ȤkCk۩䘆7kJK"Juȕ;A֋m'zwbtDsӬizɫ\;[: 5z_lF^g'&cq(gul;n`̦lK։\5cL-m[yd#7s\NE3~mT};`g4nfJ"omtUBIX-mv~Gv.щhv氃[EQ3z`QTZG&ftKkh4:flGFDi&l#[Nw4=U͕3}7x6{6%̀%JA ˵dk̖mIVKW}OpTK}.L2qW8>LFʵEnk g5I\m@y]̬f*n_ jX;&+\-.M9[( yd"Qd=-)?:>З04 (zCeh1kj47*`C,Z |EƊDYLo4j2Ef3)9O$)&2#Nngb񲄧K}ew茳]==4 1XaDސ{'oj1k*,hyuJ5Þ ^bFu.W[ZPv.{d<&FtZwCnvl>m;ސ*4j \J7 k-|3]\Wn*EqoGvNB9U\ gt6|Zc. )+~ɐ)~xr:V.ofUy}R8z8'sZe]71T6o~^gWە|^46.2)BҨw_-8pEXu&RiPVKoJ&i6f[9Ս TعUew]0$ G]+X US0'RGF_ħH˔Ou MSSm|b\r.?*)51*}>/?hTX^rѲsaӻ+葕u<:5M=DlN_z҈)L4fooV8JGKڭ+z")2D(ֱyz§t!+ 6*Wǜ\,ubҨvQoQn2kuNk \y<=s+pvW:SE>vZc/ |.Y)razVzE.y373x ^Bav'̩kay\c S}Wu&K[|ryh0ʣΛ;T[s<;vx$"^c#6?;Z6{U+|5^({T_/;|?vbL3skiڕ~5;r,=ɬmZ߹u^Hƛ22:RRbݽm7&wmԊྲ2m0>Rjlh]H,4e`RqL-܆H@FύF`ս'Inb$~k qZGU?S ` o:IMT=G&sY ͰUQ! )z-[+ۛǬ 8ɬVavD [O JȬk1?tE NeO.pM>‘DRMnKu[\y{%cZ>uϓD*[$uU_GƷӼmXFvjƺ$ufj@^vd6۞Lg n9%2 ?_9KM53n$y7+쯑~]f-D;8ޙ dN΋w>*|, OpX[(Mm+klQy>.73s,P7L65f2)9to3cAiFӸAi!_(i~iH%;cD35r םUOu~qˋ* r/]?sfpFTabؚɏfbo'&?׌,YAiC}0soS${0U+/H)IF䢞;IFjbipnq@ue?7+egj>W͞ 0 oG'u,m*~y\?-Y0jwDVcoNv,ݤmU5둨mgOLan,RҬ9=ң!M3C HPx Uq_Z?Dl|#w>H:]i*2׊.m1SCHsZMWʃW;,+b*ǥ'AseuoK=71Baa`Fȵ\yEjMJVvl~h!n[A R(_J<w$ڐ.=)(BPd\xUŌ5ՖޮZp yZ\38 %ٍM3=!o1Ќ.zْW7& n}wiunUKu.+ EgH DDEs$3IfzEk9@ų|jBdCwæLVO),gJ;2y 1&*~sP=Js@lUgzf^|' n-[AWES"c)o5/4MIn`zNwO[(+ni%2|CT\vӥ݄n!:uJ*¯]KSe<>J,Nq |ӓm )Qqϊ-ϙRlj3y%B> 4޻А JlWг;)qVmH߮ DdhVk0"+~T!'v4eQ>h)JpI B5vzl5DŽrC1?=C\gWE$B,6GFlM#&EWl?׷/s@ jG'M>0n嵙Q{Րdusܔ`ي@KwyB?Ŏ}ÕE>(;_eZeMKMJ{ e۶tl]:d"ny*q/) Ȏ}h:׌xH1 W-CKUQ gxۼRN~RAdNĪ %&+Ŝ@VE]ؒၪ[(UU@E;O\I,^ڜxk`Y3댧0&8$Td?0,JM}YBQd0nMuUo[LeC R/_.Ml_f}W5 yfgfڹQ|S˝O?̈z]-ITq5 g}tqc2R=aѸ>W_zF5k_ye؊/+smNʓnJJn(S&*%08oӥ]-?O 8{}>yJ1ˆ*Wq෻W{.s͗FO3ʘJ_SDr)`ݦǛc=[@$IoIV*K;s1yQ?Pw>wt>Ncm3Zv %k'WW$u6#7ccܰ]|ގh^|rn{UmE3Emܜs5(4jqGpӈQ;fR{λz&H! ?(ֹ[TJPYPU=q^+ G 4jWx5p/joV8_s2/~իU'O=/myY^ĚqQzW o5\K Yrͽ!nΔdzmr*9] K.vf$0&>1#kLe I)$;bs Z2cׅ% n٤9QT% d)ÍtTU[׃mKyfsSYwd K. ;cyN\>]'ja6Tߧ~lR fkk^thc>S Gz;cuF1HZg|;N{wZ,nպU܉ټy6u4;hY:\k~t#t5[GH/CwZqUU-f,q};TB \^[.O'|xĐyi1)nŷoǵ 6Jj5`%te /0wq0WћNvE-u* oiv$u_s26*~JS;{H-; TOSb E9|!O\oWߙ:"3dRGMh }RU}؏paђ!G%l4sShL~-[‹SlʮJ>p~+M'ש Pk=y?GbEDzJ=+rT=>hX={:^\M+Wv[geÄ|/°k%lɭ~]}Hhk!&b9FA;{l 6E.@Si,+= FĠ-ҫi-WW4,N|ԮfڏBWTɢ݂NWP,q?yLM&1fO(UJr4Ɯjn9{2l `ī ]$5 qrS{/%*Wd>3p[rPI~}՝~+UT^"A`T):{3p*6b}(hrTH 3ܾڽ_Ydhq7 \ 3՝5ې:_/F@ט c]XvZ fdSwުѰ\P{b@+:Y45[g $e̹307)c ז~pRT^mt0}Y~ә 6m]ߢƌ#Ϟ_yAFi9gD-@!}\*0Շ RX2^ʷ(:-菉igڠ}&tg+>_qA_ƃ&`ԟ>Y;o%ϜIQCЁeY \m{ F |[ܟcO`:Jqj WJb"`XXip#D.*=}uZ4&eݦ>ZO@LL/#GPQ-WПf~IϿޞ YGM@?(J^) Gcq;0t|Q IcƑ灹0ߪ}5U#%ݑ\0`rwac',.p}DJ`O[\%gǿ^7`$OzKfNR΅_먇qZPRmsAC, u xir_Fr])/xܪ+~ѕOr> SBnY/rk_-%hչ?n~g )m>۟:$"]a̕XY-¥&^Zs8*P x\ENWa |({ /`t%ݛ qj|x%: L๵ޖNk&8ׁF`ǿAꁪJ7 %4w/s8}dM]/50WRҌxIEFBfJKnڐq| tL!wa~妲lw57BshLrw|䚤PDfb|ڃ'v_9_>e<ֵ~Z9sYGfĨ25Rw纎0+ {swU{>O% vS,NW2^Í9a.=nyALVܧH0\;CUGJf8) K{/ӗ@C{ٔ۠s1:Et ԺMs: &9],VP]׹k\e_f(uOniEzq5|~nkM&]f}߳u{VO2" B :!w`?ԭ_?BPx+8Qͭ .g5V4$>hzu`o}@%JFztXdP" /=x?۫rwFo]$\v3UIMey2icJ+&36ít6 Adr J6 W^糥?ϒ#X`\~% jn?sy䀇A』YGb뽹͕^KN=;f kPSjVnqw3JXK\D4k~`El%:? $s"r1JU9XL᳓I]Ȓ*p@@hxt" xX]Yђ_U1ԵWHe~?#srymj|:1Y}oH&j^  F~m{dAH<2 s۲"7A[/WƋ;t_#Ւo:Ӈ֒[(GNjiWn=L- t y'Rdna0jVsʙdNW*dd_87\`z,TF|RogwԵ(}@sJq=pf޷KʘqeV*{D(=_JͷU,/fx`$,I_O'0- [[q!* *dL_?cGQ͍n]t9ߤ)\-b aBH)lsFۿ|1i#N~-yy/`4`j"[;7>>%vmܶqPPsk՘י!a ,(ڈ.w+lΝ|# R^KEnrJA=. 2\KKS|/ {MKl{ucytkw,ӷnytt#m2{ (Y~ac#Uxd PPf^Z:xOV7z.?<*ޢmmW.q ,j#5 첷-_Av6&iu8lO WvQq߅^puSXGx[m ABǧz<82cqlJ˔Yit4z/WD]Go\ʤr{GXQvZÔ.*tVd󽊟)GH{7S̟?BlJ 9PxC Ӡ{oDaMoWaIe/:.)RoeC]rEѣ_^{/@0o>3';a3z|lk2%{R006m|+1y´&ŕp2̹.4ER{4Oc)΂S/uɇ!|9 ",;w7ϑ:=0$?U d[nJ%Qͤm7&̛n)R5TXZ]Pa#ɮ)'fio <1볏[`E蹃r@`yP2db T_ߧ%T^K⁛+F?oC抧@h&el\ 0h]Ub_OZnŒD y3;N*!%%%Sb+f%ۭ0 owjm4ʯdW:UPeUNݾަ Еvَ?Ç64`ۻp?RS!($J9Er{k?Q;\5jpB$?t6.T`w\aǟ0~[7 jF.՛ϴ/jR19.aTÁjWcp02~K>? _+=r2 M$| օqoqtFCfKPR?t\WkU쪟֤ R&mi~:]lYF |?=-N0;`UX_e-yt[A RnP;TGY: ]4?|̉=H. v=}n#.jiCK,[H\򇗞T~ߩ5J$]Swq,7Q" a!r&,>L6$*ϸ<ִA݊1}- ˧~3mUlW:Տf|x{196uߚS{I`R[o< ]t?}~y~84\:>ҳcN.kN0quO}L |{ST7l4PK"ز36Fn%z6DC ȮMtg,*Rn'rԑ%{ l-lWy#=E/[l'63w&",9FVWQ1o5a?OJ>aSa `EךGˆUeZYC1JGe E))DhlPF}zU&Sm\< li>LAAg}{W-sOZ6\ꃟg'WfF2xX-a4*CO`/ʾ5}iN} ܔvzA~y>rA.-*K%ߝv\RkM|]K`sStg63y< `xP5%P=\fUfK>W z#vw"ֲTM'K:" (Ɍ?)1{WtO.>j95*v{"Ԅru+;MSbOVesV6~jy)fՄdy~q7K!|85ժ5ٰb>E6\U2 !aDd*wh%ut3"[w+#so_p'g,N(c."hz-GlbR}0'FMæ>UwKh~·:qrKy&h^ʭ'ViLu$Pshh)t #$Y&?.9'.', .yt=y)V(NDd&N 3:.b3])+]>tr*2eqӥTA> :S+ [V fe]PT.^ =TvkXvhÚznXD5B_ ?, Nu(N$ӡ7E%8i &g65a5/KkR>0;ԹXU[=sz}=o&meT3T(L/:dO審>N7T:uxoz~2OfǛ4"2}+ ,$JkD= zQ1]hrDDƄTvcJn["j\5zv+JX\my\I}궜9;Om(`<+wI6uiZN[sf+@HRZF1\Gr[tŰ@waޛ=ܚXS]+5@+)!?U6N[9KFn]kP A>%ݎ*rh6o,_y.c5UdMЎp޸>~\H7(Q!]uB+=4^$eپΡ})w*VoQp' XS1#;ÓO!K9aNя|dGdfwhU%v)ϑ"j ̹ojZt2݁Mz4<阸_觮I~83zInCx9p%G+ ]!j³.;<-Wi ./R2*!Nӻ#)+}YڏeޜsпȅǍTSS~0MypA`{|&T䑾P8n=qg5M"67hԵAv}jy]?vvP% l1s7+sNO·$+#=⾅U4c4r騷}ZUxp.c ]4_:}|?v*/p!#d{K/z`wY5Lg<)D X|1OA7RDQ,jڸD@pJD̚]WCW(RQoCUG[)|SI v^ZцNTr-ڱ)D#΍Ze\Ga%V2/_/"תO㵽Ic~~ Taȓߘ6az<24b?DMe/Qv㯻?1웰;=Y_Si 8_>ag9aAua +@]wmJ~7lAX*$knJ gk3sAۯ.ݽ `33&!RH4ڙ[@ W[u8&*! y 9iMVvG&7njM 7Wm>35^5$l=7h 80j{}Z@ ەHхKx&NiJ?Oe@W6bkmrJZﶇ*ݧ9(#?wUl{/ؙٔ1 6QD>ir:G5ݡ:==l]yT9OBoE&TX %ufZR?{)BdAΔ,*0丹rn1H- n4q; 3yF:.nu$(2d3/3ވ)OF!{]jy}&Rh X6/91煯]Br2mP=KEM2߸:PsóhyldnZg钤1W+[S^J==qI!i]z49w֛]RmUVȗFF(_c$O~GER7$=ѕe+F-NKS7V1ͺ +U7,Wy?N"< Ta{ֻ i =[[{Yd&Jl=c9 }"}L)Bq[>OC>X0 N2F?.MOO9\ a)CBɵC>+ԁGbSk8D+-{ACs&0+s ,b<+ɳDvB]ڿD0U\mwQ ,Vq"ax򷀢)k^`LKҸ`tɮ6@$!l4|t~Cjp"w8?)г3E%~JOT:cjz Dg<-mR2^2=9='a3j;d22W;1uW+ }&՚\fqhvƭ28o kCRPs\,1HM&p5%&OӏJ?Ǹ85G{>ʦg>Fh`=G-\ύH{asGuFɚ$Vv'N8aχfpNNUO7l83aԍ48%sWԫsSb1_{>Pӿ2c#O9雝5Wx!͍ ]cZm*df #iVH_a{;]j>=YQnfIw8ĨE"dc@+BtoaNۣܼtX&PO[ŗ#p!\k zdmt-c {#g 'Sc:|h[[h5`ӣy1_ʾߛ<-_q9XMp}ƵUU3rY! KYX:xN`(ea 0(Fzw`Wwiċ(PW!Zv`74G\i1YGKt=ϭԫX4 rRREJAmsF?n!s ϏٛT8 ův,UZGo3KLݎA^CdҊg z԰5RȠd `-`sN/֟2ٯaWm>0=|m?oSz?2?g]h1IiLJ{gjVy$kf]'z;y@m* E7;,f)<j\p9Ns:Dz6CXAL"0,ŤL{Z5RԼ\sB&bN#-%rfpaT5 FX3СV6#5P1, 'rYVgX[Bʹ#tY,3fNb⌋7@U?nL]PV_m088,&7kj*>(63 Q:/]4IS(F OJOr]lg!9u"F)G7I~#\|~& P%ϷOB܄Ś 6LƵ;/^{ 4d #M"))/_yu=[ߟr[_0 Xn xdΊn5+DK̀=š OE}{8 x'vf*Et0Vx[Y^vja6)F B\QXkۡ5";?/nL|} ?>S!PZWFl]A) BSɽwE10I$q%Y>bRɥ\l%>O H%"1tco}_K{/r&KTHߍ9hhEi=Ѿ֮K6$ zpL;tHs <:f@ l&ik3BHWdHm7 ]`~q@ mɖwAktv^N9zy䡔i>Je&%4bv!L9F4ꅣn;_M(U%ϛA`xo~-oY=xo.TDN>/hMt?l}鶲 bCk *-ַqf RLHR >g7ŝ03{3/ Iwj1*X`]mǑiE~}q#Nja]omk6K-BV6Ynz[iO]  pJg*am\Oq5s>򁍍egwVћm ♻+gO`EI\Wr@<)"Se-$L,OҮO!ۻ5>c:qKt؜)gkf4ʐ/dRVOpˌuI :p܊C| e~iQiR w[dS;jT5H'6u {3k-zz qaߋb9ucs]I3dc-+ç?٥FnRk.ڗ?DxYBN{HY]7 )#\RG9k ż[CLvx7D7`f-5ҾLj^Qio;'_i\fFdQw 3^v*#3NytX\f$ybbz'zsq(ݣ +>u.>GcZVZcZC|N^T2:vY7例pj[+-窯-v7. R'-|"x!;%WxBfzK+6g 0}rgJ,L冑x:ZU35L(֑.=r+vIG܋I;|-oz*X29uxho8.w" Ul?HII&Ob~`b,s狭f0h-uk5-UkR?=l\ zz?? ͤnt,N_Xz fl<@NsU&!t ھIA]0߅AQz]R>^>ʼ~ {RR@зbESG0p\V( 6ډZ~#V/q"S@5~~#7 4sRk\謡劋Cw"U1·C6J-p1E5f,:B\W4:]JIJ͂:,TIu?sL =Ca v@ЭV[nOB!tAPGClD@iD 5n.iN:,q+U5!WP+~+j [rMËSoU_~q^RRV̴&_oED?v`?$ BKq]x],^:O2FMNI0Cȯ^*BhgT 7^. p;GpsAMƽW^՗?4v`f헙¯=4Hl*lLG>20؎O.#@zÐ9t3[ =dlUNܻHʛz]zڽ{]@or~Ncnл՜aAXoR}u/ qB%- x_ G3HL?ztHc3zҷB8 [ IVBȍNE;fGt yv&, =1Bg8ᴓkOgq"08$$DA} S`W5 }C C!gJ_8[WC3Lpnj`)Fm}tJ.E g[oG[ZdZ4{kwڌП˕u*wfj)%0`P{Ac̫ HS?Ͼ h .{:C&d: vȳ\O@~āh׳{03ɸ=>_6l2rڴ-n1T٫9Zх +&:߹'FBrhhQ1mGÔ2Ub!sa~0-at_XFU{ADs4$ձ)N{HPk=JnjMn ~9GXn(ƞW'B;*\Z"Wq+G)2 d9. ܁NMZ^0-sohrmnw$FYN_]=}'̮e3b)NCE\߅`74//ki_Spm֬{?ư"WۂSu"rv!*f5WX`Z' & [8+)МA𢆟1dD = @-"oÀHwY07WpKR6%w}TgÑ9fA>_3oxo[9w(%8۱|UP*xGD-r0j03ί>𷗳!bGbV:ݪ:p߫T*FH-GIhɌ$Ɵ&piFg ^3?Mbf̍L~m@wh;ъ1Ufu.3h<ҥnf0Qh{/Oٕk(:vxϿmCl_1TI|3ohiDT/rܫ'W9D}΍+֒'d?P>l2eXIƧ; EPs;U}D,klw$`Ws[pT cM%ƿMM@05NAqzwvtTC-J%y0Djd8qW/'E}[R 觅Xēz~jzmڠ|4gHXO^x-{ Y \D-5;hRk7yoFQpC?H͔[A|) U[R3$V8Prb#i*S6=S:rIq wbzn*er>8BrGZc(!u;od/n_r|}[y{o_#фh_0{1FSg:!+GJ6tٳN6V&ރ_/xh2˹W.k3&u}L4RAM&p]q;Z E fm?`ly\^I0&0q B;`Yݬc]Or$^37&U1n?Ttw+v>'ΔAa"=:( AKH>G!!I5|խH݋S[=zU^@nFX(c0Z 汎L $CƫM -r?,ԛrpQu~ vzuE7^e|]if=HƜsp> Ӹ{mf+xaG;m!o1uz#< Za]GU|꩗BdUESy+Fm"`'ڂM0as2#ndχl#‡ܻ3"FFafҵ5jeɘkLo?NMh#zW.WDIO*L Y_*Bbˣz rM 劎6\`iϴ-4Cg'iVĴzF9a`0։by $ H Aewm s>Xի51rs@`}/;b8#kc׭̙'+A/Z$0ek|b2}y~ R3㈂T^ru󝀖O".SD┛?&,a֘k:hҬ(KJulHR5o6ܲhD@#[~KF?䘟$]&1|妑W[fjHr܀Jg{ίVq+62C'ͦ_b%p:/ q&uNF]\leUy%oO^%O߽,J^fy$ ^a|NiI"yH87x{y4 Ff8 y(.F}ܯWh@G}:i%? -V9H EG3kBܹy0yNJAgb(=-пm;K-׏˯D6o8v#HyG z?ځ4x_FĤi2<AӾej7}Зm. O_o;>Qh^ôHKȯN sQ- D&n)?Jg*DžiiJ+8H7hD E:PXS`[ o|4YrXec}kDXwuK4<,++Eκl4~2񥫩h6ߨi=Mn5 !BRcT'je_\τNezXZ@\gO&\Z!ٲa} ԤO /9 C)ϧswV݁VgYxb ~f<&E,e55)9 70,Ynr:˶ٙ뾧sJVpXY@G3I9p#7'V{@<_ Ιlb;Gg"we3[}͊p>@lvhw.{$$wIrxYQȾ98;v/x~zg@,LFzt4E"r{眨V$IP}{ۆX ߘtcH Ud'ȸINtӊHS`Ǝ{=|CZT ᴧ Xv3Ӕb`OA=->I2ǭ_44ۿ XIfHE`.OtY?sfOnyq@z/^s~+hvf7 /z봲̢⥢[ē.Ȭ/PV&p'mL Cnɸ{rߤ}W\?zx+MȒz?㽧 =kkۗf$Wp`9tK*I_n-jW۷# qe=@q1pJ5TiUTG˩wt3Y1Ύt8~<|{7;\yjJqะ;<P@Ph9]鍕y|@!4yu‚]0>k_Q.ĩՇޞ#6mPx^3QaHܼ "whEW浞g{3%-[l|< Z/.7hЭ#>a ic> 10c~NWfEbsW8`t߀WZ$X1cU0ڕ_PQ* Uh*$ "rrNzf_Rrok`nJ ~7o=Nr!^Ȋ SDH!ڸ1}82]W~XiP]RB-;y~kVWZkkLicd%AOǤld.A-%@'6CRk _64 E8Цn\'RKrdzk aebiŗh xeEP++54yR8ZVխs''ȿ𼃉S-7uNU~ۊOґH+3ɡ. b-gKMVd]'5nWJFGҏYz!hʬ)~Jj;=4ϛne8*.$Fr4uq%=]8艽~I`jҚJ7UI) =΅n2O3TϬ^+K@A&Ynu)#z%RMzq=T3+ ʿ : 3, S?J+ ++ۮ-~Jz` VZv N8"[xl)ɛ_yqʘتiNv q{ڞ!^ѩl am]-+!Ҫ /HaTAZ~ɱye2}s jWslnDCs}rj#`?o/KGw},~#gJw?u`O~ M390]n},BDhp`Pj"JZ뛿}S'=4\>vn_?>3lz4b/ ;= YhUG}s퐹[#5BLPa6`65ͅBK[[nڡ璏e5н<5IEjoĎ{l9<«Lsxo'C8޳e+P ``8N3 avog.ƙ(. ur]Z ~2hW6FWpG#:u;Jw7klGL5Ep7b QLJ~% ,:cR`&ASm iԶ싃بOpv鳹KchV)[!Ce0m+7V*Ҷl`°MP\ݞ c]R=nXj}{դVԍ-fJgMҹdjPuqt&" Z u?J{tկog+.msg_SK635%qk[=uSjZTKgm^kì=Z/;ǂ[*&L@"HljrFZ_Ӌ*foZ?Qo@\N |漧{r+Lc ^s Ep5>xG4"-P5Nx+_^F歸tK&˛ut7¨TRW轭yTeRN&O?CwlU܇v/(YDE%e"Q]pR]-@2&,E9&)9/՞߰rB[716||bvaO{{jACh إeol/U9f0Wb'D&݃:=Cy(.~͸8ѥH5{?_iQ`mC&ᎅJm8n!z|j^J`,-.zLʝ{VqY@Gl aRۭ:==O5*k@{|"0vBU6eFI.Hk]]/ћ0\˙7{{W&%|h-ۗg}JG Gn>uF;j>pľ9g<<wUfC8A&lJ82 cJzc4R f=YPx9DCb Uf>ECf@.0m&+šWMC г%l987]:Byn 0mht#!߃dCbrtƴܚkʋPB qX go﹵7 ,C{ rCp(^eŏʧs(@jD kևP (ٔ2zj z2oM ͙@Xwb= =5f79 Wu>8$i.Wj2&ZۓF[Vn`j;r^)Z4!9nFOϪWhR{ V:~:k(i [!/' Wx_>ҕp4'5*& 0U2).,--6Z #0[4w`4¶ }g߂LWFGRQ^j4~t2adOv3`ׁ)t3c6ܫSegr,9fHV0|K!_-lbgSRM**Mvn3{Jӏ`w_k aUū#Wwʜv>@ffE[gt&<Q{2z:,nzO.mYXax*5}oԵD9Pp} b5_뗹R<;Z/SkKRkH%M>QRr7ܨF\b/{P.S=3o=eU/f+[:u?OsVD OHaß ?z1cj={%YJ<]xcߙإBjz5Dz32V(M9ӟ~t~8ĮCs=~:j0IF*i3#XэnENo|~cЋɵ8w36۩ħL<ݨz,Nk"3.vQI3f~#BN$[A?W-e2K٢&nB b;5yă7+ "UUk`le4wߍɉKsnD|L raӉ !gwuvݴx_՛ փ=|ЪA YdzEdU.+쭭>PMS@43U;*UuZg=aԋ`~SusXԟ=_(|Fci! jЍa>UMNY逨y-|=T9[:-wI}8+VNaTƁh]Tƛ|1Z?:ۖXh^bT4/]nx v[O6셩 !a)ETLS/(1ZIU/-l*'j0Lf'|zpa󀟸>zyT>=g5+P]\[9xCjC|MY}85.Q7 ȿ\v%1s:F;e5غԀ(UWg@E|Hwqp>W~R,_쑛H|׏ Ccu߫@ȉt8id4B^D]o1W_Vp6rӿ>9MIz_MpNJfNy'@'uLUצ;H/f3[+fZ v\")/@:ګ9mtShXNMaBuv&A'W+lMcEWϲQ۟si8,B3-Xʦ}:C@(y @~޷9; 4[<ćݿ.` 8<_U*nD[?s7sX J&Kkg|nS+mk}ʅ8e{٧8i1:Dr\U~1~H; ʉ`$wLΤi|`7TFp]hr@D>keO5v! v8e/]@je)]e<^hb2x(*OΒOglDyy(k5/-ZRen{]s:+k ; L%[r0'UO?Oc8՘%*b$1LV=}$}\]1Z<:63Jax2uQ߯[@?oq)BGPP +hnۇKcn`.6PB7mMrMރ| oE`pLHBR[8kV}lc諹mm|NɌ|פE7XUzС~OOk`0@VU0<ױH|zRcr ҌwpࠃVw\*wlZZI1+ ˆ$݁3woxܟ 5yMϟ=^$3V/[[ihC-0߽kQ%?rYPC`7 f?gG:d/2 VoLpޖ1{[q;4}n]O.3jvA@N{z`8hJxnHpg\X4a{jA~uP%_k5Y uc@Djy]t˅m[ݱ+:$8Dx`|hjul4h/d8ׂ*Qd[j6iSL$k)#2Й.jo ~i;)sJS&p- Svv}°iz(vs:K;82x rW,CO!7MT`,.g#ȧ{ 9;1:HZwp̈aEGi3Q`e%ov?kUeއlE[D@PEDAE=?<#7}M2RJXªZj9Ә5Ρ#D^mXʸ60:jM7A_+ca˓Z >L f2(n@޳zI^1." oFK7<6tJў,V|Xvl:k]&G,Nx\#̇AH[V[Cf^[1Tn”\E/>bxIW7Τ<v**^h,@kvSiY_vި W:'w zS8#1 ߷ucds{Ж_w @tp̈́ZjWW/j7pZӂ/;jT Yua?<#64Q(l{BS/ǜSml XlX u dH( G 0ƒSm%Z]O> L"֏!ON #=|Zl`h;8n`G6035 _LZHڢWTgϖ \M(/  H.Y{B?}!n%@` z#m[kZA^-PڻYn^~1THKOW6uXp0\̓6D\%k{~UՃKrQySK,Gr)]a@T?8Y;_l*s:QsQH5SJ5Ke= m5Ju6͑6hLL91YB Go޿EA) f}Yɼ!~+7V!W&%wRK"9\W}# uH{(-4^H``W }8;WԌ"A0a)bEvH- 'K<}[ D+Y#cU{.:"dgNpΟK|=1ǍYa`]Dct,<)[p%Q2ٰGhlŊ?#̉o^֛;[쯟B[k/kyBA>w;7slhT'?|2)u!l@m$ 0Fbgo?32rU~xctdwKL>~.|O @~@icQ`ˤπշ=x$ ^b,)AVsYAt] 0[6OiM}*C? IF $-ٮT 쪕jXM ʮனV?SE$9jb-뮗- "4B{ާ=_?̟gk ˞SA|Yrσ.Z4) H  K=vY,GԲ2^"B;.,Ax]0XOI7Z|'5]kf!Zwv~'DOlv<\z^QbQɹUi҄\U`>y4c7͔ 쮍dSBK7Fq:P3&JėhgᵾF@ UgqCMF3sk)yy|Dzkx\dL_jOdm[@J1KXp<%o ijW'xLiWL<㜚|[JAG7Vcѡ >f&m:`+\w.:-H:aŵ(۟O -,kF_, 1Zg=Xvs]0_Ao8\lS|W{2c>*3hCitS-^ѪizrL?B":7EO$w8D>rzJ ?S VVO*`yw 覐OS8덖Ta KFaJm#E S6- vv5f2?L;t?:Ugi?Ų_{$3rkLE.u/UHRn9^@/ƅ0}4s,uΜDp@ @B%f,Q/Ǭ^;Έd1U2VMLFLAGҰo:Kf4Dmr[l]ޥLJǫz5R@-({%}&_\^&~֟&u7$W\=]"?o?KC)^ɳ׃鏇I @h#Ng;?Uo`fr.K(bwhT2eyQ,0RoݮΧp=Q͵ U k8-/j7M*̻yD%ǫ(f.=v~خ5K5au&]z܍4lgD/3/{¤Y@odL;? eKU>3.3LcԽzo_7%<5FIye; ZGuzߍSϕET}N pj2H6ƻ g$4co"QVK2&:j>R:""kc~nґXTݘNX5ؤ@g)̢wطdyo0o^&iD5σ|<2|lǹ$9 L3"!YOx^wȼf1da]c~4E ]8Zbl܅ fbάt/5_]:w4 a}8w­6>=}`a@S)^`RtkAڷdq@9]z{ZO*eja\VilGЇ[w%ֆOcD/ڈFb9{,W`f w0G&r[9L[T>650A?=ZS7;飼aDb!:|$m=jܳ9ĢKU6jSFmycߙ5 8x: DFDs1ձ:ZX s[/-#6? ZZ=>)h1q&:=Fm9 fЧJ iOw:c.w!M7$l?j~khqF6N vz,jӬRrEhABR+0珚ˁ=a,$X{}cFZҋC錮><?RQEUuDn[3*q#Ay^Gى}*fxdUsҫL8pNjd'5z|@gX'o=- Aya‚!X^I罡phNڡ?}{_^A("6mCo@X<Wך/ NY'<ܔr/@Kam'fS-BqCx|yKJܞl){eZ< \|3 o5 /M{1$a6;΋Ny?=,ܶL|=wTŮ{ b\K1wؼC7˪Y) A:y7Q?wĥC0?K&K}~-U~ӯI3]/$'/.?{Ycӛ!,S*qh7&c`qx͒q)5uFw^aPRpf^[?1>?vMwusyw8!X3kr> ӺL !,/B|⭡mGafe^88_[`F%\#e3$ N#n2R7A/׿Hiz2Z)5$L/7ܪZ(8 3]v %jzw=uw\36o". L9w&,=0feCL7v }س8mXmnٰ !N:AM?elhfr~#:];v vhtֻ0=f%rژN_c2U^_ y韇V p#~IVDi}5khPra4) ގI[فl@-s.4ip&^nj-3s:uhvr#YFDaGm)-;֓UX%o\֕J~ 3 ^O?F)? iJuß+e8E[x)d$F9xj[-OmoLf 6gSWAO9HG?ϵXlsEƣ.W_U YW<[E쭊T=6\ 8}]QTQ] 0pC4.Vg/\V4ޫUm6m{޼pG%E#Jh&>U}ɥmiDDq:h904G~EI^vL#7?.}),bW5?J̔Vq!f:Z='em-&ر6gV6OûZF7(uJ# Iu=TsQflqor'}CR֖ Ǫi ʮzD4F$iF8@5/W3ftd#cEzemLh2MIƱR4<\LHھ؍ScmwFa}AI}X(Lbfۙ#Oy Ire&[f({*VZs& ,o^}$}+(mw.Kь .zNwk zkK~Se4yǁz^ǻxxwz9OOBY_`-v >ʙJopyrĮ+j=(V3oμ[9( 㟥4 ("S"CTH}kk:3PcHSrpX u??-ww36wY|_MtۮuC4AvX Q-Pg_2iܬٜ'wO-*ZULЧ㬸cgGPKsc*3|s<ЇKfK]@huq&$'36>s8f)wk du ߦji& gX@/ltr"GWn}rK>KT fe}o'h/ٿ FUS 7&Gz/_h~dIGN(kF'g@0\剸 ,`^<j+ێpqF| mlJ)FBnW͗SÙ0#iLs*<{%3v~Dŷ) d:֏M N HjuM]术cHvn)!z_gtLLxA7L:O\j4?h'b)I۶N􂽋"O`K3vIÎ*o t]!_G@ vA?tɬ|Ripb@/=޷OꕝJ:FW)w JrF"Sڕ`~-q7!w^n[H\Wq~ï &7mr/pqcvbX`jqzn|J]uhp5h-nBTHَ*`vuG~M=:ս_ѽ%qyFx,p_ӾP`c qdnM0q~_͙g  /p-ح &x*ol|2I6#@wLhizlƴJ=B t@YY'ћ9ӥeMf hrAsds1{d⭅ѠqhJ{{fOmu&.{sBāNȉf/)?f^:\LA ݛ:"#iޗFtgyԸ'xz|y{& ,R]/CUjm}0CѶQ{J+RzS"T,IVt^ 8yp!> >Ne=VлAfʳ],_ {0WKNں^XֶЛg BvߗKX .'eT<'h#Fƒ597wt2ɔaKgȓ~Ccf`RH/Xyׅak;FyQwm_SD, 6)s4*WC!xН^+s{rd!U\wvc+Sd7ѝrNc尰wwɬKxoV'^uw*ۊ=Џ%62o 0,FLĺ"CL'޹曍2ݴxJtUR1Nl=xT['R'5lBK׻e1U2KZ͋xt2XPy.\5+IP8Z=B#7,xqZRԹ+k"&)9Č ɓo!2;3gJjeڲ)=pb=oyiu[BVs펾~o<\{.*<=]H\$|LC@Ҋ 6.<>>W`q=u8eQ$lzx8}cx,ӛ}p&"G`vƩ]ou)q*_Sͻb "7C[WEo^A`}.gmBu_^'O!候 Uj+* Qmչd\pM%H[|ZPo,?r$g3ԑP~ :x- 1vY8i1r8cPXb`>OFGR+#8Z -?Y7|5ֵNwe\1E +y!5;<OZȜ'Cv[E(UjINWHzޮ_u珦Z4|z?6ng ,7T7Ѐ:t; ECt;VGLa|-"vt/D6qtv|&k۾'WC6!zY'δg] wl0!mvy2i0KZ&{@!G6ZxPmοa*ӳZE);Q vrg)Z1FB)c)OO/ĸg@̅ma9/nLS``mlQBW M&ѥK4qlCגʷ}=kc8ى@G35wZvywԿұ&ls^͑tum. -¦*[JFP>w$.6d^~km5C +!Wm4g@^X։^lȃsNj7[[̓`5u/4ÿ'ФަIQՙV w87{{ª XwOO;aUӦhqy`QcOlwouC|w_{`!hnۺmPP< ʒ2\g =L$[XRiăq}w;F=V{9Pͽ9t AQs(Qn6rXJj*YͯCrOAwx^X*ڗY8+d<\[ \;x}GIA;efSl!N̂Ư# ۫UDt‰=Aa\Ϫ8/* h(jNdݐ17IPP68'R)S[߬`UDZlL}I8q*crx2wEG L[4 du›;;ə:9㮦E szN9䪯ԴW~#mH[V?Rz0tgt*`6\\%lمx^PesM侻UĀ*Kؗ&p[#X5Җ\Hؤ=/49cYi.v32˥CP;ryEx /έh &{Kc@oA̭kg 3xяГX b dbHvDr6-;bt,TJ!{_uF;Sp #(TΔc vFk(\d.{I3Fj ZI1¥0h ӪSz+.Rܒf13 }QZ-Έfk\SF:X r_DY7u xإFњOq?2_akVlY(&lN+Q|hG]{wrP9UJ8[(J W8c`\ t$b, <s/7]>7VOY3*=oO^k?n'?Q>b} :k 5jI3n@Sk4F>rhUm+[l s|R2L9Pg 5/>R0d_NKŴa *VDRSaK߷̣.G$3׌b4 ?8:~tPZ7̈WQp7/uPR%fj6߽i*uT,j#tz<%dP L#n<^*7(/$z.!z^.į:Cd 3z}>F֪~26z4ct īWCeykx|qwD"ПFNw;c<7LJإW6{IE͈kA  )RXɀ^Q xdbXqp}ī̧ٱXJ{[3t:ظtdt5Xa?|Q4ګ+"CoLY/kAGv35tYN\,~C*K_vlOp/oFY dABCo+m=8*TPŅMYtuYiq#8 *8ۗ$ߖ2η5fq2w|̦bLKi>t-*?^{dO.tLo!1Q w/H}F0&kQo?pꃨR2=UUY#,8B9cSۓ2yh ',OsꄍR"3-+d;D_Tm.ڱS~n`Ʉ̐ԬF[쫲V'&(Z`2/>(>hR|lƈa7OX4yWRvH̲Ȃ9,blQ4 R);k4 4mD3'wo c* je`DMa~@SӥHyscj}Yh#4S5idWDm7| yWYo3: VmV̛yE)Iu6UڅewDqL[*`ur?..Y* ކV,L7ƧC1lL Qm9Z^C>}xgq"oAO Lz[>, >0.iٮLfv{DOPWG^b2x]&7gp֬9^^V^2:`^v>ҧ͜.3HAVpT=˦9䉲TA= z~9B4;|K`o$ Č!/({8-0NMG5Ã~:@߁_GE+72lJ)zżckQmYx$ß\F.sv8+ZIȷ~ʚ]];!Y}<rK֐uw(db\" T7!WbYIo/Q͜ ]ЧdV*^#>x! TIa~JT,YtKizwFʀ%v7M.uF{7Nθ>o.9_ne5ߖ S٪UzOwܧ%fy]S[2.uꎂNEGNk7un] ݅^k}̺s.k);|?Iż850^.ݴ+z(nIn6eeqKMA3mx|T^n\Ъz7}6^gtOfYZQkҸ}pER.^x~|"膝bpH(n`Y^v8>!r}Lݢ[:Nv?k ? {Й4żv+3my'쩿<ڄuͿH}ܡ:@)ܶV٢K md  *7Pwmq$H wNvv>sK}|Cm vw wſ}ZyC4KXBG(``ib__ Q.ٳ I Dqt&Q~4 !)d%f2Y׹Nk}3Q> zu" }W-~VdiWwh,ѩ 0m~wV;8[ml?_pT𞗷+ҺV;D.rEt`L^>I㼶e"nP\f(c ׶2qC+^M!aYj2 ]>%huwm٨ǏZnui<Va:mӣ~=oޞʀJiXe> 3"#iy7=.pZ 4[s}hFˈY@b#_MZ}dV?PugLũ3_l|n\=<O` bՎ,ַgpyD<y.êH Oz f~Z?a9 %fs4YwCt5pkA&|MgVՋ*%>a;aX7ӿcɮS[Iv\Y5Ϲ­8gUexc ?qtjiΜEۏ_Ήڈ`Soul<̰Swy'ߔl𠹻ȟzK) } Ipw%&[>6mq!WȺR2*4??yxI Fl=)T\pyC2lZ-y)ur'anfxĚla[ӵz| P,}incDFN{2g1$OR9('?(_P9Iͧ4!?Mу0ZpVR~rO[)JROI3 n3=Xt[~f̱^n4W+bowMh: csQVGElk0MB?Nf5#\G񄙳\AL fzJ x&}g@= 2VッzѨ/eX6PQnPʧ?L}a-ʒ'ߡZY_D!(ph:ӓ>,4p=j_6}ѷDlTawZ*hg |r} c=3~HCΩ>;DVK W." 98h>J]3ۖ‡Z0ꟼS{mV5y/0Emﷃvcԟɜ-N79"S;-b̞~:8>?<ѫ'|K/WcQjX>&'&+?wǔ(ѱΚ(u!jG[TFs0M%:f(3ˋN \еwpoo^F@a7Cܜsj\:;%q-+f6H.$ӵ} ORKok/O)2`9T?P(I1P4¦L fi]n=bgk'P+ɻ*˳~D}Ɋ4i%Znp]."й]vN'֖6c4昢/ŝL Ϯz忣MTȩ6~62C 3'* χޙnZڼ0= +kS(z."-8wz`:Qӡ_>ڳbMHz J;GƓU|n{ 2G_6c\\Bv0oW8` nx\=BXՄ(`njK<{})&hY3M 69^ k\X"˨}:} w9*'O"\p#Z/d2uPݍ|5uOv}5vCp|ejJ4FLsV]8 hFܝ)rQ8͘n m{on 3Uw} ,8 T27'!9XkLC 7@mnDf5\jԆlWe'tHlȘOҫS(4\4%D̯XMޙdVJ9̖jdExw31Uiz*аR"C 9rKjtC{Y2SNRwaD- T>\Ê;5ns3g v;)Bm؈";bն4I%-Cz_˩lߕnv6K!tsjR5*\ *mngAzɣ7(̶I|@[^ԣj ]zvxګ-l݃ҩ )˼?>}l9v)Ujd*up5YhW/|=}{sRK^w0fo-(pE7iU|BnLpO^UÁS= @fux?d.m4o^DR=,{-Ya$5ZI= 1Wφ0Q .r4Fô8I , |ySOg-v̝_;3W#JW]@ Q[`G?ivlngۋ, jzzz0i<5/.уJS`ԕTzb3%Q[k.S6Ч#Ch`7 ك+vDG"qx@fRNVn:MO>lҮr:ԋ;qcJ{ Ceڿsǂ>qu[Fqƣ=PAdE."g ú흂گ׮P9qdg)C}n=nzu_1GkX(ws2ob/ Aδ:C9/躀]yGK!=ṡ|HH=X4ƫ֕UYt{]c}d6Ѵnxd&nvj5Cᾄ?̛s^^JcW?.C.)!2wÕ\ͳW^{: QLH;eD|ZT C0Յ{| FWz![iuXD@/.Zbڌf33[m獗7Da=SyXŗt ή\ƮnKv{cZ[tayNO 'T>MuCl*ȨABo`jS r[pxW.ؠ~Z-DqϺ!'ysf-^b&o4yOT/ok R~5=d9HH^ޖFiB"R+z` *5w}7cIc<i4DDy$5ɣ.Hbh| zGf}+E/t1}iiwdpt9hX5-d۩k=LWwޒlhoo2[^֮]9BhP댸XuXo6mC?fK$%Ϧ!kPEvc~an]J.۔,B~2X0fLk%E{iךǕ^5{t&^3uρVOavKw]j}Qz^Hm)&9Nc]ra="%WT y\-Lp+\7qs62 2G}*uؚDWbhxlrژ60L< =l΋<YjD~@+v4Kk__/_w8kpRp&]6Mm?%Un,~ٸ]ĐJ}t,M<'<{ ed.F2ɝگZK9!'/ў/VCH>^>r.f^ܤ:\w^VΠYN`wZpef:-A&ĝ'}_=_)Me^sc)/ ^Y"0nH/vWwA;Ĝs{ }a9z k 2X~;Dp k1s8 ơ=n8wJxvjow+Q>K7e2k~e*@n(Jh2kw뫺Ym/F)GcH>u wimށ=uSgO{-)qÒF9Y6rKQ>JgL KDz1fUE\p뉥p&2 񞺮*dȨ3nzqQܱҮدo3%nEKmUd6 R$pM"@G{Zݑ[*Mx'[Io{)֊m&$vwHG,'\J,VMCjH!%U;oF䊣1Ju\/O|v`TKCRRH4U1;gpnF^ޗ{nK/Ob,WzZ59||)̼F_ '&BuTt^V0/(KXYwS7AK YWي{bSAo\V>2ݑu<;x3U"VtP}"d+]IU\[]5b& Jp/\} cAb=<+g$Ȭn_7a}1r375l |kklɨԫOmd@RrCjY{0~ԎJK/+EP]Λ͙.rWm^0|Ld'HmM =! [ UZΑ'3UBL}O_3 k56C?t v6;..~[o/UG@a/k0YF \:(nW,og9(L$Ggv*kQd**4eȐBE??WzA-4/zT9giFVy8ј3 &I@% wapdGC ʍF ^7G[_,$ehMySZxA0MHR#Jw.yt߼Ѹո-ĉ܆#\5dӼǯz4٩H4US+i^r'E>N_tL+kqr$N~Hs@0Rj&tTuk%r3n`Y2# ׎ϺD{$3I+58&]ljC@|LbLg=m=eGx{N[i3c4)߶^M?24A 7U:T_, -莪W 0P>^ 2Oۅsp Z]¢ͣ>xLiU}:M&`2CǍcrhwl %޴/ ٖ6.f-ӇK>wKqϝs;"C=Z"S6}3 Jf٦[,^SK<ٗ6~ #s|W?Ҫ̿VDW̨~u-f/UdZ=)ó5BO.P!9mI/-]'Iy1bٖ&6U`@vn%Oؚo%Ay8ͫ&l*@Dl)pAKQ5?.@,zՠZޮ[0mXQhꮜ{@+Q Ҙ+삏_(ZgQ;zmCL h`d k+6 }3PX񰑿rPü^cӘ5?$zG w!],l9ԥ;ޢVnIQbwoX1K2uGQ^#Е^ոZ%ycYz73i]{s vDA.(q rY ya+twu ZTŝ o5jS\y( 0rwR~;{fͦ\W/asX/ɡ-ҵmjSZ þ&=jXU *jG5\TLGnVP^'rv+U@|C2}xqꪦ}n2R- Fuծ$s/#NrH:҆Yj\ 5 rl)c/RT=!PB˦'H"Mu1)\xN?^kD }lGy4kCc!1b.:)Q_7q=E <3gSNn=m Me!C6Z>O)?~6D/Nu[וEY>wqLslh)5X'4K9%Irkv,>G|ͺO.a64&v>!bWaS/v 0-ӡe}ٹVCVa>ȷH*.7X`ǧ2]-ٯ*p*2qlƹ۾hA/lh$ٴW+`ߧy?.VS i4]m@FC'\OwȪx?h-"&FlG ~ #YT_Y׫dn';+gc?Euφ0ʽm ⹯hd#\aJzJ6 ]&j-Vr2#~i(S&.s?Bemt"w?eHlhtT-١f-X0 症̻w {OF>ǰ,D]&r}#OD/S~ǜnFކ95eW|iEߞEb!$a'W滚ySNzwTfmV?jB?9!L?(yʄ!8kS[)5%eOV)*t]w/cdsեzdNv7Ow2XjƭX0ڃbm/YCR2ĸ.7z1rEB0toŞQa4w:݅|=b/L6~iau9BVR\p0w_FℨxGFA%Dv?2džgyaS[{F頻DTvӾ6ʀz<eLaĤYW˦цydUjakܪ"W>24Dts Yh hr:UM~˧UG8h PC8-ܲ]x$N/(^ oᏃk6ڝXnԊ3tc"湠 _~6l4:Q+gAzP\Ԫ?+Òy񶢒gVǟ>Fn 7r߃c#>;O^jϼzT<.{q)DoLnTkxs[ lH ~;=/Frd^#zf `JNJ}CԬ[rl*W(~t~ѓ'i3Fs42- fV{|AU3H.mȷ|.L6#s!co\SB]}ؤXPzy)q"ʥtOs˭~R|Lyɛ714-汖?Q}bOVc}:|9,E Yd22'?CN#2Y@Xӝz%OXMtޱku23=Kݣ듐T3TԮ>}! m%ʐoFHHsngYZWӷA4a>8xC[k8.MJC҂,2AJFKty>oӞf4b)YKq{1e\KI&v/`ّ2V =#+1$zqتX4uw9iLT8ݾaG(pyhXm.}9|zAk20ekV.,P3sl$p&wF~0ms8ՊHh/BTjGLyX=%iTVl:ru&v_J5J[5nd1S&9M) d_t+<\*!ԏb8B3jV3Xwzɾs e|rC0)RX{&Kʜ(ŜXQ|N72q G8|L',?Z VZD*x2L֧WU%vߓ!V Dsj̴wX삢]ɰE00ƛ=2TuKL;OKX3따 !6T**j':R0ϝ  d'+t䘙y.j1J\R8K;\Ƴ[ gJO}܇\{>˥cR@~x.DHx[j:?9&<_i-:8Rҍsmߺ[M&Hb1Ϡ⼖#~R'c`!a0)LXc}UA*/±}[=HY+{=4a^5;vUsR #,OŲjhY_Jaf׿`q\5S?E|5ݖ|ۙmA<Лw/)4y] 0=˃QEJz ÀSf{m'#PlnThPIkS!nOVr[!y"|X[u)]{'2}AWPrkUe7wt)Z"l:o?FSAJr8w)EubVZ#!$oy!XrgXBINV +Vss.#45)hYqT<+"I30.,Qi쳣Fz™PV+~)re rut/ $My@X `Ĥ8<[+ޘH[Kϻ >{DR c%^p['Cծb-746[ݬdR~k9 B8=2+uѰ.TӔda%Q;ݔ"ҘVsV\=ܪz! OdY0'Mp'ΔPZFU`ɫzK%(v+0F=T͖UҪ`^z|gU 0 n3u^M794';[84#wcg"K r?e֧Ehp9S.9ٝ _Bk8'dcUtY+O. ܶ$EMй(S]6`%`V۝WYS}v&_᎛uSfU~[N; )x @;Ѡ B@ B~ gPۇ/u ̝ދk{$onĻcS8)[f2N=G\?\[GR5zCuv ȭ#y֌_>_IψBηMFo{_6{oMީR?hMPw,Æ1YN tԺ0ՒƔy@SZN;Z6!^#oePVdrꬭa}E4(xM3|r~Qv9A6ؚ}wUQ+O}9>˩g}EBK55/F<#&ym@yi-xh(P0sLV# ۽[,Ͼ/~ntX7ێй 4zxj״L(g:Y;/2OB8xG' cKx2 Oqb/7EtWA1yLgl ,Uf~WH^n42UI2ڤ^H; %Z.α]dGǾV!h; "W֧@zP>*vv0ô%'Y.-P&D "kŃ^jv6wmo( Fx aL;BIP A"5z[[~cokeFx}!D̆C9F6KƏ39o~`N/wAxX/0>榶 -kL0 8gWPood/ j OڜPbG׼mCkQ]6n.ͰBbFxay$=zAw+טo(sX?[e7ΐطbeYzX)XSr7ْkC%SрX%ާWlunN"uslTsZqSޢt+ |!G{v>UߦOS_ӝD>U!{r^ʿBqH)o6ZCt^;"e^>Lk/MЃJv~1imT[g<烇Mܒۜ{%(W\Q|o;!\DGd3Tpȵ8`L]?b2p=ռJ[Wf*@I⮊~f"6D/$k4:~:H~$}m@98QoG(7H1 8<(cQ\W2͵ 6jKlGS^sH?PN|x6V[x@sS0_#H={IuϿWgnӷ\BU@~T2ޒf26.Q,כS.M!RpQSNo.qQ*ym>«ޢcLM J#r5}؍kUF㮣8 x>0WYqfqgS<_oHeqzG@߹q=ly.f9$ȞEt^5E,߼wO2 dzrr;bBof}a5arWF(^5.xc+p 8*L]}zB}عpOP buHxf9o&/2" {]Jkh{ו 06Bvr }i7 9Vy*uR6+ofn5fSyP^2z\yQV_s:2SPנe)̍30. ®>ދRMU[k.sW1Ҧ!)w}`c4ԫ6&H~('y6邙%8pHLoΨc=>o7ws-U輖T ,"*&0sVM(=w{UX.tg391NvXryu!_1|߀7"]aIE@eCK_#Z/IijVH}T|E?dzR" sovv3WfHЁ<ÚgwGi Pw;, *q>\ND#9>Gfu oJȥsLd(b[;[uHFyE?ݻ w*xbv:#ɆkJGL\wf4!~{ jQxnuyMJ7[oĐ fO܅}or^q8u2+Xxjkvc;a3 U[aZY A أ/Z6f #?ֶH|Y+He̥8weYX`dwov  k0:N-RLgt~k\@yB}LQ+@pSYxWVO1[ 91'7݇BOh?^ae)ϼ{" wx_zg˄T)+phl"1a],(4`F^%#i*ԾS줩%(nP*Oo)-''{' /&_V[UFS?ˌI sܛ]kXmOUWkaNFntt\[iX: {cnFDNI}9CV4J[S[ZtZIEWA5g6A4hܴM:~ٹwi Zn$AP*@jb[]ڈW\piGPD|P^aU>ҍ)F q@ 鬤vw L-bMo%vov d>eآpK]?)1wTWNyY܍gZ>uZ 5\|Wlۓr&Ǭ^ [o 7Y眃qw5ZsT>4drk9DZhn/q׽diا 3\Ja,nrjR+TE=м: Vʆz7n& @rTt9{1A3tʮd_Uq%jϣ=+nF?7ίâRx ʇh·Eԏϭ ^0Lii>)J$.ZmC_)/&%wTo޻U7pZNbKP\]!zo2f%۽ֳM)n ng*w852(rR@مd٫5d;U:J^{#{Nlkft;#ϱXS,fW2YXYwI\!|ȕtg\=5oe{4*d}@sdYpo>]z,e+`}X^e )w~A~06A,ӤvAẗ́'Ȕ:mig0"Uӝ7r%eяK?}d?^aIB. OS^qå#R,49.~JsgNDi)=j;Rj k2=^BrgyU2S4s•18L͵[0Ӏ6T{gÑE:TcE 1u^Wy$k1l /9y{F(Umۺz'*H0(Llcş\^KϿx ]; l zgF2F2r=Jf7^Ash!M>{Fq=UsjZ/7'!̔1J;=Uq-/!i`>E LPqѽ,#l`$Àͷ^&,Fdw@ kJV\& LT|HINƓ;_:}1;s{cJ.#aGֵFr _OdN s#i}nFy ?3ptfU^QjKyqL"徿a-CYOj@ǃ+ 2^ ozHޓ̻Qǽ8)1'~~8 ޘ,|ÚHg\IZQǽgGaeEϜ2AMfKF{'6v쟫 ;Gƀ']a堓1'qs{ϖW1V)~Řo+'tA-f,澡@M6 Joe6S_vC{SBni,Oj?\u21anUi=L*dw5`]@-FBMlF,hL.aEۙ]j{uQ9j ii&WC 35ר&`ӽZaΗȇg=bwwoV - BI GFiuÐߧw65wm|)GEUӱc/SԦm,K_.r\B35oae/=wq/S{J]C[cNx25ʼntY|p](󺔐]z}ezThe s pRnݵ$F:3_OQC=+W:wS2yk[^K" o=Y=Qzm_B⏫seݮ-dw`"C2&a^`AS6&O9O+wJz.sP=d?l\CzTŸBfu{M_ݑաii}6U ذ }"4ⶩkF{y++E x`Χ{7:9rުQT1Ó&Jd2LL)ٝ;$e[zlLB ~2%9=c~7x\CdI4sX3Mv-sQCfc϶;[*^M2ƃdfv)W~nves\zR٭1j0(V ~WphWF Ib18:-/^ e>-[8XO`*vĤY-i[vZ+?WiثmU$nѕ-=o9Rz: ɓȯٟ %+rI|;;"wd}`$0{}NZ0es Ǖ?3bxUL z^;f^ hoN=+R+wS 6-BE `5ǘV àGk: 7d 3aooW?TMdl<*s}{Ufqۗ"Lt6wIz<ֺ\>C\m+1wW\[zmIPZ2ѳgI~. ЫߡsKJHfrT^HI)1N[蔐u#̡&H+[_TPlFuE?˅K|e?%5`0ӽV2 yNʕ]%ȏ Wt a["/`25zN#xb펧2k6W.GLA7 0e Wﯰ9Q\ i~hbreo֤Hmy{s݋s4T )JAejpsxcR 诨bPA *L̊X3_ѿhvTᒶA&_3*mg|7OQD9kMwgR(p勝drkKgVA6-uvZ-^lB#.Hm{gr{dg¾՘bRV1}Qp5R*S3ԓD}93eI b۹)Gފr\,kP[+ àtxOJ);k1@Q..9q=9rvjZAz̾O|t` f,6k6C uKc~i"C[O'sqWu[z9rK";|ݞT~Ff*~ Ff0/NU'6 ~ګ&_dƆ+U,1q1 M,)!W6#v9ugjY<'mm|:r̝ 3Dro%2-yU=(: ML. dsR{{k֚R~7L>JwXc?:X`]}B] k,cBA՜esVi(&hpiFs`,x[HE$m7_>caj!ɴlA~|J:Sض9(W,-@FJV%nCZk/B7OT;ڭOvQ~#:%~(N;$ 2nU4Brܝ{&-%9ע^:{c?.EʦDN'64Ӹwh[&܃ib2hVjXֲG@E A'[Ӣm0V 3[ʨP#=3ݯ^ʣ1(\\b͚<cw,WH|{/cnF=cG@Yb('%w$<- <&.tl+&>p=0#ȴ ]7 -8pԸzMk(T_l쭎:1f nS͆ʸ,Tc.3"P6(mS) oZŌMF@YMkNS=B.Zr=!KIsר}~@ A%`W+Fn.TI?`ԞNFAJvssz9[`"_Q?As*At 3hW4W]nV n[U{ieN^V<gۛu<#nzM Cq5!k?; }\QvӨ^=o^?ai{ֵR{fotIT3SȥrX^ijJ5sfuf2C>7AnG~H)Ʈ!~(<\m&1A0Z;H}2y5|}(52wP4fA"Gh*DgnDk$IBȭ?N53oQoΫt$yo[I]+O8th@3ܹy|.?&+,z>2[ 1ͭMq۸@d޴1вίpŁakɲpu k%留QP5W JSr=70&Y>N:Kf^O\TKi=ku%; 䋲_fTFlH w~;dj,a7)crZɢl) [j^FlCMAл) ):8tA&d r[>4bn`Cf$ycqa☐ @na\:&mT)UtڕٛM"{V8 "+Rd o6dw_:O='B&!v7%dj`Ũ!lAe]=z5:(TArUu vT.7ak}h! +sa7Չ^lH~yAΛmxJf2 FgfZ $8W֢.+4]UjYj[V)1:$LY#f4naeKpCjch,QnZ]EfbGWv "frXmzňoj:5k (3ZO'>Tx1dGcQ! 8K3骶~[>ojQ.g/ruZ 78ضc|J#94V}l܎ix΋ b/slYFAv᳕w]jIl5&}:oI?uXFdH62/M8+ )u0eӇԖr=1ݍ*k b:c ^Я~eh?n[{nV[%c=<}xEQΤѥ9lWᵢn/4-bDGr;Aoskx BQچENn YfmUNUB,6NRXz'IHΥt&oq=ѹ}!Z(;JNpV9>h%4&wrpA$pP M -m:?~ިy-'b*폪c؋w^ acTSf_3c MIj#ECnVl>L))ٓ cQPNk_͈VKq |3<Ӆ{׻IAyDQ/%ΐa⅘%GKɴM{(o38/Mƕj:Vo_vη,meND_{vs G6yr7A*VNG@u@溻ACv:V^l֜-ڕV{5D"h}A24Gb8^(3`B/'}rd^3 5 U}M̝1(LcЛx13*bZ hqQI-:] K'E"ԧǿ2%W 'o q?2Yj8 Xq6_T)æ+w%ĒZ}W/3ϵ5NdByü%aiq(dy3L[6-C:윆,6^rJ+GkZYoODhP߬>_%՚+*kmZ\m :NznӏWw\c-5!6B(mH0N^&ܒHMㅌ2u JV$޶ZyRdLk]sj6Pc+$b?L2'UX1Za+>] [qչ#ŷ45ֵF%)OaUcጇ؆2H> w!i/˦փ6Q}@{3a8,^OnӸ5xɢvmML0\":Ȍx"$B ^oozzaf:g$H&:5:uF}啿mg:}/_NJbO/NeDmVM6GmWZp&Z|^K _\#%aE4lOq_5=lte6w4jǭTZ9क़tJZ ̌Rk+΅ δq&h:zm=ٔ|z}'T^" .^ꌟѭ v\|WkԕI`FvX0CxU,O/Ϳ940cWPH6׾jd(ـCMΣnJ gn R= d!t.O>rL`7 ?yƝ, !e+"/`3'\p>-Y,ޫVf8fpZĭ5,|Uxϩ{g2ŴꞳ }h& Ѩݑ.=(:n''Eˀ{; ^S|8EZ|:hZlMW WRd-7Lq,y=ǫU_%TTUԳ{/=ZyȲy]-bvԋk rMjuc8ٝTkzOBԈ~{b<ܶiQ̢ hgy&}Ac4ֿgPMkڰb WDhʏEy:SIK=C9SڳYR`uP@9U|fѧqL:Δwog}cXbzm?}_'|3%n~MDvR^4+ mUI4kٲ6` ݸp=Cd):m@9NJO#< UJwHu-ρw%) UnRx?D5٤/}\_ǯ6Robph.# <*գ2ϺK9wrǟjvNz87͢T^aHPG-tS dK|_YU1?TY(2ĘNE\35:iCRSISwk{˾HM`'ʥ 9;Wc9-*@^<) c@l)LZ(<}slj;Mo&-~Fbfai0+KcfOZF}: [@YLc$7Gm "ajx^f_b_O~qdd* lSݓX[⁌[qZ!/ŏThޏi[e8lǠWׂM<}u5vԸ AS7U쳇-R6 ,|vF>ڮoѾl :O!:aal;7&m/chãB^Ӹ}b"sK)t'|*u2 i/z0 c_Vo 5YËpI#R6qK.Ӌ \fj?}iÔG~wFvyN֘i?Zj¨K-'ā[Kϟ7-Oxۏ`YoYTTVcq37Ӈ9~ g1)uq+uy1CB w~SN#v ޥxCNpAq[Lv?OWfHU:\WW{L9Z`lះg\?Ni 2S^xƸ )RvY$ P]/5ޞ#r1yE1lgn L!8[*mD\Lc>b S|!Ѣ.w zvl;MeC8%%o.ȍ{O7ΊKgvz>l=-ȸD: r&IU;E.œ;\$Ev:wTzŠPoUUwqR?uѯNNd>SJxV6$XuH[PvnJ۝%[GD qcD6XC?ES&ۻ56C_%IK>ӿ2P9iaul=@8IZx^L*ueY;ՙ}:ȯ8 D +N$ ,/(@f<գNAI֗5µBrse(M)߱ȕ"q(^@H D _ 1_)b1ƏDܭFWHI.>Gɤ ?WEc%j |}V'Dغ@ ȼ$J0^UjĆ^Hbkb1)41.0Q)@ rg5ûϽx+@ 2kv2D H;I\VZ:3?mpTR[ _`6z"XSV?xi'bQs?q}:%8\ #ԩ 2mv*jVt#+"?eq wKطቇEg<\feS򽬨Zg̨Gǀ1^Ng\cvska$e1M֩%(4g}PFLe|"ĝ7ِL?WGߔqh-J !&'2 H:jϹ@Odōc>ZIISiRcz7)f^nqίrkt{/(M9TIa ;[nZmzkh NVǶކɯF\3}?PH[0Vߖz`Fy/ΝJha#6y[[y?[nSBFl=w,>]K r[nyujֺ/I|{4Y} {D|tc}UmGD᱗6.aAݽh\:s;<WsF77Uy{ qa$y [v ݢikb;JʝP0_CW|}7o\#oe`@6&C0>|bXM-qՑA$ ȹrc?wh]"ĥN^nQ.ܮ 1{f6TΗ $CCBS){g?h0;l4Qj*FӶr^Mco[(pLjh67+'ՑR<=G4D#ZƳދܝ}eD;{>۔z*FbSC9a=*nM:(]G@B(SDi2Mjq 'A=o ̥z-|{2]m j<=@2h-/|Cc]k(-acai:=] -\߮)q|Qy^}r_jtN RzӃVVo%sfFhώV r\AُNP+[lJnO9Y&tfjʻA>٨pzkT )Wz5x|ܳ=Ssگ9y I`3;Ö[3L*3KSz"Ҝ,6Y1X]:Q9?B:O4xnP&,V)04;}.^ԻKJH}OZ12$rl;oSR[rz,ImǯSPfa[gS}YYcs낗IQu[9i 1n4^k2p^T 9ї~2}*Yܵ ߘEÞ$,vڝ3'ɨNs0}M /)9 igRd҄K 3/:~N&*'4\oRMb)kkǻJg@J}+3ɑa.f@궻rV{=Awm4 ] /Rw+uB̤QW%ZǎڅИnasTH93rLH~&1WK#v'f p}bi+Luآ$ـ5*px]'b7Yή"02<Ù*S?,02#Jޝn 7mv gwal6X c,ۛϐ01,qYh6_cA.$nVRsA t2{{p^\FPưlqZ%ٚ>g#$[A+e1\3 57 멻tk&+oHSf;,c:ޤZ\@SUYL6զW<m= Ckn5yӀ2Fy,TUxNivI4y"ߟaȚܜV18.ߗs.컇4e)i^߄;yۍU5Im5@ڥF~{A%W2{ѢpǁβƋY~>Jx(6z L|Ju2-=Fz˒:Xg9,dkLφO{#pbb]̎=i SXfc5[2Ԫ_~?gڛ|W K` kYj aZOWqLoȇS.|˝֪?؜uhȯUgC50cg@%BTY^XD# |! H[uνO QSs_S8[sLА~qXm2a!Fʸ]7jVEz205o] sᇄ۹9ٝ:71iexmS;j5A="4b̬Zn n0%/eWct͇է8[g9@9ZUT@ƳigU')Xl :LZa Vqo^ "{xʙLMXo@1Gg e[W"ۤйS{`u$$1]gb(b6m~A(Ә_DIIJd _ݧó  _${=?︋xOh!e7Mvγm@S]qP&CSַbP{/Zwhv_uSJ Yմ[,nگ)mJ#.yVp@nS.8g0og=[9dd|kOjF"l (&Uw eXNjͪSVM8!QU߮W8g^BJ~xG%D}<ۄ?]|eN>݃rEL;Ŋ}<c(Rb|L&چ3 ҍuXnmJ99w*U9Cm|ʱ05ۋ!ő>ę}F? $_D.#^',S_-ӊty6VIl6SSs*1 Ws$@vGx,o^U[-}k;D%,s:/4?|Fn+m v_<7VN1aq+e5+tE?w% z!;67Z#2ZOdOwJdUo)=6` ij|dfp^x;Jk|ѥ"@% k>%R%b!IoDr$.w=O79!!x"dֱ!D1lpF[]VpӸ%2Ao|ֱe<ڞW].D Ff|Փ7.7RZ)RntP'P{gIVc{p6#Ҏ` k&fEE9g_~:8ˋ<2e1-3U3)k*߉y8! &ָqhVWz9g$/;'5'O|DHj3L10wV7/˛r:[8h &D7j#}.%VkmԛIfahsn tP pH46u؈ODƃuF? gzDmݞQ慮CX53҂75С*ާh+6>7K<݃އPFN%DD ;6_Ba- ]{vvϝ\4Z04l,s֗Gm~ݘR|Y{y#|G;r6o?=0$JWCORE*E]*$v;P/$rXO?łZ,`Whx U߷wx0E[\7XlV{pg |fx^zR% v7%D ŀE%2vl 9ZHE̐znkٲ;LYeMF`{ ʋ8$Pn1Z/d(LRh\:wkoW֣ po~3zX,\.׼I v >E~!f0皳(Dv ,bk.y>xiGtw Z{eݒ{؉A72ߧlBO/< Nqyszv@ah*Q0쭂SBOQۣo>~{_ϭ˨}bVM'hrv*4>ssO&V7vhP1PYHXMH2ڜ>}}'HhU3c.XDž?^mx^Pf^],CCa|bN ^Utƶ^gxk5F3~{8~Fm,y~Sݜ#;k95*|Jl.BͶ47ϗNi$'eLDI7-&.w"{ 9syJzWuE&=2ź«fx/-~\ }οEݳǡZ3y;er׹A +n &!,\uf*4n|eCH= fifM ʛV8QQѼ4Fh.hoea$ ւ2~n/ ׯ^ߧϵƭt^ B*aN=Wjzx'2S^ի#-Q:UPf&ꂂ$SkҮdS|\c@Mz|]mKebee ߋB.Hl?To=~KܦLMǘ@#3u: $'\JepLpXg, B=raΡE7VsĜMv3ZSKgWM8}`rGƞ(DVa.A=Y+ol~<48tCb߿2e@ˣeu^o@5V `Ɠ{VG6 _FEjͤłs"Ԯyk 'pN-5 j w:{98`0È4{H+YZP ት$N_=Yb0SȠ;`jA{ZM !՞0n35컗E g6= Dž6?84UO'~Gޟ2 P0 i( o_@kog5:dfm6mؤ]AgC/`Gz2HUϋ_64%4 eѵ죪},'ufp"֧|n |$ٟ`t}.pޘX73I|Sߗ!W|^f>mnp 55=2jNL Nvw>}a'c<`v%LuCC5VI\ #x;XŷGHv,y玥Zcz 2p)<[; FRa\9;N;lmBN Gfb,ԄHꙬImUD@um`XR Zgi|ƌC{n+,!5rtxi\>zY%ߘM'vs\km]%0wuՒN^7ĸlxoh_8$u {WlOZǖHwW!xC rO%\v\g%Bo7iŇ^Vfu ,ɥucׄd7HH9ck-FP2}~5}[КUHfO,jF~586roTi__lA%LR9\WFNE6̐Y%D&Qzorؼy59D ~a%2[aa(ٟ[v!fq,Le1*撪Ĥ,5bz\ÞG{k}, Gtirˢ{,;4G*jCf:%#[p)V̍.Ul-Vm{KPN>o.&ЁLwӮer ?8dJэ_K~>QHQ{JR1ft=9fםZѿMku-nnWӾ<ho]AVq3&yf2424 `PNL邽Zm5A;B/NqVogSuSlW(G?z(Ǯ|glc.#v|y-o^S'bYx]di/";0Ąt|vut́Z=BvɵGJ \25Lb_jOYRAAQ#cI;ݴv2oe.= s:b_3|O*:.M:ίp$$L_"[~ EJczPg *q+3~SN[&ح[ :|h.{?/<d{Z ҴYyE籊x蔚pU6(ʠ#mje[U`p ;7}Tqt_kJ XB$s$Qr ~\Xs9oSL@=v-3]+C(V6}C6i1٣r&ő|7*~M25>cŕr 땘Xb Lh8Vi\ol 륨o28VJ*BD,ͦ9LZWY]Qf„Bm9O"Fz;;I;xLTN+v:P蝁TΖG5L\9 2SdZ]5d2"q˪M~΅UhB Nr2"QebH &VPޓd3/5剢+VLd˙HKC*_ Cض:ђ;Fq1 }(.en~55f<qczݗDc~|7WdMo\K2g5d%ʀ]jE7btoeIvG&]zz?͸sX|^|r}KŞYh]qm$yq~гN7+;s^\/Y\f ch51%ZFCI'utMN]1zd\.+-AGApYJjl>:י'S. =9^753AGUWkljEKl *ukWƂpE}7BOova3z ѝ_aL#)gʊ-|`'Z꣥쟔"?s$m?^J.G٭ ؿۍ&[U;[;=:kn "k*vi :qɥ_|ae2fKXae`=ߐ2b&rA L~cG>-NYe]<t鿗p=Nཟxt0߳ӲNBqdLLY]":Wޕ1Ǐڟl-"|Bk3ۡٯBZ[wڐ-X!SރRvN=ol]C2|~.ᤠB?|QHCs,ME-jQOX-p)22װNg7k`Aw@vn TeoܗÝtHPm4 Δ2ŋɯސۿ'o;G|tD+љ l2+'bzxtGuuVp4t>+u%i1zMOr7A۳[K,(pTL,Y.H^.ZMe|8 D=70EP=!0!^'_,ۉqC,m>d"Ff5+?\Sޒ%_FKs';.e;ffM%EAQ8_ܪa~s WdB^x_?k̳> uMet&)"䥘َE ny3L)jKaFv0me/Ow{n}6X%0p;ߨ-Fwܘ?G/[q~Wc|sTPA?zӃV;V{Ysr)sU?(?#h N!dU@mT2?o'Civ|k8^Rڅtjd6Ͽߦ6+\B@"kM;j# "/mJ_e;r귑`iQvエ>isZB_M9e[I w^gto^.1>[ ZEz\+鉚kVTiRJ])Tf wAeh`h4X̡ xz*tQmw4wщ?މ#¢&Mu- :oviCwƙ_ ]qTpys)|fm\6Jde&PY8 g>^e {b܈#n>!]qLmki6~ g lI}DͭҺr.:8+ezZ9c &,^U57hQéP-?notlj;,ƙ;lzBuHz2,R+iGp`^{B*t$.wTKe\{]缛|hn<gj)xͶ>l%g'>VL~^@b|ZHs#}/̛Fu2 A\m``$%-XԤ~/1ͅ;Ϩ9p,\&9.GmEV6<|*K,VZ+嘴\AdgxYǗ⶷QJHPƒt-WEOpW챎.s!K`\_ȗ8ⶾAnw=-5ڬ=Of>}XaZg`nV0mjpfclO 9DcnursD=0akM͍>ŝꜦxp DKr^f5(~k$fؤLn5HT1>J2pEsM3w)z!=s"gq3 꺕J+zyy^lX8 od̩YF(D9oOȅ㣛{Y|zķ&7h92 P]6QГ&W->|3 d25 g$([Hf(z xΫi ) ҹfM,V˅;.@ja.,oC,Bؽ Vu|9Xžϯq#37Un>5X|7kʔ35Bs6Ayv e;F䜨;ͽv2Q \_.Uou^'%>jP8lϹm.AyV̯WJ;%s:ZIުytjeDj.^[`!-x ,|S|A4rrW}pk˻z7o|V:`boT3Ͷ&ḢYwВPd ow*G BMS idd@1^ZSH_ k)\b}c<ƺ >e:>fgЫ),t]Te[?Xq4pŽn8n%~bN۾rVHԂ5A(jfLy^vӣlL cQS]v7Y͈,tգsgAGu}:9|"t t*_ * PD6 bu*]v)+xfj\>8\w<0q@zdWVWkq#|H= n !:=y{h -/&`۩.}vP. Y/۞- !DuTL!:ڗ_GAU{PɭD Z THluNb2l85Da\ċXi6n8rGzwīRe0rST'w7;h)e[ 3@E/<*3kLUc뛧)qTk8S%/4 J&.nG3뭦$nS @ 20+6]xӑ1mE0R&o&땩G |7*2׏v_XC/G3.bZ$>R{djں m ff%7tμ>a7'*t&^9äm0o^&F!bQȌ u-KSGrKӅjB:gSj^VWcgfdSFR@.cT +bIf9WS-ńD*Р=pC(&7*O^;t/V|6OKJ|Pyx< u ԎQT?RP ޝL^o3szƇG|k2h Bo,,©(XeKPo~܊n-vO2U?.:1Lij'; gcLڦROvw<Ѕ뭷 FS396NҢ?' m==n-cB لB6%gwM;,urU܍' ;0w^(c85[>;)2)q#VuU07T1#df_r5jv|'S67GE_~oכy㠌.Zw \Yں4Hw*40U{ #wk5N?:e-4@`|{RS[l3StUф;љO_-a3 !L5u'B晱C.4]Ws]:Y8an4oDZ Pf(~;'dʤ(XhU__ԈNM"Wf #t)yȃ|e.4⊊Vs>? l|K!]!XjNw޽-$,ҸH]^0fPjef5МF־LffB٨0j<=TIUGVgjπ[|/)9FAܛu}-f.,ad }d v] ŏ?AMvlGk괄VԹ@V/otؒ0l֔骺e OԊ>s)6*z:(!5nYʼxDZœZ G?5v( 6yʎnx$lNzg;s$N4BuP2y<; /c1`4'DK!g/ZcM_nF> _/|jQJXkSaV\o%(͂IcL@d, >DW\ecR7K@ ["C7( AkHz\N(%|Zὲ3 㜚sq wߗi̳ނs_ێ֢5djW͒#T66Ld 7)~#84B=)*Z$8E[=@qv?oQ[ɲHj o*`24o'7C{ #;}SWymu(^2;$TCdH_58UG\!hET>lĮ) {o?hd]iLp|or4枒qii %e%+, a<~x瑏3rG#-b>{o2y r e SiNhR,|X*g#f_ l= mvr |<ʴ0O-(×JkQk[m^]^1_$R*.YNjڪ 0zyunY.SNZYB66F߃'IRS(S˿JxYneE)q5jpP w#%fdʼ4,ܡ6;O,b:ͧ(Ni&"K+^ fC3Ժ2zNN{h{OLԕ(|-Th4h@i0Bi"LpֻGgK2K(L֢NUL#c@f>{[ݲ9m:h,j7Ӻ\9Dܯ,I<| vDc!tx)[vku :{/=9'm^lE𵹦;g^gw Y\[ S爛2MJ 7y# 䬰#s.Vad(BDai pWK6D8L09F`r,s[bD]`;S;*7/70\H"YԒJ6zaہIL/0|c ɒO]ܷyŪz-1IġIn CfLB;Os&\{uzr00`Qd5$73>c=[ JznCwrH/TR˿Ʀ!')4R`g*UU춍p_kC꯰MW1ZY4w 2+ q=w7uHК7?Uڶe"mizi!x;|Eى蝚m6Wxg~; b^fCA姷K pk"~0 Zz4m|tiOvV !'9M\I`whݳ AN{OPqV"Ԛޫ!h۞R ؑI;AIzdV]G.Fs)7nȜfͩ<^w]cer^gva]EVխ_˙K tUߠ|}Zm| Ȕ[9%] T!,'kmi2[~pݒgӹz)ӋS3VqPj| A|C!fgTK˭+&;peZ<bm҇y!x.G֒Hƍ刘\IMő dӔg68gqZ3nMMϡg5o|Ut\>B7|_ASZY( m9!}Ħ}o0 B1`#Bo}NqEX[o =Nj7a2j^Ӷn,1+֯?QZ8E7bJ*wJ0^՝Jm<[mJX?;\ltKҍ:h󽟍j)h /:ΐM{X'"':ņ*( ]6:p[W tYn-oЛ޴Yˍ.\!=ʡ؛AoY2{J {[v[36Ms`)zH}Jո"\Q'RqȻ{ϠR41翬1ޗ!a!)&U?(wS;d9k먠Bt]ɀ dD95ey&<⏓}^$Jx`qk| ~"ry#!ɯBs*K}![!(NƧ# dE{ z_x[\fOvu\dC_)ⰡPI`Θz<7sDw/oPscLd߽ ߹L!o>Կ;_Tȴܴ6_[OL~veIu+oATun9XzNoyf橿A;o]6sJ^%dPAtt`(#\gO p,Є3A3I;<۳QiM!mz}~04 @F&I5j<$뫳UW^h]߀\_ b 0Z"Jp^Րw'˖rv K]Z.ـߩh=`DWb׮冞?QU|xYD0߷\|眏pf`6`OՊauֹ_jxmbA*OFl#ǣRJ}dnQk-pzk5"m [|uc/CqoEvY&-TfW7 ^z 20GYN={^Mk8HS+u5\zeybv ! V!DIVFwa-tL@0(35 a7+M/?lgrD 'ݽ腓1-@s65^̫'W2}lWAq,p'ªtvQ{A›ƑݷX?.}*N^z>mc;"jK*~9{:stIMN?aE[fuL<8?]dO2)'{(.3Gh KNVҡØ aqԼM&xn n1Ȱdj̣uk 6˝+|&ƭ?r,,|Z](kcoz)skR0U2SoKgHt~qժjX{%|zWX|$ʖN꾌n}Voœ()Բ歟M< n>L'Iw ~-a2{(w 23Hroնw{!w\;Q~R:٦:a4} fJꠒi>,׸kճOX39bQcFx_N:_W==Ѐd zq8ɱ2ESsRcu C@c@^:y3=OV(ԅJ_ 驪'q^=Ck]jޘwp\]aS^ gj Z̉ʦ(qBa-4Wn1WT?a~,mN>uL( h:^̀ҳ?[ALol+ m;BwhfZXL=fR,*n'OiG^tW^.0ڛcYʜJ!0Yjcݹ,z@I%=޵vN l"_ 4l }ިCMˠ_B`/r 17RMg[Kr ߳iH㘵ib;'J^ka,x[gF+\t /֌!S:#SQyjmƴbdbC~vP)DF twU:$O\Y5Ljj-hF&j)MZt8Di)ZؠVL xm͚8Afytn>`͕AiTَQ(~ԅR}}2pJ_j6LqwΧCn[ɀϩrqIl@WMβW] [M'ސ'xM+Tj;rF-:n{z'j}$VOQ&L[!Ң .mejn;HAhڮ wx~՞'!TS3yp†daCmNŽTP#K_kXrknlD_|*~jgsЏ1Cׇ€C'҅MC%Ǖ Fn?BNGy,WfS?cyR)h D&&ɯ#+k7j D- ,jܶ@%PT%4]=c 76yuera/]-#{WdTXۓ2B}Qn]gO-.a@(dgUxpHéNr*6 WS‰z-O]pUh2{xx) *ކZtϳZEd?^阑2˨2gZߥڔGp&:c?>5Q7:x݄:@Z.6ѓklT427ܯ~(fJ[K^Ģoegižd JRu2~'SJ7}lfYc%egn~IWdİ}6`r-ChhCԂCwhoskh.]Mzvg%f]G.J^;fKYv;Dΰc9ۋ6d'X=c}6&6njg_T1nݶOqiѪ:xKp\h]%+NIo X!q^uz}Uj[W r$W] vD7A"+2sFowa %#g~c(ynrQΈJ2``@t"^CE`3aEe}:)O yeN矺f&5xNq廍Ύ)vsj;[t-ԑ7]Ns Wdx`{>z̸5Em4Q PLɎ39zUfuT `L7Sj+EgG}܏ 0MUg|Ӗ镕C z3Y y\\xericFΙ-1oa˜e j%Cj%΋1ױ\7~,ҌGYZpCz~)̺=jxsgeme:.koD]9xutCuW6Vs쮳d)w r2!}(r/h]W9=)q xu߽R5wKڬLqq=EFhNfǼz@VM<'ܿ7Y}-2>ǩ.#SaO~vw;eĎe.kc6{pgq3=Pe'{T[Y/}_w~z7kqϵ wWOۖQ`m}I"?^_qs>s>ɲBy+ky ^Ҍ\|| 99=yP^Ӓ/|4^c;lK3)pUAuwZTeBaSKT=fw}^wM\YۍO18 0-B-޲3 O#Gy9 ,~h,k=/yU ??v` 'NFgЬG &k:vyIYdܹbu͡\ 3u-rw+?{ l\2 53M{ͫGS?V܁)fl*ݚJ#3O{H?e;Ȑ{C)=pZsL(1F>FZs~>G_9Ҁ5%|t9|^).؝V旟-zkr/,6XVӰyyBe}o#Vrެf}{MXXsZuo\>~統 .PUX/wBg\S㥅E ߓo}#o=DoY6Hywً72~(<*vm 7+QC&]g']sʻ8<jըWgWLsdKx$̮ɿ>܅L5AFRGo,8*E+&8Na"/tV:q܆[R5┡RimHk+ίKqX2(v:&;w?f5>*dw@k@pH<;)xp3![t+b$Βpiy |b~5fE+a\m&$ר.w[>,m^NG[]^h3Cu&EׂY_?-Sv2[zs 7\?k`Ց֎4AMC}?C{M5˚@͙*WvwkF*JV8p,;qy/#|^4?%\r !{@ixuJrf<9jg|C1ֵ8p|1V|hl۸S/1ST$~6ȕʼ@1O%K3(R!(MeWD o6VA|}θoa$fYh|;a:},j-ljwIgDu{Z >+nh_P.0†wxOrMC"{W|CMGĕ!Zd)/8bVQNwj2eMeE=PɵtqWwڧ4#{eq9ڀTFfMݡ&+SVO*zհivnU$ *B}!k^&"cVo/;n F0*&Y^CV[\t|lӫ$.~;)%3WCz0|`,m+* HV"8,$ h]&H:&PG?vU5S#^Z M^F>w@A, MŲ.jf$ͧaQoQb0&_Qi_|p11%pfH;asveO/!V&^a\';zYZ76񈵾k2R,'l>4C[JU{?Qu+[\VC۫Rq e9pGF2d鏻09JQWx&k>rN ./Y+GK6Ŧj$L)'E>ZLOE)eid*.*(~ Ng4-N"GnCsXu9ߎŢ"(%Ik&&ľ:]TCJhuo^bzh[F|Au(ϹZ.egaf{R+X e4W5\l]6rVX ` 関]RW^h^ F`)թk\Q}Ls=\/-xj=4#*cLIz=t LJ #,ZEzɻ=]eiKʦBK=.e~O˹Y({.ڃIٲqBTpcAaYl>ԣcGx]\m4z^,%Ni ׆=6=l6Nz7y2,Ԁ>̈L _4]~P]RX_ w64pR+9p)[aXCc̏Gv44iP ='[j;1sWTLdƠ[Ԭ*_3Ti7*-}%Љ`AaF\ޱr ^RE86Y-Y ﱳ,'g6и_Ky>؆*Œ>h$U}]3vw0l"oWuWbޢtr4/i"~6Hb 3xtq;3^̘:23YP6n1mVxsJb&WCXe0-iv z8IC32 X'_>Uvګ)%1O긿*&`[? e*ޗjr+f| MktNǖx>w}O: `427NF ^+N֧i eN8 +Zyb( NVvߏzTneM2iBo}MVw,IgV鱵'n%=;{Ğϴ/ Tcw^(R_9;Ս u=OŏkBDDN.;ך({y~"rf;1+޼;bP/7Ũzb ǗFk=!Z gGF;{?ET!쬊8Vi9T}vvg֝a ^lDqJw\n4v2?^>oV 3{ABL&B/9ӎyq|ⴉ/n&- c)J;1~?>#x8 q $+@G"j/30 퀊 n;CdopC]47Po ҂@d`:9m;z^&WFPw4 4ѣnzcڞwF]̼̍}.A v׮1ZM{hDYsCYhho ːBl^>,ֆ*`'ɓXBFqB2.wh_ 3dX2Ɍ+9?JuM/ r8/#ԥ }IeK?xcZϟDw1ouuUi3H/zM97nT^;]L8#aahe~*w'> M$-m^w8;G~-9mdVdr]ɥ?EZr Ꮎ7oՖRfA$aStF_$2bV[iɍٳY?^rvv4.GV:>7W{z4S}֯Zt޺+a|m0x2S,> Y^@(pȂk(ɃT jq&(DRz'ѳqu v|Xp4qg<6hD}V4ep94l kjxN0$Vtdq:_~UL1k+PN#,$?!9CfJ(x]0?Wm#E˳6Ÿ3jZ.dlUK_P32)+Ws. `hr-u5?}vk0i pٵ7{hf[^; 9EYAr7h6nHQn%`[xP7 l!.J\CC\ߕ{M}HK'#(c` ]j𪟶t۷Zyosmv&ܖ>ޗhyf+u!n4(|5i"yPқr1DۗS6TQqikK/z7[J9k AF~?Ax'4w8 ,YN{e3l]>fݫna\Ɠ͌H( J;>7s9Kw,i{֮a[}o՝e{2^|*g@i_(0obfޘ# ʥ?]6S=̐6P{Dz왽YLmȣnp\s99ߩO hIov3J1{HfIߜ LP8P˧om'<;6"E7%m0-w'LԲO0 =t1VLٕB#}SQs#6)*Vttԩ(xXmVgwYUP ]od^9IKE MP:m /{L2U47UNDL+FbUc$8FBU:]կtuNZ)]w kbHR'=E7>L3^_zm#1ޗ 7s\^)(4pnYΖQ(s/9{l59wqܸzՄd)܎*ܱ Vt KAdiʫxv %d"[ϒ~P@3DKܫCh\lBq:YE_ s;sCCwѳHRx߫15ǦyܐԎ_8h(篸˭ r*mF&_rA;#SL{XO (܈8yoݱQAe,2z{ᄄH6Oְ^kΪν1 ܅4f /ގ}0{;;0pbo}mx."F:NZ00~TYȝSzH%=W@` F`A(,X׀LԟM˅oEZU^*qJc3bfQhA”ƥ2&RԟKwC ˗ǂF t(t3"C o3 Ԇ!lۤ8yٿ35J>Mg<2|=Z0MEU7vU ݳf6Chi1xʹu Lo1x2g"W_ :nx)c^򉃆Lg@ugϙ'ɨt XDVj#(A~1zJl0nz;zBw:*UWןw[㊝7F4D@:@GУpUӴrŞC̮{3AQΪ]C;C*Uo#}Apg%YZP[{׫55߯']?-%[V2K܎uNuه7#i/|, +t@.0ª45n^g ^&&AFuK)͏f|*;m.VXsss1je,{</< '#v3B<'|cy#V%&-q`8c*{oZ!lVD:|a~bq䉹7E158innN-$ڵbsg,(e$3EMIm 20!e=}Do_y|)DS6I`[qH`ӴfRD#+KravSsW(f=q?Kٟmb-iV?$p?Fʨ9j/Fʣd)Lmk-Vݦws)SՊE5)`%.5S7r7_: Pj CFS0Oo3[ʮXpa+=Yv`TkqkW+-o|׾hW/]5^:\nK,**bة~ƣGSQDgN; :C3+T -&Hzb}Ӑa_šQ8,вN+`'ah;~/K(韑],HV~9{-+vxKadҦSkNcK~tޔ5N QLu'W+X(&g9sJjЦ+:پT ~/]oT̉*јF4 I/_Rܿ}Ikzf Ȯ>L O^ ̜a]nڭAj|ÙMG'vvsVtdjlͿ"}|z- =σe>jE"!|Y|#s6DY$M2ʭ\dwdL f.L7ku$QHkǗEZuEQ}3 >Ş6»ީlffM7uL0q pWp3^~eQ0ЏfG8*GmW6:g,BY+^oWYdU=7O8E5hps]:撅\7\a.7Lcuߓq21͝Zj{Tߢi5h'q,uR+]E[ԮhcMeA) pɯk|ykqU'ܵ߼.i4L",'tm땽㱳6.%ϲ劽=6ʳWW DbD.wۭ>ivLqtӯgZܹd2YE{NzXoM_6v뭛#KUx]Tx7}(O%O|?6X,t#>vP0f ޷'?7uYwGyxAW pߏG)ofE曚dPґ#V=ZMpSg&>L@bT-/mz;b ջL. Ϳ)>݉T[͘~-s0G\yQG6X&Y^aG,X^a۬`=*iy/BA;E ];mdnja1#=yVp ^H+"4~ l! qfnt^uzB]#\[QٜӦ9:HWw$bT'5FI%9 N+͸k"#|aET#02-hỎ id~m}4sr^kfgˉ> 83mݕNO=\7vg2D*$H7,.>tY{2mprI3$fs[;_p O'(<WR9XzعItvAt&Wlt; 6".jb4)iDkeFQ_avMu*L>ja ?\Hw#I,X#P#g e ^.ds67"U8;&LrZϛΛJwQ>jHգ{0^Xx(jM:fvsw3Q y!6L'p!,jRZ!cƭBډ"y|IC C 'WHA[UpbG+M㵾(&k Kf"na:6e )5'l֑)ikc ;h1L˯qjL; =߾D .S[:aD>,F:4mu˛G8< g[ f-И6۝yMy,[CCsowgK_s (H\S4YzgxYx#i͉#?'߹pE(^V}enDh.1ki|ԥ IۯhdA?A\:z\-5ΟUN1gR?~= Fewlpɏ]=y |<=A("ӽÞp3> 5ePֶ-S:r.o/&_u1-Bѐ,I\v}yWdIsaµc޹nO8DSmD(!t墈yɢ q~=?KyBɴJ͵N_}ׅnJd )2XEpnaVC-2tῨ~90VcͻGmp#N?Q.B y+@6"O,L$dlmwry>O T['A4vQg$ٜv3_K}ɴ/?"qxW}$@s*qI?~-͠LT~T{Z>KVKJH0T~IҌ~ʚuYxMjcwl6yXEiqQ˴zr ލ\-7ۨo !(<<?bQ<\(XG{|$?P{H5J؆#˷e&u'8*V @*෹_cBgѭU9fs&g+kN)=͸qcc#nE^ <>gÐLHFeɕ&`y!B=x~f y,$6qa=[q!-3\dS.b9KD]y&[GV'D\T%9"Vp̢%Cn3?>To}QDꪸzq $_ԃBܢplؿF~n'ĊWfqzlh@RYNXHoY+_pJm^Xm`n.5 d*K.&aI?ZV}~r6o}iR|z\DЍ^'\mtI!H${4?. [;_{ HTlױ%TNN? qzV < =yO*M;6]U(@s pV?ߴg[QN-6WRO&\6Vbgݧm-$5C9Yi/glt c/;H᪮Qnmy+z 'ml5^M^,w}@6NIz.h@B:i/Y)>#c^py;zCO$F͓ѣFʿ683KJ.Ez Qm<=^K\,?/[tVj&NJ!\YGϚSP= YuU_~6>5';3w^7(_#5,+-G=I>U~eE]LO G%{t"<"ټ\ܓX4 ꈛcBp蠌Z*ɃՊq-G)RJsDp» xaR4&tEr<:Yzpz\[5`ձ[p;ɫŰ_\;־^u@~<+Շёj6˕Ds_2=y]swiU(a1Q rA}.Fo&΂A2@V|]W?qkzA= Hr``'?~vׅ!᰼Lͩ歓m33 `.ҘL{Gkts`}h4 rT)I+44 >\$-:Sl=]+P pL?)ӥ.K:jn)/Qvl zi,;K?T9@]`O;̢NӲՓTg. GrpTty?kKQ("3f DA1@@JTe<̬FS6`{P.Lvvs&-Zݗ FS|#Mq*s׸aHu%˱ 2/=_|/iq"isaQzN{B.x1V܇݅$RWj6ǤdCɏ2'Wl>:#{}2z] [aNSmlٖ~͸NUہ3Ny;D܎;P׶ nt$\C-p:`w?U64  Lr[M{gw~@X2dqJYTKWa*ק@`SQA~,ll~iEDo7]ӕ땖:%Z BE1.v]>Yi%:{[jk+>&>a0u~ d[ K~..ZkP\I2Jze5m6kI^.ga*Hu_;_R|&6Yߞ%[ìza'FyP=./%&X;e~qe݃Q^bY tׇt ɠE|ڃJ㴧Z=%@'v!R-m%X@ m̧9YelʊHw_GC>UQkt eRN(\=J)=$~>UlHK>?Zn  Lߑrыv8`)`$|!9y?kol@Bj_vgT N˔*AṬxu,uJQs[E߳h->,X+Ƕ-ԯ;{'7ZB88=cJzQH>`à>u-DVx6&Ž<:0?]0!.i {&<#c81ۗsVvp$mitVj]g"!7bFY.&(l|=~/LK*X]fxxw;L66Cۏ,3gZٮ5qyr,:A Bql%E߄ıw\P㄀R8Q;rzщL~ ?^pumhO*ysxAaD}S~s\xQ1rm1[׺߽IQdo7$eeRyDF9&d͒}=*ӥHfY AEDй+|8~j$ܣ l"HB>0W}Z"T,𮨤ud$1se`ᄕ/39=g,ɃhLlbP\c~S@ Z h#3ƷX^z"\.Yo X#η[ew5!+a`YHw+b4MU/42{!Bud;IJe^pC/|k 7/aݕ4cA| AL~ɮd=h=oTz'b _;j̡FF-AQŜ.iDb$_"pVr9#S[1 XDY`{"S #8P+l7&Z)"q'ۥ(vrAuB`CUāde̴U~.z5SS_#9Hf<:.XAQyK-Wk]I%0|f GO9=we M @z*4ð]ѿ;' aFRLM]Q:&ryʚW3S+l&]% W9߸~68Xc籑Y8adhr+E)+}YoShAڨ`4yXs;/VLMh B kWuVàiDg*] G R> wB+uoCBA' <"/_\}ҡo62VWҫ4Tuu8c;k4iyR&o&joDu>'trA 3?z%[S@no#c#'eM5Ao  K )샌!bSҥ3Gb4]k9WuuGUHj%̲aTeY3lnSu]?BT!}hp07_ڈz %{nj1DC Bz8!˰V Rmp=ݡ2d:هңgnZ`EPNxa4Y{;f( #%Woj&vYӀZNWx)KkneL[=ڲik倽jH1^D!{$bvhGc0kRCWrw;[m]-J.Tr%S'$$=ЌCެi\^8irn%R[Mnz[ʬQ~&)Xn+'*(?!]$F%5\ܹP¼zi:bOK=o8ڳ3U;XNzmO֕3|6zS`%v!7 Y YjwkxKF±)5*h+ip4ll4ocfUfaX7m\FY" aL~V9rYjeGws~K9tءrDD34꼛VU$7B-_޾3QR{Q~_퓟At4hp=~eK#e轋0Q)]KLu/K pe1,G1uFռ ^ݴ0g?c"gᩏd(>cfY)vvc{1<;+A~9[;8(46=ӫwhNǍϯ !Q 6ffhy #^IbFBE$AQj1J^fo1ܓR8۵aZќlL؃[/a7N8s^0Ywn1Y|гEgźt=JsD< @#Q6#Z7hfv*fz<>d"}9NE\+WF )P{Jʰ`˴%;v+ϙCke>OlT($Ng0>8Fݹƻ괠/+3gp3 O@P%!y ꠵fƃ֘}5Ns51֜"gZ[fV|i W\uQyQ_w fMA"2:SPt}j 0״(|[oGhWdyZX)Ww6 nǫqlw(3ϏDd2x1Ǐ*t&` nɣOXVC?OZ՛NX8s QPgtSҘ:G+OASG DuuOQlN=himK/TWbIP9t8 HݫVk98x;ɏ0zJ$n[+䜱Z3 msot!\\>f^fť܏j3f<Ny:\ K`yFu;f>y\ك|Hyg'+ e~{/٥sbXyTVffJ5y)]A&!%KoLUfa=i ;|:la d{'0iMR&t!sY qO[6U*aI;݆sH_ ;u~<N97*7mtsO60FvNjElozCg?gkY>וWb+nCחG2]rdVICkʟ<Î0J`e W"E{bXW] 7f"b[Gu/o}[8>12W@e$hBtNwWf7m8|b FE4B oCdnQ05UO qoyqVk 29=a"H0Ca~*W)gh V} ֱyW@ߵޭ]w|( 9߱fT|yg36 D4n@/.FD^BFvw.of5xgSFbZ6T.n|R]oAd5:Gzi=RmAfuhϻJOr_WˈZ'Xo~=4n'h$=&ˍn~;o;~X[y J^<$2lm;ݒq("b=ob\4&L\'K)YtS0$İUa8QH~A&ii`oM2"g7YSeG=wC63~Y5zϡ=ĉ>na6טɮL['`.8^,&Њ mo Ѹ&p# pK,nTW֑E}:\ɬS}x=f@pf̕O/?(}632A>2)0 !G2ҎnU kuVRv/V'!zꙅ &q{1f0vF@)$dt*34wtZ^ßIG'p&lo`g9.TӬ"LJQ||}DfPZ!'6Znhhf[X.Tra5֋f cǙns~/]64K!@ Ƙ;~~637 9&MֻUek'ol3!\7_ω;zqPcW z3v ONk{Xm諬U{/,[*̻V7B_MnpOS< ?( 'k_]T]kVhL swVmE񬷬'\bZ>B?;{s&[Ka#;^HGL쨧(OT p cxby5@]k V<>t՞yHͽIA+7|y1!v YZKM,x3ܕz?ʑKMH߶ف70YØh0 oCan^J2Q0lr 曷)̴>bf\fJ{1%9iq|s=L'7QA>4_y_>z wTRkzᛗ7'? @mA=dG.Z}+3ZshQ].C_}G]{+yw@lOq_!>M )f3w0qog<ժn=E Sʏ\w<Y&^?ջa]NIkHǺ-)ew@l0U<XZ&P|д0GljL~ vJZ(3 'F. Th:]ǥtXgQ&+9mYiT@ߵǻ.?Mʯ08Dmk'1U]$W)GܝHc.;3AIgW\/f(ɔޤG;(TN1 t7u F涯\s!Q[Ƽ+CJn7P~.UW]{+U]+\ "t}ah@f4hd$+|%uct[8SaOwZUr~Ho$e+L"SeP*nD˭]ɽz)ܩ JG HҤUtic3i;o|o5 Xq{i@\2l4uKЩ+9 XUIu\5Z데*`X hUa̯+5y=ZC:Nt ֏#\3\>矎ݩ*"HfA4"Lc}hA~c>?R^9ЊM^ =|u2og.UjfЏ鳴O=q`޾4ßbgk^T-^nG< q IMv[[KəƜ~M݃r2$AjZ\.r B 5j"ڸа]k˹1낖 lk&B F+A$OFͺ|_Zl6^S OzFP B\c,[0Oc\Y -¦{+b@DЭs#:vxTCPآhќ ܧO;e 5ZDqWgk|qn~qݚ|K5x:͑=N_m9x0D_6l9-׺鳜#yCtYmGqϓbmcY:ׯhﰹU1jӽQy׻T*v7L!6Lܯ\a6ϩ 2a_t,6Za3J?jp;iyPfuw~?[}.޺qq:i_8:uu_Xc[zȂ 0+'eӒIZEQ?uL#et#:ߌRh҇7H-=>w&u't8=w4ZAp.V$AT䰷IZT~cdŷvtʻpܓu")7|Xpd&,]cv0%=n8{LFWH wy;Gzף{(~1}%&5ࡹ~<̈mVȂZ[VW`AjFMLF: ωY0Z+ "vEnh9 9hs~Qr->CȖu3s㯎g뗁q'ŭE߇i 1p-$J `h:33nUE`.DAN.V ;jHh] S] '8Dق͆ޅzYW,8;1V䞐ĵq!ke>:I"d92w ޡ*ݵ-T {g!kCfLs+ n(6M[fWHnO=sm[,8.3gMgsw2oYxJ{QjYÓƴ.rIr-iak|Rܙ<^ޱ*r{bbE_8%R Yǯsڷ 5K Ĩ*/xPr`tT .=wsb$~ΣR`Fr퐖 w Gnr-k*qJZ(0Fzm&n9_r\8Sv~o}T9Au <&[_-D|k'vz,>줜mxfQzXA*zn5<F<+5!dq  {)ДONh2'so3ՈKdo< Y<Ur5o**Kӵ2{2Θ<^NUߚcsi0bF\cwDcs'n, H&hE`Y-RB`v?PNOY]Ӭe8)Rٛ_G`` QZWi&]6|>fי&[ ~VZ3ZW̱^+[/b7}ʐ\ P |Z63u?4Qݸ8=~d؟gۓo)x^uHUaNOsͺ8d}z9Jg/|,AMY+ gHiH-Nyr| {U#d{<?+QQ椛>!"_d/ msl64[%|rQqVt+Dơ7. 0("9}%֏%|`1>[وdS./Sߛfc g Rqj^$/~?40HY.`*8"ZصQzhuKj|?&6?VY1F C7:E3 m#K1G{9׳ncO,LFH|+ՙr+-1X[N`Ndxeߵc-uvr¸^s}aA,ٰL`t~tK\YfAҎVM5Gc[,=684E•,UgYZ;S:ZauQrf"DOqJPUOfk$ tnAWc5bFsS()&$*4WzDs3 l$ʊ>.ˠ@*nTڻӼgbD+P<> M:{ɮleOڬ`ᡝC۞-!҆dZP_ZVEY`3XQ\=+2($[>s6.H[l67x=wTѻRL1{Q)MA<`K!-P:ԞZ_}KkU/+Xe9O+4ϗǦNu-Ɯ,֪XN:ey0idޮg/cU^w0@Ư[N/bz jpށ>E&fmxY=%J')}\KI.+\e|4 놾> hfzPKs!EBUbV < ;N>5^Ab P3Hɀ`Ϝxo J\NϪ޷QIa?r=X't:izu7Hp={2=;vѢ۫)TFއFx#:_ӚRPjvVk/Ѹ} Bsսae8]w{j'_q$GVq:[} A{piل>5D-Nh]4~ ۣSG2TA{,౿;ʂ6$pF:̞wm,L|셪 0’6z&j#ZǬ2] d~TMOKbV26F>URlixAHŃ5Bq3~6@/a6!_t?p'>bHA+5"%7J=^ k3Maw>^1m{kqic4m~ݹMazj}T ή$eb7U؈\ꦞq}ѶM^3rWv٬Zʄ^Yj C{`6{v!sƧR?{WX &!c{l9)O~qZꙂ4`'%/_{-!2f$'T+Hj!R2kRjS\UÒtf[NE)4{2/x AS]mIKArjsTn~&w䪿w&Iq4:.b 0qb{R)4j > :+wKu;w_#9ٿ&?ۜ|o-cha aof;7/pL6T!HX 5 kg:y5~ja*stL[2bJ)V~@w[a/_/w[l;BM:,NH߬_{n}uoѵ?v-W~xOVݙj/%p$ߛ%0d|S.cm6 `V̘9Q~PYl@ʆ"H z-ɱ[))Kti\(jwZɻK"7@{7,e \v+~H+< ogaN8e{^;uUQxr궥sK>E/PCW[[:Yf@%S6#˜ο{|e ` wD{Rq.|ÀΩܴI%&z Rh K|uoȞDn+ (^pORv6FxN@Yf0:;O`:T9Y<^8.D2{=Ouռb>ݭ\PF2֥G R9 Ve%V+~R75hTf9e>]9Fxiȿ8 .;}.&{kUm*hDg{/;0ۇm޻ وU UV=~f;$ǼgO[>?ZdK0/f9Nfl*r1NGJ4',w9}0!ZQ⼏Xn\e1]kQrRD<[}ZlR$f:G8`Y z<gt=Z!1![E/AK8ep6v/*֛&1KN,0UNUߕn &s䋝V;ᚮ(Wy Y_Ō[|H^wi%^zo Sj:ov]v2zfo;sqyf>kkS5Vo]c& Fkj3f|A]K75d[M@]f(e/2Rʲ.fZP`ZB[2Yf-D@VPB{RL:EwیΆ씳<F,ArnRS= |sYxQ>[bgMг5S,r|ԽnM,3m8oI*J h!C"Do۾ꜽZ*{SB5 F _$֓xZAٕ΂j/n_Q.]OvX_9:)0Mo}Q˥<~ގyl V jWŵՅF%u<~'= ]c0r[ṋ́ B3t+jRߨ:)O%yRy(j Lw/g&d<8yܡwg/Ϻ!Mռ' !mawjٕu؎G;[Uz3͉D>c\=C3 ?_wzz."H6wc5cۿs9T^=3[4|$ss_Pn_3J>[3}Hi\Ց -C-wPO y2h\z⥓` )Qtf=^JhMIkbΑ-So`2"_{`zH߹Ik{7FEZ圭e4Atf:]:4.zwoG*>cW>Y#`&´t2T t ,u-څwrWY)^ ޡ (7M9`y*(kqZr%jd{X MUfHq)9bOr*F5mGK& q 7>t׵8y|AѧA/Gs ϒC>؁:.S:STo/ʊjir34ٌ23Q˟Fׇa1:"2mbFJ&̦RƺIj:'BP[ko ~WgU_DVz ݾ>Y{B ?2(G$8%Rs+*g Av=Y!as}VOBd44w,Z?@3tE`H'{S_v{C1 Uds23<(=97؊i =<5^;`;1C]<1>q=8cӝ +(<76\B {noLw֛U4E דoT̙'yt*P/UKg kpԏi-Kn2#b,* &$=\o7/j2cnA&.rI3(J/Azwzom@v?Zie⃭$)Ɖ+\QyBrY;oRV-.{ɐsmn~S٠ifކEٶ҃ϯ4rg1M//5o)~)HJOwLܥ,)Z>2M`@)mi/fͤcȧj,Gw^=Bc54TmW.Cٕ#;n;jtʇen\0G^g8J2` ?Z իsc5,~ffrtݷuIZNf 2:KBџ@sиp4:/0H9|` <&0k!ScϝgmR@* \'rD#7iQ^-3(]Ӥr迗CDVΰxgbjT0e: א%J_Ffٯ;. 7g8pgesJ7+641 bܪ ۊq :D@5NqG`ם9luDG4J[7bW 0fCMѻ>vWE|aN 6Zo]U=C<Ö@ust'{6} zUTXH mXtFm/r^`wS >ATvqN*Ģup/g 0ǾnZxswܚrG kt,6 %e2vWi9>ҔDkWmmonzwS]v1ceK`SgD6jU\sĜjWyJ`]2ŽDLx.[Ǭibe2F9XcE69:,NvT!}&=vA`%3,jx/yWbml aBP(hfn dn :kHxpnK+Y;߉(>ٿޓ<(θ5M7acɻ\^~;0pѹzXOɄ(z䆈L}o,kl؛UkA~r\s2AR[ L>,b@#nѓAX1< n跟)bH@ٮt_[|2oߥF=M**O5x'\7uE{Zger}-`bi۬krlKǣ~JM]nҬݲ[/V;4.9QYdԜ_+0D0-Jif {\~ElUVz8 J^\2tyYjnmqTpPv;b9[MZ{PV^rp+fvZ2eK40r0z_Nk_.|?L;$SA6ϥ]1oX~A|PPb1?eY;$r@%-Z%hG@vt+CL'VPūקQ~/skapQۜMZ#Iް_Cq"Zl '8Yۥ] = gqy~T mh;UYO:3}|Q*A n<(n5VWxV$e?]V1X G?n1 LS={\J})' Z{B]9K,P̑7 ychDk}D B}ex {aZYѢʩ+wq$[NQCN!dQ?џ' Vk:3P*k5uKb V+ͧ1j׈-um醄{IDʴb 2s\8uI I1lU,eHcȍ@A=}nMjyC?/RY+kOFƵ,˩=7Hg#i0̤:UX5:h=y rKȴүil@4)wwf$fnS_QKV" TGR7=P?^sdvԝ-AGlեPޫxS=fb5k}\ڨߓ|g>qajN|B:VFP E?°D=ytZݑ7S~/-.ށ}4Ke<k=LbFE@rm{"=qZaQ>l˩.B? ϽNܒ^n~y sr++f)`Kɹ1\Nb=d*>+ܸ m<^Ҏt.K$:H [z9@ۼ sz@hf ʰRA|ܚdY޿y(_a#~P) os7dv]XKO[ܖuw(x:56^\ߌe|z,Z:+g\XJ}o9*F6[A͉ zVBi!^ +L]mrwoC| !"0x,[w'<~\Nrƀ2v:YV#•̾^TAF3ث4H[wlIgӷ ՟D㯓.$Xn0 N$cMnyF2M}+ gtvhJ}|ޛlgb>x<6j!$bTl}rSt+?V#rS<{zWQ Do"  y#]HSO˿(V۱?T Uy/x2A?8%s]Lt'ɏ޿tj0-Rz{Zݭ9ҿ=z$CgZi|jvi̬U+jH~Hid7pJ&f^^{0WQYZXP6|R풻x~>KɟF3*&A:3A~єq2J z vFKHIL:18cGz l>+a]& )dC~_8/ נ]4./8ˤ3lnnp tv3 )%޶'m|wmtMK6weBvt!7Z]E93(#1/D*޿cFŮ#v*-EYDOG t'no;W%?5>jEDz0 Zm(C!僛i eaG4j/\% ^;Y:rN_w#5䶟7E$ 68';S:J#CƷ +~X(h)GlOdV9xP|CkNh ꇠ'9}-Ypzýi c 72ߘvU ~^|IQ3,pDd;fϻx rfB>Y?$D40i_#{$5 Ȟ񡻛xVi.]yEYԥ16/c\#F{(\p'I|e@:9z^72)T|渟Et֐챊3hM׬ibg4"%җ` +Bq0(R}m@m-RAݦm<x@IO8 waS}^N>yE*Z g%#c?[FȥSa9`YOG' eNH^ Zϥ s79+O3=aCu}-7>Pq|źfY_[-}%mrNs@~~]`]kyB}{?1+AB K@YRGhfdf:on%&3m%tt_Rh*9UR87vG1hI3OAnc]WOMf[C_39V&f=-ؕ'Il?DX0BP%Bd.C4p>g?9 {w])!O8N?H L W2rj_ڐWBS=ْH>ĭwzx֜*/ vjo6jT;V^=HMtaw $AcB[ay}zqOc,%[*mZ'Lv[KƯhw-d"J3>Q̏DdW>8B;M[fBmwLxPgN=ܳ4mhTkod习ԺkcJ"u"nA|npg,r)T(y {46f+r8 I\: 1;^YOTk熋2nV?vt&}-~e Aģ0 rk5_-IS̪iژS` Rm(sύUƝ[PPn}W/=yf/+7]De%wRoIרq khм$fV]=ZYHyt$j&?-ʯ">tPyn۩G=b em ;﵉feUy=n’D}[jpp(38 ,i՞|Hk0{ XW%^dDڧz+<`) bN3/ze!: u5 .ՙl4_]د&:/J(mGc{ b Sܼ1T̚?H㳈cG(04wfbS`vp}l(3=/ r6>E댙TUNflB(Wte:ޟe~#tpݨ$6"8TΘVr?{]8[2 1wNy|*Qu.ʅ+ǧj?huJNj9|/&$L8>YXI82OoN|tDj Sefrt5H5ƨv>u mb *Kk(?4y&O"O%q<cڒ׀EDnuZwký,V'eRoOͲ߂qcpOF$R0d﫴k:3 m#1NG ퟻ/wWνRwֶidY7\.Ca0O0^ 2>X*a'M6?=ޏ<؜"rŨx-Ui%^t ]^X^ XwA~5|aɓ[i۬^}:5uL{+xzY _l ƌ7B|d [̜cxv%4ѽ0e=whP7I5:vJqњ JJɘ+CrͳpkB +bn -f39COb}4U}Gj-﬒hq<|0HzZKS* ^R7r{ jF{WNj }a۷zÁq9p=]RP3@Q6u:ha ]q_ΕZ٫JkJ$|Գ7诇PqkS,`7<&dmߧI&oue꧋@Ѫ})`ˉc1g<7<.+e@N "? %:]mӛNk|աx{>/ozVּv!~ٻGI@Q #_Dr\F7x,3mi?!sX25 y n&R5[>zi xƖou=ksnp9̏sf k&#mXQܾqw| lLa^;vʫm>ʋsk\V֚L2ciw3=㖻xfQkH n<7]-\3Dě-^䉪3V8"}E(<]A/R*gaIm9EV[Vo$]rs~oz m]27Kԑ}Y^Of]G 0 NkƷhd΅ƳѾ =F-FsIYhO['7o;nҞsVHQ\qI ZNy㭰i.!!`tNndޫ.֓S?Ze1Z8^3[U۳jKCa1HFqm.8>.~na^}F|MPou6hW]e:/᫧} =5W=n0ΘIm}+Cm2)-,5,-VKa-ƒnS7_(3zv wݷo.h=α7`b>yRz.wv+ť (%T X߶7gDr3N4qkyV}kJ]iP'=a6|I/:){Ȇi ^O=\7/<;}MF^"s2WF2?}geh]~3yER2?7r̍~ƙ 0 V2>LPsv>\|Vs^6w3) a^aWk56ٱrrKCTOƄD |ﲱAkQn+C(z_v:T*Jg`d`n7ۚ2jL^|Nܤ1H˽V49^Gk2s%vY*v0E&߯c<14Dd 䈍29l:: xZn\4}Yfn2]@5$|h48*LU JIk_xNgD@ zl,y-JT~V^E)E}/97w=0W:;%mf2`?z좳p^[b o8&q}Oȹ.4r"F T7XTG/33PDp;] gHF9e(AL|fY .oY5 .eu!\&c2[2Ŋs$a{NuOoZ>h};rWZ;' y,WGRZ'h~NR?`ޜlKLqh8mV8wZ{l)tm߭[\YIΤÆ5.ebЧS V-vkn0}[$=:^F#:ia6;| }|('Df{Nֻ'aWusa휙i@8$i]޸[#FxQǠ ֮U^A;mv4JbwkUqwЊ9zuBᙗ]8cl)! "G ʪ,v9oz ")Fx;PE"?>]{\OFxl?̖x57ֈQ,=d.sAgH0}IT"p "ˬQ|AM;)vE ?3s 60UƎx2?ikqع/ 0q6rDJOʈ_%Al5Z͢Do`zا?y1S| /܅Y?h[Ty ǚvq!#[<ϛޖ3* =>)JJSYctXӥv.Xa|Fԛ bl!]WLQ) f+/{ Έb5x55z |/8-gͽv^ ?/?y×@p~>2<`LZ6 \pȨ7Vb2q jk+ڹanA@rCuuzz&S|h}뎸YPa|:{’H*Yzޞh]*CPIęisM/12CoLLëS'fTw qzިGmXFadpO7v {1" k%_<:g.#NL52I{a3gMV[nN~( jxlr_{΁'n>W>Yw,nex(RCRbLA  `40ݟ!zCmAwq4֒ѸI}EܼMT`en#_/c]M_GufL[i˓W+ir{ }ʥ|.੉cJljZأO[Z Kսz#b)eťFsMU1Q%^tjㇼ6C5/YE89+W&/VXN%(#V*ȴoZ?O~ ]RG+' C!t,729P;.*ݽu@<9bV*NƮ1FkXߺY#YՏqQӂAGaC!J7G[&UCyewr0WzWt :tbgp>NFtc%V0'7r1Sq@ahFsCy&RN5i*p5.x!FY2wb6*,AIz2 <3:egXX@Nyao@˵",bwټ)좆S\ؠ׍u9v }SH+> /6cv75TJLoHװ!oZCsCvӺ?J&HU8,X\BehO`V95 ٱP/+E` pcNv^[e"fZu)YEG?;]doW 1C|a^Ǽ&ȗv&;f"~'RYØX9maf =eB13(?n3ofĕ~]n/0o':A[jr3W͊j2̶0xAe`vc'G6o!,ӎ1zR[hy4[[_fZsÒ/6^nKIH[oγ{ \}t? T eĚ)'9(My!+3iDYƮt:Mo|A /p3 E HG ?,f|*̺ly;nk찧с>/jze]_{Id_o'Z>9:ѸvIu*ͣf " *Z8{dΥ Rr2\iɧc|L85n8FGښr^F+oJ]oAj)p1oq T~ 8cgV5ee |՛CC>Sg&}u~8'SƊ".Rq d((R9Rr̹( ~\ ʪ0:1$s<={Ӂ;jB.|t|SLڍ6M<fZL(/4|ߢxD^I,J"HNob&멗‚7L|kj&%[rz3`cݱnwCܦ}7kyyWUzx Xf\ ߃u y}4q7gf-c a{1}U%^d~ynߛ'%TɥA'7 [ʤ)o[D8)ɮ5m7RktujF\I9l(YGO￷j/띶naiDOBs]C$FON8!Uʌ7L݁I"&!:)Olj d`xF$( !^@G]b?U"tWb/$㣽aܪ(5F5ai!;l)&0:q+Φ?.j{="8C`o?X^JhP[!&m鍶}3#sc&*jھؠxw2 &"Spidc;t%gR 5*\r ÈI&}|\'dW mZ)ם")á~-6 pcs;P/ِ|- $g$>Z7]1Xէ,'F/Ѻ$2[.cfK騨$rʾTÅH _hDj ɞU)K #(-ƀ6n27VD%4!Ms;9W)eM̵r$`s X6VV}d-l?=,aGooDHMkd`SGh?UE3݃JBܡ:"+Qs:tn jɞ % (A׍ꡈjlHy A~M}y@G+OU嚕mNF9}2pJƃ_~a~f{MpgDkݑY /h{}%'' ;OG<< )isr9,LIHZf[E!ˈ "b]jS91: ì-M@Q:֯6ʰYfɁY:gG/~Y^{o—ܾ{t~-~sY|-i?wq篋 =}3t:33 4/G wmۅl&v[%՞vOOR^~EXlxU0us-wzznJwH(Coq˖(uDWgAoɞ%0 Ћքr]7c< {?QnUcȋ1B? Q/{+z2g?@jaQüX fZǥ( 8R~j+YF1SbEp1z41Ew:KCi#ߤ;ctfOCw<1.'ƪpgpPyC |콴=ޫ.6#٨[s@6E !1^S`Wqo]%jLgW~,0&jt_V/?u ԗ~i#ԜaNG)K.$ߌlkbثjMZ(COPBqIhxznrQ0hjh6{g΀xoSn֫8z{ |SC2>r_w!*ujd 62ξ7.ղ̬R~Sqe\Kאyx@0 j7m?Dh &ua3߉'$ϸMk^;ӭ\qx!&xme՘8jc+;Һ=v{p{e[z!g uӯZ,Xq^]Bk,. Vb&SWs(Hc\tڐ}r'S8#KcINۡ%H95X 91g– oP QJLeHU3qQ;Z+*fN*j8&fy+H1z3۟.*%Vh4]&S8^?ٚDbދcP-NJk4n?$A&{MicPV@F13 {,_b B@c+um^'%Q Q(x#>7gogWGٜsd%Kɸ(z5zh!rBګq}YTBƟ/bu+3>Ʈ>zw&= QD4ȥ-3UXQm-ͅ*$Sxns(4x1ԃ6$~']@'ar s+RKnz~ޥ3'Z5L`462B^zzE!?me}9#-&ZP;8QdiT/Q'cנK "JH_n eW'vF~,gI]V&䛝i_60_,z-&k نem9j@ aT0[ ڲ,ZAp 5%nS:4i ϯgs!7VOa?>CϒM8(#HwPOl^fI` ȩ&v#189e,_р!69]Ӎ̆_}!` բ'7_}mfwYqsXۡy3-m~~L?EMg냶7)b6n WX>uBl *rډip8E4#`G ='1H^:'MW{p+@M|r>׫t/ yB?^o+9zqږAw4ד df' $?D*AI1eڬz1 {R B^{ ^E- nߎsѣ{~fr^s%Bpoʇ곉ɓɊ422+K:~MwȭBmqF~T6cUi3IfIF6О,؇)j Ws3*? c\Snb;d"f2muC!Hb{C]ddcD BV;hEqQw3 rhV)zRǦCLTDћ5T! H &g,wmGWzVc{;l}`<ޮa1슽rЙaBE0ۥۜ?ZP;M Gū=TJ)Nr]'s@9H°E:0q@3u[-"%0u.%c^pTu[f7f5pNT͈t.LQE <-ev!מ-AonVwPCfk{v%xse=ܷ9N\Oh=u(CRY,^y,`orW==(XKZ2OߌrրV?"yTm_~쬞&w'3^J͏bj=Wzz75#>M~fm9S;{Wb>̭➩`m|g{{9SWCZ3)xLaB=w n^? 2%/ !ԙ&Ѽc,P9Q~q%A[N:9fZ;5rqYF;)>]BOB;cgR

4鹅V e{ {,uڃx g]{o;8rs+ eʖ2$Of?6 ̹Nێ%@vYiq&4$xIԞퟃo oA5m8,Unс2΃UP1x;s*; =ЍquӼ+m& &m8mʕ&G$&[wSuL.uΠy@.lwT~φ7(ahM3-?(CFݝA51m„ww08WMK^g7/EhfwbLح/"wnJi4tI,׈5y`gbK#/iZEV.fE `z曷ht[ŁB/Nsȁv0(3czya W%.jw8(5I*2RYge·jb~`j* FD*[@{f E4sIB9Uk(@'!w}x^|uIg>EXl~х:@k[£hK B4O$=eVx2prz8~77E &2njAȫzٓ2B/\س2Dh^-f+-oZm\?s1-7 oH9~kuUP&A|x,ښ o;evNK@rf#_W}?bZhtF~̅Â~`Pf3gDs-vK]g'}ųI Z,:]l[;*7ʼF.ݲ>L; jPD7~H;}pvX'GI]zgF7}2}]u7e壎t^n@Z' $0i.ݗs uCF"b*>WTAwطL -8~LHU^o/"KQrbrxak^nA hS_Qgn+T#F~-QE@b^h>ۉB _ o%>eFq6k[lz_$!"'2jzƻg\x{GUdwo*)_3n"~6gMxӶ@:'p<W}$-Ӯ#}k(_Y2f5jXeA A>F/Wwcb͟h/پ/3(wU׬G'ZF K(}ӎfyMϭj}闇>dvT2u'icXM;{kTM[y,`FF/XdO[QfqgPٓ?64Wj9[,k3W~guRYn):Z A?,wnЖ1|BJ7 >T_\?mRx8C9UǛ-Nz'(Vl(+~kd]o LpyX@DE#DӶ/ZԶ^( ad7kw#h_<[.|N/F:m6C8wy4Q׿ܫTjgl0OBMi1R#[NlT4c=~3Hv*c/hsLl.v l^6E~&k؋2֫| Ɛ`OXpa. jCM$O~ l}菔QeMyMx`H!ުQԀC-}f.հPL`&fAѲb|Ō K "Ys0o[Ƹ#$?0V=7|c9~.Qv?; ʳ*QX<:@zzߣ52ۣpNg\Uk̾ܒ =1W942t~ߝ!E:и(]3v#eN-&4[ SK3 &TɊM9<|{*g&3#Fv:3(3 av*K}? %,vfEϚ[b P,Pۍ fK*-߽|z@Ǹh^jv2.X]FijwHUYpv gw?JV&AxlverDOҚ)8=?jfn~s'}fҘp,8upJÙ2;*_.e`4.w;op-9v39^?.NHF-[tO!\_޼5BdRM4߭P4kNLwꯧB{uƬ_'_hjn۴ĢYo;\Jkf7כRSA&^r*{urAޛEo-؇h?v'92)bQٴli)mjIFwF@OA@iѩYĶK<@wOq0O4|iqqd3=enm$¼/ob*T0(k6>U{&g:\GXV{(20xzkVђ l胦ͤe&9GJ>9-9c҇w]A.PQi(v]Y$R x:LJb{V#<}Rw)_d ..!:3 0 \pMXU6G!,Ӕ \:a]~43P?L? N$K;Zc;!, K=d$J|a3 'Ց %z* | 󼎩U9nf64P0vO2 |=-_ Ow4, +pdmPOwAHN6|Fݠۯɸp4wZMn2yܶT#-|㳱vFpv()w\M$o!/pk`%5=Yjomn4@\)yb.Sb ݤ#xU){Myv~s VsL@Ax7;'1 ka*eUq ~vo!5$Q Ѭ?j=\$ ~*Z5H e4|U=חˠ[6uJ}$w=i{ pۇ/'jBt36K-=y&ihk$zњ!PfSe 3QwQP渣9|dh)ȴLŸH4!f:aGb,!*CP[y~iܡS<6m6𕫔P@2 uT Ȉøܞ,۬4]&̈J|X~ \S%=B-fRIo8l4!T0ߴe!=*J}k|QVCñD [&-y>ɏF~9Es\r3SF~+ 3JT72C={t^d}\2i)UדdfvA^!7ɞ}"FU2w\І˟H]'+%4Comj@)֭^,OL>Ĵْ̫7- k7n(er{o ]HB448V Av_;Tr:2 rx F5Ҧ\ +-)K3xݫM(Sd[3@K ޡ܅iKzs3&DQ.v"HB[/+?2;?tf] 1F;Y2}t:-H׃z:4΍r6<m'}6Ɖ%Ɍ`Nsr0O%nRa(*`~㋎F>YSPo8, Ph"ΚSmrU&l}/ O]inf슋߾k~m\2Oქb)rF;[}i IwœuQv]A$b΅XK>*N5^hoyaBdAd29oBXHX,$zWqi; k׏~ΎՇ1ÇuPaEJM=U[vտnf}J:Ĕy_Zb=j&.TՍV5%x8k-mZplOytd ݵRv-; Yu+3̲Ӛz9<zR+EHփY}t=V2֩#MLWR3N=h_nS>MFv0Y/(hX{N<20]b۩x-@{ڠ̂ZdMݩn%Gstޮ=(i lj#fdi PsU楋mA0jX1JsE[At[>@xGRD\E8yvT`[vIVsOXUr>&j etλbr)V\Oej*pL Kvycݹ;N*&h>/+6[8'uVT~ҽY5T`.pt7sv|;5+V!x _l. ӢfHŒ%:瘙/s.@vqOneͻ 1CzK[i33rnSl`BR#x[)\jӤ%_jtgJO2 `, V=fS#c–3j̅GE<,| ̩ߝ&}s&qn邨 1zY~Ql,cx]JU{cmX)W?hȯ\eKi sƽEF7_O!jc}w̻ޖ"7thzueehf=:kXh]+x9yf,nׯ>={.8Qk  K73 ޟ3S^W5ƈR`NP>m*sE'Y&rE}|,+ >biJԉe= ʽ=ݵ G*aq՝V|^G*~ΧdڤW`葄t!~ma>$B8tj㎿*WH Vx^C\Q<(2tbVV" =fz3yq>djaiwy9J1K罖TY*69zzeOj̔[ uEʥh&e=mxiYǠD)8dkUWB?1>v֖敿 +iGVgغDn`~E5 *>9ҿ/m6>[;L 43SrYDʄ+ 1kpa#ğz(:";Zl/SSK[29Րues(戓 Qq+W|-6Ue)7fG~Eqɔ ZqԪ6nk"Tا,bEFRJ8'2Ojz 5{ ;:5 E}s8gĪaW=^zQE D* 9 A%Si CWI%FEu<96ayh7NW9hn}b.‡}DZ175P+2Ia9O.t]Se_t9 LL8&]:_Q=M֊bN'C8!:,^EA9'MKHjgn_5{-~mŹM\)O&a`@vꊗad;~LFo3ý=p7Eg;^2B vņWyrb1Uu3MC6~Tx8ȨBřLRh;>p",D|Zbfۭδ JGF??l ʜi]xRcRfrfDeq>d^R@r9B(<תSm7`'{2F&>Glj ʍyp-[dG^)օ\Kȫ~҄~VM7(* ߿ e6AG< uޝʶo9ȢvHlH<^ׇx;hJ!/]e'wQ 1s{igR}ىl}2̸\ ~GAhg mmc3"E\ ë\ӭeZCȟîd}xydr~,,6!pUvdCOou~v'UX SC>88!$q% *1ؙ=>7,wP&8-| ̛cnoND\Ϛ9M!o*j;`wVp0mE-qu !wo%A X͚UF+ dp)ޠGðE,L=Edlr~ᐤ'*5秥0ARɧQtv/ٜMt5e_Y&3ޟ bBG4Ը@FT6ߗHN]d~RŒfa W%]PWk눛M9 ! NY Rmi0:&NN9,rMAkhfB\ {v +n fpV췂E&51l(YBTJ Eщg}f]M{Z%& R#S1MZ+Ƨ-2) GR#7~X> jz=\*y;S BkT:KHzʉr,é] X<]Ôv]oBDhcz@f:ch-,iU ˎk1̾oN1zfK) ֩; V^˞+>llɌ^AlK ÿ׬] #b~ޝLb^S:Guǰ?w{o2`i[3֩xDFΪd ʼnŋW;E3g>0E-nU=HI|1Ks跗=5Ls` Ix?L!\M*AFqt =@ړ++'f; =Ed ߪ5.|ڤ{ޓDyv Z^:a>RsP>25fwvm9x#+3ѿbQ;Չ2X^qeSTShG}NW5sO&.3M{).la~On[!Dv- & pwQN#v"G.CZ=7*(2Gl\([|y= 8zx߄U"_Fxuzt4U _H7)> nH]6˵/%7eۗ`"~di %1`ǭm h^aM,c9y SqSS} EuԷ1+j|z|sY:'W?Gc0WHV{:E6NNn/0ӟb7LZO}:XYouUY2;ӖjE`P8lԺa)l"bX,ĸiϱ}p} z# US(8U2EB #E qVK֚K* ?Vgs#QԡbEtmMcpٽhf0Vx/#J̨BQc8"kajV ԐjᇑF;NV8\G;d<N$u%븀 ig=oKK @ӊ^ 9)d:;mE_aem0% n.-5k|LAiܨ⅍zhADRϿ]cpp5l,gG̳uiuoTc}ʨhS L|~Q~' e^F 0??:-&8a@vWlͷO^ qT;op:w~E~j =IS;_صz_@ѷ0Mӑ -DkO>ΏO Wl{Fݛ'/lTIJ* qOK5dN<4o\O^cukE)[ jv?@oz d3om<.J\ʳ `7.`cTأClߩzV60&q&wq.zE[}?"X*Wb%ʥg }u1Ͼ `ˇxȉ<WHHJN ;I!RcM:Fxb@zmi\ rr'w A/Z}Φb4>  / {fKʎ WxO٦ΫhWF>2ΠAavB Afjo-)o7dԘ+Nn!O',H}OEcc )<2kj*Mݮ1X&D>zCQ˱AinU-aQr47^Vg|<8<dt~[3ǰ&`Tv=( OJA[H ?8^^O FeAEԼQ[W㌓Y4O/ ִ|1^궵~2g9A ޻_Nܘbq:.ja9?ȏ\XhhPYr&4L_4&;>{H.{wT yrXd"ݫbyw(`rh໣1c Ǔ6DHSe rۏY?~;J]Rʞl  S(Y+q3', GM072*|;s} 5PV Ռr,bvBtWpvRw ~!Ľv%rq^?vؤߒF]vkX`kVUv\]Rc=kD4zbђα msZB /e^c4Am)aG*-uj~Bu>tPqk-#qaR-3yhPW ^랆)ªշV";tY=Urd\4NPJ6<-: 阏7V^~*ľւ+UmΧ2z󰷸?Qc[rҰ%#6 gwnԶY$ eD1l LC^?OGURwgٮl=tߌ;* G1 %W?Y6:\ LZQƉTT,1Tw\RLJA&wƆaΟpDz*v( v=Mz&^ ~v[PYg^ZZĕ2d˴{#մ|6PXZ0[8ϊ}ɫ昉NpZ^Y["7Ș6Og! 9M?Həx.=v2ר]$ìfR '!eA0 pkm tA&d\ %y[<}R/A0 sy;#oMR] ]9CEd EM`ҽS=<35v̻}٧d)fR[ &Nw[@ x}zt]r$u;jK/#x.i2B퍟XB N c zNf(=ךw&`ߖaARp;JXI9{qK%ꙇdz"r ",_4 Cz-/Pp,LE;Ev#qs?o'"O&]8בHhKf2%>zJu.ģ ]T28Z}Վ7^Io;Id" Ȑ rx|jގi6Z>Ee"Cpw{SwY2dYj^oP=gɅ-N%NUr-&Nx.~_t_  vޢ %|\WX/vf t;Y>R-jW g7HQc&s 87cFA]ft5[cGr'M#ͽD_7Þ>z'UCJS n@ M|h,<{G*% e&e67++Ѹ6BQ2hD\KT?p_o{7)i}0d& nP?3_X&U?D"y:RceξWfmeu2~5=rwcKj* C9ZĜ1 /?S7t(Wz-ݹea vQsz{Dթ1|2|9^ڸ,QNֆIai_,JWL%c<|MB1S{+$eZ؟D m6Se}M/NIsc_N'NgDO@^ $ 2qvekʻbJ[p%㘚${}Wx#' ~i~,1hl>feg'@D7tSVR>pMT@t9l-FzߐyO݃~*M.f#ߥFfwJ[K-,et`Q2e7^h^8~k8>46(%ZUHHCbF*T[[Ui5tn7<=3t8KȗI%~Ψvj[Zj Vp_KHQTn+?GCNhd Ͱ)Tkw{7K?b}_mh a _w[nuV[%rJF[:YFL3/CzydT;?ݭ9n^q1}v2/ Y4;_+fc)e.B 2֔oV ˯ +rUT>/W V .GNt3ۜkW­S'_ծ6a5jFt,#|n!ͨPW(G SBcIJZϳ))M$:zq4x|;+qgB#,q?9«~gf}У_]MUl_3бh仛MoI<#,wDZE3ksJ|EE\`_,ok\Ojy95Q?txLM*){6fwo] P&A_\k굆7]}aD&S:;NqICi6jSdDd}l*@9 N.n,:'nŞLxv., BێqK 1e݆W\{5J^/".3iB,Jz\w-s~,ɊrR= @rLQ׫fwgrگCw(\\mkPyOo>B(,ղUΕ)qll.$7,pC;º9O-m 3SZim6E/b,XnB/ sa)a1oW8Wvv»)m{i*q',P[Fx W3%O*ٳ=WmߙHBڧ[c; FE 8*ȻhSy! NK_FcG(9Ѱr 8:W:SduL>vR ixR !ТR;_}N\,L(s3Գf f|ޣ\: [gޭ1=X|#n'JȨ v딝p X յuqo~VBmv5_^O@y쐠پK%{\ĸH[OCX=yrȲ FSZ[0˭vJ7lvÖ*wmRAt_df=nXw[ F sƉ|9r3$9> ׭c{3,{|"vs@WIKݺ/A Mf~B,ӯm {JMWj0Xtn ufƎʎ F/OF@UkpG@w5.~Ŷ7kp]wXy,}BY|HjMRU Q ֎ ᳹mI7VOFx{3iث`U ⛌t,V~mJZsUȮP7Hg]b>{Ͷ PR bt>YR nTB "ӽLNFPCK+8;~.$e-33Q8! ID i0 A _˟>{-fH9=#1@(oSՙug.1Dvr.&b+NRy *Һu}Ive<;hf*["ʷYΣ^#P OApa>`wȊpM]U}ȏpaYoٶLӎ Y<7"PށBK/Ͽc*Zk,,[%.N%5shӜ?Vv1,h +prt>{l Z3Lt_Y91J6\B?X9X $,%*FI0'i0*]j909=Yy?'~k3]ٽ.ȈK_o#y^SU{n:o~Ӿ7toID7>| 9-5Ϗ4$rZMGw&D}y0y ۯ"y0Z)c4IGu5lUOx8q'PΌ(X'_A2FUhl4onNӥ6Kz3Nٳq.tkI:;m}gV|s0{$mVTʪBs5.4z֐3Ʈe^MUh4{Zw 0ܘ|㦽g욯$9t֬M${=NWk{2^֡z1 â偨F!6kohyK^Wc{g~"cTlRnB@ :P&*UsxO"QձmCWow|6AD6qJ=IO& 'Dڗ딓Au~3 S}{97]&ge~Y 3NJj!車"5P"c-_+qPSEj+GPCEzeғ萎7I͉!:P9^[z3ן/NrZl7MxF-j|Ӻ7z:++TU,wLŸw;oC/nٿ5 fÜ<%+Abu׎/Pr Q)7, w\Kuě;Ԟ_ G"&5hKF!z 7S]gyʘk.ōܸzoCR|Er{?dޯV~s ~88};J}pM=+u(E=@Cլsa!77Woh|Hy1) o yf-x\wzsK-i%mӰ<[aƓ42z"7^ʔi8oTWu[L1HfᆯV *1DB5 qe=2eA7-!"E]Ep&MKW2YMQO&UjQ ]ayV~uSYyv]qq6ʙKKYnwI5Z+KebϷ;&d_P2ڍ #%_wY'Scnb#,luՓǮZEҹײwKef෬@I+;_[,o@ë4Љ]/*c0bm/KBu"Nz0$I'Z΍0+n68QDGBe*ybe^+d샛ɋ׬: ڏ__zVڧt?kn?I2j[poy\*iC\9l%A6SZNftj+n$ ¤4bgocC,s5F|9.p;Go/XX\ASf|ՙk sZPR@By=grpR̗-|ץlU3{~RՅ`%Ut)®B9c[ׅ or3Ak~O>>wi IJ0aB|\Ŏn)5h92˦h3^%!|wrJ|y8;4mENרx5}><:)**~=.78\#,J 4V)9@nB1r'AdH0>&y}j챃᮲qDT b> %|+|9'+CQsYZ{?W܉ӹ~FZL΁NW=L/kRq6]ef9s{ͼMV.*s)`pNzR#53Zft:_}MW 4k+~p :&Iψ;}2)r lȨAC@YQ]`p)A NܗWX ulY@M̧#gΙ߁,K/7\l5'Z!T Ə/ڹzZ̳;s/VݿsxF- Cd9+)ձ|6h6#8ؙ5&ƴB:1^֗~ts%BeTwȠU˞YR uj-c`9Oin'Q90#S}Zz5VhRo3૗(n >U:ʿ(C>dX>S" y#>u*-`~JVm(k8֫5ᩛ UUge/{q RJwU G3sxHz|`4g%kX@|I;-f3a9\A?G!Oլ7M>Z,DljꏺZ:Oc 4Nav%BJi0.WB{Y:ȿd~ u^hD^:xfTlhICo*]P sX@ٻJSifO0oLԛ؃87gw$t.t+2uwA+(l -1mՉ~&)@vdqMe~puvAg'[KY!5$7=B-{h2w}pSU?}Ufޚ}R ⮹)2r'bP)TJ.Sd:ކvh|b m؞`F]oJ%扚z C7ֽ)jCU.弗cD/K>q0LKfY̖|+wZx]d셨E=ߜ߶! ر_`{jV/1OvQ'QՁNO2Љqnn/m}ץҪuX.k]MdV4fSc۫.03b(19P870B[:qaGj3h.cïU}<:CUCwkW9^Q+o<" ?y0k^o{Z2ʳ </-p;+Z_G IdT -<|tUxa<<B=/@Vz]/PuDzP,zz"zb, L }jُ2I\Ư8,޼q9S+?H pD`O⩹/?_٣M"w坊@u_t :%Qܬ[:Phɍ,(QFov^i4U!<_???agL\'nBnm*]AW$hWەSrƎSP|˲:J.X|$CLlHYfEYm4i@Zop$N84fhl)%4|c{rכX>e. ?TJK;v }W%jcp^9훥㑥Hk yQK 'n!:cyFmܑ= ]#exF.S-%c`'rw~Xw >)K)t UOIT<6g'^F8HeA84V_ Vus)\ 7C=y_#AJJc»aooq>mqcuVqI$sY 4/컺KOq0qFi^L%@LU\jx. XHbݡG#ri<ňngC:ܯcݖ1 mpIR껬^ڎJ4a2O/>ם/*ziiUܚ32xO*7~wm'wGߧy[&Xj&.p*δ& ~șx(m (u6[=r~U;Z^S[Zm_^<2 :ݙzymg3]Wk{?'ia $wPsk:qyU$c6+i:N*/# Rq>^\l7fCd< G#v_;1ɸ\(xV@-eSYּ|"ܛtpyknUT8䣣cѿU‡VzcW5S,I dwkV vFQ!oEP\p, ϵtl?PцDKHfhI\~DִJx!}Q?xuϩdZ7)pG<}z[A:!;uAdnS<nR7oTۉ_=8j\NՉC; ;KwDvr{ʥ/*Vh>N֘rʫw!$"b@8y /~%O[?E>u&rk]owKώKT F\3]!7W]aUk;W#gc9bVS4Oԁ iqq! 2f_;zH>76 SͶHP Tƚ-N3'$jG9L5Wn;ܘ @&{<#̛Z}KdAq-sUx|kJ Ws JQ?%}+'/7ƟO+mWq+  Hj>?Bژ[GִαPba69h|q0g8S&jSNި :eLp):+)xy9ÛEGZ}N7^v[y -}v ZѠܴmס׶mʹr}X@"\nUN8|ϖS90]V2k$H7O nrtw2], }}KE\.aAswKdOn3./Z=CU@02?feP=o͙ 놦nE8"{u?Lon^ { :}e3A0畉Zs0lv%&9.c4,OS!mqrZC;VBGWeTdbn4i?t2S3g͛\V5҈I"a˼Zr/kP'L$5K\ڏ(|zg,ʿO]>-1=~{0gߚCu~"^cx 'm5vC58~l |^Ȣِ@&Zz]wӺ=oq^5Õ9cyW/T`1,޷8nWaSW!l.A&٢D{^ Ĵȯ/K*kmR|MYECum{ۂG]sCKEp[ }E]xåh*Ta飰VZH4?71雷xjCaSYX/VC{A!.3~$I l:ؕ[s ]΂[d.j ͽ:'~+CbR== M5^)7VQX nʺ"+hB}oA=8GBT5Bhe/>ٗnH^{8᫅1vD\!Ɩ2]7n{׭Ūt.,h6<ύB)``/* j8x2pO>}T@=u9 Cq K3Ƹ ` >EMw]/j9E_<D1N˛yk^-OwoSm( Z>hQ'Wޜbͥɲ!d M>i:Z$rb¡ːξ&Wlet?ϣ yt{e >{NbOWzQ=X> #\WlyfWM[/&-{] sh 'Iܭ:׃ ݍlr3' s̡޽'PzNVpX*O5Ֆ1œ-sv&dit'1,JUc32bT陝wZk{*_L01sP%&sé>Ʃ9`ʦ`>x =( -AyM.H&"A }P9Lsa5aQvʧ12ߠҌLf-ݡ''~[k~:q ˻>Hm-| N?[=­ᴨ3;qv%:p7l6D s=%,u 5ꮣJO~0ݑgjekpE!q =w^3CGoڮ{ίHPdHd T0+b߱*PH ٞFr9~O/GA{UCd-"$t|Qg%==j)&Ty?:h7~۝ ۙ ^z*=cpd[Uھ$ j=ʑ< }oiˊUfV3 D>}3]AcrCS}fvsUH AJF;2!r S_oNZŔKGW-JEwR4*M)_B.7̭b_Z q[z. Z=̉e.QجKEu_ًktʌC\Չ= "ѱќWKHT`4cqS/auAի@Oө/5ĸAȾs.j~̴0TF"AnĉL\ ˤ1]#tor NNdg{pPFw vY@F!5"X"kW{s?HܨkzMSp\Kc.cĘd<g $ O7 RH(Cg׍$}^-W10$_XNu@n>Z^yrZ(:NsJ/Xf UAx IpMccX+T-ٮ'{ FԽP2w:W=Y'I^gͨqȰVX)"W۟`6-7 ~$ilӎd TqeWjd,\3zk--Y6&19걧 $,a٫_VV}u $L?nkdwOށ'?p]m²lH~BIU".(jAF',TUAǶEBe9}1Km֧Mr[cT Aг F|;7q8oez-}yjHoû#I!zTae?%v3GrZO)GEֺmpaAfmH):,Vƨ/%kŚ\A ; 54!ց6( ҿQ#Fl[tp[]RBaXZ!`O=K! H~DM.7I}+p> vVٳ:t*H7/~6|#Bquݨ2ILw,*B]0cܓ>2u$Շ=dm5K f 2'b\Vr'v–Dr. 3$ ga9.Wb 87['׻p{5',88tN S-]|fٻr0n@~f˨4b32a u?/FfGUZK]KzM׾Ly4?ѹV+ -oWiBwO^"QQd{ZU:n1_aimεJ-[c $mwCj#/elda1MU% zMuP>Àmd7@"_`Q!yXLyUd{i!rt;fknRȕo?lNNG՚,?`td#$F܏vIIo* S6[ړd^@mtxQ7sBde,m~?PjH^w2@6NWd'mvzOۇt[G>qdֽ-H󦴱Id0= #>'=W m8mdI^nh\ݰbֹ.R'ь=cvp"ro_-z|սcgbcb9\;^1^LtD)$Kb&-t0;~{&K|:+Ob{^>Bz路ǖ.龠,eo`vdyh$G:"A $Db۵;u׹Kqj#.%OW\h|% uayxSzGw}:}{P٣ 1RZZ`ެҦg,*sJrFn ^L&(k*\%#/i=ɯ+ɯY/]D`]k ')J2$&|j.̲xw]GT U.2OqD:+ '܆Yɰ7LTrc#*.):򗊨p,~M6ki7Ȥ-5ӡ1w)9<*S?w(ó/QQ+w7RN%{2WzɮF j/Y^=Ff;<Jc6ǸPYY=TY.TzW@t`̞-HuMqzB DggqF3n_cA?(bd]ʦ/߽iz.O.>G[U37=)ʣ @fVgz姏Amb{A1Z78'52lQ:KaHHȮ94 4-ceSnkԫ4%?)3*YSTiLAe@+<<4j"1cH9y5Z>wcRo`Tvq+tΏP׫U<|:&F1{WG^'eC+Y=Ԋ'V|X1dޏ{a̯Rr| \JXewzb?&E}V^Tyh}ة%Kp}@:\ĻcFQ\ϢfRz_IQs++@t'^[2 +1HC}VB#djd2}܃'mj!=ctIkp_G=l^!1~ˢ46<[A#6yMo^gݼ| 3ް4s x=%884)A6sc?}ժj3%Cg=#וFQԻCrR1me{mV_6B1s9yPL;~HWwO0;h֙5ì.?ev6qVUKGR'qʴau6#P?k+'}rtruGT|cxaK~Cfno.JGW{25+|L6Xa,." /iteOl0U{^R~&o) ~#6J*B#,avSM`""˵OY 7UrJG!aEqT"ts#^I.k IE=5&Uc56k/dS>GΈLC~X\3AD%x]g\f'˨Uk jbGU.bvxb+?dDpڞ?ĸLُڊ[=֫3ړ !?kրH5I*vD/*驠}lkF1t}p9ۡ.sA5aOբ? j10v}`΋Gg=}1tnZNw|gKhR,7ll i}ȵӜu,\y X&nwVoHvs?LJ$E0fQXf߿t}eA =п~% 3mpYfE7nP$gw c[T{wXMt^qnZM Z`Wg8=N _R=r_) t\= l*nugFu-;$h Ҳ$,ڼʫd˲#ٖmɫd˖Ȓ ,%mvhB -P@Ze HHB H}3y/~'#={;3Wޱ`Vf[ϕl6܃Yx!0y;^M_ihmzi=:9lQ>a7{S'\HoQgaǟ=V\h`9w5NL&4waK34JΩMO-qML Udgܖqx-'mp]QVY5cUjS-uvרclYȭ 23GߖuZg*s2 u^_da[E'ߤQ5SnSuϴjkyZ_XU+kSR342n=3iKd: [lPX@OWGnf'9)Ҙ90/51`&X?,Nfk-om %X=E }>x-@Q<4UݣI6 V2OGbrMKΐ4̝n rC#=C0 :zix!HC_Srݩ1KP^4:8Z:-HhVkRxTuo(iO/~ƦOI_IxQ{n;VW;:)ÚՓrDk ;=N{[ߔћV3s/`am%gVPa,V-IQc>q/M-vfkaQqw0\U~&ݠuʟ⎌-],=@@:[[>;:r:llfq&Y* Ӭ5'kCmZ}4 Άc*iʄ9bBoqh}(8*Gk M`ur;S 9ΆI~v/SNG@Ww8ʻ5̬β*uk7CgTuApX?^jeYɪaέ) 0ݸ:d-0kKВ792&Zʔv;5.7Ν6oۘin a)x6GUC)}uF-|Mx>7;w=*g\Y\$dP=?בb v-0IWXG)Î{wsNS9ڗk#O:ksWq`"dfJ5,f4f5L7jړ,7ʓF\F,;Y,mi=rxY̶ df@Q_!^nέrh|]٩d紾uL 5 ΖQ[hJeԶ*._YCOFKNvk:,l7ey ŞndSFg}~4| ݣ}#i}LU< 7O[uҾxTUkS U*xz:*ՃA MT4٩)i,mAPdvTZw[( o1͘amzjv?VoKjk𴷵 s C}#x;i6'%]재ȳ8f:J[5mƆN&*&W ʴ#oi2OM6t[uթ]IC;[6!][KesߢISg[U 㝰^V*{`eTNkOjVVØ9O{NC[Y{"mp,z9bqxiVIX>{z*OfzU|Mpbē4u'T;+ڂ #VGw͸˫ܕƙ^.9TIJ 3wg Q:7=Po,3eUJƦFUu#ؙblwt~f/i<^KmRpQFFVO>PWd첵 Kk `~}Q4eo8omcI-6WZ?vt(TIV-Ӝ;4 ;,nOrSXZYyv]pD:}e L mIiQ^8lo,u,Sٓ_f0 ( Sa*+OwdNzxj$i<=l 6;K&Rz0z RMxl-0IM7 嶼f#fteh JMijaȔ1ug4u}c- ~UPSS߸mcRk̨o7MvMtā&?WYZ5C[c3CсPlbl3נISk'UjG+.J23uށ`Yw0P傷_sc3Z(ݑ H=t*+G]Փ5R8+7?2ڙ?XӴ[+Z3[fnk{@K 4pu+2U&%O;,V9Ǣ+.]Ib x,06&シv6gtw$ iEtJd]QUHL M'jay@ gBc>Sw]𓍹?g4;T!.~ WY].Ro*~_h1,&Y)kIVgh|qtUCgMjJ ̹mZk |MdG^ҕʚ.+Rz:z˒apR)iGK*nn/m՘MI"?jkaCKEiUp_IMNVnɁ=kTAwVYb26jglY6[3*i:2|`G ^ LdT7Uxk.NMq;rm7{lEތPK~u%o h*]ZWi0T,,o)?=%c)6}aW_%W5&继iw]*e%id99,;)r]5靚.;,D$ɓ>HSWYm14uU@@@?H *V2֟a1ZDr|gKb(]"Ml<DŽ_ ~~p)&ۅ0|OAE'$`3/"/'s;lo˅m>)g ]x;Ox‰BtE8!sȋI4I~x/|^||/ }p~lo a+"J-yJVCy"9guVKAp{⡇sG})F+H{L?WڢlH& Ll* Yk5蔼FdL,3DϾcI-s"r=4gmT/3ΏMSRlV/ƬS؎]' Yb`{q3K4^^PB d`J̴ZI.#}|D,Yy3zy0+J.kbUi0VǍWǬ_N'@^# 2*x56^6;dF@;Y' -S̷@lqį>*fnNa6yk02iv7fwIvYglMiʌ çӮ}t _4WA^On>òV,\* ~_ 3 .b& )ئ= ױjyh>UlKc۠e!ryηޠhi?3Q% YMyA=*3"P M2 =;'1u W4r!a'|̇,9Ew#;e>[BN$;Cl41eEboЇ_(}>ͶDfWE~/&6pOxvǬ Sb‰pO?&l CnSȁ<]%^.TbMI{.,&2 RA.e?jGv'bk%Pqd% ^$Ja~>.ND.KdۛdV%GGF\!7IAr4DI|Qn $o;Fj+Ӷy:%FѼW`B6{522 K"Gz-|̴Hlm">,]C6_h>!baNyG #_~tiGh+w'B 25Rt yVVDZž~Vz.876V9).N^~J^}<'=~$WץïKO 6:M6/YP&Z St'A#!H  s- OA})<}d@q4,C22 >zHz |Hf{~E}ײ/ڢϧ[8/TSPVi >(fNG4߻EOl' %<(o+'aE,F\o% yh~rg^%caQ-81uJ<ȁ<|H̆ {o Ls ~7XT#/'F~%>`?5E. bD,! 2=@|m2p+NǁSȁ[1jw71𘼏yC^7}kb=xD~5pq~o:\$AMto:ln[>ME/&-\A -c퀶(NOΏSb}Yos~̅ ȲnooIc{31u ӱ9>N922 :z,|̴@@|>/?/ͭh~7oE @v@[o|ab>}g2fޢNűvy"v=z ,oB,(oumV| A9 -eEJ.}n(fΣNE4WA r ϭ79e>@Kb.\Ffh~g@w}=]A_}".NŻtJ<]OYu,oy*D'9,'Ws4\NڣMbNj >}jr7-"dyVUq.NMĬ+S+Gc)<#$jFPʉ >qY亟'i54\ 201N;uu cdȌ86 :! Qfɐp75ɏv6mw 쩅l7J xKQZ l텉>N;1xEHw bHt[ 2K5K7 "A) .N/x)tь[/"W,즗/%key2Tp5ј:)z%jDY/S!7,W+W˔ D泷Gb#h>H@(B/V}e+*Pn'ׄoWjϢڷ~$(>軛O/c"w8=33QD9ǏǁeYvɍ\s{' V| |P'%r[%y{aPGb)qփY^9ķec7}l-6AQf~7G~'͏~+'mqm[1k hM۶#_[`Ae@[r[#|XZ&:N۶ﭡ:)G0a 8JT^*>Kwg=ʬg )͟dt8߾71su >Sh3ec7gNx! NUO1:u67c68DssP+E z`A1 &yhl_*:eN᭰C[x?}N Y#G8((rxv! |g'2]93QEs|n^P *q\ ^`A> O 䲹m]4򮠊*/@Ux>y'f}@Xa^ ,XP ~y{,kd y:%G2ǓGDƄy L@F<(|OQfm'}O|ODzt}+f^NA^&> ,oV2Y&&2 y踭reY9#-ؽb3h>eYFHF\/ Jt %BxsDɗJs<3vfNfYGN"xxԣB5zꠟ^LhHkgB,$x$/Xv)8ŵ&bٙ" '-wZ~A}~2q{cEx?3QF3˰G"+!e0(V >NxʺtHxv꓉I_#>HL}t qO\a Y#C^poo5qOG)F x?3Q0J"tHCal!H-tLdHMdL9l W zf|{~(o/@d40;N;񫎘uJdh?r|HC|!<`\6/&W`x?z-fA1g5@WY&8vdOKYNaчA󰸓N|?+2(gD,_ZoTGp>hnrƽ^>@wAK3D# {џ`~+ {;Iu-V78?TOK¸a sq?y8焟sq88C|a7skq,%5e?gp"TkF^'VK|T2)6afX~ l9\,ˤ:Qr-VL']G{`4Q8GO퉣#q#v82G8AF/9S0Be)`FN?|s'\ cvȳD.$"O!saYS:I,',<er+!>f$ dzY!j!ozZC q ]Bp(n8roFjˣW*8 F(%S.3)m9!el4V#`, V8W0̈{d7̎Yr`/`vح [a&!]H'<,ϓĹwӗy8?מnEh_q~<Γ5p=R#t}C؍tmB&h/nC@ֲ>y5lF/Q6EcW`u8}tbv OJ;VLgEO_y~OX-`DH#R4NtfH4[ʡj)HɴNJLt@*3^,CHZGoϤzFvV8l?%?JgE܄mN)5ӏS~&ia`~?bleRs/b웻fO9I[cSw]Q&[۟'s94f9&$A "AI9Cs 3|jnOz~Ӥ f,wF 4m[z--Qy49e5-FU4#}V7Q};"E80hG~MV *80VV!aOnn a$2ATRW^` ԑhoHȥILHw P5SٜQIGsow`nlj*JChð fASE?MBrJEe#}mz؎Ŷc y|_dž1"ez1pňgyJԧy8m{߁s,\R*[af4U O>=<*Wp:8s6ѕxҋLvNZZlHapn;'d>0*::x~T`znC ddCL@5tbW&d'Vԏ&8G NGB)xzrY}!r*"h.BL֙&DPg3X8%"F&{dq v76#'_b\=JyS(Z)3Zono4ru dkEqD  D,e4 Om6 ߪQhؼ%zk̶89%-GPT-i5jwM{)Xi`P d$QiLfh1+X"3rLc"QyLi:`ƺu{۾?`v6 <,:8wܼu'\h䍄TfvoJ ]fm(˿!Gnr?T"#z#=̩\'/LE粹u֚Xls:s:ѵ$jFȻE0$zDN8FUXP)-vz 8N;9[P_ I?'_C#>-O6sI_md3!ןc7Z~c[i2 $M؇zN \"[gfET("d_M=fzލ/ B>#,k 2E1D% m|X\_jG.Dj&f3%uv>awV=m[)5Z,\ah,g.3T#ªQvǩOQ2դ߼cȪ-|l24]o\h16oq[U$ J*-v7޹w:8*~zf+eri}IkEװȉߦϱxT,]<#3^kjVwFc1HJT@],_kj 'מ&2 UFͽmoכ[a9a=Dxrq\X ?C-D8y~1WE²zImqKYP<Bȩ'B4hA"I9D#1r3YU꘳m[;]yxt6'Wb%qQwa:seRÅBlgJJ%bSmyc%gqgYcI۠E[ʺo}>p~8~?4Y39S'5z|@Ű-΀Yo0; T: h!E|D̍tګ"AY~m~0mN<y̜2v^] i?UzxoD:+ PPIjcs v_r WRè߼sآ-NT?·JLT &(-%#_aV}HV*8 I_cja$!&rd & w)%`hȢd t+:Nn6ay:->lXa;Y.!רLIH fLbc BhL*Õas1PYkM'-L$zxCD Ƿ)WbOGÞZkfHW(TI* 9t)&*W8W\;r+dD͛u Pr C*?͇* ŊoXc#)U @7( H8Aj ѨLl{ *:!!XUM~Ö~AS΢eߟ04 iSԟ 9r?h + M jW?^TYLx1ŘcHdU$Neօr!b/? Bc-Np!HuZXU˱ɿ<>5(Tt6Ipy.^i&aC\O!e䳋j5P#ALH|kځR|w-{S :1ʻM 䬋O}&K%Fs95:k IbpгT'NCG:'>OߓAcp iSb鏖G%$HӴcȨe@**Jx%6C Y.5Z bJ9'\*1\kn !.DG{UHj -?,F {h~]oa&C>_&e?8w6'U&P~1&I;=g)5h3|3A I̵giX}FlI % I I?"ۡ{gc'DDx I?3=cñ3x#k4bTkys'pj3zl>)Zdt2M/[ideA^dpP#Xeoktgj協b8xnuԘ<s(,E,#?nƯicak6M@fθQOUXy~wZcnDb4'IcNաAR&=K LY;I`b^y$mCZ2ezrOSOD|@l Iɴ,6XjM>8T5ªV oXw|+9K.Br0F;=ҐHLc:EJ?CduE;`2Cz`# 3QH=b9HIQH_PҴo6#TiT)^{t*3H\#$~~LLeT 𛢡Ǡ5~3&tgib` I#ܼ!v 䄤nZoG1ד2 wτrBaM;G*,㷰wtQP'v"}CU\ b}F?L`& ۆ=ZnfJO qHƞFMƍOSs % 7ں )+o2x "t7 XEuRNGr]oTf67ΙJuOͤFky~{-1U.:-#>; cNY% ?tOf+j,>8 id>s#.&k#F~e~c/gc'8em8{=JN:hmT #*Yls<{T"0 j p5A"Huk;>r|ɐ'{mu^fh>O(!R&Hl]{?@$PS錻ߏdo ^ݜ&rvٵOoBM狤* T2M2 U^,[kxpŸ"FQ-M_>jTz 8zy-XN3=Bl`qZ,5M&kS9DA2u$*L 2BX*d\NH?+.3@NЂˍ>߰듲6R/ T]l8dop9eMkYg" zHN~ æLb ^v;yiVz!~~cm#*emb^X{L;|X:.fPٿjQ9E6Y 6\c0X=%1N#Wo5bNf `Tf>6O0ӕB-N}!lj^E,WpG#MC dya[]do(~~MN#aW9+'C{3Y[I N^Ny % }xA7dN!1~$àlt{>8})>C'Y og![J+w.*ض[wW-S)̟5I04Ը[wy?y!.U3QTϯno@*d$lUcGhd^O;xm7IMgӨ()*Gwx[wNROͣUs*[u=@OP64-(ke_O?:;2i4:TpVmvγQ^䀓]ެ[?8VZIN>s[K,J3 I'Aƛn{}N?Nxb6T`|sV4s+ϙ'c ԛM&щC[TbC 8sKRBPׅ(9 :ߍ0k{ؕjIözg8-LaEMxE256N;F_O*y5}m㋧8B[872 ž8xm%*ݩT/H=8,.:WY{$8|\*Њ ` a9s!>hH0Pj 0GM68>FPHDH D :[q; q"35x*6G l% [wp=CgQkBŖiH8q0J__zy2<~W:[K -g̙,\l&;N?IGʭf7 {Zm" p>Xg-Lszy]e&6ozt95N=e:9_Hmy'zЏ(c$8u=)i4X*A+(ݠN m XP!KY8%ވ[=f+9=IklK+9I6u*;K(YlhN.>T.Qux aAC85WSNG%+9;SPfBcVrA-y |]pJҝBazNUf#༐R#Z,TJ'l'S*oRF'osE3Y)d֤S(lUxl#QndQ9U pB 0PSgA³1)"6ztg<%GU8R3|'RTϮj6D@§U9ɬO93kb4-}?֝Lf}ssh=;͉T~'-*0_N=xN]~feZZᙘ;ᅫ}Df}C#H}ƝpHpGq~v+9%ζzma!^}/_w-UNQ: 8q=3J(v@( +)E%atd&2k8z :v-H'YΗD@GsGs,'sߣ ^K ΟI &UɹegᐘsO3g79MڹTdҞa`C0S7_j Zyfn唂S/x_<7n>FUvAݕq9\OxSs2Fֈ_]*GD8&hbSFnryt*[4s S+[hlN߇G#!]I*pNEk(DxI)8b۾K)1؏$gDl"I:t|T >vIyCi,G4 q̪.J 6{9#wygh2?ifO&%77C)rjfn-Uk$Vf4đ3te<0nUn ,gP?h'k:GjU'VZ8ޱ.VHL&3uf|༮1Ut b3bZ1bT#^D=ApNNYv:! yj$3;dp+noŵ)W*0N28G1^mEkUHA.)x1p>pt`#seV|wQ)S!-2Lt*j&ibD}KL$%=k#R"Jϣ5WE=͘=6-RA·c |Ɠ̒aVG"<˾UUDdDz=΅O|ZݭL}({8{/0W3;&wHnBƶ+=w?>Ni+0>;aD⓱Bb7z, )T7`9;u}ˋ% p 1"}:!w61hd2$[LHZ4"a-s0,)@"tO'|3tR?+h; 1b1 C"2BIvJ$zN "UY?d7 1h5빵gFo#$$#/hl€ <u9B=Nu} `g'<ÿfQ:ސs|̑#}ʛʓ1^;@Xo *i D8n:S.ҖSFS8IwU-=U^N=E7׸zcȤ/1N!2qk㭣CrV9C7 ^n1v@W?44(ܩ|,K I^ ou.K=_"*sY@Wq}[ ZPC8 A AB H$D A w;azB9t=ٳg,ςڥAL 1xpic='f~.rsmG0:a+UpLLD#_bW Ciu05LD54El~Cڞv7)҅21PUŨ`<Bʜ|1mkn]eIxeH3InatIht!!?w ~ObEZ9I$ f Q(kvn >J&vYO-.vĄԑY%z~/7~ߊ\dݿiJr9 G^MþX m7pq&]H3c:<"idA?6 9Ft&mooj44WM 9NδD-.z{LJ8>+wgB%YԕTF)2ǜ11~[fo4O(S5Pu!d]sǏFDb(2ʄ兩`$x! iIRG<`O\O,nx!;fOȉ<\ ,h0ۚ(sK2)P야:%-{AzOX/50.]x=g?N+6$c ,UUy,)SbV ]nnkw7 Sg.'_=`8V˙c%;v߮]dj@yԵt*Ḽ=+̓E9]BHPul%:J{`R4Vޔ+YxݔBEϮÎ%bBjiD~83`ڵ 898WHpBH4JM63};:RҤHĸ㇎ލÿndC {9=ĕqSlx3]{P/ .e>ss }vWEk?[+#'w,lk/Zerf{E¯tw牡Ga2a/ G Î]F! ~9gY9>P 4@x(Z $Q:z+1;%RL~bbȸ?0[6 XE%6&ID(u< 8ظa񄴩ײg$=?Ԝt?}}ő4fjɑ{0mݞ;O98͉2̛I)ѯDc%39f̠y(D$YnX@m0jDΚkRpsiնQ+cwg"'Ԛ$zn3gX|ĩk H2GFi% &]7lCzm=iVV5 jte]njD3EvzWħdڍ) g'"!)IL4>;NtYµC67l̝޷zge0NDSwPNM;,M ZAN~h! ,x!'\̀C- Q>ULHGEbB~In}'Ӡ~Yl 5u8Фl-1FN-E1c/J|;^͂7 ?cV_}v[OxypdtYOJ{8#h ϧ;w~7+^jVW^ݲ߮cӁ4:{os;L # < hgYT1}3{ͱC81y!'^+ T*@-D5L.DBQgo 9~}vDbI+\ʌ" Euz9"!򏽐Sڶd43G-6]4f3]L:mƸ L|a8xt|k$VH;V!@C0U-)4ä r ! YeN]Aiwg]S%z몆ѧnU=U0x_:zA:_k1觙apB׹NZai> ֖_Eyg/?R z`%駫hFhPZWNLuTJU:JUl5oSXP%2x݆R[T1JUlQ[$64TVb(U5+T{i*nk*\&TrջoTo o*R[]joTVb+UJU*Eg+Ue@jJUlR[z=lTVbWX![Vb)8]SYJUJUJU*׭ETՆ.^rdS{U]WTVb~qU{UX㕪غ)[,:EzQD-Ɩ׼TŮu9P1T{Ǧ84uzTTU[[-ןaC*JUlS-KCJUlǦkyջլToyl*~ c+U[[_}*U[vZJUlVbג>z?Toi*~+:+UO*\(Z/ *^(3DR[_z,8-UVb׬$6u8+UnS]tNr4JUlY}ږkBKu4-..]ޭTŖuRRQbWOoޥT._-JUlQ]guTŮt.QY]%;XMד~H*R[]oTVb+UJU #˗JUl*vM*OjJUPWTŖ+1װ!WVbPs"j*U˭\N*vV]JUlv&!*vrUi*Tߙ:ޭ?u!'Mm9t⸉S rפj_ hR ?BemUô7T-5XS݁3F1P}V!6Q6^Pɴ>A%}ɯGV$PB8Z_ ZtoQKm)֜U>;SUL˴a% :BE7IWTt\Hi1UV ^!#XIT h?!1ソC:ENŞ_ % qVlSElQoV ٨HU |vI QᏺJhMS%i+,c@V|VܗܢU.Jv`s'=`Ld8əqlf*W%,Zb "Ua*Pyĩ.1@&puJm$>@!l#wr^M7 XO@1HF~.INZ!4U5]"n-k(A'@x,IxQE&H=Z5L&8Q*[IzE7c2Xc`u1 g6( %Bcm%g~7EwQ&:ua A,!#E_X`I `FbdXA^U]: U};hN6Bc껱@,DNn,2/Mba􆃡F WAɽǫPu0@ծm?q*z7$>J2XFXHD4EHy>aH.,Lq0^ܦұ|+Avb$("BUDXd} 1ZRhZ,ƈ`Va~?D]T X+A$X#^)x ]%m`BP,$O<\",=2pFEae-aҾsw,$7~]Pxv|P(= *Uxg;Az=d苅RK|L`!EԓFYJiQ`HzDQĻZ6-J)Ekad{S%M8˖* _f.vda>F6.`)c&."^vbײ]ť.$1|'&%1ٷjcq,\2$CNɑ닜d6I VI? ܋%R[3.fE b $42܌T6R9CXj{qy=^ CľX+q3D[8(m:YU/}5,1뮹i O4FD_گS,jIjPE٣7BhQ~g:|#d!QO?>ǿ E>DbrIB\W r.y9ወU-1gOy)\!'x Q2Y +[蓙 ){%D<|1ѯPuzڧ/C>.LqK떜=N.1 8/*?Ŝ_THYr3j %8^j{!wFVpfgOuщs&8S 8Qey[m/< BP&g_my։и&OSS0GŽpUmHXI̎ HLƂX+#\ 9-z/\!|:w 6;EKo v)=gtRI!g?M/ =|/gFKr3mϠ .7ח-<[{t 9Co₧e'8E*1DGHt3-㸄 { ^{NagZ;~˗^ Z7LHB ^y . {CJ 3:9"v["ifc + GO1byeYaU Bcs+,"N0b uqqf.'b\{` /8SG +`hDF]Hx0̎2>J(T%,~dx<% |,LV_{[z IeֽW'(" +ֽS6fvmxg=`^12F ,|u=K3O]Ȑ[{-<};|bi9<  0I dshjPY&O[8 :w!FmgxťdGVƬ" ~ Rtfy m !+%Օ.}5z.\!8KS# +Hc]0=\YPj HRPы>9)ENs,93b~?kߠn-m뛘4Ӥi#ltn-j1Fm#RY&&s;L`PEV⊈P̛|箌{炥CfcO1j9aq3aB[A/+&w8X]M~"~䶽V_P g&6M->i hleG!fg=kvl{}r<'xj^e:yr'f&"M:7x^?u $}}Ҧ@؀5nfL7a=-BӉo;އj~$7aQlҌp}vZ?w( -(ثkԢ?(SF+Y(ZkLL2q0<"ɄQ;^ h* F֔WFQr ,Kg`7دFgs=$#ncvA_z4wn`n1QQxbikko"z/aCq]NJFa7XK$ %[fSj3O'w|-]f}thdefCs7/`vZ?&vO&%޲糄B_)L׌|Aid E_3X iC?Fw;&<)zbZe`yr+sZ5iW%ֱ3Yiia'/VnLnp/k=| 3l˝N//|Yـ}蘒cq%uF\ؽ\|?urohiblV̲gngw_ac~nY?!RtԞ8XLӋ&9;|۾+7|15@M,h7spc^K=6:wZKz>||ժ0G{'wJ˳ʲru7nɪ-\<[c 'lu^t5G:0 Q*. |Os_6[Q;@eȦ]i*PB?p0[wMnL>zN8X繋p$-,,lVA\ CrY`H%G?CGZ̳WpAZC_z5dY(M8Q7t!%5'>SS HsomC|Ck *i3W/ Yؐ!4h2P <ߎE/uɯ9 IGΊ`A+7a)1{,ɒe`yv-zK^8ؽ{)Xg:AzDj9b{$48mȜV Xm \׻Ű"CZy=sf,Wlm`Az7B`gnK[fȖgoK WZ9.9bF8wel-}B>uh`n,s_s}b';opFӝx=9O <-qS`u#(ģCl]Lj_z"y=3#F֎͝9`2jрmrKf}V2X-84 gvQ_xLߟa]ƹOn YYvwUwRr]=s~ "!nm ̝Uj`阁a QDDBDN<ܿ/Ϟs8=_=(Zgggg3KP@6{ܽ pjf !.\ <:J( ,2 P6|tD!-2RFc͂b "<(Zl:ʒU\E:,J5RyhhXpYlEG[FӨFNƄŠa;^k!^ !"UFV 5fiI2 8fj,b71#1^1 ƒ^+[,uݜ&jvxB֙gos]ah@M,SJ`bM5;\<>4A29^PC4Kw0:Mj5jVhL6800d9$Xpkpz,"0 y*m. >%Q0)jK^>D4&$[7X;-3#XI $\e%F >vYs, kη0֗Z}Ă^x%*D@w[:,51M5IęZgjc0aq8![t鶾lSlU*~ҳcOvYgaobS"8Q6]3,fm9q5&M> l.M`#X4{8͊Rt\knHˀdpnE4.C>] X$sE jSAeSer|tHL e];ߒ2^îhVȯO={;pJ3YT"s\YadgCb9fU^`yq7`]a ;-y1gA&, ,6XyK]fmdWca6ZdT^c_eTB֗cVco;bjPb4R˯g鏕j\ϲoe4:d, Wm'Y&gQ_^vL]y,+ - t!YE$/3/Z춹x _S ju=Z-/t;&b?eqd 6oC*nfy 5Zr޹}:{e_u=u6.`9y)&]*^jWoB|r;&'`,5)#}ou\ef@p&[56/`HdΛ>xz1dzbQX5Z^ Nmi4 qzYmBȔ~!]V;,6d`,7#aGh<<'/Z^nG4!^&X xiE"ϞB t!)o|\ma_BFY 7ly%<'@, u%}+zf3@L1gkeφ%&UEiXXE `~a[~k]jgT,=:w5!G.N,eZX%MRNG Xob2DyTWZmwx < ʣ_ZQ ҙe)}[ T@@A)0 :)'sX4ސ!NMRYlnդS}7;{.7?6ƤH',뙯vqȃp%IziLNObymr*LeN2H44B]Unx =*-ST."Xjl^hr|Yaf?O,(3@McrS;Îp%1kB2?WmDJKY-|Yp@ҎCE*hF{ R*%CZPfYi꭯ϬK+8LO,BhEW9y-]O -oXsUE+n(}quKgMVR!2I*X&e8WZ:nEHMy!WM/oU6! F.E?vS 7:^nf?Wh*K dˌ2L0`G'^JȑΩ4 \!9Eka!e^ 폖)>z7tU tLSp2EIu"}uxɼx4(J$:C|$4H uH$H x瞥 ?@vE9Me_ff[Ҡ2;L:ـxsՖ_rQ%_(2>VfņSٚhl Ҍ4LKM68s7 9F8+8rѹmzI`)i̮"$a',57 e *#..Է\mMЃמؼbySndzbVP{-Ldʡn_eFh՝>l4_G^l~5Sn1*; 3.f}ZM4&)<䔦0TgruXaX`I+ShgbDp15ݴ&)fy&#lx oMWY9oq{/LDՔxV~ aT".ͰpլWU&Jʋ3oqol ߈ՌISY2Ghx?:$b|DV|QR%l>a_^$Yu}CA,L|ytemb5Cq&**.2ZmO80HR3V,NeV"2K*84i72RӟLA5f Kc 셑'BHiMYT_}հ J`)kίQf+\mD,DT_dh ^(xQ٨t<(SPGdW+;eeUeo= TꊐfXנjpzw_(!MbDN¬e ES@ji ⹚Zt*u ]I hZ|q/"bE; +CQf@Ye'҂|ѹ2k ^w3Rc[H4^o/4ZcwcRJBʏ]3*MaU?HV(oyp%dx~-W`q5YN0iqX8sMops'xP*VIϿ'ż1PK[2+d pí7񍆡*D|i(ki woxVN5d'7n iG2bR}-p4{2! I+@"ii;yB iijKZHiƄ84,WJ `D`dA# o +H)E\ i,շaY}WE,J$!XH^ wY8ƛ8kHidBTd,MEv<1Dx EM P?# 'V.UPw9tV\dl;SpC4d'ksuVظzx JG{q a 5)F{fJ96o5v~ȑ'ra@M/nnH9:=롕IB8x1RMGZ|*r*k3_egɗ IJ+J*;^f<0p4 #G  nW؍/ЭJF||.6d{ es𫦊8END| 5fko$(Lt5 U] ڇ'* L 'jYd>J~N \hd;Sp"FF"&G@1&5@ `?x.6[4\CEH_C" ~04#t<?H&!MVHb7}[ӷS'i٬s 0OaHӑ&ÀA$ AV!٘,.uNw;2 DXl)YZ&aJRPiX8pp$_@FH#:IdX/ˈ],TtMqXNŔcOo_i>j҈&8A;EEgRK7|v״3=3% Q?%NWp]$yK4G|EْĀ1]`!qf MDx"`-$XȮg pp ph(@0U]_L). :)aCV{,pDHqУC1GpNHIYK?2f~ZehFŹܣ!}B6,rg9EYG%F&GeT~ck6]b6χNOȿjzhf% Dgy?>w dcaɘ %1;e9  kz#["ǻ̃xk#šB| 톉4`vz^A謳q:}""M88olp縂"WچH@,q!͋k "utBcxdi ~,0p1'2ԧ 8xaɀ:d @ $, U=#g偬" NA7O&#q:9ǃ{|"<J[w苜,2uDGA5M,oA-?T4NTZt֡ᕆȳR~4'0@0@s$),R)ZU\yFjTZִm^A^d8CxCk )LfkMW7cn2k7Nq%՛jyP YAXM/ %ApĹ"4>s G’=a3^PiW?P&"Z?W  # n> OX,C |aayjzU"rzٹ! |BֻC u"KBP6i^$E"p[8n߰E_ii+#D[,2fM1 n2pk,/,JC?PDUȖ]ͪ:Tx,϶\j6Gj8*E=! G"lHB8*֚e:{|ίʔbF(~H4\ɨ8w$4u^l<[r2Gg8`\!$(< ,5MFġVvC\?I؆JsZl XHD0 70Y5!`>:Px^ݥQ{"6yk`Wo;^ȨHZ9(8ux8/jŝ0#yy YDI$X$H.!2AU0L&`:aGW@PvH9S&RSQ @ pC<O{sBӅ/?;]?n{1~݇7~X~w}-?l~a{G\ 0}@F1c4(͗(D(\DF9#~-ƽߌsʅ?Bĭiטп>_$@jd*[~Z}}z|iNF8$l_[wYu Z4|u!n /M;pZsD5?~xi6hkTס_ݢlG\- 懶B`>CȨ!B5nBZeujU*ebNq H; R> /6Kvl~H[W&-}z6R3H6>jhԩ]=6Y_U_QĜ#qe N7N L:6jۇG7z XzZuFwj7JYb<>|F{CRY5s:y/'e*kU6,& #A 򢒖-/0䨧GMf*c@\#Dp']BŦ*eUC\ȨE1`jݚV!!0&B%E Y]id(|$"!ŴuXlvA:WzߙMZx̜b+&=Q] M"bZM,"/Hi|r#N -K~?b 3 w•_TRS%ϡMn{#ND!'{P$z#3`OOfdA0&:5ܢjzFdL2똗/%]XȖ"`Ak fm6&xH$Ga̦wwfmC}m%nb|(fg+Ƃ6Ybu# #NAfE^]IkYK8'v^t?,5jW2_zqfszKT5?2XL]k[Cw=%-Q/Cf@@,^#XKi߇r=#  HQp׷Xs d5:d;|5be;-c9a91g$5HwC7I@ JPP@@@s9/{7Aa^իujszo}k}e;IۀWZG.VK9,G7X,. XT:z<sGwK.XvB*"ݸϼke2Zt5 ZX(q'{ms\mlD { %oj吗S*X!((T|lʹ=ͭ6)Ewx^d_5dWNeB |`l?iFV+Ryỷ(L ?M$Lk)ԌBnQS:kx/9jδ}РWRc=GlwpA-7DiE~}d׵9Bak1D96)735/̻ z:ebhQQݤ(" Y)N 4午iǐE;$7ĺ}PSTCIWzuqOm.kL̗ < Ӑ]&Vb=bՈ:MZ]~hΨ_B)UO;4o[-l 2, neh沊jp2u [Be J睤cH)J˿"}7:B˳82'^mbwAϕcSeAS)2o_> v k^e^>c2=C\:s>ʐǷ-pKݮXv) .0SVxyO@`/\ͽfZvRt"N}9A%<=3BUŝ5 |zV^IfYX c1foK^;9)9âtv_gaLd'`ͤ00QqsvXjY:z&o̺G,>& Ʒb;lmV#jK*駃3H͛C^Yo)щZQ} ,0}HQO+k"bOrDWCL6X+) z爏?DH+*LD!CX՚yc{1Zg  "E!ΔϢ(7$WAM_@+` Q{xrWgEa"h=UQ6oZs뭎ar|vv $H0t;=bү_*d^I90d띵8 9|̠0'Xa(NW~#4Rt o -h_h(qbA0 { \RG = QB|Wq!~N58z\*)~}ą?_8,z?H:ފzx8VJU2>

b#vm XNVIVz!o[cfDh>?3,4:|rCӍN{J%!]-o7Žy7#zI)űRz:(|M \ Y0Y v92:BMR"EƎ?#`kdr =J]2 r1 F+8"Jc 8? ps3`ٵ)xU ӞX?z/a ai^~?񽵖 L9P,suЍ }wSքP@\X_aQSr#9|þ;YcnTd<'Y渳;XDjR,`gYOX*bA0ɓ 4R XD%X5D22zH`CXJ3NGp h63 M?[{xvezz!Rm6ShtQ,% prt]mfX$&o`fτD_OȤ!zXby,05k:5j)<rw}yL mi4\1_$4Zca֝CO?SMʥUq+[`GAfyl&fȆI!>Ne+5J91l8X9:<Ѓ`xhfHx6 ʚAu[;\b Vb=‚q{Y\e,zܪv*3/auv6g\~z>lM?,Z)Y:\H6t{ԳkJXp5x][A/WK/t4 tZkb ,<EU6%S/a1\xxXV[<,Y +uXQNʑL1Ť9 :Z^sj:hE*"> n66c2tѢc;+lxxt6<^99O;S!hwq,ͯXXbY$2#>= +N-E`aYI  DR(Zv>XοH "ocaW![dc_evAîwcLz?4+ڴ'jZA`8;˜>F. #^`LTI)sk^v5a OFDmo6J^ew&)x&K bVII`JYMwF+vw e=#.$ t\JVM+ŲGHg!#$X'CXǰnc?M+ZbΩؽށld!Tė,\,5 j琗W_hT"?Qqd  _:;FtX՝ES ϽH>, ,Kݼ b.geW0[9u=zoŨfe~ RܠV|>:p@ފVN Es8zȱIz\xZ;םw zq)6FV,!w@:G̓n 1iG÷,Ө,EJ>b&M%Rw2c?!JodU\8c9<1HTl)Xy;RH) qa7k{e`ui{ko/172%3YiBNUP ZٿE,v+rO~cfh:G2œ2S NXXWg;PySK#>V= q>טO77 ?(P/ FP v'B^BG<#9>mЩ,Rx*"q_f7LfS,YIi(ec5wx UA)nb[` exBt52kJ9wp8$ &q3~y.&M9"0"h{ kc 7C1k~ͪ7f_M?b5n-gD T)TL@A$YaqsGN'\MWϫWqmC&<6! 7^ji Bl^ko^dd5o":uO:K$ :{)!Fv%So5屟x|s-O  }t"͸&֫{ d#Ra$ C#Jb=|rPaS0Y:`Be-2Tuvs1(F.nPKC?,WJ-:"_>+fp`Aj&[+,'fD@Zoi6:Jc? #Vֈ ~I$ŽC$rC[V27:{ R-)CXfciz]F>ʿuUK)iR,}$8zǽ5(9|)Y&d\57ݱ賘(2%M:(!XCgm,$ Zަ]y91DXu<O__pd W``e+JITzFu mxY5`7Q8SNE$zl[ d&i3#[:bG!''\NWϯVL!8cEQC^F%S~6:`@ĖmZ`MԑSd`x:d{{!.[%BU۫2kй!h6n|ͬEɴ(gVI?4fWjۋ6Bm 8eV wq$د n؁rNpްT*/K2Pa  9^+nm`SWSљ;`Dux,X0xӿ.]I*8 'z<"i ]"wLai@>|4 uHOKϽ<4[ctFH3H3#4H3"4S/G4`ր3:b?h.്p[emHWyBw3{-1Mr,f"a IY8npa Ur``]SF^핔IotYf4G`<i f4u#n.2]mCq35ݜ7c^k4 bVx=LLڡmwL9u86sd5igq[Ff{uYG)mUɮ{,$nwZ; ,fQ&rj4O&jLg H92t4hZ:5=A4_h n'f0aZޮn\xEpny , hx\``h3iJ,v` nP">mpn6H(jVr&&-w-5woX m6w̖[:waȉ牗Usk(e:H~Mnh*gW]vA ,g n4LҙB-ح+pp4)gXLYe YJ){:Eg+4h4\5f:[_ltʓI4Yt;ubpZuRե^x-݌H3,o`ῌ\S9BŦGCfAfF] ~u1,Lm^n/4AF!iFU rOr&#i UV -B4!M[H] J:{K-&j>KsKHYA)oHCA1Diȓi{5PjZVO,>@Ym‚|3j ^w3RsH4Y_,حqRռZBߪGdu2̨Uh^M/9*m`OhFVFМ5ĹN7XjwϣcZaVY;6bw]٥Ss.>hhNߧko[sh )Fg ?ggÝ^񶙐gՋa0n~( a pn4\J)>/ bǣ6nOiȆNRE@diֻzC iT(4LHd HsY587Q587YBȁ#pi ۬ i %³HT+!Mᶿ3:j9UѩWw!xxހ ۸Û3`"Y54 il"\dTe>&~2 ƁF&؝ZݣV|%ˬ{vaT@UiȪ`LF䍬VQzfA@l/j š[#?X|-/4il Ik(rt XZc/NF^N-VΫժ2Y-oaȁeJbGNۻ??P:Ԛ^6|bD{n[M]É4&v8'&ptg %Knu!grd4hwa4D|Di\Le\ #U7ج!q}"39SP5ZLoi(rZsGm]A 򔲫Պ[Y3$'Vd_&BrщwVػ+. DgiTt@p 9 8 ˣ#Mnv 矰>LADҜEzg\9T 2M{ߒš[`I3-^N+Cp`J i#,2Gr=DXI/ K6C9RZDmzSAb7K(LfY24udt]Cyen38=oPt'Gzi5a/Z\#njVt [ F` 6alBޱd'*dM KFs.@CEr[ (\(VS}l R,z$N,#(8p0tRky?q熆zC;l' O."#Cr4bNFc%a=>%ÓB4`_i?8f'9 Ӧr7EK3覰fbQ+!WIO J\:,8!%fkq Qk{kν*8/|r;wyc< T7/TZU9GdPT7Z;i0`0N¦xI9|Xl4]X47,l~فXxx:.@;y8r WqہE>gFC4%m/JG谩"sxd,bMaHILa`"#P ?g遨Ÿx[aog!LS#H7ɘ=/m|'EL[ނD}jr>ނ:# iȴCGg D&pHiH6GdO8!00 `\s!,TCiSې. IXX nEq'3.(ieA8EhKtY~'Zz*6=g5. LK0>@Ha>mrp0#M&> tNHZ"_kV5_˭;Rz<*c_-{7!Ld4S y>nWr@>4 ]##\dѮH]~/ 8ŭWk&Hko?\b6vp" 8`єA\I(* Y"1f!qkpHq?OچLs]b  \U#00=d {2K_Ʋ'0jlt  p*͗3~$zדN^?'E#keUÚ, ̴ Ƒ,5Kߜ fR`BBN>B˷Y-#wСK M v@ClR~dq _Gr G<[lg :&}XVҮ/p`[hXP2`A?j,Zɗ $^~cYy'`ϓ1Y4 @d,(v?r@Hrl/zr }nerKY GBoER(u5TJگ7O-?qƻO;ܝ/q/'S)i]QOUrllEn<` %|iV^;RF(^3NMQ\/,ZlYfA~˗ jN*<?rR;hRQDj|K|eX6xB/h.D gLb55WbBQ@ . 9 *A$IΠ*(TDEDAKP;;Uٞfw]o3S]]}Sӵ|eg]s_&f|cI1\Co?@E!cjۥ 4}ӝ>T_1Q]f)?QS O;E2MMք_@HV.k8XJZVeDoŗ dﱦkp_%m&i|S''3tҵ}i_'=d=Ba$)Cim$ yOryǧ58'*5{Ye9EҦ{{[~Sm}Eu{򒵥Yxƽ{kz֥ezǻjoJv ;ժM'[Brٽwƚm~|/c9QmmH6v}oxkJ^*c3tuO?wUρ|zS. )ݥvxE>()8qfU\1pc)w|06FƂ_N_xGOi}CX¼R3E-WDCgF8f(2e.lNa/㤗/vg$_N@J:fzQ/J!`( ..34XІ `N!F08cid׷ mu.7R,kE/zqAi P?/˫S'ǖww>BC=`OL;?G3sMkSW}k •vkCPqFqϲca_pK16qS8y=Rcvƅ%ӕ{(S@z8#cq mŗfLr}}]6q!v}lW=%tBc5;(iGzPXAs9۟N=Rje E0DqFĠd\1c,&RDH:7ɦs: *R?o\F{^kW}2CW-RsT8NU>ߪ'g-ӧ=F{_ԗYTD`憄gE-!-0cNABkzL#pZ5u)/V/ 6igN p,|~􎚸v W)L1KԨ&b-Ty1iX8b8Ka 6ikK8l`cAN>Msm}^STdVb@Rvr:e*lb-0xNTҍc%4l$FXQсƶՃmUGUTfyo e1_(u IX[`܍  u0Vmn4QZUݎf@ ЙXn],B̓#|RIXX.I& -VG TKHf+ ?< hYDMU~U*U[Uo @% bn1rIp&$5p#ϨzHbdнꮪkiHu7Q*g bx\f!1"ƈ4{b I̻)ONRu'Yaa8aI8}‚+uZ0f .ߍrYm8ˑw5'_0I+; ORp򈀑kMnuGfK&pB81%kI"qK8C+\w- _%,95Y&F:X8C`:e8 υ yavfD31<;\ 3Rr01 _ X+i^12DDXl)GtFb6dՇH܍d0jggryz K&"wXD$NpBC; =a^0\zqLDr}$ %}Hp’aJ'[-cf}d9Q| ǹjd%2x$w`% )Sc$6Jd2pb=iΥ͙0>q)ax%,Qc;}L08)zq{Jw0O KLMw Dܹ> Nˬ.v&wJrwO~C"0)Fb^b?`gx<-,96HB5gnø`.bJz-H, ܫbr&kNMt)rv]4' $Csa N;Y¬xD&`2\1L09&ljYT*걔Ty+<*:7T-dЪݡoQܡ'B'B z.1ԉ>WN(Om;BwnVx(WP(g yCrVZ%V1C c̈E-Sve<*-`X,$:\(\rp ιVc0 2ͥW 4TFWK] dbEcRf|3,+bY cgd$҄g#|0IeIw@JL$7L>+bYwO&jpIe>tr0|teiS;W8ebE0:Hd'Tt@wSt.=<"v^ܢvp$ǹ'VĢbuF'ǹ"v^JΪkbEcr)0+bK)fbEpw9+b*cK<)cE}kޕ{WsQuUݡ;2-}/lu 5ս7̝* 6F7+l:\*4*d*rB갍 0I^Ր{tP:*<ԊJTX[UNo-[}jDµЭXJTxWzUW $B*=#6S P  Щ «*Ԫ®*e5zG,+?g|*R)0RjBݒMTHNӄ{7+)‰0"!ܿ|#T!JjRR3P)$Fa oڜB{*̧B~*A*,B*:Vߛ˅ԡ/SlTxLTLNS5fS!Ԑ>C( %} 1p =0 'UKzQaQQ?GD~ 'l}*+?O2.S?T8@& 妐o` PPa= Vߛo ilmU Y)T))4()d} 姰~ pV[}EB է>73}W e&;7ͨ6J!~,*[}}8׉HP< cV oPW {% 1Q,r( bKzKa˳O]5eUĕR2Zb/e!y'zR'Q8(R(~=VJ!?"VrU +(Pu0< ƻ*5?>'{R'e_[}I&I!>IVI!<~wG~B 5C ApD M0E Y9[0_,%q()f-T^FCظ3)6Rx;x(7!zG{G!}G~G!Rh p>kA.zZwiH?)QA'dA(B HAFQ(QQQH=aD=ڢ^ BFdZFafrFgFaiF1}+߉ YEZE!\E0/ "B(,nVC(܉B( B(Jl˰%Rn:V9!8C9C!;C<CMRҍTLl(W-Ba/C0Ca22C j(5l[}WUBEh # P:x]TF*vS O!QY[_)}%5 ZHȓj{sG 륰0XI$f쟤KZ )Lbm L$f_൞ڌKnX=/k=k3k=k3\I$fJͰ\q'63mabmڌE9dRIؿYy>L7g깾9'Lڑl:_X{IҤIlU~}n\vڬhP[,s)|PPRV[}~V}al6A A[{R.%)+[[ }2qW)gdBLǦ*Q,r>>,l/I(+գ@A<_Es'{ΣO) T|{"ʗ)lRz՗M_ڏ2x (b|3ðrb[''hě_YA7Ң%WY rmSHY@KRsG' ' .EbȎ)Rj^t| }wIʔ'2gM8Fs#} +u''9[)Sġz,%8ˢ78ӿvʜ"w#7D䄸:{) ̀\Blw}2ɹHXW_vY@"Wxbx3g*#hLMx%e%j[}OALվ5$o&-M}_qAZ_ad+{w9[TlȊ}n.Eni/3̈́k>x22oԨ꫐!0αO.K9?_Dž뛷'ɕ<}2ci׷ }8c?[~dҾ5ǎ;[H Xf:hY9Y/~j+.оLsF~NR.iQo|Njeȧ8^Wg=o8 7vl4\o'y!G$=[}Q!9ϻ9O\I8O;Qtm(XAp'#7yO8zQ{s+(!< yC?9G&i}+(gޟfqE&BZzNU]ΫRTyu[K.y_D =_r̬YfF{-l_Ldl&aNtK #2{3_%J6 ~ TT}iIժ1mfS =#|hpc/WNO 6==483ͧCUC]jV3"==?a4:#|\Yl,y"4 WslEtBW t n9]s6;݄sv Ohxp}hnpbc!c XU(QX e(SZJ{u#FP12|ٗ`s9V:V[kZ9hMV"{>jBmzh[,[`UhF!)P`TFr+V;-/t5[xpup~ͦ7Hk6UX:5 ut # UAnFUUQA rIz jy<HE,2 Va} Y@ t?*Eb!F1F]ɶdư8qcqwBU'`7^uW"+pqRS2YS8@1;"{Nmaywrg`Fi':a$aA}ک+l.MW7[y|sUHS)zNJ㛢1H;5Xe5Ud:Z%}#7HD#֣2"N_'UY{RDRy}}Uy[Rh+˾21E|mn*Rᘪ~Gp Q}THuo4 ơc:ǒcݴWMd+XEnMR7'o=8͜}xhFP< HSI-^/3LѬ= #zx7xpG>oqDh}=Dǃ8n8ól'8ѯ{p9>ޞ.Fo3ƣX:Y^= ~ߤ țtb{4FMd?ʯQ_}n "_+i;LOa=(8LP'X m_}x7 m} W[n~?BD!#!"KSd?[}O/H.u^wTyO}*-Ok.*YiW/3hBi_塟4HEd+[q;Uޖ*韭y|uR?KPE_?EAکӐ %ۭъ-iL7xDb7ܑjA!06N5EZPoM[pb|i &m>ՑXyԖJI蚂)6Z W5U?Ո{#=Z͈$ol# LkixFb7m3ssj-GveyjOvbmFZk3ϑkk7O}}GxtL}lWֿϖl&etFp${X_m9R҇>[d{;[ٿEc~c|!3<*ލYcOp_WNٲIxclQU7ꓪ-~4VG|Ñ1FaN\T~y˯_E[zG!mo |Oiۧ-V{$!ؖj@[=DiMPUgD?{q}O~Rv/y󕪬?l ߑdq; hHu#oD`-=U$&ELdu£*uW複聁@5=(PVWR Oe}k?px>O'%m`&;So\> O==he6"X:Qh/FqdL=z=mk^ kV*hIؚz Y7Xo'm%Omn+{s ;wlg+:>6/y'wZ3OOn9W y ǽ,sy|tņW3sϲ"Ry_bTl-ƦknUV^VsO9H3F5~?Rc zϠx4d?HVݜ]HEȼ(We),O\48&/nLYjݐغ>e3euul3}LKyʝ2Ӻ}R^ tBD'e?5|1ѽú2eMJ?wσ~sx٬6f}U!eU!eUӖ9ԍ*2J)Yu [vXqE,.*)9Lnd":}=l ǧz̖V=jNf5ABQ@Da$LV}cә͔Uc`##iDPdLC ʱeM 'ԔeRF3CvXCm2C]2#m$wOY`azYhmf:{ȱ>@~o +f#)scovZוZzwǯX??1bnfc=ӭ#ӭìH(d MLG}~Pf#pޤ*YU]V,v`U'agbj`uO`U9U10*SNBk֝7V^[f[[^ ^J^⸋b˔8*Qpޠr/f-/"XͬY_ǽNzLj=<~.Y=,u:FMNy:NN sR OSҳRWR1&>1m9;ҷ~ՖkF&ũ/si_ıoS%z`kz0ףSо 7}d ] ZS!8s8u#$DHG1^1LSuzH}z/KLmѷ-]I?@f芷#6-tsd[Gǃu` f5׏[ЧnF[35Fm$" dF7`G=+Ǩ_~/Oۓx9{gO>4˖N'E v9EQdi?K1o%Oן~:_6 /~!ULQ===PO=SHܥ!HKz婊/RIOד=eDOiؒz~Si{rMD@4D"xsa)c^iKk dFʓz>[O/m #6+~<|SXxo?]lē;OW158Sf=zO Jizߏ|iJH}ΓA߃1UGDG KVc;x`ȕ2'yna>Ȩ^#mC{\_< R-ɏ[>HD}aC*_7x9ކ\&o3}+r tao]~m罋B.ve,X)}ҧ:i7 QJgGJo}Oo-ګ[p\.Br( Ssyԯװ/6܀-Ʀkv ڥT+|kz ޢ#(ރh~{B}z^fKe( Ճ@YPlwV]֜q?JoIHuѝ!VRZFgo#1-#3ٞ^Gzoԋ[-~{+}Wh{}3c{ȝ^<$R!R#oz"T_ω^HDDl$26wʖz%RZysABmߊ`U>c[#+ォkku7Ҷ}#-kBvyZ~@*d)-`wm3?(d7 u-XWX?YW[VNuu9l]e['V3cۼ[xvSNdvx{h':J'9r9r>^Oyr?潙}yfoCl`8M-1wy73߽f:yku!tURhM{[eʉ\>4>Λ57Hkl3/A{Co};ohkfocOz W/QΝǟC{{@"RJT+r>~AOIwtofN1GP%:f$:2w;A-P7򇷃9u-֨)jS5$Ŏ.uwDk{b=(*"6{K 4$*7ev̜ff%wD}eA173yGTG);BRR<}]t*T(/@n:cL,NTK;Ƽ0\R-H/aɯS^6Pg޲v_Hù>z?vԸoeI+9$',u}/7_HoPvUAT2,Rw$˷}:VhNJ},Úw^}eY:VPgekXIYI*UOZR@j$)?*?W֗( WSaPkVM JU礚$|5Ygu+[Ɲ*SzK%VeK-Tyk뤛ҫ[tSB\ʕ:QO]U S"}JTwyt稜Pr6"(ϟѵ]ThݖJ%ͩy7-UiV%T^=A fdOJ_a*ƫp~QK` 2x?\@1׵ #R]fSgn:Aw܉.~t+l Ȗ(شTi)RIf(;FFt*{6SoqJiH$.)]nO|&B*A>\_T )9^#oB.`Wg,eSD_$#hՏR4Šy֍dQz*銔gHqcYΨ2R&4euL'5W"rc})="5PHYRuuTJ ,;lHT9R5tIM+d%wT}z %wT7۩mԍ7MV:r[S+$]ԧiC҇sREKIɷS_ %F_h{d' Sߗ) T/ R4D3eEIKގ2{PX_r×$쁯8YLa8ԟR(>;)|dž?Ug_ږxSyV|'ߓ K).r]^;I:Ҍ}r{].M( '{?S¬Rdm{`r_~?˟wyҍ.Yr}wH 8G=eʁʡr)Int+=J>{=.ro5?~ ץG|-wQzK=H姫܇ , H9mw^۔'?G5 X3jg};T:/ȌSG)J39PS%?~! >zk7s2讠2.ltѐ DC;]&[(fH'+yB8/>&})PެO%󀒹|1l ,CA&{݇ CW|4':P>yS[K- o&O,IAr/+ |-&m<-oB"$(߿=Z_U-7ӧuYnr#y U^r#TU u?k|ԫI[IzץO6~טrgA5Dn2㳿5?]WW׃}x}ދzݩkUK|*PgUGѨ+ZuTmxߚV\oM6D;]FŞҐ7O@f!j2'v4@eV.$W긫^>/u}"VT6$<'x44BTEZHK{cXWU>yS[^@\IqPgG(<^e%Ϡ".b. U&<8BSIɏe.U__ٴ*%{}cB#Ec.9T_r%sScJR؃`}d>eKYdyP5]ʖJͬvPY;~3}]?EK kʺtN(Vܢ‹E ]**,\Rtpzяj4襟FixQҰSɤOfԱ)Х(з(ptE (]0hMavъE˸JC%\cᅮ71RifdY6fd|o$+{UOyo)A9A؃H|/~zp[o3<%{PG;}Y EFQ(x 5Rrm UIWWqIIK2I)뎊\q^ҽ%TISHa݊5IAi"FZ"WtSᵿ&6%bqQ]tx+?&\M#;u|w1IR̷ s\U*ĉ#/fy WZfrrFzlG~?0K#ʽ#h *B2n,8:VKP++w 7#S(F^"+eawusgD-a!7`P^L|Om0Le(ԽR&hN?F<<bFUO4Ez+^rnFiׂRu,'>+.B q.l&$s>2ԡ20TEɹ)y܈;r_Cݛ7z-8[nf`!7\O˅׳I.1 NO98oݱXç1hI'JN =C+bCo@>4oR_R6f cT A\r;6hLSBkȃN>臐"aޣ]4;|m/6xA1Ej۱V5sN+ t@k#h[~pLM3иs]䙢$C⨅ 8 r豠6nb־_G^Ȟ+XNg˿tMY\T&iE[zz# Cw$w);>:oЊ#l=Sz'__9q+4NhA,tis/eyĥMrIp8g{,i'Lm{n>6Zu-]-h}XY;Ϛi\& 3˜Ŵ-=}r}Ց}o.kޣ؝8Ϩ\%{ŧ3Zh"4N>:s/q_BE !)A̝cd|11{F*ϢcX*a 2/hD !: ~AM}^&ލV@$BȀa&S.'/Ex_6Cx#ĝ0#c̗Y3wϋ)p[.lUzBx((es4Eo}"b; J"$(* ώRYܫ4h1} bbUd&}q1L"z(K{vxִՁz$fX,,vCy}b7KȀ루d}+_%03fm<fb1#}9^Ŭ&f0kiMyy ɹUvr dqOپmWhN3絝41?fiؑ%3[ܞ2cF5c #G1ߠ1f4f|Y; నz2Jhb&0P !2Y}r=X$r2wݩ(‰E{913X9;1(ARo 啟#nu !8+2_f͂&(>މ<~VrZH=|lA[\ 8mc&1敀Зz׷wg֮u SKB5`8F(FkmKŒ:O̔2kDsL4D<*@=4 ͹fz^M!ocA~z'渞O?up]oces< Dݷ{][ZZ5̵MC,K skc#Wf~!̚2Q&;Z8VzYI  ͯ2~r[smO\` Ca˾Իg < O)Ye@ G c={ˬhgG%l_CH#fXjcD![n }1 @y]涀2`_o5\#F;)vZcxbFfPMP}.cpp#c\*_pƲe%PdAqCnkmf-|g4"azb=$EtPƀ88M|9'Adcڲe%nGqN1-{>_xsW٠wgE/8 yKXYQ e:LJh?j7P :ƚ?*oa1ʽK L }ߦ]WFvU3Zmݷ{mk͵*yz})̭:g=tEVQ vkCCDOTE۠BǰhsQP[Ơ-7gpy׵wa b>3kZh~!3Z88WJpm8\TS=v.814JhPp5Фpg5QRQE(L@fΣpXX< 0ZӍ3bo?s@u>1ň$()NRGP MѢU({9UHѣ<XH?^u3啠QԟWg4r}hCTJpDѓ;\}#w*^IW|S?&6mz+@DDo},}gŒCGܻs [@1g4?uWB-Z5t|'LDUBeK&V+aya)KeXXn[7DbU{Il 3NMt!J=-tf%4ZeqYX3 ~wX2򽓯^̴;}/61zrFnu\jif2!jdbVee L[wCAFN0sa_tFmo|(6hJHr݃#EeLvf{z{ŒWCF5arRY>J;qYyҞ붡0:6|@-pBs؂@u' .2/?=`Oo?m^ /6tc,@qRz[-/FL@OG0:6{'k c49wc@Kᑐ{td2o[6o_^mfX%*hbjs- ~D.0:[uMLN΃1WeYeP5..: AMf,x$YPU*BI 9$zjY QG۳kex'd7DF ʹkl|So'd;M<kh ?Z ӛ5ZVef%QzfbZeT@(z59gw&DatyG(ON(cPJs!8<OWFv /we2*5]U $zjѓPmk?6:Q.+cV"<sϧYx;A9zTUx +'B UEh9P nYYX!/W5,Gb8}Ns9~zӠ.^mZf01ߡaJNf65 -/E~: Q.& ( xh~*3)9.&:A?-{?^݌-X}:U&ncUM \5-GOBnۺ y7 ʲr=giGKֶ:qMk9 U'Q%}TE%kFFyP nYlc{bclձwxk!#"J )URWkXљeo>jq4 IOWwe\[|=:;`ہVEuةMuU +{U!VjU\ SZlYir!\lY & 0\.fD_2=pߖ}l?saQ^^CmnS.rRUXгm}g>@v9ʣiym,.d؜J>vڶ;N @`q@4Sv] D!JϬUby&{޸ V~5t w*8jQVV 6I_yȝ#Q :`ϾeN`p.xܐ={Ehۓl>|TcVfY!Tթ2^ hi t`<-_3|_R9XTpPUU@B[@mXX͠]ϗbysKW?]eL\U*W]+TE[Q(auqec#XjX!:paZtLjWIꗧOPs aE\Ƭ\/@;xo~rClősv|Q |kY;ɦZbi=5LQ6&拹AoM(PkB\#PYw8{pt>6ȹ;Xyߜ01 =k8+ͬX=5Jz6B2ւYhX$:0ڲ,+csÎ9[̪bt&X=g+tP~cP?JXؔfu.Eޞ<cy2 V( +&>+(8OwZ+KKWxړwq׼3ekayUN艪u=PQQ~PбJԱ4_6+y%_u˴:`>hw}&kۻ,lX Jm]'OFgp(PD [˲F';]G嘩/^mi+SRuB&6at1˘O-\=sYs,->^㜥oR`8+~P_=5W51GZz.>/E1n:jf ʣML,<._`dayGO-ϔ.9vgSgk7g5 ݿV-OJfЖ:wjrc8^ei^<'7zVjsMBQ?Zg~G(&]5fS+2rOcÖoOn8wg^ŇOQ9O,̬YPg'kqO'9e˜U7YZlY,gSMal6|LwRT}"~b\l%bDcc@ z 2dE%K&HHe𵈉,u\k>tFm(\ȫk*.f[I9ױlm?gY 3GڎJ+{)}GZƆY(ٺwv(V{:QQ ⥥ [K&Khr{԰sWqt (6բX-{zn~h艪,[(Ψ (/ .>/uSn&]s%̎s7]JTXYV‹uJ~)XP=Qe љBs/g-Т9gMhF61N:yrP]Uq POlS(OX^Vщ٩^<3nk\|c|Ml鱸~;ظ mf-~}̴BFƥuiU)VzPlTN<xr Jv߰Au"|cB.j#{8(ܺQW(JtbetP<ygLm.p1SLLં le_m#B=>~~z<=NT)7WXJ՞M{muN W<畑1pUUŊMA@Vn~hboMqJ4DAFHPb!{ KKۏ1TB+5C\6CŁ{NuV9cBմsWZ9V3Q d3@Ĕ+ B 4AzJ$CVDᠽ艪2(ΨGǛ{jkJߴ 5GU0ԏa7(. V.s?XEt1Tb.J -/vCCd@囿 vvg(a~:хOb1`S:r #zr ,~ͥ7!%_UɻgKQ歩 P꭬GD=(ddiiȖD\tbhųq׶CuZrLz8x=.'a, pbB#ƳG |vB1c҇ID|B67U.D<|-\wdû_.i9˗Go7_ ;wgEq͑<; 4 h2~sFDŤ}|.JAaC x %%q+nmwqQ]]bM,kL1&;: 0C{/^ņ` {G={x2D&-&gΜZk93ǟ,_vXVڥ9 ,(kmW ߤIEtJ"mb?5a35j.b3,s`a{[=WZ&1ߔ_o.ʰov\k^'Os;&Zf'ʾP q<옃wP#*<.NDGD՗5D;yijd":Iu3"2%_JySS/k ] 7s1o=B :pÞϖo63uѫsC- Vg ?-S I3mC(K}Smcs{kaAf-d bGNƄiWSQ2:M={Y͹^}\cE֮J*V1:ҭgמc7j맋t$[cc#szҞLz EĄKx4'Ɩ=xzƽ(0h$jZ2@4M.{`\N3c_H_)`Q;.Dʙ(NY.*vq1ÄC].3 JDA,}>":b$R%jbG)fD'٭|}P5k!.ۅ,_qaWF>?md]נea9bZ樮*>#&2]THeYP"D f_GEtH;AĎԐ@%e[X475YrHmz(pz8t 뇃_~u&0viwYod^= GxsC>:b]ȱEXS(5q3?O@$-JZGBaT"&MEb"LKhHrgjҲf^@#2#JhȀH2a!g&ـM%!>=dÀE/[10aYe AtCFr!f >#F2GL:7-49x.(I2T!JUŇ#WH0.fXHc"hcâH6Ԃʡ׻BђC~P{.߈ OL•"mh+g9q]IDp[QE*:Q(M|':f0 brmdʙ&1EQ:us 1zI MSVJ. 8(<#ȈDoB* y:66e:;ƻRub) Z|FzƌiTȨ䩬l'62"f,KՒ;vqHluC}se\O1aQqLӮ$1#fJ)'3V|+ÊAE &CC!aH8$!픋x: r&>n 205*?$@ET8ЂB$&4&&7":ԅF $%Y8/˸^`<?]}[ MΣwǤhiyeY,RhG+IE 0d&/2ĸ2xa7Z,kҡ'ߛ<f\"׋e>}PG"'}e/8(oݞwJκV} cV<ə^P700[oxmz 40H}''ҟIߥO??|"L5cA J.^'F_6r]-ほ^ nޛc̆?AJt}}rV3\Cm[wӯZ**h{/;o SD4YSmV*r?ZnGTTИY OϘwn%&>4]I Kz̾?oK-g%HVtVcay0P}3(vK+5@g)&NJ\IL4zOzYc1pWoW%F_xޮ2uVV*By}ryHB5%9)v6x+>>Cgvqln`[kV[; Ĉp;`Tٞ=| Nf V蒒vq7R'ic-c-4o`K5UdLyk^ͣnҊЛ3BBg14> W\b֭/O#LG Is!:|!EfAUQK'cNŦ;=h%yqW8I+*\ sAcj0Gh[čy$q{9 {wn`9&DHrɈŌp谠I~ >>@}G ;x䮃<0byqWr=hKCo`!$t1"љ#.*&dIcWԯ̢G{%.iI6qI foF<#g'==pظG;2b}e;l_ل ^aV._o$--=z-8OOb[>m%+0wDǸBNnLRE'ebO8}hoWo$&"{RF"aދANDd}VPwuݻ}$.zZѶ_ }tg,1.)7boB ƜFϱ7$)z@ ϥ %H!i䃄/% yvtK{vNX[[lq ^&m1:+/YY7R#-(@cM6R)@+WD-]pk~O`'g6[S|zurճ[{{CkmkKVVX J5517Wq=賍};;'`,F,]=xmߘG&M;q(Tc-&[zw}&vD ۹^IÝx-| {nPJ-KȴD1/15<>jOȰmYu5_,\k΢n~A|7cʾֶMs=Y4SiXiRDMt c F|Ɓ?ptճ^uֽ߮S%"ӋDMOvXn)XSaE^:i2׊xwϺ%۹673yD8}YP+x_2p:9{'3;{" RF&U[JMn%1@'A#1}hxx>MDA,; Ƭi;hiխ}0p$FgY8|Aj?Q_yKz$= ,0xbP$7 &gis' b!"#R%jbwJȾǴp`S+Jb+v"$2 PL/MTEoB¨BAe%I=ˢ@(UXo.1jDj PQMP}\ҋ Vp,(y=`@esG](l؎bOu[k EG_JL4p bDG--mGp >1d$*1m3%\ !DLcCC:cfVİR1?9f@u5C7i3Ĵ*Lz:/"UG,I0p \[Lp>JxȠ8ŀ +eϗ7Y%=AJ{K-! . 522.&81٩M8,݈GIyq通qcgF9La&{-SK ]:"Ԓ.`$RQ e,_Jh514P EB[}_tlb2*%U P)fѷ2HĈ!n|:yspkmLج<՛!7d36knn݊z2.@YvO=8(EOUP(PP P ɬ9ޥ-&b>IML͙h}hfs%Vax>}Vleul̤gF>1{a'ML*TX& ZUz;~p#Ǽ6R)phQ*!JZ\KFUR쟽 #u,|K~¼t\\m|#~qw_tZXؾ5A¿F5Ф\LgkԾ(`q->Inɋ>FkqJ+ir)njj=f/όiii(_% AUR%U̲ԪV^ORda~YT? >tpvz6E̤& %YMPuƙhR UOɯƯ'/K]i 7~>r'Xّ-EB*aĕ~fg Wv j2eԌ;tRE>Έen%s@atFm4Gyς*&4ԧW}.gc) ,bӔ7&aGp? \_[6m K#(Im\:R 객!(Ψ.Z= xTO/Ps;YI #. >/٣֮ڲR@aZoq]CZhb ը׊:w_߁謺`^y \8f*%[Ħ_$Ώsdʍ}BatqYXp$py3ؒTl.ޘx!l>{ޭlj+L]e@=4DIDO,FatpQdyl*C#dV>+T%6f1I^w8_,[/}{W9jYU$P3d(O- BsR @21*EDR -3M$L>uin`Gl[7V#fZ @:>;3MRmQx9[e@ ^X?rʸcMUDx;[ͧ}#9jfmYUѶ4ʛ]KyJ FlUtԈ#j WtޕIUAH3oRQDD[FgNGD%@V9"a+^>ĻUHZ6!ʭ)WF ~gwkjf]Hm`hl0ը^ƨڌaw` K- t`P)xi 9WnM2`ؗwZ̹m=hl+-e:j&uMaɗj5tjkY,P,a΂O= [9dJ)VdW|dMY:yzdV( +&?+(X%%+SSWZW>͖}}A[g/X5+DV(Ψ(?l $V+HpcҙsC̻VI멆箏;zn/odn3Y701ezY?vBatFo@y, H:~"+ulq?ngH՛]ZJU֞l,P3 w Zh#o:PLf)>R\ \Ǽ^UͰT=-m]?1jw _ Ǭ"( s{}6">Gy֤SW?ݽ'Gc3 umD4cӆl,GBy]j)D"MZT rڦs;|5yʙ¿ڲ/h՘[,c:"jojOά& 5z61E[Fgrz髦1)lJ!":tP>X>smo=z]IВvn3`R>x:V Pw, vwY&V?ۤkX&]u;{,X3+}׭}z%BiFBՎށ=Fx ʛȰJ*>~YZ,Y˷&GDe̹g\㘔b;-[Oj ӢRcOeȫ)Zk) 0U(5 ͬ%ѳ s<:Eb>ʣCC}.7lV`Ņ6,fJĈvǧ W}Wͬ, Xe=ɤfP Q=QuQ3.%od9ʣ? ʡٲ kEjZᅛCϒZԍG^=[؁,Ĥ"ЇImF-%U)[(Ψ ( .CGUʊkeܳN)!I'xp JXĢ2ij"+1%V*Տ-%U)[($|P4'I- ! xjꐝE%4kT >.JW2bo6DUUŦWR Fc&9?عs_UJ&!(:iBxç~[>MYVLeUTuSkz}چ#EL bRRKP+'^ %\l3iLcӧ0smt~w3{ *:FAVLVL,^Q` 5eZ:xR(nCvᔳ艪2(Ψ] 1I.UU\n]eov;_jをʴj4: }P P(QG΢"* =Q& cH]'P|$XْZl2n\OFfGµeE1eIńP?Gil&P._Eլ%O""(6t}K?ŷyz\:\bP¨ Ȩf.;A6нǩG\C=IPu:ɀLMJ(>\tL1dST:qiSb Vᬲz.tɿz{Kb"XPBѬ(>?C+3N%ѓT' 8ɫgrlKvQ h Lb3l5Y#v苟u_ӇuνC]~al#/UJ%NPZGbGN QMPf]@dT\6Y$z ʝmCNP Ȱ >BSQkݮʸZ44籡qe%CQXx~Jᛴ:YIMZ8xu:| }FT\MQݔ@1%Pl&Au,,q`˳'J+$+…O]ͮ#׃kMK:vinD ,Y}a7gsN dWRإI;z{MHBzB"E! Au]wy>dL|df~O?斎cv֚̑9Y3wpS>vjԥqW#!H iWRp縯to 3lױqkZ-_euFʉǤ``q`<>\!cCC ;0 cS]Y̴3+Z.]A}1#>JWLK_A/oȇu-u^g7O]sеuOWwxWnh[RJybBZ2:瘢R̘鲿.^Db̌<"YI?j,f)e֏nv`q&R"D @/8+ !ڏ_~7/8|ItϷ>ar& V}raY̒r˖ex -[* ,1 Rcs3;L/f 0гdʕDU0qv8AW?a8=䣣W[mV|rXft錉K.CrfKf5|z9bv̑۾Y3wр&ˢna܎´.%psz{'. o0K c 1"1!M|ފ0VHոF8azlFK̂N92S 1@P|=;aaSi!d7%|}ݤ/z ǡCv].uk-XY/*' BYȄLQ;ɮVp_Of#"!U3 GM]6ne^Ȏ;~q♫k?F"ym^8xycWga݀.<#/vF|0V\q\&-~D Pnb٣xK ύ4ĥH@k20(p*19mu i('E/s lÙ9x9qu$Dh;590/MfC-3ׂ8t(E'wxw-Kk{(b(fc_ :x6pߩ; pmznٸËo^rg7X5Mj̊8wI'֞5&>SH͵)_/s֝p6tjUڬ.W=?؆?=N\9s-͈ wEQ_sd"nx;5>>(0̘Ҙ44` G{@xG_-Bpf-X F<_;-k-]'̴rVol5+ z4/N8yq#4Ee,,BBHI Ƙ.2=ci#@ @zm>qaM ȯ/M1rx8u:cpQt*.@ IXbvE \^Nâ(:4r˜讱4 { uX޺ESeX΀B*#S;0,/zf0̵ DG|a$is#qxK o!?AA%wy|sgN©ș9\+_;=H`d)rQ%@rN$Wv+`<%K.B0 n"%7rP 0DXb?5uw~PhDbrBbUx_}ENb?nC-aa;hKh~ nZw#_ geooS/גa2oBOX{ZX7$?)~N ruNG&$04>y;΀جoN 묔j[ ߐa#BZ >"@>+= R9l`De/ 7ιR }r ADrezV7Q.96g7?U^<Wi):b㍓ yDz\i9I#9ÅX Elk?WXXz刖 .n_D*oW!P:Rpu 4GHcDNKjCbfydƴZR` +ӳV2 aC5O.JހK1 h0Vdyd%Ja "BÓ&3c0FȌ>f' `c efJC,!E!D^ xh!3c~D$KƓriY##sA`2_\=s2e+_oĜ{&+%#:^ʐ(㡝M8kaF@2LffE3fc1rEˬq '!.tȍź@/t8(DqY.$@-yGj!,#I2}AIK䊸10"tiQI F+p֕,x@:,(zdAjP2)i3 DAcMh\10PjB4l'c;t(g91 ח)X/d &,M\}/']`:"&2S Y3w @L@Y :(639P9|*u1aҐ)*W&!(􄥒Ǖp˼% ]Df³@}N CtamUr:-I=W&FaDJiHH&Hqz%"20qC |d`E!!jgxLܙV.xI&8=OL((?%/qr%M! (̩9%9+bu92ԮȢB!(.+`k}^ u`]&|$t]^ѣxSN 0a)q}24xIhKsB^`7ʊB-`q@',DTi`N zUe9gŕ$MbW+B_p@Y>i4 W؍2vEҹűL[XWv0:8k/~Bpp]avHaÕ-îbWئ񁅫\>ȃ?,E^id,W˕@alBv6+2x%swrUc?pEW@\W+ao:e W δɱ $R_rKZXة19a .$'ҷjoз+Fr?,^)+H KXZnֻk_bRvZ BT鳃08ˮ w W۲l\Sާ\iUQURG~Wݾ?H]?GXWc9FhuϑW?ur ˓Fsd}|K/J䳅| ༩בHT`rɧ(tָyTMGMg̰k|S\QFuD1ЂeS{]!qd"0(7=(!GZEths#(\3 tDh繉H^Pkq"3gvT@Ҍ ̘@! uPv`PiМ4q.yE݋x%sM9Pփ 2Myn;pnH GxB>G = ~Ebjs@9ρL^fH$lX FۇX`+h9ρǜ@G_V=&M\"f(ֆ68ρrr$殒y"lRBd,1XcyT-Z.ҷ= _YIrcX1Z7z=}efBaNW Q쮣e+n=|<$:"y[y]tY7^Q7<0Sˬ;@h `]4`%O\aJ<*=cD%W}L%2p֕wDN,&7.!&7?rvUǤ$pwB<g2Maz"|AȋltUc Cryj8ρ*ŤRa`C/2a6Ⱥ6$9\ȥ&jeyw/O4H"?$|ɟG!9x. FAAJ%| 9.9P.!X cR5C.eryqlz#vIJ}(q0ΐ$7t9ρЮe.+=8yt50-Z4iy[H, D)'\f]Cm#OyB%.2QsP2f Qd Q94ܢ4v哦cX\KҘ.#ٜ!4h[NY-<5nДZsxBVԢIHC:s|1Ab)@$W rТ<ʇl %lȐEs|.'d)Y>[Ӗ8ρ=E% 9P>%o$ d )۪@*]Y21fغ-3P3547s(`@HB+%m{peW;XUVI$+!W^PGp`5Hڎ}4v6 ʾeuRsTvৄ++ s%]\+ (vm{_ڹyg+&?BS2qQ ٔ-Nv邿/\Õ2'EH|#IXWd)bW1Sd`apmCe9yԃ"nv҂y$ܖT w=Z[<ʸ"}A3zTgԶ|uƇD "0x\pA-Y)/oNP*zJ尧l1/;߿_J5>#8\?5>%+dXCt便}'-Zh]GKZr\yTQ PȣݵVGQLɱcjM{cO6KPXULFL8%fZf5Sajx-*{o-:ki* :r\`bVW?Lǟa*r"t}biHD)US=>i|SPeBC0LKv>I'GmDLz:PlFMPĥ֛9[/Yf:v@y]`#ƨB#+ŤTMHk8k~㹋۬Xn Oa:T H_;iY!tmePj= Q*4bLC i fo4w+ַ]iɥ}gcp[OmpCKEWV-yF ?ۯ~dSKORHvz%wk|(Al i%@<4'˚/\aϿV]OTH:Z*VђUSH.i;3UC`ZM;Sv.Ooݓy&@uVחsDJ1mB!]{VT'=Tek ~O$m;nUjp5| J)(i >|6tu[7:v"[лDSD4B7R _r ZMK&.y>`:RcAM?O +j54jIsնނTo8%jc ,l6yu:?z;oo`Jz bSKZDOkRHZr%՘ҤRvUGuUDU!&DM/nS_yG-;͟>`L%'kJtJJf #E%<49-jlm׍[m|xo)3Dh!tҦT\-Ǘ5jkL1|6 oB`H15&aHW TfRlؔ36(`K~7xĞO𧨪?ȸ,1.a/=atӠB$vKϽL5LGW169U:haᰝGG9?@[JԪEzяm#aTMROpf 돾y; Y1(;W?tIg\jv6!ǦҪCCn}-h!2 SvG5~jIv~=psS0=~/W[|W}uO0E!TyKڬxWzop=#}Ӊ'.l<;3&US˝QґBhiZmZ'_0i"|ʧ` ?Jc`ezD0ݾwScPL9]T;/HZzr7ThlZ-]׺y{w}<؅&?LJwA(&˗;9V]L%qc 2paQH{ [-YezJ٫S.}?7LAܷc*%)? "SA&zړ[-[~nݲSwxWc M?Uѹ72кT]"u'~nu&Ȗ]yECm8oIۯDK_0 27Lǟ!ѦJEKB T+i˥k:릭i2>tFw[µ'ԞJ넟ՑnGGbCu#A(F|E#::aЅ]_o7LmaZ(JJOհnEc9ptD䡔\lѪ568x!H}X=%QcY·P'"vb ӑ\U.i%USWg:XTXpOon<'vK;DR;4cXԛjKZj07D!8>]'-TPMYSY/(_I~݆vjQ>C"iV qk6mm/)Cg`:Da E`PDBZFCgO˶s7Ōвh"-iOs]>x_ =su緢/KS_툟aʞ:Z!P#xF:F4{=-UV+)WI[׭>$?ܔdἥH˥:>zEIdBNSމm0M.fOy_^' %БzUYh"NnuONzgO\ L:_]tڽ=G1O*?GNPܸE~Zd]}"LJWeFOF7<)JJB]OQcRjAڬ܀xGIG[JqFŻ1Wˊ)ƕL[umjTYl#ʾ/Zk$d^ n}ZhT4F"7lFz u@' ()&\1?pmLu=idS()ɢ޾dQC`vPR\vYr)0%4 &OS%iFH7?{O=z>.Loa:_1e \z!UkMn hki _ŇVԎYk90}C<13+>{dT[+xҨKxQRuO`*~^z;l_=M#n<;XFIA %t]9:*iuˍ„&n^&*Js4[ nd;5ȹ_1tLnx;cS{ҽBoÊ|c (@qhŇt#֙un>z*cCUxL5V˟f4<);~1܍Xě$ߦݎ)~Dҫk J*(%PV?If( W/J)  ko5 Pe"Ϊ3kAk~G^ق q sb '83ݸG%LL)LiaQOvljN0|jv#!xU%WhF%V#&Q)>gm/k4l095F]6) y15)'Z;Y@fKşkW jGLg nsůrS̼#G pu %R#sAhpHXr~ѵi; ?od40]Թy+.B X%Rb$MWe-MdȨCg?w=[SHzK7#Ӿ#+6L J`*%l73z Vm X1`霿}fc_E=gfLpZF)V`CQ,{l`CWTDb{FcGI1$}_8~q0yugg0eϽ燐:=>g фҝf/l7B&i̱K`ɫIt E1cԃ/Si|&GWc܁9ßN*N`(S) \Aq$ 6m@ L#4 uPT 9$!zD΀GڣO@TS0 sԋ24>q=vx_ zʨ*R!X Wt]C@m;} mE;Q>R>;2 nT VYy鶼mi0WMDt|@juz2QM)sZ= #)3#"'`ށ[x L<{3ڣ߄P;oa[ ,ӈ ~d3jyz(h6F_|ZB7WP»*aJnOE ~'&4 ,y=7\퇇<~6 'N|z+(P7SqNO& e9_*RTGZG: @iTpB?NqdmrI#&Ս:lsi+{wN.' )C^z뜊bH)L+Xj>AêQ)c_- kռCM޼ )$X LV51vR%$ =NІWR7BRfi>+B;-] 7P0{YN~.edSvSH $4[*}E\*^KqED厯6V5@  ]܏=ApFL"sS"">](z6u .7Ne_ _ƇF$ F_%TT/nXˠ:1S0:S٧_yZ"1XVDO PP{ ;J4;J]Õ[E<#b J);yn%*ڴv8}Oq:=rW{ΩuHl(xZQBckF&ZL\5pJɥKrzCHMw<~CԾpJ{Yk4>%e{D؄Dwe<"rJJ cj.Ny8ӎKV%;m=| 05 4?"Q3 ŜF+k2Bs2;QH*١JIVoRJĴFN893r$u6[L Mm.mnaQ [f-l3oiyf/j4q\Aé:W t;Qj%Ōp/hʏ胾 gJ yj=g17Ω^hNBfaNs܂fo:}N< 1}nI$I&,p9* ZM9U RDx֭st. @]ǁD|wiW_WZtTa2z4n(N$-^#p-lWqxصhcEŮkjū y~$#"- -hR;1T\<ŀbx :.Yɻ.[ێa˂`BG9K\pfaM%KLr"ED(%B怏ju+B_)u+ ՛ >|^0b) R)-$2TtWz(Lg1bY#[;-Y :Lxs;z֯dwU[!O$w/{dm&QSb2@xc+yJ3LkcW.Y9jW1 ԌJj%,ԍOv Ƅ,< p pͼA=ׂ{nE!-|c/џ_En}1tO8EtMN9KZ]اu2* 0*4X=V),f99=rq~2&w-Yu+<N'ΔCG5ğb HyC%9%%wY`ocO~ |.?I"*0j2;-Eq[] KMݢPh訃JƟxǙ;u'$E?OѩˢW⾩پ4(JZ86eS6N| dzƝ>ǯ3+so^i1yO*Hɳ:`Lu[it`+nM~ 3 $'pz:]'P~Ѡ|1 (Jy,2KX߫x_2;^ɺ)9POqzJ$!}.+&V,Z[N {ߜq6B` !4y}z&F9%&pn#7 /?Do׿A}Ʒ޴Ԯ>8{{{^&>vOaNs&s@mtXZE@vi̹yA! ~8ව9л?_@ Vyhs9]+'ϯjb%\yLh#zA ?߃tz& 8=Ild5hH U+zzp40(T|S]Q@(ⒿK^J0G ^OퟳLB'gASMĞP-#Fuu$'\!ϡwF>\"~ƽ7 ZuⓁHO*4RPXjXSg @-D 'ȡV{J]Kޗ+ W. ;ty6@ /Y/F2+ohS}7 ׃ֹ@٠N|h~\G{i\jNS@y@ -ȃg9-ihHnŜA1Oky]~ gȮcm%<ԣ3kEOՃJ啁@^\ot0 hȇqDF׿o\߁A~2s~_žX~g@ ^W@@EŠYBPLP3j2%Pcgϴ۾nt8k>hWm?H߯ wi轧3!'`[`gA@e>-ԍO\Rj%ə@юց>{N'9 9$QH Zȝ3y!=S\T]yNyE,"I/^e./[%](*[Tdf'MOb"z +/^yTwt7WyQN#6rnL^BE 'ͶOh4"2IjL g/{6SjX,r gi5-{sbZ2[Mm1g?{Bkܩf q-u szNsg,^5l}Ze ;ͱKֈ6uY/VHd) n9#ṔPrjT#(~qӚf8}>?8 NY ЉIDL*G`*uږu]H_˜iY+)$X;&0.zR)ɳfrwyu**c:e Y280贙Ctڭ/^na6 սCm#? VSNLŔƹ+Ԏ1.3EVV̞Na Ԯ e~gХB_&a!nR W 蘜<%#oN?ɩ%7|H2kWVӻŽY*O8w3OYrHto:5!9YJk`r9Jq 4%yYAS<nu?yAUSpSDbzSwÊu^nN_li.j N틏2z8loNԟ:5|im4[dZvJk>|85Z80XY3g Z 54kn\FO*;QoΟQ}NCkGb&95Z8Uc'*m^+4Z8um|pj> 29[tcG|l"jOIknN*̩Sf43@u-'=?w1 N2aڡӚ&;ko>ԔP#LO'lhf>]7"N5@eDW6INˌȲԦJAZy47vbܥO; =(GLNkF%:0le5ӞL}͵=]^ieFM5Be8e2q^O9>u=iۉ4 SSliz\V[D"9kX WfI7*/O dlʙrg5@k|qtO^HVGz3\ZISN[ӛ)sij@ 6A Nw3rj]rʲLw.9yY Fɳ\-i?W>?e`޷) j!,X T% :ZiumXHжXᔕ{_+9=h6QNm4['ւ,Q]ނ᫪T]&EU#(ndCJF9WtYu;27j԰(m(*n=h}')7VHyH!ڻj J9S҉aE"吚"}kKV_c@.sSZQuDמJdΉVu"'5┹9gQśl=8tgfOEB +ugM LBb/sg@?}B+,\صT7FHtT >يulSj;tm4S3Zz`)8R %W^8SP>KY/FHTTE:ۇ::jSs |VVB ҋi^E?.;gTMBcb&;f5U ڴg}<=93!eNe$J;@])/o.~MYtEj,Kڸs;)Z| CpQͦn1˲U=y} |~/{ vUN\`:'vi(mg9P딩PL'HMNk9yN~Ϣ }V:wwYCN SYE8e , G2HU~$ʢZٔSzQD%aRߟm 8^A d`tt },j&-jG721mvK:-nM{?'yn&"Eln3H!"Щ^9# 3pZW--|&kcO~D8m6#G}tA(08nVBVPnԣ|!AB2COm\ɺ!ظ'w0j>?TS(tO@IƝճqd|{0jԋOjц8-vȽ|>_ 50jn2oʩl`><?(:S]>RT9*XUCD =Q;Zh%Nn;4y;~ߜ?&$.]3tN//h©υ;|-x+*T'*tO ҀV/c HZ=d)jqr$@oلOH&-m=;5GAN~]#O*jSC^*C{O&'c^QO2+٥:{NN<}[Ј񧆒ta=Rv%W7tO;+SLg+#[;ѓ/$66͜/8yFNǟEN-ԀDh^uK%Kg޵ Ɠ*xelKйq/^pAo3if*SБjH,cQ 2G1b@_BE' ?m6]KW(8`sEmŽr ˡjv#Yԉl4eyiu?tܱ8ӀpQgp r)NJ}._e:)CO~zt꣺Pzlc6MlHУmTHɟl܃'Ť󿋸}̃A,7?%J*KܿSVd8>оT ׯ穥@4W? 2vrqUbAS=r]7#r 8Kq EhP }r)YPsOkKOu16켎$*'=|籏Us|/(QƠP~9bfrMUk V"-_J_'uZ<ÇrCZ6hdU[='F>?y>/ QqN HqʙK)=($_8%4~'ڑ Ӛ ׃k~xԾSc^pӨ?ae8M4WNw :wTLbd@՚܈w6ί^Ck3q}(Z:X WG.L8{" >crOq)̏SW @(p=5S(! BkQQ?1 ȹU[^^e'3׊Hdmmm3gIOxRU w߅gĽJ5}p 8?x4\+cF Ԣ$Fҫ`(Y]y+%rr:&N'G?mmUmc56U|=N]x[ +E*N7N/MKlUU%CTA>5;*jE<_<,6vT>/ee8b=]+r=Μp5} >"'s7!4aw~ '_4N V``p9.slDkB8)j@"!JH KlX(2Ir_F'=|~[~n|n2s2M'A`8=S~1_Ϙq@h\{v *} VBoN_zq[FƇ?0NC<﫹V/C5VE* 䪛tR+WqȳmGOC(tg"CUBGyYDԍjB*+5ݖ“? & xHC(U_N>YF:*1);彘sNDat$>qܖYyPl;pˁQO3_go\{x?j'U>=<,x뜖!Qc1A_ za,aY9 8ViЍ$Uxn}>oE$.JtXSt3H' %j<->9y^ii=W}:d;< HI* #sT\'j-SµBYW~ʫz+t@&2$'WŁҨAêQ)cɪ"ۡs ?)^9!Ճl㭂cjEMfI暑<W/RDrAq76+G`<$"O/-78^A!15%ͲOj3wYD+7z~i=Ⱥ~ґy[y8;NBeUHgd*8wikE%~kLKL`L̨;ZU\#,N mh,OS"W"eZq8Vr,XW}wQ 'OgBÌv JUS<)V#6iUӚ ;&$צZ;z [~9ayRyx+;@"MHtP&WwSNIiz3P\ )t9gqJзdg 9ƞ#G@_#J&ᯘheMFH~n|XfB=*T`P%;T) ISUMJhZzé3'g4tFN#órfkɖSly%,WQ<1@V7$cf lɜh>D(ddNJNaS`Z_ʑWN1&iٍ26Nr9uL8%"b>GȐ)D)SZ申˙D֟攳T=z,` ^yBn=D> *zӡq?h & E9pDm=pOE2l/U S2; -2дXfVo;e66KjIg4q@V[̈J'@VY>ː+OJ~s}㜚:ShPYF.#kӜ-1Y|N"+wL[/!qRɀm| ib?#VSNB4us8|"{v0tq ]` P?zpQMteh ܈QH[+ F[:,^.5l] k] "WA*HZGpE>Z[Z vcx'7=N{W Nu\w]Öks^[ޛNϱKD*PJTVRRV*V;7)}ƽ`ľS@"ϥRx[ I"~eQ]s(C5(./bĊ"F vZtd=Pv>kwZ_^+CH^ȶۊM. ;nd1 N*W$*g ,&?)\(s:&,,(5b$JX Ri9  ;)Yx@8+ Ay zA݊6Bh[zu^lyf΅%WnQwUAJUtQ{fE@B"MMJEGE8]μw3sۿֽkq$@rL֗6''מc?TR߬t%h-Y1yn+ x* ,MJ H.girtulA뽎1_ |g߄?%6i s&L_\A'|[ h@ٱ@^=?tѓ~.'^}ѓ^yoo{z6ofTgZ=6YԀX7y?¬̩)vs(I6(-N?wB_#CHD{IwJlMH?G)& EK^1rӠ߱Zِ7>d[ =ӿOTox]GGSu|fw81*6@&o$'6TE)!c闡o1@;|"g ,o~w!`"'QְATQcC1FDAZW0ߍ} yC~ XtN{Ӗoo)5|9Nil<ٜ|35~9c~5ԧ |=+3+ӎ=KԽߜD<,,R߭ϼA}0 ,J_; t[Q1)Foa׸_??'^ᛌ?JԍHft?8Jj4Wc?vțXOA]h7<.[Qy Tj YsAKA@w 7@wx7?f̟+qrNzP?ۨ Wbo~Q=bD”Mߦ|pşƼP; 1w& ׭B]5kPq,(T6TTr|?EZnKt!U6 ӢsZQv0>i0De˖1Q{o@H%ϼ0ɦ@{L$J# F L-{5Ɲg@sy Y|}j3;a'?<;~'0_S _Ӿd}w1[^uzww>s hil-6P9k&3)7&Ns z:{vjd~Aܫ``x/t3ϋ"r[8jPSo֟LO A^ @'ٖ|tUSf J@cx&eenb:&@2Up2?;~`Ww~ssǴlI'Yx0ԧ׋o-=-Uf.M)X$EkQ5,  ot/ t31?ENpz}< =:%tC@Gv:KׁcZSUj߻ (q1pۙρnC$H M(~PqѓEey 9IW%iF qL|X$Ť zķ*QvKr-:K,V68FI2wT못Z׭Z?$y˧S;"qIūrўeZVj1&1m n܋ٺ,=J Usj v^s*t֝k앍XaaQÖ o vaxa;'ˁ^y;_e?k üi /4 2oBu lH]sЁn1LYasA-# NlF`nmGw90aᮍ{wĬnCK^w/o4~cfgZГ6-%T%PohtICfdH>; zPJ4js@NПRjjjeCԎ%Yݮ7<|l}~mOu@/sU?ʬx x?B8Փ(s5 +4,x 2^mNr@^HVU)ӨU;9"u+y]}ǨH=#wn@s޷ P>1Cc79:freF &!=R.Tv[8 &3*>HT)F*a꨹L^nAGVU)h[ĵܢT9Z39nO iccTNpmyɰ}%qy f6R⴪{U!1*@qF%O2[rz\l>j l\uݳ0kaèy>ͪ*VU ߢRk4 ͲC;, k22dUὅntsw@1֗BQCucw(=!#,xnzÄ.UNgG.SE¡eP0FY{-{ݿ7j" aH MPYO5zi!b%Wv`RC4¤\ϹusZ$C(Y{Э;kymEE2L}W j[9ҌXy*_&sڍeO35}ƂJhMSȕ zՁm<|C\p q[ ̲ᳬ {U4׫q@ R%}k Tr g~QB<U/9K: U9g7>?\p:b@9:/z{3Wk+ G]M,J9*eV#שD(/QK`SUO{Wx'NԕQ-^wm9MC|}ŧڬeB8j ~$r@{B!R|]maV ~rM>⩬V`SqL*Pȥ?$fQDh_PDU1/ 6n/lF $j):b.wŻ= XQ x'Dwr3sS(Rȋ)t:~~fIiMfX z?=îJa̩lxe|=~5_~U<,Lu4}*xD~k۸knyjȩ; rm0Ȫ=xB@$E޿{64Zyg_#L&us*.E+Mǫ8 wm0Q7N:7kPԌŖG a>sSc籇k՚[kk?Vi,P (ʿmȥs{%AHFmͥdQȰ@ ):XU5S5/c":ÒH%zXUT!TEQηBfTQ]-AT,bl1bYđL+0 m5w!3̌P]G8Az㮻 74bZ%CV0d{T%)q0XnZ^+̌b@`)N!Q0kz MiSsb>I( 9[UJ9UտɹY.x8jC(QnW BR␴,c%||9fO#_ut7bYXj;7ħe5yrD6dUS˪=n|:]d9ϑBUK s~L.iK˪Zk,5gf+oa6ucaXONkot;N inנc`^ՎLX݇4c>l\9DNezd64~w+'wbż6Hi ^ ;k[[P `#`yaS; F8N!r_ ƪi|hz=<~*~aDkf6gqX3 G˖B1-z}֦^W7vZj\fM 9* ۊ31ONq!S)_I4VB;C+b0|gwLh<=b (ϯa' h :uںҀ՛Tn!.#|{є :dU T屪wY(#qZ~*rDv >|͹<6Ex71^k]%ZP{rmmi-ɟ'SBH l+[׃1I%) ZQD 8fQ( D 5TVec`\5/kV2] qG-@$7V=%U6!RkǨ,[N(n]2n) e֜1Ҧ*sbmʮ緑э붳q{\#̊`(G,y:q雠X R(8mZG>NaPO5󹪑0[!f:t 8EiL\O( ROO❾Rv4 @Zh|e8-Ho.fqȓ`P6T+׷&_wECS(RuW:wG5X!Xp*>-pZq؄%%㩠9Ca"}5(] ZR/VNd<$-myjJUywhzE{(KE9D N9A7p,rQt(~Yn>l8bLuqQnMXM4hZZ F] k/` `dwAnLN aArV l}7 *+@1UTajJǧ(ќ2Y*-EHJ, ` p"`f|f/Y5 q=Bk5G,U`PaSW:x@}{VzKkt쪏XN9*tG#hΊ<(jh{u+Z5 +ua  "7p5<}`NYN@h(?X+FTa0*hlR@ +eV"VEWX U*uWOT@HVOޮ +j3ֻ9[,:dO/SUE‡ӬYA+ukZH[]9@eԪT?@EՏQ_@)+H0eOkI_*ֿ$Ĥv,(5Vsj~i2ZkMUN}\U+3PBi6BO˸.6 0 NGͳkqae[4i.0<*zѪgeju 2 @E5VRe*| p8u>V2ƢB^Um mH5}M9dV W1`N/4b8hUÊ^VK+f,; v~zH ;mO<®)p*eЍQǀ4l^,EkULtʠ VB>:UUq'ó(4hSQ[a+ӭf-zl27E_<_@rT~\j4b  HQ: Ī**H3H(VrNLliEF+ASdT b0S՞q_E{jZ;PuN@u|qz4u*u spV5KU7 Ut\cXo1 6UrTJ@~ s"ը0?j-%PMb냱Ph )Ί.ܜRM:&~h٫33XXkYRV Vcq+UNU{*NeU DZFt؏(SU"O644lV5N_HQ{"j!vlW!Ue*)-/<Ö@U}29 ,Rit-QWfE)W JUD*TkV X0[9!dsGh+ ͆V_Tf$=ȩmO:fS OS6%{Nc6^!TTU%uHOE#eF%)=TT^L܆W1Շ`!2 Tz,pcTT6ԧkW}jiGmT8Uh`#CA9*6sůq4骚,(Fju?J`eqeS/YMSE9|@f`h)%pqJZ5 <$ݲmNMeŖMN!Vz  VRaE ?"74^*jC4f tXWbev}SQQ%K!~2gO}?J8G}SjŘM/c>H"L7,}e0uֹW`A0Vc*?2bhZEǷX_oh6j,]+}gSNtRi8Ng:Ъ(ljbA,wfQ3Pŏ. 4#}4:)-}SonO8%N΂cʏ;NmeΞU:U%]Hl%71bSeNi/ *e5]I~ MY%o!9[i_~'rJgv8EL[f8U5Gr j N 2i_FQLY}IϚzP|OS\_k?p:UL*\(~=S9-D8gP03u->CE2 h!/T━dtRTcKAAeOEuNi ",]72mYlNǖsZ=-Sz(lNiKӠGvzw:-s DtzI(Щ 2f@|ui٩IyT~~9(q*2=%SqZiJpc@Y{JR2kOSSVL|tZvzDZ9 \T~eǞ /ri}IٱeӲcOSS`kS%7#{ˎ==͝G1lFx޾BE?}J'V2&\Twb\k핍Xgga_l F{l{mJKֶ^ъZٔ#;tt`j9IH0PL̟mtQ{6E].`%5A{m"-ZXwK.hD\y$f]`;i(𫋈5~$?0YfL+ f(n=κ 2:+H[ҳFEs.=3Ijw~ @f/|,")ZYHT)F@~~:o+l\R#PPe XtG鴷ߠ_E7Xmڋ]O G;nrN,UFx &fZz%p=$m(f,x r5.Ȫ;Euz'G9:]Dda "+IiVeGmTFvz{`C=B$ 2 1/,5o`OڡmETʅ<p،Y-"-&3{ct1qUTzOȪ+@#jU#.{0Ƶ\~ۖVSh丁(^Ԑm^vr:m++ Otv`w }lin/%N9J$(5"TǨ %ITX4FM/;Ul O0kaèyf`U* gM5 F,,:tz85yI[\Yj|zQJ,\1(7QQCuc(=!#,x2X/4a_ΰ}/SEše<-kAΊi[r ` ?€ `(z *Oedv`)O[/1}Ƃ:hMSȕ †WcSּ(?isÁ,|Zo-=V&?\m &NES2lAZT ?Zh٢GV=œ˩MSD jrwtԆN%0HYYn@u|6wb0ᇡ@Yl!TR 2ܨbw YȬSɑǫ5mnupJ먒D62UB-^*~ BUO{Wx'N-9!SWZDV )3i]G[Bu_m)X%`@h-S[)pK" !"El}gWŌ,F0c0}S`Nih0@!ЪzD1 dAUt:;Pi7l_BWS٤訊*rK0&dyRe?t)E)E贛"FŘͦ]][m hX|\!S8ÊS(ˠ#~zjF xNYm: :T8lknyjȩ; A=ȪgEPf_c[ϼu!4X[~!rh-UNc9lqq*F`69$>71#8( +XSȶifOiBx҂`qVJ1@IT!* ^| !diz@%AXەْH/#F=M9 Pm>C 2qi]wyT#ՌC_qʠ > j&O)qNo!TZ)"L6@[+tQ "U:6)2j~y$X#Ulw|fœPfY!(xXUVUit4U===R#&,nv` $eeX`Aih㈴Lw#fȓgqq2(#&U@2ZR+B֋~l5 8kre^ E4VM2s:r1 :k1P!P4$X=mZ`. 2 }Ԡw,5˰k|i X̷*YUTŪy{>.[Q! l?&GeU@-T`^L gB3j70ں10\''P wpi̓F96}.0[8:iF$s:>XH7(V?=1hJ(Jd?~y'(P o0z.ײ|*r  1<žpojdlϥ@T[TMyX|:m꨾EU ; _3s>ƚW8"|\l3J{["@Z#WF/rlAc[qbf:K<9 `ZR$p+!N ȡ@Z1MTl MG‚P5'@(B(=j4 v`A8@沺[H `1@*5w].RǪe}P\8-KQKQKHDNI CA_?ΣP]:0Ť.ȔnTi H{ײ}-"~%ZV$\qA+! >o]UTC(Bqkf"Y Z"lL`Oc1 0zXzũmjUJM  sq@q^w4?Tƪ糤ʦ:TtǨ,[N(fR 7 ml͙eie=MWa +Ml VwkBr5~ݨt<6uˬZ=rvѪs)2EQ$NS)4q&CT9V$ٺv°Yc ^КƠ-G!,Fa2} 4z*ߵ^XҪh`M,N RΥ yjY| S"<⋐jo6RnWY " i͠k׺*>-`h1/M`׵橠9Ca"}5(] ZR/VNd<$-myjJm51Q9hiUA ؈(:$?J VT*[l~ i,@4Œ&Ʀ6()JQ uW %5*0¹c:~C5~ Zo~<ձ*9ztնmP!!"& QưRFN0 @"GO hO5#h_8)'(n yBš- f1ֺi)v9aE^4Q_IL3-հnlŰrH`h -F@`{$Ƒ*A\bHSw  X0 P``E+zKz6GhV 6`.l )TmNq0"X0 US,AjF(Re0B 9e:>ehw S@aEmON `qQ:GªrN]qsL{ZHW)RGQDȶLכB'^+EW^+8+dĪ 00O{ij~̤9 Un*`s4jH=Y 75$簗LH~?{^Uz/wDHhi%HA "@訣37;;3̼?94In^qC>k_F->0F*pAO͎SšK^j9ݟXݑ џWv.Xg^IMyz~7F!kVֲΤʍIske*YmY3g۲#s*֫>nW-ZPamM.jC *ָQ 7)ֵS <i0 F*LZe=YUdTA?l5EV"*ɠ}۾8G,.o_@V6lhg$(%̷+9c3lP(KzgE|sv*eO @Vll?{ hJw\}aׄbLjXcdI7zrxU*@Kr+jk3mz+UZXST0Tu8Vmrnz~6c:8d ,: ʒ`' ;qosX 89$4A<9cҗSern-TVX10b' i4 Ț߾,k;yvJe k7g=0U+h}a_=xq݊ϫ>JvLU9Ei#ڈ4XyPhhl8YR@V|BϯNlp6GU1{ULhb,pb"ήE9+7nSȢiHS_߿bZƖX,;^Q`Qņ=:g`i_DO??OTig_콜MZS TҚ +yfc0b"@5p)<kΚ [M/ ?_xU>2UJxVa7ı2"JĪK;kxϭ!f~+V:klE&0xͱ[n&eW4i4%D LM-<taAVbco.Zk{UJT?g)/h/%+ӳrS#+5HY`t{ɱfWRSf%m}YYϡ +Y Xc}N[m֊|],T5u⪜F/if*L]EgԣZ.VY)6v-Mq<3kJ4^fM+j+G+;^&Wx2,ʱ0U֯A%$ i;U?ujԼRi wUX pPfL Պ]<߀+9kpDS߭+ U٪-[9&y{l\1HhtMC۟[K}UyoyJ6gSvJډ/%kn:v bIZ3[ťNY0U>v eӔџ94D4SYDٱ$^e `/<>r  VƐNOc[.l5˿QEdBIU'WM"`ΚhMHTc ?`7|Gz5JTIVo+4‚Nq6ΎɨRU$VgbQӭac[S*TTu4R8Ly*UlCx @Tଯz(4ڔlʍRʮ'{gi;:4 zz:90`9*vS=JRUpYT7|-q6Nkת״V59_th9 הX4eZ\Zgrۑ*yTyյ᭩fS:dfSSb9$%$"lJ'9+2jJ>|;-pMOMllّ*J,Yuvԩx ~xnt֗3g⏝fYڈj{A /ZusSy>]S%GVVTq]7tf֢}Z_oٔdw'K@y?TlkR S<Ejvo lU?u#_ ;oJ+ڔL8nsf5u)iʶu?ua`!)~+55՜ߦ:`<ٙz*C GS Sg֯ePKU'J/\д5YTʯ\4%"N5>}Sȟ^TЮ#*~mҴ2)6jfyQ NS婾7ү`+)*̍?<TP}R?uV]N~Bm^_`? M2T>~ƒW„fNiǠL4ĸoF0ͤծ#zewpQM Q<M)hULRTY v_<]p|4,4* ;u2nEiŕ}O*P|;&E4ȁhA?=ۆ \i̚? %MY*!*>~b_*tn7UvZHK|6YG}d%'5)U)(vtdyc~=JPC-vN/S9kʳ؏_ EM((,Nh>9iwݸ5QTcH_N;eY4 s:1kv BRӰ)OL}kOUS˭31SPA|jA!K=;iT+{[k[%9+{ǟf/?8bل]ٛ[2j\dn4GAc8$g]Ӆ<% _?͈)Lf_/*ӿ4;ҢLugٽ2HY5f[y1?q$yk)_/$_Ϟ/I~J77fw>|9y8's:Z 9&O>g¶;^xc:o '9+;`}~{}d=y4$y݃ !rݍ7$2f%w\vϚ;9ɺ$6mx/_m:x@Z ؕ#ԟ{5, /Zxݶܵjݫ$?g@=ګ/y ng{3`ͫez͙͛= :}پZ !gxeNjAONan{ghd 3O9c2g7w&g6U+t۷J%0' ۜnH{ и3g5sNp}P+s}Н^[K_=e8$P-[݇[`wމDA~M9PzP}l~L70RG?aiCޱPJwX"7C<&ތa\}^{9dٲ%LUo;@t\]Y6@%O" Io旟ENN>x֊D/[yBt1翪]FNǴ><;y䧗m~b#wk].rw"Y G۷%pGo@peK_~<7wDyG(ӟf9U#z:ntm|LLay[lWsu_n>..?V;K iC ^rlMΤ gi; fw4_ z^n~pc75X`3@`X3 #zg$bY5 W{UYe7`Ma6sP0ۛK[o.K=mI+?<4x#Vr)䚂wh[2{ ƽT^,+ЛV4y1yLz墕Q^6W=bY#OKl^V{s7ΔDA攂'FoZ%0IP:2$I(ϧ A `0*.hd'UJZ S(@oكht;L+aL*nߖ~Nכ4%]:תUUL(Njrk[ҪWe].u9/cOE:*>uQZ Ze ГJ0 sy S.Lޅb\V.-*s0&aup*ErŪC躑kd(% -WwQܿSTӖh)|ol;ϵ%W' -z * ^;j*>$o"2 uV[:ثsRR,zxkUtr (HKt^kk@{VsUA"P涡W:ccJӦM$WnŸT U0&Ao.[>Tz-Hk8Ъ$6'߷onW)E޹JՅhkԌa]nĠZ]b.Toobql,WA&} ԪLk5[cȶU}3/1(w5WXVYUHc~4x0wȹJ.] VuongS5ӵ۶gMy&ؠ7 >>Mz xA?28-c(S|_i_5LKJ6-mmڂCim|08R[TFVzxA|פw<_5LQTAD﬊EΪIľj$r/=2⫲oBӛl,.yv \7 ^ےWh=NOcжd0cos Cg{dadBFVFVf. ìDVf$|Ws fQѦ܃{aT0[gtҺQSKZr-EXhW/UJ-u[ti@>>7[nsOL)3!z'MzG4 Ꮠ%GN3%~n{l A!ѓf@pO*oZѶCd0YzŹt5ЩڶM,5jYq)''/i N=Kk\ڴ7pM-[ jBl4fմq3ѴX jMGW8J$&kMFFO %F@Ԑ`4@pV]MZkMKӒIiqdM}h*WcT*D[ԎM;:ƨ~ Q3O_ LhIwl)! 2CɾdkQ}x<;UWPv+i 3S *O ƌןNx3p;|AvX@4=Ľ%i&+T>ʌGu~ɢG#5\HpS4Uߎ] ȟjNJc'B4:ڌP6e2j8͢QԷN 1PEvzuc#Z1СE.ND4ͧUf5f/rSSؾNUt]e@u Ue-U[jҲ,7Xdׅ<@DӬVc"ptXRaI` LL_ӥ]'5,Tj)YUȗ~SUƫ׉0AUCGh׺u)DO EG?7oe1&i,wy[BI3Ȉ1EXk22 vX,N^2vXzvtTO=# P݅+ zl( fp ݟNg4B|M+3hRAvicWӾFj5,ubY"ܺWW6UO];u*}UW-T>JQCa֥2wenuT Te)SΒ۾_W]%kg@7BaC_4v]Byˠ[XX(44ѺT)1VPz\{Q3Kږ--n@ë)Tse;]4v^˵@+[T(:rLL!v=Zl4 :f_J_*(qe^&t P&%|kzWBiBѩPd䘨O,m+BًlT(Zy*?iL{æɛ:+i3hn I3g%"M3YY{A΂=V(=njH vXRo\sA#K2~ʹ?'B;JdeɤW]y bPg=m78ai2Iwz \"u UWSFS֣r5uV7!ɒn[_>W߾Z'@"#FA,`]3}EtjٔS DSN*VrϦhzD4RM|i,4[j/Xn[qc&wTnTTMɯnbZMKfE(Wf Zu0s81϶dQDӠߘ9q;B^kx^(TeM-:r2.Rѿi Y*T.}?.\@r.2y[^g@'RApv:;itߠ@ A^{V]tGS;TTSܿiRjK{%*cB5X %}utܡYMn3< qmo& Psmx fMV$a TWeQ)U:*l BkxEr 0TsWFPӉMn{y@M@{74zK:ka[JTxX3p[娴lyׄJQjZ((U9*z1g` =q*]ӺK2k!Sɓ E4 Lml|UVWtʔ"RLlJsTgchX(WMƪ4UnRނжI< }_?}ٚ^Wo-:J5Y;RM=-ZM+/4mnHK> T1=kI^Q‰ \ɢn(U)e=|<< ~C쫝z^ɍ-<}>hB2ؕ?4j HC8XD49ic)|>a~ : /ai~pS{epU3n,Lh ^BS[/{!P;#NS&O?aOA]yoE~k74:VVHW]Tw\R%TBwOSE-kFX,2h1t?Aʧ} 4h߇}_{mW{k|Sn0e6VUjP}*""R,UkX7(׶7Gqצht;+Mǟ? #6O0{a=_6zfks*C-XJuKYRPoWFqܡAI}Vk҇_ y>/aBG-P9VX5L7@2,EKX G+TVPd u0a-SWD;]w/kEGMݤ{nJ5O=eSO@Bk+ 9pzvZA6B+I`z6 *1i"ʕBQ fhUjXjֵeG ȠE b?9c]q?F;^_m Wɗť"k2~_ç+t۾=4Z DOfH[ou- Y\끉Ws'KUn@R[-MiUz!MPRz%|k'%"f97RzI1C`mKl#PuHϭT~Tl ڪhe|_%6Dm i@4x| >>;߅[wr+u %Sy& j7M'ty)X eMk|jRuZ}_j:kxŐuY\SUA#UÏ~o߄7< W-N W*6Yh\cRZR5F|~RV.Opu,oHߗv4ͅ?*Rd#[i;4^*XFOw*݅gƸksASS'8׾@M,r-Ptbw h/>ME#v82Nl]5Ov? 7$OGB>y_Ӣ';̠)סպPg*(7y6U_:t1`yf4 *\KWCekmkpupԘw;)W7\}_5yO@+@-W~ag>$Y0Up?# Kߤ$]L*L 59ly> yOq7om6l?-|dԲFwlһȴk.Z_ԓ41(vzӿO9MF;9 unܶ n|y4@GϘ/l8nfnh-kDPǎ[rT(7V=0\vVw{}?nXw_<G4ͪi~iNʫ&}- CA@^GkYAW Rx7{UYjbxPu2n3WAzbG~,= #?r+u觺~;zdzMta;R!?('oRPe7szznܾl <,jwVJ Ifh h%OTU^}:= ľq{:xJ =zF dK G/Gy}G?u30gȻOiN.e|;H+Љb^|Z">HsMS1+{niMu)AzFw?]`{A[@Öź-ۡ9P,y #?,YQhT*(=s(g*ۗ{`cw\h\RN<5: $8l;kVXOaG?E$=_?\\ahrϣPk]Pq(5a:V:JP w>z:> 3>j{+ @B/:B izФ)MAPbEr˛߻;.gggqR&A*ǼsЫ${;wnG?R 5m x"Rw=^M+"#l -3A>^t nz<>| @JPxc`J}+HupZF=( OUyY zJh+ۦK׀3':b4G2\ Cr_Ƒiln`&tmςKATeԅYOwuX\ 1THNCKPCLަLw=gm.wUWu+ ۦBs}~3烪? ?ӏvH+J#!}&A-,ǜ [L9eRʂW]ЫݠoK={`u55#-JrnҴ=NQjjBB;(}}28SZFWҪӹM=~oLz |]@uAz34ZZ3}Nԙ1*PU^!$GT.mꗬĩnkV0Jf>=*m" UiM=z!'΃[4{mŵgeUIJ/%iB 's-TTԗ,珴?[SR[S13| Tu(Ūc.~ 8z8:ڴI:s P9)mSluoЪf+6ԛjtoR 5H7&jY ?\0Jőz p/BTZTdoҭO#| :J^j͆Mr~3桧YUSM-uѦU},-dpAgmqĪ]Q+GhF 'uT_rK Xՠ✣OS>D_ Zzïuu:Z>1I@LsJ[OM#H{ldTT߃_Ic/\CNGk@-ϡjx5*+ߴ9@o0pV& P܈ ^St/1F\3M=~I}&]>3;7Y!{tؼg/YS73 ] hJQ蔩B=ৱy5:"F#FnT N&6 o~ b> _9'#xwW=]vyH5pFPsz&T*:ݕ VTUWP0׭&iNglz\{?߃OQ~؋7 հb뭃':86g7 \2z"CP I߮=0`I?ڿQǽm갅N"L+H'@±ak7zG͆1F(7l)bL(e;)lcw`7r#xӶNⴿoE& }.|路 } BZd,mYȠSE@PU`'Z?)FѫXKE i `3ƞ1(˦=hKm/oڴ˪!_OnD},{p ZԘ &` $ PYQUSa{Sz ut2LZ(ӰnCzdzWGε*5.~ijZֶ?O=կ O s+0G` A˵ۀE;69: hXGX* NuZ]Zm*.lS/#mScUO܉Si_ зNK.7 ;`k`౳C pFPs<{XYMj/~E J'Ń](4ꔡn򌥰oU1Ŵ?B l~DnSlݟZ+p30+Y+u/hx $ kՌVO.&6sPEF |O@M8u̿YӫR,XXIUҝhlyA7^O[F׀M4 ,\*̚~Sgȱρ^-m~@ce0EE Vx`5UۉR t.5XK4@(&W *@URoqۦ.ֈ"Mxlw `S/ms 7UFIW.ҡS(Ve7s;5@өK٬_&cOx6~}JkA@LR!Ӧ>S_g\7(ޙǦWJF}_8!㎃uwZ&Ոpv`Czdo^}h.<g;cXG"ZfijMm'Y=dӘb|3D o{Sv2ź s6e6,_XMc!%"xdֽG,}PDP>6T4){r IdGyKkx^g GOmj-jSӦfM*߶4^f/Ҁ@"YߊcwJFl҇2eN}YMURgjEթ9T9y`.B|y<*/*v>N8 uR<j4} i)Kjez@=/k V$C>ƛ}C+e`VJJNqcAyob0oT1WԚPT.Ǧx;[^hD]rjTrk$b[fq.F7^u؛WAO;:sG'|?^a=V&{YZdDP1!TO 3Kր&6+r@@ӕ9p荳5X_h9g,ɚ3G*[qN׌cҔq~1|ƿ9U xAlX)y:`9Mt*$ڔ5q]xK5Zՠނμe7셠ZZSfJr4Mn⃺"6|`ҵ`Sm7߸rLHj ;BXN/ `2j.?v^n> 9f70vzz\ ~jȽj6QD6Y=kӷܴ)?β>[.:<Xj̘GTIH04*Bky6#Tr,Psfp5cٗ@}GA}@N$N8 T6MWm;ϟ7?q˟x9|uĹk`yWW@wܴɀoGxʠmSU 6͋DX؛ eua pRwJzfQ=`beF*njuYYnõ?[`Qnrk̥OAw[ć~}Xum}Z/2<ԝlMm?-Ȧq=P( ^UγR@GR^ʥWMV! ^5dtӝ{ ~u }OWozOQ|-|U~']es"OIWYj TKfY>woag?]rvXjZK@)@y*Q ,j`b+򯐔XSd--7{~4r2@y_hL¬L [k&-qZ6Ao/^/w"͞ r<*&O^1I@8ִ̊;_"+znPoag {]~߻ r- i-צ0% z;9?r3?1o#/| BO]=:8DWoY+Ai@@TfV56T|_)O|oO %&=yg !q+44?o_F$aoi90{=5g2uXԬVUꮷiq ӀGFK Jn ˟-wZM@lzܦMyY^|.^O;^w|T }Ua'65kZޤ̠f>*ǼsЫ${;wnG?R 5m x"Rw=^M+"#l -3A>^t nz<>| @JPc:b 5d<6>"p& ?W"k 4|ldZN % H.ٖ7k|>Øo6c(+]`zPDTn;]g.h:'oNM`4rV}[q2u(hgU[[O+\,;*`D%W AȿtԹvLW3 HZ0[ 0lϷ7=ipI@O‚[/vTX1Q'c@Ųi$(1]( }b} Jl Z89$i0Dj7c"fs7㟣bG8lqß?߉)"F `1ZCNV8gLsӓ$xbY+ `AtJfbŲ)C MCpѦ& 0ۣl2__FEpi5jTMѽL['-8o*B8%-wßҦl{gG_oAY4l;ѓR8{+>kL,VxAaZ,Ų) rl?}6m[ZS9V?2U Mh9ʭuR8ސVw):S辣.UR+#UO jғewb`5k| l8AөfA6~󇥬@s&^5y,fUGϴ)CVX*{K^0먧&(&QL^H^`O.[y(mASULe%0u,+}?<W"jFQ iRtiue( :/J*`RQPA!{hP֩OE@@Rv*#-咼\oeMoHD%ʚdOkZ&t㟲mdiՒ۔Ql0cJ% ,Q{0f=4hEvjmWkX}pjDP&NGc o) r"j"nё,]!T" Lefb~<824,MIMJSČeŐZ-i^MР^iI)ۦh0*^pp4AXbH” d[w7=`o+N R}84 #3NXƴزۦjGmZx6-& CnLı. P*n;qJ괕%AZ; B Eb;IN:Di;U Ҡ&7MG1mSlQvbd3Їd!A"c@֭]0=qW$BmM7P*7Z-*^A ƭC0x6J@1V/UlH9BMK9uVΡĠѶMjZ vtզؗ^\=" {ll)QM{^IR& *ĻTm RM hxP5Dj 2k%^:-ȓi"-+) IrtBּ`Ϯ4Rք%Wi,@JXH-֩ҦNM+d3TWm n?Fua`Ī ӓdZ?Vzmʲ_jYՑru])CeߴڟmӼ%5E)) ׼x0]zRz0%x:@=@ i?|w: ؔ_XAa麣z=)ngpLγJOT DNK7$@\Y?v:S<6:'zQݣg#8L8СN+TJ}/t 0h4lj Fut\[tTRMџj%u[QTPk^Jr:)RO:c@t G,3)VUvlן6s)k'BGK]+sJ:=vt}O.^}rcg4OoDf )q\js#ן:zJdR7T^T]?s`\6mV;8Aٸ,\ ۦħZgFOuos:]N9W)C_~P4c9 1 e,=ȫ5QWB$KLZ 0W"ҧdۦW>.^fC h2AvSW+NWF(ROvIEJb9G̜:GO[m>߶D/Ger |C>0$01[i|jSFNj-(0uT]|h+2}PDχ7`mS9_^\TфypȐ%S1j7yW rM3[PF4yOe(n>H/it^@Rk4"H1Vwӽi6}?kS4Yaq"/FT sp~'y-]3ĹBqis X48LXGW3C#"$7͔4%>ylMZCsMT+eQP6>ݨxҚ,%6j3`:)#Μu3&\ltPxJHOLE geg8LS'ͦl: grl\`gX.=&}T҇ *Щ(fG|fze&ʲm*?WpN!vVd(ʚ\EYf1FF2{+ 1#ۦBsܭRsGX$۩P){UJ sDPU]r7#KhsH |Za)&v )qT:3gZ,0#ۦ9:* 5~?m9OJFZ,Wicd-gZTlRpz^'Fh_c<9mSP"9z 9E p  RSOt+l1&+;:ͲmjJ#z(Ȕ>Q!:Kfw3Ԝk-[tȶGi^$G/mN. "S K fuiG<˶ieذ,8bꔍO)21Z7`,Q#,ZtHnsٔ"eXcjuA#')6ͱmɼH)72u kTԘk(DTdt@T"pEqDEEk-jTč%5/&&/&h7553w6۷駞:RQ]*i9HaZ:ϬKY|"ܪө9)$<1Jt}i& #٭ L[IxjsLCeШ?ii诊==>4nK1ťO_3Ƣ5o)zR uӦFABU#>hY6LE/<cZ>˼spa줧[Cylގ+rL)mZa,˝eJgɜFv4qbP1<xΑ=UCG<7ǴU,fd# M C#'Eםo˓Lnku+XkkwMnhJ>l<ɚZ&ސMY/\Z,gGŸ"t"Z\~ڬXG O7*ZiTG:gm -VyxU2%rL(7bo 7΢Fv|nهj d׾N5*C)FkVRڨO[u꧵Z*8/Cii| +L\K|~Bؓ%M2mEGQ"9kdJ4dx+4YL"%Chu1TfrUEÞzκ9yGq|i<1 -۞S4^ 2'N6ȑg9\ZRFfꨲfPYRY[ͤTY/v(VSY,"'ӂ>QI\GOjz;Q. \X41 zce0bX.ޙ?hRK*Y}%UY/ΊԲժNz}䪙NfG-hO8 9p<ǾʈKg%ic1-4+{Ti[Z2 <{R!UesiT j5˒?wAaIDA4mC&S<*B&۟Zii]kTeҖ-IeU R̥a+N:h1-y7D$CӶ$sRx !SVlO $ĴQsʃWHrSpv9`Z=S*L 0#1a.䄋372'ؔ{ a #:L0":bQEL?'Z]^= s\$ESݣATTqY Rlbh eĐҹ5dvTHjG%:td昺%m3mT(5>QOe,uA=} K"Z I8FSIŶ': v֟dЏԝD),&>1NUQOm?gUwJ{SLGHIXREjQ {7Ef9n8xo,]ul7nnD{z"= 5 =qp# ⇻e'}اu4jH[z&rULg5y1ubڹu.&*ۡQ*޶wnfȆ]b= "ZiTm:D˽7HJƃݮ2*!< SnJZiOsLtT[xI5ӴgӯtJ*[wcY9ʵ{ 757s ~cth6D0f;QUvgJ$CG()QZH)U2M3&—qc3yp+tr1U-Jcyxwgl9QKYNl='+tYcc77qtET1twlC?>{Q,,u.$Ŵ@ڲ[w mOsLˆܖy@.41j/ձ9=]+uo}pVfLl] *SApXmld~DCW.#:X3a6ȹ79Qn$YRUB5Iz5K;7i?NmTjc;E H!t @o q\Fa]`P)Ǖ2isLH)-@ozʹ!0 hWcyN(N$YRM֓}GDsW1 ӍVOdm}l775jIbxA̢81-BER`iR3ПɨTXW/TmzqFY-K +gM!^o;heUMS2 + BV-d +M M>U+!LjIw:Ѹ54;]~;LDP6)Sy_TI otYEZl4緀)s9\t5 KagowĨ V ;D-Η^m4DAW7||UWouZR>t_[^lASVҲyW #LUkU0hLS2%7E#)@qѝ5+K\qU}u!D3-j]X!+"|M#z@ )TK'e.=C%FF`uΫH1Y j9,IxCpUһ"kҘr&0@n=)ܔzrMA'dN\% i_R׬g: 'iMq?.8 Q^.Rgjji*ai2fE1Vi-:؞Rgx{'_DN #mz$iOJRy869Y0`OU:yB%Py?sȧM3'LJi> {DiYO3Lݾy*'~tT5Ӱ"*yʿ^9٥GL<1qs7K ~4mV萶ոl|,JZF]92 Iqp#)Ӫ}dNgN^&.jO*@P ˩V=cZ~S6]fP:n'4 鏯vsc3瞸w AxMI'ViT=2WmhP8f}OxvkI=VSbIA(&Z4&G^iiv%L-!9˂mN@M:o2Hz)ݢx{iEuZI *yo_h3>&9!H^k.=I 413JiaG8'nƚSᛎaiYƠ3A?t5YdcZ JWlȊ5j rx*NϱIu‘=lMxJ|LSsL+dec-QE&Fq(̂Nk $]tc Օ`Dˢ3h8vk'<6ç49i!:ݬ=JyZh%Y@s$$J@)M9MoMfsLKVᕩlZ`phi+z̡rKf8D1aO:L]jli,}>]R:CSK])d{k M{R6Ǵh^)lEBF|$S3}[_G7LБ{csL;O7uQ=_+~վsR,迠W͔xUT=RyhΎ LV=JcvOUK_h1r|{:ˆtΟc]Jڇb5`+hPU="QꃖO^LE/<c #\;=mo.ۧW+Lt<4k,Xto;˜Β9 H3 icsyT-4#!{ssLCSIx'Hkoh=|zЈ.:mhI&kv< lZf9n=z ۼ ٫m`V]1k6#xLÜ̾{vW. ,LvRWadDuw7xp->d']dD~~2olvN[zUs*/9~A˷GT2gYG࠺ >gee n8"[_e-~՞3gf׿.CL~u/x<=*A#7L2 {i|L/6,Ywa&W \Af@?؃;hSwdB$̚g߰a=B zvcN U: gW;I]:#ϔ}X/k4'f»;oOpEH.hR68c=3H 6dKfxf^tUG{uYo=n{BvN/^wG3o#gD2dHwh{ffo쾏=#z3{a!@$óoȐoCVG|1pk^j=O>䐧_9E^KGsyڪ sk Y߬ܚ,2| 2g'g22{є^qoUǗuzW%{( RYE3ڝi|_7>wr2- >Uy=eYy** ѶWʊr﫶ybrħ+V}U͕TWU]4*8ɛ+z}qV[j/}52];k_}7}5no>Ƨq'bzC>'S rC6DFE]AfvrL'phzo]v014YWytS̀wTzh g+g:h]j7rsOQ/as%ĝƔՏC<)=?jN$q>l.A. :c((>!X?O.wB{@cL ×ݷ kz=~>}ҝ_R, ~M^lM|_>`&gZO7O-~Ve\m|Ɨ5~Sf__eٹ\YҲ,/rZ@^j Z-/rZ@o=hMj se|j*KⵂO _5z@n] >PrC{8C%q?=T*x=TrRWCB2P)rz }ZZx=T*r}=T**{T_Cn#ySkؑ2T;~=,}srZ@nZViu%ǯ2-ǯ5T{ۃ֤fiۃJ[~\ez*=|1fJ|omO]Tf0|W _O/ [?ïH-TC}~~^ F^t&$I/TKH! |_珐> K| @?BlPHڠ?ŋ߿}睷߼[oH+z1T3OP 'BhH7^^yyK⯞G^xY>1`-+66R .73O?ēO<>wcyGg=NfϜH R |Rڡ ^AE/9T]BO=A ~{{s/ qǭ3:BLؠهKP$H8RB'!6Rmo妟|M7]wu3v?qr͌+g\=M =f PKPIN $x z.K]>K'_:K\LtA"'Oز~!fjZDbPA+]*/ /8޸&=3sƟ;{3LɌX%nyNtO'Px`mP=48g9cFx)NFFv3'g&?Vy*BQB9gAQVC1iQf&B2MVE9,5GS,ʑP` 3A EH07`xg= VȤGiF&<**ŋSVE9军nB|JѯAF>MʃdRmhG-b_)@ !+Pj%OO;r_Gnp ('>ڔJ9;* \-ey'wOP"䖷ۖ*"΅vdEq.Բ$r+!VTBb'RbJ[Q nO*KGv QW#O9T\y"|:hG!jekh&-kvžRJU<+U[Qth&ؼmJ޹oUY7NyEk}:=Ԫ6ӷ+ү>v4U~6 "}/\ms2aI>W_οzU[(/k\Uk\UE1ŪW]u;WgF>+ ՘z04PcX ԅ_=ٹʾzb_\Vty' \ 4*?%QQQZ+=eB__qPTĉ 5"'N:P_[gRQ bU =#c*V {aM(<M ?S78"?IT4*Su?\KsU1l >]9f%4b6{IEy< C|}$SUOv]ȗ;OjH*R)JWzS^NL#[)2_q*VCPER(GOTė;$(JnHe"3AVR{Q(ScIkgY.ޞ_ؔmO- xA b}pLt.ڤ8Y N{3$DcY| Qd{Y-2Jq^N:!c;E)f`$6OK9+Q!!J#^r+!_3xJKt}KKnY"$+{EE@Ѣ!lP"J:7dlZh KJpU]J2zD!( R_4KPڋP+TQi^Kogs% A(@EW'uEJ7?1eRظC /1CX"2NT24Fżl-@su)ف(-3/,^9@$4cDK5Ep/ 牠@T~Q:LEcL= 1#5, $P@NKgO(?z@uǀ;/uA7"M>CuI ) K" ђCc8$Ue#E(BSSBrb16/HY+$Nǔ0U葺8J#Px^&UZM'(*PUB&1C0F/ZͿ&㢰1(J Tty]Der0Zǿe)Wtݧ;Udu#,@*_ZEt 쇺*o cꀍlUi;|S) f+&pq;(TOxKu7-v! lQOoW} _UJ| W雯RYT_^KeT_^KeT_^KeT_^Ke#)jA61__8-|k/sf1'b~SN.l;7YsȚz-XL`~1EYLgMkIm_8BaKPz-|||Ҭ^j"!&OՔ%?4_e6@ ~j&lS+sPN뵴_}M5+r*术[,D/ا_'WLv.o8xv6pm—Akuͧ߼`bR'Ro' QsûvmZ]9v|}K3$q߈~<~ȳ.Ʃ!ݛ©)+64[-⹶kr'GvkvǶ ΄w?ş'v]?#|Vr%vGM!рSȘ:R__˶ޓT˻ p>Ưco9v(;)0f$ʽ'&|}K3~H\%o"xތiDS851͵hyS5~?cįq,$ǯOv=\ ,^h'ǿ_ۋAbs)MݱNWv7 |h LQy -BOڷ Ugy\?E\{^o‹ߑo^Ɠs?G{E|~-~}Yl>~oI9z=BNF5Mـv)?Ƿڥ7<~ mVszoԮo4=R丵߲MeÒ\ɬm61]}naniDvW~cgݕ{p|.xۺg9vO>e l+Ol-ѝgֹ3gRb}nnߴ;W'yv;M<zM~pm@=-h^Ro^6 z 17ƼnchY`>χphގ7G#ŸD߸ q,4E[9e1IZ3ӂD[ޘ6)La#71AUbw 7jiffx/6ƣHi|2 fxZo61kL>cVX9>X%ި4p)T09, 丗ɵqs&ߟqOsq|b.oO#̈́x7cfǩq?8Ȝ :3">c9*95GAM5=ХFlB0y_ݼO4wƧp}ߏ1f\ \χph +ܳ^$0I0{6>1;^67'޿̒8-KX1;(֮{ "$(*D* \$' K ,H WQQT(,䜣LUN;p+~y]ٝ=KXbPϿ= 7r !xf;}X>;QwpS~ p6!s~^@ǁ8~aǻspaW@r!3yoDI, |5R=@A@,EqC.Cx@.Br%y:2a  ֚; p3fj*_aGvMG1=Y~֧a|{ r4swIL7gיv^r*%l7ȻaxkM>o XsM64v0/a}";KpO^[n+ зXe>9.\_/̌m's)ːc5q.0ǩL_YzJY^0ߨyf*T2_1,5bW\S4Ke`x[ K3ߪW0?(oQ 齪P[c"%ߝୃ^xb93@.r0M3*9lA>.gT6 _OD|d.C<;D`&@wCSgVj.8!u o:ҿuHW!ey[3 <.c=;9ɝdli+u6>?VY57x?)sOOjO\9ϿQwpniN~=)wDϮmQDv.Bv@a7FO?Ȼ) <[uUZT%,Ch{>?)sOO' 9]ڟV.)?s*_CԿF?n*Z/PܔI R7sRCf֐ jhyU>Lm]H"u磺\HeHY7: @ =yb#̌o ɺnZzcDŽ|Dkp'n\lq]r3|qg /ah&sL &on]Ћ~񆚩;S'f^kB8NԭËl;&?~.D?kR3s?XRw>z.Ǽ.oj [- mNZLw`YS9w=Εu\zZ#NzRSMN?78_x\Sijz?3@?ݠ`sltjBFns'#sICn4'tGO7~9tO z粃k~Vԣq=T]Эt9;.Oj6:D\h*Y9Sѓ7zS'k%[5S|o.r \29|\~pc vqhOG2ē=x==ȚlOT!?.s#n!ng=kOPSoppapN]jl\>96=8R\&a@:==k2u4EnQ[ܿދZ~pQ*꿤nAU~v!cs uHeHYG `0uFO^M9MʭDD'~pu|M Xސ\7xuED89uW|Ȅb҉ѺMp\L-G <|jk5yMDRwn{~p#[[o8x''mZEd |D[(ٮmR}/?2ċwaPHhjVo)/zNשP-l\:>2D3f :'o<_Oq~yo<>I?KSk4[x=? 5X-jT` 5=s%+hO{l|2:Nç ^b74ۮO2Oq؈h[2ħ P8hyS/ucjxZl5P xpAONwzBVS8uM~.&6'rcã5D|d.C< zH @%'@?S?` LOy ~#o?Ow>P7gCu"8376-gO|ϱB6_}hmJO~R?ϙ ѓ7;@o2L CuP/uX[۸x4-#8O[je.Ctx_AM;w.puǨO;v<5 'gNr\2މ\+8FR5o\qƅ#C5r%OG2ēIy,&CAO^=2!=O"B2AOӼfSr5P+5ʚVxR2!=!]CϼXK#G8mLfo:D(m\8#/53!ʜR?uOz{<1ƶj慪jc'\03o=Qw:]L9'9_R<n8h`'#sICO{9,@0T3K3ٝ4d : =affvfƅ'/עzN>N&ϙh2;c1C jhyw8p@܋/%sKGnP7΄uLzBP+5Gӭ~jjO GY%O@6#.2!ڃR{n`@ퟣzN={(ç+j4zjl?PtKe`ԝP7R{.*p>f} X K}IUa!;&5q@R\Y@P&̋=ox 2p|n^֛jdkS rsdrv8'|)j'8MF<ƹ}q[i!2!~Mz;xI ]]|l[=&y,qr|3Hj~yb>M7x\[ԾzA= 5df[R0I ev~5 s=c&9z-5'9'|%2Gs{Gk ιx">2!=n]qq\/3+n͸'?t3Sw۱X^w5xE^^Η!K UrȜ}5]<OR{P3 'l@Vz{Wy' 6"jZUZz+P8gT[p %X;kZg^n s~1ke"R)ӸVu֒j vL|\z+ bi4ryL4w#=FΨP#h 'l#CpN7 -3kIX kNѳk1"uLz"?R!5θPo[A8{Ts'up\qgM:uDmoIyo8j "Z9] w wƇR~.~ƙ=ݢZv {j39`8LFOYo2~֑&;χ&zT6Tڙː:u.~r=q18cLLA=S2ũӆL MAgjh]qZ<7E׷W ,W { k Dj33O2wqh[2ħ(\'{R'>vzhtڙZz'o,@>+zГ/kI6X5#6;Cxc̏]q[ixes%jV5ozy{tYcu _9p3ɷ!WO4ii)܂ݝ5W<ߘQs <@|oGϼ?d7'VjNW;B;KC?Y]t6N.2!ڃ#^'~a.^iesO"!h&+C\ _А]/KV^Apr'S< -hM72ăg"r9 55z{tU]*euC%<7d|(咫WU!_~ng [831Z[p~ "xQ9dghsPeh>Ղf2Vfeׅ*ύr^5\;r2qjghM72ăgԜTu ;CsNeuRo/]iMdt܍D{(hdN@g"5HeH xh ͨ!\i$ýKA D&A3 CC%H@oA!_my 8CBsE;\9:(xMͣt%":7WUt|MG  geXf @re^ W~ٽ1%d~߷cAc.C|&Cfj_OnټW].nb=nr.>5(a]."Axν#r2qѺ+>weADsmPk*p55szN[[nI<||m\]~n~Lx/d~Ao6ڂs,^eAċC8=h&λuhǏ;ZG5C4Ke`>rp55z׺zNmV7 deؕDžvɵwݛ/^u W|y۟ Ac.C|&>4Fvgqsx "Ksx(  |I*\."Ax}7>|d^Y Vњs+oeAϨ=Z;4$x}>h&Xp7̭ W&Z]46Nlk.2!ڃR{==5wdhDm'Γ^[WyDnV߰ZDNJe`}LUL̋d 3D-眖^XAU׻ NCwҫZڱuؖk-=KM'hmOoTjːTZZgԔcYu:nW-_DSֶ>z.kX kʂm.޺3>2 <^K^8<޽@]gncXMoo;08<.^\fQo]  2=kx,\s;>tFXkҌ&q&Z~ 8Mqmv@w{9=w7{_ާoz~E9oh֦z#2!n>& ݱ'P'u^;VjؼO51^c] 6mm+.2!ڃR;\x*C{6sKԽYYQ+fr=#/P@muL>]jv/2^ݸcW }Vcvq컆ڂ'^ 2 /Po> ݱMjU&KG&w,?Oq[.szGk.2!ڃWCNԼ{Կ^>o 4շwxs9!_?so\)_r2q+iOdnXOGk Ώx">2!=v>_} L@ | UTQ#*i11T'W2G 6bj[5U7((k1 ZX}zbjIVMZb:&WtRkMW'c,M+f 1fc+TV=>(fvB;'y_7}їJ<ǘ` {iyO-E=^ŷzH/700{x| =MLE)8CQw6ߠ5nef3_ p&[˦  C\WkyM.k5]zF^yuoש/^;Mڬ:\-8 96gssTĕ-:9BSbw}ɔw݊; 9-N NſX٤s Epԏ;w:eU٭8ǜwTu{8%r-z{mM{=:Uj\|ԏӛz_Xc1p/K _Dv[}{.@:}[+q븏i02Cpn#d=(|K7佘=onyO/M=ּך:^]^wM ӋU?ǫD=XӽT[YU'VRu;5FwPSu'5_wUo"#Om|?TQ;mӭԗLQk#]U^V}~]]wwTf'rIT=_BUPOwҪ_Nu~5oDwQsDF-𛨅~`~/Я:¯kioq{D+{/n^Wg6: ~ ?y/︭ 1ĥڨwb%:rgЮcFJߐ:tHKw[4aO8|&F9vcƜ]~8Ǿ" ?<hv落4R4Ǫ~}lHU?{o {Q)ʉX.as_uX1"?o4 F:}uۦ=َbmpfH'@a[{7{ך/0!Oy Z?mfCM]6~jLٱoN8o:vm4h\˞z'.~׮44$D[WǫoF~>KA>W ?N#"RG$,1cSfV4аmmMhإ /b:_Z Wo_o}oiN?tfđh_ARqˏVf(rǠa53) hإ򳓱3E6{6|nSM:Gp="o ϗ9Ai%HPo;ga0!ACVv c6ics?hIetMn_[?İCۧQ/^OoH}nԥ`bIҰl)n=n !5V}~*t{uiw?hg7~c8?9Qѻo:kMm :B|D* QcOQ{jLrK-:iNA'^_'l?brlEKf5dC*\yo6̜13a0"S1t [GYsH NT10#f6zsyvwݾ'b&EMfB}NVCϴѢM͚_0 &n/͉vQp#E;/ܥ[vrjy˛6j [n{sNE(Zfjg<6%p]/cx :a}䱋X.U뛚޴-gVؚmB.E*:ܨNSkk^n|w?K;xz衳C~<ڈc#-v9:-'P:G:ˏys,\ew=8-ɋ&uƷn[n΀3z ?g` tL*ҵGˌ[u'^\|YW">x)Xz]]O;4@'Zl,@-8=]2 =koX:i÷=K3NѫϫDG:񐏴l,G3W)eG:ef6Z'w2'; i Cſa#w%Hi~bxf@~^}KE'_^tG|;vJ{"ٿWSnףm;OVCa)j߇0^吳KXŵ:5BIAs^}vU3nv|O:n6Y-4DQy@cN> @hL)V4m},{M# $Z COP,.$PR@]!>/Ez~m; ?H tbJ+ r/cP! }BRyQx"H*> Ek: jv @ƾX &wr*(9ʉWBcNzpyZB6Զ3kI)y+ Ee`^G]cs SIEz( _'$~5F)Z?,§1ȗPҧ]J/VMɹo[_%0\ͣ1g(9d|:wVs|x;j ljn9YЄ]0LѤ)@ef1'cΨuPSD.Q~넗~'&˴09sԙ? Mi緵?u. T1&UR'=L[KW! G>8MG _ %XYTo&_|q$kKytP Gc,h7YwAD Qs^Cm>ۢ_\f؃OI{qmP VJyʉWN>m|3 l6:kD۬>>z#&YRǯkv⢣ TAUިQxūQyo z )>هB6wh%b994F9) =JI[>e=4yXWB/RK˿Iw9H()ђ*&c"dH'lo4t-F#BH.o")%fqk5y ,l(U ٧M,w?8I0WKzŝoׂ~nu J5-Ȅ~]6۬mT): 6WW3c3 KA۠qϻ_ I័~ym[R( NH fH ~.ǟ_ QJDDx I? }Ì߉^ qB1TS/=9u =t5M,M\:{ Oov[Cn^id˰zQh 2]g뻸U-243zm18 L (:W裗 Ə5 lwl H?Lz?7 w1Kꕓ8lF3Å*c628x~<ވ{SƩjуmn[ó~sVU"\Paw- &u>]+\glQOTiZz~vmQ;8$[`6J~$ǟqtQZڄ)б6[ǃҠLWa:EroQهnȢYTbu0dTl$> rRXNc<*kB@RW4UUUIo'frp]oj IkdDDGo;մzqoa2Ѹ< ^c!FI==a`(XrNHJ-Vvz]xnS/RN]߅rn̼}n8ECOl|b7-CmL@̈́tfY#<wq4 3 ѓjک5G& nB-5D@c/mq<x-*S0S'pe>?G2'MVyW,mT,z60bkU"E\94 { lԯ7dyﰻ籷I9r G>,5Dt*fr^%R)OvY. 1$Pgj7יX{q?zlZFbִ j~q NQ'A꣓O=1D[)&Hps.vp;{TЋ륜p8&D4t#}Hb|ȃ|8-I~:x#H!O&~g/cWjUNιWvj _@ФOQՄb.R+diL`TRziSuH >@p5pjڱjFѵؔSalmBh<_?œNtu6fIWT E'?_-D rFNbBƹC~t9Bp _cd_{_OA"XHO> oRaӆ'zocWo'\ K8$hZc|<,2sM }.BjJd6`^#;ݎxB|~=x.$VRf~5j7ѡؙ뽠]t]N.>#NGw,C$dUM]уPgogjT2ʛy=w>;v&Kj:*iWv~vh.7̘Jb nާ#ťfKu]Qr0Qχ58[9u]w2KǧsBݙd52l:1T`.|CD'+ 5:~}c'w(|[^.Q.q:(jf["lH̍Y9ys|[C3k֖j:4 Ӌ/G' b=o1I Ae.nߋ,Z|ZN\©i|;xro1%I)iP,,-)ufPSzpR Z:WW0ZڤUK9Lpb!,qŧ ` MFpNT%AX`!8B  DR'=߁S5V-_qEƩ78.70;šNx[Y+^gvgqQJzVutˏR L8-U7υwlRl1/眦ɘ-֘nwxt'bdBRAԯ>o> w 3iZr=gu^`?yv1"VJ:@OFeF~bR[\VY8wp#C NdAgc?t5 k'օJ A76B[pBgp"TrVØ~;nS?MfJȤ#>!W.f3yS5&Sfдk V-6:sz&$zbh5ۆu;ގ9!P<N͢[ εfw93sWl#8O9 QNHGt2s:5WKwdWP$:I?'۱6iD}JUvj蔣wi"xS{&s ie:5Lh~CQWU2K)M.!/0P>S2gqRzԣ~a;9yY&Vmv\ Hs2k:S9rfR<G=Y:4q.7"Y9/rNRz91 C9`71j:IōK.ŤϼO}֤ɜ],.'eHIV.81'$Q_rNbXn[NTx;MGNQ}IN%)4QOrrI'+㷿njUL-r/lj{ fj2+~4iiq3J55]\\ HFJh|hΩd95KO8<.9DU)ruV{N\yYTACy3ќ %B39ՄlUkykNgxmiO878u? N rihN>iM- \ު[}-)L˽\Y6FLTCiS)l`|3Ɯ yٕ ܖ׼1'$3Yڌ$dcݏ@Tl *MP`9o3}9k{mbjJ+$d ilGw U5&hhZsˍ6ځ3LXµ<ry <9!0*iYv).xP·k Mf9g2y[>zJ>8m^^0M{㶾jUw6(v?rUfd'pC1Q6kv#I7^R*ژR=$|9ZաZPZ|>a𭎏W $&B `LDLrE wjIR\mBq*$ a!/D^mq7KjNHYޢS{RЄ^Nq'Q)\$0YcKq(FFm7GΩnl MI OuY~bp Uk8!dEfkvb,(iOi^ۭ^x3b\h0dt$<)89RC+D&*4jbRNb'-LlNp*\M;{B 4toh&G {yM>T9I%c $\xē`I_'hu!~ag#*DLG4%YYJUm7kђ 1j{쵿' KƶӨ }m4Ot*ۜ))4P*; a nyи#lWvvv=]ep E7U* qO"1guꛮrH@،ZM7qP c OT+j^v>&. l-}W!`9nDte.C9V0_M%3|B8z4`'i0$8A'U8uWt4%hsi!X9x苈 Z%η4=[iu=VjSaorp_fb;/FNԠ.5e t\Nz M21NXўmc`709kzK[.'.hTl5w ox.5eMl:b&{O']MS&h%?㴽yc5 w nN=g)ˉ$;)x5 gJsm.>"0Zj1S=RNkjmFY3)|69x0æJMv$MB tY(4_cѠX2fjMiq9P/mUye=At#9< ϜPx 0 11•\4i{Ae6H* JŤ#\}VY:Bl=i 1ox=#Xfr~~ řRt;FZǔ{a od4 Rj{ B{ǺX g<:#ĜJ*b9Ι~= 1/EpNQNϪ<Z/KlI&8AvXǔ[9՘'kEyHߙT-@.x0&?rv:E"K~/LT*f)LX)J ?bϿDQHqH&DJ$]y ~@]fLQ[]|VBL 2cT L1`dzaI^ʩQ+m%ё 'C2LVf6;KM3Nwi٬s~:*!Fa4B?yS:,;y8(vC5x@YB7򶩢 f&'C_d](S ' Iϧb9@.'HD F%VY;#c! HCL$Wp'VH)B{n;=_HȽ[VNF%F8j>MC^vbi^ %d:[w5' 5踩gF' >|U \%l^!xSҢSs11Hpǁk>\dh3'D@@sM5鋆*eYkW8;hçcd\Ϩ7TbxZfm/\$ZXr &X=L@bM>=[GvG<}IGpWp~NaKɅXo1!$6ǟaR1Jt-yVN[\}ENZTH}/WƃO/;y?j?%狼Ab"NUKlz=I'R/8r'3h"CkiebZDeBLE0F1-#bT@6 hTw̫"^mg'ѵIl%Kwb{+xxpBOط|} 06jy+c2mYGK<QR&R9?˶G&.sAQJnDs%*hr,4q(x/51'3ub B6 2 {;SLW. /<76jzU[n]N)7r*yBL"-IvPgpW> ttմ[ye~ץ#_1Z60YVy ۳Ak-6)*m R=x=ew? =|e*9ί,?}T(=\p]OB;z-5w֟@H+4ܙ[/r7DTuʥm5 /wjUݷ$ײ/$x'K8I t2>ĚԝgkwBCSEOw[C>.x|U|2:@`6vOiJ} 5:n/۬u݂^W\ XH_ %L\rg:C.d|up$} 8Qi>4ێX-g7tr\PM5o|{ ]eᆾ wWD'dJBI} tr|. ;veΓt!>7l̝ޱ<(:Ycծ;q+`2LSGr珽6uwnKE@"!? |='?4\l9g~/g(Bȉ*fӣ"Ty!d#`ăw l*hBv] 5 8Фl-1FN-⢘zO҆}|ծN }eМQ#ٷ _~ʮK^opˋP@Fidzj7ΐ0Ar Y_L~*~ _<{Vlp}:Yqޚ.K6~jg93X[s&q;L # < h}gYTw9}f߹ۏt{þ_<8BN- Tu*@-DTV';qwB2I+Bʈ" Euz#!t)!'_CumkLiz Z6V锛Eo{9}ttʨ c/sfl҇RҾHvjb @ DcR|8UaPDE yn9,ܨ bh:rj7@䲩eܡ,N֧<:S3!;*UDWm76ݿ}l[يBؚR[?aCHA'l;V7oh4T3'[Ϸ"fAR}Rhkʯ31u'Ps^=/ՠ&T͏ɚԢ練})+%U/ےlؔzە+ۦRo[wTGTym@_ۖ+I+q 4Ro[T)Mm6 v%zJmv튬+^Z[K[-`!3}]pF+[\VmW*I+zJm޶RoZJmvҢRo[.VmZi[ Rm++-X+˕͡RJ]JjW.׭rՆܮs+pSU]WWmV~qu(+uS siMo+FRo[-6}C]{rRo̵.Mi*+RX.Ro[l]ˆRo[zէRo[.Ro[%z-M؊+kX]JmVmRo[Tm뷠Ro[%z-ۮ#}*RZ߂Jm֊VmQJm^JmQfBi޶Jn+XZcۮ]mDևVmekէRo\Y*еiզz۲ukW-W*t*kZ\V\\- ŞkvF]3UxRob(E%xURoպDhv4Vag65D^u=zJmvKVRo[Vm++,_Rm+z۵i-X+kC^Ro[\ˆ\Z]KMJJۮsN*kRmh4)kU+_yu*U*5vhgξ;Dnll۳oNӖI}s4Mmn*R询T2Q ⌾#E(^@Z_Z*toQK])֜W:+TUn U._JΐR2=`Ld33،U.aկJX*;QE,T*߈C]LV*T9DI|CF|GFuz5 p0c}<@7SMPMrQMtRM 8K]US%o^@:cFHnU|= ?0.4 DB֪f`Cq^w?RqX;i/1M9,z13cdy ޟl%zjDWL%};MD:<.2]E '0F$F }$"5\C_W>_T8 Ӣ%t˩LKnSX`UPq#UݿWuVeP۟ Q2B&B%`g/Ec@ C2$vaBd8h"@O:~%+A4`aaF/(>Y TwOfNX'XP/Xs} N9zMSb*Bo^t׷Qv` >OI* c?Lj)G %"xcI N+T `˫( F8"2~i_KFӒ.(H>6H (aE*tO wsD)Z>&"I},4H(0$=(]r]u\C"|90.^^Ib&iKPj _.VdΚa>F6.`)gʱ6."^Vbײ]ɥ.$1|'"%1Y0br,\2A%CNɑ󋜻d6ItfI?X 1݋)R[3.ʱfE b $/42܌T6RZ9CXzry5^ Cľ+q3D[8(mN2_"jbx$)Flڷ_ej ,AN$2L\%jd8$4X 83rxa5 @A8 '^dI@:!4 s srXăx>Fl6k-2Di9#繝e?t̛.kSgUVXXlX\̳j)Kt,ntfxk3G_@]2va@fBFX fOEH <5QERbFx뜪0a! H 2)U4 "("K@J m(e~4K?}8b7VD |lGF>"< .*6d&fxo"L#w sG]! 1cAfv !0@G^V匮{AIiU9tx}[TiT>^b/jbwOB*$&Iz1O2! )9Fy1]+}| ¢bEb%w8-z Ub*款YYDC&x [Xq/a+> cB! e5ͣ*O ,E RPn+}w-ʋRޑW>>TR4|&f Rг~9)~iFH{$@޶*}SuYXIx{&{.5+46Xx9*~!R}_"ukcƕm'kx1V)3cUFLнEn>./d )ۅxiM\EI XVQ?*mx XDcDX7h/%"ԣ|񪶫xF7wREz}I&$1 DSL(׭rOb@8L" LBH(LbUU8w^C]xᐓgw/WD%w+c̕->><$Ԡǔ>>teS${w]F-?t-o)kؤCo,zW{e; ll3 m? tHvHxWIBzTcq,kb5aj"4Ta{fY2Ҽ`=5 i4xNjpC ]o >ߧBE5@}t3F?k[W,ejIIxwJCJѴ-D6 W I/N(H6??D z? EO"b IB\9g}>γ'祫Zǡ/CsX"(!@(~Xp/7'=WTxKl_HuߑuOw= *[Q䙒疔햔gsI.!8Ճ`Ub_THY%r3ZmM 9%:8᷉g^꺧!wF!VpfbO]4<~1K9Fy^-83Z$8γۏIYnYD_1rpnaiw.сntbꔐ^7yUk)P~T/GzcBi΍upȚM.ճc k&fML{wAa}j]9ýΉ酁` YEOCJ&^ΉYV .N{d[Z MX:vՂm'm]ne 堥pwV @l2:3qw~tu Ff F$1 nź8ؑ3fǧ`\ߜ۰Hbg`h|0Hx,DTaޅw׌( cAlB0ja k) ?gBʞ&< 3-.]vO&,Ż>C_ .]2prkܞO]4X0GR+ !0=b<-1N,YH̘EJRSàkrO12[j]|+»/_K^"wDcfD fX L"„{ H5rQX qO+pn?(k߯wς":zutmaeԢ{m9U||{':ezݵ|x<9CTS_VCn?e˻Qt3iύy`.< >mZX415oL65хC^]4=gw-ٍ'R9CTWԀRĿ6Lrl%xM;2D٭9@,?02ؔ aͳs^jĦbt$,"Ea.ͼD}d]p [暒p#<&~ѳn>t m Ʀ-m?rtۿg,n+7ofp>7 fG(73*݌=BgvAlF 6Se hZl!rWEK]Rl%\2[v ZwA9oja CSfVyvb< ǻ4>'y׭b a%U:$_}"vnƾsuh @&G3fV6myoZ|躭.؛pO]|a2a#Bv|xv Dl0.]C]7޹g+ 7D)}"Q3=ZT/>^rƔcF B~a׀v-m_b(9Lx׈ͻ&8it6:.%9+n,J2@f@ z甹\MF ߸> /ɍ%M2J@hyK{O;P{zO],5L;To>Ϳ^dav1m.D0%"|̸m#g⯧ ܻ~)WE @Kx9ʱK~ҸGgums x@`IKrN*E-ŏ D`ahdO4) H!:)-mp9)}t a&6uM-(pC9(uUxCIİ,H(Xz9<, Fp8+ ˫Dt0oCbLky9_G.-l744h4o9 ytcS-J}? RtF/|{%5jK?9ݚ}- yީ )Fqtix O^GEL(uJ)Y@vR\Ϝ;>ÓdU>~2C{sI+HqG˺EZ987 ,XXwga}/DX+SZ`_!M}bT#loWoͷu(-(ثwA`,#,h-Rum&F8b8T̨,^;vt@ HsKp(y^w d`دFI+as}ѳ?lg.Axw}ҦkG",YM ^j /..I@0J<+ߑգ@ޝn }[7/`Z0xѻM=chg %/R"!L׌"A)d^Az/΍-@ 1J?ީn9)a|ә_c{Ω6יVM:rͻ/Z%0ws[L,50f̧~!f-zņw|iL2ǯ r2/s= ;yWS wk~1gqVN- ,f,9%xƗmcSO_6eu+ ȿiIJl2M/'N:z~Vl,b2#7ã/&N%b3Kz]bǙ"<=#t i_ӌFfM,Zړ>1wu÷t8X |˿N~t8SZLu_%k>1w Vhhl4cFS6.^{F-fwrɥ9.^˿> e9XƧ2)r//2c? N7 hI=p[,ʃw#S%a)|U0W5dC۸z7Ȍl슱pM1"OGnoG}bYGl?0p;vhla'`ڜiՁvt%d,|}1*!(c?l;ɺs? Dl&VM[;{u 3`:jOǢۤ<2|f'2o,E .ď=DpUШ=L10.`ijէspYvrڹk \< տ#1HӁoż;3@f`%n}%p;ƅ.i˞8e+{Y#vnli ,8ۺL\``1w%F9,HbAVX4RtFx=.yy>vYfg|9iK#vj&m}?L{ج'MⒹdyAnjR917'8lہwwPsw ,XWs~v{O>kz%U’>.~yg-b;O8cx)*1>>wiHX2n#X ,:,-=ՁF84)cA*my]?9K2b1?˄lU, -lu}B,ַ[7cEO=2d߳O+m8Xm-]O+[CsN7TI#+,`"X ZmcO^6MNwLnHSJ,ndOIw麮Z,Ml]3X؃w˞`1bqH'^M}#{Fwɽ_!9vXeNǙL.tb_"G-+zꆏ޷M+1m8Xm,]eƼ6^M3}{ߴ. 9K/{OL<g|%*)>KC od_-,Xz7utC2ۧR 5w}lN^S`)|^-s=bYo==t>Ku+)vom,;y~Y}l‰ˆJ]r On)|)Mji`9vqC_.Y929oMamiC3'Ϗ}úG-r?qyd$9pX, R!FHH.L#cie GWo?;*dk`s9sA24M'949'ETs 3w=z} osϩڵUu;k< *:  Kߺ"%tv"|}">gs`M{ R'VYcE _`NzyB^Ootˬj: 9l\r$(BLTz YժЧ/iEMH$埉Hh2-L hz4y+z9|TdZR,uM/~ Nki6 - y5W F&a X) )E7WX8nq}^:cb>DvKH^[^0릃%{5Ӕ6^n8Wt Ks9F**8^stL;lrr&2I"P>V'/^ =|`$JE uw|}Tm ,)ҧ05fkeNŋ%VEi70*[r>:WZ73e2]}S[Dqr9UTb+WZ ^zyWۺ/0֛@U!u+OHSÝFVk==_&c?PyKK8#1 V: y>ט[7 X/ FP vG>dU*פiaUө\$Su9!xhn.ދMmghLUH)Ƕou݃gRs镭j^Cn,/Txݴ+IltYj0[d2 dA_.pDNG&'b R'>xa-h*.ze|~մQleqJLQEXE$:{bSuN^yv)>[:\U7ih68bzUm|٨ԃ[VڸLSEiH+F)WV?rݵ7?:,C2R\ϬP7o`A  *Ćj  IQ2JD/rO.Z$@Q[X$KfZG>RJeDHVF_Kj/I? ,jc?b(pWظ3X28e X2uyl,b<c4uqʪV&1X2,Y:&K-6b;(T [M-oVBL5JX8_|c1~D:(%3Z\df;<<مlJŒz8+$ghz12acH2K9fdCS1A=?r^2o :.ZPW{mam7l.Z% _W)/J}?ۭ+'#oe:^2;4Dl]SA\}v}t,,q4ЪY4_h(o6dTYZe|aDzٹgFoXiwmD&EDBQrhjz V{v4yn4_hn'f]?SA Y|' {uF`!g@ÛleV.n=t9c)Mo{XKEfݔfKI'#SpF݌N(3Cxj;n?<8|l :JY|¾8ݰ$Y!WX'^vVmXj2Kl8rcT3Zn` +$W8>ʬIeING+=3OS7GUp@ Y:fz #Q(nfQm|E. c+Y:r v3'v: YUm<#kBOEaL>ZP+eeVe} TꊐfЪA1[bnPBܫUHCF ϧ A&s9xxҶ[A/0#v4W 4<4b% i*ZQf2C2{5Pj"6g=wHQfH yFUiEҘB!禺\Cv6߸OJs5êJSixuc 0NJyLAݥcI6x]Y3YMo46g*qn¤)f.0_ΣCc1P*VAϯ;LO1/fG c2ly|ECc@5TI*:sp^oϲ0V:'nY▐895% ]~g3AcTi Mᇀ1Y i&Ȫ/i"%,4AasZiEoXs&]ri d4(K\! (E\ iCjx-Ƭqnv˕4gU=/tۭE欢3\542TQ84-y&vhxblQ*[>¹R'sT hlHC5z%6[|?Fadn-p;Gg0 ҈r{&< ^~ҷ4jFW;tq73ϳ`@M7Cv~ ^Ϻ[ROdBW8x 1M⏴]#/P5QE{2[=9x!1_aӍ?9q1jNlq#>i^b{#lG404dgMvvv'PZ$DTћo"ιƶS5b#h㘚 ]d j?,K,\*!"σ!?iId]}~$ɬ<wI"VzOn ,Q6<6xQ8>ytdaav q~ TL&fU7;M6 D NXӴM M/$Ұ qJF}=$0_| Xjjų'~~z{KTS>)?BF tdސ%8GϷ^|st],m678u/> ; pX"Bg<>f֠,@A n7Ir/%-*c/ޟorqB1?Bḡ= ]hf=QDt9:u4"us}$g/h\i b@$?4H#4W% OF02;&vSDX`iLf 8uQ조D@ GNyo "R,@|g1#l҈n8HG_b.`Q hJ-k]ά:Px86,…CVډgٻD1uiBH(3 E u!u!Y5%`鑯*n˩=Qydt(J,%9ԞmpV}x.iVtCK!8rB,`@<귿Y>,AHzߎG"&7 @,2X X=Ɩ;`/B![٠w\`]xChZ(ҧX+_%[.Qp9Lbሴ"z_d9v(e E)Wlx*(Оc>e\x/>)ryRX=@@O )ւSEbfOvloLcIZ 0u%UUD_6TG40jgi˭qs6J3*ԀwH(䫻e+:$rOH dYl}t멺5a !7U=qg,K5M0dm 艱;>?v"./p5IaRl;? dsL!˿UO%acrH}0GxC1htCds% 7``)Bu.dTcjؙRp! O<MyÌ`T&I/=2RPE^=Q ^dJnM-_m܇C&8, 3bޟ$`bv@3FR- 2Ä#$Ʌ?7]& ^F:>Od" #d ?y%]}q5"""/"b=)->!-g,>ĸI=(N{M>3}wO]w>2Q=j;C_~λ~m׼;~;_ .U?I=ƧyԻZUi\Sg=>|1笈uY 3ﹿKTd>8sϿDaHLߟi־] C3 W/`Vm _qOq?#`vo;_YyKiCI}1 WۢǮC?ov=o^XsymMV xyKS8AFI].V敱ah+n:8]XSo0HxPA+R3ҕDxW@@Dw89Fb۞76],(t*؅|4D!WžLfV:q]yKFa,1;b wdإ_݈892S~oHy2:"r{0ײ|d^iPg˵;]yIaR&ā:4ߘ!&dAPĐעYRB{ݽ@j gf+]#T 5!%[uDN1H?plzXwY 6vZ+Rԋq gR+ כ[pt=s^D3 FյÏM<$A~LbxiC$e\rJr֕~{]lc4/dk,Yeh{<i'3C^/a>cl\UQJ͑I<h7@橨efәwHi|wO70`uU5Ue%_ ?u=r"u ,e: K ,\n ^l~Kv}H/Mz-\zfllШwwyX-1X1:S>CIWqg ׎ݹ9d*p[[>o@tn Đ߮U^-UHv&с뷶800Fs,d*`Q[d>A"W]YWH4,1jAbRDd!}w8X"f0Ƅ"BQp,Y9=]T qM #;S4# nWOJauA PH4EB Yswf?Xu12ijŲiBbFu22E+ ZspDjZZanu!>-;^9nñh;xӦ^^fS"z9q߀=n^b92JJC{6o0⁓\Pdt5-OJ;͚{1f%@:_ Ija%5Wiܙq911_; ʌJ)T`,5Xkf;gC0D19_UQk3m崽sŪؾkftԸ[IU$<£tXon\h[,3y*Eګ̶:y!6.tFNFU oH5xIQGV"~fk @o d_ktk w%vpgk=ˢwM*UJ gBܸm"-ݹ*YtE%]өLեk,;iTWT%-}~Is9 G~3@,:_t,KaG}vym[o<  2c6Se!f;}^>'?F1r~zxI5v(bG%|-a#xXTh3މ )(T/b hX{.xm܏P/JtlǑGna{X/3  dX[]P]gJI@*mƍ$X~,z>Ƽw~]nYQGu+z-TD"W D918BY G|q-ak>IƐ!A;^6tkV60*䓲Ÿ&[& Եg3T XJCu1WUdP׉p_DNHLإ|ǕQvx%W VB,y JؾlxŲPԴ@xCrHQsϨLL" VAP ^>L@ I"4duՐXY`u &/j|JFDL}86X?WU}6YA l{6'wt;8R61WӸ߬%+e,#&@[_6j43 䒲/=9z.-bfkΤ3 rH+x,@,BtmF8P ˯ENkcWM gF}B Y iJJS3kKE}3vVJ:#8xyxy[v~N+#⵩(b8)v]`eQ泵fӔ'SpEg CSVv!I$xGl_յf2T*)/`3yl-hq )JfAZphFo('DQ)QDE /ч(3h WRځw!$^#@/>2aj$ &f{6Ҿ˜@CG( @EB)E(M=$Ayf؊M_CVRV)v^^kaTx.[k:1/- :+M79ዞ1 x0DaA>0="@ Jˀ.C_){92íV|џTDy PU؋u oh,r6e,ʶu_qww'F܉J(-HH!h<!}}vR]~ E7wڵ\79pz :-}aKDO i>`"vDכZ[B1>D9ߩEM&Em郸xAxri{+UryW^q\ohBSg!5WMf^^$^(ó8r q)7M}Xh+xz ${bڭt2fEVcaӾ18BVÿ܄&=(aͺFY\ZSOC8#fDl*m0vt=]/G-ִbFΑ="mTXNʾ]M@8 +OV#%jCI>(mkjE el>U})J ;^gI ri:Z0 [*jS3 rk;Ԋ]H88p&30ƚLaLCgvkg^\IU.k6twq4̰kT]ݦ_y GdHO$]6["yTugp;cyGX[zl#E"X>v"feRN͸؍mrXk` e:vcX)9|~iwT3E w 5zKX<`;m$bR2?΂|B-M+ G"Y^P r+>(o$ slqb1򫨙iW)Nɻ{_z4g61U;]?;uUbn9o5 Wa6ƺ&c<4Vv3!\pAk ̖pX$B -f6ݎ=p75_IiDBL?eWo^^֨U*ziؾޛW/f檩RJm-{] 2Y.VRϭmӁB*4]tچ8uԒz+?/T Y9K:kL8wED܈P)G4{;Fp|zdndUU $Yz?pp`bXVa@,[k`!O,ѷUm~QO_tE $vU΅籇<:#z@ Y4u?VT$q W3VVGauj4JE|h7ۯ5^Ƨf*p]xcfb>ƒq'[ҹxEIn}ZIlFW'r`fB,s2j=-V}E]ː.gT,2lWqgڭCNz锂Kf9,T3`YYoL_ɬk6}2t.pQ߅AVujQtJlȏw87&Xܙ4eؐ*G)2'lqGZ-Ć\Pu;)|h̡O۹5X;ΞL-P.7j_c2avq8!e[ҹxpL~}zԧ^զ!/x>fobsBL]Sk{G\ OZ\ F`+Xt;p{- 3NEjJߔd(.gO"VZRǩ~eIť f{`YՆ.$rmq,!"e2,#Z̺ BA7ZElv՘a{\}6Z/5ZRcL.*tqg^ǟ>"YViwI,oXXbYgF|+`7!0,ȤQ 2 X6Y, Xu]Y4Ekl\nSt18i56/8k kJ]L:j2-LYJ8+cSbeh->ޏ7c bY=mUۥZ -`9STSK Uf,q` X藏F+V0.3:FB]H"dϔ˩Ųy@a!6!jf0KNzȤ#ΞkMmjcjTeLB&kLٜ Ze+O~Gx#N,?ʲnZ9Η>-Z?Pc+L5v5.C&_2ha'C̚N;iE<p\oj ? 3y3G.dk5hqo#ɀ2eje͜^1xO!@}~:^ө QɇpYiT{2o c"- uM6X+1iw3T˚ 1x#N,YM\zz/l(t% \uL֛9y7TY  *Ćl#1#rR@! H>  tD,%Tj* :  +KLVuG[T>Jlɀt,s\1 zBīiEJEuOtYcbnϘ&ЫVr7j\所=n`YG]gz=w ORPX˨4tG|s;):F Vٜk YAQ{}7Y;3[AM Xi2jzٙq7 `|qrpL{>nWh˭J9oJ ̢*ɂ[l?xZpQVW/tiRɗ˯zw*$vf+ -pug8ӕS\|\a`edp*ՊVf}/|$,xZU|A3nw]mlPC$L*kGgXv )UZnWwFroup_mlg 2Td#X?v'TAle `av+J+>|7tS%ZFs.3Ts^gq*ejMW'%XfP8:+6=dp\ I*W24iG!"&l}ADHP܀E!-(3qVNgQ;߱U_ekR O%obg8 ;O)󚯎|oؙEsL[5]ru7KE a,u;5LGpXl{-{9![:Ry O-$`inqgW\/xR}lmP-3M\g GEz3TZ'pO:" 1 [F=-Ss%!DPnVZeLUVȩ0Hx6d> ;$\(_4DOXiuca6e:dk$~'hJcMS%E2ċ Ck 8 ;ٯFC?qI.-yXKzJѹCO¶5fP9C)ec//fΪP,'Z`iL=VFl/3$ i̪L֘9g#S$ iГɂd<J%_:| (-(,m eiq (3Z 7flZ71n;&v|u ,Ld'ؙ}V9Mr(H3Ұ똮tgR5t \#SGVV茣/%ܞr^e<e@MQVG\ibf ג (W [q|4>ptUͯsy^MnK𒉟13Ri84rtZ w40Blf q;wyx4Z)[X=LDA[.7EPhUMUQZ3ZmjӰRٮ8iA3BbIX#ԚnfⲎFK"`@3 s&{OO\Nȹz<%vQZ}REחN~lb]n"^f` ijlYgyG#νL^*WܨZݩބ2{qЛ$ -P)f|ow[f`5_ÀPf)*3 xFL7,|$@B ə,=eV+2˪u$ j7vE&7Qfߺa.34n~y>&F~&EӸ]>Ŋ;y͈2CؙX"r/dLo*3BW Re;y]N 74`4 )c7+n$lOF{ƶ(!HנXmuXp !Mf\i3jtGKt4juNnO÷҉Z_5Ct7i$_45i(3 F!d(55=^ |$(!>i#5/ZĻ)#$]qnj4pPR&B]3鯍9h5 ([}!>Xpn ؜asVb&L6Wo+n~EyTMC,[u'[Z]LQՔӑ)^luy&~ajM!M45 < 8k >qL]iȮQbLGYo)<+_zˈqDYF0d[Yfl ikRedi[>2ZZ]l4e۟v.~&x={CmWίR$oqHc:3?o5t\ e6=wy ;}3RI4䏲: _iLdWNǿoVQjRUr{- a:;%TNNƉ Z8 MW[l}pɈEjZkzh# |. ÀLi '7j|s)@2"yߓ0Ĺq t S[U Aœ:;WPlLd!} ILȏ$~;x~LB&̊sq]A<. D4+mrr<,OᜂHglaau q~ JJ16'km,ҷ D ~OTYs-1 MoTҰ qJ&#$fI`w}GF2`iUCȔȩ:}44~OF'eMF *M>]7GpZ;7{e tj ;XՅ r|%]܄+>rm/bG`!qDx"`=E ]\M/PQ<a-oȩ)qK0! #<ȼ!Kpɨ[]yj6W>mCqjC;:MeVᑩFH9dZA؋Ir1v)DoYu+ <6K [` ]3L샲#8 Aۓ)'#1WpNHIYGqּ6 5 b.lVv&:P@g:{vs4 Pq? RWeTlb5>xʼn2*n)h.jFvQGCHǞ'Z,_с(`u85xIK*:科V[?@34Ba= ]k_$Dx)JZ.OȗLC"9;<pwpXT"<˄4UHnIsHi9ٺ \*LZ$:~&6P3^ |1\0YAy P 9;x"ڹ.1ÃsxL1X@|Te1#l҈i82_]1 EKTZي;ײ}j㰵KLjNehQ`4#Q>%8 VZ`P,ݲ6>uЏ(\e+cVwնnfq q8 e%JBBL2_R,$Z-ˌ4W6 Q8ȿA@dUtppxt 8( & l4lѨ("ʿS'|cA*E8d]J-="f|] B7D XH( 9 /F.c4loUFjzڮdTJ]Ep?D+` }+< gepAóbmZ,s)ހXBqHȂ văf΢M!Ygàá  rj& B%U75v<"5{j }Dj{YdEuDAwod_w)m]s6PHw:G%ySu(JL*EZrKrCn|÷Tw:[JmApW3q+ `-)HW =Xz^Ŕ{"7=(iǐBQE zV,Hı|rRZdtحkqcC&.BW[La ]ν*8Q>d +O}Qk<]Kd5;o5)!j[w*E*v"tLJ X W2_壶?Cy,2* ɂÈQ!AmE4^ll i9|UO,7*@Zߩ4Qj.kB:2 yzV3ShDCp%WQfM:zK<;"\r .oW@﷼E`6(˼Ur9쫂){Eo Zq,tB$AQoukNe+lv{i$݋ieRyuw+:Z+X 87ՖQa^rKgH"Y;?Zna\slmSDiDwfp `9Wq8x`H\02M DQjOae@1;}_lx{*[7D [f ƵŦ`u w2s,2\r1D]ڊo5!oXAq( Ŷ3p?i(OD 1d<(9o%C1Y?n>rӈ|mʮ; 3^M*=2ȋ`{Đ"q0K:2LbJ8SƗUĢv~AAXBVI+VU/P'ca@h@d|r Ce7``QiUjBun`iص:p! ?Ŵ Ә|Nn6c +ER57UL|iy40uje2>aE-0Et^MQ8}x8s"d!.V' t?b$ܒ `!s8A8B"@\X{C<Ȅ+7H'ȏ^IW.'GPR(=i?1g0O]G뿭xG5Bcb1~BY_X9 ao'=N /8(w{ILFNa!!BW[q#n*bSkM )5Aq؆>&-Xր Ȍqw :("6g'G_S#W Db u{1ĉ8 A"oADl)ڮEӅ#EQ4*DP"HЛiGZRM(*f-姬,H'(_~ 1w ˁMVrKbQn)5j='Xa(RRaXDYޏ&F 9#"B9H9LL\S&B%0 8?!#k z-q$2 ЉOHSݦ!EbUEۍh1BEH$C;`e4yZUA)ʑ[S}R*z 2hpl2)6ݯDP\@\-)U4"$'w!2HTj @q%cBY{'EUۀ ֈ( bQ( i " DP`x(䠋`$**yU  ""D]5tNWYS a?>7u֩ӿƓw9R"zҌ@OtKOW!veqҒC6*狆'5ك絓f.z}%I*@I^Z'DJI\_$4?$FЏH7Iwtd'pGGNd3.q&iu\"(lg}g\ӒKӋQCAqFN1s#@b=N "&4#-3L#Inޠ(9܌vhL'-ɨ)r-n=8eMvpiN}ў,.:>蝈!yߓ3P2@DZ}zd$-Q2$J?1%#hҒ77zJd bd?GV-O3iQ"J6Y$wzvp=Y<,1>z DԁHOtp8+Yy{@} wLn=qzAqHBjt:x?##z>ob)IN&>X>愻:O@38)z7?_HDEbiAfF3qUOɓC%#F8-՟{X䔠c򍬋ǃnJbc0q£{2Hu&ԱhS"wp3Rgr>㓆R" LB:;p"u BIKǙGxY]#e$p{Jtz(Qc|1 "DzDC0Q:]LtTG|cHdd8dʃuS9iݜ>17VtyGvdz IfLv} 9wL܋ L09ܦ?%Q2J.P0 250=eɠt|QZSO酩ROS!қSoMOIMߛFKK=>15(}JGTtTcUO:-}D$UӾNq-|[19s>٭pZEOC6@O۲x)1x@z ?hݙp}BTB=TxF_ TmEU1;ͷsNC"yo+Q$C%A7'ܓԜē<3ͷdew|۞gceq&o27qQ6isE0ZvF0@3S7ͷEMdpw35-smj;>έͷch8KL3oۅvq[>3sm.Z'|.ܵCHoۭvl";7EoyL-e}0ikXl#֒WZdp xc%kz-cvn',JV>aSUNU_5Lza0*y(XYgjwSRy&We `BXNU;3-`'UVW%vUnWwUW%y2рT _5Lj+^*Sk@P*k2*w+ZPRqU*We@=Rv6K\QPwR.3oRB>;ʫ[? y #Epqf8=T%BU.TCU U^TFUFݲ+9Je*)Bk̦JnJq ˩*שR~&/.(0*I*U*ar*'̥J^Eey\V%)gR(;f,3?S@a9OrY3yВ*3*?RQrS>f9͢*X*Y*% CQ-r,ʃٕȻ>TK%TKܙN?)E^yԲc*}1ڶۙ<(R )rJvVX%XR%^R&dRy&jrz-y'W )R"/R)#5R#;R#wߌ*/q}/ʡHJIPHT:>7k\FeiTFjTFelTFmTFqG^x.ڵvQ|QQYHŨt02*)2KٕwjuMQ SQiYQ_1+hQU\iCʣ'R~DJYPF= /4~e(ީGTD%ITDJD2AJI'P)[egWqG@yJ|܇J J,JY>OPBOQIӋ+/GI_ ??5\x^yxIOo':|䅟tvӡC+†Gw/2>\z-ʗϮS+oW{GqYݠUJ5bxϧz?׏EOFݸC2ٕ׺e}[.M/#l.oL^yhtTjEZm>PwI|pIW)I;$o }^Ͽ; upK+x_}ϧ4kWv{oayJR3:;)^ w?;{[i.? GƗ}wUی~KG5_I Rwd.&\?፫9 ;Mg{.} 9^[CqggJ~ϐڗfxs+Դgp[[;qn0}g.\(&&gH[g_n~&7? ˮv>7?#} |"y?%x?Tt,7?#^)ӷ=Sv>FL;g,H=#^?| 0XO_v9cyr3EOK8ߓa<p|r'3Y1+X _v|X1'~U4cֱV'"1y<2/+`*x\-r;,KG *3c;l37c34=DoıUݾ"F}#3.e'ǂCH͝`u'-TѝfֻZƝd69üǖm^i~p۳8ޞ@kꭌ%dw4f݁"vG$vcWWjPnl7sho6ݔp9}qnN9vbHDÜ9'۾8rv)e3ۡ\gn*aO ;iv-\޻ [BE-[VgeL M)]fo2g_F6_^.?Mm;/sj⏳Kms. w.v2YٵƙLTױ7pzdt r.lϢ9,sgQd\ 'g)3\޶3n.ts6w^ƚ;~:Q\?:Ү#^3uAd l bʟx: lF_2 @ƕ` q?^b5>1`x֏=907=]Qn{N's|1Gݏwph??,_:/Na 8F%u q_NNFa߈=fJzKk9_dl6c&l ?'_ߧϼx.J|ll}:{K(oyMI8n!a9@# 'X|IiN7_$>o0$-9 omJů4۳8ޞ@kꭼݒErLbg3[Tۋo"HK)[Yj9%͜ќTMűMM9UlQoa圆8rL@S)~u*.; fƧ18dB1\8[)~w]A`'|~H["~{9_]pֱ>4 >7777Mѻ7(tcDO_nQ[DY4:IlTXؗo7[MĦ;߻Yb>@{9/>2ˌH1/qIݙq3Ѿ~D"KrE࿈/_e 8b[ LY{SY/M,<s x:vFt(:8 ;5; *;gu}`q|YD>/}DYWװo-1K` |EHL7ofl\a8m/ط.#0ȼҧ?ZxOì"O>#Kgl7TW3cD'SޔMt57$z҉LD7_FcݍIco;`{&b~,\e4X2{u8ױúKDgSHS+1lNOL5UɉDP)1TMs=#׾Ży|._P, Wqlq+/?xx|ODѽm> H[Y*]g6=ɚUGhٜA+tcn[`OD-u` zŶnf>o3|4o7ͩ_VGwKy}L[bڞv_M~o%#;Rճ?yg՜g7.+گkXeZm[Nnai`{ %C9P0{ćQ?f-yVN>aZr+,𰉺` Iԇ⓺`+Nx~ڏ BA>΃W{yKH}{"Em ."57Oӝ;)ER},]wj2>p`ߴE_>B}Bߑ| uw\ ;#i{ sLd=Nƈ &v-̟]0=){dLin! ƻ<-ϱ O ydzJ絨8'z|)`(}_ǿo`\p},*moIp>pc*v m@ƃv) 5/!y|P|N;vλ KfdtGӍkwu_؋NLo 7D]0^_'RI Ŧ:Rmj'nSgm>bv?C GT?ޕK>ȻMv@D,:~L7i4.;,>ǁkw(v?XwziǪ{bUivHT;>}j؉vR!h?VǎeGΤ{ebqk:vqCo o﫨Q?ݽM: b+OlgcG 틱xWΉ@ i=ͱٴ~,Enx oMQMy n*|BĪ/Z9-e!ۋ"bQ8.gWq΅s*ւu[.]m?[X+;?.'ؕ:Mgːw /䜆N.3WsN UOX~}SԯJ^I7[}Qp꥝`d5rZCy4dFYp&r5lyP\ EEtڷ菛5/.נS'T]Ft۷6] `N;9t=4{Zv~ [7=ztzu9ޞAK͐mcgF\2g ?%wK8_Svsm*G(&F6}p,:?-elb=Kz >'_/NC~桾x-'o>&vKKߤI=a_@δoQDŽz/#8o8~S2 ̀oA;@ ?1w$xyyyN}.rl9uݥ`] >t_;fߋ`6g"߷5qص֥kJle=|p~~v#Z=n׺߸=lsOb?rP. vq4f~_Eb,c`%Kj@<8ܮrCnq{HDZrv- G9/gW{W9'uIs;=/N)l\'ŦFf_Tb6o] qv-\M#K sѥ ?\fp}Vׁ 7;ERnw_bw=P ?g\._R ? ?%chg#XK}5Vr3d [B9!??Gr.:W89r]\z{g 87`s7lu{ DZ|s5H{!kQt`m[Ň+0 Mνj }b(e{'ra=H{9o q{>~̤tb?&1>r'~쿃hG!'Y}edM1 8F%u q_NNFa߈G[|M_Z"c3wm\w ~؂`r6_/` gckG!! ߏW9W;'ſpNTo-Nűks?e{Sz:\i;=_J|rvK*` UD HMg& H EJHBzP~^9qDD%{3gN?}̰3u=m%8I͵1u^K@鷙6Sר'2[Ub\nQIC>&=1mif Q?O^&c1M+/8m ա!F/Sn1p@iohaptA1|N$'r|FS_>/c;tU Ld)N|܃^~936eF-T̴0NŠ$=ER-* Qg9ij6$#/:\8f+/10Y٘(ԬtCN@{G)J—t eϧrKNg.W0-&YH̱PI?PMe0LYg(K[@{>0_{Tad)|"6[_2&L~{tM]].S.GHWiIJyVWTj*4Icg 6_Sz.KjmdI?}}Kjd7ci^<[4$ !ʻehQۺjR{]JW_zM@jNj-!xVF>-I9g4ug5tiOjK< J]ɼפqުVf6ɸ忇Qvji S3P(+ؑ ](stG3v$amIݔu8Sfi5ԏǔ[ӓzXskIkˑ5eϚBH/뫏.[ߨ|-5Tu7\sYC{\tD”:ʳ-iJ%9%UR8y9Ys\NR%.CeYyǮls5 փ$ވT,-}+u)u-uK$+{%K=] I|I-᳻tOz_-<x_ʕ>i3SމgoV/g V2Nϐ{YQ鼍kޱ' i9DjeiMZ[Hm-,w,zXzI,YpN_=j/eO ;>O- |zKiUsOlT ZZHoPTI!{h!ߟZ]+Պe$)G<$۩U&S^y3$r^nQ+/3r1k@渁$3{Q:6ݗI=$tIJ4rgi#*fcqϣ|.gQo:&j&_ Y 7N(8 {ap<|#ݘh sT >d-6e]vW<ߓIWNs#K#O )/|rnҿqmuּ^Z[R䢤3c"ySWW .a}5*틏|ASN4k})iyG;dڟNG_w)[ؖiCm(ͥlO'GSZiA:yZI M&'?y~o%'/X'3^dX26uQְ39EM>P^$rrS~(ԘJ^y<Ǧlls֑Tٖo&-'kIGD*y|4$ϧ̳Jy$'IXINyc_/'+ SVifZҿ,szOjM]eF ʟ\n)!K-i$yJiEJr:qJN$͒ JNݿPrKKr/,yӒ[R%/|?Jz_IP{Pǩ_Jn.ɾ?%*vg%+,d1}.RNeؔ|Zs파14φ|ZȺf}o4Ťac/[jnq.[\ڐǤHN$yr$)krԑ4gq.-Г;N, zgh)RbuJo+~c]p;:ְ]ՐK~I^gR=O]t;|$IǬw}-loޫ7\.Zނe]/yw΢γ?{<90u~ SU4sgq.-}lML/5۾faH\cT^\Φ$g1"FsY0yFN=m7~="bL4X#p:|~q=G8ZhxGHun6?'=u^9E՚ǎԯ86$a.~DG}mX2ʁ ݑDZ +USe%@3)RJ{H*^ r" fG6rTKM¢FDc!QŹMhhࠃ?}~qnK?~;cc@cM bl#MSO!RDFGR R(mp$d,q, hB`6 zx&`MlC#eqz_:r4iF8hfiؤIEEߎλŃal .d$y|8~1ٰ]u;NfԖc&6blMb_ n0(y>X=O:n^u\=kc5j8`88aMʹPyy\Fh6 FMBC葯&M8mpʞ+6[u=as̋1k̚#7OVƍc=Γ{GG@)j0.z'y@9=džl?zG}p;>o7yƛ㦼6j|葯D6Op_ݧWmWNnπѥSU;Gժ*jgPZrq_ kͨŌfvW0ny73ߟ}ΥC,UA,'"/ԩDZQng^ \%󙞧SYyF}隮=cAOg1#ƾ2,qh "!|PN) {iڔkY*a t24ˇ2fFŷ 1V%Ę; `Y򸏖WFz601@ JǓ NZ:lX.YMgm'McWcG #Q&S./]񄿱^p6p{V#ĝ0# c̗Y3w ١WY2.l**=ԟN}(( p"AoЖ=}m%b L/H2%c3zQPxzr/3hjxdLL1A!"3ں+S%.Aqnq\1XXyPb/G `ŋ~oeK@s4 K1̈u9r*Yi<4u0DmnֶpNG=*vdnqXE~\'=>x>kt[ݹK:LzT"=3c~R" J,O-=>dƆ=͑1G&cMa̗PQCATB+C7!௕e_{J) wʾATJ-#Na;dWq'^ #13_r *f_?#F"c\+2_fMG?j ʠO`J^(\دU~~EݎʽS Ky~IY  O>:p7O͆nb`X}ڮ^ݟ1TubmUiبfU-d9흘 3w֡̔2k=WƣTsA)ly,UzhW)?:#CD"rn\}.8oÎֽ3kQ[rT܋A |ztnpf\Pr͟ݘsbȼs($Y3ft5fmݾn /9P/2&2"*i^-4itH^g/;;@og7Om3qXs SQ(9e@.A1Z^̗Y3WƂ 5Ф-܋J,j3i2.~u]&fTjSDjJ͖ f5PP6l̿M}gt#͸Be'v؟ݝL/fĻB5sh2#p99'*Wח-3-QA1Et`[;2=AJ32x B pc,pcBqNMUdS e%j3"ѼoRǩ@ yh]-_O`_9X.PzrTܩ4H]rJ8x쐝nmٺ3?o5~j1¢VֱA6O1iǘ똭c gC`i7:qZoN#h艪hwKHzC J4{]n!2|éXՋ2L}T,O_ޙe&jrF+6 ~+p_?Cۀ[.{&^v<|zwu_ًLqBqnpj;`ڡvMC2cԗF62_;tC|JrVp9=q0:6|XMp̿kjP˾);URK%'o5mn7^5=(7Wr kz@$,YhUfX nqt̿cj܎5$mS/wgRu=B1ԫjp}=Eƶ0 y#P 2(ɺVS=,[aƂf#=Qӯ`UT+!J'65ѹ{.?Brr2e%/\㱤!^oNRg}T`U]"\(r* . x*?3))~oǛvdms#kTvpof)W+mQй}7AyZQpuU||YV3 ǒvpU3_A`xuONvXyPh4nlk~UpU(x< )+'' b@';97h_l~{}8jD] V8Y"f%_QDD[Fg`5_yp"`q .Ÿ^sk>yS[}dX-?SKE(k{rS<|:QOȃH0ϛF7М[AXv:qqW{oZO4vln>,i}= Gt~s.V$qRJ)r?"j^w_ g\GEEGQVD+_м׺/Ef0ۇBrnf(r;i4i=m4>k T薘aw>Z%->Fxd]jbu=1lQ:Ls#^7 Q p@fqRkbz[6nZaVuq`()K;BEq(P|@F6eewZ; Vfb?W d\;/ H@VysYVO}yo%LlBawb+`c5=Pȉ(?dIXy\5e䨲 ʾqΧ/mh?sѫcK{:^=je n^{OQPNplsn ʺ~+9LpՖ,{m#Vq aIBIƑMڲ@gh6G(x_,\}rn U 0pױk`f5[? XΕkU?fj7gUg/EatFvyX,KQ]feVw;"j^t}i_9~jl/d+^<'7 +7!(.^{^G(x^1eX}활tKVb߭?X%|XlM TUn1' ! xbK֋Hh'r$H(]Lq PJ){6(JD63'CBCTQٷ5v>_=)1HR퇻iV2z QjUepgєzW+3V J6NZGju" Z%:|.bj#{8(ܼP.JzB}Bn?l9u+'7)%&pU@S(QFrpe/칈B=n~?X =1NGaTX ׺X`8A{Oܴˊh1qf0p`Pzժ`EAO ѧOZg QrW 6G/T©daou!旁kN-)pMƅe>c\{Tutpdd1]<76/S(05ejR (n.GÁUʠ0:CX~Yn7/9q8> [G3p;.(ɠ5.QPJBK?ڰ U=S0a9( V^v'Rnvx b8 iK`.Jł- Po? iBU,\\ Ph4,5!`a&~iĤG FSK7!%7X?Q(乨ufQ]QO<ܝT@j܌!2a+.=N?pm9m?_NSx]=K_$.P( 4>kʠ_lE+>rA>DO<\pyG{]KENrl5Yx{7?[lg/[/dx *.~a* ϑ; 4h2]W}c>GJG=DOUa5 nٺլ_oмGUCAv\|Zꄙ*j:g3g<㢺5X%&cb/Paz{(6 @QDz僧'y><_>י'# Ahߚᜳ^>3..Jb^&۝7iu2#:f%6rjPh0u]q9.b3,s8=z)Ϟ+Toʯh 箏;yihp;[]f-ŧ[דFe_(8N^v;ex(]NaV'#F"mKĎB"ƞ0%*^dv=KThRzh/C5.{RͭB+ifгwXe[ጹmfrjjPmK^ZF U!̉=ѵ N32g9Qc|xs7SQ2:M]{Y͹_}TcE֮{J*6ct9uꅛN_GlgOH~=[ZF=>. '>҂(m[:4 :b$R%#Q&+iJVʼnWjH43&Xgr- G;OzA ve>Sv]|3Qke]Ubt \gXZ9|DtHKĎ#$|}PMbpV!pslإN3nz,^5h){X"{9ψL{(%R%fH$(Q#oq1{55$PeV3MMk֮\+R \?@7;S?_>\n*ՕrL@Q?DѬB"*.Blٸ'1\/aCaY:OhLn ɞ=j)2r.RD##ܵv ϿXJA,Av JD %,bGt@ 4yY&/\yѕpbz`b'1bv4}+TZyt ZB᧰Mf@ @2tN2H$]ܠc"*hdvAl9"dDDZztX4UcVRJʠj&c*='KWebD1?^],gۋ0`dFQBW9z$GG80 d>1">W,w9CGDDAHEcj8%`cQDUbPG;Om)) ܥΈ㌹hFaH TrRi(rOWjV pE#V$QX~::L3FDҔT,璨{ BW9y&U}2iZ%@,84xkb'cF0#96~w}xAK;.8s~nkjd~X+_q3h;~>;-Fd=#2.<>N 9oO\InF'+bӔqYDN*&";F+,wfZZ֬KbDF|D)4 IF=?474qkw tȩO10`!a9O~->coE1K˷2T-p b24؎RN>'D^Y<I`3q &:.ȔԨ`23{-.˼/DbBcbr.RNC]a@R¸ ÌSpLշuP<|wLz֙?_0;&T$*3MXIfr#E&rsq@1WvQO""^˒eMX:$,Rnc%/2q|h^W/rR<Q|gϛU1}☶Or}w*= `޳zmk\/jƫ?ccA'L!<~/>w!/:u1qOGd<jPt?*Ӵ?{S}yv\iQk>^]%k<}>yweȫ7/^#yc PJפ{?}Ar ?ͺ[9tRwOwӯZ**pᬻ/ۿo SD4Ymf*r?ZnGTDИQͿ/O/wn%&.w~$ fk3_%+~20߼(r~ʾYydR|}'w &'=(xW8PΫ/Z4o:++Sŏg߼{>ws$ȀI!暒眔t+si#Cg7S\K?fZa4n=3Ko3#2.`ŏK½wxRe{W-xw 8%kZKJ#XneȰObu5IhIP_.af箘EŖ7N"n":hFr]HȴB"< pRKغEI|(!w]A'!,hD^6>?ox"z 6G*1΋s(ZVy"V S9'@$r%n#3 MPscB$g)ZxAN O x(c{xQG< َ÷h7p'ӊ@?FBOBw #2)9:oʈ2bQz1[~%O(zM˽YV蘔k{#&>U{5"&5ӨXr̤#& {轇<0l6i۾[AZn؀eM߬L+] >(5 ?<xM+[)yx}} HvDeM ԓZ'tPG_7=w8 f7v(B 8HKW]˅[ٜu+h~}0䪸&m.^A?!':r\pc ]LZ DӇqnFY PLAb")eQH!YHDTAguWo.X'ܽ+1%qӊࠃ?cqI;|ox4 62%_~!I @\Y" :6HH>HXXgGNn8wpiguX&;izHȸL up#;44j#rMؒ%Wį1 ?fkW✜gis-":42E6l;-{[eu}3wqY?7_'w\=;8w8ڶiZ5{fjǼy-F'Fm91c1b'7./셟[ɪA+簭{G9Q 2 LӕJ&,c NFAc!|Xw#:AY 1bG&,vF,~u[a8 %+I ׌NG p؎~dgs+I )$#z9Y`*%'H1bd/"_ jfΤK}w}>̽u196!Ss%8԰q17u9eDJzbG&,jPQ}P P ݄/+{~/BK:?*f8R2eu/t}h%^xT<"#>6XYA Udu)'X_*Z[9X+/QSQh2^g:\*{_|>)x("ǤtlgҶ{*McFX#IiJ)wPx{3S5Q-gE1Yw\ҋs,&]qqB]ūz-7CWnmZXX7SiZ46V522?MO7 EtΥ/Q{%۰5:ixɹڸTrL)@7)|H*,?P+8<3 ̲#S΍;6t~@}pŧs;{}d%&1#ƖK#p>PMr" 672%\ !DLcCC:cfVİR1?5f&@u9C7i3Ĵ*Lz:/"]G,I0p \ꘛLp>JxСȠ8ŀ +yW6%=AJ{K%! . 522.X&81٩M8,U݈GIy通~ҤG>Da&{-SK.ʊ޿ ~jH0Q2E%z \bN/:61Q[{(28.|2s6wiai~bz~S -#w_3Z1j:thFoUޅ=r;$dG4:;}n{ū{ZïGk+f*m 3tzJK$1FJ6ZigJhbzh+ɨQw#ooUk[y˷]tpdƈ!u%CT'VnDq!'QBaR_HÇ_ P`6:}f[+>хK &©7?gPEA66N]}P+PrT%([R%,KJ+ae\-EFVE~0C7_ jרgXLj P QU!ЙJ(ZqolxRdޱK.\KSSC|}ً;ywkm6Tc#DRM7k eRՄ체GZ!O8zB<: ~YT \8V(ʝ(cŖ"G Yf7 #.{[>[oP{)flء+U*)wFLg.stC.(lu8 3j9{<W94>ſw!TO<IITKSF]x,4p~ml][P_ί?+U\EIjcґJUAatFm4w`zYGOјo<=cjqRa1'Y};{5UY6T5P֛n\Ш֪ZXCc]}g7붣0:]JIvJ/qɼ }.^Ud{5qI_>Y D-@ղ%q`n\c艪WmDatVFYj%dH` wQ-CjFit1oق坼:756h4KF鬎QUS5QYAN>}DatqQX$py3oےTl_p,r讐7wWV6MV U $z꧳0:?z(*".\2+ZH*\ؤig.=/T* V'R UEj9P oYx*M{#v)72M.%L:ya#l5GlYX7V#Z @:>;3uRmQxкm9k3 p s:eܶIWǥ*~:zЍʾjfmYUѶEȒ.&L<~nAk#/ijlfYȬ4cFVJ@4>%+: .?JX @ gѯ:eݵM.Tǥ6h;C=hQ-+eU/'z62heCLt|<[\c{Q7>o1:rDףk}G6WS2[}l]][hfQu Ty@6K~ʣ?C땎YVl,R O_s(V7VY V(+yg4P o%VGѯ{c\67sM/'M=}ytH7|39{5T՝nZj辶Xݜxwh>28 M̅\#Eh]3}'ʠƢNVڒ jjā# &cuH9`†eU5> +TE[QJxk D'_6Mwӌ+yE~賲K+k UM _jrL.ݜ~i䁰AvǃpP{TSj)`hz^Q b@F ; wιgVjc|K#}nG+;Ϙѣڦ_ZVs֙fRHV|YV9ʣ?`aZ ъLbnq糖'gokˢ %IzV,XS1PCȬn^N^Z|qgWw9+M׈Nf°BmCUb\r25xj`z)UWR<Щo7d:{ZV]'6rDatFm4Ggb JX F ΜsgޱJ*0jx#go bOf-l6}ZVU]E k'Fgn~G("yc*RťO?ӱw]%$\n홚)U[8pŨ(?- YeVrqz Z5z]+yP^ K% ѳJCнGQp.ҭ0׼GNlS57roN[6N^y2#RAF|jPg [EatFQ!&lby36"2CUCkoH76wrOsєKӋ8cP}OyGP`qGء2+`MJ:%+a|šX<ZغwO/^1Ds>PSPw`υǽG'2 aϪo/}V#KeFś"b2iƜ$,ePDʸXJDD~sE|P#jT>$(LeNL .yLṰѳmCvfAs+rg~K}sdʸcZ`73p>lM*0TCan>wiNʹ ͭtE:JQkgJU%G3fM{P7S1>,Ѽ9Q 1_SK,rcSs4>[j1=E]ڀʐW LU`|VT74FCD>6|#dHtFmMb>ʣC}.7lV`ō6,zR℈f V~WͬYM&_{Z˓IM7kB=4DIDa&GO((fr'ğ+R &W ]z|n|ѳ\e%&M-)>Lj#5thi(JBatFm@|EPp2RV}.uJ I<5?_L4eIS`YY,2C+QRPP=QLR9W eؘJOsԢqHTN3Iډ*XjqtO,S(~}WoEOTE[*V*hDǕ;w{~J)Q'$q7~j'suѳ) ʊIS]ʱҁT70njP˟I|FJqp]ἄ+m]mri\4>! z lঽ}Vld^N1SeY6ar{Pߡ' lfʾ_+ _Z )QF~ϑ\ˬE{N\/ =prЖ_}J]=YV|o_=%@N,P(@h|A$҇IFU|œ ^lճے]ôL[ ~mg6soq35:bR\e̤IJH(j wbsh5F=˔DOYa@AXXUi22,O9wchp}vgEkd\M]Zqe%CQXx~Nᛴ:HX9pl(t@ 4aLbv]d@x9h `gO|VN7W4[sǝ448۝.w jέAzXI#/y?{UC&I-IHO(R ]D@Q׶뻼s̤'d&^>O;~O?с<)a23T98vŠF1;LΜǬ;hu4^:#ʃ?D $|hoȮP `] K¯֜̎92Sˬ;9y9M0|{;Qp3̣rv.Ơ+/b8۽v54Za,4b cbiː\,Y!>Y}ud^̎92^;0k8DtY-3CCsvQ6օ?8vn%}Mxza !6W$6&o[[Z+1|5.42NX4`.8=c̔Bb =Ѐ(9~ώsPДoȽaZƝ_# __}7^Mq='zkÖm,bcVL3e%PV44&og+.;'"HH$FfU}zc"a̋92'/O8w#{ y'Ј% âRp6VOl˗c׾gA߆Q'.>'/"y3>^J8}.E=UY*i(7BKQ%ga(Һ` ACq EmEFwd^C%f K.?` &$=̣{'gkĺ_)61sq=:NK+h4Ǐc4fÁ70:xsQ'~\E\0)FQ>`q"Mf$]#PdR2%lifi/Z+_ Q9Qaa^_vtY2j!eflZmxM'4XH4pJaύ@ä r|#a<1B4 }#g1#4QXbV.~>]:Y6+1̘SoK "Vg 0(p*19mu1I('^Es lÙ9x9#IA9pf a<^;H?[g̯yrH?O+Zs~ gGpg>ã=wuwr6/ݚjz+MxņK_sjCe՟]\m*L- 3!͵(s֘p6`i2['o^>?6ǿ}s7. YDE1G&+'/_sv\č1K!I3{HANu{70l0#]wj7R{JD~-Xm|0Ir9|K>BS^gOѣaG/:yyk3X)(c^aa'o Q<ʜ`" 0069 ۶=`ꓛw@[ۂ BX!G3^1(:{ $,1l;KƢ NV*uh1]ci-/:}0# &෋Ȼ|ű Ϸ? v?NP$|28#(({-.~ PB|Ž w!Kd;uu'F0S4Zwqyy;΀9Lg P([`!R5kCe [)U[[ <}+wκxB^?*TZNxyz4p9<70mxڂb1v" ?QQ鰻xPGs{R.=}+;Eb6T -qZO˺=j%+d.P!WyB8&aNWl25u2H|DSdsnh9.#3CU𥉉;Պj6-d[M[dٻ(E8g33?Ytߐ/T9N+eB),i~h##)-07TcN8'g` hR-%1mjK+׶dѝpEx@ rTgW֪5j*~[beZE^|sr8' u7 uE4IR"on(zu_|Ǖ(!EG @M\1rؘ _&UgYZVfӵK+"$Y}rل@7BLP\,M:1Qs#-xG+v:0@7 P16INT#XFiF+|C5E&!R.YAQao(Dof'-ڻ'q'! dN&i0$, a?)AlPU`;X s㼈%ű'@&p ^LHP(SYq u|nKnCĄ ?@!X(0`CE1(y4\u '(#y"|CE8 ✐1E7L-1rH#e.=j:|}+dzo, Ob? wC1 `vj3@KU_--hi+_ D3rX:,EA Mu;-Ė`Il oK!^N ?ǒ'|ihGF7#+2S"eh*1]h}db#k2]bl `8i$J^a "BÓ&3c0FȌ>f' `c rdf9JC,!E!D^ xh!3c~D$K)ƓriY##sA`2_\=s2e+GcĜ{&+%#:^ʀ0㡝M8kaF@24ffE3fc1rEˬq '!.tȍź@/t:(D|9C]! K$N'JxV v~#+Hh`DfA@C4/u,F, UW(eEV.j\#d&:-&-%cdv+>`EE%5 H8M[]YÙj?k%$@ћ& UC~脒IIkI rOkER5]!esvۑ#seaQ4!{(9 7a`l{l44b`̚c``2̒m@%G嵁˄ގ䃆(mTV C_( qeR;ى2NOX*|\ K\Ed.< t$0tm@O6P5 ╔seb&L$d;+dʑQW(j{.,? HVdv't@ɚie+d($MډCXb"^'WX_@@!SC+vIa \Xױc^-E, D%J&Ab8Xd(+%/ldGh A$ OGG.m@pP,$] PŴ@xB w}e+I?-) j RRsSD~f "(hzIZHVr;pe eI kG#BDc [3]$&JNiIsW[Vua]۷s"*;Q'~~د) 0OTlaAF!Mx'A\xB`Z,ID-5{/yJEABm簔މ:KZnGI$6IgI2@[^D\"%j S0-\wTZ r WiMf-/\IM%FEM%9 Fp(cTpE0)<t`i0XH:wq{!Jgu7*(|]BnB{ALt2mGtnTOI8޿ o08}P i6y*^s,;\Nyre*bXH zڕ7hUHor҈eLH۱ i J*Hc0k\6rI*olp` ’c+Vb"zD-KHqE;}5?!~Ja®;W)paW@+lpU. h ";\4@2J| \06!;9;9*oM"g+e H@r+7nӲ+g؇p zW"ev{LfM?Q~U~?ctQ<=.=Cg?G9~#~|)Lst^ es (9ۋ>kwO"#dnه$LLv3|:J #vx^ԧ-ۯܒb˦' [$Hs|$<1(7= (!GZQtisJ>Sy̏́L(Ŋ4?}2_ڔqWmKvGg*LY7 cW)+4T!XD@Z@%j A @^'&9׹ϔsu$uvCb+bA a{ %e>Sis)*,[sيg8}Ls߻HrWIkK8=vǣn%oqee(4jr(s γ"+˲>%QsG?:ҭSqxf3^w claS*l!&$˅Jt2rɦBFz7Ń3gߕLc\#4qY/98$̘4J 6&h3T%s!i$cdv0LFA,+DAD8mq鉳TA7U b&e/3#5Ɠ)"!JP1(j^Od$S>Iñy>`}tv.ݩ1<9\\"tq`EX(%Ge 3 b}rC=Icd;Er3WBI;CX90<=c Cryj8*˹T3(R _WXUMqs.f!tJb4t9zLt 9.۝pĺ(Impb!KP4ֹϔ8ϟuI~H%˹ϔo䇆v7.4Zi2C{0-6 QtI*ʠ$YJ6,.h@B% h AH' `$Eccs QdJ/>S><.qҊ4 I2'đdS SwIYM:NLS>lWn\GZ+*f>EL 5TRU]sC΁]-i; І+s?qŪ2GL")\Q<+p`5Hڎ}ovExǾeɹTnxʱpew+ ^]ŮM$s*+ d3>ȃ?,nָr3usIp&A}d+r xe<%9>ű!9;]h /[3-xr9 *,E]`ݷ W βwZJ -L=J V:j7=p%{k3LeBry4ܹϔO$?N>{&rR?~q?ߣGU=l,gF!K7-iiXKZJՒ%J*b%-u뻤y+t좥Gջ2\ `JL,Wuզ=[޲ \zrLęUΪ7wIKAj-}*Kw-mkir ROP7=4c0JP,8Txt;{QKBo6jj5dWOWKO멺vjba%C*M3?Mki~jд&U2Sb"9Fm%bbӾWf3|R*<\Tb͙j?ٲWji~ 6tX$0LDB:֛ -W?4#L>)k'+ޓΙ4ijS}Tj0q -P>&u.}bՆ-?8OҀv =Bt`S+Ϩ3{q[~u+ßZzڹBS.i{]CI0 `cOWL ?}"XHDU=Yh66z!v=mD!Uk)]NK\Ҕ=A{J=P BOdlڙ%hpxI|Sk,a۝^y)+iǴAc乞vꦺcZjr\i|f~k ~O'-ڨU>5d$2 (iًZ< ?5tZ]") "zڪB5RRed_ PQK.y>`ڟRAKL!?O%Km~#բނTo*=9Bܴ:s7\-7sv?5"jXD:uҲURCI5Uoe[ծt*JEēHՙ•moi[wڶcTrMu)dgdp9!DXLUidM:m>84#~OEO!By歵ԩB%-%Ji?>\M`\0}~OS`TE h"POv~M,Pm:sZ20A?S)2zj8qiMD.]W!%g]OqH*Zr /R|RTj3Zvf ӏ>>tI? \WVD.j5-3|~l;< Fu$*Ҕu.i/}vΌ:zOTVnҾ&Z֞qPd~2UF--͚k!2 SvG՛ۿFWs_<J+ץ]D㔈}uO0mA!\%)iFʹfΩyRK Be6 rΎ]5P>cNz VtaόKONMa}ӫۨxxԱq/ t780-Pis406LC. t70T'*t^ "%\OfJo,{/X&A^)U&-mlmuڼcO~9m|@KրVO32nbɈJIob}뵛;osnj™߈[44ψSWI:RH_SJwRT'֕YSԙB ;#4s-籢'_HO:}ny˚zZiӁga?41-趠-uT0Z"ZI,_f띶lcMύ9ċþ}o17w=3 Ց.AGbIJ ylD0yB{Nm3#Lmaǚ(JJOUnEcyH5]pɚVk_EIm#x1\™]3ōS9q_dR>{b{/+S' ~+:u](kO L9K,_';X3c?L~X=&5VfY·P'"vb ӑ*[A-JVmTNG5p88%m4pOk^e;-TP YSV/(ї? 6utԢ6|NE*'Fj[)T w޲P#I S`-+"ҷObDi<xP;-fGE@ilmk|'sr~a͟c jIߎW!Ҭt^¨Ek% tx[ G85.La:_1e \Ӛu!UkM.RhkQ _ŇWюa39 }CIec?sZ2}.{T[kxҰ+dhLTWپ{*Fi)xvJ dK鴟rtU< J ) M\7&XX\,k$ ^߇G83؅g_շtLn{K|.S{ҥBoÊ|= (@qh:@:7zBKCxQ*8lhӕۿMO O^p{Vo7~k=9J;D!z֠yQ5h#i~d1JP/Y2:uW}z3DИZh'^xW!wC;5ĥq x'?F٫ S ZXԓ.oZ?! n^mEI|Zx ሉr:6~Bٸ5[$m݅&2 &hooBNͿɛ|S|bӜ mT)αZ-U6pS _WbJJel՛T*b V\3 QI~> ?׾Ӆix\n?3ȯB\HTtp-htmR{jvB9iZ)}] .*LunT*V t\H+܊׶MR2|dȨO._$z =5ߑ) S4<1z ͌r"‚>V X:篫m_YO,zQO~L)8 ^kFͮ1kaepZV`E [QzUDi*XbWlwc=v$'䜼 askChߵ%:?~LtRz(Wqȳ]'OC*`"TB[y[֍fD*#˲ݗ“9pL:%p;w <Pl^}}tcdSvz1}V HL-3rII?شoփg~N|z[YX9-E04b7ٌ@ ^zvvN\ ~H2( "zMV؁Vr,z,ZyE$SPym.^Pcgn%NgGN%ZFU Y+|jaq<];RDrAq7 6+G`<$"OP/-785%̶Mh3wYD v|2i|?=HG*oe85 ;ǗUi"I@K(X+<0[;2&.ntBYlϬ5ԔZaU\#8ND|mPwS"uQ"eZq8Vr,XW}g.; =!nfVB%*)@SiBkYiͰXfckSLIϖoNAT 80a]n))-\S8L;-Yqψ'c$@Ҁ[ {kh$sύK픫G" d*`$iJX)IRMOm8mfĴSjDcxvN9lmmruL"ev*'*q+wIْ9ш{=~V616*!¦) #{bMR2%5Kia7k$48)"b>GȐ)D)SZ申˙D֟␵T=z` x]}o?? ʱzauXF4CDAAѸX@}]0/C3^"}> Mm.m~aa̼v Zf,l3oiy,j0~f64tD*bFT 8BGLA_DXyR3X<^ sShPYZ#kC,m>MgdS֋MnF2`cg:ȠՔSPwE4g9N'Y }Hwp{uՋNGL5h+GcFD2X1@19Us ;-])=nhS:qjm;? ֑\|Vzx*. b@b1rӅ䝖kϰe:0uBk9{Y RHeѾJТ9Z݊PW_ qG$ شH\ n~$4Iį'앆'ʡ+)"98T"9"F + bd+`%k@7iwk/{E{ =Vnn'bもy+QCb2@xc+yJ͏LkcW.Y9f]: j%,ԍI6ɀƄ < pͼ|A= - 7Ah[mlyf.E=VmU`:4% 7 T[t*IT*kRq#̂&Q5O_uF0Css0m}1 -EPy_YtW>eTryQ ].49h0|I Vё;~e?q]Cc>|؞#q{y. MJt2*HUTiz i-SXr=szL6o?W9rKs:q*>T WVOG*)) _;|"p yO|'WQi)3݊7ZPLhJ9G@G:P@0M@(p=w\rpMv>:r{S?AVvX M5%ĩ)9u9*v9ucҹ;N\cgV}+`8&3Ug+u%"Tz$Vܚ|ANgHO*t^^;] a $t*jշU|CeH KMgm |# )= oourJ}vT+#`Gѣ 9}/[Oo~; v@iEBvG%k@@RZjPOuokCyǼU\΄0ϫ_nџ^]os۔,P7& pW 9 $⋉Pz1Sݙz@ϋp9scjjE&c^"?zL۔LqՃƵ@$Y*:TbWi٠Eҵ]=Wۥԓ JY}z|crޞi1Li%j~󔟯i"̊ք~>Z[|c{]e ?nVx'r~RwGywmAZ糴.Ϗh͟fMݻJcS>2?=6jwc<.L~&ӑT~N-JǏzϟWњ_+w™g1]c szt,5l}3f6}sd)0A5CmXm,KAU :alB9-gfr9AVVN-B&%6KJcM.n5T*N?c}?MJkB~jr[O?`:29v!sie:/:TiԙŸ|e[?-ӗ85[Z8 *ƢӃfc⣌^,N%4ө1?5NM95Z 93Uԫ{d&1[tHk>|85Z88DYg; Za c70{nFO*;e?QoΟQ}N MMnsj>RqNU27/VPpꐞ&cS|i)NeOrC2 N'yZOi63}vJ̩Sf43@-'=듿bi1F)Q+p2fl*V~l4MHm;'}VSSB2?YÒ!1vS%gCRq1*c'~iOtZjD6U: s̥5H!$Tvs;,59ejW>:eR*tW+8:<Ύ)fd:,봰OubjmN+2j"yx:-)%ӿ?}2ߴy M$UZNgXoOMuڲZܤmr Zmʊ笉 ` t)\&S#n8%cSΔ%ܪzY勦{fBTu= 6? Jrڂ޼NPL8k`;mF۬\#fO%,;hS+f`"K8oIWnzS%+ :V)jRB`Z]kCV8eHQ;蕜2(O V5SkMv.oUU.V7,.)ejv]`AE͟95,f:Z6ڰJ\ϾYAtP A!Rũ(+RNZRΔt2kXH%gHv[ew,mns*9Y6K̔9٧oH) $9/hgaQn;4lǧfOE|C +u.g `LBu+_=?)U)7r85[V9VV X[O)ѩW`qvI|_ }'H0a28~SlM7$vKNq^}}#ՇHwPqI uNw}l@(.8徲*Z *H/]tGQ7 jrKW(X?x![=tffB˜HovWh_$N]6.5{U 锋~NYqHh1 e)WG51eڼV\aȖ}~r`pz^{ vU\`:'viP)mW9PmASaʙN":B5*}~^d8K>rWX\CN SYE8e- G2HU|$J5h)K0"}눩p/(NDRXR&zXi?>eNK:.~>:pɧa&"EΩln3H!"йj9# 3pZW--'kcO~hX8m63K[t̸OC(08V]UlNtЗPV  =uZ~rp.'L:u}`>|85*ѩP,T{;VƙJ!U`tY/&IBZXX@ߺm}697=?+`8=lqߔS)IcA><?(:K]>RT9*XUCD> =Q;XhENn?<ŻW}??*0&ctN{,/d©Ż>W~ (YXiv%yRt*@'k@nܾba }2Sz8ea7"&딷g[N'~v=#O*jUCV*C=v I&+Sna/J+ڭ:{OM>s7{񧆒ta!=Rv%W7tO;+SLg+#[5 1'Fďj0%.eNŝ/9xR?}VQVt[)~}-,M*OD:3U=WlyM]N\t[߆.if*SБjH,cQ 2G1:XK_yBE' ?e].K\i85T[B)>] ~[=G:J216avs#~w|S<+8SkqQgp r)NJ}._E:)CO~zt꫺Pz5MJoH< ::Й'Q>]$V?U(+9L#> SV=8l#UVꇖOo5ku P-)B^֑"uXH'i/tsYI/zȇ?(և~K@&r+98L-(PAH[zZjDP}k*olj'G'e-P/&4S(ūz2h~R(O?/SЊ[Vҷ/jZ*4z.iu.1<'&pۉ$_{F:ѡs.]s;C|Y$ f) m;*P<#:@FDZNX(z|m'*0T R2A<%{ڊHG=9ȅI)F}$8 sZ?yzɟ 7 ՆӗMБi喁,yS=.(Bxx_auF?OWRNœʖ܁Eȸ׉cfZVR&~:SF7<)"%''7_ˀz1I=K䓓Ym0t=鬋=kn~27ᴍ{nY`#~uw3{RNFZjĉRͷfp U}J&蚿Ym'F0 Y"풇riqYtړKLS()ɢ:}ɢȇdv).U9ӗr)8%4 &OP;,A\Jy{oa;zKT^5p'q)n@2SxAʐIlZ V P|hm&5E˶*!%>#=ռk4l\w[@37׿*GujTi!Ϙfp4i)xc"2 +sW0Fw ) MܔQ7v&IsZ/$y6C:G/N:w > cr?_)b͏S @(p=5S(! BkQQ_1 ȹU; !x7f&{I׏xR5[.OTr>8gJ2J 1ZjFG# E~Mf<@u%rr:&N'gmHmU䭣7>Uvѱ|(W\Otڣ"Ng|8FKlIM%CTA>5;*jE<_<,6W>/ee8b=NQ+l-ΚpӲ >"' 'w '+5N Q``p9.slDkB8)j@"!JH KX(,Ib#PF'=rao~󧜦aRs2M;<_u4t %R#s48[,9?ԨڴrFM^ VmԸ-\_(!zV 6^IYY]$%c??~]Iՠ:)_A׿S4æJ㎑S/r3NRJM0C+6%fExO#\ Dshlbs}n4e05%:ݦ1᳗4>B{pZ]w`>)R% c:r? NB?1ܦ39 pHym^+$6!~F i缕:`c']g@t]rq ~[Y~8}}Ezm)a>,Fx~;KZUe,nIG^E@X! v>A vЃ(h S )ooZ7rMLS.v_^D O:0-Dk|@juz2QM)sZ7#1I%"'`ӾA[>pL>wc_P;oea[,ӈIڣU Ow_#sc #pʤc'i.JRHj}uߊZI(xm%"gX? OjExzmbFy=Wn; uE@O TWP<oӅM:Qk)"L@Mr,^*U^M\0!?*F5 'ZK_qQΚ>i蔺\i7#vZ6좺E1z `KR>a[TݸGBLaw_'w0";aJCUUT7yWLO!b`EJ* Otlr,^jd73t ظBWbW9}M3NjA_Wb3@ĥWT@JTJaa`Q.p%M04` 2Byg|}ɝ@t*COJ2>4Y]WnAX/ XjxBGx N4im[GAQH ѓ}nc)͎c(d2C('~vk;wi"EmOsɧ;.,}v/% Sj4LWDى$e bbmsAūvZSzv+aJuHՐv~>$# - -hW;1T\<ŀhx}* ;-Y;-[מau|aBG%Vsr3ť9ʢ}CUEsSԯzMIb?i4yHh_O*:+ =@OCW&SE rpErEX1@V@V2Kր.o*^ﺝl_m'{gNd}fVnd1 N* W$*,&_)\(>s:*84(5t $JXlbi9  ;Ix@`?; Ayv zN@[?{%UwG1!HT D Q$EA%"@QAPTQq13㌎iIo:ke~tWwtC݇Cuuթ}OOvߞ G3>鞇=G`NlZKh KR1}ZJ)I)v:Q1,M}/:}m 3(o'#/^s`bPZ]7$o L-wk;k/Oo߫SN?N}|mgsx@:ܱ;[5YƷ5ǏBTƎM>kR5i&r ]=ZEZ]&<> }rᮧ? j~ߩ+ni}k138R@8JY/r[pގ'>t ~ `oFy}ͣ]Z AZ+J .\i/Qhh0plr2򵏇Ѩ7~G Ryss?q߹vP˵wZvdjPSETGMTʤc Akrk5sF xc&rxsEh>qz\MW5%w?֯ƽ?A6pܳv?=zc4yO$9:JZ=RZէ͚ ; mIMl}.zY` 1mfJw/+-F7%_|aLk@'sɟ|3|ļu#R޳w qnAXinݢݺe:'j#VN|M zbȋ8ѣ%oMX89rǿC`/͘?yS~~>v컟a`y? w?ٺrݠ kA"س':Ziq AE@A=|0// 4~G8is7o"8i=fňwWw_^ǽ9p; 6G@N_8:q5F@PPӨSo_pG__0W ph:m_Ȧ6.qLL+}Ib29nu4I> /b;gfe %:`1fHBEa3t5ha sn_Z~p_L+c߀I?&b~G0?/Y_|wd1Ku>y`sǷ?t!͠ k@ׂ݅ a <ȝbW:S6l=<.~]0=gj ڹ!cg9͒[6nP3ˬ/?oy}O_=~PhIG8jPk\C(T LDW^vԴ7@7 hi G2ilɴO.͟Ͽ,h?f"pRnW>x;.^jϽ=}IEŶ׿pMn}|8Ib|a9CF_ q'|&`̻!/}z<^dR+_M.mqE8]՜ޤ[]e2˧%]dcg-,杢%:Šђ7w?`?+B)*W/,S!Ә5Dߵg2q5?+14wzL&sTh_Xxm)֗v-<_`ˋ n&u 7> \y0kp5dἑBv}}  OFM0qIn%ܲW'¶ׄ|MY^8l:v5z74Yr,OXQBw`f{O Q3飹:4 .K0, \w`f}^Z*7sJ\Ik3Rw5^FfmҰYptٍXg`;<:Mہs`[`Vnnn!mªX֗½/GVؠ7oӰ!z7?yӴ1;o #q[xƧ5ޛUc `,u]υ4{mi& 5-a|ٲƕµ[y녩K1W ʪ:Vu`߶WVk: Ŷg,`u66lUn46<n{2c۟N B2n%Fo7 `pӃr K)X9n{,Z [^ fVk 7nܞ5L^V 9tji zFCL[&3+L*(YŜ^ #Vzd|kM">Ċ Cq糂piGzH .9Z&^&]ΒT{TkN3ISȵM†|.M#bMZ'y8k֩NAy*SBn*Wa 8p;4_@ٞ_urs2GGF[V1X>zCޙ7\N77GhOL珈AӠСp޿w}ǜ,Ω -:mB8~~"|(yTI*!+̛[M ,S{*0Sr_9pinSͿ%f͞ʎ4c䟫guՓXstXǮiEwڼUlV>8% ) 3o*ZӾwa>O)!Z_ݶj4S"dB(DoNݪo X k,OZ5`E4k0!U%1Cb,>L" bba+&i*v꒨xkX5,&`LwJH;&R|eNM,vH!/B4t~ǁ4CB,@/G &r=atD%sj`m|/__-ߠTJr0rOS#CB~mOYNͬ%eH^VDN')UmCӕfYdҤ/΅խh'׾\'\pbug 6(¤NXAӎyR{P{ i/K\s: 9=)qh%yL .ym0f{F^ BON,Gkz]058!sDZ_UӎОྠEV ; _Kd1OqxMNx#e[ζ}DAlyRШm"4h#o%$Hqtl+Lcwq!S9_R*4s8%w$ Vh`4w\hܒzb (n hvM ZPsTz) Åbdژob4RIjٕbVސ%H`cߴܴ%$"z'Ѥ]sw/Arp-Gu0u 2.JgOESZH+?wdnީcV*05Њ &1Bq(̢P23 *EDub?T1 0fngr{P Wn y$] oq -@**1V=%u6եVkiQjٶ87p/܎d=)% eoԜO>;fhmBpZC`&u7wx[n7@15QXz:q雠؝ R(q>NmS#SꣶDT'fl$MNo659C`jf)ӧ@qɖX]; J{ҍf:/v~s8-Moqȓ`Pe&6Tk&ӤPNᤈ!v@S>->' =ؔʒTJɜG0~(_ [h1xy'7fKGh.YxvHd Ωhc/R%Zik=,9%@燦HX=:9:Q6'[&{c8JYq(cX4RFN0 @AvjF-ڒ܊~ٜB"0P^FS8 :?,F@&##lxޜ_@>L3-Ո9aŰZ}9jf-F`;? U2GBd:0D)Q |yOK>@.c%BW,Vh@[ի6VZ5jxs<&4ʧP)Њ`TnPM80C(R=՗l =e21>̂$:E lu&(ڧs$)~H;ilNҞ%⣀|Tη[:K_oKzS7lJ+0@*x~IW,VrVNqONINN"o-k(_?8LH4pj(GJˍdTpqa\Uš7*4bՍO% j# 0KSaDI-TNM: 4P-,vRZ@nG:̩ȪUwL1ubqj!ͻ&A7QDQM4jP7Pm[(VQWed[E>=#=αjiB+R8TAmQ4(@cb[UtMQ#9pVЊ*z2F֤`qJci5>w5ڞHsڐsPt!4GR)&#j.a.RX5j,j,UH !C8]V38E!?0@J @m^tzu*VB05;wR\gU?% cDT (CxĻH1sгBZ5wUVݷJ (!؃qZU=(x;G# z `X*B+ꚻ5P[LL`ZWZ \*5t aJ O0FhH3Us qk} nn7Is_ρ" pubMRUm\C~`X6TqfG`he @@? 0K4'K 0/8M{}ޟ*tTDC}eh4ʀ8+:Wzq+8+гB+fP,aO)&BJD tT謄]q<0ݫVUʯO^/|ҩhU E9O=~=jIG;Cf PO19qр \e( ڶQ;:YտR*r >ArV>sGFU x` q%WXT 5V5<4SQQ?ըVAbX @!r@$iGYYiU Ӽ88EZW'uQ^V0h~h Z Ǯƈөs\O'{1rVIUSњ@IX +`0kszG}* R `.֤V+ʬD<# U*uw_y* $|@+&w: aQuκ`qOq꠪Uf +bpVJ"@+1i՚uװL[גOԑ:8O{@Žix[q OFJ@g kɜnˣ__Vb zXcΊaYjqi2U5N+1*gAԫ|CТ2ΤB 1W*ڜbXY@u=-)wڪ!ZF;`h,X1Hk^b 1ySQ'TCe*E,Oc:EjqrȬ@7 bJӔQ.3*J+ 5z}&]+R,`N+TDUfٮEAIm%tY;tc1`ͿD͋hMINĊ@H5'[:lɩ, ZTVtk:YM`O/ە&9UHa$)_eE(@bUVAkcL*E*RU%q9& 233U,Z je "\%UeH=6>HSN*-7;Vk!f]ԹBp:EE%q/u*aS%0n6"Vq`_( {,_sTJ~ DQa@j# h^S8Tb}0j.i>դӹiurX=E239z΃4ȒzRBP [!ZpSsj^u?~W*pD"O2;<,ZO=NJQ@t;+ِ2{@ ђTHA5Qj>N%꤃8լ:Rc UUc*:K#t 9uDE- f *Ռb9V5iZliΦlJ̦99D*\UzHrpsJ#U#G3LI<*],DF UNs"LΦtTVI-/Ӌ{`Ik[}Scf12x:S+qS/IWu5F5TiTw$(++rL|hm5*05#k@ۯvN(Sb aTrW٪U9u6EMVZ6E8܇XO+ 75J(DŠ@q~EQNiTچisZ8,۫3m?ʳSQQ%K!qgOc?Jv+1"^Y?8Ց"IaNwԴ9(WM cT Ó/:x麟XtU1@5$"jN9Ϋ1:vNQ*7łX R#?eH(gJW]iPizRZMY`Uk13Y͟pʜ2m_}o ipJcVk_eZs+j !wO(PkjJh+8ȿHSTsJ8E9)}psk='i~5Bwkڕ"RYV*;N+mW>Nk=Nc7uJ h%E0b SgN%(bW9Ʒ@bw&Q7JJB4rYJ:)SBT>K)(G5xƀét<]u|BBVpZsit(fQ4ΚHzPbOgp\YRka9~uT, !cQlۏ8i$>q3ShٟA_8**4v8{O2ЗTBT}Akt"zP\7( "A{3P!L(tN˴pJe .j?K~EpH7>hY#/KA>GIG܃B&0bNkNM:ɣJӴ2Q1>~?#}8uJ9p{Ƙ?ѩkO b@^rZciqʊ ӚcO>Ә9 *bO<%X6 -F?{Zs8948.Zs*Ii[sipӢy&4dN'%bк+~88g?YTNa~-Gk7d2B3ǵ'X׌CMvGZ~+{T =&uV[lk3@Ǹs`A П.ztY #=sw 9>+݅h?h򼸉Ij"̤wF~ifobfWMX^&`pa`f ߀3飹f{t2;|d/"_/WUoz\5I'us/þ~%Ǵ) $XJeV V+EF`UZi;p2^&?[Aq`ÈeXzǜ*i; JonR% ;z#XEyL[aM6D-$ N}9Z1q?mX\}`v5.ت;u~%G;:ߐ@J[CTN3ZiKភ~Ӵw#DaqoRsiA,DkmEʅbp Y/Rmf3煁rc ('qUZ~M6 Ue 0}.#mUS:${<"~OsrT3yA 77GnPㆷC; Uva WjnYB?&Nh{v=2qcf%IZBٯ{9]"[/L]*R`Vձ{lVk: Ŷgg&;;|۔ύUIek9o{2c=n2nrqp,h@0waowL Yh)sq 8k-IΊi[vYq{D aaqBO笶Vkhk˱Pg4άX%dV|4(Y!e[NV&35hѤbȆ)b}P`~\_edv aP-XTkN3IESȵM†cUֿB\~Orp S eFU/¼L*OG t\5p X3UA۟%[4K9&x>vg7fruM*zCޙ7d+7IEqQ ZVS79NоO0Ӂ95Q-[ݝ'aJ{TI*!RVf9k#PHӲLM&18~LWN\tT>, 5{*;$OZs)ͭ'8 ٱ+INKxT'%b XpD|Wb"p\ET˴Z\`LMs>V չb}She1LZ_ݶj4S"dB(DZqd [ 5aJ,`Ni`RC.YJb>X|.rUiUt:?py}9lܔXBw٤贊$*l ˶ V5Pb~*~a+3w)N/ pDl+ٶB١6@8Шm"4h#o%$HL:'&va^0jOcJUaܑZ t#Dw\hdb (ﴸ9-2~dW`S*K!o.#|{ǪVչJU1Zo(29hMM[^B"wM5'HpG<EM<#SQ6Ísېe{\ENZH+?wDjJHjl7Ty*A=U%q:0q Y(Bqk2#¬ >P^[m"UvY7 uY'3mNC'•A1%IcwܾB S̒:RS?Eepi0 8Q9ԜY kdyL2'^X 2Vݨiԅmm<ʬQ=rRvhuǂTӊ/qI+zydJ}$.#!~F·Up99lS{*2l$GϘShmȠ#(e) qAL͟%[b*vx*]*hb7WH)\QnaP}/6N&V굄 $;@ ^^"U撹՗lS!oSN$q=b`&,NEON jΑz!q:9J{ZFW)RG(oR>n-R([}e4bԢyWU{{ #D&@B TAP","X csܙyfkv6;9 $8{pHY{ַ}kSFWڀJ.6lXvr*tv5|Κ, /fT} 2}3عސi>c`&\$?hުl3].$ w`z8UUUxy hBuڥԔwCxcVlbe-Lܘp-;R0'b#֫jyɢv֤:i*πri+]P5y1(N ?eL!>ߵJHQFVWeUZE@ÿ.M/?VSd%,1spڴa; ؐ YE,i]`xY=m*@YҀ8[{%S)+J ҴB# UzW*8b>p3r+j+3sz+UZXSTTu8Vlrnz>6c:8d ,: ʒ`' ;qsX 8!,4C<9cҗSern-TVX10b' i4 Ț߾,ky;yvJe kg=0U+h}a_=xy݊ϫ>NvLU9?<5Gh4 <@Yq*9B d*KA[mOY(JDsgB )׀|v欶GMX 89VY?pp=9IU U16YzV+DNK;slMx @Ӱ򧾾14T-Y@cw.+c { @E9V5ݨd 81amQG2Ng7R*-C?0y'_UWX97eT;[ ؿD5] )*^ڲc_`]>SYҨ!4Qs>Zgo#|f=UiRVƪc`ݿ /5U\EASSmP]4MS9˳X ^pMOMllؑ*J,Yunqԩx ~xnt{Ù3Nj,WTmD5>HYSre:U@.`g#++*z94-\kс}߿֗[6e*]6 z5:w 'j?[r5>t!MF^rMUQ*abHknCN=Hn﫡bMi6%Su:{1YMݟpJm'ܴ&4L4e֯&34UG{L;;SOe;n^hꛡRRyj R%#s8J5KSS٩g߱wZpsjuSDߏBTV&%ӆT,iAP)}vʶ_)ŧ<;-F |}5EV%Qg{>WjHJiOͳ NӈaSF*§XS\? U)73T~w{Vif=>tBTSO^SSBT>nGS(ZG%b4UO_u>N"U]4vaE߅:i̴zsgNS@ŃsC)MS`4`gj?{۟nD  )eoY58NЗTBT}vY;U%?U>:*oYNZ,:#+>iBTsjTH_6hV+^JhvzNMD5=z?YS~.(UP(jYߋBl4@I4}Eb)(o4iXh~SKM#֟1F?UO>/LAi&YM#ǟ/mӛwK#ԣ"ǟFOKSmioﯽRl%4>}ԗ_~|7?މF:=~'驓_|=wzZdw{=A>촎V W;BN*ecmxM=e۶g_Û AΜ=s+\r7?q8Ȟ=~{B+.\W?攓D,]eZy;Ynaú'[_yE[I+rʾZRy7/\0{-8˗ܹ6qzf˓/®^p.869Ѽ]7ЬaSΙ;{_w?Bq=>8faN2ѼwfLqӦNgMBݱ|ރufu8r0r3 WO48p& ڷt]wp)\]o-!{o'Y uˢ9uؼq vHyOokj^oCB6Ҧ2SzF3J4VSIᶥ0X$"`H\cDŽԛq2̓Wk/Y.l S <AWA1PɓC'у/"ѭhP<]LW̙/jUk֏tx<6>5Ս)S{9}߻ X,CktuuЁerjA8ͣ}7 }s82FN@j ;<}OƼ_^^F= IL~7/tm|llay[\W\Z}||~3=Cw8r ![0/$7tz{˱a6;2!zn7BB6jBb75:e_\)Mz ^k.@5R_坱^D"IԾ5TkU7ӛ#l,/\*zs^)tmK )qAK!Cےk$M(Zdd H_ ޴]?%ɋΓ(g3'00 *LyZdږXE`ν޴ 8KS F$=s.&Ahp'L>傠Vôtta^"T)jj)4L %gJ0 Θ1 j@ |[%CoЀtNWyWY0?rLï:i*3*PxAomIK2_Mt}Hr弌= RLOLԉGi5s%@O,`gU \q-Ÿt(L[ZU=kL;UUy#* PK@Zys]98-ѰS߸8w|#os%KbNTkAZ T'0WN5ծUuI>E Xe4t W=PkQӥX*$o/FJ@9P ZR0/bc9KI:RZ=΁V1@ˆ^̫+ێ,N6^R1VØXc@ك=x|-u$3glXnGZVUn9Hb=t8K)Y.@Xˠf t|'6-Uwtz~l_qmҷ`AdV5l[7{ӫrWsxe59s@$ ]]$Ϧr%jsMKϚMzBޤv|2/Cޤ`l2/<[-x͍-V|=WI LM[+Azr禿8K[%͢ffkfl_ \>/ -P4~Z鿘MSz'Z*}+cq2~BOk5@[G O^$፣Y]&YU_TwGDΌɦMt"3@kKD/z//]i>JCrBO/#Is}ye!9{zJf'Xrh>~18^ At]=Aދ*IE|פ5D];ܾXT@MI\˨ ̾ e/޴ac7xm_>֛旡k[R̢ Ѹi 2ږ^^^#~Qvm=]]l__BŬt](Jtb&~ѮkјG_'Kr#^gP6mvZ|کnWw0z\ NW (UR.-Zhr}Evy]̣E5 4|~k N6},1M箖-WԻRD)K`MUj\GU4=ZE3~: LDK|z]lT\Y7/ Aᡣ @8k22 vX,N^2vXzvtTO=#Ex[u-3hR C,t:8 F5 r.ˤԢTO `ҴKw5:q.khZݢ\Qg0vߑu+­s ~5aSԵS'//k ]B[^~"K)ȱP``^0Tjܵ\4}UPm|(=fHLu ]{\;~#jZJUk5BPͤPFxWD5 hzj5{1{M  .a`w6W^miRL9Kn+}EPEfuU4 As*C{5C)eQhEƟF5$`?Go{ԏyLÐ?;Bgv@-wB 3jntu,[*jaV4B6N6nn Z |+wJ^sʏI\skzʦ 8V(|yAt^5}mTbD^+,)2 cͲ1*WԨcџNLA}97A,}x>J;ØZ| ;|/ZMMS+ (KEdۑG!N9Vu'}ih|5LfpKY4hhN T̀~ͥ0MZV,rӪPucC|/Y,R$OjJBMG?I{Bܶ7cCӕB !#]S @.ҳS,jV.g@} @—3cKgA@Y?Fzmݼ[v(: -swn0$Pm:K*5 h(/hn_+VcRYQw+2XŸL  Wryt\)l]Pf4pj7U۴fz Kj -Z4#*vԽˇ}CƾKi.4EVv{=t nx=PnhZ8uy#S0]ȘzL >Ǒe6olhƀ(:epE>n*' e~Ȕ:Qu:}_Um ~M/h=xALA}4$?wkzZ,f;^^ Z]g^a@>U{Ը"c1BIr3ٯS{@G9ΟF5umΟ5oTI*Vއ3e.5}VuVrݕU*T>TFy0Y0LfKMAR7N9D$P.q sV#xHL}Ν?jI4ͻ?ԫm0蝏A^sCuO곗fqmIvc `t(@Gn\ Xj'J6 Oc&C3!f<2sT2K*LCt&_Y]G<|La8;Fw<5"qī׮WŪÏ|=_xZo*O_rVq~ֽrke6jsnΠ\ph(6j<?*N5/:V@+-++q.1o)T}+<}v o} ~x 4]j-d:i `\(~ڵe]K3AtzhvbFoCU@عmB[]Ϣ~oYC5[a{I 1)VW\}_5cy{B܋@MWnLag>$Y0Up?# ؤ$]H O,9m|<~ضv>a 6< WmV<-V? 2jYq;BN\{~d5/˯?ji:<$vzߧ Zq۲ڬ|4@L#l8ffnh-kDP;5w6ĘIPv +}6v@w˿w:= `ȲeY)c\r^7OuIih`U>wayUقܟL2fZ ;3zW%L͝Aiσ,4wwPmP̧3-'^rqaM#[&5$}?)zO# cN)'Q}C<=0ow޼Zy?(9Pr(8| ؜81k`XJPqB.hf}9ƽw{~{}x78赞;B@g> Mnkvapk;t7f'KH0\vVw{~7~׻Xw_t dzΰta ;NfYrdvYՐw?o;ށ7CjχcoB|Br:Mm= 7DESƃF*nwV=x^ ]?.: C #as쌾34?> Ё~b_ {Z$.3NY,u"HJ+"xZL usz4v˫s[_~S's[BTg[MR$0u̧?]22្|_m 7lUf e&̄)fڈ#@iA9SپK_ۿV=G%Gǿc~L;>*[B^ޑHH)CE4)QA !"Rtu]׾|{qB$&:z2-3<9MG0 gmPmwХq(";ED @kPxt:RWZ @.q)hYhppTW U={{/~򡶌^_s`B6 M<$cuyqizn[%Z|l?l 8Ѿ;BҬl3Yx H*9z*ȫ${;woƕ3K[kڴlIQY~G4.^M9-TGߴ */}“C^U7UW[lmߟSR~7X :,RP{AcV56Gq_}?;or/Μ[#|Yvub[c]i=g{vwrrߨ\?wzɵ sffݭm*^y)ܛm)߫{-y܇p}Mz;?w}{2iLN£nZ-1JYԩoXR%o^K7^@M_تK7 a.0lOI3 Mif/ѐM.(ٴШ1 4_~XkAkd^N+CC6 NMb)TRGe] ѪaA0CFXzwтlTh*t6h^]íyw~Jڱc˶'%q<@664lw,oӺIbw%KlJttӠ`L: 4kadPpT" V:Tohği|e /+MWtzߩz H_Z=/`dE֟V5`7JuکY+%+I 4+K'%C*jj4D$'}Ik]౔^/WlSn9YB6MSkYypJP8n,4c:-h9*NKp DۓJL 4+LN EC.j,*xT;R. \yNS{ZaGTdotzN6-?rGMT_)7}Ky#c)^WC.sWF Rݒ9r!+nNkuw~l@Nt:?d+UH^œ&SSuno@qXͩm?E s}ؤmˣ=,ҩu9u1d˖V\9i d>,]BE,痢W]vΧp!zw%6a䋊w1Y`+ku3!|!WTJMyϦ=tuZ 4)N^2Jii7{!gc?/WSuJ  ePC:i!!p9WiLb~zO5EȦ]{hŮ=Yˋ`@5@tH݊p0Bl=Rf\(8z,b &ð[UZ 24:}ƧUPzl(4: WgcyK gL;ڟ4RE/]t1yFofZx1 j;ptwSƯ4{hո _hY|R@6e6aqHmNѴnr_esQ UQɔT?LJN+:x oU/)ȘIheO'O⽭Ϯɮ M2Y'{1([\:aS+{o;Xɖ,zUheZΜ%&LǬyGC@]QߎnaQ5]Fʥ@Aطۚrǣ9ߺ4g%dOj ^>mw mW@9&%dM̘\'MŪ$RR$Lw(s~[]ߢgvqfeGloTЮʬ'/A烯@@r3?ؘXuZå\SolxRo|A|w5ݤ!u4PI7J$!%rCiWmad6~¬fgE6jG]ݭ[2^֢yc:UZ !􁍚(X}84S>ԦSNglk3}ĥkA^PoSd*YW-9az)ymjBH?)\@SڴS;5 Tl[_j5 'nqTn*hn=5U,| *9~4)oa/`[ v:JoUs6/:PCUJdC/ߟΦ !=J;x:pGNw;|pC7* WK^ Pu'5ZJWd4N*tT1Z-aW4#S'B6 >ίx{} puvW/v=|'Z8l>Z}PrR2FU6mT@!Kr.n)[REyV y~vB;6-dȦAil:Op;kzw?Gz|' s*-m;[4Ly [)Iae TiQe;J+ ]M}IĄ/nI_R+5-(.߂a}/qnan(`[ju (y (nk@V5as#x=d`9ZV0]|:˽_Z-PfBnζFfm,[4*@;TW>ŭQFn?q"A_ n;EW#ٓ?شKgͮA6-=c!9m!cYT?j8ȡl~b# &c $ _+3䯨Em G7]c~?=$kScpq>E4.\u-x84yrT :ͻa 32?R: U2Loim:Z42ݿ0VՖco|\lȦY,i2_a_ ֏p㟣?6/`gݾPg>}>Iw@Nf*URk+NABS,GѰ]Em*-jS b@#4dSϪ w:+ȷsF_6 x2t=r o;՗>%'UtF*T-iWВ'A<)7uMPҤSH5龕We1annis/B6Hߦzg٤?@ca?>]Vd.`k OPR(`HP(SREoN)AeA(wt17"JdCʏzSEh4޼ */XM&<Р`Y\*fM_8ӿC7+t=z~a^1kK ,%mIR\jSi"7LkT UJo'![#hJ ~cӸϾ!>߂Ͼ ? eCJnU6 ) U#ъ0 bM RǗ1a^4 oV<@QlD7\'߅.Nr+UB ayUz<@4"/ h@U^2~[ۅ5VuzUeMg8XJ߽S_Qe.U)T񪠚*pڷo€7@oB/@zUϴdz{SJMKֈRe,,y dYuvyu8,ߐզ)fI~5ԯtCPnޣPw6nS3kpR@z]Sk5 TmY"wѤEQJ'vc>nM!GZI>4N22Σ& ?fJP_'q5q"܆g?yն{צFMOnP^ʦM>^ z:4ݺ,Z'&[_j kWp<,xXQeN#[PãDmٿ{'L(+[GZHOi6jM]ɦňo :q{ je@ѱ|V2!jpԸ3Uh@c&5+(4WT<7>_X;j p':TVR)7~|=?HsiȦӵiצޚ*㿁6zr7T^¦͇q ÷RkT^mPPCGJzISP̡ȸi@< %N">$G6 N {1i*Ǧ*նӿnjcg֪'V@n\[t| ś+]#,N**5c$B1SĤY6}J'/̴_RS}Wu1c/ihYvDy[Qoxs&]Uc>U~ :=wn5ef.LuT)mJݪ[p2x(7M 3@uPmztT[^e VBg,Pf XE^NWל5sL忳B_!/0?!a۟A.AN@MX0qM MTUPe:AdpRiњʋT]ef-]RAI>R(0?K>:tտÈ˷aѣoB݇ƝPyj. %M1LDN[0ߙ6B,wG&藗I^ C 6wC-96zjo;A/P\' cԐr 旚^צodѦzʾTb_zMg !ɂTAT˫IarB)s¼ z^j{_ֻC˝d>:k\eZ/vŅOC6gӘ7NIFZ9=>O qZjUCPN G3O 䯢fhqrt=v/s] V^x=%vg_){~T'g՟ꒄle}6 ?z \H^UZՖ8 SlhN=w1IPhPI!>P:meB{r]W|Tz|vwc>p#9\G=es}7%q"t?t{<ঽhȥb ?-|qĕ -똢t[a3WVPN n*~e"?߾}N= -wwJbhu̅PxTþ I&jEm} 1D&jsB'Agϝ'.e+C.}&_Q}#R`֯G1ڷzD8-~Da~?͒MvY6!7?<܇h+dQ͐Ug4@$ֈ3+'ew]*+.[WoPs7wzǡ\~pZǦ)C/]Os_70/ +xQ}f(;g98 'Lj8c#rJSf,L}/6?Tc>;;fy̧ߦ~!a+44K=PDw@;zJB %cuVfT]~PsSt PPAh)ï@T{:wG_CmRNTk1W?ltyH6R^9K^ِ/~؞p}7Nliyތ,WZ}yUuUU=7^ʙz-5mZ6VKo,kzUz&{]o>ɋ! zߛ 66)yUUV~N qP#~ɘ}ܿ^{{:d˹^o3ww}{2ikžKmu ˺,K[X=nm0Υ{v;:4miRNGKG-YZtn`1ӢZ#'_xEpEcl7hKl\{TJy9e:腖S-\: 1вE ŀ*J-XhS7Xˢ?)T_CPo ~ َ[ߴ󼁧NZI10}%q%2/%ҥ ^JziO] CsXqвeܺ*7Qk#?1=:Q1`~c߀zzϽS ے z҉k o<#֢csҦWP]/؀z9g  :}s_>Qs_)8?{o̺LkGkS6b@NMb TΑc'U]@~V'U`tJOYG73u˶7-;߲`vs|˕W^H*sNQ 1`굣aZeyaR"•PY |GE{Ok'ykDuƓZ{ 6UݧY{=il@T ; ,uR_2#v81CiiVl*eȦgQ$f -ZHbp1+Io #9{( HtJƀr@fsRMYR/kNPm3ЀBNUU+&չדva@x c[ng/?h@eq,gȦ !2e,Ӭش Tp},1 I:|nѫDAYMo ^&1VN\UY!rq KOeS=T+/׷ eI%IֽīUBȪ#9i aYkMoΐMU3e,ӇaLΖX{̢?iMd J0JPVwǯ2 Jtjw}G9\V|G}S;?_{TTu~'UjƗ 'tj;:l̀^xacV9f>i@^u>*ުi?Ҧ ['[ku0s[G=,c62j%qED7s%nm29I^%R))# ձ$&7Gl7ʊN6MȘN]k:i]egE+R{CKҐ S{T5~$ɚm ToBW?Udꍥ$YVS b\j|/I^ fvTIG5:rMc!ljdAiTQj(S*=@xKaf},j3PJ {UkNTSd]~QMh@uDșYvԜFrDAՙRʐ')R?TywTݬwl곦NRl:>S:x(/pE)d4H&Tlj)TjfmVjw4nU ^  Ga;8piPӇ(Ө=ok=szULG5}:ljG զ2fTȭ_8WT -k40%k -XYqwU Hn#e4€+Fre;U^=O4h:-2OC6 32SNL EAb@խ-Xf;JKHJնM(Vn U2XJ7^Zk&= (xh5@AN/Tu^$zZJh9:k312d nZ6 6mME/OY}=ePKYN@F$)U"L)\-cTiɂ !ٍ[U)!*s%I5}?O]FN!l%֩7WߛVI˱P3Fe:ӜoP)4_9rYLQ1M޲WVbsjzIrʴ6 rɺzT1Be/y_"-SB65OPm7c6kXעPG($O h5R(zq(Lc9)fA5,[H"9 U}*ka<?M<S י8`2!U_wN IL'=%C5n<­CIcJHU%dk.5Vom,? a3ld)`ijvgUǺPITr Ū[[\ZZ݁Qds(X"G^@}YtϦ /zҨHeLU^ Ys !͛+p,YV Ȳ*j x Ӵ_~ʾצ5(#ּhQ5ۙq;J&I\(ӱ);TsxKS $7H4_,`S P9:fV`Q4z)3a[ W1`C%M.eL)7/QӀ/Nt굂L}=M1SvT#Vx=z;;KUlRMU:-2&w{U@6U[oZ폶ijJaAdh8:řbPzܳzwIU/Y2q@EM#wҩϠ`SM~QE(aqH} (9*h NC OLZnٯ̀sdWۥLypu6%z)#4LA4СL}+Xl9~pr 4tb6ulSݯ=lG".E_j@{ gTHIOՔ JMɟk@uZQTPkj*j:ϸ%R'N~¢A5c@!n4 [fR:*4? 4JO񧪝| U@%JWv fw0c tjQ~׭ÌtbūTn*j= ܯ iG?Jh2fk6xb̂ݶa\6M{VImոL_<ڦM!I}4t[l<.wNn'sB)!"͜yfTwWKgcܺ ґ`@O) 4LNC6 e|>;jɄHgmscǭ"ō`'v+8?9 >EN?2U?~:i e h4;G n>2[4jrtN6 <ܮEQPO؎'-2iSި(NK_i﨓=_nD-ɓv1Aų"`Gz2IR2qgL?Ml/,>]M I4v4hk'J6)(JVcEY>owrL,5'd,)xZ=̞j'DkDDQΤ匍UVpSgd'Y _hY|$e+!Zm2tCj}ZFq ANbq 4xHwSZfa);_P+2%wj*#Z8q^wq/dS9rv2aZU(m|iX=NVK_yT4 iICΒT9O!ϓʦ~Z~V4i1|r{ęc T)8w^^''MA<99GB6 ~zw Z\2!H`3Ovў95Q^霐M y̎VUd*MTHg yhu9sNsu%|sNlmz?dF4YwVg^5cl(1%QKĊ-%bE`È%XƆ 6=lQcP5/g0w-]\yfs}7y=3#^0j}6!Ȩ"^<լ H¬^8!%!A j[ GBSm-\s{&כ!L5& ۼA34#^It8t/yd~e4=9v7&.,LUk]f:8 vE%D$ꐬ h JnOY:ϸu'2>̭~xڙ1]bBCHS턹pigici!  Vt.1 )VH|[lT3 žj/CYTƤKL f`ڶ=-vLzQ-1 )VH|x: HY6+M{zxi! #D<)~54|\Q=J'ŷ3mfAB??C 17l ʷG$J|ЊmSl_x:Ĵvxt۠CtAe+JL[ml:۝6gnxM3L;{;1XZsSk$dO5|%(1mky9>Hk!zWʉ OӦN7hկ795Bk:Z #8Msa :̈́W (3`<}U^qY:Z߼mjF;S5)Q#Kh{CuYp4ahC+hw.[qܿe&ͬ!|UI gҸӣa;o":.YiZ>_'r=З14]saGw޳]*_MorQ%gs89$y*ͿKQModxVOÈfwG~'DGjVA[#..U(AYR-8">T' Ȭ2\U,杉{\g[lO[iio40bV>jA8Չ6Җ52\%7Cʒjze[AziE yx'5=(WG\= q %X\= q Q2^͉Ȩ2\5FZRbH-KVڤ: '^D; r'sT7H8N cnVLs< va}_:C< '#îv"AQ2aD琉2F@ !Ț߉1qcrӰ)HICD;i?m4j*ZRNW@dsagDgϺ *(m v7ۅ4=̓^Ԉ,pv; aT]^^cM Y (;(}/4h2/hFF\Q!2qaOE!Z dIEIa^UUBp D7"p:r NB4â.LU;i{:?0] afg.2jMP::@O7Jq_Ucwu,PBtVG5v)m&D'x'\lYgYP.01U^'wRcx OQ?k4sqN8ɠN < kheC&*4(#cUI>J$k~q`i؊EC`Zhߐ5 ʩ?.C ޽SV&<厠U4lKDl9[OUK@vvpH 5]Cs{쨒LjZ 4}Vb-tSTD?խ\:~!fP8`QXj*UAQmDw|m NIqNhBbLOeH4RSUs{a/1h*bzDx̔(5_T&ݞѰȺDjKv5ڬ;M]{d: =qp ⧻ewAO*hLDʙL;y iaR_]@5Uk N5 WT ]y?xiiȪ9gMDn ~~;g{Se ;U5~C>p<ӚnNiOKLkTZ 8Q#Qm@խ[fY9u| 76Rj`^qv+g!jeĴ9 赏:W/Mj./i8 jj0ITD('a²&Z*ȲY Z&ʫ'ɮ13iRbA$V")NtIiR鏋d4Z_MkJmREIh&[AEElŒ"6ῺD .endUCꃧSSqzhD#T5$Cٗ>)]l%Y7UW_ 7l7r74?bN:@qy;i*XSC`%%L.΢R#A485DӖ,iyC5k(jS >$(M}rt9f'jk*M RHZj-}@Vp]K-ݨx OlZ1K'9.#F$}9԰[֡R_&YNUS5,,!j Ӧz-шy1Pi{k⡱gʒk^DMd߉ o xV< ]+JL]LY97'~HDRNª"qG ixfәxtua`׬1Χȟ~m%74w&G66ȷ9q$ 2 uLe~mqՉ+! ޽5\AϤLS5dOWxΊjJVT}=Cgx{@5nQGI Ob{č΃iS{ZbZS{3T R(u==Qϼ9"792qhωz~EcVWe?TԳkk ^~jOKL`Z=u=c%t\7>xb戛iW ~tm^&52:[VꛮL^6TJ}ak?KKZ>4KLˏS2ɜ2 A]?:GRUȚO1}M]W I]7Z`M_i02?*18lm( =v't o.wkc?ۑ3=q' ^q$5񰭛)ꖩFN[ӱ%`-7MCYBIGA0gc?5Ŗ۫$im|i[Dkb2H*ڤ@ҕ7M0;>'ZP}̗8I e,i,1-a"VLYCJ?Ly7$[\;>׌؍Ršw,f܊u`".f:!M#Cw욻ͲJ/?vJCM@q{FNp7cj6&#&lItׁPfIwppH7R'JL?̖V-'ٴn vȠɎv豆 5tV// qD1aO:M[jHiNVV1R:ZCSKʛ-SZQmϯ&fv Lyjz3mi5r~EBF|$5i#ks2 #;I!̣|ʌ!%ōu5&qn_f)c_PeJk<.W>tōjyhóeL!%Iy!yQ4i1}ØYru(\.(&C<24òoG'ڜ=& GAR/)'&NWDt)1OL 6;QT-SØM%z}EfyΚ[jԖfX䰭D F-FFfMEB{ :O'f&Ƥe ]W 9Td&Jplcqo\s{ԖfXaq3U f%:%OdټW _b,8xЅ}LTg69@'JsQ󇧋 KLWJ$n !O@MR%O[E ӤɼR{C3vfLG;@KL bCeOµ%Z;[``끧oti~bfR.*T3 žjo&%u3];&Ԗ'f&M(#fyd(6^T/1Ͱ,=L7zS…Lh3t9Z|{:Ìt/1-~2b=`+hPU="QVOoSdX$*ߞ!% h&IOAi>ai_|aUǦsѽYlsv: 3L;{;XZsSk$dO5xzFi;Eo=|zЄ t:_/Nڢxjƀ y!,˳TvE5'B_ƄυWosٛ}{YX _k#.6*6Mo>8#)+4=+4=Whz\lz_q=Mˏ|Ź/~=(k^{7>U8{P(2={5(iw_}W4N8b0= +4=WhzWhz4Ώ/#}̞_aO=(4=i_]Wt~zh[Q●E׾&H?wAwi8 H,'ťw:.uȑ8.yȑ"Y!^;VF<:q *\ =v*'ޠ_J"Maѿq^6uG^#?hdb4hknېVoiEmD[ Xlz 9姷?6ߒTMgS? /MY!ɠAŦ7p`W~f('>BR 3_g,/TIMĻ~$c/^>C+!AzCߓnxPKoz?'e&-Ͽ#xP?~g{9wIMoР^|7#?gr#dፊxxOH&}[$z=/JW zCI߾TeK3":n KxgBoT|́s+]z{*wo>.>[G(}~foW>}J߮LW~|,ҷ&%~%~A[tz%ۓc|]\=(RJ߮|YoW>%*7|9差+:?J߮|MM*}a_%9s酦MsgH_,ǿ"+ʗ#()}R$:SUt~[>Uە"ѱbſ4ҷc~^X{]r*}2bEb^UvcQHLbo׋z0|_jϬ;7nϬO Dk0/uay~^Y;skkϬw;Q'}&rD\pQprq{m]b^y W=D䢻<'sĈdһbAMrr'cqrzCN? WNq}ƺ+i3`tŢ{/EI Nd=D_vK5I rSocQJ/I~s C<)>h.K| ~zsOޅwU;'Ç'g}!.$n%g'fپM#=w^-yki)_{iov݀})T}Ώ .(y )6b+ѣկ/_qwJ> PڃU][_{(WA[_{|ǗE}/}chwIC7kW$t|U97⽆>Bn?!Pwrߧ7P(/?M]` [)_JjG%Zd\jB6iJ\5K}%~K_{ͯWaG9P||wJ{/KJڃ@iڃVuMkR~+k^=Y] /~n{`q,Q}X} nzraٚ ,6a^(`Z*I_?kQ ÿ?WWaA'i՗_|g_B@UO???3=I8Fddi'I 0tˆu^L5a=N* l<UAN=SNrPPy U9ڔ%32@3!<0X/r̤5WV 3`rPhy@ PH65 jc ld(&K<3q108Z^vҬPTrj@8Z7|gPvwl3lr3Lygpmi&y B]B ۨ1d( 3F$7 [EnϼB6#)OA#BpoM:r@Tb( KsYUA8@(,HL8JJ(& ! ؄YV((@[rA9 l2>C}!(\L=Ql KwbuQBJ9~fϳr0POQf~[ETv<ȅ f F UU * 7i\boC`(r* pX5ZiWQ ,|,mKw9;* \-Le~gwOP r[i}PZA B;8j@fKu/} +ރBlGPbJ[X eoOKGv~GL9T\e"|hG%fukh&-{'<=1(o/$GeV5LR'y5z[Cy>ue>icQLL:ׯ!_l77{`}vͼY\o壆IV2+_5H3eO?\(r]Qoo-(2=հs}䞚\XLd4 XܠɅU!)=5\ch\֜g8;ij =#aZYBe9MYV9.T\qxAE@Q3rrXDl}e"]~V( W8\"rD`~RXBaaO9 EqW:</}('Np|OR&)!0* RLqu~9tt]6wPX0#shmnr=x 5@fCy$SUOv]ȗ;OjJ&R9T~zWlnBl Oi`}hW~*ʗwE9z"y GQvӞFdT,^zCH^ H>-{{~cS˷=TLe)q`k\qfH֢GK|SvM^{{ ݒ=9.{.E3&S9-~ =S4jFbé#rO_OMUd= r>U5'K-ٗv%KJWT!fʖpf>)(ܐZk3,å4uu(@(6}Th,Ai/Bk3CPE嵖x-KͩothJސ IQ 'E( S1Oz3J7?1/o}2l\!!q,'jZZ#bx@@YƂ@ZWGP1.91%Z*@8gyji"(5_ԥFSSBi >d@o`F0@x5 #1:' Sb'Ǐa!Pt:u2b.C\)g.i62( GBPP;%` }Gj_FK֫K1E$h=\)]ap#uAq*'FnZFQU?([PTZ-Ec `@_*LJRHZ(y/P}tu )aҞhZR.ww兢Ud؀O`Ҁ Q+6chf?UeKTldL ୘Mi70]7B5 `5xFIYʘi|1=9p;eQwꄾ=ғGG_U$m`F%vh=%S5hgsvtd^6"h.D\F89Z?C'fh7eقoE:;D^@_u+չs`hz~ULbxk wYpe @gꙂJ7<$(T+:7%UKP-#J(!Ĕ@O47;*],F6 4穥W&ݖ[ۛ^1yDHxQSr?kZ^.8i4t$DXbaWjJ`Q b0c~HQ ?K9P i\R}'hG?h!_?hJ&lL_p&`Wr?|ï&~~0+ɇ_L>`Wr?|zLOzzӯld@Yu z_L&~^>J/K_52yLNyr?|ï&~~0+ɇ_L>`Wr??::L~0)~ҷ~0v$b  OX.\+BI?G=+`X,`}DU,g7-(IǿpZ;!`"~0~0E%/P,BBL_%K~)hL΃PLVv,i MOw:,$Cx0*)a%ʄ ivT4ݞʹgEOӣel39|!} E+kw}O ƞYShѳVn$kh}iG ϧ?2'a*m0Ϝ^r8S>dˇy qjSAܥ>>.Rϔ=] !"g_aE!7u6yn<~Q_}ԥ2~]]]~%/_H5Jg>i}~HH WG6R"F9y|~VϻfS/ʛg>Sp2x=N4yb,fYfGAN7! ]rWUe/0SmWB3|εKVJk?ÍYҼ$>K6?gI?,gwx%"gތN7]۾j7/拄gN'iv# ~(zM_ʅ4_y,~Y~of |FpnJX2Ũy.<mfFfF4p1|~<ߟ}'qI7hiޏo#{jލzIh9|FZƜv4̼n^ѩ.\fġ泥ӌXøtSR+.˥,vYvW"Cx19}\mhe͈X58u'"[Zܴs5j0OtB!JOV BdXH")YXiܧ~{P.kc,xn^MUro,}T-f47@ ,m0FR?ғA>ծ5Ajw@_v+}w'q0!:!Z z6r(,7v q#2+ kh;NS>`+pG #Q+< ک[ g:hx S}$5K6c}i@NТ Y7'{|xc&{]~}Xb_GPW>0n| +04~?žKq Em}8#O{h8@>pjdpE]S U Ty7R{<{?K?$r^x a*^99{~E"7QbvL9O5I'աTGw(/ c8 ~ J@ZbKGDH cmPPJCmp0712Hs> IDATx^tI}ƅĸ< bq5QT%=<: 00&&2DD"0yW:N} }ϩ[?}{ @oG ;v÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|H @-V ;kv÷X ^@ b @ @`xa7|Hݓ'B 6F= bN PU@U1Q@s"@®* @@®ǮTvU9mzv=vŜ @ic У+DU]UN#@]]1'* r( z9 @@UaW @GacW̉ 6F= bN PU@U1Q@s"@®* @@®ǮTvU9mzv=vŜ @ic У+DUvO66F ,&I>(;:iWq Xl9~m*vE.{nne>XLЮ*5 . o @sag @n+5@ ,7o  @"Λ1kv C`aSv1*  PO`qapzD ,)vn=|_Hv) Ȱs+S(аw׀M @`x%C3EeU@TX`=W @`pE|U*v봫Las 0"@ΡLY. X[r̝vYD5@ ,3||@XdɺK 0Bn3n9T! ,(vS.#@ >'а`K 0B;g1o  @r®fնE]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1]̾]v+1z '1[jh% Z.t# i @@+aJv  @aM+LZ VKnZa" J@ص]F@u !@V® @@7®Vvdm <)xq,O C3T-o1XL0 7ѻ"Kcl{m^LA ZnA2U ,5wNv{i^LA-әP@MmW;D[w * n ^SPH b1/Mtή73vý6/] @ -U-%};ivVD*VwGMH fv3-L' 즳'I@o 0ڞ @`&a7 @tn:k{"@LvK fv3-L' 즳'I@o 0ڞ @`&a7 @tn:k{"@LvK fv3-L'_=d"]V#  @ "tY. / @ e5 @ O.BH.P>"]V#  @ "tY. / @ e5 @ O.BH.P>"]V#  @ "tY. / @ e5 @ O.BH.P>"]V#  @ "tY. / @ e5 @ O.BH.P>"]V#  @ "tY. / @ e5 @ O.BH.P>"]V#  @ "tY. / @ e5 @ O.BH.P>"YҋO?gٵ @ }  Q@M6Y   Q@MݬOO#@@@a7q?s\ϗ' @ 9̺O?4 ݴM?8>큽 P@M|vI I;OӏM: ;#@@4a7iǟ >q7ihnҎ|.\vF@4a7iχӧ_t&vFHnnv>1Tݴ;vOM;{#@@a7mO}nv2F(nN⡝ wv# &n8snM~)q&Ӆ[b / o񫉴{:c Ri K , fi󍮳N V@K B鋽 0@{rQIx[le&N\=E梷_ zRil1v/,Qq^$6J،%@nww5 Oz3='f[ Y;S2?5y면{6CۘU wsw @@Of  @`nJ?G3 @]n*>$M v]4/u.fiXs wn Ĝ NԩL:i DaK~-veA ~Zpb?S5,K@u/:j 0멝oNe~ٚ #P/|Sy+v @@8aYSu6_!@]o]r᮷]w-1!/P/Qf.U[K6Dq%pcW̉ .J]neLn]y=>mVS@ٗ_Kݧ;i @CaaSVSzۅ^[c^,O@3퍙 0aqÒ~ɛ:hv,5d_w|x]KمV̅c<N 4 /@(v^]2-~lWOp &@@Haukν',]1gZeKбoB 3mL%P?Vr{/L;aw|}hvẌ́6@@h&aw(Zvӑ݉VTB/c @ಀ[ I^B 1M f@n w/^Y"@@a&.|rziL, &ewp[W~T*-J;%&>gWݘR^*6Qa;~euwM.]9DhvbeawqQ&okZ8vyteo.}2mlb ;uk2ev-u[mۅVK2]YLoPXj_NrF !@@aw݅kvܼu΅XTXRؕ"VdpS.uS"@Wѻ<{%j^.M%m?,_`1aw ׿7R2oۼg @`.-Tv>qpe%_Ogܰ @`0ń4yp3(k[s|4qp;"V#ԅ݃S=<_jl:v>Gv_op*®Ņ % %wqϗ?H5 @zaw]G|+6: @`rwc/ɗ @aO/nIm*>qwg haNޅaZ ,4<:Vl4*gJg9[1 ,3؝Y wn"d,2dΦ.ܽ& !@p5îW$\X wo D@{_)iF˺] w$MnMvf= w/ܙm @`  ;*u˓ 0@ݰ[<+`|SeP&/ܽC 0@fr1d]wS> 0N宻ԅg2,+d]K]|K# XN֕/Ne~dk @`K ;YW{*\+5 ,(d]2K]Ť@2vpwWz  XJ؝/Kq.oS~3u*Ӆ\JX@;HvCJO_aO#@ڄq4.=Ko,\I؝8 +`*J΅CS qW H~=~cE .<хIRR:u<n݁ @_&aw[n;7]x[%@aA&۩p7Q'mwrdlަ;0 緆խϟァn 0b<-)VTkM@ 4 vs\̌J;K%@ _Eݧ-g7=9#]yu, N~O+*p妞A@®WS2?bI|Rifh .` w/.S$@@@L@ϗ @`9n9;2] nk) ԟuM]{e9* K۔ wK pVn.]Vw.2x3u*KyO0 7S޼aӾo`h.P?NV®ywvplLv%7vmz}f w>q7i;&® 6ݢe\# Q9 wVr'0Eح@hpv =+p]--P7N~]i}M8W%v՜ ;a%z3 `®Hȑ]W_Oݧ+f 0$aWX+3m@  UeF9a"fZ(.o4v͉,S%@D@ؕh ?k w O@hv7;9y3x;v>qw' 0]ަw]ͤ, 쬐Ϥ @`qnq-k>᯦΅=* ʠ#l.yUH.Rku.@!, ]ݘXi, ~P0{aWj[ wڳ @@;M?SvX͆~7v4۵  @@1|]&_ԅܮ @`raκ o nepz w/t2O @@JQvri'R]߿:T3$P?ևuaW?| w55m& «pnpg:j p@[feىLawu;<1u΍$]mᶗ/ WN@ jm*Vߥ  @@;.L1vmꭥ.Fש;b 42p.iQ.MmW4hvwS)+њf웩S_fByLawU[{7Ri]M3#VA$6d;+jpݳ&b?t"OGOIZNf]aW5$|nNr?G۩6֤>:V93d!r['h6 MTaWK2vJFPP@kޙY'^]uu~Wvt6՘- 첩 |ԅ4г?w݃c_=9~}w)pΐ4eeY~,upwտ٧VxhY}?+w8CW #Uqc?=iU&pI@Ye4y??<~ZO<~,xϩ*>~tz9‘?5h"zs׻yOc?C??~O?o_U z|/|[<X0Iî춘Nno{ 璦Ļw=i??~;~ٿwYxeݶ6?v5qH@]욧;v}o0iZ]N|\(.eΜ < u.gQr 2.ml^~3w:R 4 ,)ƒ[S XzBq7mX@[߃ltɖ&𽪯6vRw@FOdT[6D?aMMoQ w P$R\4IK]Ro:ًC,~L$0vc n\35BGܺ=@@ ,z wc]fU/={<zSYrɷ uF]K.eCa?| lF}E踮6a…]Kඩp9ƪ־s?Vz)aGɽs/x6F % ~9iYZ{Lͼ&7fK0nɿC+>H1хB:{vc/5x-Jwy;J&nу^vl@q_inڣϓFQfF`RM(iW/®v,y2oc;# Mބ4{ng{|{7-ETcLQawg7dӾ7곟m˹ Eͤ7 ůnB%X3){]v?൜@m܄⛛P)^]c| ɨK9ݴֻ~ o+&0l>^~78>Ob&⫝ Na x^Mǻv]$ xMX[E~]]0oͧgky!]拌a$6Gͧ2h~v &}6@̶7;v t/}61"]/ξƅ-0lB񿹟MXg_npoc;/|an ˞싼a]]/o %ͷ&;U: sLa7w[o>ݜ=u?B˷6 [=x;˄a܋D'@7q>0|c ca7{ Le Ñwg>38{-0x o~km]ލ908Ov5( @@}6_I v`m s/ ڻ @/Wv5 GA`JI)2OO2N]xͷ/sd?@a  @`~a7̀ T]< 竷Uh,P5iw®qlr;ac @@?vg #P=]N!@ nN5n @@@ CڄT]<4 ;ac @@{rZ|A&a '.>a7Q.@hvS98sՓ؏ @@aww0 k< 4UlDA [@&ި4uIUݩ` M1(voo=;aW  @@ݰf~ M1(v{Y{Mؕuh*P3'0Oe M1(v]ve]1 4 @ M1(vރpNؕuh*2|.\]C  @ @Ӱۤ]iؕDc)چc I*ɓ뻩ꍳAhvo, WIA*݉my[]&@@+awlC V]8!P;N[H T soD9vEugUzHӄ]Y] .. P?MV" +@ 4Y. 좯 @ d% @ O.@H. P?MV" +@ 4Y. 좯 @ d% @ O.@H. P?MV" 'O8QJ T U ;vݵĄ @-j{ Н@ŰXW<8 <T J® @Z@Y  0 $@ag  @n+5@ [@v>ggA @@5ޘ'qf sCj@E&vї  PWbÁ3Yi'6 ]f%-sd $ P 0iح3.HH 4 Mܥp4B]) pVa].쮷L8vV / o  @@Y 0 $@ag  @®[k~) ;=s{ Jv;#@mn{S57]vï; @`R&awt/v;#@nN HIZ8nqnҮ 4 Kuκ#@|L v3L$ &O`9) 6&@a; _R @@[:7+iD-KC"(E\j&@@C6awve8+2f89wyvvP @@@#}_tgf  %0r3  @X@Y 0 $@ag  @n+Z]R *&v55mhv}PΑ]kŤ Xa֙8 սSr'pjmϾeϞK# 4 [N؍DڄƘۯ)Q`JIa=v. @k-l 0&@ZSnOiߞL 4 [ݭOz @-V ;kv÷X ^@ b @@[/ t|֍&@hMn'Y*슸 &@@9>ww`7 POQ=Lp , %@@[M첝K(hv®' @@eaW @?awF̷2nvJa7 G/ŵU5^nB`tKC% @B#횄nȮpN e]i&n7Jn * ^N!QK @`îm슸u><̂@`n#_ԕzUl+v< +Y)]%z{E̒;=qdCKzw%̱}W hm_ulkԄ];۳[_3L.]eq7e'^Se}*/s ;\캙t Y:} 0/Svcp0\Aeź3_+ S@e%XqfY ;n'(ON}=zKs̶>Ж ݑ]W8Ysoi-Luvd7+;<v?0,*b\sm4Esh[hiW F,$&jepM TYحUfWY-ߠRuRtԍ#@ nrr;$@ | w &o йA.w5}S nh7Kyl]uҌ ] T",Mߦ,Svs5>ڷ @ p @ u5 @ p @ u5 @ p @ u5 @ p @ u5 @ p @ u5 @ p @ u5 @ p @ u5 @ p @ u5 @`'wY,faSv!ۮhvZ,E>V q*a'" l2 v~^!J%@Ivnn3vXv.0j,P`&s緼ltE0ƬiSkV P[`hn/y&1˃4ʶ7[˦Y6zȢ&0W{7hpMDaWS|[5>s3g9,s  Љ^mT?gυݼ(Snz>^Irl__aTWGaWuI>h|ՙTژi3ؾ SyYO*/K~s \)/p5Vj®џ(9[=jȝl cFl7.qҸoO?ۋm֪^Ւ{Q;qmIv~Ϝ<1Ѩ~^2aWKr{dKʅf,2N_yΥLaWmlK\Hu\*>x).c ODlή) S:®+chfk6NSI/6$Q4T6?}&L!p*Gv/'_HqYa̅mb8~PێCL#pO H_{T#J\xjs'N;gkf=NvqfgLœC@ss)tpwag{9&wa98<:sJn'NLt{ MɛQ48B/<`Hf.*k`5; '?1o,$6ea=D/q}a˝~En˦lޒ;9ɍgMAX۴<'us, QzzplnR5_'(/㿦j}椴jޝU5ӭ( 8<S+vO[omgԋ^C®+ch5notrd|Q2jh! 8;H:z?~D t08ݵaSp86wԴ:دJ]SF@aWqg-G[?>9zyXw[;κi=1;7®.ꙫT۝]ɢnsrNXn~,5[#@@@`e = ӧwxL͑c6vA=q V=]:t~Fk !@`®na p fu{Vi̺K(v%Zav'ʉVwN9lK#h, ; súS5vq{rvaZPvq{rvaZPvq{rvaZPvq{rvaZPvq{rvaZPvq{rvaZPvq{rvaZPvq{rvaZPvq{rvaZPvq{r S.;IENDB`nT$AUFTMΟ 3rPNG  IHDREGQE"sRGBgAMA a cHRMz&u0`:pQ< pHYs!!#IDATx^\ThvP`4+6D1ƖQKbK콢"Tbo(XhXPE$ry{3ѫ&fX>_ YOfV|N3O$y>OaaT]9<sS6rpKu*XVVVf E5*yՙiʣQWs^w4Gn;5T*Rx|$Au2M ?`2_6{YWOhCj5ՠFDuդ(Nɛ{^U-`ھ/E7 !§OnmV0j* pxQT~ȏ}K §=U <Ax1RTqL8S9qɆÆ,Q;A,- 7&r-t:T6KUJ)wU ݀<@ >[&¤u<T_Uj)a]]*.(fۉ+jdXNJEסbCQ]L.V}bԀ9ÊΚRxEqm<nhISQg\۲$B$qgd,|\jM8-c2#""A\H Ȗ݆CjrWx|WEZ󷺓"r쥼~W~z6QäXi >I4>-G>'c&;zle2v͸('/Jl2@4]'Ŧ݈bM&BPk1Rv32Rѝ 0yq UTMDF~(Z f,(+RM@8ا86EqIʊmxGbߒg2, XG OZ)K\-F:rk ;a%amR` !C+T՘ _] L:!M1 0 '&0٤yYO_uoKr$a?ȉKڝo%@mtG֜* kRh|X" F Uȡ1t%j,d 3EU5Ww..Kp&f02@9'/\>@|sOrQ9_KD5N]Sar .DѭA">{Yc(dtd}͏cPj[ H w"?f#`p%j vFOO׶DSIBҽqee`0u=-9IqULY٢#@(kcRjyV-ԊLdi@ȎS|0HʠwL>B^3$x} )3:"xJmWm"Ș`EmhT sQ8c;ze eX;P3;2Vߩn~6ϒkJRTYwPjy @:U&dY1 ġ=.pQL6z_~>A8 hK% dj`~܃+dQHessG40--FT:*$%Kf%YRKXLRxj]P; >P܍;xR&&&ll<} x?mBRl;\%əg\t{`Ppnns]GOQ x !5[ҽ%#S/Uي-V݆dZ-$jy؆%#XRnqj[hbdh0a, SNɴS2=9SfdLTlC>53"!C$+A3rzshOr(p4DmӲymiTT^մ }!z"~@3?/O%VvZW,W ܁%` u: QM*`5+O ~vj=%Aie>i|^Z@'r8$p$kɶ)x4Cey2{ !u IKĪ;Ov|J=?T|;Zt狚N-%`I$XR>I]\ہiԀj-x`+Od k+ɖ[IQ bPT62rnm!{%Q'@ TRNKVUb}`Mı r~ Zz=TWM)=A5f-tнb"A gDf-%4VFQJ42 K0BD9YuNOjE⵵LLq@@ #0hX8Õ&-Q%f$#KC|Zt%q]-8͊SM-FuQJRHKROAX0!I][ iL-(+Y26%Y2nk1ٹ7IJ yx4e8'; P/!Gay,=s]fdX2} f]aCFAzr*juI"kSDCpYf " Y2:B ː!$ ]]%Esĝ(;Zhb85F!O{N+/10fnZXXMY6SWdJ9izX`2eG16v]pvoD&EC,ՙ*=dأ _hGzPu { =icKu2A-a(5$S% ]̽ {˗%eIt)9`JY+.QHq9*XZQO:qI&9'mc>ef}sFvK}SC%$GatyRpvZ(0Ga:چaX@a!a7IPCdCKC׮ȑW%5|t HU,!&c,´%ݼh_1]@jomIfz*]~ ^> GXTu03cZdnZK3 @) PJC”z Q7R{2`nqwPKYnuMN޹.OW! xA@:[3d:SۏjjLڛlr=0uF崑2aFz RP!__*;Y6HY3(E!,jF ۦd7Fpy0;oFo0Yסn1M+`U2eIq ˾ ׮A{M:##ߴgu멠^끋ƆZ LLU Ffc( PE[R ]-(<&P:lHr!Oʾf3v]'%N/{ V鬘0;P>OS@#(;x$n1p }Ǚ*U8=3:j#ГdT z@~@͔L c4kh^My#,8ΪZg}qr<}Jj|ZG +EDKއ ͲtZ2i.لQ)!Cµ 2d"7SZFIJzjAZ? ꙡL5pF 9$ ;h*TLCSc;yJA)TERyJ#QjB #ã_ VI#&R`;6,(qpBZp 7W Nު׋PMr4:r blm~ℌ`mdlL7ya`,^@?16`%:#KXU~A-^ȍ#1Wb9olsBÐhӈ\'i|g[%o4_jZ#dF0yIIb¶A1d 4 ! t6%Nj0c K:p&Hx",qCvcW*;ܩg.9 㜙Q@D;zE{jۂ3Ksa[bS[meOiCQJ:G! &C'؃%%ض`892D"L" +uy+-Ch2Ƚ^])03 +o=J@Y }anX3oo. ۆ^1$ ;XD3% ŕ7s?XgUAe(nvjݐԳONXO0-v5W~V ~0.0DʘĖW.hXNdU.dqTlT<0dNC,zk  u!t2krSan4n=P$OqyV[ $x'se!uh~[}&2|R40tdnd&50p%/C@O l1Sebvd' Gd&SKle( 5-ibg|J}amJ285CNAd2fdA0 X0cԱe1'! è4qSK8,ՃԨ([1Sٯ(k;?xЉ6-SG$ +*qD`F$j {ɫJY+Mptٯ݁sG~O #mXሖ6˒XF -\o{H3KYsw(1rtH@Rd0#AESg`YtX a]cJM%Hp&Yatv]%. BJn c~pR`3q@pRm s$CYMjFv٨?Yr^yޭHTU` ʒ!ڼppyA4qLΘ1_^I>gx^-u9kἵNZ׹ad5bCHAl, Yne VqA]Ce ݆Lwcf0fՒ'19x!Y )zH8.`x "=Q!7pJP|yK+s#e:27BE׼H)u_XQط%k6\`0V僚tt[ e9.h޴:h}k~Y8;f]OCZxbmZhV^w$8mM{nCIgcc/#FÜ4w8ϋAQRq~T]-n00F`Wv1Am2-GפtF>XY~ɇD 1MWgQUX صfh^7/`*QvV/i2ےU1E176&Jb;7F +;:J- cq (`6IxA0cC0~b/9e"IY˹Ny-Бq83p,1XhuCUe6&_Jk.];ǎ4(QzGHya=C}FW\[Xref)f垟05RE{!ԝ9uOpGHJ`e66+H}M5yK)ysO6XE߄MBzz35.؈[.̸yq<2!se xGc}rS;ZZj~@6EIpx0=RfEK$XNprw+ ]WI]HBhdFJ @̭*DHNXDvP?; ; ]8ǡ0rm#4umaY1вzt=Ki^}oDt)"u@Z y`Lu/ pm;N(,1.ݰNv8WT}9ðK&s߄.0I6C|p4ҐʦdVn6{p  ] l,duAw=tM̨0]=v+q3x/_r˺Uՠ`V%'ZV喙F*&Se,yw:݌!<6(fx%\aeFMʮV0mkOwbKˀbp'~~=j ]W @![5haf@&՘}>_*t V,|s-UbPbDbհ OW!K0! wbLrT+QG-1_lRˌUT^!c\3mӶ3-*:jU'}spbYĿ { ƛ$)옱AD0(ƭ5v . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+zEMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola ili esomeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol ili esomeprazol. x- " d " d+cgc$   K S   0`to je generi ki lijek?  g World Health Organisation Generi ki lijek je onaj koji se proizvodi bez licence inovativne kompanije i prodaje nakon isteka patenta ili ekskluzivnih prava. esto djeluju jednako kao i inovativni proizvodi, ali su zna ajno jeftiniji. FDA Generici moraju imati istu aktivnu tvar kao i originalni lijek, te imati framakokinetska i farmakodinamska svojstva koja su unutar prihvatljivog raspona bioekvivalencije. Wikipedia Cijena generika je obi no toliko niska da si ih mogu priuatiti mnoge zemlje u razvoju.0" dZgcgc gVc A/ X.Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  !",Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  W8         :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 (()  ( +   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZ=Z 0  ;   -  0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtjgZ/ZGZ3Z1Zf`/  I 9 ? )STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&Zu "  +CAPRIEf lUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}tN   z %, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uzplacebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`;5,;5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   /89:P&  ` f3f3` ff̙` ___` ff` 3ff3f>?" dd@,?lPd@   Z l<@ d`"  n?" dd@   @@``PR    @ ` ` p>>  H(  H^T y H "yZ H S B7 C DEHFPv @?q 6 6 n(dx  G b q %(@"B y2 H ZG1?" H T$|gֳgֳ ?"P  X Click to edit Master title style!!  H TPgֳgֳ ?"``  b*  H TXgֳgֳ ?"`   Z*  H Tgֳgֳ ?"`   Z* (  H 0܋ "  RClick to edit Master text styles Second level Third level Fourth level Fifth level!    S` H Hd޽h? ?H f3f3 SoaringM    L](  LT t L "tZ L S BsC5 DEHFPv @?3 r4 rv$[I_l3HxF 3 %(@" 2 L 3 CRENGCJRQ1? `TO`TR`TO`TRR`TRR"t L TXgֳgֳ ?"/O  X Click to edit Master title style!! L Tgֳgֳ ?"pp   [#Click to edit Master subtitle style$$  L Tgֳgֳ ?"``  b*  L T gֳgֳ ?"`   Z*   L Txgֳgֳ ?"`   Z* ` L Hd޽h? ?L f3f30 `<f(  < < 05 "P   " R*   < 0 "   " T*  r < c $ ?"  $ < 0 " @  RClick to edit Master text styles Second level Third level Fourth level Fifth level!     S < 68 "`P   R*   < 6( "`   T*  H < 0޽h ? ̙33f 6.pD( @ $  D D 0D "P    Z*  D 04 "    \*  D 6 "`P   @  D 64 "`   \* H D 0޽h ? ̙33  }u0P (  Pr P S DH@    P  A? H?ekvipotPicture 6ekvipot.gifP[ 0  P 6\F * 6Miligram za miligram, svi inhibitori protonske pumpe imaju jednaku u inkovitost"P PgR$    P 6Kp   1Izbor inhibitora protonske pumpe treba temeljiti prvenstveno na cijeni i individualnom odgovoru bolesnika. NICE Clinical Guideline 17@0 2kggH `. P BRJ TMoss S.F. et al GERD 2003 - a Consensus on the way ahead, Digestion 2003, 67:111-117(U0 Ug T H P 0޽h ? f3f3  @T$(  Tr T S ZHP   r T S [ H  H T 0޽h ? f3f3  P\$(  \r \ S |`HP   r \ S 8a H  H \ 0޽h ? f3f3  `$(  r  S zHP   r  S L{ H  H  0޽h ? f3f3 pL(  P   c $L"`    c $`L"   B  s *޽h ? www3ff y(  K  s >TextBox 4"1+PK!Zf[Content_Types].xmlMO &2WR=cJ`F0iK`#̼vLw 9uSq:w`G ^i ½KI)c/ $oVjTMRc|}042ҥCƔM̏P~*ka/8^DkHbL8e i"K\XN\6rco4y@_;oPK!1_a _rels/.relsj0 ѽqCNo^K [ILcX&m߾0XFo;>0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!0Wdrs/shapexml.xmlTo0~DYP&TžǶlAP:4M}5l9\)ᒩ~_z)%ց,A(sގ?~љ/K>9$7`/u2 8ܚu \:pe4PK:FSr %]R9Q"A+sS#Ct&nri# $̫izict=$Xw1o(3,B۹u?jV q.H<[/وpVOZvO a?IHӡh _fS "kYbۊ9CIɫ˗~ }h\s˩ل n.`9%FO XV #yj`l OCLyu=Q;ph bv&o⠈ ;>dqAf7mS7깎⋱iM'wz $BڜJt781Z 7~~TP`\%~rQ1pF*emvs?>U+@ÉU.}̺@nb2fٷdU{ ˎP5alpЁ`DlW &$? -fK_PK-!Zf[Content_Types].xmlPK-!1_a /_rels/.relsPK-!0W*drs/shapexml.xmlPK-!tdrs/downrev.xmlPK II ,Ograni eni u inak AH2R(0g  <  J?TextBox 6Q  Unutar 5-7 dana kontinuirane oralne terapije uo ava se znatno smanjenje antisekretornog djelovanja ranitidinahJ3 (0 gfg g@L      N'A??&tolerancija h2Picture 8tolerancija h2.gif2 T  D,TextBox 9"PK!Zf[Content_Types].xmlMO &2WR=cJ`F0iK`#̼vLw 9uSq:w`G ^i ½KI)c/ $oVjTMRc|}042ҥCƔM̏P~*ka/8^DkHbL8e i"K\XN\6rco4y@_;oPK!1_a _rels/.relsj0 ѽqCNo^K [ILcX&m߾0XFo;>0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!r,yE drs/shapexml.xmlV]O0}`uJ(l*< TyI6cGSZ~|h&x&\Ǿ\rSIƖZx˙PK!g֑Ij%F|+,Nl0Y٤sul)* c69t͢Sar਒nwЩTKoewaeX >] ;mUa;aQJ6Xob =WaRyGgAlG >J'NS2 Gƺk ֺjVzRJ^ ":[z7#&Û fI ibqwĻV: G7#Xq,Y0Zwr$~0I.rQS:qxAʬ|fB+7dp&cʒ:mTT:Q:f i9J;apiUM 6m{sm;w8qll̢~0j?H*v  ; ܥi$B2 Cy8[ 6ŕW|7UpF"yimFy AUJ2 HM$x2|}E%?G7N2`ľPC$rw X8b9%kĐIK{6/l=읇ދ[՞e!3֢ }ԁtm]W@f_ d9pGxfxZXߞ~C8"K9 9v_X*!\:KWǿi_PK!drs/downrev.xmlDj@@BaB/R7Z*!uPHVwgڌsV| [;FAu(S!;K n`~0jwtFĆ 1n`,#妗$YJ-R}窬_6=MHROc""?J-r}N0D xé@PK-!Zf[Content_Types].xmlPK-!1_a /_rels/.relsPK-!r,yE *drs/shapexml.xmlPK-!drs/downrev.xmlPK & (Fenomen tolerancije na H2 blokatore ne mo~e se prevladati poveanjem doze!(L0 Le2 (  x  Jt?TextBox 7  1. Teyssen S. et al, Clin Drug Invest 2001: 21(4): 273-279 2. Welage L. et al, Gastroenterol Clin N Am 32 (2003) S25 S35 ({0 {g   )   H  0޽h ? Oԟ{ay___PPT10Y+D=' = @B +|  ,$p(  pr p S ƹHP     p  A$? H?,mjesto djelovanjaPicture 7mjesto djelovanja.epsP< H p 0޽h ? f3f3  bZ(  x  c $ʹH P     3 gA? H?Faza I i IIPicture 2Faza I i II   64̹ k Faza II Citosol: konjugacija@0 2gg D  60ѹ`K  :Ostali IPP: omeprazol, lanzoprazol,rabeprazol, esomeprazol; ;h     H  0޽h ? f3f3  X^(  Xr X S DٹHP    X 6` ~Dugotrajnije vezanje unutar protonske pumpe mo~e objasniti produljenu inhibiciju lu enja kiseline pantoprazolomHp3 Ecb*c4F  X  A&? H?.duljina djelovanjaPicture 10duljina djelovanja.gifW  X B߹5j 6`Sachs G, Shin JM, The basis for differentiation of PPIs, Drugs of Today 2004, 40(Suppl. A): 9-14(a0 ag %  H X 0޽h ? f3f3m  cm[mtl(  tr t S H 0   i P t #"*  t s *|"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Uudrs/downrev.xmlDn0EkA)R BDUQw$`9'#%khw\v4eqiu˵ideRp#a隇ZD4!lȠ۞8vuCᦓ$y[ oCpR/epQq:^AWZA4o_GM%/PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Uudrs/downrev.xmlPK Pi F>6___PPT9 Terapijska skupina* " d&  t s *"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!drs/downrev.xmlDn0Dkz)R UTBoxI :]8;7z`[q!c qZm"1)Rjt\tZ$41vjb8uG-}->m+gY$-N vPuX?,zfCQxxyiϦ<毼޵dr\[ L%/PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!drs/downrev.xmlPK i F>6___PPT9 xPrimjeri* " d & t s *"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!YDdrs/downrev.xmlDAO@&͘xǡ;l_߼EKW<Ĺ O> k- yXfj,"Bا IyI6ı;Yg0 vnj$#iPbCo%(h{/qlh֣m;U_NA_^QZA49m.GW=@zPK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!YDdrs/downrev.xmlPK Pi F>6___PPT9 ~Antitrombotici( " d&I t s *"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!drs/downrev.xmlDAN0EH5QVU[D8O@ kl- ym'7L8)*CR)}YA?q 1JjCVΓd) 6j試6 1[=NX,3?JN#@cvǿ:jzprK4 PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!drs/downrev.xmlPK i F>6___PPT9 Aspirin, klopidogrel, prasugrel( " d &<   *  t s *"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!|drs/downrev.xmlDj0DBoF !P0$ǍL+Ɏ9Yvb$Z qtˍD;ǤJ֫%]xO!6"A8Rڐ0s=qN[)Fj|βi`|3X;SVa諁z|6o "Mǿ zcod,A~PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!|drs/downrev.xmlPK Pi = F>6___PPT9 (Antidepresivi  SSRI( " d&Z  t s *"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!A!drs/downrev.xmlDAK@2vS*"(8f`v6ݤw߼{|h[1cYrZW>Yc)jy3Y`݉w4c-C L].e Y 3ŘxJp,{N ;z5T{hM5l\>ұ(}ߕ=)uw;<44z _.4Y\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!A!drs/downrev.xmlPK i = F>6___PPT9 "Citalopram, fluoksetin, paroksetin(# " d#&J     t s *'"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!=aB*drs/downrev.xmlDAN0EH$vԁRu@ 416I鱺?z_ol#:8Vp;@N_n BD8&' \\^1׮=uEDpQAcKʚ,kSwtbLWR{6.&ҢPcKO5_ŷUi-c6___PPT9 ~Antikoagulansi( " d&   t s *`*"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!O+@drs/downrev.xmlDN0E kU[jimw\j0ڲiR~<Yccj9-0Ӷ-uy(EPABI鋊 mcw`ѕR;#4:IRiPaKQyswg)=nُRD!?;|{L3U+&Ӈ} wDh r PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!O+@drs/downrev.xmlPK i = p F>6___PPT9 xVarfarin( " d &  t s *D3"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Ŧdrs/downrev.xmlDAK@aԃJ추(6=8f'lݤwAo=fȇα"A\;qX=Yc\(f}{\3i:V$\Pn N]ŘoxNp,{;N O*({SOE3rj$+Hs.x+ 4o=HzIPK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Ŧdrs/downrev.xmlPKPp i F>6___PPT9 Kortikosteroidi( " d&  t s *xC"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Ždrs/downrev.xmlDAk@B2^n-P,1Mo=jȇƱ,A\9pX|~Yc(j4Y`ݕ4b-C L].e Y 3ŘxMpʷ,{N ;·*(ZS /t)yweOJ6___PPT9 { Prednisolon( " d &  t s *E"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!^Ldrs/downrev.xmlDAn0E5+R0U i0C#$Ţ]Ԣ%+ FqnuŅϗ5֖I<v|6 )*(ChR)}^A? qN 1Bj]Zd* VJlh[R~.FAg7Mno'?J=9@}}/޴hrz]%FK_PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!^Ldrs/downrev.xmlPK P i F>6___PPT9 rNSAR( " d& t s *HV"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Oٌdrs/downrev.xmlDAO@&͘x* QBum;.m׻7o|EojђeqnuŅadeRp! Sm;RBD!4>/ɠ؆8v' ]!.M-I2+ %6ZRL%>1kӎ~/ S rtޢ䮗h-APK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Oٌdrs/downrev.xmlPK i F>6___PPT9 6Aspirin, ibuprofen, diklofenak, naproksen, indometacin(7 " d7&p     =B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKi i <B t s *Ԕ#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!-drs/downrev.xmlDKO1 HH\iU*DZͮ8!1O87_W6p7@7v GPY-Dˋ96yKN*&k4ЊZܴ1B$.SHi\}A{$iR+zGt?O+7nոz%4ʿ(O1uvY(n \PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!-drs/downrev.xmlPKP=B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKP=B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKP= = =B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKPp p =B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKP  =B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKPP=B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPK=B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKP=B t s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKP t 6pZ3 TClinical Knowledge Summaries, Antiplatelet treatment  Management http://www.cks.nhs.uk/antiplatelet_treatment/management/detailed_answers/managing_gastrointestinal_adverse_effects/people_at_high_risk_of_gi_adverse_effects(0 2f L H t 0޽h ? f3f3y} ||0|(     v xaxaH?Title 1"PK!Zf[Content_Types].xmlMO &2WR=cJ`F0iK`#̼vLw 9uSq:w`G ^i ½KI)c/ $oVjTMRc|}042ҥCƔM̏P~*ka/8^DkHbL8e i"K\XN\6rco4y@_;oPK!1_a _rels/.relsj0 ѽqCNo^K [ILcX&m߾0XFo;>0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!En!drs/shapexml.xmlTmo0>iשBJ!jNlP >VālAзӴFœ}Ͻ\\vºZ~s&TZ3c5;s<V" :r{z؈gmB]mv3V8"IBea}0Wv.TZp)GfU 56΢UE!IpX2է+7ZTomfxY{UuڼvI368^8`:#0ڶ^FJ% Ͱno״Ė% % P1%Vd0]O6y1>M/l jtnU^dz禥3!NO`\U꣚_R"<*C$/ DPK-!Zf[Content_Types].xmlPK-!1_a /_rels/.relsPK-!En!*drs/shapexml.xmlPK-! {Zydrs/downrev.xmlPK'g   (Kome treba dati IPP za gastroprotekciju?))&cg   I S .Table 43"  ]*[[PK!^[Content_Types].xmlAN0EH] tA*ٓj2<&i˂E,-ZQy*@2:k}*da< us}UmYdCJAk6N8Af=UYi)!"-^@t+ S6ƕoQ9JBLVM\sUysnJ7U|Il2\PU&<.~[m'E;Vx PK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!X Sdrs/e2oDoc.xmlXn"7_`ߊe Xrj I{<p#dз3aelv1\˜;4Ȕi߻>ot= )Rо{;wss@н͌)zͦ&3cFTZ&U |Uf`r |1 #NX9nK^!5N8E׬_½閘KI2?TuH Ҧj_5C,3qOfًYn񻐛ǝ0Zp.͋߉Z=D@C;aW{REՕSl0Z(4 @WNƔ6WMJL̊wxq4:ggFFAcGF7O[&~M$biP,)(k$j!l't8NEfee4}Mt d&&:nFm=%+/?ADku}SF &_Dhե ܀E)͠'L}E>K6Q|)j؟IaNHpx!((ŤpF낌AwĶ|Ws{ǐf6vm0Wd}jqutMfxnl|@Q !sDxm kAv0f3Ur3 +]LJ׻lj`H׎y% exndam5fg]Q6 5.%eQoŒTvyL3x.@j-98hSM ,1+Z>oOc+2S 8EMy|3>_hQ"9|sA׻gqU|>F)S] ̥2l.pJ1bA<.wϜl]~Tp?oδ{st;vTQ;Y.q̪&p% nʫ{  D-]u 昰[ҪG0ݟSVV^s](^n0_n)kՍ.[]lC&.8n{=؎4i]UM7s@$4"z^Cl"XuǮ` =jDXw% !PA0miӦ*."O 4[2& 43M*LN/(1}BONSJr\P0-qJ:2 RwӽLQ̈́&+xw;UlB,Mꄾ=;}zqQi/~'2vaׂy>q恨Ѕǫ"|?d|g\%X)HF5jIJΪ}[1 cmoO'hnK3W58Q@D2I501[{}vv`/4icT ٷh`ܸOh2.ksd|H\y0/M5 0<7zNjkxq~\KV ?|Ng9~]ռuԕPK!bdrs/downrev.xmlDj@a9BꦅnB[ZDKSA/ٓ= /YfiʼnzXV4@V7\)|>A8L . Kǣ%&ڞNDKPA}H銚 툃WޠকQ4 5v^SǛ#nwfV_rdx]4{ b] 7@WPK-!^[Content_Types].xmlPK-!8! ,_rels/.relsPK-!X S+drs/e2oDoc.xmlPK-!bdrs/downrev.xmlPK  I@  0"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!)drs/downrev.xmlDj0EBwRBqZJ7Jvck H+Hwp.gM'r`:I@V\+AL Nac36>EM}*/2'']evxp$I-Dž{znoFAU$|i6l?~;no@c/?KyF}hѤz?@|PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!)drs/downrev.xmlPK  I2F>6___PPT9 $Procjenjeni gastrointestinalni rizik,%(" d%&" ?  s *o"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Oy_drs/downrev.xmlDAO@&͘x-TRF$^r|&˷X 9_[V0% k.>_ |@X&'Z^_-0ն-uy(EOQABJ鋊 mc`ѕR;#4>I`q–+*Qy0yWۛ!{hMm3]+&ӷ} wDh rPK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Oy_drs/downrev.xmlPK  2\ F>6___PPT9 (Bez rizi nih faktora<(" d&&  s *y"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!2drs/downrev.xmlDn0ET8PA J i<$xnX,;:WgL#:r~ .Tz72)8j=g>EUm*/*2G%:!FWJpqLB-=WT6aƧ-2=lɯR7D!?goԇVMoW } wDh ryPK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!2drs/downrev.xmlPK 2\ F>6___PPT9 ZvUmjereni rizik Dob iznad 65 godina Ulkusna bolest u anamnezi Istovremena primjena kortikosteroida ili antikoagulansav(" df(" d&&e&$<T  s *@"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!.drs/downrev.xmlDMO1&fLI@V AQvM[v 9N7r=Ft|mYd έTr2)8jtT۞we>EUm*+2Ƕ%]a+vGi]̤B-=UdG~w̦yvv_n@C<q_QoZA4)^O߮;M%PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!.drs/downrev.xmlPK 2I\ F>6___PPT9 BVisoki rizik Komplikacije ulkusne bolesti u anamnezi >2 rizi na faktorah(" d<(" d&&<&J  s *"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Duzdrs/downrev.xmlD]K1E߅0_f6-"Z_nf$q_o>޹ù٢X$A\8mR߽߿Yc `10궱 !Gum.e(j&%N]ŘxNp,{ [ZT?Va}V!ퟧ[_]导>dR~ GoC$$d r PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Duzdrs/downrev.xmlPK  \  F>6___PPT9 NSAR u visokoj dozi*(" d&   s * "PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!һdrs/downrev.xmlDAK1BC7`յi)т t3 Idn =7_=hS0d ȕ^W)=Nc)8Sbt3\RJ$9*\Xd1N|G.uG,r:)m+l&-jh]S~bst}FgLJTv<^@0 ̆+ χ`#S^iPK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!һdrs/downrev.xmlPK \  F>6___PPT9 NSAR neovisno o dozi *(" d&/   s *"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!*Odrs/downrev.xmlD]K1E߅0o6i)Kt3 $K2nzC;O{ۈB4)xf ȕ^W)جG "xG a:܌1ԭ b j625YCߒKbxJp,{K 54<~mmϻ-m^[m?{yQ]_^PZA29|%Fp$d rPK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!*Odrs/downrev.xmlPK \ I F>6___PPT9 Prijelaz na COX-2 inhibitor *(" d&"    s *"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK! Mdrs/downrev.xmlDAK1BC7`i }v37%ۭЃ=ygqe`z"&dgRpf'RKFd4)una8wG:)]+E1-;Z5T~{ۡ_du|?C "ѐf3T3_^P Uz1Q\iPK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-! Mdrs/downrev.xmlPK  F>6___PPT9 ~Aspirin + NSAR*(" d&   s *ȵ"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK! Mdrs/downrev.xmlDAK1BC7`i }v37%ۭЃ=ygqe`z"&dgRpf'RKFd4)una8wG:)]+E1-;Z5T~{ۡ_du|?C "ѐf3T3_^P Uz1Q\iPK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-! Mdrs/downrev.xmlPK F>6___PPT9 ~Aspirin + NSAR*(" d&E   s * "PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!B3G4drs/downrev.xmlDAK1!& 6-RZyn%zCz|񍧽kDG15e0WowO 7ON`:ca/[q%2ħ5m!e*kr%}9XIᮑJCB-j*a؝[ n֨z>_A06___PPT9 #Aspirin + Izbjegavati NSAR i COX-2 H$(" d&&#=B  s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPK2=B  s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPK2<B  s *Ԕ#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!-drs/downrev.xmlDKO1 HH\iU*DZͮ8!1O87_W6p7@7v GPY-Dˋ96yKN*&k4ЊZܴ1B$.SHi\}A{$iR+zGt?O+7nոz%4ʿ(O1uvY(n \PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!-drs/downrev.xmlPK 2I2=B  s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPK \ I\ =B  s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPK  I =B  s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPK  =B  s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPKII=B  s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPK I=B  s *1#"@PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!Pdrs/downrev.xmlDj1 Cw5H)QD[?0nf7ɒu}R̜9|eoёcQpJy"1)xRb2\;J$9*010d1\Knc}%G2dٻXsJ0Pq;ݭgUNx(_[aN+Hk}n\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!Pdrs/downrev.xmlPK I8  F?TextBox 11  Lanza i sur, Guidelines for Prevention of NSAID-Related Ulcer Complications, Am J Gastroenterol 2009; 104:728  738jt0  g @g &g g :>'   bA$??MCj04421390000[1]Picture 2C:\Users\mb3528\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.IE5\VG2QGZ1T\MCj04421390000[1].png FZ   bA$??MCj04421390000[1]Picture 2C:\Users\mb3528\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.IE5\VG2QGZ1T\MCj04421390000[1].pngI   bA$??MCj04421390000[1]Picture 2C:\Users\mb3528\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.IE5\VG2QGZ1T\MCj04421390000[1].png  Z   bA$??MCj04421390000[1]Picture 2C:\Users\mb3528\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.IE5\VG2QGZ1T\MCj04421390000[1].pngIg  bA$??MCj04421390000[1]Picture 2C:\Users\mb3528\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.IE5\VG2QGZ1T\MCj04421390000[1].png gZ   bA$??MCj04421390000[1]Picture 2C:\Users\mb3528\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.IE5\VG2QGZ1T\MCj04421390000[1].pngIFH  0޽h ? Oԟ{ay___PPT10Y+D=' = @B +  d$(  dr d S dHP   r d S  H  H d 0޽h ? f3f3  h$(  hr h S HP   r h S t H  H h 0޽h ? f3f3  \Tl(  lr l S HP   r l S P H   l 6x ZClinical Knowledge Summaries, Antiplatelet treatment  Management http://www.cks.nhs.uk/antiplatelet_treatment/management/detailed_answers/managing_gastrointestinal_adverse_effects/people_at_high_risk_of_gi_adverse_effects&0 f T H l 0޽h ? f3f3  sk x(  xr x S H   r x S h H @   x 6H qGuillamondegui OD, Gunter OL Jr, Bonadies JA, Coates JE, Kurek SJ, De Moya MA, Sing RF, Sori AJ. Practice management guidelines for stress ulcer prophylaxis. Chicago (IL): Eastern Association for the Surgery of Trauma (EAST); 2008. 24 p.&0 f :ioH x 0޽h ? f3f3  0|$(  |r | S $HP   r | S $ H  H | 0޽h ? f3f3  @D(  r  S .H @   r  S / H`     6 `0 8Gilard M, Armaud B, Cornily JC, Le Gal G, Lacut K, Le calvez G, Mansourati J, Mottier D, Abrigall JF, , Boschat J. Influence of omeprazole on the antiplatlet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (omeprazole, clopidogrel aspirin) study. J Am Coll Cardiol 2008;23:26-41.F90 f ,     6    H  0޽h ? f3f3  P$(  r  S FHP   r  S dG H  H  0޽h ? f3f3  e]`(  r  S LHP   r  S A H    6Y & cDunn SP, Steinbuhl SR, Bauer D, Charmigo RJ, Berger PB, Topol EJ. Impact of proton pump ingibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials. J Am Heart Assoc 2013;2:21-11. 60 f@   #H  0޽h ? f3f3  p$(  r  S  H`   r  S  H``  H  0޽h ? f3f3  $(  r  S TcHP   r  S d H @  H  0޽h ? f3f3  $(  r  S kH`@   r  S 8l H@  H  0޽h ? f3f3  $(  r  S H`Pp@   r  S ؃ H`0  H  0޽h ? f3f3  $(  r  S H    r  S d H``  H  0޽h ? f3f3  $(  r  S HP   r  S x H  H  0޽h ? f3f3  $(  r  S DHP   r  S  H  H  0޽h ? f3f3  $(  r  S oHP   r  S  H@p  H  0޽h ? f3f3  $(  r  S xHP   r  S 4 H  H  0޽h ? f3f3  $(  r  S H`   r  S  H@  H  0޽h ? f3f3  $(  r  S  H@   r  S  H  H  0޽h ? f3f3   $(  r  S HP   r  S  H  H  0޽h ? f3f3  0$(  r  S xHP   r  S @ H  H  0޽h ? f3f3  @$(  r  S xHP@p   r  S  H`  H  0޽h ? f3f3  P$(  r  S \HP   r  S  H  H  0޽h ? f3f3*0  (    x0e0e?Rectangle 2    ( 3 *xaxa5%?Rectangle 3 @   V  H  0޽h ? a(%+0 $$P$(    x0e0e?Rectangle 2    X#  ~Wxaxa?Rectangle 3"RLPK!Zf[Content_Types].xmlMO &2WR=cJ`F0iK`#̼vLw 9uSq:w`G ^i ½KI)c/ $oVjTMRc|}042ҥCƔM̏P~*ka/8^DkHbL8e i"K\XN\6rco4y@_;oPK!1_a _rels/.relsj0 ѽqCNo^K [ILcX&m߾0XFo;>0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!dp:Q ydrs/shapexml.xml]o6>`C$s3i.ScAtY4JNmҺ{n#q|DI_\Ipmgf<mlq޳0(Jef*Ɍ7_|T6(GA-tGY 3r[]hSJAbAUjY Eolça`T ͞:qp踈~fѲpQәU [LK96>, }AyC/&_LK,R(12GKha?`;%ffoU06ſ+eu$o og0=J 0yl3g1$Kh|qXOJA(KsUI!!^KnoePH_oBiQH4i)À$E9)o`9/UKE+@ͯEb`fin,3S2%ob%`B- EKi:,&~;zwz71WdkWVW%dRl /g}J&Zi\9AÅ)U 7{0zPa__2њ5oDDkj">޺I[ $]d Bl"2|DLSZ=o YKwvya.vby>+7Pkjuh-gX oвjM9|A !8a]X wm;I qA7N&kq}ې.J]{mFo"o@1|>Yy$:*-l+`ʀp\3ϲiû,7:`wC&#5|6r>~CY{KnzԢ@2R>՝DH4JoAA%Bb>~JOᴟB<+u#QYO8w`w`e6(8};.1|(^}ý°ӭKf]pur\gHS60-:ɠnlچ d[LiAk}KF6)`S^f7s:7=lK$:mF:a:Vpc/?!Xhvy4[hOv^~nEl q5ˋV_;N%`P[?o8U%@/J IBu ض ՘fHKd'O|i @xM5,wt8kX珡>eNhe0}Z%W$>uarPE]XW%;pF<vY&{Mdƽ&-]ZUz^UFz K1֭Q'Ǖ8C7k|Q+}jqtXd(ґN'x;/ll?A;)Hy fAbD$=+:Pl]АZCL\ c߂7TP oGcL^GUҏ!^w{C>[})6}n9gX;gQru =KVV-VMo0 +Cd2̨$h@rE_.ɯ%%q ; AH,f$ލ$Jx%)U 6$d k^Kq2e֣7jq t^cD\- WS4@! 8C+gcڳw{;YV=EݭӸL>kŢz|MÂi:ɥSI105zZaBf$1t%Q;f(l,VQ`.J[ } #JWV6 %'`A$Z0*}DžH$ӂ7A̎ndXTocwn~v vK&5K&mv+uNqc7e`X \Xؚt ֱP/|H5b: ~2Pwj10+>q}G8"8d{)+$[M1-poa mmnwx)rqK*g!buM@T  2T`y; na`OFj6^]c5P?z T~,c+rSR7PK!R~ drs/downrev.xmlDQK0Co.]M!PV]sd[ >÷Mv'w`@7N)܁Y``ݙK:U ¡@&Ʊ24,S:o1;=2ϲsz08ғ:tRK4uz1oJ]_M "Mܮ9|65y>^"y/&SPK!Idrs/_rels/shapexml.xml.relsN0 HC;M!v4ΑI6jDK'pѲ﷿43HԍltV_U DVծپa)!}P[5'َ81!M R<v}<+fupQJ>eF?*XH9x rZۉk^&M ޱIfQlϼ SPtעP'AO oh 14 Ɠ\ʧ'\Jw[}PK-!Zf[Content_Types].xmlPK-!1_a /_rels/.relsPK-!dp:Q y*drs/shapexml.xmlPK-!R~  drs/downrev.xmlPK-!I drs/_rels/shapexml.xml.relsPK> @   8http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_risk# What is CKS? The NHS Clinical Knowledge Summaries (formerly PRODIGY) are a reliable source of evidence-based information and practical 'know how' about the common conditions managed in primary care. CKS is commissioned and paid for by NHS Evidence, a service provided by the National Institute for Health and Clinical Excellence. Citat: Nonsteroidal anti-inflammatory drugs (standard or coxibs) - prescribing issues  Management Who is at increased risk of gastrointestinal adverse effects from oral NSAIDs? People are at high risk of serious nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal (GI) adverse events if they have one or more of the following risk factors: Older age and male. The risk of an upper GI complication, such as bleeding: Doubles with every decade above 55years (for example, roughly 1 per 1000persons per year at 55years of age, 2 per 1000persons at 65years of age, 4 per 1000persons at 75years of age, and so on). Is twice as high in men as in women. History of gastroduodenal ulcer, GI bleeding, or gastroduodenal perforation. Concomitant use of medications that are known to increase the likelihood of upper GI adverse events (e.g. anticoagulants, aspirin used in low or standard doses, corticosteroids, and selective serotonin reuptake inhibitors [SSRIs], venlafaxine, or duloxetine). Serious comorbidity, such as cardiovascular disease, hepatic or renal impairment (including dehydration), diabetes, or hypertension. Requirement for prolonged NSAID use, including people with: Osteoarthritis or rheumatoid arthritis of any age. Chronic low back pain and 45years of age or older. Use of the maximum recommended dose of an NSAID. Additional risk factors for NSAID-induced GI adverse events have also been identified, including: The NSAID used. The presence of Helicobacter pylori infection. Excessive alcohol use. Heavy smoking. t: M   h 1 c h   ++  ++ ++ ++ ++ ++ ++M ++ ++ ++h ++1  ++c  ++! ++ ++4 ++ ++|[!0H  0޽h ? a(rЙ Ɉ (mVy@7 H4  Ե@(,xdP<(ޛ80/<,  <1m(Oh+'0= px  < H T `ltPowerPoint PresentationoweMC:\Program Files\Microsoft Office\Templates\Presentation Designs\Soaring.pot\Zarkogr50kMicrosoft PowerPoint 7.0t O@d@@@; G|<g  6:& &&#TNPP2OMi% & TNPP &&TNPP    &&--- $  $   $- $(( $(22( $2<<2- $<FF<- $FPPF $PZZP- $ZddZ $dnnd- $nxxn- $xx- $ $- $- $- $- $- $ $- $- $- $- $- $- $- $- $""- $",,"- $,66,- $6@@6- $@JJ@- $JTTJ- $T^^T- $^hh^- $hrrh- $r||r- $||- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $&&- $&00&- $0::0- $:DD:- $DNND- $NXXN- $XbbX- $bllb- $lvvl~- $vvz- $w- $s- $o- $l- $h- $d- $a- $]- $Y- $W- $S- $O- $L- $  H- $  D- $  B- $ ** >- $*44*:- $4>>48- $>HH>4- $HRRH0- $R\\R.- $\ff\*- $fppf&- $pzzp#- $zz- $- $- $- $ - $- $---&&&&W&--&&/v- $WaaW/w- $akka/x- $kuuk0y- $uu0z- $1{- $1}- $2- $3- $4- $4- $5- $6- $7- $9- $:- $;- $<- $  =- $  ?- $@- $)) B- $)33)!C- $3==3"D- $=GG="F- $GQQG#G- $Q[[Q$H- $[ee[%J- $eooe%L- $oyyo&M- $yy'N- $'P- $(Q- $)R- $)T- $*U- $+V- $+W- $,Y- $,Z- $-[- $-\- $.]- $.^- $/^- $/_- $##0`- $#--#0`- $-77-0a- $7AA71b- $AKKA1b- $KUUK1c- $U__U1c- $_ii_1c- $issi2d- $s}}s2d- $}}2d- $2e- $ $2e- $ $3f- $&&&- &($UWr0AVm&5(AJIfPSU&&-&& &&-&&($UWr0AVm&5(AJIfPSU&&/v- $WaaW/w- $akka/x- $kuuk0y- $uu0z- $1{- $1}- $2- $3- $4- $4- $5- $6- $7- $9- $:- $;- $<- $  =- $  ?- $@- $)) B- $)33)!C- $3==3"D- $=GG="F- $GQQG#G- $Q[[Q$H- $[ee[%J- $eooe%L- $oyyo&M- $yy'N- $'P- $(Q- $)R- $)T- $*U- $+V- $+W- $,Y- $,Z- $-[- $-\- $.]- $.^- $/^- $/_- $##0`- $#--#0`- $-77-0a- $7AA71b- $AKKA1b- $KUUK1c- $U__U1c- $_ii_1c- $issi2d- $s}}s2d- $}}2d- $2e- $ $2e- $ $3f- $&- --&&&X3f--:%4Sp/^!Bfy* 4$<<DSJlORTU--&&&G&w@! $Xwaw @w f- @Times New RomanXwaw @w f- .2 R 4/17/2013   .&y&  . 2 f1 .--I@-- @"Arial! *Xwaw @w f- .-2 cKLOPIDOGREL I INHIBITORI '!.'+..+'!++($.,. .-2 aKLOPIDOGREL I INHIBITORI '!.'+..+'!++($.,. .2 PROTONSKE PUMPEo'+.$-+''''+1''. .2 PROTONSKE PUMPEo'+.$-+''''+1''. . 2 8-. . 2 6-. .2 8 NOVE SPOZNAJE+.''''.$+&'. .2 6 NOVE SPOZNAJE+.''''.$+&'.--q)p-- @Times New RomanXwaw @w f- .2 Prof.dr.   . . 2 sc. .@Times New RomanXwaw @w f-.2  . arko Babi    .-. .02 Zavod za gastroenterologiju       . .2 `Interna klinikao      . .2 ;n KB Dubrava  . .2 qZagreb .--"System f !-&TNPP &_΅_________________________<_<_<_<_<_<<<<<<<<<<e________________<_<_<_<_<<<<<<<<<<<<<<<<<<<<΅_______________________<_<_<_<_<_<<<_<<<<<<< 2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` ?&    $       '!"#o$b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8 ʚ;iM)ʚ;g47d7dv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LETL___PPT9.&?  O = . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S aids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanEv 0( 0@DArialNew RomanEv 0( 0@" DWingdingsRomanEv 0( 0@0DCalibrisRomanEv 0( 0@"@DMonotype SortsEv 0( 0 ` .  @n?" dd@  @@`` xp;(& &       !"#$% ' ob$ɨa3b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8K ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LF<4dddd` 0LF<4BdBd` 0LF___PPT9  ?  O =b KOJI IPP ODABRATI?pggg  FO emu ovisi individualni odgovor?  $$g$" \o suradljivosti o vremenu uzimanja lijeka o komedikaciji o genetskom polimorfizmu (CYP-450) J\ " KQc @,     IPP i klopidogrel &Klopidogrel metabolizira do svog djelatnog metabolita dijelom putem CYP2C19 Mo~e se o ekivati da e primjena lijekova koji inhibiraju aktivnost tog enzima rezultirati smanjenjem razine djelatnog metabolita klopidogrela i smanjenjem klini ke u inkovitosti (SPC, Zyllt 75 mg).` " dJcchd I + #8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+zEMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola ili esomeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol ili esomeprazol. x- " d " d+cgc$   K S   0`to je generi ki lijek?  g World Health Organisation Generi ki lijek je onaj koji se proizvodi bez licence inovativne kompanije i prodaje nakon isteka patenta ili ekskluzivnih prava. esto djeluju jednako kao i inovativni proizvodi, ali su zna ajno jeftiniji. FDA Generici moraju imati istu aktivnu tvar kao i originalni lijek, te imati framakokinetska i farmakodinamska svojstva koja su unutar prihvatljivog raspona bioekvivalencije. Wikipedia Cijena generika je obi no toliko niska da si ih mogu priuatiti mnoge zemlje u razvoju.0" dZgcgc gVc A  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y { | } ~  Root EntrydO)o4; PicturesCurrent User/SummaryInformation(z (>PowerPoint Document(s DocumentSummaryInformation88  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanEv 0( 0DArialNew RomanEv 0( 0@" DWingdingsRomanEv 0( 0@0DCalibrisRomanEv 0( 0@"@DMonotype SortsEv 0( 0 ` .  @n?" dd@  @@`` xp;(& &       !"#$% ' ob$ɨa3b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8K ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LF<4dddd` 0LF<4BdBd` 0LF___PPT9  ?  O =b KOJI IPP ODABRATI?pggg  FO emu ovisi individualni odgovor?  $$g$" \o suradljivosti o vremenu uzimanja lijeka o komedikaciji o genetskom polimorfizmu (CYP-450) J\ " KQc @,     IPP i klopidogrel &Klopidogrel metabolizira do svog djelatnog metabolita dijelom putem CYP2C19 Mo~e se o ekivati da e primjena lijekova koji inhibiraju aktivnost tog enzima rezultirati smanjenjem razine djelatnog metabolita klopidogrela i smanjenjem klini ke u inkovitosti (SPC, Zyllt 75 mg).` " dJcchd I + #8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+zEMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola ili esomeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol ili esomeprazol. x- " d " d+cgc$   K S   0`to je generi ki lijek?  g World Health Organisation Generi ki lijek je onaj koji se proizvodi bez licence inovativne kompanije i prodaje nakon isteka patenta ili ekskluzivnih prava. esto djeluju jednako kao i inovativni proizvodi, ali su zna ajno jeftiniji. FDA Generici moraju imati istu aktivnu tvar kao i originalni lijek, te imati framakokinetska i farmakodinamska svojstva koja su unutar prihvatljivog raspona bioekvivalencije. Wikipedia Cijena generika je obi no toliko niska da si ih mogu priuatiti mnoge zemlje u razvoju.0" dZgcgc gVc A/ X.Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  W8         :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 (()  ( +   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZ=Z 0  ;   -  0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtjgZ/ZGZ3Z1Zf`/  I 9 ? )STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&Zu "  +CAPRIEf lUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}tN   z %, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri u                        ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { } ~  zimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uzplacebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`;5,;5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   /89:P  0D(  r  S H @   r  S   H`     6 `0 8Gilard M, Armaud B, Cornily JC, Le Gal G, Lacut K, Le calvez G, Mansourati J, Mottier D, Abrigall JF, , Boschat J. Influence of omeprazole on the antiplatlet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (omeprazole, clopidogrel aspirin) study. J Am Coll Cardiol 2008;23:26-41.F90 f ,     6    H  0޽h ? f3f3r "!{)  -<x1m(  2  http://www.cks.nhs.uk/ns ՜.+,D՜.+,h    On-screen Shown-s&  &Times New RomanArial WingdingsCalibriMonotype SortsSoaring9KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJESupresori luenja kiselinePowerPoint PresentationMjesto djelovanja IPPDFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija OBitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja CNajei lijekovi koji izazivaju GI krvarenja i oteenja sluznice)Kome treba dati IPP za gastroprotekciju?PowerPoint PresentationKome profilaktiki IPP?Kome profilaktiki IPP? KLOPIDOGRELPowerPoint PresentationSTUDIJESTUDIJESTUDIJESTUDIJECAPRIECAPRIECAPRIE2CREDO (Reduction of events during obsrevation) CREDOCREDOCREDOCREDOCREDO META ANALIZA META ANALIZA META ANALIZA,Rizik krvarenja prema najeim imbenicima,Rizik krvarenja prema najeim imbenicima,Rizik krvarenja prema najeim imbenicima  Fonts UsedDesign Template Slide Titles  8@ _PID_HLINKSADhttp://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/peo_ZarkoZarkoeople_atple_at_increased_risk_increased_risk/ X.Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  W8         :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 (()  ( +   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZ=Z 0  ;   -  0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtjgZ/ZGZ3Z1Zf`/  I 9 ? )STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&Zu "  +CAPRIEf lUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}tN   z %, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uzplacebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`;5,;5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   /89:Pri) E<xmo(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanEv 0( 0@DArialNew RomanEv 0( 0@" DWingdingsRomanEv 0( 0@0DCalibrisRomanEv 0( 0@"@DMonotype SortsEv 0( 0 ` .  @n?" dd@  @@`` x<)& &       !"#$% ' )ob$ɨa3b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8K ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LF<4dddd` 0LF<4BdBd` 0LF___PPT9  ?  O =d KOJI IPP ODABRATI?pggg  FO emu ovisi individualni odgovor?  $$g$" \o suradljivosti o vremenu uzimanja lijeka o komedikaciji o genetskom polimorfizmu (CYP-450) J\ " KQc @,     IPP i klopidogrel &Klopidogrel metabolizira do svog djelatnog metabolita dijelom putem CYP2C19 Mo~e se o ekivati da e primjena lijekova koji inhibiraju aktivnost tog enzima rezultirati smanjenjem razine djelatnog metabolita klopidogrela i smanjenjem klini ke u inkovitosti (SPC, Zyllt 75 mg).` " dJcchd I + #8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+zEMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola ili esomeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol ili esomeprazol. x- " d " d+cgc$   K S   0`to je generi ki lijek?  g World Health Organisation Generi ki lijek je onaj koji se proizvodi bez licence inovativne kompanije i prodaje nakon isteka patenta ili ekskluzivnih prava. esto djeluju jednako kao i inovativni proizvodi, ali su zna ajno jeftiniji. FDA Generici moraju imati istu aktivnu tvar kao i originalni lijek, te imati framakokinetska i farmakodinamska svojstva koja su unutar prihvatljivog raspona bioekvivalencije. Wikipedia Cijena generika je obi no toliko niska da si ih mogu priuatiti mnoge zemlje u razvoju.0" dZgcgc gVc A/ X.Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  W8         :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 (()  ( +   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZ=Z 0  ;   -  0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtjgZ/ZGZ3Z1Zf`/  I 9 ? )STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&Zu "  +CAPRIEf lUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}tN   z %, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uzplacebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`;5,;5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.:Kontrolirana studije  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6/89:P  $(  r  S =HP   r  S tA H  H  0޽h ? f3f3r=K^. 7`=xo(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanEv 0( 0@DArialNew RomanEv 0( 0@" DWingdingsRomanEv 0( 0@0DCalibrisRomanEv 0( 0@"@DMonotype SortsEv 0( 0 ` .  @n?" dd@  @@`` x<)& &       !"#$% ' )ob$ɨa3b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8K ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LF<4dddd` 0LF<4BdBd` 0LF___PPT9  ?  O =&e KOJI IPP ODABRATI?pggg  FO emu ovisi individualni odgovor?  $$g$" \o suradljivosti o vremenu uzimanja lijeka o komedikaciji o genetskom polimorfizmu (CYP-450) J\ " KQc @,     IPP i klopidogrel &Klopidogrel metabolizira do svog djelatnog metabolita dijelom putem CYP2C19 Mo~e se o ekivati da e primjena lijekova koji inhibiraju aktivnost tog enzima rezultirati smanjenjem razine djelatnog metabolita klopidogrela i smanjenjem klini ke u inkovitosti (SPC, Zyllt 75 mg).` " dJcchd I + #8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+zEMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola ili esomeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol ili esomeprazol. x- " d " d+cgc$   K S   0`to je generi ki lijek?  g World Health Organisation Generi ki lijek je onaj koji se proizvodi bez licence inovativne kompanije i prodaje nakon isteka patenta ili ekskluzivnih prava. esto djeluju jednako kao i inovativni proizvodi, ali su zna ajno jeftiniji. FDA Generici moraju imati istu aktivnu tvar kao i originalni lijek, te imati framakokinetska i farmakodinamska svojstva koja su unutar prihvatljivog raspona bioekvivalencije. Wikipedia Cijena generika je obi no toliko niska da si ih mogu priuatiti mnoge zemlje u razvoju.0" dZgcgc gVc A/ X.Kome profilakti ki IPP? Uz antitrombots ko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  W8         :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 (()  ( +   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZ=Z 0  ;   -  0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtjgZ/ZGZ3Z1Zf`/  I 9 ? )STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&Zu "  +CAPRIEf lUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}tN   z %, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uzplacebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`;5,;5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studije  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6/89:P  f^(  r  S =HPp`   r  S tA H     60J,V dLanza FL, Chan FKL, Quigley EMM, The practice comittee of the American College of gastroenterology, Am J Gastroenterol 2009;104:728-738. AH  0޽h ? f3f3rs`=D. O`=xo(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanEv 0( 0@DArialNew RomanEv 0( 0@" DWingdingsRomanEv 0( 0@0DCalibrisRomanEv 0( 0@"@DMonotype SortsEv 0( 0 ` .  @n?" dd@  @@`` x<)& &       !"#$% ' )ob$ɨa3b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8K ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LF<4dddd` 0LF<4BdBd` 0LF___PPT9  ?  O =&e KOJI IPP ODABRATI?pggg  FO emu ovisi individualni odgovor?  $$g$" \o suradljivosti o vremenu uzimanja lijeka o komedikaciji o genetskom polimorfizmu (CYP-450) J\ " KQc @,     IPP i klopidogrel &Klopidogrel metabolizira do svog djelatnog metabolita dijelom putem CYP2C19 Mo~e se o ekivati da e primjena lijekova koji inhibiraju aktivnost tog enzima rezultirati smanjenjem razine djelatnog metabolita klopidogrela i smanjenjem klini ke u inkovitosti (SPC, Zyllt 75 mg).` " dJcchd I + #8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+zEMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola ili esomeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol ili esomeprazol. x- " d " d+cgc$   K S   0`to je generi ki lijek?  g World Health Organisation Generi ki lijek je onaj koji se proizvodi bez licence inovativne kompanije i prodaje nakon isteka patenta ili ekskluzivnih prava. esto djeluju jednako kao i inovativni proizvodi, ali su zna ajno jeftiniji. FDA Generici moraju imati istu aktivnu tvar kao i originalni lijek, te imati framakokinetska i farmakodinamska svojstva koja su unutar prihvatljivog raspona bioekvivalencije. Wikipedia Cijena generika je obi no toliko niska da si ih mogu priuatiti mnoge zemlje u razvoju.0" dZgcgc gVc A/ X.Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  W8         :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 (()  ( +   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZ=Z 0  ;   -  0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtjgZ/ZGZ3Z1Zf`/  I 9 ? )STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&Zu "  +CAPRIEf lUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}tN   z %, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uzplacebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`;5,;5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6/89:P  f^(  r  S =HPp`   r  S tA H     60J,V dLanza FL, Chan FKL, Quigley EMM, The practice comittee of the American College of gastroenterology, Am J Gastroenterol 2009;104:728-738. AH  0޽h ? f3f3r>=D. G=xs(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` =*            !"#$%&'( ob$ɨa3b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8K ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LE___PPT9  ?  O = . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+zEMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola ili esomeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol ili esomeprazol. x- " d " d+cgc$   K S   0`to je generi ki lijek?  g World Health Organisation Generi ki lijek je onaj koji se proizvodi bez licence inovativne kompanije i prodaje nakon isteka patenta ili ekskluzivnih prava. esto djeluju jednako kao i inovativni proizvodi, ali su zna ajno jeftiniji. FDA Generici moraju imati istu aktivnu tvar kao i originalni lijek, te imati framakokinetska i farmakodinamska svojstva koja su unutar prihvatljivog raspona bioekvivalencije. Wikipedia Cijena generika je obi no toliko niska da si ih mogu priuatiti mnoge zemlje u razvoju.0" dZgcgc gVc A/ X.Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  W8         :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 (()  ( +   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | }  ' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZ=Z 0  ;   -  0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtjgZ/ZGZ3Z1Zf`/  I 9 ? )STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&Zu "  +CAPRIEf lUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}tN   z %, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uzplacebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`;5,;5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6>/VRizik krvarenja prema naj eaim imbenicima,,( ,fTerapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008)4Z4" 1   # 7 /89:P  f^p(  r  S HPp`   r  S l H`     6UfV dLanza FL, Chan FKL, Quigley EMM, The practice comittee of the American College of gastroenterology, Am J Gastroenterol 2009;104:728-738. BH  0޽h ? f3f3r H>/ G>as(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` >*     !"#$%&'(  + ob$ɨa3b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8# ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LE___PPT9zr  ?  O =>i KOJI IPP ODABRATI?pggg  FO emu ovisi individualni odgovor?  $$g$" \o suradljivosti o vremenu uzimanja lijeka o komedikaciji o genetskom polimorfizmu (CYP-450) J\ " KQc @,     IPP i klopidogrel &Klopidogrel metabolizira do svog djelatnog metabolita dijelom putem CYP2C19 Mo~e se o ekivati da e primjena lijekova koji inhibiraju aktivnost tog enzima rezultirati smanjenjem razine djelatnog metabolita klopidogrela i smanjenjem klini ke u inkovitosti (SPC, Zyllt 75 mg).` " dJcchd I + #8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K?04Supresori lu enja kiseline ?Porast Ph dovodi do boljeg cijeljenja sluznice H2 blokatori IPP&2 6*Mjesto djelovanja IPP<-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff@ . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC(B8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S  .Kome profilakti ki IPP?Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP?(Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z23  &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  Wb          9$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 X()Q$$3Df  ' +  %STUDIJEReduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'  &STUDIJECREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7              ;   - /(STUDIJECAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 8 ? ")STUDIJEMETA ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(f|C- ND (P     (*CAPRIEfNa po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&vu "  +CAPRIEflUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}N   z $, CAPRIEfRedovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDONa po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9D  ."CREDONakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ,/#CREDORedovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfC*) 0$CREDO&Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w .1%CREDOpUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDORedovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,! 5  ,3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPP  4`4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!hG  .5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99vf   =.VRizik krvarenja prema naj eaim imbenicima+:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!g   5 >/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)qq" 1   # 7H/89:P  $(  r  S HP   r  S < H  H  0޽h ? f3f3  @d$(  dr d S LwHP   r d S w H  H d 0޽h ? f3f3  $(  r  S HP   r  S x H  H  0޽h ? f3f3  #(  r  S TH    r  S  HP0    6p r 1Dunn SP, Steinbuhl SR, Bauer D, Charmigo RJ, Berger PB, Topol EJ. Impact of proton pump ingibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials. J Am Heart Assoc 2013;2:21-11. Lane L, Hennekens C. Proton pump inhibitor and clopidogrel interaction:Fact of fiction. Am J Gastroenterol 2010;105:34-41. Hsu P. New look at antiplatlet agent-related peptic ulcer:An update of orevention and treatment. 2012;27:654-661. Drepper MD, Spahr L, Frossard JL. Clopidogrel and proton pump inhibitors-where do we stand in 2012? WJG 2012;18:2161-2171.B0 h 1f   #  +  %  H  0޽h ? f3f3  $(  r  S 0H`   r  S  H``  H  0޽h ? f3f3  $(  r  S (HP   r  S  H @  H  0޽h ? f3f3  p$(  r  S HP   r  S  H  H  0޽h ? f3f3  c[(  r  S 1HPp`   r  S `8 H     6 4,b aLanza FL, Chan FKL, Quigley EMM, The practice comittee of the American College of gastroenterology, Am J Gastroenterol 2009;104:728-738. Lane L, Hennekens C. Proton pump inhibitor and clopidogrel interaction:Fact of fiction. Am J Gastroenterol 2010;105:34-41. A  *H  0޽h ? f3f3d    (  r  S CHPp`   r  S C H`   x  6Eb Lanza FL, Chan FKL, Quigley EMM, The practice comittee of the American College of gastroenterology, Am J Gastroenterol 2009;104:728-738. Chan FLK, Anti-platlet therapy and managing ulcer risk.J Gastroenterol Hepatol 2012;27:195-199 A  'H  0޽h ? f3f3r@5$079rA(^C2JE=06GK3 ο]P?s(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` >*     !"#$%&'(  + ob$ɨa3b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8# ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LE___PPT9zr  ?  O =>i KOJI IPP ODABRATI?pggg  FO emu ovisi individualni odgovor?  $$g$" \o suradljivosti o vremenu uzimanja lijeka o komedikaciji o genetskom polimorfizmu (CYP-450) J\ " KQc @,     IPP i klopidogrel &Klopidogrel metabolizira do svog djelatnog metabolita dijelom putem CYP2C19 Mo~e se o ekivati da e primjena lijekova koji inhibiraju aktivnost tog enzima rezultirati smanjenjem razine djelatnog metabolita klopidogrela i smanjenjem klini ke u inkovitosti (SPC, Zyllt 75 mg).` " dJcchd I + #8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K?04Supresori lu enja kiseline ?Porast Ph dovodi do boljeg cijeljenja sluznice H2 blokatori IPP&2 6*Mjesto djelovanja IPP<-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff@ . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC(B8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S  .Kome profilakti ki IPP?Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP?(Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z23  &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  Wb          9$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 X()Q$$3Df  ' +  %STUDIJEReduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'  &STUDIJECREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mje reno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7              ;   - /(STUDIJECAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 8 ? ")STUDIJEMETA ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(f|C- ND (P     (*CAPRIEfNa po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&vu "  +CAPRIEflUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}N   z $, CAPRIEfRedovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDONa po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9D  ."CREDONakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ,/#CREDORedovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfC*) 0$CREDO&Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w .1%CREDOpUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDORedovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,! 5  ,3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPP  4`4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!hG  .5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99vf   =.VRizik krvarenja prema naj eaim imbenicima+:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!g   5 >/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)qq" 1   # 7H/89:PrP/ P?l(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` >&     !"#$%&'(  + o$b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8 ʚ;E*6ʚ;g4GdGdv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LE TL___PPT9.&?  O =b8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K?04Supresori lu enja kiseline ?Porast Ph dovodi do boljeg cijeljenja sluznice H2 blokatori IPP&2 6*Mjesto djelovanja IPP<-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff@ . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC(B8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S  .Kome profilakti ki IPP?Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP?(Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z23  &  !" KLOPIDOGREL ,Klopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultati>Z  Wb          9$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 X()Q$$3Df  ' +  %STUDIJEReduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'  &STUDIJECREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7              ;   - /(STUDIJECAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 8 ? ")STUDIJEMETA ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(f|C- ND (P     (*CAPRIEfNa po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskulafrna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z%Z&ZZ*! $  f&vu "  +CAPRIEflUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}N   z $, CAPRIEfRedovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDONa po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9D  ."CREDONakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ,/#CREDORedovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfC*) 0$CREDO&Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w .1%CREDOpUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDORedovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,! 5  ,3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPP  4`4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!hG  .5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99vf   =.VRizik krvarenja prema naj eaim imbenicima+:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!g   5 >/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)qq" 1   # 7H/89:Pr 1?o(  .Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  " KLOPIDOGREL jKlopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 (reducira efekt lijeka na Trb) Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultatiZ  2M3nZR        2p :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 \(*R$$$$3Ef  ) ,   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7             ;   - 0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 9 ? ")STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskularna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z$Z&ZZ*! $  f&@u ; +CAPRIEf lUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela,a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&Z~Z   f}tN   z %, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v -/#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON ne                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  ma povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6@1VRizik krvarenja prema naj eaim imbenicima,,( ,LRizik GI krvarenja smanjuje se do 50% uz IPP (RR=0,50, 95% Cl=0,37-0,69) Upotreba IP-a mo~e bti povezana s kardiovaskularnim rizicima, ali ne i s poveanom smtrnoau. (RR =1.04, 95% Cl=0,93-1,16). Matula MS, Jilma B, Schror K, Christ G, Hubers K. Effect of proton pump inhibitors om clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb and Haemost 2010;8:624-264. Z ^]< ' 5>/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)sZs" 1   # 7I/89:P  D(  r  S P H @   r  S   H`      6 `0 8Gilard M, Armaud B, Cornily JC, Le Gal G, Lacut K, Le calvez G, Mansourati J, Mottier D, Abrigall JF, , Boschat J. Influence of omeprazole on the antiplatlet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (omeprazole, clopidogrel aspirin) study. J Am Coll Cardiol 2008;23:26-41.F90 f ,     6    H  0޽h ? f3f3  $(  r  S H@   r  S l H``  H  0޽h ? f3f3  P$(  r  S fH`Pp@   r  S lg H`0  H  0޽h ? f3f3  0$(  r  S HP   r  S } HP`  H  0޽h ? f3f3d    (  r  S HPp`   r  S | H`   x  6b Lanza FL, Chan FKL, Quigley EMM, The practice comittee of the American College of gastroenterology, Am J Gastroenterol 2009;104:728-738. Chan FLK, Anti-platlet therapy and managing ulcer risk.J Gastroenterol Hepatol 2012;27:195-199 A  'H  0޽h ? f3f3r01"Z$f*R>*@> 1@o(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` ?&    $       '!"#o$b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8 ʚ;iM)ʚ;g47d7dv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LETL___PPT9.&?  O =@e8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K?04Supresori lu enja kiseline ?Porast Ph dovodi do boljeg cijeljenja sluznice H2 blokatori IPP&2 6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S  .Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  " KLOPIDOGREL jKlopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 (reducira efekt lijeka na Trb) Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultatiZ  2M3nZR        2p :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 \(*R$$$$3Ef  ) ,   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7             ;   - 0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 9 ? ")STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskularna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z$Z&ZZ*! $  f&@u ; +CAPRIEf nUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&ZZ   f~tN   z &, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!CREDO Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047), ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6@1VRizik krvarenja prema naj eaim imbenicima,,( ,LRizik GI krvarenja smanjuje se do 50% uz IPP (RR=0,50, 95% Cl=0,37-0,69) Upotreba IP-a mo~e bti povezana s kardiovaskularnim rizicima, ali ne i s poveanom smtrnoau. (RR =1.04, 95% Cl=0,93-1,16). Matula MS, Jilma B, Schror K, Christ G, Hubers K. Effect of proton pump inhibitors om clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb and Haemost 2010;8:624-264. Z ^]< ' 5>/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)sZs" 1   # 7I/89:P  `$(  r  S XWH    r  S W H``  H  0޽h ? f3f3  $(  r  S HP   r  S l H@p  H  0޽h ? f3f3r+!.m#" αY%@o(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` ?&    $       '!"#o$b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8 ʚ;iM)ʚ;g47d7dv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LETL___PPT9.&?  O =e8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K?04Supresori lu enja kiseline ?Porast Ph dovodi do boljeg cijeljenja sluznice H2 blokatori IPP&2 6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S  .Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  " KLOPIDOGREL jKlopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 (reducira efekt lijeka na Trb) Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultatiZ  2M3nZR        2p :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 \(*R$$$$3Ef  ) ,   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7             ;   - 0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 9 ? ")STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskularna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z$Z&ZZ*! $  f&@u ; +CAPRIEf nUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&ZZ   f~tN   z &, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!1CREDO (Reduction of events during obsrevation) 62'& &Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047), ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6@1VRizik krvarenja prema naj eaim imbenicima,,( ,LRizik GI krvarenja smanjuje se do 50% uz IPP (RR=0,50, 95% Cl=0,37-0,69) Upotreba IP-a mo~e bti povezana s kardiovaskularnim rizicima, ali ne i s poveanom smtrnoau. (RR =1.04, 95% Cl=0,93-1,16). Matula MS, Jilma B, Schror K, Christ G, Hubers K. Effect of proton pump inhibitors om clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb and Haemost 2010;8:624-264. Z ^]< ' 5>/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)sZs" 1   # 7I/89:P  $(   r  S HP   r  S  H  H  0޽h ? f3f3r%-! y%~@o(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` ?&    $       '!"#o$b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8 ʚ;iM)ʚ;g47d7dv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LETL___PPT9.&?  O =e8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K?04Supresori lu enja kiseline ?Porast Ph dovodi do boljeg cijeljenja sluznice H2 blokatori IPP&2 6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S  .Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  " KLOPIDOGREL jKlopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 (reducira efekt lijeka na Trb) Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultatiZ  2M3nZR        2p :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 \(*R$$$$3Ef  ) ,   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7             ;   - 0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 9 ? ")STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskularna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z$Z&ZZ*! $  f&@u ; +CAPRIEf nUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&ZZ   f~tN   z &, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!1CREDO (Reduction of events during obsrevation) 62'& &Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047), ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6@1VRizik krvarenja prema naj eaim imbenicima,,( ,LRizik GI krvarenja smanjuje se do 50% uz IPP (RR=0,50, 95% Cl=0,37-0,69) Upotreba IP-a mo~e bti povezana s kardiovaskularnim rizicima, ali ne i s poveanom smtrnoau. (RR =1.04, 95% Cl=0,93-1,16). Matula MS, Jilma B, Schror K, Christ G, Hubers K. Effect of proton pump inhibitors om clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb and Haemost 2010;8:624-264. Z ^]< ' 5>/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)sZs" 1   # 7I/89:P  $(  r  S HP   r  S l H@`  H  0޽h ? f3f3r."  @o(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` ?&    $       '!"#o$b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8 ʚ;iM)ʚ;g47d7dv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LETL___PPT9.&?  O =e8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K?04Supresori lu enja kiseline ?Porast Ph dovodi do boljeg cijeljenja sluznice H2 blokatori IPP&2 6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzniceCC( C8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S  .Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  " KLOPIDOGREL jKlopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 (reducira efekt lijeka na Trb) Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultatiZ  2M3nZR        2p :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 \(*R$$$$3Ef  ) ,   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7             ;   - 0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 9 ? ")STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskularna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z$Z&ZZ*! $  f&@u ; +CAPRIEf nUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&ZZ   f~tN   z &, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!1CREDO (Reduction of events during obsrevation) 62'& &Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047), ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6@1VRizik krvarenja prema naj eaim imbenicima,,( ,NRizik GI krvarenja smanjuje se do 50% uz IPP (RR=0,50, 95% Cl=0,37-0,69) Upotreba IP-a mo~e biti povezana s kardiovaskularnim rizicima, ali ne i s poveanom smtrnoau. (RR =1.04, 95% Cl=0,93-1,16). Matula MS, Jilma B, Schror K, Christ G, Hubers K. Effect of proton pump inhibitors om clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb and Haemost 2010;8:624-264. Z D ' 5>/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)sZs" 1   # 7I/89:P  0$(  r  S HP   r  S } HP`  H  0޽h ? f3f3r @y1  {@o(  2  http://www.cks.nhs.uk/nsaids_prescribing_issues/management/detailed_answers/gastrointestinal_adverse_effects/people_at_increased_riskF/ 0|DTimes New RomanDv 0( 0DArialNew RomanDv 0( 0" DWingdingsRomanDv 0( 00DCalibrisRomanDv 0( 0"@DMonotype SortsDv 0( 0 ` .  @n?" dd@  @@`` ?&    $       '!"#o$b$y3@QO,R$wUD@'e"$~&g1e #b$o:RQ99BT~b$AUFTMΟ 3r\$ 0 f3f33f@8 ʚ;iM)ʚ;g47d7dv 0ppp@ <4!d!d` 0LE<4dddd` 0LE<4BdBd` 0LETL___PPT9.&?  O =e8KLOPIDOGREL I INHIBITORI PROTONSKE PUMPE - NOVE SPOZNAJE998Prof.dr.sc. }arko Babi Zavod za gastroenterologiju Interna klinika KB Dubrava ZagrebVV.K?04Supresori lu enja kiseline ?Porast Ph dovodi do boljeg cijeljenja sluznice H2 blokatori IPP&2 6*Mjesto djelovanja IPP <-CFaza I Endoplazmatski retikulum: oksidacija, hidroliza, redukcija 2Df=f08  Bitna razlika meu inhibitorima protonske pumpe je njihova duljina djelovanja 2O;ff> . Naj eai lijekovi koji izazivaju GI krvarenja i oateenja sluzni      !"#$%&'()*+,ceCC( C8+8EMA (European Medicines Agency), 22.03.2010. Istovremenu primjenu klopidogrela i omeprazola treba izbjegavati nema vrstih temelja za proairenje upozorenja na ostale inhibitore protonske pumpe. Upozorenje o izbjegavanju istovremene primjene odnosi se samo na klopidogrel i omeprazol. x- " d " d+cgc$  K S  .Kome profilakti ki IPP? Uz antitrombotsko lije enje: Viaa doza aspirina Starija ~ivotna dob. Gastroduodenalni ulkus, GI krvarenje ili GD perforacija u anamnezi Istovremena primjena lijekova za koje je poznato da poveavaju rizik GI krvarenja Ozbiljni komorbiditet, poput kardiovaskularne bolesti, oateenja jetre ili bubrega (uklju ujui dehidraciju), dijabetes, hipertenzija Infekcija s Helicobacter pyloriHZgZS 2Q  ,?  .Kome profilakti ki IPP? (Preporu uje se svima: na mehani koj ventilaciji s koagulopatijom s traumatskom ozljedom mozga s opse~nim opeklinama politraumom sepsom akutnim zatajenjem bubrega Injury Severity Score (ISS) >15 potrebom za visokim dozama steroida (>250 mg hidrokorizona ili ekvivalenta na dan)@Z -Z24   &  " KLOPIDOGREL jKlopidogrel je tienopiridin P2Y12 inhibitor funkcije trombocita Metaboli ka aktivacija klopidogrela putem CYP 450 Kompeticija za izoenzim mijenja aktivnost klopidigrela, osobito putem CYP2C19 (reducira efekt lijeka na Trb) Klini ki zna aj je bilo teako dokazati Pogotovo u kombinaciji s IPP-om, davanim preventivno zbog GI krvarenja Gilard M, et al. : vea reaktivnost trombocita uz IPP Druga klini ka istra~ivanja varijabilni rezultatiZ  2M3nZR        2p :$Kombinacije omeprazola i klopidogrela - porast kardiovaskularnih komplikacija Food and Drug Administration- (FDA) European Medicines Agency - (EMA) Preporuka izbjegavanja kombinacije klopidogrela i inhibitora CYP2C19 \(*R$$$$3Ef  ) ,   %STUDIJE Reduction of events during obsrevation (CREDO) Clopidogrel versus aspirin in patients at risk of ishemic events (CAPRIE) study:' Af'   &STUDIJE CREDO prospektivna, randomizirana, dvostruko slijepa, placebo kontrolirana studija s 2116 ispitanika s vjerojatnoau za perkutanom koronarnim intevencijom (PCI) od 1999.g. Do 2001.g. 3-24h prije PCI randomirzirani na skupine: klopidogrel i placebo Dobivali su 28 dana (individualna doza) Nastavili su 11mj. 75mg/d Mjereno: 1) nakon 28 dana: IM, uzroci smrti, hitna revaskularizacija 2) nakon 12mj. : uzroci smrti, IM, mo~dani udarXZZZZ=Zff "  7             ;   - 0(STUDIJE CAPRIE Randomizirana, prospektivna, kontrolirana 19185 ispitanika Bolesnici koji su visoko rizi ni za IM, ishemi ki CVI, periferna vaskularna bolest Izmeu 1992 do 1995.g. Monoterapija - aspirina 325mg/d ili - klopidogrel 75mg/d Nakon 12mj: IM, inhemi ni CVI,  vaskularna smrtgZ/ZGZ3Z<Zf;#/' f3 f  2  I 9 ? ")STUDIJE META ANALIZA Navedene studije (CREDO, CAPRIE) s ostalim slijepim, randomiziranim kontroliranim studijama koje su usporeivane klopidogrel s lije enjem za koje se vjerovalo kako na njega ne utje e utje e davanje IPP-a Therapeutic Outcomes by Optimizing Platlet inhibition with Plasugrel (TRITON) Platlet inhibition and platlet outcomes (PLATO) Odrediti ukupnu to ku i interval prilagoenog omjera rizika za one koji uzimajiu i ne uzimaju IPP Randomizirane za klopidigrel i nerandomizirane za klopidogrel, te randomizirane za prasugrel i ticagrelor Kardiovaskularna smrt, IM, mo~dani udarjZpZrZ ff=pE (bj(fDC- OD (P     )*CAPRIEf Na po etku 1,1% bolesnika uzimalo je IPP (od ukupno 19185 ispitanika) Uz IPP IM, CVI, vaskularna smrt 11,7% uz klopidogrel 4,7 uz aspirin Bez IPP-a IM, CVI, vaskularna smrt 9,8% uz klopidogrel 10,8% uz aspirin P=0.047*Z! Z!Z$Z$Z&ZZ*! $  f&@u ; +CAPRIEf nUz klopidogrel randomizirano IM, CVI, vaskularna smrt 14.0% uz IPP 4,7 bez IPP-a P<0.001 Uz aspirin randomizirano IM, CVI, vaskulafrna smrt 9,4% uz IPP 10,7% bez IPP-a P=0.439 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, a ne pri uzimanu aspirina (P<0.001)7Z(Z4Z&ZZ   f~tN   z &, CAPRIEf Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 46% vei nego uz aspirin Neredovito uzimanje IPP-a Rizik je bio 11% manji uz klopdigrel nego uz apsirin Zna ajnost rizika odnosila se je samo na ukupno uzimanje IPP-a i na Omeprazol, ali ne i na Lanzoprazol55g55Mf! T E  -!1CREDO (Reduction of events during obsrevation) 62'& &Na po etku studije 17.7% bolesnika je uzimalo IPP (od ukupno n=2116) Lanzoprazol n=218 Omeprazol n=155 Pantoprazol n=15 Rabeprazol n=9tE  ."CREDO Nakon 28 dana-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a uz klopidogrel 11,1% uz placebo 10,3% Bez IPP-a uz klopidogrel 5,8% uz placebo 7,8% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047), ali ne i aspirin (P=0,258) P=0.315)Z0 ZZ0Z Z2ZZ)00 f2F v ./#CREDO Redovito uzimanje IPP-a uz klopidogrel 33% manji rizik krajnjeg dogaaja nego uz placebo Neredovito uzimanje IPP-a uz klopidogrel 13% vei rizik krajnjeg dogaaja nego uz placebo P=0.141 CDCfCt*) 0$CREDO &Nakon 12 mj.-Primarni zavraetak studije (svi uzroci smrti, IM, hitna revaskularizacija) Uzimanje IPP-a od po etka uz klopidogrel 12,8% uz placebo 15,9% Bez IPP-a u po etku uz klopidogrel 7,6% uz placebo 10,5% Uzimanje IPP-a zna ajno je povezano s dogaajima koji se doveli do zavraetka studije u bolesnika koji su uzimali klopidogrel (P=0.047, ali ne i aspirin (P=0,258) P=0.315 (Z0 ZZ0ZZ3ZZ(00f3E w /1%CREDO pUz klopidogrel randomizirano IM, CVI, vaskularna smrt 12,0% uz IPP 7,0% bez IPP-a P<0.024 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 14,8% uz IPP 10,0% bez IPP-a P=0.014 Upotreba IPP-a je zna ajno bila povezana s navedenim dogaajima pri uzimanju klopidogrela, ali i placeba (P=0.027 i P=0,025)7Z&Z4Z)ZZ  f!D  } 2&CREDO Redovito uzimanje IPP-a Rizik uz klopidogrel je bio 18% manji rizik nego uz placebo Neredovito uzimanje IPP-a Rizik je bio 31% manji uz klopdigrel nego uz placebo P=0,551, ali nakon stat. prilagodbi P=0,035`<5,<5,t!  5  -3' META ANALIZA  53510 ispitanika 4 randomirane kontrolirane studije studije s klopidigrelom 26723 randomiziranih ispitanika sa svakodnevnim uzimanjem 26787 uz drugu antiagregacijsku terapiju bez vjerojatnog meusobnog utjecaja tog lijeka i IPP-a 23,5% ispitanika dobivalo je IPPt  4a4( META ANALIZA Uz klopidogrel randomizirano IM, CVI, vaskularna smrt 1,41% uz IPP 2,0 % bez IPP-a P<0.053 Uz placebo randomizirano IM, CVI, vaskulafrna smrt 1,16% uz IPP 1,38% bez IPP-a P=0.397)4(!f!ZG  /5) META ANALIZA p1) CREDO i PLATO pozitivna povezanost izmeu upotrebe IPP-a i pojave primarnih dogaaja bez obzira na antiagregacijsko sredstvo 2) TRITON nema povezanosti uzimanja IPP-a i primarnih dogaaja 3) CAPRIE pozitivna povezanost izmeu uzimanja IPP-a i klopodogrela s primarnim digaajima, ali ne i kod uzimanja apirina99tf   =.VRizik krvarenja prema naj eaim imbenicima ,:Kontrolirana studija  Tennessee imbenik Odds ratio >65god 4,7 NSAID <1mj. 7,2 NSAID viae doze 8,0 Kortikosteroidi 4,4 Antikoagulanna sredstva 12,7$!gt   6@1VRizik krvarenja prema naj eaim imbenicima,,( ,NRizik GI krvarenja smanjuje se do 50% uz IPP (RR=0,50, 95% Cl=0,37-0,69) Upotreba IP-a mo~e biti povezana s kardiovaskularnim rizicima, ali ne i s poveanom smtrnoau. (RR =1.04, 95% Cl=0,93-1,16). Matula MS, Jilma B, Schror K, Christ G, Hubers K. Effect of proton pump inhibitors om clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb and Haemost 2010;8:624-264. Z D ' 5>/VRizik krvarenja prema naj eaim imbenicima,,( ,Terapija s IPP je superiornija od eradikacijske terapije za HP u sprije avanju ponovljenog GI krvarenja (14% apsolutna razlika vjerojatnsti rekrvarenja; P<0,005) Terapija IPP (lansoprazole 30mg/dan) zna ajno smanjuje rizik rekrvarenja u visokorizi nih bolesnika (1,6% za IPP prema 14,8% za placebo; P<0,008) Upotreba IPP-a bitno smanjuje rizik krvarenja (meta-analiza)sZs" 1   # 7I/89:Pr{/ {@